<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8" />
  <title>EPPI-Mapper</title>
  <style>
    *, *:before, *:after {
  box-sizing: border-box;
}
*:focus-visible {
  outline: 4px solid #000000;
}
html {
  box-sizing: border-box;
  font-family: 'Roboto', sans-serif;
  font-size: 14px;
  text-rendering: optimizeLegibility;
  -moz-osx-font-smoothing: grayscale;
  line-height: 1.5;
}
body {
  background-color: #ffffff;
  margin: 0;
  overflow: hidden;
}
a {
  color: #0275d8;
}
.clearfix:after {
  visibility: hidden;
  display: block;
  font-size: 0;
  content: " ";
  clear: both;
  height: 0;
}
* html .clearfix {
  zoom: 1;
}
*:first-child + html .clearfix {
  zoom: 1;
}
.loader {
  position: absolute;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  background: #000000;
  z-index: 1000;
  transition: all 2s ease;
}
.loader span.spinner {
  animation: spin 1.2s linear infinite;
  border: 5px solid #ffffff;
  border-bottom-color: #000000;
  border-top-color: #000000;
  border-radius: 100%;
  display: inline-block;
  width: 40px;
  height: 40px;
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
}
.header {
  padding: 0 18px;
}
.header-basic {
  background: #ffffff;
  padding: 0 18px;
  display: flex;
  font-size: 1.5rem; 
  font-weight: bold;
  height: 108px;
  padding: 8px 8px 0;
  text-align: center;
}
.header-basic .header-title {
  flex-grow: 1;
}
.header-basic .header-title span {
  position: relative;
  top: 30%;
}
.header-basic img {
  height: 100px;
}
.header-basic img:nth-child(1) {
  float: left;
}
.header-basic img:nth-child(2) {
  float: right;
}
.wrapper {
  margin: 8px;
}
.pivot-table {
  font-size: 11px;
  font-weight: normal;
  width: 100%;
}
.pivot-table .top-head, .pivot-table .side-head, .pivot-table .body,
.pivot-table .text-wrapp {
  display: inline-block;
  overflow: hidden;
}
.pivot-table .side-head, .pivot-table .body {
  float: left;
}
.pivot-table table {
  border: 0;
  border-collapse: collapse;
}
.pivot-table table thead th {
  border: 1px solid #ffffff;
  color: #ffffff;
  font-weight: normal;
  max-width: 103px;
  min-width: 103px;
  width: 103px;
  padding: 4px;
  overflow: hidden;
  text-overflow: ellipsis;
  vertical-align: top;
  text-align: left;
}
.pivot-table.text-view table thead th:not(.collapsed) {
  max-width: 153px;
  min-width: 153px;
  width: 153px;
}
.pivot-table.text-view-large table thead th:not(.collapsed) {
  max-width: 203px;
  min-width: 203px;
  width: 203px;
}
.pivot-table table tbody th, .pivot-table table tbody td {
  border: 1px solid #fff;
}
.pivot-table table tbody th {
  color: #ffffff;
  font-weight: normal;
  min-height: 103px;
  height: 103px;
  max-width: 103px;
  min-width: 0;
  width: 0;
  padding: 4px;
  overflow: hidden;
  text-overflow: ellipsis;
  vertical-align: top;
  text-align: left;
}
.pivot-table.text-view table tbody th:not(.collapsed) {
  min-height: 153px;
  height: 153px;
  max-width: 153px;
}
.pivot-table.text-view-large table tbody th:not(.collapsed) {
  min-height: 203px;
  height: 203px;
  max-width: 203px;
}
.pivot-table table tbody td {
  min-width: 103px;
  width: 103px;
  min-height: 103px;
  height: 103px;
}
.pivot-table.text-view table tbody td {
  min-width: 153px;
  width: 153px;
  min-height: 153px;
  height: 153px;
}
.pivot-table.text-view-large table tbody td {
  min-width: 203px;
  width: 203px;
  min-height: 203px;
  height: 203px;
}
.body table tbody td.cell div.data-wrapper {
  position: relative;
  background-color: #eeeeee;
  cursor: pointer;
  justify-items: center;
  align-items: center;
  width: 100%;
  height: 100%;
  overflow: hidden;
  -webkit-transition: all 0.5s;
  -moz-transition: all 0.5s;
  -moz-transition: all 0.5s;
  -ms-transition: all 0.5s;
  -o-transition: all 0.5s;
  transition: all 0.5s;
  flex-wrap: wrap;
  align-items: center;
  justify-content: space-around;
}
.body table tbody td.cell div.data-wrapper div.break {
  flex-basis: 100%;
  height: 0;
}
.body table tbody td.cell div.pie-wrapper {
  position: relative;
  background-color: #eeeeee;
  cursor: pointer;
  display: none;
  width: 100%;
  height: 100%;
  overflow: hidden;
}
.body table tbody td.cell div.mosaic-wrapper {
  position: relative;
  background-color: #eeeeee;
  cursor: pointer;
  display: none;
  width: 100px;
  height: 100px;
  max-width: 100px;
  max-height: 100px;
  overflow: hidden;
}
.body table tbody td.cell div.pie-wrapper div.pie,
.body table tbody td.cell div.pie-wrapper div.pie-hole{
  position: absolute;
  top: 50%;
  left: 50%;
  background-size: cover;
  border-radius: 100%;
  transform: translate(-50%, -50%);
}
.body table tbody td.cell div.pie-wrapper div.pie-hole{
  background-color: #dddddd;
}
.body table tbody td.cell.none div.data-wrapper,
.body table tbody td.cell.none div.pie-wrapper,
.body table tbody td.cell.none div.mosaic-wrapper {
  cursor: not-allowed !important;
}
.pivot-table.text-view .body table tbody td.cell div.data-wrapper div.data {
  display: flex;
  gap: 4px;
  align-items: center;
  padding: 2px;
}
.pivot-table.text-view .body table tbody td.cell div.data-wrapper div.data span.count {
  background: #ffffff;
  border: 1px solid #000000;
  border-radius: 2px;
  color: #000000;
  padding: 2px;
}
.controls {
  display: inline-block;
  position: absolute;
}
.ui-segment {
  background-color: #ffffff;
  color: #0275d8;
  border: 1px solid #0275d8;
  border-radius: 4px;
  display: inline-block;
}
.ui-segment span.option.active {
  background-color: #0275d8;
  color: #ffffff;
}
.ui-segment span.option {
  font-size: 13px;
  padding-left: 23px;
  padding-right: 23px;
  height: 25px;
  text-align: center;
  display: inline-block;
  line-height: 25px;
  margin: 0;
  float: left;
  cursor: pointer;
  border-right: 1px solid #0275d8;
  transition: all 0.5s ease;
}
.ui-segment span.option:last-child {
  border-right: none;
}
.segment-select{
  display: none;
}
.footer {
  position: absolute;
  bottom: 0;
  background-color: #ffffff;
  color: rgba(0, 0, 0, 0.87);
  height: 36px;
  min-height: 36px;
  padding: 16px;
  width: 100%;
  -webkit-box-align: center;
  -ms-flex-align: center;
  align-items: center;
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-box-flex: 0 !important;
  -ms-flex: 0 1 auto !important;
  flex: 0 1 auto !important;
}
.footer .inner svg {
  display: inline-block;
  vertical-align: middle;
}
.footer .legend .dot {
  border-radius: 100%;
  display: inline-block;
  height: 10px;
  width: 10px;
  margin: 2px 3px 0 6px;
}
.footer .legend .label {
  font-size: 1.0em;
}
.legend-tooltip {
  border: 1px solid #cccccc;
  display: block;
  position: absolute;
  width: 300px;
  background: #ffffff;
  color: #000000;
  padding: 6px 8px;
  border-radius: 4px;
  -webkit-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  -moz-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  z-index: 2;
}
.spacer {
  -webkit-box-flex: 1 !important;
  -ms-flex-positive: 1 !important;
  flex-grow: 1 !important;
}
.hide {
  display: none;
}
.tooltip {
  display: none;
  position: absolute;
  border: 1px solid #cccccc;
  background-color: #ffffff;
  border-radius: 3px;
  padding: 3px 6px 2px;
  -webkit-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  -moz-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  z-index: 2;
}
.tooltip .count {
  color: #0275d8;
  margin: 2px 3px;
}
.tooltip .count span {
  background-color: #0275d8;
  -webkit-border-radius: 3px;
  -moz-border-radius: 3px;
  border-radius: 3px;
  color: #ffffff;
  padding: 2px 4px;
}
.refs {
  font-size:  12px;
  color:  lightgrey;
  margin:  0;
  padding: 0 0 0 20px;
}
.veil {
  background: rgba(0, 0, 0, 0.7);
  display: none;
  position: absolute;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 99;
}
.veil.open {
  display: block;
}
.settings {
  position: absolute;
  top: 0;
  left: -600px;
  bottom: 0;
  background: #fff;
  color: #000000;
  padding: 0;
  width: 360px;
  z-index: 100;
}
.settings.open {
  left: 0;
}
.settings > div.title {
  color: #000000;
  font-size: 22px;
  padding: 20px;
  margin: 0 0 10px 0;
}
.settings > div.title > button.btnSettings {
  -webkit-border-radius: 36px;
  -moz-border-radius: 36px;
  border-radius: 36px;
  border: 1px solid #000000;
  background-color: inherit;
  color: #ffffff;
  background-color: #000000;
  display: inline-block;
  float: right;
  height: 36px;
  transition: all 0.25s ease;
  text-align: center;
  line-height: 36px;
  padding: 0 12px;
  letter-spacing: 1px;
}
.settings > div.title > button.btnSettings:hover {
  background-color: #ffffff;
  color: #000000;
  cursor: pointer;
}
.settings > div.title > button.btnSettings.busy{
  border: 3px solid #000000 !important;
  border-top-color: #ffffff !important;
  border-bottom-color: #ffffff !important;
  text-indent: -99999px;
  width: 36px;
  border-radius: 36px;
  animation: spin 1.2s linear infinite;
}
.settings > div.title > button.disabled {
  cursor: not-allowed;
  pointer-events: none;
  background: unset;
  color: #000000;
  opacity: 0.3;
  text-decoration: none;
}
.settings > div.title > button.right {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
  margin-left: 2px;
}
.settings > div.title > button.left {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.settings div.filter-type-wrapper {
  background-color: #efefef;
  position: absolute;
  top: 76px;
  overflow: auto;
  padding: 0 10px 0 0;
  width: 100%;
  border-top: 1px solid #000000;
}
.settings div.filter-wrapper {
  background-color: #efefef;
  position: absolute;
  top: 226px;
  bottom: 0;
  overflow: auto;
  padding: 0 10px 0 0;
  width: 100%;
}
.settings div.filter-type-wrapper h2,
.settings div.filter-wrapper h2 {
  margin-left: 20px;
  margin-bottom: 10px;
}
.settings div.filter-type-wrapper ul,
.settings div.filter-wrapper ul {
  list-style: none;
  margin: 0 0 0 16px;
  padding: 0;
}
.settings div.filter-type-wrapper ul li,
.settings div.filter-wrapper ul li {
  margin: 0;
  padding: 3px 5px;
}
.settings div.filter-type-wrapper ul li:hover,
.settings div.filter-wrapper ul li:hover {
  cursor: pointer;
}
.settings div.filter-type-wrapper ul li span,
.settings div.filter-type-wrapper ul li svg,
.settings div.filter-wrapper ul li span,
.settings div.filter-wrapper ul li svg {
  display: inline-block;
  vertical-align: middle;
}
.settings div.filter-type-wrapper ul li svg,
.settings div.filter-wrapper ul li svg {
  display: none;
}
.settings div.filter-type-wrapper ul li.checked svg#checked,
.settings div.filter-wrapper ul li.checked svg#checked {
  display: inline-block;
}
.settings div.filter-type-wrapper ul li.unchecked svg#unchecked,
.settings div.filter-wrapper ul li.unchecked svg#unchecked {
  display: inline-block;
}
.settings div.filter-type-wrapper ul li.indeterminate svg#indeterminate,
.settings div.filter-wrapper ul li.indeterminate svg#indeterminate {
  display: inline-block;
}
.reader,
.accessibility {
  position: absolute;
  top: 0;
  right: -1000px;
  bottom: 0;
  background: #fff;
  color: #000;
  padding: 0;
  width: 1000px;
  z-index: 100;
}
.reader.open,
.accessibility.open {
  right: 0;
}
.reader > div.title,
.accessibility > div.title {
  background-color: #ffffff;
  color: #000000;
  display: flex;
  justify-content: space-between;
  font-size: 22px;
  padding: 20px;
}
.reader > div.title > div,
.accessibility > div.title > div {
  display: flex;
}
.reader > div.title > div:nth-child(1),
.accessibility > div.title > div:nth-child(1) {
  flex-grow: 1;
}
.reader > div.title > div:nth-child(1) > button,
.accessibility > div.title > div:nth-child(1) > button {
  margin-right: 18px;
}
.reader > div.title > div > input {
  border: 1px solid #000000;
  background: #ffffff;
  padding: 8px 16px;
  color: #000000;
  float: right;
  font-size: 16px;
  transition: all 0.5s ease;
  margin-right: 6px;
}
.reader > div.title > div > input:focus {
  background: #ffffff;
  color: #000000;
  box-shadow: 0 0 10px #719ECE;
}
.reader > div.title > div > input::-webkit-input-placeholder,
.reader > div.title > div > input::-moz-placeholder,
.reader > div.title > div > input:-ms-input-placeholder,
.reader > div.title > div > input:-moz-placeholder { 
  color: #595959;
}
.reader > div.title > div > select {
  border: 1px solid #000000;
  background: #ffffff;
  padding: 7.5px 16px;
  color: #595959;
  font-size: 16px;
  transition: all 0.5s ease;
  cursor: pointer;
  margin-right: 6px;
}
#filter-options option {
  color: #000000;
}
#filter-options option[value=""][disabled] {
  display: none;
}
.reader > div.content,
.accessibility > div.content {
  background: #ffffff;
  display: flex;
  align-content: stretch;
  align-items: stretch;
  height: 92.4%;
}
.reader > div.content > div.reader-filter {
  background-color: #efefef;
  border-right: 1px solid #ffffff;
  overflow: auto;
  width: 200px;
  min-width: 200px;
  max-width: 200px;
}
.reader > div.content > div.filter-opts {
  background-color: #efefef;
  border-right: 1px solid #ffffff;
  overflow: auto;
  width: 200px;
  min-width: 200px;
  max-width: 200px;
  float: right;
}
.settings > div.filter-wrapper > div.controlTainer {
  align-content: center;
  padding: 10px;
}
.reader > div.content > div.reader-filter ul {
  list-style: none;
  margin: 0;
  padding: 0;
  width: 100%;
  overflow: hidden;
}
.reader > div.content > div.reader-filter > ul > ul {
  padding: 0 0 0 12px;
 }
.reader > div.content > div.reader-filter ul li:hover {
  cursor: pointer;
}
.reader > div.content > div.reader-filter ul li {
  padding: 3px 6px 2px;
  display: inline-flex;
  align-items: end;
  width: 100%;
}
.reader > div.content > div.reader-filter ul li span,
.reader > div.content > div.reader-filter ul li svg {
  display: inline-block;
  vertical-align: middle;
}
.reader > div.content > div.reader-filter ul li svg {
  display: none;
  width: 24px;
  min-width: 24px;
}
.reader > div.content > div.reader-filter ul li span {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}
.reader > div.content > div.reader-filter ul li.checked svg#checked {
  display: inline-block;
}
.reader > div.content > div.reader-filter ul li.unchecked svg#unchecked{
  display: inline-block;
}
.reader > div.content > div.reader-filter ul li.indeterminate svg#indeterminate {
  display: inline-block;
}
.reader > div.content > div.nav {
  background-color: #efefef;
  border-right: 1px solid #ffffff;
  overflow: auto;
  width: 280px;
  min-width: 280px;
  max-width: 280px;
}
.reader > div.content > div.navTainer {
  background-color: #efefef;
  border-right: 1px solid #ffffff;
  overflow: auto;
  width: 280px;
  min-width: 280px;
  max-width: 280px;
}
.reader > div.content > div.navTainer .navGroupSelect {
  color: #000000;
  border-top: 1px solid #000000;
  padding: 6px 10px 4px;
}
.reader > div.content > div.navTainer .ref-sort-order {
  color: #000000;
  border-top: 1px solid #000000;
  border-bottom: 1px solid #000000;
  padding: 6px 10px 4px;
}
.reader > div.content > div.navTainer > div.nav > ul,
.reader > div.content > div.navTainer > div.nav > ul.segmented,
.reader > div.content > div.navTainer > div.nav > ul.segmented > li > ul {
  list-style: none;
  margin: 0;
  padding: 0;
}
.refMenuItem {
  padding: 0;
  margin: 0;
}
.refMenuItem > button {
  color: #000000;
  background-color: transparent;
  border: 1px solid transparent;
  border-bottom-color: #ffffff;
  display: block;
  font-size: 1rem;
  padding: 6px 16px 8px;
  text-align: left;
  max-width: 280px;
}
.refMenuItem > button:hover,
.refMenuItem > button:focus-visible {
  background-color: #ffffff;
  cursor: pointer;
}
.refMenuItem > button > div.title,
.refMenuItem > button > div.auth {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}
.refMenuItem > button > div.title {
  font-weight: bold;
}
.refMenuItem > button > div.auth,
.refMenuItem > button > div.date {
  color: #666666;
}
.refMenuItem > button > div.auth {
  font-style: italic;
}
.refMenuItem.selected > button {
  background-color: #000000;
  color: #ffffff;   
}
.refMenuItem.selected > button > div.auth,
.refMenuItem.selected > button > div.date {
  color: #cfcfcf;   
}
.reader > div.content > div.read,
.accessibility > div.content > div.read {
  flex-grow: 1;
  overflow: auto;
  padding: 10px 18px;
  border-top: 1px solid #000000;
}
.reader > div.content > div.read > h2,
.accessibility > div.content > div.read > h2 {
  margin-top: 0;
}
.reader > div.content > div.read > hr,
.accessibility > div.content > div.read > hr {
  background-color: #efefef;
  border: 0;
  height: 1px;
}
.reader > div.content > div.read > p,
.accessibility > div.content > div.read > p,
.accessibility > div.content > div.read > ul {
  font-size: 1.3rem;
}
.reader > div.content > div.read > div.meta-data {
  margin-top: 16px;
}
.reader > div.content > div.read > div.meta-data > div.meta-data-item > label {
  color: #aaaaaa;
  display: block;
  float: left;
  width: 140px;
  margin: 0 0 3px 0;
  padding: 3px 6px;
}
.reader > div.content > div.read > div.meta-data > div.meta-data-item > span {
  border: 1px solid #eeeeee;
  display: block;
  float: left;
  margin: 0 0 3px -140px;
  padding: 2px 4px 2px 144px;
  width: 100%;
}
.ref-sort-order {
  padding: 4px 8px;
}
.menu {
  background-color: #000000;
  border-bottom: 1px solid #000000;
  display: block;
  list-style: none;
  margin: 0;
  padding: 0;
}
.menu:after {
  content: "";
  display: table;
  clear: both;
}
.menu .menu-item {
  background-color: #000000;
  border: 0;
  color: #ffffff;
  display: flex;
  align-items: center;
  padding: 8px 12px;
  transition: all 0.2s ease-out;
  cursor: pointer;
  float: left;
  border: 0;
}
.menu .menu-item:active {
  background-color: #ffffff;
  color: #000000;
}
.menu .menu-item:active svg {
  fill: #000000;
}
.menu .menu-item:hover, .menu .menu-item:focus {
  background-color: #ffffff;
  color: #000000;
}
.menu .menu-item:hover svg, .menu .menu-item:focus svg {
  fill: #000000;
}
.menu .menu-item span {
  font-size: 14px;
  margin-left: 4px;
  overflow: hidden;
  word-break: keep-all;
}
.menu .menu-item svg {
  fill: #ffffff;
  display: inline-block;
  margin: 0 0 0 4px;
}
.menu .menu-item span.active-text,
.menu .menu-item svg.active-svg {
  display: none;
}
.menu .menu-item.active span.inactive-text,
.menu .menu-item.active svg.inactive-svg {
  display: none;
}
.menu .menu-item.active span.active-text,
.menu .menu-item.active svg.active-svg {
  display: block;
}
.menu .menu-item[aria-checked="true"] {
  background-color: #ffffff;
  color: #000000;
}
.menu .menu-item[aria-checked="true"] svg {
  fill: #000000;
}
.refMenuItemLegend {
  -webkit-border-radius: 100%;
  -moz-border-radius: 100%;
  border: 1px solid #ffffff;
  border-radius: 100%;
  display: inline-block;
  width: 10px;
  height: 10px;
  margin: 6px 3px 0;
  float: right;
}
.clickable-row,
.clickable-col {
  cursor: pointer;
}
.top-head th div,
.side-head th div {
  position: relative;
  width: 100%;
  height: 100%;
}
.top-head th div svg,
.side-head th div svg {
  display: none;
  background: rgba(255, 255, 255, 0.8);
}
.top-head th div svg,
.side-head th div svg {
  position: absolute;
  top: -4px;
  right: -4px;
}
.top-head th:not(.collapsed) div svg#arrowLeft,
.side-head th:not(.collapsed) div svg#arrowUp {
  cursor: pointer;
  display: inline-block;
}
.top-head th.collapsed div svg#arrowRight,
.side-head th.collapsed div svg#arrowDown {
  cursor: pointer;
  display: inline-block;
}
.top-head th.busy div svg#refresh,
.side-head th.busy div svg#refresh {
  border-radius: 100%;
  cursor: pointer;
  display: inline-block;
  animation: spin 1s linear infinite;
}
.btnColCollapse,
.btnRowCollapse {
  opacity: 40%;
}
.top-head th.collapsed {
  min-width: 0;
  max-width: 0;
  width: 0;
  padding: 4px 0;
}
.pivot-table .top-head th.collapsed.level-1 {
  min-width: 103px;
  width: 103px;
  padding: 4px;
}
.pivot-table.text-view .top-head th.collapsed.level-1 {
  min-width: 153px;
  width: 153px;
}
.pivot-table.text-view-large .top-head th.collapsed.level-1 {
  min-width: 203px;
  width: 203px;
}
.side-head th.collapsed {
  min-height: 0;
  max-height: 0;
  height: 0;
  padding: 0 4px;
}
.pivot-table .side-head th.collapsed.level-1 {
  min-height: 103px;
  height: 103px;
  padding: 4px;
}
.pivot-table.text-view .side-head th.collapsed.level-1 {
  min-height: 153px;
  height: 153px;
}
.pivot-table.text-view-large .side-head th.collapsed.level-1 {
  min-height: 203px;
  height: 203px;
}
.body td.collapsed-col {
  min-width: 18px;
  width: 18px;
}
.body td.collapsed-row {
  min-height: 18px;
  height: 18px !important;
}
.body td.collapsed-col,
.body td.collapsed-row {
  background: rgba(0, 0, 0, 0.2);
}
.body td.collapsed-col .mosaic-wrapper,
.body td.collapsed-row .mosaic-wrapper {
  width: auto !important;
  height: auto !important;
}
.body td.collapsed-col svg,
.body td.collapsed-row svg {
  display: none;
}
.body td.collapsed-col .pie-wrapper,
.body td.collapsed-col .mosaic-wrapper,
.body td.collapsed-col .data-wrapper,
.body td.collapsed-row .pie-wrapper,
.body td.collapsed-row .mosaic-wrapper,
.body td.collapsed-row .data-wrapper {
  opacity: 0 !important;
}
.top-head th.collapsed:not(.level-1) span,
.side-head th.collapsed:not(.level-1) span {
  display: none;
}
.top-head th.collapsed:not(.level-1),
.side-head th.collapsed:not(.level-1) {
  border-width: 0;
}
.top-head th.collapsed.first:not(.level-1) {
  border-left: 1px solid #ffffff !important;
}
.top-head th.collapsed.last:not(.level-1) {
  border-right: 1px solid #ffffff !important;
}
.side-head th.collapsed.first:not(.level-1) {
  border-top: 1px solid #ffffff !important;
}
.side-head th.collapsed.last:not(.level-1) {
  border-bottom: 1px solid #ffffff !important;
}
@keyframes spin {
  0% {
    transform: rotate(0deg);
  }
  100% {
    transform: rotate(360deg);
  }
}
.attribute-tooltip {
  position: absolute;
  border: 1px solid #cccccc;
  background-color: #ffffff;
  border-radius: 3px;
  display: none;
  padding: 3px 6px 2px;
  text-overflow: ellipsis;
  max-width: 350px !important;
  min-width: 200px !important;
  -webkit-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  -moz-box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  box-shadow: 0 2px 10px 2px rgba(0, 0, 0, 0.3);
  z-index: 2;
}
.attribute-tooltip.show {
  display: block;
}
.attribute-tooltip .close-tooltip {
  cursor: pointer;
  float: right;
}
.attribute-tooltip .content {
  margin: 0 0 12px 0;
}
.attribute-tooltip h4 {
  margin: 0 0 8px 0;
}
.text-center {
  text-align: center;
}
.text-muted {
  color: #6c757d !important;
  font-size: 11px;
  margin: 10px 0 0 0;
}
#filterClearButton,
#codeFilterClearButton {
  float: right;
}
#codeFilterClearButton {
  width: 100%;
}
.btn {
  background-color: #000000;
  border: 1px solid #000000;
  color: #ffffff;
  display: block;
  font-weight: 400;
  padding: 8px 16px;
  font-size: 16px;
  line-height: normal;
  transition: color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;
}
.btn:hover {
  color: #000000;
  background-color: inherit;
  border-color: #000000;
  cursor: pointer;
}
#status {
  display: none;
}
@keyframes spin {
  from {transform:rotate(0deg);}
  to {transform:rotate(360deg);}
}
.screenreader {
  position: absolute;
  left: -9999px;
}
.meta-data hr {
  border-top: 1px solid #000000;
}
#filterClearButton {
  padding: 6px 12px;
  border: 1px solid #000000;
  transition: all 0.25s ease;
  color: #ffffff;
  background-color: #000000;
}
#filterClearButton:hover {
  color: #000000;
  background-color: inherit;
}
#sgroup,
#RefSortOrder {
  border: 1px solid black;
  color: #595959;
}
#sgroup::placeholder,
#RefSortOrder::placeholder {
  color: #595959;
}
.style-picker {
  float: right !important;
}
  </style>
  <script type="text/javascript">
    var isIE = false || !!document.documentMode;

    if (isIE === true) {
      alert("Unfortunately this map cannot be used in Internet Explorer. You will need to use Microsoft Edge, Firefox or Google Chrome.");
    }
  </script>
</head>

<body>
  <p id="announce" class="screenreader" role="status" aria-live="polite"></p>
  <div class="attribute-tooltip">
    <span class="close-tooltip">X</span>
    <div class="content"></div>
  </div>
  <div class="loader">
    <span class="spinner"></span>
  </div>
  <div class="veil"></div>
  <div id="reader" class="reader" role="dialog" aria-labelledby="announce" style="display:none;"></div>
  <div id="accessibility" class="accessibility" role="dialog" aria-labelledby="announce" style="display:none;">
    <div class="title clearfix">
      <button class="btn close" aria-label="Close accessibility">X</button> <span>Accessibility</span>
    </div>
    <div class="content">
      <div class="read">
        <p>Web accessibility refers to the practice of designing and developing websites and web-based applications in a
          way that makes them usable and accessible to all individuals, including those with disabilities. This includes
          ensuring that web content can be easily understood, navigated, and interacted with by people with a wide range
          of abilities and disabilities, including those who use assistive technologies such as screen readers.</p>

        <p>This Eppi Mapper generated map conforms to the World Wide Web Consortium's Web Content Accessibility
          Guidelines (<a href="https://www.w3.org/WAI/standards-guidelines/wcag/" target="_blank">W3C WCAG</a>) Version
          2.1 Level AA to the maximum extent possible. These guidelines explain how to make web content more accessible
          for people with disabilities. The features in this map include:</p>

        <ul>
          <li>If the default settings have been used when generating this map, the overall colour design has been set to
            a more visually contrasting appearance.</li>
          <li>Links in the application have been converted to buttons to accommodate screen readers.</li>
          <li>Aria status updates now inform screen readers when modals open and selected records change.</li>
          <li>Tab focus is contained within opened modals.</li>
          <li>The style selection functionality has been moved to the top menu for easier access.</li>
          <li>A new style, Textual view, has been added to the map. This view presents the record counts within each
            node in a text readable format.</li>
          <li>URL links for individual records have been made descriptive.</li>
          <li>The map generation tool will inform the user if the selected background and font colour contrast meet
            accessibility requirements.</li>
        </ul>
        <br>
        <p><b>Limitations</b></p>
        <p>At the present time, while the keyboard focus does stay within each opened modal, the focus cannot be moved
          to individual checkboxes or radio buttons or, in the View Records modal, to all fields in the full record.
          This means that those items, along with the nodes in the map, can only be selected using a mouse or pointing
          device. In future updates we hope to address this limitation.</p>
      </div>
    </div>
  </div>
  <div class="menu" id="menu">
    <button class="menu-item menu-settings" role="button">
      <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18" viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none" />
        <path
          d="M19.43 12.98c.04-.32.07-.64.07-.98s-.03-.66-.07-.98l2.11-1.65c.19-.15.24-.42.12-.64l-2-3.46c-.12-.22-.39-.3-.61-.22l-2.49 1c-.52-.4-1.08-.73-1.69-.98l-.38-2.65C14.46 2.18 14.25 2 14 2h-4c-.25 0-.46.18-.49.42l-.38 2.65c-.61.25-1.17.59-1.69.98l-2.49-1c-.23-.09-.49 0-.61.22l-2 3.46c-.13.22-.07.49.12.64l2.11 1.65c-.04.32-.07.65-.07.98s.03.66.07.98l-2.11 1.65c-.19.15-.24.42-.12.64l2 3.46c.12.22.39.3.61.22l2.49-1c.52.4 1.08.73 1.69.98l.38 2.65c.03.24.24.42.49.42h4c.25 0 .46-.18.49-.42l.38-2.65c.61-.25 1.17-.59 1.69-.98l2.49 1c.23.09.49 0 .61-.22l2-3.46c.12-.22.07-.49-.12-.64l-2.11-1.65zM12 15.5c-1.93 0-3.5-1.57-3.5-3.5s1.57-3.5 3.5-3.5 3.5 1.57 3.5 3.5-1.57 3.5-3.5 3.5z" />
      </svg>
      <span>Filters</span>
    </button>
    <button class="menu-item menu-expand" role="button">
      <svg class="inactive-svg" xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18"
        viewBox="0 0 24 24">
        <path
          d="M15 21h2v-2h-2v2zm4 0h2v-2h-2v2zM7 21h2v-2H7v2zm4 0h2v-2h-2v2zm8-4h2v-2h-2v2zm0-4h2v-2h-2v2zM3 3v18h2V5h16V3H3zm16 6h2V7h-2v2z" />
        <path d="M0 0h24v24H0z" fill="none" />
      </svg>
      <svg class="active-svg" xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18"
        viewBox="0 0 24 24">
        <path
          d="M13 7h-2v2h2V7zm0 4h-2v2h2v-2zm4 0h-2v2h2v-2zM3 3v18h18V3H3zm16 16H5V5h14v14zm-6-4h-2v2h2v-2zm-4-4H7v2h2v-2z" />
        <path d="M0 0h24v24H0z" fill="none" />
      </svg>
      <span class="inactive-text">Hide Headers</span>
      <span class="active-text" aria-hidden="true">Show Headers</span>
    </button>
    <button class="menu-item menu-fullscreen" role="button">
      <svg class="inactive-svg" xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18"
        viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none" />
        <path d="M7 14H5v5h5v-2H7v-3zm-2-4h2V7h3V5H5v5zm12 7h-3v2h5v-5h-2v3zM14 5v2h3v3h2V5h-5z" />
      </svg>
      <svg class="active-svg" xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18"
        viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none" />
        <path d="M5 16h3v3h2v-5H5v2zm3-8H5v2h5V5H8v3zm6 11h2v-3h3v-2h-5v5zm2-11V5h-2v5h5V8h-3z" />
      </svg>
      <span class="inactive-text">Fullscreen</span>
      <span class="active-text" aria-hidden="true">Exit Fullscreen</span>
    </button>
    <button class="menu-item menu-about" role="button">
      <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18" viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none" />
        <path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-6h2v6zm0-8h-2V7h2v2z" />
      </svg>
      <span>About</span>
    </button>
    <button class="menu-item menu-studysubmit" role="button">
      <svg xlmns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18" viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none" />
        <path
          d="M8.016 15l3.984-3.984 3.984 3.984-1.406 1.453-1.594-1.594v4.125h-1.969v-4.125l-1.594 1.547zM18 20.016v-11.016h-5.016v-5.016h-6.984v16.031h12zM14.016 2.016l6 6v12q0 0.797-0.609 1.383t-1.406 0.586h-12q-0.797 0-1.406-0.586t-0.609-1.383l0.047-16.031q0-0.797 0.586-1.383t1.383-0.586h8.016z">
        </path>
      </svg>
      <span>Submit a Study</span>
    </button>
    <button class="menu-item menu-reader" role="button">
      <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18" viewBox="0 0 24 24">
        <path fill="none" d="M-74 29h48v48h-48V29zM0 0h24v24H0V0zm0 0h24v24H0V0z" />
        <path
          d="M13 12h7v1.5h-7zm0-2.5h7V11h-7zm0 5h7V16h-7zM21 4H3c-1.1 0-2 .9-2 2v13c0 1.1.9 2 2 2h18c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 15h-9V6h9v13z" />
      </svg>
      <span>View Records<span class="record-count"></span></span>
    </button>
    <button class="menu-item menu-accessibility" role="button">
      <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="18" height="18" viewBox="0 0 18 18">
        <path
          d="M8 4.143A1.071 1.071 0 1 0 8 2a1.071 1.071 0 0 0 0 2.143Zm-4.668 1.47 3.24.316v2.5l-.323 4.585A.383.383 0 0 0 7 13.14l.826-4.017c.045-.18.301-.18.346 0L9 13.139a.383.383 0 0 0 .752-.125L9.43 8.43v-2.5l3.239-.316a.38.38 0 0 0-.047-.756H3.379a.38.38 0 0 0-.047.756Z" />
        <path d="M8 0a8 8 0 1 0 0 16A8 8 0 0 0 8 0ZM1 8a7 7 0 1 1 14 0A7 7 0 0 1 1 8Z" />
      </svg>
      <span>Accessibility</span>
    </button>
    <span class="style-picker" role="group">
      <button class="menu-item bubble-map selected" aria-checked="true" role="switch" aria-label="Bubble map"
        data-tippy-content="Bubble map view" data-style="bubble">
        <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="16" height="16" viewBox="0 0 16 16">
          <circle cx="8" cy="8" r="8" />
        </svg>
      </button>
      <button class="menu-item heat-map" aria-checked="false" role="switch" aria-label="Heat map view"
        data-tippy-content="Heat map view" data-style="heat">
        <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="16" height="16" viewBox="0 0 16 16">
          <path
            d="M8 15V1h6a1 1 0 0 1 1 1v12a1 1 0 0 1-1 1H8zm6 1a2 2 0 0 0 2-2V2a2 2 0 0 0-2-2H2a2 2 0 0 0-2 2v12a2 2 0 0 0 2 2h12z" />
        </svg>
      </button>
      <button class="menu-item mosaic-map" aria-checked="false" role="switch" aria-label="Mosaic map view"
        data-tippy-content="Mosaic map view" data-style="mosaic">
        <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="16" height="16" viewBox="0 0 16 16">
          <path d="M0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2z" />
        </svg>
      </button>
      <button class="menu-item donut-map" aria-checked="false" role="switch" aria-label="Donut map view"
        data-tippy-content="Donut map view" data-style="donut">
        <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="16" height="16" viewBox="0 0 16 16">
          <path d="M16 8A8 8 0 1 1 0 8a8 8 0 0 1 16 0zm-8 3a3 3 0 1 0 0-6 3 3 0 0 0 0 6z" />
        </svg>
      </button>
      <button class="menu-item text-map" aria-checked="false" role="switch" aria-label="Text map view"
        data-tippy-content="Text map view" data-style="text">
        <svg xmlns="http://www.w3.org/2000/svg" fill="#eeeeee" width="16" height="16" viewBox="0 0 16 16">
          <path
            d="M14.5 3a.5.5 0 0 1 .5.5v9a.5.5 0 0 1-.5.5h-13a.5.5 0 0 1-.5-.5v-9a.5.5 0 0 1 .5-.5h13zm-13-1A1.5 1.5 0 0 0 0 3.5v9A1.5 1.5 0 0 0 1.5 14h13a1.5 1.5 0 0 0 1.5-1.5v-9A1.5 1.5 0 0 0 14.5 2h-13z" />
          <path
            d="M3 5.5a.5.5 0 0 1 .5-.5h9a.5.5 0 0 1 0 1h-9a.5.5 0 0 1-.5-.5zM3 8a.5.5 0 0 1 .5-.5h9a.5.5 0 0 1 0 1h-9A.5.5 0 0 1 3 8zm0 2.5a.5.5 0 0 1 .5-.5h6a.5.5 0 0 1 0 1h-6a.5.5 0 0 1-.5-.5z" />
        </svg>
      </button>
    </span>
  </div>
  <div id="settings" class="settings" role="dialog" tabindex="-1" aria-labelledby="announce" style="display:none;">
  </div>
  <div class="header clearfix">
    
  </div>
  <div class="wrapper primary-view">
    <div class="pivot-table clearfix">
      <div class="top-head-wrapper">
        <div class="top-head">
          <table>
            <thead>
            </thead>
          </table>
        </div>
      </div>
      <div class="side-head">
        <table>
          <tbody>
          </tbody>
        </table>
      </div>
      <div class="body">
        <table>
          <tbody>
          </tbody>
        </table>
      </div>
    </div>
  </div>
  <div class="footer">
    <div class="legend"></div>
    <div class="spacer"></div>
    <div class="inner">
      Generated using v.2.3.0 of the EPPI-Mapper
      powered by <a href="https://eppi.ioe.ac.uk/cms/Default.aspx?tabid=2914" target="_blank">EPPI Reviewer</a>
      and created with
      <svg fill="#c62828" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg">
        <path d="M0 0h24v24H0z" fill="none" />
        <path
          d="M12 21.35l-1.45-1.32C5.4 15.36 2 12.28 2 8.5 2 5.42 4.42 3 7.5 3c1.74 0 3.41.81 4.5 2.09C13.09 3.81 14.76 3 16.5 3 19.58 3 22 5.42 22 8.5c0 3.78-3.4 6.86-8.55 11.54L12 21.35z" />
      </svg>
      by the
      <a href="http://www.digitalsolutionfoundry.co.za/" target="_blank">Digital Solution Foundry</a> team.
    </div>
  </div>
  <script type="text/javascript">/*! jQuery v3.3.1 | (c) JS Foundation and other contributors | jquery.org/license */
!function(e,t){"use strict";"object"==typeof module&&"object"==typeof module.exports?module.exports=e.document?t(e,!0):function(e){if(!e.document)throw new Error("jQuery requires a window with a document");return t(e)}:t(e)}("undefined"!=typeof window?window:this,function(e,t){"use strict";var n=[],r=e.document,i=Object.getPrototypeOf,o=n.slice,a=n.concat,s=n.push,u=n.indexOf,l={},c=l.toString,f=l.hasOwnProperty,p=f.toString,d=p.call(Object),h={},g=function e(t){return"function"==typeof t&&"number"!=typeof t.nodeType},y=function e(t){return null!=t&&t===t.window},v={type:!0,src:!0,noModule:!0};function m(e,t,n){var i,o=(t=t||r).createElement("script");if(o.text=e,n)for(i in v)n[i]&&(o[i]=n[i]);t.head.appendChild(o).parentNode.removeChild(o)}function x(e){return null==e?e+"":"object"==typeof e||"function"==typeof e?l[c.call(e)]||"object":typeof e}var b="3.3.1",w=function(e,t){return new w.fn.init(e,t)},T=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g;w.fn=w.prototype={jquery:"3.3.1",constructor:w,length:0,toArray:function(){return o.call(this)},get:function(e){return null==e?o.call(this):e<0?this[e+this.length]:this[e]},pushStack:function(e){var t=w.merge(this.constructor(),e);return t.prevObject=this,t},each:function(e){return w.each(this,e)},map:function(e){return this.pushStack(w.map(this,function(t,n){return e.call(t,n,t)}))},slice:function(){return this.pushStack(o.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(e){var t=this.length,n=+e+(e<0?t:0);return this.pushStack(n>=0&&n<t?[this[n]]:[])},end:function(){return this.prevObject||this.constructor()},push:s,sort:n.sort,splice:n.splice},w.extend=w.fn.extend=function(){var e,t,n,r,i,o,a=arguments[0]||{},s=1,u=arguments.length,l=!1;for("boolean"==typeof a&&(l=a,a=arguments[s]||{},s++),"object"==typeof a||g(a)||(a={}),s===u&&(a=this,s--);s<u;s++)if(null!=(e=arguments[s]))for(t in e)n=a[t],a!==(r=e[t])&&(l&&r&&(w.isPlainObject(r)||(i=Array.isArray(r)))?(i?(i=!1,o=n&&Array.isArray(n)?n:[]):o=n&&w.isPlainObject(n)?n:{},a[t]=w.extend(l,o,r)):void 0!==r&&(a[t]=r));return a},w.extend({expando:"jQuery"+("3.3.1"+Math.random()).replace(/\D/g,""),isReady:!0,error:function(e){throw new Error(e)},noop:function(){},isPlainObject:function(e){var t,n;return!(!e||"[object Object]"!==c.call(e))&&(!(t=i(e))||"function"==typeof(n=f.call(t,"constructor")&&t.constructor)&&p.call(n)===d)},isEmptyObject:function(e){var t;for(t in e)return!1;return!0},globalEval:function(e){m(e)},each:function(e,t){var n,r=0;if(C(e)){for(n=e.length;r<n;r++)if(!1===t.call(e[r],r,e[r]))break}else for(r in e)if(!1===t.call(e[r],r,e[r]))break;return e},trim:function(e){return null==e?"":(e+"").replace(T,"")},makeArray:function(e,t){var n=t||[];return null!=e&&(C(Object(e))?w.merge(n,"string"==typeof e?[e]:e):s.call(n,e)),n},inArray:function(e,t,n){return null==t?-1:u.call(t,e,n)},merge:function(e,t){for(var n=+t.length,r=0,i=e.length;r<n;r++)e[i++]=t[r];return e.length=i,e},grep:function(e,t,n){for(var r,i=[],o=0,a=e.length,s=!n;o<a;o++)(r=!t(e[o],o))!==s&&i.push(e[o]);return i},map:function(e,t,n){var r,i,o=0,s=[];if(C(e))for(r=e.length;o<r;o++)null!=(i=t(e[o],o,n))&&s.push(i);else for(o in e)null!=(i=t(e[o],o,n))&&s.push(i);return a.apply([],s)},guid:1,support:h}),"function"==typeof Symbol&&(w.fn[Symbol.iterator]=n[Symbol.iterator]),w.each("Boolean Number String Function Array Date RegExp Object Error Symbol".split(" "),function(e,t){l["[object "+t+"]"]=t.toLowerCase()});function C(e){var t=!!e&&"length"in e&&e.length,n=x(e);return!g(e)&&!y(e)&&("array"===n||0===t||"number"==typeof t&&t>0&&t-1 in e)}var E=function(e){var t,n,r,i,o,a,s,u,l,c,f,p,d,h,g,y,v,m,x,b="sizzle"+1*new Date,w=e.document,T=0,C=0,E=ae(),k=ae(),S=ae(),D=function(e,t){return e===t&&(f=!0),0},N={}.hasOwnProperty,A=[],j=A.pop,q=A.push,L=A.push,H=A.slice,O=function(e,t){for(var n=0,r=e.length;n<r;n++)if(e[n]===t)return n;return-1},P="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",M="[\\x20\\t\\r\\n\\f]",R="(?:\\\\.|[\\w-]|[^\0-\\xa0])+",I="\\["+M+"*("+R+")(?:"+M+"*([*^$|!~]?=)"+M+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+R+"))|)"+M+"*\\]",W=":("+R+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+I+")*)|.*)\\)|)",$=new RegExp(M+"+","g"),B=new RegExp("^"+M+"+|((?:^|[^\\\\])(?:\\\\.)*)"+M+"+$","g"),F=new RegExp("^"+M+"*,"+M+"*"),_=new RegExp("^"+M+"*([>+~]|"+M+")"+M+"*"),z=new RegExp("="+M+"*([^\\]'\"]*?)"+M+"*\\]","g"),X=new RegExp(W),U=new RegExp("^"+R+"$"),V={ID:new RegExp("^#("+R+")"),CLASS:new RegExp("^\\.("+R+")"),TAG:new RegExp("^("+R+"|[*])"),ATTR:new RegExp("^"+I),PSEUDO:new RegExp("^"+W),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+M+"*(even|odd|(([+-]|)(\\d*)n|)"+M+"*(?:([+-]|)"+M+"*(\\d+)|))"+M+"*\\)|)","i"),bool:new RegExp("^(?:"+P+")$","i"),needsContext:new RegExp("^"+M+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+M+"*((?:-\\d)?\\d*)"+M+"*\\)|)(?=[^-]|$)","i")},G=/^(?:input|select|textarea|button)$/i,Y=/^h\d$/i,Q=/^[^{]+\{\s*\[native \w/,J=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,K=/[+~]/,Z=new RegExp("\\\\([\\da-f]{1,6}"+M+"?|("+M+")|.)","ig"),ee=function(e,t,n){var r="0x"+t-65536;return r!==r||n?t:r<0?String.fromCharCode(r+65536):String.fromCharCode(r>>10|55296,1023&r|56320)},te=/([\0-\x1f\x7f]|^-?\d)|^-$|[^\0-\x1f\x7f-\uFFFF\w-]/g,ne=function(e,t){return t?"\0"===e?"\ufffd":e.slice(0,-1)+"\\"+e.charCodeAt(e.length-1).toString(16)+" ":"\\"+e},re=function(){p()},ie=me(function(e){return!0===e.disabled&&("form"in e||"label"in e)},{dir:"parentNode",next:"legend"});try{L.apply(A=H.call(w.childNodes),w.childNodes),A[w.childNodes.length].nodeType}catch(e){L={apply:A.length?function(e,t){q.apply(e,H.call(t))}:function(e,t){var n=e.length,r=0;while(e[n++]=t[r++]);e.length=n-1}}}function oe(e,t,r,i){var o,s,l,c,f,h,v,m=t&&t.ownerDocument,T=t?t.nodeType:9;if(r=r||[],"string"!=typeof e||!e||1!==T&&9!==T&&11!==T)return r;if(!i&&((t?t.ownerDocument||t:w)!==d&&p(t),t=t||d,g)){if(11!==T&&(f=J.exec(e)))if(o=f[1]){if(9===T){if(!(l=t.getElementById(o)))return r;if(l.id===o)return r.push(l),r}else if(m&&(l=m.getElementById(o))&&x(t,l)&&l.id===o)return r.push(l),r}else{if(f[2])return L.apply(r,t.getElementsByTagName(e)),r;if((o=f[3])&&n.getElementsByClassName&&t.getElementsByClassName)return L.apply(r,t.getElementsByClassName(o)),r}if(n.qsa&&!S[e+" "]&&(!y||!y.test(e))){if(1!==T)m=t,v=e;else if("object"!==t.nodeName.toLowerCase()){(c=t.getAttribute("id"))?c=c.replace(te,ne):t.setAttribute("id",c=b),s=(h=a(e)).length;while(s--)h[s]="#"+c+" "+ve(h[s]);v=h.join(","),m=K.test(e)&&ge(t.parentNode)||t}if(v)try{return L.apply(r,m.querySelectorAll(v)),r}catch(e){}finally{c===b&&t.removeAttribute("id")}}}return u(e.replace(B,"$1"),t,r,i)}function ae(){var e=[];function t(n,i){return e.push(n+" ")>r.cacheLength&&delete t[e.shift()],t[n+" "]=i}return t}function se(e){return e[b]=!0,e}function ue(e){var t=d.createElement("fieldset");try{return!!e(t)}catch(e){return!1}finally{t.parentNode&&t.parentNode.removeChild(t),t=null}}function le(e,t){var n=e.split("|"),i=n.length;while(i--)r.attrHandle[n[i]]=t}function ce(e,t){var n=t&&e,r=n&&1===e.nodeType&&1===t.nodeType&&e.sourceIndex-t.sourceIndex;if(r)return r;if(n)while(n=n.nextSibling)if(n===t)return-1;return e?1:-1}function fe(e){return function(t){return"input"===t.nodeName.toLowerCase()&&t.type===e}}function pe(e){return function(t){var n=t.nodeName.toLowerCase();return("input"===n||"button"===n)&&t.type===e}}function de(e){return function(t){return"form"in t?t.parentNode&&!1===t.disabled?"label"in t?"label"in t.parentNode?t.parentNode.disabled===e:t.disabled===e:t.isDisabled===e||t.isDisabled!==!e&&ie(t)===e:t.disabled===e:"label"in t&&t.disabled===e}}function he(e){return se(function(t){return t=+t,se(function(n,r){var i,o=e([],n.length,t),a=o.length;while(a--)n[i=o[a]]&&(n[i]=!(r[i]=n[i]))})})}function ge(e){return e&&"undefined"!=typeof e.getElementsByTagName&&e}n=oe.support={},o=oe.isXML=function(e){var t=e&&(e.ownerDocument||e).documentElement;return!!t&&"HTML"!==t.nodeName},p=oe.setDocument=function(e){var t,i,a=e?e.ownerDocument||e:w;return a!==d&&9===a.nodeType&&a.documentElement?(d=a,h=d.documentElement,g=!o(d),w!==d&&(i=d.defaultView)&&i.top!==i&&(i.addEventListener?i.addEventListener("unload",re,!1):i.attachEvent&&i.attachEvent("onunload",re)),n.attributes=ue(function(e){return e.className="i",!e.getAttribute("className")}),n.getElementsByTagName=ue(function(e){return e.appendChild(d.createComment("")),!e.getElementsByTagName("*").length}),n.getElementsByClassName=Q.test(d.getElementsByClassName),n.getById=ue(function(e){return h.appendChild(e).id=b,!d.getElementsByName||!d.getElementsByName(b).length}),n.getById?(r.filter.ID=function(e){var t=e.replace(Z,ee);return function(e){return e.getAttribute("id")===t}},r.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&g){var n=t.getElementById(e);return n?[n]:[]}}):(r.filter.ID=function(e){var t=e.replace(Z,ee);return function(e){var n="undefined"!=typeof e.getAttributeNode&&e.getAttributeNode("id");return n&&n.value===t}},r.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&g){var n,r,i,o=t.getElementById(e);if(o){if((n=o.getAttributeNode("id"))&&n.value===e)return[o];i=t.getElementsByName(e),r=0;while(o=i[r++])if((n=o.getAttributeNode("id"))&&n.value===e)return[o]}return[]}}),r.find.TAG=n.getElementsByTagName?function(e,t){return"undefined"!=typeof t.getElementsByTagName?t.getElementsByTagName(e):n.qsa?t.querySelectorAll(e):void 0}:function(e,t){var n,r=[],i=0,o=t.getElementsByTagName(e);if("*"===e){while(n=o[i++])1===n.nodeType&&r.push(n);return r}return o},r.find.CLASS=n.getElementsByClassName&&function(e,t){if("undefined"!=typeof t.getElementsByClassName&&g)return t.getElementsByClassName(e)},v=[],y=[],(n.qsa=Q.test(d.querySelectorAll))&&(ue(function(e){h.appendChild(e).innerHTML="<a id='"+b+"'></a><select id='"+b+"-\r\\' msallowcapture=''><option selected=''></option></select>",e.querySelectorAll("[msallowcapture^='']").length&&y.push("[*^$]="+M+"*(?:''|\"\")"),e.querySelectorAll("[selected]").length||y.push("\\["+M+"*(?:value|"+P+")"),e.querySelectorAll("[id~="+b+"-]").length||y.push("~="),e.querySelectorAll(":checked").length||y.push(":checked"),e.querySelectorAll("a#"+b+"+*").length||y.push(".#.+[+~]")}),ue(function(e){e.innerHTML="<a href='' disabled='disabled'></a><select disabled='disabled'><option/></select>";var t=d.createElement("input");t.setAttribute("type","hidden"),e.appendChild(t).setAttribute("name","D"),e.querySelectorAll("[name=d]").length&&y.push("name"+M+"*[*^$|!~]?="),2!==e.querySelectorAll(":enabled").length&&y.push(":enabled",":disabled"),h.appendChild(e).disabled=!0,2!==e.querySelectorAll(":disabled").length&&y.push(":enabled",":disabled"),e.querySelectorAll("*,:x"),y.push(",.*:")})),(n.matchesSelector=Q.test(m=h.matches||h.webkitMatchesSelector||h.mozMatchesSelector||h.oMatchesSelector||h.msMatchesSelector))&&ue(function(e){n.disconnectedMatch=m.call(e,"*"),m.call(e,"[s!='']:x"),v.push("!=",W)}),y=y.length&&new RegExp(y.join("|")),v=v.length&&new RegExp(v.join("|")),t=Q.test(h.compareDocumentPosition),x=t||Q.test(h.contains)?function(e,t){var n=9===e.nodeType?e.documentElement:e,r=t&&t.parentNode;return e===r||!(!r||1!==r.nodeType||!(n.contains?n.contains(r):e.compareDocumentPosition&&16&e.compareDocumentPosition(r)))}:function(e,t){if(t)while(t=t.parentNode)if(t===e)return!0;return!1},D=t?function(e,t){if(e===t)return f=!0,0;var r=!e.compareDocumentPosition-!t.compareDocumentPosition;return r||(1&(r=(e.ownerDocument||e)===(t.ownerDocument||t)?e.compareDocumentPosition(t):1)||!n.sortDetached&&t.compareDocumentPosition(e)===r?e===d||e.ownerDocument===w&&x(w,e)?-1:t===d||t.ownerDocument===w&&x(w,t)?1:c?O(c,e)-O(c,t):0:4&r?-1:1)}:function(e,t){if(e===t)return f=!0,0;var n,r=0,i=e.parentNode,o=t.parentNode,a=[e],s=[t];if(!i||!o)return e===d?-1:t===d?1:i?-1:o?1:c?O(c,e)-O(c,t):0;if(i===o)return ce(e,t);n=e;while(n=n.parentNode)a.unshift(n);n=t;while(n=n.parentNode)s.unshift(n);while(a[r]===s[r])r++;return r?ce(a[r],s[r]):a[r]===w?-1:s[r]===w?1:0},d):d},oe.matches=function(e,t){return oe(e,null,null,t)},oe.matchesSelector=function(e,t){if((e.ownerDocument||e)!==d&&p(e),t=t.replace(z,"='$1']"),n.matchesSelector&&g&&!S[t+" "]&&(!v||!v.test(t))&&(!y||!y.test(t)))try{var r=m.call(e,t);if(r||n.disconnectedMatch||e.document&&11!==e.document.nodeType)return r}catch(e){}return oe(t,d,null,[e]).length>0},oe.contains=function(e,t){return(e.ownerDocument||e)!==d&&p(e),x(e,t)},oe.attr=function(e,t){(e.ownerDocument||e)!==d&&p(e);var i=r.attrHandle[t.toLowerCase()],o=i&&N.call(r.attrHandle,t.toLowerCase())?i(e,t,!g):void 0;return void 0!==o?o:n.attributes||!g?e.getAttribute(t):(o=e.getAttributeNode(t))&&o.specified?o.value:null},oe.escape=function(e){return(e+"").replace(te,ne)},oe.error=function(e){throw new Error("Syntax error, unrecognized expression: "+e)},oe.uniqueSort=function(e){var t,r=[],i=0,o=0;if(f=!n.detectDuplicates,c=!n.sortStable&&e.slice(0),e.sort(D),f){while(t=e[o++])t===e[o]&&(i=r.push(o));while(i--)e.splice(r[i],1)}return c=null,e},i=oe.getText=function(e){var t,n="",r=0,o=e.nodeType;if(o){if(1===o||9===o||11===o){if("string"==typeof e.textContent)return e.textContent;for(e=e.firstChild;e;e=e.nextSibling)n+=i(e)}else if(3===o||4===o)return e.nodeValue}else while(t=e[r++])n+=i(t);return n},(r=oe.selectors={cacheLength:50,createPseudo:se,match:V,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(e){return e[1]=e[1].replace(Z,ee),e[3]=(e[3]||e[4]||e[5]||"").replace(Z,ee),"~="===e[2]&&(e[3]=" "+e[3]+" "),e.slice(0,4)},CHILD:function(e){return e[1]=e[1].toLowerCase(),"nth"===e[1].slice(0,3)?(e[3]||oe.error(e[0]),e[4]=+(e[4]?e[5]+(e[6]||1):2*("even"===e[3]||"odd"===e[3])),e[5]=+(e[7]+e[8]||"odd"===e[3])):e[3]&&oe.error(e[0]),e},PSEUDO:function(e){var t,n=!e[6]&&e[2];return V.CHILD.test(e[0])?null:(e[3]?e[2]=e[4]||e[5]||"":n&&X.test(n)&&(t=a(n,!0))&&(t=n.indexOf(")",n.length-t)-n.length)&&(e[0]=e[0].slice(0,t),e[2]=n.slice(0,t)),e.slice(0,3))}},filter:{TAG:function(e){var t=e.replace(Z,ee).toLowerCase();return"*"===e?function(){return!0}:function(e){return e.nodeName&&e.nodeName.toLowerCase()===t}},CLASS:function(e){var t=E[e+" "];return t||(t=new RegExp("(^|"+M+")"+e+"("+M+"|$)"))&&E(e,function(e){return t.test("string"==typeof e.className&&e.className||"undefined"!=typeof e.getAttribute&&e.getAttribute("class")||"")})},ATTR:function(e,t,n){return function(r){var i=oe.attr(r,e);return null==i?"!="===t:!t||(i+="","="===t?i===n:"!="===t?i!==n:"^="===t?n&&0===i.indexOf(n):"*="===t?n&&i.indexOf(n)>-1:"$="===t?n&&i.slice(-n.length)===n:"~="===t?(" "+i.replace($," ")+" ").indexOf(n)>-1:"|="===t&&(i===n||i.slice(0,n.length+1)===n+"-"))}},CHILD:function(e,t,n,r,i){var o="nth"!==e.slice(0,3),a="last"!==e.slice(-4),s="of-type"===t;return 1===r&&0===i?function(e){return!!e.parentNode}:function(t,n,u){var l,c,f,p,d,h,g=o!==a?"nextSibling":"previousSibling",y=t.parentNode,v=s&&t.nodeName.toLowerCase(),m=!u&&!s,x=!1;if(y){if(o){while(g){p=t;while(p=p[g])if(s?p.nodeName.toLowerCase()===v:1===p.nodeType)return!1;h=g="only"===e&&!h&&"nextSibling"}return!0}if(h=[a?y.firstChild:y.lastChild],a&&m){x=(d=(l=(c=(f=(p=y)[b]||(p[b]={}))[p.uniqueID]||(f[p.uniqueID]={}))[e]||[])[0]===T&&l[1])&&l[2],p=d&&y.childNodes[d];while(p=++d&&p&&p[g]||(x=d=0)||h.pop())if(1===p.nodeType&&++x&&p===t){c[e]=[T,d,x];break}}else if(m&&(x=d=(l=(c=(f=(p=t)[b]||(p[b]={}))[p.uniqueID]||(f[p.uniqueID]={}))[e]||[])[0]===T&&l[1]),!1===x)while(p=++d&&p&&p[g]||(x=d=0)||h.pop())if((s?p.nodeName.toLowerCase()===v:1===p.nodeType)&&++x&&(m&&((c=(f=p[b]||(p[b]={}))[p.uniqueID]||(f[p.uniqueID]={}))[e]=[T,x]),p===t))break;return(x-=i)===r||x%r==0&&x/r>=0}}},PSEUDO:function(e,t){var n,i=r.pseudos[e]||r.setFilters[e.toLowerCase()]||oe.error("unsupported pseudo: "+e);return i[b]?i(t):i.length>1?(n=[e,e,"",t],r.setFilters.hasOwnProperty(e.toLowerCase())?se(function(e,n){var r,o=i(e,t),a=o.length;while(a--)e[r=O(e,o[a])]=!(n[r]=o[a])}):function(e){return i(e,0,n)}):i}},pseudos:{not:se(function(e){var t=[],n=[],r=s(e.replace(B,"$1"));return r[b]?se(function(e,t,n,i){var o,a=r(e,null,i,[]),s=e.length;while(s--)(o=a[s])&&(e[s]=!(t[s]=o))}):function(e,i,o){return t[0]=e,r(t,null,o,n),t[0]=null,!n.pop()}}),has:se(function(e){return function(t){return oe(e,t).length>0}}),contains:se(function(e){return e=e.replace(Z,ee),function(t){return(t.textContent||t.innerText||i(t)).indexOf(e)>-1}}),lang:se(function(e){return U.test(e||"")||oe.error("unsupported lang: "+e),e=e.replace(Z,ee).toLowerCase(),function(t){var n;do{if(n=g?t.lang:t.getAttribute("xml:lang")||t.getAttribute("lang"))return(n=n.toLowerCase())===e||0===n.indexOf(e+"-")}while((t=t.parentNode)&&1===t.nodeType);return!1}}),target:function(t){var n=e.location&&e.location.hash;return n&&n.slice(1)===t.id},root:function(e){return e===h},focus:function(e){return e===d.activeElement&&(!d.hasFocus||d.hasFocus())&&!!(e.type||e.href||~e.tabIndex)},enabled:de(!1),disabled:de(!0),checked:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&!!e.checked||"option"===t&&!!e.selected},selected:function(e){return e.parentNode&&e.parentNode.selectedIndex,!0===e.selected},empty:function(e){for(e=e.firstChild;e;e=e.nextSibling)if(e.nodeType<6)return!1;return!0},parent:function(e){return!r.pseudos.empty(e)},header:function(e){return Y.test(e.nodeName)},input:function(e){return G.test(e.nodeName)},button:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&"button"===e.type||"button"===t},text:function(e){var t;return"input"===e.nodeName.toLowerCase()&&"text"===e.type&&(null==(t=e.getAttribute("type"))||"text"===t.toLowerCase())},first:he(function(){return[0]}),last:he(function(e,t){return[t-1]}),eq:he(function(e,t,n){return[n<0?n+t:n]}),even:he(function(e,t){for(var n=0;n<t;n+=2)e.push(n);return e}),odd:he(function(e,t){for(var n=1;n<t;n+=2)e.push(n);return e}),lt:he(function(e,t,n){for(var r=n<0?n+t:n;--r>=0;)e.push(r);return e}),gt:he(function(e,t,n){for(var r=n<0?n+t:n;++r<t;)e.push(r);return e})}}).pseudos.nth=r.pseudos.eq;for(t in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})r.pseudos[t]=fe(t);for(t in{submit:!0,reset:!0})r.pseudos[t]=pe(t);function ye(){}ye.prototype=r.filters=r.pseudos,r.setFilters=new ye,a=oe.tokenize=function(e,t){var n,i,o,a,s,u,l,c=k[e+" "];if(c)return t?0:c.slice(0);s=e,u=[],l=r.preFilter;while(s){n&&!(i=F.exec(s))||(i&&(s=s.slice(i[0].length)||s),u.push(o=[])),n=!1,(i=_.exec(s))&&(n=i.shift(),o.push({value:n,type:i[0].replace(B," ")}),s=s.slice(n.length));for(a in r.filter)!(i=V[a].exec(s))||l[a]&&!(i=l[a](i))||(n=i.shift(),o.push({value:n,type:a,matches:i}),s=s.slice(n.length));if(!n)break}return t?s.length:s?oe.error(e):k(e,u).slice(0)};function ve(e){for(var t=0,n=e.length,r="";t<n;t++)r+=e[t].value;return r}function me(e,t,n){var r=t.dir,i=t.next,o=i||r,a=n&&"parentNode"===o,s=C++;return t.first?function(t,n,i){while(t=t[r])if(1===t.nodeType||a)return e(t,n,i);return!1}:function(t,n,u){var l,c,f,p=[T,s];if(u){while(t=t[r])if((1===t.nodeType||a)&&e(t,n,u))return!0}else while(t=t[r])if(1===t.nodeType||a)if(f=t[b]||(t[b]={}),c=f[t.uniqueID]||(f[t.uniqueID]={}),i&&i===t.nodeName.toLowerCase())t=t[r]||t;else{if((l=c[o])&&l[0]===T&&l[1]===s)return p[2]=l[2];if(c[o]=p,p[2]=e(t,n,u))return!0}return!1}}function xe(e){return e.length>1?function(t,n,r){var i=e.length;while(i--)if(!e[i](t,n,r))return!1;return!0}:e[0]}function be(e,t,n){for(var r=0,i=t.length;r<i;r++)oe(e,t[r],n);return n}function we(e,t,n,r,i){for(var o,a=[],s=0,u=e.length,l=null!=t;s<u;s++)(o=e[s])&&(n&&!n(o,r,i)||(a.push(o),l&&t.push(s)));return a}function Te(e,t,n,r,i,o){return r&&!r[b]&&(r=Te(r)),i&&!i[b]&&(i=Te(i,o)),se(function(o,a,s,u){var l,c,f,p=[],d=[],h=a.length,g=o||be(t||"*",s.nodeType?[s]:s,[]),y=!e||!o&&t?g:we(g,p,e,s,u),v=n?i||(o?e:h||r)?[]:a:y;if(n&&n(y,v,s,u),r){l=we(v,d),r(l,[],s,u),c=l.length;while(c--)(f=l[c])&&(v[d[c]]=!(y[d[c]]=f))}if(o){if(i||e){if(i){l=[],c=v.length;while(c--)(f=v[c])&&l.push(y[c]=f);i(null,v=[],l,u)}c=v.length;while(c--)(f=v[c])&&(l=i?O(o,f):p[c])>-1&&(o[l]=!(a[l]=f))}}else v=we(v===a?v.splice(h,v.length):v),i?i(null,a,v,u):L.apply(a,v)})}function Ce(e){for(var t,n,i,o=e.length,a=r.relative[e[0].type],s=a||r.relative[" "],u=a?1:0,c=me(function(e){return e===t},s,!0),f=me(function(e){return O(t,e)>-1},s,!0),p=[function(e,n,r){var i=!a&&(r||n!==l)||((t=n).nodeType?c(e,n,r):f(e,n,r));return t=null,i}];u<o;u++)if(n=r.relative[e[u].type])p=[me(xe(p),n)];else{if((n=r.filter[e[u].type].apply(null,e[u].matches))[b]){for(i=++u;i<o;i++)if(r.relative[e[i].type])break;return Te(u>1&&xe(p),u>1&&ve(e.slice(0,u-1).concat({value:" "===e[u-2].type?"*":""})).replace(B,"$1"),n,u<i&&Ce(e.slice(u,i)),i<o&&Ce(e=e.slice(i)),i<o&&ve(e))}p.push(n)}return xe(p)}function Ee(e,t){var n=t.length>0,i=e.length>0,o=function(o,a,s,u,c){var f,h,y,v=0,m="0",x=o&&[],b=[],w=l,C=o||i&&r.find.TAG("*",c),E=T+=null==w?1:Math.random()||.1,k=C.length;for(c&&(l=a===d||a||c);m!==k&&null!=(f=C[m]);m++){if(i&&f){h=0,a||f.ownerDocument===d||(p(f),s=!g);while(y=e[h++])if(y(f,a||d,s)){u.push(f);break}c&&(T=E)}n&&((f=!y&&f)&&v--,o&&x.push(f))}if(v+=m,n&&m!==v){h=0;while(y=t[h++])y(x,b,a,s);if(o){if(v>0)while(m--)x[m]||b[m]||(b[m]=j.call(u));b=we(b)}L.apply(u,b),c&&!o&&b.length>0&&v+t.length>1&&oe.uniqueSort(u)}return c&&(T=E,l=w),x};return n?se(o):o}return s=oe.compile=function(e,t){var n,r=[],i=[],o=S[e+" "];if(!o){t||(t=a(e)),n=t.length;while(n--)(o=Ce(t[n]))[b]?r.push(o):i.push(o);(o=S(e,Ee(i,r))).selector=e}return o},u=oe.select=function(e,t,n,i){var o,u,l,c,f,p="function"==typeof e&&e,d=!i&&a(e=p.selector||e);if(n=n||[],1===d.length){if((u=d[0]=d[0].slice(0)).length>2&&"ID"===(l=u[0]).type&&9===t.nodeType&&g&&r.relative[u[1].type]){if(!(t=(r.find.ID(l.matches[0].replace(Z,ee),t)||[])[0]))return n;p&&(t=t.parentNode),e=e.slice(u.shift().value.length)}o=V.needsContext.test(e)?0:u.length;while(o--){if(l=u[o],r.relative[c=l.type])break;if((f=r.find[c])&&(i=f(l.matches[0].replace(Z,ee),K.test(u[0].type)&&ge(t.parentNode)||t))){if(u.splice(o,1),!(e=i.length&&ve(u)))return L.apply(n,i),n;break}}}return(p||s(e,d))(i,t,!g,n,!t||K.test(e)&&ge(t.parentNode)||t),n},n.sortStable=b.split("").sort(D).join("")===b,n.detectDuplicates=!!f,p(),n.sortDetached=ue(function(e){return 1&e.compareDocumentPosition(d.createElement("fieldset"))}),ue(function(e){return e.innerHTML="<a href='#'></a>","#"===e.firstChild.getAttribute("href")})||le("type|href|height|width",function(e,t,n){if(!n)return e.getAttribute(t,"type"===t.toLowerCase()?1:2)}),n.attributes&&ue(function(e){return e.innerHTML="<input/>",e.firstChild.setAttribute("value",""),""===e.firstChild.getAttribute("value")})||le("value",function(e,t,n){if(!n&&"input"===e.nodeName.toLowerCase())return e.defaultValue}),ue(function(e){return null==e.getAttribute("disabled")})||le(P,function(e,t,n){var r;if(!n)return!0===e[t]?t.toLowerCase():(r=e.getAttributeNode(t))&&r.specified?r.value:null}),oe}(e);w.find=E,w.expr=E.selectors,w.expr[":"]=w.expr.pseudos,w.uniqueSort=w.unique=E.uniqueSort,w.text=E.getText,w.isXMLDoc=E.isXML,w.contains=E.contains,w.escapeSelector=E.escape;var k=function(e,t,n){var r=[],i=void 0!==n;while((e=e[t])&&9!==e.nodeType)if(1===e.nodeType){if(i&&w(e).is(n))break;r.push(e)}return r},S=function(e,t){for(var n=[];e;e=e.nextSibling)1===e.nodeType&&e!==t&&n.push(e);return n},D=w.expr.match.needsContext;function N(e,t){return e.nodeName&&e.nodeName.toLowerCase()===t.toLowerCase()}var A=/^<([a-z][^\/\0>:\x20\t\r\n\f]*)[\x20\t\r\n\f]*\/?>(?:<\/\1>|)$/i;function j(e,t,n){return g(t)?w.grep(e,function(e,r){return!!t.call(e,r,e)!==n}):t.nodeType?w.grep(e,function(e){return e===t!==n}):"string"!=typeof t?w.grep(e,function(e){return u.call(t,e)>-1!==n}):w.filter(t,e,n)}w.filter=function(e,t,n){var r=t[0];return n&&(e=":not("+e+")"),1===t.length&&1===r.nodeType?w.find.matchesSelector(r,e)?[r]:[]:w.find.matches(e,w.grep(t,function(e){return 1===e.nodeType}))},w.fn.extend({find:function(e){var t,n,r=this.length,i=this;if("string"!=typeof e)return this.pushStack(w(e).filter(function(){for(t=0;t<r;t++)if(w.contains(i[t],this))return!0}));for(n=this.pushStack([]),t=0;t<r;t++)w.find(e,i[t],n);return r>1?w.uniqueSort(n):n},filter:function(e){return this.pushStack(j(this,e||[],!1))},not:function(e){return this.pushStack(j(this,e||[],!0))},is:function(e){return!!j(this,"string"==typeof e&&D.test(e)?w(e):e||[],!1).length}});var q,L=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]+))$/;(w.fn.init=function(e,t,n){var i,o;if(!e)return this;if(n=n||q,"string"==typeof e){if(!(i="<"===e[0]&&">"===e[e.length-1]&&e.length>=3?[null,e,null]:L.exec(e))||!i[1]&&t)return!t||t.jquery?(t||n).find(e):this.constructor(t).find(e);if(i[1]){if(t=t instanceof w?t[0]:t,w.merge(this,w.parseHTML(i[1],t&&t.nodeType?t.ownerDocument||t:r,!0)),A.test(i[1])&&w.isPlainObject(t))for(i in t)g(this[i])?this[i](t[i]):this.attr(i,t[i]);return this}return(o=r.getElementById(i[2]))&&(this[0]=o,this.length=1),this}return e.nodeType?(this[0]=e,this.length=1,this):g(e)?void 0!==n.ready?n.ready(e):e(w):w.makeArray(e,this)}).prototype=w.fn,q=w(r);var H=/^(?:parents|prev(?:Until|All))/,O={children:!0,contents:!0,next:!0,prev:!0};w.fn.extend({has:function(e){var t=w(e,this),n=t.length;return this.filter(function(){for(var e=0;e<n;e++)if(w.contains(this,t[e]))return!0})},closest:function(e,t){var n,r=0,i=this.length,o=[],a="string"!=typeof e&&w(e);if(!D.test(e))for(;r<i;r++)for(n=this[r];n&&n!==t;n=n.parentNode)if(n.nodeType<11&&(a?a.index(n)>-1:1===n.nodeType&&w.find.matchesSelector(n,e))){o.push(n);break}return this.pushStack(o.length>1?w.uniqueSort(o):o)},index:function(e){return e?"string"==typeof e?u.call(w(e),this[0]):u.call(this,e.jquery?e[0]:e):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(e,t){return this.pushStack(w.uniqueSort(w.merge(this.get(),w(e,t))))},addBack:function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}});function P(e,t){while((e=e[t])&&1!==e.nodeType);return e}w.each({parent:function(e){var t=e.parentNode;return t&&11!==t.nodeType?t:null},parents:function(e){return k(e,"parentNode")},parentsUntil:function(e,t,n){return k(e,"parentNode",n)},next:function(e){return P(e,"nextSibling")},prev:function(e){return P(e,"previousSibling")},nextAll:function(e){return k(e,"nextSibling")},prevAll:function(e){return k(e,"previousSibling")},nextUntil:function(e,t,n){return k(e,"nextSibling",n)},prevUntil:function(e,t,n){return k(e,"previousSibling",n)},siblings:function(e){return S((e.parentNode||{}).firstChild,e)},children:function(e){return S(e.firstChild)},contents:function(e){return N(e,"iframe")?e.contentDocument:(N(e,"template")&&(e=e.content||e),w.merge([],e.childNodes))}},function(e,t){w.fn[e]=function(n,r){var i=w.map(this,t,n);return"Until"!==e.slice(-5)&&(r=n),r&&"string"==typeof r&&(i=w.filter(r,i)),this.length>1&&(O[e]||w.uniqueSort(i),H.test(e)&&i.reverse()),this.pushStack(i)}});var M=/[^\x20\t\r\n\f]+/g;function R(e){var t={};return w.each(e.match(M)||[],function(e,n){t[n]=!0}),t}w.Callbacks=function(e){e="string"==typeof e?R(e):w.extend({},e);var t,n,r,i,o=[],a=[],s=-1,u=function(){for(i=i||e.once,r=t=!0;a.length;s=-1){n=a.shift();while(++s<o.length)!1===o[s].apply(n[0],n[1])&&e.stopOnFalse&&(s=o.length,n=!1)}e.memory||(n=!1),t=!1,i&&(o=n?[]:"")},l={add:function(){return o&&(n&&!t&&(s=o.length-1,a.push(n)),function t(n){w.each(n,function(n,r){g(r)?e.unique&&l.has(r)||o.push(r):r&&r.length&&"string"!==x(r)&&t(r)})}(arguments),n&&!t&&u()),this},remove:function(){return w.each(arguments,function(e,t){var n;while((n=w.inArray(t,o,n))>-1)o.splice(n,1),n<=s&&s--}),this},has:function(e){return e?w.inArray(e,o)>-1:o.length>0},empty:function(){return o&&(o=[]),this},disable:function(){return i=a=[],o=n="",this},disabled:function(){return!o},lock:function(){return i=a=[],n||t||(o=n=""),this},locked:function(){return!!i},fireWith:function(e,n){return i||(n=[e,(n=n||[]).slice?n.slice():n],a.push(n),t||u()),this},fire:function(){return l.fireWith(this,arguments),this},fired:function(){return!!r}};return l};function I(e){return e}function W(e){throw e}function $(e,t,n,r){var i;try{e&&g(i=e.promise)?i.call(e).done(t).fail(n):e&&g(i=e.then)?i.call(e,t,n):t.apply(void 0,[e].slice(r))}catch(e){n.apply(void 0,[e])}}w.extend({Deferred:function(t){var n=[["notify","progress",w.Callbacks("memory"),w.Callbacks("memory"),2],["resolve","done",w.Callbacks("once memory"),w.Callbacks("once memory"),0,"resolved"],["reject","fail",w.Callbacks("once memory"),w.Callbacks("once memory"),1,"rejected"]],r="pending",i={state:function(){return r},always:function(){return o.done(arguments).fail(arguments),this},"catch":function(e){return i.then(null,e)},pipe:function(){var e=arguments;return w.Deferred(function(t){w.each(n,function(n,r){var i=g(e[r[4]])&&e[r[4]];o[r[1]](function(){var e=i&&i.apply(this,arguments);e&&g(e.promise)?e.promise().progress(t.notify).done(t.resolve).fail(t.reject):t[r[0]+"With"](this,i?[e]:arguments)})}),e=null}).promise()},then:function(t,r,i){var o=0;function a(t,n,r,i){return function(){var s=this,u=arguments,l=function(){var e,l;if(!(t<o)){if((e=r.apply(s,u))===n.promise())throw new TypeError("Thenable self-resolution");l=e&&("object"==typeof e||"function"==typeof e)&&e.then,g(l)?i?l.call(e,a(o,n,I,i),a(o,n,W,i)):(o++,l.call(e,a(o,n,I,i),a(o,n,W,i),a(o,n,I,n.notifyWith))):(r!==I&&(s=void 0,u=[e]),(i||n.resolveWith)(s,u))}},c=i?l:function(){try{l()}catch(e){w.Deferred.exceptionHook&&w.Deferred.exceptionHook(e,c.stackTrace),t+1>=o&&(r!==W&&(s=void 0,u=[e]),n.rejectWith(s,u))}};t?c():(w.Deferred.getStackHook&&(c.stackTrace=w.Deferred.getStackHook()),e.setTimeout(c))}}return w.Deferred(function(e){n[0][3].add(a(0,e,g(i)?i:I,e.notifyWith)),n[1][3].add(a(0,e,g(t)?t:I)),n[2][3].add(a(0,e,g(r)?r:W))}).promise()},promise:function(e){return null!=e?w.extend(e,i):i}},o={};return w.each(n,function(e,t){var a=t[2],s=t[5];i[t[1]]=a.add,s&&a.add(function(){r=s},n[3-e][2].disable,n[3-e][3].disable,n[0][2].lock,n[0][3].lock),a.add(t[3].fire),o[t[0]]=function(){return o[t[0]+"With"](this===o?void 0:this,arguments),this},o[t[0]+"With"]=a.fireWith}),i.promise(o),t&&t.call(o,o),o},when:function(e){var t=arguments.length,n=t,r=Array(n),i=o.call(arguments),a=w.Deferred(),s=function(e){return function(n){r[e]=this,i[e]=arguments.length>1?o.call(arguments):n,--t||a.resolveWith(r,i)}};if(t<=1&&($(e,a.done(s(n)).resolve,a.reject,!t),"pending"===a.state()||g(i[n]&&i[n].then)))return a.then();while(n--)$(i[n],s(n),a.reject);return a.promise()}});var B=/^(Eval|Internal|Range|Reference|Syntax|Type|URI)Error$/;w.Deferred.exceptionHook=function(t,n){e.console&&e.console.warn&&t&&B.test(t.name)&&e.console.warn("jQuery.Deferred exception: "+t.message,t.stack,n)},w.readyException=function(t){e.setTimeout(function(){throw t})};var F=w.Deferred();w.fn.ready=function(e){return F.then(e)["catch"](function(e){w.readyException(e)}),this},w.extend({isReady:!1,readyWait:1,ready:function(e){(!0===e?--w.readyWait:w.isReady)||(w.isReady=!0,!0!==e&&--w.readyWait>0||F.resolveWith(r,[w]))}}),w.ready.then=F.then;function _(){r.removeEventListener("DOMContentLoaded",_),e.removeEventListener("load",_),w.ready()}"complete"===r.readyState||"loading"!==r.readyState&&!r.documentElement.doScroll?e.setTimeout(w.ready):(r.addEventListener("DOMContentLoaded",_),e.addEventListener("load",_));var z=function(e,t,n,r,i,o,a){var s=0,u=e.length,l=null==n;if("object"===x(n)){i=!0;for(s in n)z(e,t,s,n[s],!0,o,a)}else if(void 0!==r&&(i=!0,g(r)||(a=!0),l&&(a?(t.call(e,r),t=null):(l=t,t=function(e,t,n){return l.call(w(e),n)})),t))for(;s<u;s++)t(e[s],n,a?r:r.call(e[s],s,t(e[s],n)));return i?e:l?t.call(e):u?t(e[0],n):o},X=/^-ms-/,U=/-([a-z])/g;function V(e,t){return t.toUpperCase()}function G(e){return e.replace(X,"ms-").replace(U,V)}var Y=function(e){return 1===e.nodeType||9===e.nodeType||!+e.nodeType};function Q(){this.expando=w.expando+Q.uid++}Q.uid=1,Q.prototype={cache:function(e){var t=e[this.expando];return t||(t={},Y(e)&&(e.nodeType?e[this.expando]=t:Object.defineProperty(e,this.expando,{value:t,configurable:!0}))),t},set:function(e,t,n){var r,i=this.cache(e);if("string"==typeof t)i[G(t)]=n;else for(r in t)i[G(r)]=t[r];return i},get:function(e,t){return void 0===t?this.cache(e):e[this.expando]&&e[this.expando][G(t)]},access:function(e,t,n){return void 0===t||t&&"string"==typeof t&&void 0===n?this.get(e,t):(this.set(e,t,n),void 0!==n?n:t)},remove:function(e,t){var n,r=e[this.expando];if(void 0!==r){if(void 0!==t){n=(t=Array.isArray(t)?t.map(G):(t=G(t))in r?[t]:t.match(M)||[]).length;while(n--)delete r[t[n]]}(void 0===t||w.isEmptyObject(r))&&(e.nodeType?e[this.expando]=void 0:delete e[this.expando])}},hasData:function(e){var t=e[this.expando];return void 0!==t&&!w.isEmptyObject(t)}};var J=new Q,K=new Q,Z=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,ee=/[A-Z]/g;function te(e){return"true"===e||"false"!==e&&("null"===e?null:e===+e+""?+e:Z.test(e)?JSON.parse(e):e)}function ne(e,t,n){var r;if(void 0===n&&1===e.nodeType)if(r="data-"+t.replace(ee,"-{{ jquery }}").toLowerCase(),"string"==typeof(n=e.getAttribute(r))){try{n=te(n)}catch(e){}K.set(e,t,n)}else n=void 0;return n}w.extend({hasData:function(e){return K.hasData(e)||J.hasData(e)},data:function(e,t,n){return K.access(e,t,n)},removeData:function(e,t){K.remove(e,t)},_data:function(e,t,n){return J.access(e,t,n)},_removeData:function(e,t){J.remove(e,t)}}),w.fn.extend({data:function(e,t){var n,r,i,o=this[0],a=o&&o.attributes;if(void 0===e){if(this.length&&(i=K.get(o),1===o.nodeType&&!J.get(o,"hasDataAttrs"))){n=a.length;while(n--)a[n]&&0===(r=a[n].name).indexOf("data-")&&(r=G(r.slice(5)),ne(o,r,i[r]));J.set(o,"hasDataAttrs",!0)}return i}return"object"==typeof e?this.each(function(){K.set(this,e)}):z(this,function(t){var n;if(o&&void 0===t){if(void 0!==(n=K.get(o,e)))return n;if(void 0!==(n=ne(o,e)))return n}else this.each(function(){K.set(this,e,t)})},null,t,arguments.length>1,null,!0)},removeData:function(e){return this.each(function(){K.remove(this,e)})}}),w.extend({queue:function(e,t,n){var r;if(e)return t=(t||"fx")+"queue",r=J.get(e,t),n&&(!r||Array.isArray(n)?r=J.access(e,t,w.makeArray(n)):r.push(n)),r||[]},dequeue:function(e,t){t=t||"fx";var n=w.queue(e,t),r=n.length,i=n.shift(),o=w._queueHooks(e,t),a=function(){w.dequeue(e,t)};"inprogress"===i&&(i=n.shift(),r--),i&&("fx"===t&&n.unshift("inprogress"),delete o.stop,i.call(e,a,o)),!r&&o&&o.empty.fire()},_queueHooks:function(e,t){var n=t+"queueHooks";return J.get(e,n)||J.access(e,n,{empty:w.Callbacks("once memory").add(function(){J.remove(e,[t+"queue",n])})})}}),w.fn.extend({queue:function(e,t){var n=2;return"string"!=typeof e&&(t=e,e="fx",n--),arguments.length<n?w.queue(this[0],e):void 0===t?this:this.each(function(){var n=w.queue(this,e,t);w._queueHooks(this,e),"fx"===e&&"inprogress"!==n[0]&&w.dequeue(this,e)})},dequeue:function(e){return this.each(function(){w.dequeue(this,e)})},clearQueue:function(e){return this.queue(e||"fx",[])},promise:function(e,t){var n,r=1,i=w.Deferred(),o=this,a=this.length,s=function(){--r||i.resolveWith(o,[o])};"string"!=typeof e&&(t=e,e=void 0),e=e||"fx";while(a--)(n=J.get(o[a],e+"queueHooks"))&&n.empty&&(r++,n.empty.add(s));return s(),i.promise(t)}});var re=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,ie=new RegExp("^(?:([+-])=|)("+re+")([a-z%]*)$","i"),oe=["Top","Right","Bottom","Left"],ae=function(e,t){return"none"===(e=t||e).style.display||""===e.style.display&&w.contains(e.ownerDocument,e)&&"none"===w.css(e,"display")},se=function(e,t,n,r){var i,o,a={};for(o in t)a[o]=e.style[o],e.style[o]=t[o];i=n.apply(e,r||[]);for(o in t)e.style[o]=a[o];return i};function ue(e,t,n,r){var i,o,a=20,s=r?function(){return r.cur()}:function(){return w.css(e,t,"")},u=s(),l=n&&n[3]||(w.cssNumber[t]?"":"px"),c=(w.cssNumber[t]||"px"!==l&&+u)&&ie.exec(w.css(e,t));if(c&&c[3]!==l){u/=2,l=l||c[3],c=+u||1;while(a--)w.style(e,t,c+l),(1-o)*(1-(o=s()/u||.5))<=0&&(a=0),c/=o;c*=2,w.style(e,t,c+l),n=n||[]}return n&&(c=+c||+u||0,i=n[1]?c+(n[1]+1)*n[2]:+n[2],r&&(r.unit=l,r.start=c,r.end=i)),i}var le={};function ce(e){var t,n=e.ownerDocument,r=e.nodeName,i=le[r];return i||(t=n.body.appendChild(n.createElement(r)),i=w.css(t,"display"),t.parentNode.removeChild(t),"none"===i&&(i="block"),le[r]=i,i)}function fe(e,t){for(var n,r,i=[],o=0,a=e.length;o<a;o++)(r=e[o]).style&&(n=r.style.display,t?("none"===n&&(i[o]=J.get(r,"display")||null,i[o]||(r.style.display="")),""===r.style.display&&ae(r)&&(i[o]=ce(r))):"none"!==n&&(i[o]="none",J.set(r,"display",n)));for(o=0;o<a;o++)null!=i[o]&&(e[o].style.display=i[o]);return e}w.fn.extend({show:function(){return fe(this,!0)},hide:function(){return fe(this)},toggle:function(e){return"boolean"==typeof e?e?this.show():this.hide():this.each(function(){ae(this)?w(this).show():w(this).hide()})}});var pe=/^(?:checkbox|radio)$/i,de=/<([a-z][^\/\0>\x20\t\r\n\f]+)/i,he=/^$|^module$|\/(?:java|ecma)script/i,ge={option:[1,"<select multiple='multiple'>","</select>"],thead:[1,"<table>","</table>"],col:[2,"<table><colgroup>","</colgroup></table>"],tr:[2,"<table><tbody>","</tbody></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:[0,"",""]};ge.optgroup=ge.option,ge.tbody=ge.tfoot=ge.colgroup=ge.caption=ge.thead,ge.th=ge.td;function ye(e,t){var n;return n="undefined"!=typeof e.getElementsByTagName?e.getElementsByTagName(t||"*"):"undefined"!=typeof e.querySelectorAll?e.querySelectorAll(t||"*"):[],void 0===t||t&&N(e,t)?w.merge([e],n):n}function ve(e,t){for(var n=0,r=e.length;n<r;n++)J.set(e[n],"globalEval",!t||J.get(t[n],"globalEval"))}var me=/<|&#?\w+;/;function xe(e,t,n,r,i){for(var o,a,s,u,l,c,f=t.createDocumentFragment(),p=[],d=0,h=e.length;d<h;d++)if((o=e[d])||0===o)if("object"===x(o))w.merge(p,o.nodeType?[o]:o);else if(me.test(o)){a=a||f.appendChild(t.createElement("div")),s=(de.exec(o)||["",""])[1].toLowerCase(),u=ge[s]||ge._default,a.innerHTML=u[1]+w.htmlPrefilter(o)+u[2],c=u[0];while(c--)a=a.lastChild;w.merge(p,a.childNodes),(a=f.firstChild).textContent=""}else p.push(t.createTextNode(o));f.textContent="",d=0;while(o=p[d++])if(r&&w.inArray(o,r)>-1)i&&i.push(o);else if(l=w.contains(o.ownerDocument,o),a=ye(f.appendChild(o),"script"),l&&ve(a),n){c=0;while(o=a[c++])he.test(o.type||"")&&n.push(o)}return f}!function(){var e=r.createDocumentFragment().appendChild(r.createElement("div")),t=r.createElement("input");t.setAttribute("type","radio"),t.setAttribute("checked","checked"),t.setAttribute("name","t"),e.appendChild(t),h.checkClone=e.cloneNode(!0).cloneNode(!0).lastChild.checked,e.innerHTML="<textarea>x</textarea>",h.noCloneChecked=!!e.cloneNode(!0).lastChild.defaultValue}();var be=r.documentElement,we=/^key/,Te=/^(?:mouse|pointer|contextmenu|drag|drop)|click/,Ce=/^([^.]*)(?:\.(.+)|)/;function Ee(){return!0}function ke(){return!1}function Se(){try{return r.activeElement}catch(e){}}function De(e,t,n,r,i,o){var a,s;if("object"==typeof t){"string"!=typeof n&&(r=r||n,n=void 0);for(s in t)De(e,s,n,r,t[s],o);return e}if(null==r&&null==i?(i=n,r=n=void 0):null==i&&("string"==typeof n?(i=r,r=void 0):(i=r,r=n,n=void 0)),!1===i)i=ke;else if(!i)return e;return 1===o&&(a=i,(i=function(e){return w().off(e),a.apply(this,arguments)}).guid=a.guid||(a.guid=w.guid++)),e.each(function(){w.event.add(this,t,i,r,n)})}w.event={global:{},add:function(e,t,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,y=J.get(e);if(y){n.handler&&(n=(o=n).handler,i=o.selector),i&&w.find.matchesSelector(be,i),n.guid||(n.guid=w.guid++),(u=y.events)||(u=y.events={}),(a=y.handle)||(a=y.handle=function(t){return"undefined"!=typeof w&&w.event.triggered!==t.type?w.event.dispatch.apply(e,arguments):void 0}),l=(t=(t||"").match(M)||[""]).length;while(l--)d=g=(s=Ce.exec(t[l])||[])[1],h=(s[2]||"").split(".").sort(),d&&(f=w.event.special[d]||{},d=(i?f.delegateType:f.bindType)||d,f=w.event.special[d]||{},c=w.extend({type:d,origType:g,data:r,handler:n,guid:n.guid,selector:i,needsContext:i&&w.expr.match.needsContext.test(i),namespace:h.join(".")},o),(p=u[d])||((p=u[d]=[]).delegateCount=0,f.setup&&!1!==f.setup.call(e,r,h,a)||e.addEventListener&&e.addEventListener(d,a)),f.add&&(f.add.call(e,c),c.handler.guid||(c.handler.guid=n.guid)),i?p.splice(p.delegateCount++,0,c):p.push(c),w.event.global[d]=!0)}},remove:function(e,t,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,y=J.hasData(e)&&J.get(e);if(y&&(u=y.events)){l=(t=(t||"").match(M)||[""]).length;while(l--)if(s=Ce.exec(t[l])||[],d=g=s[1],h=(s[2]||"").split(".").sort(),d){f=w.event.special[d]||{},p=u[d=(r?f.delegateType:f.bindType)||d]||[],s=s[2]&&new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"),a=o=p.length;while(o--)c=p[o],!i&&g!==c.origType||n&&n.guid!==c.guid||s&&!s.test(c.namespace)||r&&r!==c.selector&&("**"!==r||!c.selector)||(p.splice(o,1),c.selector&&p.delegateCount--,f.remove&&f.remove.call(e,c));a&&!p.length&&(f.teardown&&!1!==f.teardown.call(e,h,y.handle)||w.removeEvent(e,d,y.handle),delete u[d])}else for(d in u)w.event.remove(e,d+t[l],n,r,!0);w.isEmptyObject(u)&&J.remove(e,"handle events")}},dispatch:function(e){var t=w.event.fix(e),n,r,i,o,a,s,u=new Array(arguments.length),l=(J.get(this,"events")||{})[t.type]||[],c=w.event.special[t.type]||{};for(u[0]=t,n=1;n<arguments.length;n++)u[n]=arguments[n];if(t.delegateTarget=this,!c.preDispatch||!1!==c.preDispatch.call(this,t)){s=w.event.handlers.call(this,t,l),n=0;while((o=s[n++])&&!t.isPropagationStopped()){t.currentTarget=o.elem,r=0;while((a=o.handlers[r++])&&!t.isImmediatePropagationStopped())t.rnamespace&&!t.rnamespace.test(a.namespace)||(t.handleObj=a,t.data=a.data,void 0!==(i=((w.event.special[a.origType]||{}).handle||a.handler).apply(o.elem,u))&&!1===(t.result=i)&&(t.preventDefault(),t.stopPropagation()))}return c.postDispatch&&c.postDispatch.call(this,t),t.result}},handlers:function(e,t){var n,r,i,o,a,s=[],u=t.delegateCount,l=e.target;if(u&&l.nodeType&&!("click"===e.type&&e.button>=1))for(;l!==this;l=l.parentNode||this)if(1===l.nodeType&&("click"!==e.type||!0!==l.disabled)){for(o=[],a={},n=0;n<u;n++)void 0===a[i=(r=t[n]).selector+" "]&&(a[i]=r.needsContext?w(i,this).index(l)>-1:w.find(i,this,null,[l]).length),a[i]&&o.push(r);o.length&&s.push({elem:l,handlers:o})}return l=this,u<t.length&&s.push({elem:l,handlers:t.slice(u)}),s},addProp:function(e,t){Object.defineProperty(w.Event.prototype,e,{enumerable:!0,configurable:!0,get:g(t)?function(){if(this.originalEvent)return t(this.originalEvent)}:function(){if(this.originalEvent)return this.originalEvent[e]},set:function(t){Object.defineProperty(this,e,{enumerable:!0,configurable:!0,writable:!0,value:t})}})},fix:function(e){return e[w.expando]?e:new w.Event(e)},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==Se()&&this.focus)return this.focus(),!1},delegateType:"focusin"},blur:{trigger:function(){if(this===Se()&&this.blur)return this.blur(),!1},delegateType:"focusout"},click:{trigger:function(){if("checkbox"===this.type&&this.click&&N(this,"input"))return this.click(),!1},_default:function(e){return N(e.target,"a")}},beforeunload:{postDispatch:function(e){void 0!==e.result&&e.originalEvent&&(e.originalEvent.returnValue=e.result)}}}},w.removeEvent=function(e,t,n){e.removeEventListener&&e.removeEventListener(t,n)},w.Event=function(e,t){if(!(this instanceof w.Event))return new w.Event(e,t);e&&e.type?(this.originalEvent=e,this.type=e.type,this.isDefaultPrevented=e.defaultPrevented||void 0===e.defaultPrevented&&!1===e.returnValue?Ee:ke,this.target=e.target&&3===e.target.nodeType?e.target.parentNode:e.target,this.currentTarget=e.currentTarget,this.relatedTarget=e.relatedTarget):this.type=e,t&&w.extend(this,t),this.timeStamp=e&&e.timeStamp||Date.now(),this[w.expando]=!0},w.Event.prototype={constructor:w.Event,isDefaultPrevented:ke,isPropagationStopped:ke,isImmediatePropagationStopped:ke,isSimulated:!1,preventDefault:function(){var e=this.originalEvent;this.isDefaultPrevented=Ee,e&&!this.isSimulated&&e.preventDefault()},stopPropagation:function(){var e=this.originalEvent;this.isPropagationStopped=Ee,e&&!this.isSimulated&&e.stopPropagation()},stopImmediatePropagation:function(){var e=this.originalEvent;this.isImmediatePropagationStopped=Ee,e&&!this.isSimulated&&e.stopImmediatePropagation(),this.stopPropagation()}},w.each({altKey:!0,bubbles:!0,cancelable:!0,changedTouches:!0,ctrlKey:!0,detail:!0,eventPhase:!0,metaKey:!0,pageX:!0,pageY:!0,shiftKey:!0,view:!0,"char":!0,charCode:!0,key:!0,keyCode:!0,button:!0,buttons:!0,clientX:!0,clientY:!0,offsetX:!0,offsetY:!0,pointerId:!0,pointerType:!0,screenX:!0,screenY:!0,targetTouches:!0,toElement:!0,touches:!0,which:function(e){var t=e.button;return null==e.which&&we.test(e.type)?null!=e.charCode?e.charCode:e.keyCode:!e.which&&void 0!==t&&Te.test(e.type)?1&t?1:2&t?3:4&t?2:0:e.which}},w.event.addProp),w.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(e,t){w.event.special[e]={delegateType:t,bindType:t,handle:function(e){var n,r=this,i=e.relatedTarget,o=e.handleObj;return i&&(i===r||w.contains(r,i))||(e.type=o.origType,n=o.handler.apply(this,arguments),e.type=t),n}}}),w.fn.extend({on:function(e,t,n,r){return De(this,e,t,n,r)},one:function(e,t,n,r){return De(this,e,t,n,r,1)},off:function(e,t,n){var r,i;if(e&&e.preventDefault&&e.handleObj)return r=e.handleObj,w(e.delegateTarget).off(r.namespace?r.origType+"."+r.namespace:r.origType,r.selector,r.handler),this;if("object"==typeof e){for(i in e)this.off(i,t,e[i]);return this}return!1!==t&&"function"!=typeof t||(n=t,t=void 0),!1===n&&(n=ke),this.each(function(){w.event.remove(this,e,n,t)})}});var Ne=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([a-z][^\/\0>\x20\t\r\n\f]*)[^>]*)\/>/gi,Ae=/<script|<style|<link/i,je=/checked\s*(?:[^=]|=\s*.checked.)/i,qe=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g;function Le(e,t){return N(e,"table")&&N(11!==t.nodeType?t:t.firstChild,"tr")?w(e).children("tbody")[0]||e:e}function He(e){return e.type=(null!==e.getAttribute("type"))+"/"+e.type,e}function Oe(e){return"true/"===(e.type||"").slice(0,5)?e.type=e.type.slice(5):e.removeAttribute("type"),e}function Pe(e,t){var n,r,i,o,a,s,u,l;if(1===t.nodeType){if(J.hasData(e)&&(o=J.access(e),a=J.set(t,o),l=o.events)){delete a.handle,a.events={};for(i in l)for(n=0,r=l[i].length;n<r;n++)w.event.add(t,i,l[i][n])}K.hasData(e)&&(s=K.access(e),u=w.extend({},s),K.set(t,u))}}function Me(e,t){var n=t.nodeName.toLowerCase();"input"===n&&pe.test(e.type)?t.checked=e.checked:"input"!==n&&"textarea"!==n||(t.defaultValue=e.defaultValue)}function Re(e,t,n,r){t=a.apply([],t);var i,o,s,u,l,c,f=0,p=e.length,d=p-1,y=t[0],v=g(y);if(v||p>1&&"string"==typeof y&&!h.checkClone&&je.test(y))return e.each(function(i){var o=e.eq(i);v&&(t[0]=y.call(this,i,o.html())),Re(o,t,n,r)});if(p&&(i=xe(t,e[0].ownerDocument,!1,e,r),o=i.firstChild,1===i.childNodes.length&&(i=o),o||r)){for(u=(s=w.map(ye(i,"script"),He)).length;f<p;f++)l=i,f!==d&&(l=w.clone(l,!0,!0),u&&w.merge(s,ye(l,"script"))),n.call(e[f],l,f);if(u)for(c=s[s.length-1].ownerDocument,w.map(s,Oe),f=0;f<u;f++)l=s[f],he.test(l.type||"")&&!J.access(l,"globalEval")&&w.contains(c,l)&&(l.src&&"module"!==(l.type||"").toLowerCase()?w._evalUrl&&w._evalUrl(l.src):m(l.textContent.replace(qe,""),c,l))}return e}function Ie(e,t,n){for(var r,i=t?w.filter(t,e):e,o=0;null!=(r=i[o]);o++)n||1!==r.nodeType||w.cleanData(ye(r)),r.parentNode&&(n&&w.contains(r.ownerDocument,r)&&ve(ye(r,"script")),r.parentNode.removeChild(r));return e}w.extend({htmlPrefilter:function(e){return e.replace(Ne,"<$1></$2>")},clone:function(e,t,n){var r,i,o,a,s=e.cloneNode(!0),u=w.contains(e.ownerDocument,e);if(!(h.noCloneChecked||1!==e.nodeType&&11!==e.nodeType||w.isXMLDoc(e)))for(a=ye(s),r=0,i=(o=ye(e)).length;r<i;r++)Me(o[r],a[r]);if(t)if(n)for(o=o||ye(e),a=a||ye(s),r=0,i=o.length;r<i;r++)Pe(o[r],a[r]);else Pe(e,s);return(a=ye(s,"script")).length>0&&ve(a,!u&&ye(e,"script")),s},cleanData:function(e){for(var t,n,r,i=w.event.special,o=0;void 0!==(n=e[o]);o++)if(Y(n)){if(t=n[J.expando]){if(t.events)for(r in t.events)i[r]?w.event.remove(n,r):w.removeEvent(n,r,t.handle);n[J.expando]=void 0}n[K.expando]&&(n[K.expando]=void 0)}}}),w.fn.extend({detach:function(e){return Ie(this,e,!0)},remove:function(e){return Ie(this,e)},text:function(e){return z(this,function(e){return void 0===e?w.text(this):this.empty().each(function(){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||(this.textContent=e)})},null,e,arguments.length)},append:function(){return Re(this,arguments,function(e){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||Le(this,e).appendChild(e)})},prepend:function(){return Re(this,arguments,function(e){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var t=Le(this,e);t.insertBefore(e,t.firstChild)}})},before:function(){return Re(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this)})},after:function(){return Re(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this.nextSibling)})},empty:function(){for(var e,t=0;null!=(e=this[t]);t++)1===e.nodeType&&(w.cleanData(ye(e,!1)),e.textContent="");return this},clone:function(e,t){return e=null!=e&&e,t=null==t?e:t,this.map(function(){return w.clone(this,e,t)})},html:function(e){return z(this,function(e){var t=this[0]||{},n=0,r=this.length;if(void 0===e&&1===t.nodeType)return t.innerHTML;if("string"==typeof e&&!Ae.test(e)&&!ge[(de.exec(e)||["",""])[1].toLowerCase()]){e=w.htmlPrefilter(e);try{for(;n<r;n++)1===(t=this[n]||{}).nodeType&&(w.cleanData(ye(t,!1)),t.innerHTML=e);t=0}catch(e){}}t&&this.empty().append(e)},null,e,arguments.length)},replaceWith:function(){var e=[];return Re(this,arguments,function(t){var n=this.parentNode;w.inArray(this,e)<0&&(w.cleanData(ye(this)),n&&n.replaceChild(t,this))},e)}}),w.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(e,t){w.fn[e]=function(e){for(var n,r=[],i=w(e),o=i.length-1,a=0;a<=o;a++)n=a===o?this:this.clone(!0),w(i[a])[t](n),s.apply(r,n.get());return this.pushStack(r)}});var We=new RegExp("^("+re+")(?!px)[a-z%]+$","i"),$e=function(t){var n=t.ownerDocument.defaultView;return n&&n.opener||(n=e),n.getComputedStyle(t)},Be=new RegExp(oe.join("|"),"i");!function(){function t(){if(c){l.style.cssText="position:absolute;left:-11111px;width:60px;margin-top:1px;padding:0;border:0",c.style.cssText="position:relative;display:block;box-sizing:border-box;overflow:scroll;margin:auto;border:1px;padding:1px;width:60%;top:1%",be.appendChild(l).appendChild(c);var t=e.getComputedStyle(c);i="1%"!==t.top,u=12===n(t.marginLeft),c.style.right="60%",s=36===n(t.right),o=36===n(t.width),c.style.position="absolute",a=36===c.offsetWidth||"absolute",be.removeChild(l),c=null}}function n(e){return Math.round(parseFloat(e))}var i,o,a,s,u,l=r.createElement("div"),c=r.createElement("div");c.style&&(c.style.backgroundClip="content-box",c.cloneNode(!0).style.backgroundClip="",h.clearCloneStyle="content-box"===c.style.backgroundClip,w.extend(h,{boxSizingReliable:function(){return t(),o},pixelBoxStyles:function(){return t(),s},pixelPosition:function(){return t(),i},reliableMarginLeft:function(){return t(),u},scrollboxSize:function(){return t(),a}}))}();function Fe(e,t,n){var r,i,o,a,s=e.style;return(n=n||$e(e))&&(""!==(a=n.getPropertyValue(t)||n[t])||w.contains(e.ownerDocument,e)||(a=w.style(e,t)),!h.pixelBoxStyles()&&We.test(a)&&Be.test(t)&&(r=s.width,i=s.minWidth,o=s.maxWidth,s.minWidth=s.maxWidth=s.width=a,a=n.width,s.width=r,s.minWidth=i,s.maxWidth=o)),void 0!==a?a+"":a}function _e(e,t){return{get:function(){if(!e())return(this.get=t).apply(this,arguments);delete this.get}}}var ze=/^(none|table(?!-c[ea]).+)/,Xe=/^--/,Ue={position:"absolute",visibility:"hidden",display:"block"},Ve={letterSpacing:"0",fontWeight:"400"},Ge=["Webkit","Moz","ms"],Ye=r.createElement("div").style;function Qe(e){if(e in Ye)return e;var t=e[0].toUpperCase()+e.slice(1),n=Ge.length;while(n--)if((e=Ge[n]+t)in Ye)return e}function Je(e){var t=w.cssProps[e];return t||(t=w.cssProps[e]=Qe(e)||e),t}function Ke(e,t,n){var r=ie.exec(t);return r?Math.max(0,r[2]-(n||0))+(r[3]||"px"):t}function Ze(e,t,n,r,i,o){var a="width"===t?1:0,s=0,u=0;if(n===(r?"border":"content"))return 0;for(;a<4;a+=2)"margin"===n&&(u+=w.css(e,n+oe[a],!0,i)),r?("content"===n&&(u-=w.css(e,"padding"+oe[a],!0,i)),"margin"!==n&&(u-=w.css(e,"border"+oe[a]+"Width",!0,i))):(u+=w.css(e,"padding"+oe[a],!0,i),"padding"!==n?u+=w.css(e,"border"+oe[a]+"Width",!0,i):s+=w.css(e,"border"+oe[a]+"Width",!0,i));return!r&&o>=0&&(u+=Math.max(0,Math.ceil(e["offset"+t[0].toUpperCase()+t.slice(1)]-o-u-s-.5))),u}function et(e,t,n){var r=$e(e),i=Fe(e,t,r),o="border-box"===w.css(e,"boxSizing",!1,r),a=o;if(We.test(i)){if(!n)return i;i="auto"}return a=a&&(h.boxSizingReliable()||i===e.style[t]),("auto"===i||!parseFloat(i)&&"inline"===w.css(e,"display",!1,r))&&(i=e["offset"+t[0].toUpperCase()+t.slice(1)],a=!0),(i=parseFloat(i)||0)+Ze(e,t,n||(o?"border":"content"),a,r,i)+"px"}w.extend({cssHooks:{opacity:{get:function(e,t){if(t){var n=Fe(e,"opacity");return""===n?"1":n}}}},cssNumber:{animationIterationCount:!0,columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{},style:function(e,t,n,r){if(e&&3!==e.nodeType&&8!==e.nodeType&&e.style){var i,o,a,s=G(t),u=Xe.test(t),l=e.style;if(u||(t=Je(s)),a=w.cssHooks[t]||w.cssHooks[s],void 0===n)return a&&"get"in a&&void 0!==(i=a.get(e,!1,r))?i:l[t];"string"==(o=typeof n)&&(i=ie.exec(n))&&i[1]&&(n=ue(e,t,i),o="number"),null!=n&&n===n&&("number"===o&&(n+=i&&i[3]||(w.cssNumber[s]?"":"px")),h.clearCloneStyle||""!==n||0!==t.indexOf("background")||(l[t]="inherit"),a&&"set"in a&&void 0===(n=a.set(e,n,r))||(u?l.setProperty(t,n):l[t]=n))}},css:function(e,t,n,r){var i,o,a,s=G(t);return Xe.test(t)||(t=Je(s)),(a=w.cssHooks[t]||w.cssHooks[s])&&"get"in a&&(i=a.get(e,!0,n)),void 0===i&&(i=Fe(e,t,r)),"normal"===i&&t in Ve&&(i=Ve[t]),""===n||n?(o=parseFloat(i),!0===n||isFinite(o)?o||0:i):i}}),w.each(["height","width"],function(e,t){w.cssHooks[t]={get:function(e,n,r){if(n)return!ze.test(w.css(e,"display"))||e.getClientRects().length&&e.getBoundingClientRect().width?et(e,t,r):se(e,Ue,function(){return et(e,t,r)})},set:function(e,n,r){var i,o=$e(e),a="border-box"===w.css(e,"boxSizing",!1,o),s=r&&Ze(e,t,r,a,o);return a&&h.scrollboxSize()===o.position&&(s-=Math.ceil(e["offset"+t[0].toUpperCase()+t.slice(1)]-parseFloat(o[t])-Ze(e,t,"border",!1,o)-.5)),s&&(i=ie.exec(n))&&"px"!==(i[3]||"px")&&(e.style[t]=n,n=w.css(e,t)),Ke(e,n,s)}}}),w.cssHooks.marginLeft=_e(h.reliableMarginLeft,function(e,t){if(t)return(parseFloat(Fe(e,"marginLeft"))||e.getBoundingClientRect().left-se(e,{marginLeft:0},function(){return e.getBoundingClientRect().left}))+"px"}),w.each({margin:"",padding:"",border:"Width"},function(e,t){w.cssHooks[e+t]={expand:function(n){for(var r=0,i={},o="string"==typeof n?n.split(" "):[n];r<4;r++)i[e+oe[r]+t]=o[r]||o[r-2]||o[0];return i}},"margin"!==e&&(w.cssHooks[e+t].set=Ke)}),w.fn.extend({css:function(e,t){return z(this,function(e,t,n){var r,i,o={},a=0;if(Array.isArray(t)){for(r=$e(e),i=t.length;a<i;a++)o[t[a]]=w.css(e,t[a],!1,r);return o}return void 0!==n?w.style(e,t,n):w.css(e,t)},e,t,arguments.length>1)}});function tt(e,t,n,r,i){return new tt.prototype.init(e,t,n,r,i)}w.Tween=tt,tt.prototype={constructor:tt,init:function(e,t,n,r,i,o){this.elem=e,this.prop=n,this.easing=i||w.easing._default,this.options=t,this.start=this.now=this.cur(),this.end=r,this.unit=o||(w.cssNumber[n]?"":"px")},cur:function(){var e=tt.propHooks[this.prop];return e&&e.get?e.get(this):tt.propHooks._default.get(this)},run:function(e){var t,n=tt.propHooks[this.prop];return this.options.duration?this.pos=t=w.easing[this.easing](e,this.options.duration*e,0,1,this.options.duration):this.pos=t=e,this.now=(this.end-this.start)*t+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),n&&n.set?n.set(this):tt.propHooks._default.set(this),this}},tt.prototype.init.prototype=tt.prototype,tt.propHooks={_default:{get:function(e){var t;return 1!==e.elem.nodeType||null!=e.elem[e.prop]&&null==e.elem.style[e.prop]?e.elem[e.prop]:(t=w.css(e.elem,e.prop,""))&&"auto"!==t?t:0},set:function(e){w.fx.step[e.prop]?w.fx.step[e.prop](e):1!==e.elem.nodeType||null==e.elem.style[w.cssProps[e.prop]]&&!w.cssHooks[e.prop]?e.elem[e.prop]=e.now:w.style(e.elem,e.prop,e.now+e.unit)}}},tt.propHooks.scrollTop=tt.propHooks.scrollLeft={set:function(e){e.elem.nodeType&&e.elem.parentNode&&(e.elem[e.prop]=e.now)}},w.easing={linear:function(e){return e},swing:function(e){return.5-Math.cos(e*Math.PI)/2},_default:"swing"},w.fx=tt.prototype.init,w.fx.step={};var nt,rt,it=/^(?:toggle|show|hide)$/,ot=/queueHooks$/;function at(){rt&&(!1===r.hidden&&e.requestAnimationFrame?e.requestAnimationFrame(at):e.setTimeout(at,w.fx.interval),w.fx.tick())}function st(){return e.setTimeout(function(){nt=void 0}),nt=Date.now()}function ut(e,t){var n,r=0,i={height:e};for(t=t?1:0;r<4;r+=2-t)i["margin"+(n=oe[r])]=i["padding"+n]=e;return t&&(i.opacity=i.width=e),i}function lt(e,t,n){for(var r,i=(pt.tweeners[t]||[]).concat(pt.tweeners["*"]),o=0,a=i.length;o<a;o++)if(r=i[o].call(n,t,e))return r}function ct(e,t,n){var r,i,o,a,s,u,l,c,f="width"in t||"height"in t,p=this,d={},h=e.style,g=e.nodeType&&ae(e),y=J.get(e,"fxshow");n.queue||(null==(a=w._queueHooks(e,"fx")).unqueued&&(a.unqueued=0,s=a.empty.fire,a.empty.fire=function(){a.unqueued||s()}),a.unqueued++,p.always(function(){p.always(function(){a.unqueued--,w.queue(e,"fx").length||a.empty.fire()})}));for(r in t)if(i=t[r],it.test(i)){if(delete t[r],o=o||"toggle"===i,i===(g?"hide":"show")){if("show"!==i||!y||void 0===y[r])continue;g=!0}d[r]=y&&y[r]||w.style(e,r)}if((u=!w.isEmptyObject(t))||!w.isEmptyObject(d)){f&&1===e.nodeType&&(n.overflow=[h.overflow,h.overflowX,h.overflowY],null==(l=y&&y.display)&&(l=J.get(e,"display")),"none"===(c=w.css(e,"display"))&&(l?c=l:(fe([e],!0),l=e.style.display||l,c=w.css(e,"display"),fe([e]))),("inline"===c||"inline-block"===c&&null!=l)&&"none"===w.css(e,"float")&&(u||(p.done(function(){h.display=l}),null==l&&(c=h.display,l="none"===c?"":c)),h.display="inline-block")),n.overflow&&(h.overflow="hidden",p.always(function(){h.overflow=n.overflow[0],h.overflowX=n.overflow[1],h.overflowY=n.overflow[2]})),u=!1;for(r in d)u||(y?"hidden"in y&&(g=y.hidden):y=J.access(e,"fxshow",{display:l}),o&&(y.hidden=!g),g&&fe([e],!0),p.done(function(){g||fe([e]),J.remove(e,"fxshow");for(r in d)w.style(e,r,d[r])})),u=lt(g?y[r]:0,r,p),r in y||(y[r]=u.start,g&&(u.end=u.start,u.start=0))}}function ft(e,t){var n,r,i,o,a;for(n in e)if(r=G(n),i=t[r],o=e[n],Array.isArray(o)&&(i=o[1],o=e[n]=o[0]),n!==r&&(e[r]=o,delete e[n]),(a=w.cssHooks[r])&&"expand"in a){o=a.expand(o),delete e[r];for(n in o)n in e||(e[n]=o[n],t[n]=i)}else t[r]=i}function pt(e,t,n){var r,i,o=0,a=pt.prefilters.length,s=w.Deferred().always(function(){delete u.elem}),u=function(){if(i)return!1;for(var t=nt||st(),n=Math.max(0,l.startTime+l.duration-t),r=1-(n/l.duration||0),o=0,a=l.tweens.length;o<a;o++)l.tweens[o].run(r);return s.notifyWith(e,[l,r,n]),r<1&&a?n:(a||s.notifyWith(e,[l,1,0]),s.resolveWith(e,[l]),!1)},l=s.promise({elem:e,props:w.extend({},t),opts:w.extend(!0,{specialEasing:{},easing:w.easing._default},n),originalProperties:t,originalOptions:n,startTime:nt||st(),duration:n.duration,tweens:[],createTween:function(t,n){var r=w.Tween(e,l.opts,t,n,l.opts.specialEasing[t]||l.opts.easing);return l.tweens.push(r),r},stop:function(t){var n=0,r=t?l.tweens.length:0;if(i)return this;for(i=!0;n<r;n++)l.tweens[n].run(1);return t?(s.notifyWith(e,[l,1,0]),s.resolveWith(e,[l,t])):s.rejectWith(e,[l,t]),this}}),c=l.props;for(ft(c,l.opts.specialEasing);o<a;o++)if(r=pt.prefilters[o].call(l,e,c,l.opts))return g(r.stop)&&(w._queueHooks(l.elem,l.opts.queue).stop=r.stop.bind(r)),r;return w.map(c,lt,l),g(l.opts.start)&&l.opts.start.call(e,l),l.progress(l.opts.progress).done(l.opts.done,l.opts.complete).fail(l.opts.fail).always(l.opts.always),w.fx.timer(w.extend(u,{elem:e,anim:l,queue:l.opts.queue})),l}w.Animation=w.extend(pt,{tweeners:{"*":[function(e,t){var n=this.createTween(e,t);return ue(n.elem,e,ie.exec(t),n),n}]},tweener:function(e,t){g(e)?(t=e,e=["*"]):e=e.match(M);for(var n,r=0,i=e.length;r<i;r++)n=e[r],pt.tweeners[n]=pt.tweeners[n]||[],pt.tweeners[n].unshift(t)},prefilters:[ct],prefilter:function(e,t){t?pt.prefilters.unshift(e):pt.prefilters.push(e)}}),w.speed=function(e,t,n){var r=e&&"object"==typeof e?w.extend({},e):{complete:n||!n&&t||g(e)&&e,duration:e,easing:n&&t||t&&!g(t)&&t};return w.fx.off?r.duration=0:"number"!=typeof r.duration&&(r.duration in w.fx.speeds?r.duration=w.fx.speeds[r.duration]:r.duration=w.fx.speeds._default),null!=r.queue&&!0!==r.queue||(r.queue="fx"),r.old=r.complete,r.complete=function(){g(r.old)&&r.old.call(this),r.queue&&w.dequeue(this,r.queue)},r},w.fn.extend({fadeTo:function(e,t,n,r){return this.filter(ae).css("opacity",0).show().end().animate({opacity:t},e,n,r)},animate:function(e,t,n,r){var i=w.isEmptyObject(e),o=w.speed(t,n,r),a=function(){var t=pt(this,w.extend({},e),o);(i||J.get(this,"finish"))&&t.stop(!0)};return a.finish=a,i||!1===o.queue?this.each(a):this.queue(o.queue,a)},stop:function(e,t,n){var r=function(e){var t=e.stop;delete e.stop,t(n)};return"string"!=typeof e&&(n=t,t=e,e=void 0),t&&!1!==e&&this.queue(e||"fx",[]),this.each(function(){var t=!0,i=null!=e&&e+"queueHooks",o=w.timers,a=J.get(this);if(i)a[i]&&a[i].stop&&r(a[i]);else for(i in a)a[i]&&a[i].stop&&ot.test(i)&&r(a[i]);for(i=o.length;i--;)o[i].elem!==this||null!=e&&o[i].queue!==e||(o[i].anim.stop(n),t=!1,o.splice(i,1));!t&&n||w.dequeue(this,e)})},finish:function(e){return!1!==e&&(e=e||"fx"),this.each(function(){var t,n=J.get(this),r=n[e+"queue"],i=n[e+"queueHooks"],o=w.timers,a=r?r.length:0;for(n.finish=!0,w.queue(this,e,[]),i&&i.stop&&i.stop.call(this,!0),t=o.length;t--;)o[t].elem===this&&o[t].queue===e&&(o[t].anim.stop(!0),o.splice(t,1));for(t=0;t<a;t++)r[t]&&r[t].finish&&r[t].finish.call(this);delete n.finish})}}),w.each(["toggle","show","hide"],function(e,t){var n=w.fn[t];w.fn[t]=function(e,r,i){return null==e||"boolean"==typeof e?n.apply(this,arguments):this.animate(ut(t,!0),e,r,i)}}),w.each({slideDown:ut("show"),slideUp:ut("hide"),slideToggle:ut("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(e,t){w.fn[e]=function(e,n,r){return this.animate(t,e,n,r)}}),w.timers=[],w.fx.tick=function(){var e,t=0,n=w.timers;for(nt=Date.now();t<n.length;t++)(e=n[t])()||n[t]!==e||n.splice(t--,1);n.length||w.fx.stop(),nt=void 0},w.fx.timer=function(e){w.timers.push(e),w.fx.start()},w.fx.interval=13,w.fx.start=function(){rt||(rt=!0,at())},w.fx.stop=function(){rt=null},w.fx.speeds={slow:600,fast:200,_default:400},w.fn.delay=function(t,n){return t=w.fx?w.fx.speeds[t]||t:t,n=n||"fx",this.queue(n,function(n,r){var i=e.setTimeout(n,t);r.stop=function(){e.clearTimeout(i)}})},function(){var e=r.createElement("input"),t=r.createElement("select").appendChild(r.createElement("option"));e.type="checkbox",h.checkOn=""!==e.value,h.optSelected=t.selected,(e=r.createElement("input")).value="t",e.type="radio",h.radioValue="t"===e.value}();var dt,ht=w.expr.attrHandle;w.fn.extend({attr:function(e,t){return z(this,w.attr,e,t,arguments.length>1)},removeAttr:function(e){return this.each(function(){w.removeAttr(this,e)})}}),w.extend({attr:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return"undefined"==typeof e.getAttribute?w.prop(e,t,n):(1===o&&w.isXMLDoc(e)||(i=w.attrHooks[t.toLowerCase()]||(w.expr.match.bool.test(t)?dt:void 0)),void 0!==n?null===n?void w.removeAttr(e,t):i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:(e.setAttribute(t,n+""),n):i&&"get"in i&&null!==(r=i.get(e,t))?r:null==(r=w.find.attr(e,t))?void 0:r)},attrHooks:{type:{set:function(e,t){if(!h.radioValue&&"radio"===t&&N(e,"input")){var n=e.value;return e.setAttribute("type",t),n&&(e.value=n),t}}}},removeAttr:function(e,t){var n,r=0,i=t&&t.match(M);if(i&&1===e.nodeType)while(n=i[r++])e.removeAttribute(n)}}),dt={set:function(e,t,n){return!1===t?w.removeAttr(e,n):e.setAttribute(n,n),n}},w.each(w.expr.match.bool.source.match(/\w+/g),function(e,t){var n=ht[t]||w.find.attr;ht[t]=function(e,t,r){var i,o,a=t.toLowerCase();return r||(o=ht[a],ht[a]=i,i=null!=n(e,t,r)?a:null,ht[a]=o),i}});var gt=/^(?:input|select|textarea|button)$/i,yt=/^(?:a|area)$/i;w.fn.extend({prop:function(e,t){return z(this,w.prop,e,t,arguments.length>1)},removeProp:function(e){return this.each(function(){delete this[w.propFix[e]||e]})}}),w.extend({prop:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return 1===o&&w.isXMLDoc(e)||(t=w.propFix[t]||t,i=w.propHooks[t]),void 0!==n?i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:e[t]=n:i&&"get"in i&&null!==(r=i.get(e,t))?r:e[t]},propHooks:{tabIndex:{get:function(e){var t=w.find.attr(e,"tabindex");return t?parseInt(t,10):gt.test(e.nodeName)||yt.test(e.nodeName)&&e.href?0:-1}}},propFix:{"for":"htmlFor","class":"className"}}),h.optSelected||(w.propHooks.selected={get:function(e){var t=e.parentNode;return t&&t.parentNode&&t.parentNode.selectedIndex,null},set:function(e){var t=e.parentNode;t&&(t.selectedIndex,t.parentNode&&t.parentNode.selectedIndex)}}),w.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){w.propFix[this.toLowerCase()]=this});function vt(e){return(e.match(M)||[]).join(" ")}function mt(e){return e.getAttribute&&e.getAttribute("class")||""}function xt(e){return Array.isArray(e)?e:"string"==typeof e?e.match(M)||[]:[]}w.fn.extend({addClass:function(e){var t,n,r,i,o,a,s,u=0;if(g(e))return this.each(function(t){w(this).addClass(e.call(this,t,mt(this)))});if((t=xt(e)).length)while(n=this[u++])if(i=mt(n),r=1===n.nodeType&&" "+vt(i)+" "){a=0;while(o=t[a++])r.indexOf(" "+o+" ")<0&&(r+=o+" ");i!==(s=vt(r))&&n.setAttribute("class",s)}return this},removeClass:function(e){var t,n,r,i,o,a,s,u=0;if(g(e))return this.each(function(t){w(this).removeClass(e.call(this,t,mt(this)))});if(!arguments.length)return this.attr("class","");if((t=xt(e)).length)while(n=this[u++])if(i=mt(n),r=1===n.nodeType&&" "+vt(i)+" "){a=0;while(o=t[a++])while(r.indexOf(" "+o+" ")>-1)r=r.replace(" "+o+" "," ");i!==(s=vt(r))&&n.setAttribute("class",s)}return this},toggleClass:function(e,t){var n=typeof e,r="string"===n||Array.isArray(e);return"boolean"==typeof t&&r?t?this.addClass(e):this.removeClass(e):g(e)?this.each(function(n){w(this).toggleClass(e.call(this,n,mt(this),t),t)}):this.each(function(){var t,i,o,a;if(r){i=0,o=w(this),a=xt(e);while(t=a[i++])o.hasClass(t)?o.removeClass(t):o.addClass(t)}else void 0!==e&&"boolean"!==n||((t=mt(this))&&J.set(this,"__className__",t),this.setAttribute&&this.setAttribute("class",t||!1===e?"":J.get(this,"__className__")||""))})},hasClass:function(e){var t,n,r=0;t=" "+e+" ";while(n=this[r++])if(1===n.nodeType&&(" "+vt(mt(n))+" ").indexOf(t)>-1)return!0;return!1}});var bt=/\r/g;w.fn.extend({val:function(e){var t,n,r,i=this[0];{if(arguments.length)return r=g(e),this.each(function(n){var i;1===this.nodeType&&(null==(i=r?e.call(this,n,w(this).val()):e)?i="":"number"==typeof i?i+="":Array.isArray(i)&&(i=w.map(i,function(e){return null==e?"":e+""})),(t=w.valHooks[this.type]||w.valHooks[this.nodeName.toLowerCase()])&&"set"in t&&void 0!==t.set(this,i,"value")||(this.value=i))});if(i)return(t=w.valHooks[i.type]||w.valHooks[i.nodeName.toLowerCase()])&&"get"in t&&void 0!==(n=t.get(i,"value"))?n:"string"==typeof(n=i.value)?n.replace(bt,""):null==n?"":n}}}),w.extend({valHooks:{option:{get:function(e){var t=w.find.attr(e,"value");return null!=t?t:vt(w.text(e))}},select:{get:function(e){var t,n,r,i=e.options,o=e.selectedIndex,a="select-one"===e.type,s=a?null:[],u=a?o+1:i.length;for(r=o<0?u:a?o:0;r<u;r++)if(((n=i[r]).selected||r===o)&&!n.disabled&&(!n.parentNode.disabled||!N(n.parentNode,"optgroup"))){if(t=w(n).val(),a)return t;s.push(t)}return s},set:function(e,t){var n,r,i=e.options,o=w.makeArray(t),a=i.length;while(a--)((r=i[a]).selected=w.inArray(w.valHooks.option.get(r),o)>-1)&&(n=!0);return n||(e.selectedIndex=-1),o}}}}),w.each(["radio","checkbox"],function(){w.valHooks[this]={set:function(e,t){if(Array.isArray(t))return e.checked=w.inArray(w(e).val(),t)>-1}},h.checkOn||(w.valHooks[this].get=function(e){return null===e.getAttribute("value")?"on":e.value})}),h.focusin="onfocusin"in e;var wt=/^(?:focusinfocus|focusoutblur)$/,Tt=function(e){e.stopPropagation()};w.extend(w.event,{trigger:function(t,n,i,o){var a,s,u,l,c,p,d,h,v=[i||r],m=f.call(t,"type")?t.type:t,x=f.call(t,"namespace")?t.namespace.split("."):[];if(s=h=u=i=i||r,3!==i.nodeType&&8!==i.nodeType&&!wt.test(m+w.event.triggered)&&(m.indexOf(".")>-1&&(m=(x=m.split(".")).shift(),x.sort()),c=m.indexOf(":")<0&&"on"+m,t=t[w.expando]?t:new w.Event(m,"object"==typeof t&&t),t.isTrigger=o?2:3,t.namespace=x.join("."),t.rnamespace=t.namespace?new RegExp("(^|\\.)"+x.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,t.result=void 0,t.target||(t.target=i),n=null==n?[t]:w.makeArray(n,[t]),d=w.event.special[m]||{},o||!d.trigger||!1!==d.trigger.apply(i,n))){if(!o&&!d.noBubble&&!y(i)){for(l=d.delegateType||m,wt.test(l+m)||(s=s.parentNode);s;s=s.parentNode)v.push(s),u=s;u===(i.ownerDocument||r)&&v.push(u.defaultView||u.parentWindow||e)}a=0;while((s=v[a++])&&!t.isPropagationStopped())h=s,t.type=a>1?l:d.bindType||m,(p=(J.get(s,"events")||{})[t.type]&&J.get(s,"handle"))&&p.apply(s,n),(p=c&&s[c])&&p.apply&&Y(s)&&(t.result=p.apply(s,n),!1===t.result&&t.preventDefault());return t.type=m,o||t.isDefaultPrevented()||d._default&&!1!==d._default.apply(v.pop(),n)||!Y(i)||c&&g(i[m])&&!y(i)&&((u=i[c])&&(i[c]=null),w.event.triggered=m,t.isPropagationStopped()&&h.addEventListener(m,Tt),i[m](),t.isPropagationStopped()&&h.removeEventListener(m,Tt),w.event.triggered=void 0,u&&(i[c]=u)),t.result}},simulate:function(e,t,n){var r=w.extend(new w.Event,n,{type:e,isSimulated:!0});w.event.trigger(r,null,t)}}),w.fn.extend({trigger:function(e,t){return this.each(function(){w.event.trigger(e,t,this)})},triggerHandler:function(e,t){var n=this[0];if(n)return w.event.trigger(e,t,n,!0)}}),h.focusin||w.each({focus:"focusin",blur:"focusout"},function(e,t){var n=function(e){w.event.simulate(t,e.target,w.event.fix(e))};w.event.special[t]={setup:function(){var r=this.ownerDocument||this,i=J.access(r,t);i||r.addEventListener(e,n,!0),J.access(r,t,(i||0)+1)},teardown:function(){var r=this.ownerDocument||this,i=J.access(r,t)-1;i?J.access(r,t,i):(r.removeEventListener(e,n,!0),J.remove(r,t))}}});var Ct=e.location,Et=Date.now(),kt=/\?/;w.parseXML=function(t){var n;if(!t||"string"!=typeof t)return null;try{n=(new e.DOMParser).parseFromString(t,"text/xml")}catch(e){n=void 0}return n&&!n.getElementsByTagName("parsererror").length||w.error("Invalid XML: "+t),n};var St=/\[\]$/,Dt=/\r?\n/g,Nt=/^(?:submit|button|image|reset|file)$/i,At=/^(?:input|select|textarea|keygen)/i;function jt(e,t,n,r){var i;if(Array.isArray(t))w.each(t,function(t,i){n||St.test(e)?r(e,i):jt(e+"["+("object"==typeof i&&null!=i?t:"")+"]",i,n,r)});else if(n||"object"!==x(t))r(e,t);else for(i in t)jt(e+"["+i+"]",t[i],n,r)}w.param=function(e,t){var n,r=[],i=function(e,t){var n=g(t)?t():t;r[r.length]=encodeURIComponent(e)+"="+encodeURIComponent(null==n?"":n)};if(Array.isArray(e)||e.jquery&&!w.isPlainObject(e))w.each(e,function(){i(this.name,this.value)});else for(n in e)jt(n,e[n],t,i);return r.join("&")},w.fn.extend({serialize:function(){return w.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var e=w.prop(this,"elements");return e?w.makeArray(e):this}).filter(function(){var e=this.type;return this.name&&!w(this).is(":disabled")&&At.test(this.nodeName)&&!Nt.test(e)&&(this.checked||!pe.test(e))}).map(function(e,t){var n=w(this).val();return null==n?null:Array.isArray(n)?w.map(n,function(e){return{name:t.name,value:e.replace(Dt,"\r\n")}}):{name:t.name,value:n.replace(Dt,"\r\n")}}).get()}});var qt=/%20/g,Lt=/#.*$/,Ht=/([?&])_=[^&]*/,Ot=/^(.*?):[ \t]*([^\r\n]*)$/gm,Pt=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Mt=/^(?:GET|HEAD)$/,Rt=/^\/\//,It={},Wt={},$t="*/".concat("*"),Bt=r.createElement("a");Bt.href=Ct.href;function Ft(e){return function(t,n){"string"!=typeof t&&(n=t,t="*");var r,i=0,o=t.toLowerCase().match(M)||[];if(g(n))while(r=o[i++])"+"===r[0]?(r=r.slice(1)||"*",(e[r]=e[r]||[]).unshift(n)):(e[r]=e[r]||[]).push(n)}}function _t(e,t,n,r){var i={},o=e===Wt;function a(s){var u;return i[s]=!0,w.each(e[s]||[],function(e,s){var l=s(t,n,r);return"string"!=typeof l||o||i[l]?o?!(u=l):void 0:(t.dataTypes.unshift(l),a(l),!1)}),u}return a(t.dataTypes[0])||!i["*"]&&a("*")}function zt(e,t){var n,r,i=w.ajaxSettings.flatOptions||{};for(n in t)void 0!==t[n]&&((i[n]?e:r||(r={}))[n]=t[n]);return r&&w.extend(!0,e,r),e}function Xt(e,t,n){var r,i,o,a,s=e.contents,u=e.dataTypes;while("*"===u[0])u.shift(),void 0===r&&(r=e.mimeType||t.getResponseHeader("Content-Type"));if(r)for(i in s)if(s[i]&&s[i].test(r)){u.unshift(i);break}if(u[0]in n)o=u[0];else{for(i in n){if(!u[0]||e.converters[i+" "+u[0]]){o=i;break}a||(a=i)}o=o||a}if(o)return o!==u[0]&&u.unshift(o),n[o]}function Ut(e,t,n,r){var i,o,a,s,u,l={},c=e.dataTypes.slice();if(c[1])for(a in e.converters)l[a.toLowerCase()]=e.converters[a];o=c.shift();while(o)if(e.responseFields[o]&&(n[e.responseFields[o]]=t),!u&&r&&e.dataFilter&&(t=e.dataFilter(t,e.dataType)),u=o,o=c.shift())if("*"===o)o=u;else if("*"!==u&&u!==o){if(!(a=l[u+" "+o]||l["* "+o]))for(i in l)if((s=i.split(" "))[1]===o&&(a=l[u+" "+s[0]]||l["* "+s[0]])){!0===a?a=l[i]:!0!==l[i]&&(o=s[0],c.unshift(s[1]));break}if(!0!==a)if(a&&e["throws"])t=a(t);else try{t=a(t)}catch(e){return{state:"parsererror",error:a?e:"No conversion from "+u+" to "+o}}}return{state:"success",data:t}}w.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:Ct.href,type:"GET",isLocal:Pt.test(Ct.protocol),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":$t,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/\bxml\b/,html:/\bhtml/,json:/\bjson\b/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":JSON.parse,"text xml":w.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(e,t){return t?zt(zt(e,w.ajaxSettings),t):zt(w.ajaxSettings,e)},ajaxPrefilter:Ft(It),ajaxTransport:Ft(Wt),ajax:function(t,n){"object"==typeof t&&(n=t,t=void 0),n=n||{};var i,o,a,s,u,l,c,f,p,d,h=w.ajaxSetup({},n),g=h.context||h,y=h.context&&(g.nodeType||g.jquery)?w(g):w.event,v=w.Deferred(),m=w.Callbacks("once memory"),x=h.statusCode||{},b={},T={},C="canceled",E={readyState:0,getResponseHeader:function(e){var t;if(c){if(!s){s={};while(t=Ot.exec(a))s[t[1].toLowerCase()]=t[2]}t=s[e.toLowerCase()]}return null==t?null:t},getAllResponseHeaders:function(){return c?a:null},setRequestHeader:function(e,t){return null==c&&(e=T[e.toLowerCase()]=T[e.toLowerCase()]||e,b[e]=t),this},overrideMimeType:function(e){return null==c&&(h.mimeType=e),this},statusCode:function(e){var t;if(e)if(c)E.always(e[E.status]);else for(t in e)x[t]=[x[t],e[t]];return this},abort:function(e){var t=e||C;return i&&i.abort(t),k(0,t),this}};if(v.promise(E),h.url=((t||h.url||Ct.href)+"").replace(Rt,Ct.protocol+"//"),h.type=n.method||n.type||h.method||h.type,h.dataTypes=(h.dataType||"*").toLowerCase().match(M)||[""],null==h.crossDomain){l=r.createElement("a");try{l.href=h.url,l.href=l.href,h.crossDomain=Bt.protocol+"//"+Bt.host!=l.protocol+"//"+l.host}catch(e){h.crossDomain=!0}}if(h.data&&h.processData&&"string"!=typeof h.data&&(h.data=w.param(h.data,h.traditional)),_t(It,h,n,E),c)return E;(f=w.event&&h.global)&&0==w.active++&&w.event.trigger("ajaxStart"),h.type=h.type.toUpperCase(),h.hasContent=!Mt.test(h.type),o=h.url.replace(Lt,""),h.hasContent?h.data&&h.processData&&0===(h.contentType||"").indexOf("application/x-www-form-urlencoded")&&(h.data=h.data.replace(qt,"+")):(d=h.url.slice(o.length),h.data&&(h.processData||"string"==typeof h.data)&&(o+=(kt.test(o)?"&":"?")+h.data,delete h.data),!1===h.cache&&(o=o.replace(Ht,"$1"),d=(kt.test(o)?"&":"?")+"_="+Et+++d),h.url=o+d),h.ifModified&&(w.lastModified[o]&&E.setRequestHeader("If-Modified-Since",w.lastModified[o]),w.etag[o]&&E.setRequestHeader("If-None-Match",w.etag[o])),(h.data&&h.hasContent&&!1!==h.contentType||n.contentType)&&E.setRequestHeader("Content-Type",h.contentType),E.setRequestHeader("Accept",h.dataTypes[0]&&h.accepts[h.dataTypes[0]]?h.accepts[h.dataTypes[0]]+("*"!==h.dataTypes[0]?", "+$t+"; q=0.01":""):h.accepts["*"]);for(p in h.headers)E.setRequestHeader(p,h.headers[p]);if(h.beforeSend&&(!1===h.beforeSend.call(g,E,h)||c))return E.abort();if(C="abort",m.add(h.complete),E.done(h.success),E.fail(h.error),i=_t(Wt,h,n,E)){if(E.readyState=1,f&&y.trigger("ajaxSend",[E,h]),c)return E;h.async&&h.timeout>0&&(u=e.setTimeout(function(){E.abort("timeout")},h.timeout));try{c=!1,i.send(b,k)}catch(e){if(c)throw e;k(-1,e)}}else k(-1,"No Transport");function k(t,n,r,s){var l,p,d,b,T,C=n;c||(c=!0,u&&e.clearTimeout(u),i=void 0,a=s||"",E.readyState=t>0?4:0,l=t>=200&&t<300||304===t,r&&(b=Xt(h,E,r)),b=Ut(h,b,E,l),l?(h.ifModified&&((T=E.getResponseHeader("Last-Modified"))&&(w.lastModified[o]=T),(T=E.getResponseHeader("etag"))&&(w.etag[o]=T)),204===t||"HEAD"===h.type?C="nocontent":304===t?C="notmodified":(C=b.state,p=b.data,l=!(d=b.error))):(d=C,!t&&C||(C="error",t<0&&(t=0))),E.status=t,E.statusText=(n||C)+"",l?v.resolveWith(g,[p,C,E]):v.rejectWith(g,[E,C,d]),E.statusCode(x),x=void 0,f&&y.trigger(l?"ajaxSuccess":"ajaxError",[E,h,l?p:d]),m.fireWith(g,[E,C]),f&&(y.trigger("ajaxComplete",[E,h]),--w.active||w.event.trigger("ajaxStop")))}return E},getJSON:function(e,t,n){return w.get(e,t,n,"json")},getScript:function(e,t){return w.get(e,void 0,t,"script")}}),w.each(["get","post"],function(e,t){w[t]=function(e,n,r,i){return g(n)&&(i=i||r,r=n,n=void 0),w.ajax(w.extend({url:e,type:t,dataType:i,data:n,success:r},w.isPlainObject(e)&&e))}}),w._evalUrl=function(e){return w.ajax({url:e,type:"GET",dataType:"script",cache:!0,async:!1,global:!1,"throws":!0})},w.fn.extend({wrapAll:function(e){var t;return this[0]&&(g(e)&&(e=e.call(this[0])),t=w(e,this[0].ownerDocument).eq(0).clone(!0),this[0].parentNode&&t.insertBefore(this[0]),t.map(function(){var e=this;while(e.firstElementChild)e=e.firstElementChild;return e}).append(this)),this},wrapInner:function(e){return g(e)?this.each(function(t){w(this).wrapInner(e.call(this,t))}):this.each(function(){var t=w(this),n=t.contents();n.length?n.wrapAll(e):t.append(e)})},wrap:function(e){var t=g(e);return this.each(function(n){w(this).wrapAll(t?e.call(this,n):e)})},unwrap:function(e){return this.parent(e).not("body").each(function(){w(this).replaceWith(this.childNodes)}),this}}),w.expr.pseudos.hidden=function(e){return!w.expr.pseudos.visible(e)},w.expr.pseudos.visible=function(e){return!!(e.offsetWidth||e.offsetHeight||e.getClientRects().length)},w.ajaxSettings.xhr=function(){try{return new e.XMLHttpRequest}catch(e){}};var Vt={0:200,1223:204},Gt=w.ajaxSettings.xhr();h.cors=!!Gt&&"withCredentials"in Gt,h.ajax=Gt=!!Gt,w.ajaxTransport(function(t){var n,r;if(h.cors||Gt&&!t.crossDomain)return{send:function(i,o){var a,s=t.xhr();if(s.open(t.type,t.url,t.async,t.username,t.password),t.xhrFields)for(a in t.xhrFields)s[a]=t.xhrFields[a];t.mimeType&&s.overrideMimeType&&s.overrideMimeType(t.mimeType),t.crossDomain||i["X-Requested-With"]||(i["X-Requested-With"]="XMLHttpRequest");for(a in i)s.setRequestHeader(a,i[a]);n=function(e){return function(){n&&(n=r=s.onload=s.onerror=s.onabort=s.ontimeout=s.onreadystatechange=null,"abort"===e?s.abort():"error"===e?"number"!=typeof s.status?o(0,"error"):o(s.status,s.statusText):o(Vt[s.status]||s.status,s.statusText,"text"!==(s.responseType||"text")||"string"!=typeof s.responseText?{binary:s.response}:{text:s.responseText},s.getAllResponseHeaders()))}},s.onload=n(),r=s.onerror=s.ontimeout=n("error"),void 0!==s.onabort?s.onabort=r:s.onreadystatechange=function(){4===s.readyState&&e.setTimeout(function(){n&&r()})},n=n("abort");try{s.send(t.hasContent&&t.data||null)}catch(e){if(n)throw e}},abort:function(){n&&n()}}}),w.ajaxPrefilter(function(e){e.crossDomain&&(e.contents.script=!1)}),w.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/\b(?:java|ecma)script\b/},converters:{"text script":function(e){return w.globalEval(e),e}}}),w.ajaxPrefilter("script",function(e){void 0===e.cache&&(e.cache=!1),e.crossDomain&&(e.type="GET")}),w.ajaxTransport("script",function(e){if(e.crossDomain){var t,n;return{send:function(i,o){t=w("<script>").prop({charset:e.scriptCharset,src:e.url}).on("load error",n=function(e){t.remove(),n=null,e&&o("error"===e.type?404:200,e.type)}),r.head.appendChild(t[0])},abort:function(){n&&n()}}}});var Yt=[],Qt=/(=)\?(?=&|$)|\?\?/;w.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var e=Yt.pop()||w.expando+"_"+Et++;return this[e]=!0,e}}),w.ajaxPrefilter("json jsonp",function(t,n,r){var i,o,a,s=!1!==t.jsonp&&(Qt.test(t.url)?"url":"string"==typeof t.data&&0===(t.contentType||"").indexOf("application/x-www-form-urlencoded")&&Qt.test(t.data)&&"data");if(s||"jsonp"===t.dataTypes[0])return i=t.jsonpCallback=g(t.jsonpCallback)?t.jsonpCallback():t.jsonpCallback,s?t[s]=t[s].replace(Qt,"$1"+i):!1!==t.jsonp&&(t.url+=(kt.test(t.url)?"&":"?")+t.jsonp+"="+i),t.converters["script json"]=function(){return a||w.error(i+" was not called"),a[0]},t.dataTypes[0]="json",o=e[i],e[i]=function(){a=arguments},r.always(function(){void 0===o?w(e).removeProp(i):e[i]=o,t[i]&&(t.jsonpCallback=n.jsonpCallback,Yt.push(i)),a&&g(o)&&o(a[0]),a=o=void 0}),"script"}),h.createHTMLDocument=function(){var e=r.implementation.createHTMLDocument("").body;return e.innerHTML="<form></form><form></form>",2===e.childNodes.length}(),w.parseHTML=function(e,t,n){if("string"!=typeof e)return[];"boolean"==typeof t&&(n=t,t=!1);var i,o,a;return t||(h.createHTMLDocument?((i=(t=r.implementation.createHTMLDocument("")).createElement("base")).href=r.location.href,t.head.appendChild(i)):t=r),o=A.exec(e),a=!n&&[],o?[t.createElement(o[1])]:(o=xe([e],t,a),a&&a.length&&w(a).remove(),w.merge([],o.childNodes))},w.fn.load=function(e,t,n){var r,i,o,a=this,s=e.indexOf(" ");return s>-1&&(r=vt(e.slice(s)),e=e.slice(0,s)),g(t)?(n=t,t=void 0):t&&"object"==typeof t&&(i="POST"),a.length>0&&w.ajax({url:e,type:i||"GET",dataType:"html",data:t}).done(function(e){o=arguments,a.html(r?w("<div>").append(w.parseHTML(e)).find(r):e)}).always(n&&function(e,t){a.each(function(){n.apply(this,o||[e.responseText,t,e])})}),this},w.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(e,t){w.fn[t]=function(e){return this.on(t,e)}}),w.expr.pseudos.animated=function(e){return w.grep(w.timers,function(t){return e===t.elem}).length},w.offset={setOffset:function(e,t,n){var r,i,o,a,s,u,l,c=w.css(e,"position"),f=w(e),p={};"static"===c&&(e.style.position="relative"),s=f.offset(),o=w.css(e,"top"),u=w.css(e,"left"),(l=("absolute"===c||"fixed"===c)&&(o+u).indexOf("auto")>-1)?(a=(r=f.position()).top,i=r.left):(a=parseFloat(o)||0,i=parseFloat(u)||0),g(t)&&(t=t.call(e,n,w.extend({},s))),null!=t.top&&(p.top=t.top-s.top+a),null!=t.left&&(p.left=t.left-s.left+i),"using"in t?t.using.call(e,p):f.css(p)}},w.fn.extend({offset:function(e){if(arguments.length)return void 0===e?this:this.each(function(t){w.offset.setOffset(this,e,t)});var t,n,r=this[0];if(r)return r.getClientRects().length?(t=r.getBoundingClientRect(),n=r.ownerDocument.defaultView,{top:t.top+n.pageYOffset,left:t.left+n.pageXOffset}):{top:0,left:0}},position:function(){if(this[0]){var e,t,n,r=this[0],i={top:0,left:0};if("fixed"===w.css(r,"position"))t=r.getBoundingClientRect();else{t=this.offset(),n=r.ownerDocument,e=r.offsetParent||n.documentElement;while(e&&(e===n.body||e===n.documentElement)&&"static"===w.css(e,"position"))e=e.parentNode;e&&e!==r&&1===e.nodeType&&((i=w(e).offset()).top+=w.css(e,"borderTopWidth",!0),i.left+=w.css(e,"borderLeftWidth",!0))}return{top:t.top-i.top-w.css(r,"marginTop",!0),left:t.left-i.left-w.css(r,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var e=this.offsetParent;while(e&&"static"===w.css(e,"position"))e=e.offsetParent;return e||be})}}),w.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(e,t){var n="pageYOffset"===t;w.fn[e]=function(r){return z(this,function(e,r,i){var o;if(y(e)?o=e:9===e.nodeType&&(o=e.defaultView),void 0===i)return o?o[t]:e[r];o?o.scrollTo(n?o.pageXOffset:i,n?i:o.pageYOffset):e[r]=i},e,r,arguments.length)}}),w.each(["top","left"],function(e,t){w.cssHooks[t]=_e(h.pixelPosition,function(e,n){if(n)return n=Fe(e,t),We.test(n)?w(e).position()[t]+"px":n})}),w.each({Height:"height",Width:"width"},function(e,t){w.each({padding:"inner"+e,content:t,"":"outer"+e},function(n,r){w.fn[r]=function(i,o){var a=arguments.length&&(n||"boolean"!=typeof i),s=n||(!0===i||!0===o?"margin":"border");return z(this,function(t,n,i){var o;return y(t)?0===r.indexOf("outer")?t["inner"+e]:t.document.documentElement["client"+e]:9===t.nodeType?(o=t.documentElement,Math.max(t.body["scroll"+e],o["scroll"+e],t.body["offset"+e],o["offset"+e],o["client"+e])):void 0===i?w.css(t,n,s):w.style(t,n,i,s)},t,a?i:void 0,a)}})}),w.each("blur focus focusin focusout resize scroll click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup contextmenu".split(" "),function(e,t){w.fn[t]=function(e,n){return arguments.length>0?this.on(t,null,e,n):this.trigger(t)}}),w.fn.extend({hover:function(e,t){return this.mouseenter(e).mouseleave(t||e)}}),w.fn.extend({bind:function(e,t,n){return this.on(e,null,t,n)},unbind:function(e,t){return this.off(e,null,t)},delegate:function(e,t,n,r){return this.on(t,e,n,r)},undelegate:function(e,t,n){return 1===arguments.length?this.off(e,"**"):this.off(t,e||"**",n)}}),w.proxy=function(e,t){var n,r,i;if("string"==typeof t&&(n=e[t],t=e,e=n),g(e))return r=o.call(arguments,2),i=function(){return e.apply(t||this,r.concat(o.call(arguments)))},i.guid=e.guid=e.guid||w.guid++,i},w.holdReady=function(e){e?w.readyWait++:w.ready(!0)},w.isArray=Array.isArray,w.parseJSON=JSON.parse,w.nodeName=N,w.isFunction=g,w.isWindow=y,w.camelCase=G,w.type=x,w.now=Date.now,w.isNumeric=function(e){var t=w.type(e);return("number"===t||"string"===t)&&!isNaN(e-parseFloat(e))},"function"==typeof define&&define.amd&&define("jquery",[],function(){return w});var Jt=e.jQuery,Kt=e.$;return w.noConflict=function(t){return e.$===w&&(e.$=Kt),t&&e.jQuery===w&&(e.jQuery=Jt),w},t||(e.jQuery=e.$=w),w});
</script>
  <script type="text/javascript">/**
 * StyleFix 1.0.3 & PrefixFree 1.0.7
 * @author Lea Verou
 * MIT license
 */(function(){function t(e,t){return[].slice.call((t||document).querySelectorAll(e))}if(!window.addEventListener)return;var e=window.StyleFix={link:function(t){try{if(t.rel!=="stylesheet"||t.hasAttribute("data-noprefix"))return}catch(n){return}var r=t.href||t.getAttribute("data-href"),i=r.replace(/[^\/]+$/,""),s=t.parentNode,o=new XMLHttpRequest,u;o.onreadystatechange=function(){o.readyState===4&&u()};u=function(){var n=o.responseText;if(n&&t.parentNode&&(!o.status||o.status<400||o.status>600)){n=e.fix(n,!0,t);if(i){n=n.replace(/url\(\s*?((?:"|')?)(.+?)\1\s*?\)/gi,function(e,t,n){return/^([a-z]{3,10}:|\/|#)/i.test(n)?e:'url("'+i+n+'")'});var r=i.replace(/([\\\^\$*+[\]?{}.=!:(|)])/g,"\\$1");n=n.replace(RegExp("\\b(behavior:\\s*?url\\('?\"?)"+r,"gi"),"$1")}var u=document.createElement("style");u.textContent=n;u.media=t.media;u.disabled=t.disabled;u.setAttribute("data-href",t.getAttribute("href"));s.insertBefore(u,t);s.removeChild(t);u.media=t.media}};try{o.open("GET",r);o.send(null)}catch(n){if(typeof XDomainRequest!="undefined"){o=new XDomainRequest;o.onerror=o.onprogress=function(){};o.onload=u;o.open("GET",r);o.send(null)}}t.setAttribute("data-inprogress","")},styleElement:function(t){if(t.hasAttribute("data-noprefix"))return;var n=t.disabled;t.textContent=e.fix(t.textContent,!0,t);t.disabled=n},styleAttribute:function(t){var n=t.getAttribute("style");n=e.fix(n,!1,t);t.setAttribute("style",n)},process:function(){t('link[rel="stylesheet"]:not([data-inprogress])').forEach(StyleFix.link);t("style").forEach(StyleFix.styleElement);t("[style]").forEach(StyleFix.styleAttribute)},register:function(t,n){(e.fixers=e.fixers||[]).splice(n===undefined?e.fixers.length:n,0,t)},fix:function(t,n,r){for(var i=0;i<e.fixers.length;i++)t=e.fixers[i](t,n,r)||t;return t},camelCase:function(e){return e.replace(/-([a-z])/g,function(e,t){return t.toUpperCase()}).replace("-","")},deCamelCase:function(e){return e.replace(/[A-Z]/g,function(e){return"-"+e.toLowerCase()})}};(function(){setTimeout(function(){t('link[rel="stylesheet"]').forEach(StyleFix.link)},10);document.addEventListener("DOMContentLoaded",StyleFix.process,!1)})()})();(function(e){function t(e,t,r,i,s){e=n[e];if(e.length){var o=RegExp(t+"("+e.join("|")+")"+r,"gi");s=s.replace(o,i)}return s}if(!window.StyleFix||!window.getComputedStyle)return;var n=window.PrefixFree={prefixCSS:function(e,r,i){var s=n.prefix;n.functions.indexOf("linear-gradient")>-1&&(e=e.replace(/(\s|:|,)(repeating-)?linear-gradient\(\s*(-?\d*\.?\d*)deg/ig,function(e,t,n,r){return t+(n||"")+"linear-gradient("+(90-r)+"deg"}));e=t("functions","(\\s|:|,)","\\s*\\(","$1"+s+"$2(",e);e=t("keywords","(\\s|:)","(\\s|;|\\}|$)","$1"+s+"$2$3",e);e=t("properties","(^|\\{|\\s|;)","\\s*:","$1"+s+"$2:",e);if(n.properties.length){var o=RegExp("\\b("+n.properties.join("|")+")(?!:)","gi");e=t("valueProperties","\\b",":(.+?);",function(e){return e.replace(o,s+"$1")},e)}if(r){e=t("selectors","","\\b",n.prefixSelector,e);e=t("atrules","@","\\b","@"+s+"$1",e)}e=e.replace(RegExp("-"+s,"g"),"-");e=e.replace(/-\*-(?=[a-z]+)/gi,n.prefix);return e},property:function(e){return(n.properties.indexOf(e)?n.prefix:"")+e},value:function(e,r){e=t("functions","(^|\\s|,)","\\s*\\(","$1"+n.prefix+"$2(",e);e=t("keywords","(^|\\s)","(\\s|$)","$1"+n.prefix+"$2$3",e);return e},prefixSelector:function(e){return e.replace(/^:{1,2}/,function(e){return e+n.prefix})},prefixProperty:function(e,t){var r=n.prefix+e;return t?StyleFix.camelCase(r):r}};(function(){var e={},t=[],r={},i=getComputedStyle(document.documentElement,null),s=document.createElement("div").style,o=function(n){if(n.charAt(0)==="-"){t.push(n);var r=n.split("-"),i=r[1];e[i]=++e[i]||1;while(r.length>3){r.pop();var s=r.join("-");u(s)&&t.indexOf(s)===-1&&t.push(s)}}},u=function(e){return StyleFix.camelCase(e)in s};if(i.length>0)for(var a=0;a<i.length;a++)o(i[a]);else for(var f in i)o(StyleFix.deCamelCase(f));var l={uses:0};for(var c in e){var h=e[c];l.uses<h&&(l={prefix:c,uses:h})}n.prefix="-"+l.prefix+"-";n.Prefix=StyleFix.camelCase(n.prefix);n.properties=[];for(var a=0;a<t.length;a++){var f=t[a];if(f.indexOf(n.prefix)===0){var p=f.slice(n.prefix.length);u(p)||n.properties.push(p)}}n.Prefix=="Ms"&&!("transform"in s)&&!("MsTransform"in s)&&"msTransform"in s&&n.properties.push("transform","transform-origin");n.properties.sort()})();(function(){function i(e,t){r[t]="";r[t]=e;return!!r[t]}var e={"linear-gradient":{property:"backgroundImage",params:"red, teal"},calc:{property:"width",params:"1px + 5%"},element:{property:"backgroundImage",params:"#foo"},"cross-fade":{property:"backgroundImage",params:"url(a.png), url(b.png), 50%"}};e["repeating-linear-gradient"]=e["repeating-radial-gradient"]=e["radial-gradient"]=e["linear-gradient"];var t={initial:"color","zoom-in":"cursor","zoom-out":"cursor",box:"display",flexbox:"display","inline-flexbox":"display",flex:"display","inline-flex":"display"};n.functions=[];n.keywords=[];var r=document.createElement("div").style;for(var s in e){var o=e[s],u=o.property,a=s+"("+o.params+")";!i(a,u)&&i(n.prefix+a,u)&&n.functions.push(s)}for(var f in t){var u=t[f];!i(f,u)&&i(n.prefix+f,u)&&n.keywords.push(f)}})();(function(){function s(e){i.textContent=e+"{}";return!!i.sheet.cssRules.length}var t={":read-only":null,":read-write":null,":any-link":null,"::selection":null},r={keyframes:"name",viewport:null,document:'regexp(".")'};n.selectors=[];n.atrules=[];var i=e.appendChild(document.createElement("style"));for(var o in t){var u=o+(t[o]?"("+t[o]+")":"");!s(u)&&s(n.prefixSelector(u))&&n.selectors.push(o)}for(var a in r){var u=a+" "+(r[a]||"");!s("@"+u)&&s("@"+n.prefix+u)&&n.atrules.push(a)}e.removeChild(i)})();n.valueProperties=["transition","transition-property"];e.className+=" "+n.prefix;StyleFix.register(n.prefixCSS)})(document.documentElement);
 </script>
  <script type="text/javascript">/**
 * Minified by jsDelivr using UglifyJS v3.3.21.
 * Original file: /npm/conic-gradient@1.0.0/conic-gradient.js
 * 
 * Do NOT use SRI with dynamically generated files! More information: https://www.jsdelivr.com/using-sri-with-dynamic-files
 */
!function(){var t=Math.PI,e=2*t,d=t/180,o=document.createElement("div");document.head.appendChild(o);var p=self.ConicGradient=function(t){p.all.push(this),t=t||{},this.canvas=document.createElement("canvas"),this.context=this.canvas.getContext("2d"),this.repeating=!!t.repeating,this.size=t.size||Math.max(innerWidth,innerHeight),this.canvas.width=this.canvas.height=this.size;var s=t.stops;this.stops=(s||"").split(/\s*,(?![^(]*\))\s*/);for(var o=this.from=0;o<this.stops.length;o++)if(this.stops[o]){var i=this.stops[o]=new p.ColorStop(this,this.stops[o]);i.next&&(this.stops.splice(o+1,0,i.next),o++)}else this.stops.splice(o,1),o--;if(0==this.stops[0].color.indexOf("from")&&(this.from=360*this.stops[0].pos,this.stops.shift()),void 0===this.stops[0].pos)this.stops[0].pos=0;else if(0<this.stops[0].pos){var e=this.stops[0].clone();e.pos=0,this.stops.unshift(e)}if(void 0===this.stops[this.stops.length-1].pos)this.stops[this.stops.length-1].pos=1;else if(!this.repeating&&this.stops[this.stops.length-1].pos<1){var r=this.stops[this.stops.length-1].clone();r.pos=1,this.stops.push(r)}if(this.stops.forEach(function(t,s){if(void 0===t.pos){for(var o=s+1;this[o];o++)if(void 0!==this[o].pos){t.pos=this[s-1].pos+(this[o].pos-this[s-1].pos)/(o-s+1);break}}else 0<s&&(t.pos=Math.max(t.pos,this[s-1].pos))},this.stops),this.repeating){var n=(s=this.stops.slice())[s.length-1].pos-s[0].pos;for(o=0;this.stops[this.stops.length-1].pos<1&&o<1e4;o++)for(var h=0;h<s.length;h++){var a=s[h].clone();a.pos+=(o+1)*n,this.stops.push(a)}}this.paint()};p.all=[],p.prototype={toString:function(){return"url('"+this.dataURL+"')"},get dataURL(){return"data:image/svg+xml,"+encodeURIComponent(this.svg)},get blobURL(){return URL.createObjectURL(new Blob([this.svg],{type:"image/svg+xml"}))},get svg(){return'<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" preserveAspectRatio="none"><svg viewBox="0 0 100 100" preserveAspectRatio="xMidYMid slice"><image width="100" height="100%" xlink:href="'+this.png+'" /></svg></svg>'},get png(){return this.canvas.toDataURL()},get r(){return Math.sqrt(2)*this.size/2},paint:function(){var i,t,e,s=this.context,o=this.r,r=this.size/2,n=0,h=this.stops[n];s.translate(this.size/2,this.size/2),s.rotate(-90*d),s.rotate(this.from*d),s.translate(-this.size/2,-this.size/2);for(var a=0;a<360;){if(a/360+1e-5>=h.pos){for(;i=h,n++,(h=this.stops[n])&&h!=i&&h.pos===i.pos;);if(!h)break;var p=i.color+""==h.color+""&&i!=h;t=i.color.map(function(t,s){return h.color[s]-t})}e=(a/360-i.pos)/(h.pos-i.pos);var l=p?h.color:t.map(function(t,s){var o=t*e+i.color[s];return s<3?255&o:o});if(s.fillStyle="rgba("+l.join(",")+")",s.beginPath(),s.moveTo(r,r),p)var c=360*(h.pos-i.pos);else c=.5;var g=a*d,f=(g=Math.min(360*d,g))+c*d;f=Math.min(360*d,f+.02),s.arc(r,r,o,g,f),s.closePath(),s.fill(),a+=c}}},p.ColorStop=function(t,s){if(this.gradient=t,s){var o=s.match(/^(.+?)(?:\s+([\d.]+)(%|deg|turn|grad|rad)?)?(?:\s+([\d.]+)(%|deg|turn|grad|rad)?)?\s*$/);if(this.color=p.ColorStop.colorToRGBA(o[1]),o[2]){var i=o[3];"%"==i||"0"===o[2]&&!i?this.pos=o[2]/100:"turn"==i?this.pos=+o[2]:"deg"==i?this.pos=o[2]/360:"grad"==i?this.pos=o[2]/400:"rad"==i&&(this.pos=o[2]/e)}o[4]&&(this.next=new p.ColorStop(t,o[1]+" "+o[4]+o[5]))}},p.ColorStop.prototype={clone:function(){var t=new p.ColorStop(this.gradient);return t.color=this.color,t.pos=this.pos,t},toString:function(){return"rgba("+this.color.join(", ")+") "+100*this.pos+"%"}},p.ColorStop.colorToRGBA=function(t){if(!Array.isArray(t)&&-1==t.indexOf("from")){o.style.color=t;var s=getComputedStyle(o).color.match(/rgba?\(([\d.]+), ([\d.]+), ([\d.]+)(?:, ([\d.]+))?\)/);return s&&(s.shift(),(s=s.map(function(t){return+t}))[3]=isNaN(s[3])?1:s[3]),s||[0,0,0,0]}return t}}(),self.StyleFix&&function(){var t=document.createElement("p");t.style.backgroundImage="conic-gradient(white, black)",t.style.backgroundImage=PrefixFree.prefix+"conic-gradient(white, black)",t.style.backgroundImage||StyleFix.register(function(t,s){return-1<t.indexOf("conic-gradient")&&(t=t.replace(/(?:repeating-)?conic-gradient\(\s*((?:\([^()]+\)|[^;()}])+?)\)/g,function(t,s){return new ConicGradient({stops:s,repeating:-1<t.indexOf("repeating-")})})),t})}();
//# sourceMappingURL=/sm/9e0139ba8e1ddb934dfa3689c3207f552762686bca69b4d77270e61d5bcd733c.map</script>
  <script src="https://unpkg.com/tabbable/dist/index.umd.js"></script>
  <script src="https://unpkg.com/focus-trap/dist/focus-trap.umd.js"></script>
  <script type="text/javascript">
    $(window).on('load', function () {
  const readerFocusTrap = focusTrap.createFocusTrap('#reader');
  const settingsFocusTrap = focusTrap.createFocusTrap('#settings');
  const accessibilityFocusTrap = focusTrap.createFocusTrap('#accessibility');
  let topColHeight = 'auto';
  let sideColWidth = 'auto';
  const csvData = {"rows":[[{"span":30,"isColumn":true,"id":14948131,"title":"Interventions","description":"","setDescription":""}],[{"span":6,"isColumn":true,"id":14948132,"title":"MOUD","description":"","setDescription":""},{"span":5,"isColumn":true,"id":14948137,"title":"Psychosocial interventions","description":"","setDescription":""},{"span":6,"isColumn":true,"id":14948142,"title":"Withdrawal Treatment","description":"","setDescription":""},{"span":6,"isColumn":true,"id":14948147,"title":"Models of OAMT delivery ","description":"","setDescription":"Models of opioid agonist maintenance treatment delivery (e.g., telemedicine-based treatment, take-home dosage, pharmacy-based treatment, etc.) "},{"span":3,"isColumn":true,"id":15019717,"title":"Any other interventions","description":"","setDescription":""},{"span":4,"isColumn":true,"id":15019720,"title":"OAMT Discontinuation/Transfer","description":"","setDescription":""}],[{"span":1,"isColumn":true,"id":14948133,"title":"Methadone","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948134,"title":"Buprenorphine S/L, films, patch","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948135,"title":"Long-acting buprenorphine ","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948136,"title":"SROM, Tincture opium, HAT, Codeine/dihydocodeine","description":"","setDescription":"Slow-release oral morphine, tincture opium, heroin-assisted treatment, other injection opioids, hydromorphone, oxycodon"},{"span":1,"isColumn":true,"id":14999412,"title":"Naltrexone oral","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14999413,"title":"Nalterxone injection or implant","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948138,"title":"Cognitive behavior therapy","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948139,"title":"Third wave cognitive therapies ","description":"","setDescription":"Mindfulness therapy, spiritual interventions, acceptance and commitment therapy"},{"span":1,"isColumn":true,"id":14948140,"title":"Social interventions ","description":"","setDescription":"Housing support, employment support, Network/Peer-group support"},{"span":1,"isColumn":true,"id":14948141,"title":"Contingency management","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15013985,"title":"Other psychosocial interventions","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948143,"title":"Buprenorphine/methadone","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948144,"title":"Clonidine/lofexedine","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948145,"title":"Pregabalin, gabapentin, other medications","description":"","setDescription":"Pregabalin/gabapentin, fluoxetine, olanzapine, any other adjunctive medications"},{"span":1,"isColumn":true,"id":14948146,"title":"Transcutaneous stimulation ","description":"","setDescription":"Any electrical or magnetic stimulation"},{"span":1,"isColumn":true,"id":15032086,"title":"Rapid/ultra-rapid withdrawal/low dose NTX","description":"","setDescription":"By naltrexone "},{"span":1,"isColumn":true,"id":15032559,"title":"Oral morphine/Tincture opium/any other (for neonatal withdrawal)","description":"","setDescription":""},{"span":1,"isColumn":true,"id":14948148,"title":"Telemedicine ","description":"","setDescription":"opioid agonist maintenance treatment via telehealth services"},{"span":1,"isColumn":true,"id":14948149,"title":"Task-shifting ","description":"","setDescription":"Opioid agonist treatment is provided by nurses, pharmacists, and other non-doctor healthcare professionals"},{"span":1,"isColumn":true,"id":14948150,"title":"Integrated care provision","description":"","setDescription":"Opioid agonist treatment and treatment for opioid dependence, provided alongside care for HIV, hepatitis, and other medical disorders, chronic pain conditions  "},{"span":1,"isColumn":true,"id":14948151,"title":"Scale up","description":"","setDescription":"Opioid dependence treatment provided in the primary care, community-based treatment services, pharmacy-based treatment"},{"span":1,"isColumn":true,"id":15013976,"title":"Emergency based OAMT","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15029243,"title":"Supervision or take-home ","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019718,"title":"Medications for Chronic pain","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019719,"title":"Medications for other medical conditions (HCV, HIV)","description":"","setDescription":"Hepatitis, HIV"},{"span":1,"isColumn":true,"id":15020368,"title":"Any other non-OAMT intervention ","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019721,"title":"Methadone to BPN or BPN to methadone or Methadone to HAT","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019722,"title":"BPN to NTX LAI or NTX LAI to BPN ","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019723,"title":"Discontinuation of ANY OAMT","description":"","setDescription":""},{"span":1,"isColumn":true,"id":15019724,"title":"OAMT induction","description":"","setDescription":""}],[{"span":2,"isColumn":false,"id":15013982,"title":"Controls","description":"","setDescription":""},{"span":1,"isColumn":false,"id":15013983,"title":"TAU/Placebo/Passive controls","description":"","setDescription":""}],[{"span":1,"isColumn":false,"id":15013984,"title":"Active controls","description":"","setDescription":"Any active control, such as other drugs, psychosocial intervention"}]],"totalColBreadth":30,"totalColDepth":3,"totalRowBreadth":2,"totalRowDepth":1};
  const filters = [{"id":14948193,"label":"Study Design","checked":false,"children":[{"id":14948194,"label":"Clinical Trials ","checked":false,"children":[]},{"id":14948195,"label":"Systematic reviews","checked":false,"children":[]},{"id":14948196,"label":"Metaanalysis ","checked":false,"children":[]},{"id":14948197,"label":"Systematic review protocol","checked":false,"children":[]},{"id":15013977,"label":"Guidelines review ","checked":false,"children":[]}]}];
  const autoOpenFilter = false;
  const externalURLedAttributes = [{"AttributeSetId":15012488,"AttributeId":15013982,"AttributeName":"Controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012490,"AttributeId":15013984,"AttributeName":"Controls - Active controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012489,"AttributeId":15013983,"AttributeName":"Controls - TAU/Placebo/Passive controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946716,"AttributeId":14948210,"AttributeName":"Countries","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946719,"AttributeId":14948213,"AttributeName":"Countries - Afghanistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946717,"AttributeId":14948211,"AttributeName":"Countries - Africa (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946720,"AttributeId":14948214,"AttributeName":"Countries - Angola","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946722,"AttributeId":14948216,"AttributeName":"Countries - Argentina","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946721,"AttributeId":14948215,"AttributeName":"Countries - Armenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946723,"AttributeId":14948217,"AttributeName":"Countries - Australia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946724,"AttributeId":14948218,"AttributeName":"Countries - Austria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946725,"AttributeId":14948219,"AttributeName":"Countries - Bahamas, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946726,"AttributeId":14948220,"AttributeName":"Countries - Bahrain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946727,"AttributeId":14948221,"AttributeName":"Countries - Bangladesh","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946728,"AttributeId":14948222,"AttributeName":"Countries - Barbados","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946730,"AttributeId":14948224,"AttributeName":"Countries - Belarus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946729,"AttributeId":14948223,"AttributeName":"Countries - Belgium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946731,"AttributeId":14948225,"AttributeName":"Countries - Belize","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946732,"AttributeId":14948226,"AttributeName":"Countries - Bolivia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946734,"AttributeId":14948228,"AttributeName":"Countries - Botswana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946733,"AttributeId":14948227,"AttributeName":"Countries - Brazil","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946735,"AttributeId":14948229,"AttributeName":"Countries - Bulgaria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946736,"AttributeId":14948230,"AttributeName":"Countries - Burkina Faso","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946737,"AttributeId":14948231,"AttributeName":"Countries - Cambodia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946738,"AttributeId":14948232,"AttributeName":"Countries - Cameroon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946739,"AttributeId":14948233,"AttributeName":"Countries - Canada","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946740,"AttributeId":14948234,"AttributeName":"Countries - Chile","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946741,"AttributeId":14948235,"AttributeName":"Countries - China","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946745,"AttributeId":14948239,"AttributeName":"Countries - Colombia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946742,"AttributeId":14948236,"AttributeName":"Countries - Congo","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946743,"AttributeId":14948237,"AttributeName":"Countries - Croatia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946744,"AttributeId":14948238,"AttributeName":"Countries - Cuba","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946746,"AttributeId":14948240,"AttributeName":"Countries - Cyprus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946747,"AttributeId":14948241,"AttributeName":"Countries - Czech Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946749,"AttributeId":14948243,"AttributeName":"Countries - Denmark","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946748,"AttributeId":14948242,"AttributeName":"Countries - Dominican Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946751,"AttributeId":14948245,"AttributeName":"Countries - Ecuador","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946750,"AttributeId":14948244,"AttributeName":"Countries - Egypt","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946752,"AttributeId":14948246,"AttributeName":"Countries - Eritrea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946753,"AttributeId":14948247,"AttributeName":"Countries - Estonia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946755,"AttributeId":14948249,"AttributeName":"Countries - Ethiopia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946718,"AttributeId":14948212,"AttributeName":"Countries - Europe (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946754,"AttributeId":14948248,"AttributeName":"Countries - Finland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946757,"AttributeId":14948251,"AttributeName":"Countries - France","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946756,"AttributeId":14948250,"AttributeName":"Countries - Gambia, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946758,"AttributeId":14948252,"AttributeName":"Countries - Georgia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946760,"AttributeId":14948254,"AttributeName":"Countries - Germany","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946759,"AttributeId":14948253,"AttributeName":"Countries - Ghana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946761,"AttributeId":14948255,"AttributeName":"Countries - Greece","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946762,"AttributeId":14948256,"AttributeName":"Countries - Guatemala","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946763,"AttributeId":14948257,"AttributeName":"Countries - Guinea-Bissau","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946764,"AttributeId":14948258,"AttributeName":"Countries - Haiti","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946765,"AttributeId":14948259,"AttributeName":"Countries - Honduras","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946766,"AttributeId":14948260,"AttributeName":"Countries - Hong Kong","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946767,"AttributeId":14948261,"AttributeName":"Countries - Hungary","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946768,"AttributeId":14948262,"AttributeName":"Countries - Iceland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946769,"AttributeId":14948263,"AttributeName":"Countries - India","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946770,"AttributeId":14948264,"AttributeName":"Countries - Indonesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946771,"AttributeId":14948265,"AttributeName":"Countries - Iran","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946772,"AttributeId":14948266,"AttributeName":"Countries - Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946773,"AttributeId":14948267,"AttributeName":"Countries - Israel","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946774,"AttributeId":14948268,"AttributeName":"Countries - Italy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946775,"AttributeId":14948269,"AttributeName":"Countries - Ivory Coast","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946782,"AttributeId":14948276,"AttributeName":"Countries - Jamaica","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946781,"AttributeId":14948275,"AttributeName":"Countries - Japan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946777,"AttributeId":14948271,"AttributeName":"Countries - Jordan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946776,"AttributeId":14948270,"AttributeName":"Countries - Kazakhstan ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946778,"AttributeId":14948272,"AttributeName":"Countries - Kenya","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946779,"AttributeId":14948273,"AttributeName":"Countries - Korea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946780,"AttributeId":14948274,"AttributeName":"Countries - Kuwait","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946783,"AttributeId":14948277,"AttributeName":"Countries - Lao","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946784,"AttributeId":14948278,"AttributeName":"Countries - Latin America (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946788,"AttributeId":14948282,"AttributeName":"Countries - Latvia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946785,"AttributeId":14948279,"AttributeName":"Countries - Lebanon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946786,"AttributeId":14948280,"AttributeName":"Countries - Lesotho","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946787,"AttributeId":14948281,"AttributeName":"Countries - Liberia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946789,"AttributeId":14948283,"AttributeName":"Countries - Lithuania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946790,"AttributeId":14948284,"AttributeName":"Countries - Luxembourg","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946792,"AttributeId":14948286,"AttributeName":"Countries - Madagascar","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946791,"AttributeId":14948285,"AttributeName":"Countries - Malawi","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946793,"AttributeId":14948287,"AttributeName":"Countries - Malaysia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946794,"AttributeId":14948288,"AttributeName":"Countries - Mali","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946797,"AttributeId":14948291,"AttributeName":"Countries - Marshall Islands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946795,"AttributeId":14948289,"AttributeName":"Countries - Mexico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946796,"AttributeId":14948290,"AttributeName":"Countries - Micronesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946799,"AttributeId":14948293,"AttributeName":"Countries - Mongolia ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946798,"AttributeId":14948292,"AttributeName":"Countries - Mozambique","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946800,"AttributeId":14948294,"AttributeName":"Countries - Myanmar (Burma)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946801,"AttributeId":14948295,"AttributeName":"Countries - Namibia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946802,"AttributeId":14948296,"AttributeName":"Countries - Nepal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946803,"AttributeId":14948297,"AttributeName":"Countries - New Zealand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946805,"AttributeId":14948299,"AttributeName":"Countries - Nicaragua","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946806,"AttributeId":14948300,"AttributeName":"Countries - Niger","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946807,"AttributeId":14948301,"AttributeName":"Countries - Nigeria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946808,"AttributeId":14948302,"AttributeName":"Countries - Northern Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946810,"AttributeId":14948304,"AttributeName":"Countries - Norway","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946809,"AttributeId":14948303,"AttributeName":"Countries - Pakistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946811,"AttributeId":14948305,"AttributeName":"Countries - Panama","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946812,"AttributeId":14948306,"AttributeName":"Countries - Papua New Guinea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946813,"AttributeId":14948307,"AttributeName":"Countries - Peru","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946814,"AttributeId":14948308,"AttributeName":"Countries - Philippines","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946815,"AttributeId":14948309,"AttributeName":"Countries - Poland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946816,"AttributeId":14948310,"AttributeName":"Countries - Portugal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946817,"AttributeId":14948311,"AttributeName":"Countries - Puerto Rico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946818,"AttributeId":14948312,"AttributeName":"Countries - Romania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946819,"AttributeId":14948313,"AttributeName":"Countries - Russia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946820,"AttributeId":14948314,"AttributeName":"Countries - Rwanda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946821,"AttributeId":14948315,"AttributeName":"Countries - Samoa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946822,"AttributeId":14948316,"AttributeName":"Countries - San Marino","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946823,"AttributeId":14948317,"AttributeName":"Countries - Saudi Arabia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946824,"AttributeId":14948318,"AttributeName":"Countries - Scotland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946826,"AttributeId":14948320,"AttributeName":"Countries - Senegal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946825,"AttributeId":14948319,"AttributeName":"Countries - Serbia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946828,"AttributeId":14948322,"AttributeName":"Countries - Sierra Leone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946827,"AttributeId":14948321,"AttributeName":"Countries - Singapore","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946829,"AttributeId":14948323,"AttributeName":"Countries - Slovakia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946830,"AttributeId":14948324,"AttributeName":"Countries - Slovenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946831,"AttributeId":14948325,"AttributeName":"Countries - South Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946832,"AttributeId":14948326,"AttributeName":"Countries - Spain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946833,"AttributeId":14948327,"AttributeName":"Countries - Sri Lanka","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946834,"AttributeId":14948328,"AttributeName":"Countries - St Lucia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946835,"AttributeId":14948329,"AttributeName":"Countries - Swaziland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946836,"AttributeId":14948330,"AttributeName":"Countries - Sweden","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946837,"AttributeId":14948331,"AttributeName":"Countries - Switzerland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946838,"AttributeId":14948332,"AttributeName":"Countries - Syria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946839,"AttributeId":14948333,"AttributeName":"Countries - Taiwan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946841,"AttributeId":14948335,"AttributeName":"Countries - Tanzania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946840,"AttributeId":14948334,"AttributeName":"Countries - Thailand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946804,"AttributeId":14948298,"AttributeName":"Countries - The Netherlands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946842,"AttributeId":14948336,"AttributeName":"Countries - Trinidad and Tobago","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946843,"AttributeId":14948337,"AttributeName":"Countries - Tunisia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946846,"AttributeId":14948340,"AttributeName":"Countries - Turkey","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946847,"AttributeId":14948341,"AttributeName":"Countries - UK","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946848,"AttributeId":14948342,"AttributeName":"Countries - USA","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946844,"AttributeId":14948338,"AttributeName":"Countries - Uganda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946845,"AttributeId":14948339,"AttributeName":"Countries - Ukraine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946849,"AttributeId":14948343,"AttributeName":"Countries - Uzbekistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946850,"AttributeId":14948344,"AttributeName":"Countries - Vanuatu","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946851,"AttributeId":14948345,"AttributeName":"Countries - Venezuela","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946852,"AttributeId":14948346,"AttributeName":"Countries - Vietnam","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946853,"AttributeId":14948347,"AttributeName":"Countries - West Indies","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946854,"AttributeId":14948348,"AttributeName":"Countries - Yemen","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946855,"AttributeId":14948349,"AttributeName":"Countries - Zambia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946856,"AttributeId":14948350,"AttributeName":"Countries - Zimbabwe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946637,"AttributeId":14948131,"AttributeName":"Interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018223,"AttributeId":15019717,"AttributeName":"Interventions - Any other interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018874,"AttributeId":15020368,"AttributeName":"Interventions - Any other interventions - Any other non-OAMT intervention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018224,"AttributeId":15019718,"AttributeName":"Interventions - Any other interventions - Medications for Chronic pain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018225,"AttributeId":15019719,"AttributeName":"Interventions - Any other interventions - Medications for other medical conditions (HCV, HIV)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946638,"AttributeId":14948132,"AttributeName":"Interventions - MOUD","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946640,"AttributeId":14948134,"AttributeName":"Interventions - MOUD - Buprenorphine S/L, films, patch","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946641,"AttributeId":14948135,"AttributeName":"Interventions - MOUD - Long-acting buprenorphine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946639,"AttributeId":14948133,"AttributeName":"Interventions - MOUD - Methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997919,"AttributeId":14999413,"AttributeName":"Interventions - MOUD - Nalterxone injection or implant","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997918,"AttributeId":14999412,"AttributeName":"Interventions - MOUD - Naltrexone oral","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946642,"AttributeId":14948136,"AttributeName":"Interventions - MOUD - SROM, Tincture opium, HAT, Codeine/dihydocodeine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946653,"AttributeId":14948147,"AttributeName":"Interventions - Models of OAMT delivery ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012482,"AttributeId":15013976,"AttributeName":"Interventions - Models of OAMT delivery  - Emergency based OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946656,"AttributeId":14948150,"AttributeName":"Interventions - Models of OAMT delivery  - Integrated care provision","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946657,"AttributeId":14948151,"AttributeName":"Interventions - Models of OAMT delivery  - Scale up","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15027749,"AttributeId":15029243,"AttributeName":"Interventions - Models of OAMT delivery  - Supervision or take-home ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946655,"AttributeId":14948149,"AttributeName":"Interventions - Models of OAMT delivery  - Task-shifting ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946654,"AttributeId":14948148,"AttributeName":"Interventions - Models of OAMT delivery  - Telemedicine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018226,"AttributeId":15019720,"AttributeName":"Interventions - OAMT Discontinuation/Transfer","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018228,"AttributeId":15019722,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - BPN to NTX LAI or NTX LAI to BPN ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018229,"AttributeId":15019723,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Discontinuation of ANY OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018227,"AttributeId":15019721,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Methadone to BPN or BPN to methadone or Methadone to HAT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018230,"AttributeId":15019724,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - OAMT induction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946643,"AttributeId":14948137,"AttributeName":"Interventions - Psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946644,"AttributeId":14948138,"AttributeName":"Interventions - Psychosocial interventions - Cognitive behavior therapy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946647,"AttributeId":14948141,"AttributeName":"Interventions - Psychosocial interventions - Contingency management","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012491,"AttributeId":15013985,"AttributeName":"Interventions - Psychosocial interventions - Other psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946646,"AttributeId":14948140,"AttributeName":"Interventions - Psychosocial interventions - Social interventions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946645,"AttributeId":14948139,"AttributeName":"Interventions - Psychosocial interventions - Third wave cognitive therapies ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946648,"AttributeId":14948142,"AttributeName":"Interventions - Withdrawal Treatment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946649,"AttributeId":14948143,"AttributeName":"Interventions - Withdrawal Treatment - Buprenorphine/methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946650,"AttributeId":14948144,"AttributeName":"Interventions - Withdrawal Treatment - Clonidine/lofexedine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15031065,"AttributeId":15032559,"AttributeName":"Interventions - Withdrawal Treatment - Oral morphine/Tincture opium/any other (for neonatal withdrawal)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946651,"AttributeId":14948145,"AttributeName":"Interventions - Withdrawal Treatment - Pregabalin, gabapentin, other medications","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15030592,"AttributeId":15032086,"AttributeName":"Interventions - Withdrawal Treatment - Rapid/ultra-rapid withdrawal/low dose NTX","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946652,"AttributeId":14948146,"AttributeName":"Interventions - Withdrawal Treatment - Transcutaneous stimulation ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007002,"AttributeId":15008496,"AttributeName":"Opioid type","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007003,"AttributeId":15008497,"AttributeName":"Opioid type - Heroin","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007005,"AttributeId":15008499,"AttributeName":"Opioid type - Opium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007004,"AttributeId":15008498,"AttributeName":"Opioid type - Prescription opioids","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946658,"AttributeId":14948152,"AttributeName":"Outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018878,"AttributeId":15020372,"AttributeName":"Outcomes - Health systems and economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268464,"AttributeId":15269958,"AttributeName":"Outcomes - Health systems and economic outcomes - Economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268463,"AttributeId":15269957,"AttributeName":"Outcomes - Health systems and economic outcomes - Health services outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946669,"AttributeId":14948163,"AttributeName":"Outcomes - Illicit opioid and other substance use ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946671,"AttributeId":14948165,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Cravings","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268462,"AttributeId":15269956,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Other substance use","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946670,"AttributeId":14948164,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Use/abstinence","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018232,"AttributeId":15019726,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Withdrawal symptoms","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001474,"AttributeId":15002968,"AttributeName":"Outcomes - Other health and social outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012481,"AttributeId":15013975,"AttributeName":"Outcomes - Other health and social outcomes - Maternal and child health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001476,"AttributeId":15002970,"AttributeName":"Outcomes - Other health and social outcomes - Mental health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001477,"AttributeId":15002971,"AttributeName":"Outcomes - Other health and social outcomes - Overdose and mortality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001475,"AttributeId":15002969,"AttributeName":"Outcomes - Other health and social outcomes - Physical health outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268461,"AttributeId":15269955,"AttributeName":"Outcomes - Other health and social outcomes - Safety ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001478,"AttributeId":15002972,"AttributeName":"Outcomes - Other health and social outcomes - Social/legal outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946674,"AttributeId":14948168,"AttributeName":"Outcomes - PROM","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946677,"AttributeId":14948171,"AttributeName":"Outcomes - PROM - Patient's perception","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946675,"AttributeId":14948169,"AttributeName":"Outcomes - PROM - QoL","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946676,"AttributeId":14948170,"AttributeName":"Outcomes - PROM - Satisfaction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15062540,"AttributeId":15064034,"AttributeName":"Outcomes - Pharmacogenetic outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268466,"AttributeId":15269960,"AttributeName":"Outcomes - Pharmacogenetic outcome - Yes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001473,"AttributeId":15002967,"AttributeName":"Outcomes - Treatment Retention","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268467,"AttributeId":15269961,"AttributeName":"Outcomes - Treatment Retention - Treatment retention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946692,"AttributeId":14948186,"AttributeName":"Population category","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946695,"AttributeId":14948189,"AttributeName":"Population category - Adolescent and youth (young adults)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946698,"AttributeId":14948192,"AttributeName":"Population category - Adults (any sex)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946694,"AttributeId":14948188,"AttributeName":"Population category - Comorbid medical conditions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946693,"AttributeId":14948187,"AttributeName":"Population category - Comorbid mental illness","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007001,"AttributeId":15008495,"AttributeName":"Population category - Prison population","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946696,"AttributeId":14948190,"AttributeName":"Population category - Sexual or other minorities (e.g., racial)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946697,"AttributeId":14948191,"AttributeName":"Population category - Women/Pregnancy/Neonate/Children","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946679,"AttributeId":14948173,"AttributeName":"Quality Assessment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946682,"AttributeId":14948176,"AttributeName":"Quality Assessment - High quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946680,"AttributeId":14948174,"AttributeName":"Quality Assessment - Low quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946681,"AttributeId":14948175,"AttributeName":"Quality Assessment - Medium quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946699,"AttributeId":14948193,"AttributeName":"Study Design","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946700,"AttributeId":14948194,"AttributeName":"Study Design - Clinical Trials ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012483,"AttributeId":15013977,"AttributeName":"Study Design - Guidelines review ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946702,"AttributeId":14948196,"AttributeName":"Study Design - Metaanalysis ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946703,"AttributeId":14948197,"AttributeName":"Study Design - Systematic review protocol","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946701,"AttributeId":14948195,"AttributeName":"Study Design - Systematic reviews","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946683,"AttributeId":14948177,"AttributeName":"Study region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946684,"AttributeId":14948178,"AttributeName":"Study region - Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946687,"AttributeId":14948181,"AttributeName":"Study region - Americas ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946686,"AttributeId":14948180,"AttributeName":"Study region - Eastern Mediterranean Region ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946688,"AttributeId":14948182,"AttributeName":"Study region - Europe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946685,"AttributeId":14948179,"AttributeName":"Study region - South East Asia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946690,"AttributeId":14948184,"AttributeName":"Study region - Western Pacific Region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946709,"AttributeId":14948203,"AttributeName":"Year","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946710,"AttributeId":14948204,"AttributeName":"Year - 2009-2013","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946711,"AttributeId":14948205,"AttributeName":"Year - 2014-2018","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946712,"AttributeId":14948206,"AttributeName":"Year - 2019-2024","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012488,"AttributeId":15013982,"AttributeName":"Controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012490,"AttributeId":15013984,"AttributeName":"Controls - Active controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012489,"AttributeId":15013983,"AttributeName":"Controls - TAU/Placebo/Passive controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946716,"AttributeId":14948210,"AttributeName":"Countries","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946719,"AttributeId":14948213,"AttributeName":"Countries - Afghanistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946717,"AttributeId":14948211,"AttributeName":"Countries - Africa (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946720,"AttributeId":14948214,"AttributeName":"Countries - Angola","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946722,"AttributeId":14948216,"AttributeName":"Countries - Argentina","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946721,"AttributeId":14948215,"AttributeName":"Countries - Armenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946723,"AttributeId":14948217,"AttributeName":"Countries - Australia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946724,"AttributeId":14948218,"AttributeName":"Countries - Austria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946725,"AttributeId":14948219,"AttributeName":"Countries - Bahamas, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946726,"AttributeId":14948220,"AttributeName":"Countries - Bahrain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946727,"AttributeId":14948221,"AttributeName":"Countries - Bangladesh","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946728,"AttributeId":14948222,"AttributeName":"Countries - Barbados","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946730,"AttributeId":14948224,"AttributeName":"Countries - Belarus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946729,"AttributeId":14948223,"AttributeName":"Countries - Belgium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946731,"AttributeId":14948225,"AttributeName":"Countries - Belize","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946732,"AttributeId":14948226,"AttributeName":"Countries - Bolivia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946734,"AttributeId":14948228,"AttributeName":"Countries - Botswana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946733,"AttributeId":14948227,"AttributeName":"Countries - Brazil","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946735,"AttributeId":14948229,"AttributeName":"Countries - Bulgaria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946736,"AttributeId":14948230,"AttributeName":"Countries - Burkina Faso","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946737,"AttributeId":14948231,"AttributeName":"Countries - Cambodia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946738,"AttributeId":14948232,"AttributeName":"Countries - Cameroon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946739,"AttributeId":14948233,"AttributeName":"Countries - Canada","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946740,"AttributeId":14948234,"AttributeName":"Countries - Chile","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946741,"AttributeId":14948235,"AttributeName":"Countries - China","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946745,"AttributeId":14948239,"AttributeName":"Countries - Colombia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946742,"AttributeId":14948236,"AttributeName":"Countries - Congo","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946743,"AttributeId":14948237,"AttributeName":"Countries - Croatia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946744,"AttributeId":14948238,"AttributeName":"Countries - Cuba","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946746,"AttributeId":14948240,"AttributeName":"Countries - Cyprus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946747,"AttributeId":14948241,"AttributeName":"Countries - Czech Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946749,"AttributeId":14948243,"AttributeName":"Countries - Denmark","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946748,"AttributeId":14948242,"AttributeName":"Countries - Dominican Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946751,"AttributeId":14948245,"AttributeName":"Countries - Ecuador","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946750,"AttributeId":14948244,"AttributeName":"Countries - Egypt","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946752,"AttributeId":14948246,"AttributeName":"Countries - Eritrea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946753,"AttributeId":14948247,"AttributeName":"Countries - Estonia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946755,"AttributeId":14948249,"AttributeName":"Countries - Ethiopia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946718,"AttributeId":14948212,"AttributeName":"Countries - Europe (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946754,"AttributeId":14948248,"AttributeName":"Countries - Finland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946757,"AttributeId":14948251,"AttributeName":"Countries - France","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946756,"AttributeId":14948250,"AttributeName":"Countries - Gambia, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946758,"AttributeId":14948252,"AttributeName":"Countries - Georgia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946760,"AttributeId":14948254,"AttributeName":"Countries - Germany","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946759,"AttributeId":14948253,"AttributeName":"Countries - Ghana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946761,"AttributeId":14948255,"AttributeName":"Countries - Greece","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946762,"AttributeId":14948256,"AttributeName":"Countries - Guatemala","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946763,"AttributeId":14948257,"AttributeName":"Countries - Guinea-Bissau","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946764,"AttributeId":14948258,"AttributeName":"Countries - Haiti","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946765,"AttributeId":14948259,"AttributeName":"Countries - Honduras","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946766,"AttributeId":14948260,"AttributeName":"Countries - Hong Kong","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946767,"AttributeId":14948261,"AttributeName":"Countries - Hungary","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946768,"AttributeId":14948262,"AttributeName":"Countries - Iceland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946769,"AttributeId":14948263,"AttributeName":"Countries - India","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946770,"AttributeId":14948264,"AttributeName":"Countries - Indonesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946771,"AttributeId":14948265,"AttributeName":"Countries - Iran","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946772,"AttributeId":14948266,"AttributeName":"Countries - Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946773,"AttributeId":14948267,"AttributeName":"Countries - Israel","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946774,"AttributeId":14948268,"AttributeName":"Countries - Italy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946775,"AttributeId":14948269,"AttributeName":"Countries - Ivory Coast","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946782,"AttributeId":14948276,"AttributeName":"Countries - Jamaica","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946781,"AttributeId":14948275,"AttributeName":"Countries - Japan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946777,"AttributeId":14948271,"AttributeName":"Countries - Jordan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946776,"AttributeId":14948270,"AttributeName":"Countries - Kazakhstan ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946778,"AttributeId":14948272,"AttributeName":"Countries - Kenya","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946779,"AttributeId":14948273,"AttributeName":"Countries - Korea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946780,"AttributeId":14948274,"AttributeName":"Countries - Kuwait","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946783,"AttributeId":14948277,"AttributeName":"Countries - Lao","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946784,"AttributeId":14948278,"AttributeName":"Countries - Latin America (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946788,"AttributeId":14948282,"AttributeName":"Countries - Latvia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946785,"AttributeId":14948279,"AttributeName":"Countries - Lebanon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946786,"AttributeId":14948280,"AttributeName":"Countries - Lesotho","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946787,"AttributeId":14948281,"AttributeName":"Countries - Liberia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946789,"AttributeId":14948283,"AttributeName":"Countries - Lithuania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946790,"AttributeId":14948284,"AttributeName":"Countries - Luxembourg","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946792,"AttributeId":14948286,"AttributeName":"Countries - Madagascar","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946791,"AttributeId":14948285,"AttributeName":"Countries - Malawi","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946793,"AttributeId":14948287,"AttributeName":"Countries - Malaysia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946794,"AttributeId":14948288,"AttributeName":"Countries - Mali","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946797,"AttributeId":14948291,"AttributeName":"Countries - Marshall Islands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946795,"AttributeId":14948289,"AttributeName":"Countries - Mexico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946796,"AttributeId":14948290,"AttributeName":"Countries - Micronesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946799,"AttributeId":14948293,"AttributeName":"Countries - Mongolia ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946798,"AttributeId":14948292,"AttributeName":"Countries - Mozambique","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946800,"AttributeId":14948294,"AttributeName":"Countries - Myanmar (Burma)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946801,"AttributeId":14948295,"AttributeName":"Countries - Namibia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946802,"AttributeId":14948296,"AttributeName":"Countries - Nepal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946803,"AttributeId":14948297,"AttributeName":"Countries - New Zealand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946805,"AttributeId":14948299,"AttributeName":"Countries - Nicaragua","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946806,"AttributeId":14948300,"AttributeName":"Countries - Niger","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946807,"AttributeId":14948301,"AttributeName":"Countries - Nigeria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946808,"AttributeId":14948302,"AttributeName":"Countries - Northern Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946810,"AttributeId":14948304,"AttributeName":"Countries - Norway","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946809,"AttributeId":14948303,"AttributeName":"Countries - Pakistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946811,"AttributeId":14948305,"AttributeName":"Countries - Panama","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946812,"AttributeId":14948306,"AttributeName":"Countries - Papua New Guinea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946813,"AttributeId":14948307,"AttributeName":"Countries - Peru","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946814,"AttributeId":14948308,"AttributeName":"Countries - Philippines","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946815,"AttributeId":14948309,"AttributeName":"Countries - Poland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946816,"AttributeId":14948310,"AttributeName":"Countries - Portugal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946817,"AttributeId":14948311,"AttributeName":"Countries - Puerto Rico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946818,"AttributeId":14948312,"AttributeName":"Countries - Romania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946819,"AttributeId":14948313,"AttributeName":"Countries - Russia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946820,"AttributeId":14948314,"AttributeName":"Countries - Rwanda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946821,"AttributeId":14948315,"AttributeName":"Countries - Samoa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946822,"AttributeId":14948316,"AttributeName":"Countries - San Marino","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946823,"AttributeId":14948317,"AttributeName":"Countries - Saudi Arabia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946824,"AttributeId":14948318,"AttributeName":"Countries - Scotland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946826,"AttributeId":14948320,"AttributeName":"Countries - Senegal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946825,"AttributeId":14948319,"AttributeName":"Countries - Serbia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946828,"AttributeId":14948322,"AttributeName":"Countries - Sierra Leone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946827,"AttributeId":14948321,"AttributeName":"Countries - Singapore","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946829,"AttributeId":14948323,"AttributeName":"Countries - Slovakia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946830,"AttributeId":14948324,"AttributeName":"Countries - Slovenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946831,"AttributeId":14948325,"AttributeName":"Countries - South Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946832,"AttributeId":14948326,"AttributeName":"Countries - Spain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946833,"AttributeId":14948327,"AttributeName":"Countries - Sri Lanka","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946834,"AttributeId":14948328,"AttributeName":"Countries - St Lucia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946835,"AttributeId":14948329,"AttributeName":"Countries - Swaziland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946836,"AttributeId":14948330,"AttributeName":"Countries - Sweden","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946837,"AttributeId":14948331,"AttributeName":"Countries - Switzerland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946838,"AttributeId":14948332,"AttributeName":"Countries - Syria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946839,"AttributeId":14948333,"AttributeName":"Countries - Taiwan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946841,"AttributeId":14948335,"AttributeName":"Countries - Tanzania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946840,"AttributeId":14948334,"AttributeName":"Countries - Thailand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946804,"AttributeId":14948298,"AttributeName":"Countries - The Netherlands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946842,"AttributeId":14948336,"AttributeName":"Countries - Trinidad and Tobago","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946843,"AttributeId":14948337,"AttributeName":"Countries - Tunisia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946846,"AttributeId":14948340,"AttributeName":"Countries - Turkey","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946847,"AttributeId":14948341,"AttributeName":"Countries - UK","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946848,"AttributeId":14948342,"AttributeName":"Countries - USA","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946844,"AttributeId":14948338,"AttributeName":"Countries - Uganda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946845,"AttributeId":14948339,"AttributeName":"Countries - Ukraine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946849,"AttributeId":14948343,"AttributeName":"Countries - Uzbekistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946850,"AttributeId":14948344,"AttributeName":"Countries - Vanuatu","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946851,"AttributeId":14948345,"AttributeName":"Countries - Venezuela","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946852,"AttributeId":14948346,"AttributeName":"Countries - Vietnam","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946853,"AttributeId":14948347,"AttributeName":"Countries - West Indies","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946854,"AttributeId":14948348,"AttributeName":"Countries - Yemen","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946855,"AttributeId":14948349,"AttributeName":"Countries - Zambia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946856,"AttributeId":14948350,"AttributeName":"Countries - Zimbabwe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946637,"AttributeId":14948131,"AttributeName":"Interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018223,"AttributeId":15019717,"AttributeName":"Interventions - Any other interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018874,"AttributeId":15020368,"AttributeName":"Interventions - Any other interventions - Any other non-OAMT intervention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018224,"AttributeId":15019718,"AttributeName":"Interventions - Any other interventions - Medications for Chronic pain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018225,"AttributeId":15019719,"AttributeName":"Interventions - Any other interventions - Medications for other medical conditions (HCV, HIV)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946638,"AttributeId":14948132,"AttributeName":"Interventions - MOUD","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946640,"AttributeId":14948134,"AttributeName":"Interventions - MOUD - Buprenorphine S/L, films, patch","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946641,"AttributeId":14948135,"AttributeName":"Interventions - MOUD - Long-acting buprenorphine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946639,"AttributeId":14948133,"AttributeName":"Interventions - MOUD - Methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997919,"AttributeId":14999413,"AttributeName":"Interventions - MOUD - Nalterxone injection or implant","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997918,"AttributeId":14999412,"AttributeName":"Interventions - MOUD - Naltrexone oral","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946642,"AttributeId":14948136,"AttributeName":"Interventions - MOUD - SROM, Tincture opium, HAT, Codeine/dihydocodeine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946653,"AttributeId":14948147,"AttributeName":"Interventions - Models of OAMT delivery ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012482,"AttributeId":15013976,"AttributeName":"Interventions - Models of OAMT delivery  - Emergency based OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946656,"AttributeId":14948150,"AttributeName":"Interventions - Models of OAMT delivery  - Integrated care provision","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946657,"AttributeId":14948151,"AttributeName":"Interventions - Models of OAMT delivery  - Scale up","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15027749,"AttributeId":15029243,"AttributeName":"Interventions - Models of OAMT delivery  - Supervision or take-home ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946655,"AttributeId":14948149,"AttributeName":"Interventions - Models of OAMT delivery  - Task-shifting ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946654,"AttributeId":14948148,"AttributeName":"Interventions - Models of OAMT delivery  - Telemedicine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018226,"AttributeId":15019720,"AttributeName":"Interventions - OAMT Discontinuation/Transfer","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018228,"AttributeId":15019722,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - BPN to NTX LAI or NTX LAI to BPN ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018229,"AttributeId":15019723,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Discontinuation of ANY OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018227,"AttributeId":15019721,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Methadone to BPN or BPN to methadone or Methadone to HAT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018230,"AttributeId":15019724,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - OAMT induction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946643,"AttributeId":14948137,"AttributeName":"Interventions - Psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946644,"AttributeId":14948138,"AttributeName":"Interventions - Psychosocial interventions - Cognitive behavior therapy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946647,"AttributeId":14948141,"AttributeName":"Interventions - Psychosocial interventions - Contingency management","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012491,"AttributeId":15013985,"AttributeName":"Interventions - Psychosocial interventions - Other psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946646,"AttributeId":14948140,"AttributeName":"Interventions - Psychosocial interventions - Social interventions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946645,"AttributeId":14948139,"AttributeName":"Interventions - Psychosocial interventions - Third wave cognitive therapies ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946648,"AttributeId":14948142,"AttributeName":"Interventions - Withdrawal Treatment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946649,"AttributeId":14948143,"AttributeName":"Interventions - Withdrawal Treatment - Buprenorphine/methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946650,"AttributeId":14948144,"AttributeName":"Interventions - Withdrawal Treatment - Clonidine/lofexedine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15031065,"AttributeId":15032559,"AttributeName":"Interventions - Withdrawal Treatment - Oral morphine/Tincture opium/any other (for neonatal withdrawal)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946651,"AttributeId":14948145,"AttributeName":"Interventions - Withdrawal Treatment - Pregabalin, gabapentin, other medications","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15030592,"AttributeId":15032086,"AttributeName":"Interventions - Withdrawal Treatment - Rapid/ultra-rapid withdrawal/low dose NTX","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946652,"AttributeId":14948146,"AttributeName":"Interventions - Withdrawal Treatment - Transcutaneous stimulation ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007002,"AttributeId":15008496,"AttributeName":"Opioid type","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007003,"AttributeId":15008497,"AttributeName":"Opioid type - Heroin","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007005,"AttributeId":15008499,"AttributeName":"Opioid type - Opium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007004,"AttributeId":15008498,"AttributeName":"Opioid type - Prescription opioids","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946658,"AttributeId":14948152,"AttributeName":"Outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018878,"AttributeId":15020372,"AttributeName":"Outcomes - Health systems and economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268464,"AttributeId":15269958,"AttributeName":"Outcomes - Health systems and economic outcomes - Economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268463,"AttributeId":15269957,"AttributeName":"Outcomes - Health systems and economic outcomes - Health services outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946669,"AttributeId":14948163,"AttributeName":"Outcomes - Illicit opioid and other substance use ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946671,"AttributeId":14948165,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Cravings","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268462,"AttributeId":15269956,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Other substance use","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946670,"AttributeId":14948164,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Use/abstinence","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018232,"AttributeId":15019726,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Withdrawal symptoms","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001474,"AttributeId":15002968,"AttributeName":"Outcomes - Other health and social outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012481,"AttributeId":15013975,"AttributeName":"Outcomes - Other health and social outcomes - Maternal and child health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001476,"AttributeId":15002970,"AttributeName":"Outcomes - Other health and social outcomes - Mental health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001477,"AttributeId":15002971,"AttributeName":"Outcomes - Other health and social outcomes - Overdose and mortality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001475,"AttributeId":15002969,"AttributeName":"Outcomes - Other health and social outcomes - Physical health outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268461,"AttributeId":15269955,"AttributeName":"Outcomes - Other health and social outcomes - Safety ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001478,"AttributeId":15002972,"AttributeName":"Outcomes - Other health and social outcomes - Social/legal outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946674,"AttributeId":14948168,"AttributeName":"Outcomes - PROM","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946677,"AttributeId":14948171,"AttributeName":"Outcomes - PROM - Patient's perception","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946675,"AttributeId":14948169,"AttributeName":"Outcomes - PROM - QoL","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946676,"AttributeId":14948170,"AttributeName":"Outcomes - PROM - Satisfaction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15062540,"AttributeId":15064034,"AttributeName":"Outcomes - Pharmacogenetic outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268466,"AttributeId":15269960,"AttributeName":"Outcomes - Pharmacogenetic outcome - Yes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001473,"AttributeId":15002967,"AttributeName":"Outcomes - Treatment Retention","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268467,"AttributeId":15269961,"AttributeName":"Outcomes - Treatment Retention - Treatment retention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946692,"AttributeId":14948186,"AttributeName":"Population category","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946695,"AttributeId":14948189,"AttributeName":"Population category - Adolescent and youth (young adults)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946698,"AttributeId":14948192,"AttributeName":"Population category - Adults (any sex)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946694,"AttributeId":14948188,"AttributeName":"Population category - Comorbid medical conditions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946693,"AttributeId":14948187,"AttributeName":"Population category - Comorbid mental illness","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007001,"AttributeId":15008495,"AttributeName":"Population category - Prison population","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946696,"AttributeId":14948190,"AttributeName":"Population category - Sexual or other minorities (e.g., racial)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946697,"AttributeId":14948191,"AttributeName":"Population category - Women/Pregnancy/Neonate/Children","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946679,"AttributeId":14948173,"AttributeName":"Quality Assessment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946682,"AttributeId":14948176,"AttributeName":"Quality Assessment - High quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946680,"AttributeId":14948174,"AttributeName":"Quality Assessment - Low quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946681,"AttributeId":14948175,"AttributeName":"Quality Assessment - Medium quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946699,"AttributeId":14948193,"AttributeName":"Study Design","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946700,"AttributeId":14948194,"AttributeName":"Study Design - Clinical Trials ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012483,"AttributeId":15013977,"AttributeName":"Study Design - Guidelines review ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946702,"AttributeId":14948196,"AttributeName":"Study Design - Metaanalysis ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946703,"AttributeId":14948197,"AttributeName":"Study Design - Systematic review protocol","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946701,"AttributeId":14948195,"AttributeName":"Study Design - Systematic reviews","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946683,"AttributeId":14948177,"AttributeName":"Study region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946684,"AttributeId":14948178,"AttributeName":"Study region - Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946687,"AttributeId":14948181,"AttributeName":"Study region - Americas ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946686,"AttributeId":14948180,"AttributeName":"Study region - Eastern Mediterranean Region ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946688,"AttributeId":14948182,"AttributeName":"Study region - Europe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946685,"AttributeId":14948179,"AttributeName":"Study region - South East Asia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946690,"AttributeId":14948184,"AttributeName":"Study region - Western Pacific Region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946709,"AttributeId":14948203,"AttributeName":"Year","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946710,"AttributeId":14948204,"AttributeName":"Year - 2009-2013","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946711,"AttributeId":14948205,"AttributeName":"Year - 2014-2018","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946712,"AttributeId":14948206,"AttributeName":"Year - 2019-2024","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012488,"AttributeId":15013982,"AttributeName":"Controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012490,"AttributeId":15013984,"AttributeName":"Controls - Active controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012489,"AttributeId":15013983,"AttributeName":"Controls - TAU/Placebo/Passive controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946716,"AttributeId":14948210,"AttributeName":"Countries","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946719,"AttributeId":14948213,"AttributeName":"Countries - Afghanistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946717,"AttributeId":14948211,"AttributeName":"Countries - Africa (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946720,"AttributeId":14948214,"AttributeName":"Countries - Angola","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946722,"AttributeId":14948216,"AttributeName":"Countries - Argentina","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946721,"AttributeId":14948215,"AttributeName":"Countries - Armenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946723,"AttributeId":14948217,"AttributeName":"Countries - Australia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946724,"AttributeId":14948218,"AttributeName":"Countries - Austria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946725,"AttributeId":14948219,"AttributeName":"Countries - Bahamas, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946726,"AttributeId":14948220,"AttributeName":"Countries - Bahrain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946727,"AttributeId":14948221,"AttributeName":"Countries - Bangladesh","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946728,"AttributeId":14948222,"AttributeName":"Countries - Barbados","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946730,"AttributeId":14948224,"AttributeName":"Countries - Belarus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946729,"AttributeId":14948223,"AttributeName":"Countries - Belgium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946731,"AttributeId":14948225,"AttributeName":"Countries - Belize","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946732,"AttributeId":14948226,"AttributeName":"Countries - Bolivia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946734,"AttributeId":14948228,"AttributeName":"Countries - Botswana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946733,"AttributeId":14948227,"AttributeName":"Countries - Brazil","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946735,"AttributeId":14948229,"AttributeName":"Countries - Bulgaria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946736,"AttributeId":14948230,"AttributeName":"Countries - Burkina Faso","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946737,"AttributeId":14948231,"AttributeName":"Countries - Cambodia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946738,"AttributeId":14948232,"AttributeName":"Countries - Cameroon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946739,"AttributeId":14948233,"AttributeName":"Countries - Canada","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946740,"AttributeId":14948234,"AttributeName":"Countries - Chile","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946741,"AttributeId":14948235,"AttributeName":"Countries - China","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946745,"AttributeId":14948239,"AttributeName":"Countries - Colombia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946742,"AttributeId":14948236,"AttributeName":"Countries - Congo","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946743,"AttributeId":14948237,"AttributeName":"Countries - Croatia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946744,"AttributeId":14948238,"AttributeName":"Countries - Cuba","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946746,"AttributeId":14948240,"AttributeName":"Countries - Cyprus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946747,"AttributeId":14948241,"AttributeName":"Countries - Czech Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946749,"AttributeId":14948243,"AttributeName":"Countries - Denmark","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946748,"AttributeId":14948242,"AttributeName":"Countries - Dominican Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946751,"AttributeId":14948245,"AttributeName":"Countries - Ecuador","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946750,"AttributeId":14948244,"AttributeName":"Countries - Egypt","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946752,"AttributeId":14948246,"AttributeName":"Countries - Eritrea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946753,"AttributeId":14948247,"AttributeName":"Countries - Estonia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946755,"AttributeId":14948249,"AttributeName":"Countries - Ethiopia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946718,"AttributeId":14948212,"AttributeName":"Countries - Europe (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946754,"AttributeId":14948248,"AttributeName":"Countries - Finland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946757,"AttributeId":14948251,"AttributeName":"Countries - France","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946756,"AttributeId":14948250,"AttributeName":"Countries - Gambia, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946758,"AttributeId":14948252,"AttributeName":"Countries - Georgia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946760,"AttributeId":14948254,"AttributeName":"Countries - Germany","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946759,"AttributeId":14948253,"AttributeName":"Countries - Ghana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946761,"AttributeId":14948255,"AttributeName":"Countries - Greece","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946762,"AttributeId":14948256,"AttributeName":"Countries - Guatemala","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946763,"AttributeId":14948257,"AttributeName":"Countries - Guinea-Bissau","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946764,"AttributeId":14948258,"AttributeName":"Countries - Haiti","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946765,"AttributeId":14948259,"AttributeName":"Countries - Honduras","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946766,"AttributeId":14948260,"AttributeName":"Countries - Hong Kong","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946767,"AttributeId":14948261,"AttributeName":"Countries - Hungary","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946768,"AttributeId":14948262,"AttributeName":"Countries - Iceland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946769,"AttributeId":14948263,"AttributeName":"Countries - India","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946770,"AttributeId":14948264,"AttributeName":"Countries - Indonesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946771,"AttributeId":14948265,"AttributeName":"Countries - Iran","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946772,"AttributeId":14948266,"AttributeName":"Countries - Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946773,"AttributeId":14948267,"AttributeName":"Countries - Israel","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946774,"AttributeId":14948268,"AttributeName":"Countries - Italy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946775,"AttributeId":14948269,"AttributeName":"Countries - Ivory Coast","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946782,"AttributeId":14948276,"AttributeName":"Countries - Jamaica","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946781,"AttributeId":14948275,"AttributeName":"Countries - Japan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946777,"AttributeId":14948271,"AttributeName":"Countries - Jordan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946776,"AttributeId":14948270,"AttributeName":"Countries - Kazakhstan ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946778,"AttributeId":14948272,"AttributeName":"Countries - Kenya","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946779,"AttributeId":14948273,"AttributeName":"Countries - Korea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946780,"AttributeId":14948274,"AttributeName":"Countries - Kuwait","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946783,"AttributeId":14948277,"AttributeName":"Countries - Lao","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946784,"AttributeId":14948278,"AttributeName":"Countries - Latin America (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946788,"AttributeId":14948282,"AttributeName":"Countries - Latvia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946785,"AttributeId":14948279,"AttributeName":"Countries - Lebanon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946786,"AttributeId":14948280,"AttributeName":"Countries - Lesotho","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946787,"AttributeId":14948281,"AttributeName":"Countries - Liberia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946789,"AttributeId":14948283,"AttributeName":"Countries - Lithuania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946790,"AttributeId":14948284,"AttributeName":"Countries - Luxembourg","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946792,"AttributeId":14948286,"AttributeName":"Countries - Madagascar","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946791,"AttributeId":14948285,"AttributeName":"Countries - Malawi","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946793,"AttributeId":14948287,"AttributeName":"Countries - Malaysia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946794,"AttributeId":14948288,"AttributeName":"Countries - Mali","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946797,"AttributeId":14948291,"AttributeName":"Countries - Marshall Islands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946795,"AttributeId":14948289,"AttributeName":"Countries - Mexico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946796,"AttributeId":14948290,"AttributeName":"Countries - Micronesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946799,"AttributeId":14948293,"AttributeName":"Countries - Mongolia ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946798,"AttributeId":14948292,"AttributeName":"Countries - Mozambique","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946800,"AttributeId":14948294,"AttributeName":"Countries - Myanmar (Burma)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946801,"AttributeId":14948295,"AttributeName":"Countries - Namibia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946802,"AttributeId":14948296,"AttributeName":"Countries - Nepal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946803,"AttributeId":14948297,"AttributeName":"Countries - New Zealand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946805,"AttributeId":14948299,"AttributeName":"Countries - Nicaragua","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946806,"AttributeId":14948300,"AttributeName":"Countries - Niger","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946807,"AttributeId":14948301,"AttributeName":"Countries - Nigeria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946808,"AttributeId":14948302,"AttributeName":"Countries - Northern Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946810,"AttributeId":14948304,"AttributeName":"Countries - Norway","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946809,"AttributeId":14948303,"AttributeName":"Countries - Pakistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946811,"AttributeId":14948305,"AttributeName":"Countries - Panama","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946812,"AttributeId":14948306,"AttributeName":"Countries - Papua New Guinea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946813,"AttributeId":14948307,"AttributeName":"Countries - Peru","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946814,"AttributeId":14948308,"AttributeName":"Countries - Philippines","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946815,"AttributeId":14948309,"AttributeName":"Countries - Poland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946816,"AttributeId":14948310,"AttributeName":"Countries - Portugal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946817,"AttributeId":14948311,"AttributeName":"Countries - Puerto Rico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946818,"AttributeId":14948312,"AttributeName":"Countries - Romania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946819,"AttributeId":14948313,"AttributeName":"Countries - Russia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946820,"AttributeId":14948314,"AttributeName":"Countries - Rwanda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946821,"AttributeId":14948315,"AttributeName":"Countries - Samoa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946822,"AttributeId":14948316,"AttributeName":"Countries - San Marino","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946823,"AttributeId":14948317,"AttributeName":"Countries - Saudi Arabia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946824,"AttributeId":14948318,"AttributeName":"Countries - Scotland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946826,"AttributeId":14948320,"AttributeName":"Countries - Senegal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946825,"AttributeId":14948319,"AttributeName":"Countries - Serbia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946828,"AttributeId":14948322,"AttributeName":"Countries - Sierra Leone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946827,"AttributeId":14948321,"AttributeName":"Countries - Singapore","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946829,"AttributeId":14948323,"AttributeName":"Countries - Slovakia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946830,"AttributeId":14948324,"AttributeName":"Countries - Slovenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946831,"AttributeId":14948325,"AttributeName":"Countries - South Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946832,"AttributeId":14948326,"AttributeName":"Countries - Spain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946833,"AttributeId":14948327,"AttributeName":"Countries - Sri Lanka","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946834,"AttributeId":14948328,"AttributeName":"Countries - St Lucia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946835,"AttributeId":14948329,"AttributeName":"Countries - Swaziland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946836,"AttributeId":14948330,"AttributeName":"Countries - Sweden","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946837,"AttributeId":14948331,"AttributeName":"Countries - Switzerland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946838,"AttributeId":14948332,"AttributeName":"Countries - Syria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946839,"AttributeId":14948333,"AttributeName":"Countries - Taiwan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946841,"AttributeId":14948335,"AttributeName":"Countries - Tanzania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946840,"AttributeId":14948334,"AttributeName":"Countries - Thailand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946804,"AttributeId":14948298,"AttributeName":"Countries - The Netherlands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946842,"AttributeId":14948336,"AttributeName":"Countries - Trinidad and Tobago","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946843,"AttributeId":14948337,"AttributeName":"Countries - Tunisia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946846,"AttributeId":14948340,"AttributeName":"Countries - Turkey","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946847,"AttributeId":14948341,"AttributeName":"Countries - UK","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946848,"AttributeId":14948342,"AttributeName":"Countries - USA","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946844,"AttributeId":14948338,"AttributeName":"Countries - Uganda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946845,"AttributeId":14948339,"AttributeName":"Countries - Ukraine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946849,"AttributeId":14948343,"AttributeName":"Countries - Uzbekistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946850,"AttributeId":14948344,"AttributeName":"Countries - Vanuatu","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946851,"AttributeId":14948345,"AttributeName":"Countries - Venezuela","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946852,"AttributeId":14948346,"AttributeName":"Countries - Vietnam","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946853,"AttributeId":14948347,"AttributeName":"Countries - West Indies","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946854,"AttributeId":14948348,"AttributeName":"Countries - Yemen","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946855,"AttributeId":14948349,"AttributeName":"Countries - Zambia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946856,"AttributeId":14948350,"AttributeName":"Countries - Zimbabwe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946637,"AttributeId":14948131,"AttributeName":"Interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018223,"AttributeId":15019717,"AttributeName":"Interventions - Any other interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018874,"AttributeId":15020368,"AttributeName":"Interventions - Any other interventions - Any other non-OAMT intervention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018224,"AttributeId":15019718,"AttributeName":"Interventions - Any other interventions - Medications for Chronic pain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018225,"AttributeId":15019719,"AttributeName":"Interventions - Any other interventions - Medications for other medical conditions (HCV, HIV)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946638,"AttributeId":14948132,"AttributeName":"Interventions - MOUD","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946640,"AttributeId":14948134,"AttributeName":"Interventions - MOUD - Buprenorphine S/L, films, patch","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946641,"AttributeId":14948135,"AttributeName":"Interventions - MOUD - Long-acting buprenorphine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946639,"AttributeId":14948133,"AttributeName":"Interventions - MOUD - Methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997919,"AttributeId":14999413,"AttributeName":"Interventions - MOUD - Nalterxone injection or implant","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997918,"AttributeId":14999412,"AttributeName":"Interventions - MOUD - Naltrexone oral","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946642,"AttributeId":14948136,"AttributeName":"Interventions - MOUD - SROM, Tincture opium, HAT, Codeine/dihydocodeine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946653,"AttributeId":14948147,"AttributeName":"Interventions - Models of OAMT delivery ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012482,"AttributeId":15013976,"AttributeName":"Interventions - Models of OAMT delivery  - Emergency based OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946656,"AttributeId":14948150,"AttributeName":"Interventions - Models of OAMT delivery  - Integrated care provision","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946657,"AttributeId":14948151,"AttributeName":"Interventions - Models of OAMT delivery  - Scale up","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15027749,"AttributeId":15029243,"AttributeName":"Interventions - Models of OAMT delivery  - Supervision or take-home ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946655,"AttributeId":14948149,"AttributeName":"Interventions - Models of OAMT delivery  - Task-shifting ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946654,"AttributeId":14948148,"AttributeName":"Interventions - Models of OAMT delivery  - Telemedicine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018226,"AttributeId":15019720,"AttributeName":"Interventions - OAMT Discontinuation/Transfer","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018228,"AttributeId":15019722,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - BPN to NTX LAI or NTX LAI to BPN ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018229,"AttributeId":15019723,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Discontinuation of ANY OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018227,"AttributeId":15019721,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Methadone to BPN or BPN to methadone or Methadone to HAT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018230,"AttributeId":15019724,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - OAMT induction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946643,"AttributeId":14948137,"AttributeName":"Interventions - Psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946644,"AttributeId":14948138,"AttributeName":"Interventions - Psychosocial interventions - Cognitive behavior therapy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946647,"AttributeId":14948141,"AttributeName":"Interventions - Psychosocial interventions - Contingency management","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012491,"AttributeId":15013985,"AttributeName":"Interventions - Psychosocial interventions - Other psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946646,"AttributeId":14948140,"AttributeName":"Interventions - Psychosocial interventions - Social interventions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946645,"AttributeId":14948139,"AttributeName":"Interventions - Psychosocial interventions - Third wave cognitive therapies ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946648,"AttributeId":14948142,"AttributeName":"Interventions - Withdrawal Treatment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946649,"AttributeId":14948143,"AttributeName":"Interventions - Withdrawal Treatment - Buprenorphine/methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946650,"AttributeId":14948144,"AttributeName":"Interventions - Withdrawal Treatment - Clonidine/lofexedine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15031065,"AttributeId":15032559,"AttributeName":"Interventions - Withdrawal Treatment - Oral morphine/Tincture opium/any other (for neonatal withdrawal)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946651,"AttributeId":14948145,"AttributeName":"Interventions - Withdrawal Treatment - Pregabalin, gabapentin, other medications","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15030592,"AttributeId":15032086,"AttributeName":"Interventions - Withdrawal Treatment - Rapid/ultra-rapid withdrawal/low dose NTX","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946652,"AttributeId":14948146,"AttributeName":"Interventions - Withdrawal Treatment - Transcutaneous stimulation ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007002,"AttributeId":15008496,"AttributeName":"Opioid type","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007003,"AttributeId":15008497,"AttributeName":"Opioid type - Heroin","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007005,"AttributeId":15008499,"AttributeName":"Opioid type - Opium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007004,"AttributeId":15008498,"AttributeName":"Opioid type - Prescription opioids","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946658,"AttributeId":14948152,"AttributeName":"Outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018878,"AttributeId":15020372,"AttributeName":"Outcomes - Health systems and economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268464,"AttributeId":15269958,"AttributeName":"Outcomes - Health systems and economic outcomes - Economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268463,"AttributeId":15269957,"AttributeName":"Outcomes - Health systems and economic outcomes - Health services outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946669,"AttributeId":14948163,"AttributeName":"Outcomes - Illicit opioid and other substance use ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946671,"AttributeId":14948165,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Cravings","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268462,"AttributeId":15269956,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Other substance use","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946670,"AttributeId":14948164,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Use/abstinence","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018232,"AttributeId":15019726,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Withdrawal symptoms","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001474,"AttributeId":15002968,"AttributeName":"Outcomes - Other health and social outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012481,"AttributeId":15013975,"AttributeName":"Outcomes - Other health and social outcomes - Maternal and child health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001476,"AttributeId":15002970,"AttributeName":"Outcomes - Other health and social outcomes - Mental health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001477,"AttributeId":15002971,"AttributeName":"Outcomes - Other health and social outcomes - Overdose and mortality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001475,"AttributeId":15002969,"AttributeName":"Outcomes - Other health and social outcomes - Physical health outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268461,"AttributeId":15269955,"AttributeName":"Outcomes - Other health and social outcomes - Safety ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001478,"AttributeId":15002972,"AttributeName":"Outcomes - Other health and social outcomes - Social/legal outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946674,"AttributeId":14948168,"AttributeName":"Outcomes - PROM","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946677,"AttributeId":14948171,"AttributeName":"Outcomes - PROM - Patient's perception","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946675,"AttributeId":14948169,"AttributeName":"Outcomes - PROM - QoL","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946676,"AttributeId":14948170,"AttributeName":"Outcomes - PROM - Satisfaction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15062540,"AttributeId":15064034,"AttributeName":"Outcomes - Pharmacogenetic outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268466,"AttributeId":15269960,"AttributeName":"Outcomes - Pharmacogenetic outcome - Yes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001473,"AttributeId":15002967,"AttributeName":"Outcomes - Treatment Retention","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268467,"AttributeId":15269961,"AttributeName":"Outcomes - Treatment Retention - Treatment retention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946692,"AttributeId":14948186,"AttributeName":"Population category","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946695,"AttributeId":14948189,"AttributeName":"Population category - Adolescent and youth (young adults)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946698,"AttributeId":14948192,"AttributeName":"Population category - Adults (any sex)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946694,"AttributeId":14948188,"AttributeName":"Population category - Comorbid medical conditions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946693,"AttributeId":14948187,"AttributeName":"Population category - Comorbid mental illness","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007001,"AttributeId":15008495,"AttributeName":"Population category - Prison population","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946696,"AttributeId":14948190,"AttributeName":"Population category - Sexual or other minorities (e.g., racial)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946697,"AttributeId":14948191,"AttributeName":"Population category - Women/Pregnancy/Neonate/Children","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946679,"AttributeId":14948173,"AttributeName":"Quality Assessment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946682,"AttributeId":14948176,"AttributeName":"Quality Assessment - High quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946680,"AttributeId":14948174,"AttributeName":"Quality Assessment - Low quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946681,"AttributeId":14948175,"AttributeName":"Quality Assessment - Medium quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946699,"AttributeId":14948193,"AttributeName":"Study Design","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946700,"AttributeId":14948194,"AttributeName":"Study Design - Clinical Trials ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012483,"AttributeId":15013977,"AttributeName":"Study Design - Guidelines review ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946702,"AttributeId":14948196,"AttributeName":"Study Design - Metaanalysis ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946703,"AttributeId":14948197,"AttributeName":"Study Design - Systematic review protocol","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946701,"AttributeId":14948195,"AttributeName":"Study Design - Systematic reviews","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946683,"AttributeId":14948177,"AttributeName":"Study region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946684,"AttributeId":14948178,"AttributeName":"Study region - Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946687,"AttributeId":14948181,"AttributeName":"Study region - Americas ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946686,"AttributeId":14948180,"AttributeName":"Study region - Eastern Mediterranean Region ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946688,"AttributeId":14948182,"AttributeName":"Study region - Europe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946685,"AttributeId":14948179,"AttributeName":"Study region - South East Asia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946690,"AttributeId":14948184,"AttributeName":"Study region - Western Pacific Region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946709,"AttributeId":14948203,"AttributeName":"Year","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946710,"AttributeId":14948204,"AttributeName":"Year - 2009-2013","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946711,"AttributeId":14948205,"AttributeName":"Year - 2014-2018","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946712,"AttributeId":14948206,"AttributeName":"Year - 2019-2024","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012488,"AttributeId":15013982,"AttributeName":"Controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012490,"AttributeId":15013984,"AttributeName":"Controls - Active controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012489,"AttributeId":15013983,"AttributeName":"Controls - TAU/Placebo/Passive controls","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946716,"AttributeId":14948210,"AttributeName":"Countries","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946719,"AttributeId":14948213,"AttributeName":"Countries - Afghanistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946717,"AttributeId":14948211,"AttributeName":"Countries - Africa (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946720,"AttributeId":14948214,"AttributeName":"Countries - Angola","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946722,"AttributeId":14948216,"AttributeName":"Countries - Argentina","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946721,"AttributeId":14948215,"AttributeName":"Countries - Armenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946723,"AttributeId":14948217,"AttributeName":"Countries - Australia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946724,"AttributeId":14948218,"AttributeName":"Countries - Austria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946725,"AttributeId":14948219,"AttributeName":"Countries - Bahamas, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946726,"AttributeId":14948220,"AttributeName":"Countries - Bahrain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946727,"AttributeId":14948221,"AttributeName":"Countries - Bangladesh","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946728,"AttributeId":14948222,"AttributeName":"Countries - Barbados","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946730,"AttributeId":14948224,"AttributeName":"Countries - Belarus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946729,"AttributeId":14948223,"AttributeName":"Countries - Belgium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946731,"AttributeId":14948225,"AttributeName":"Countries - Belize","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946732,"AttributeId":14948226,"AttributeName":"Countries - Bolivia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946734,"AttributeId":14948228,"AttributeName":"Countries - Botswana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946733,"AttributeId":14948227,"AttributeName":"Countries - Brazil","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946735,"AttributeId":14948229,"AttributeName":"Countries - Bulgaria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946736,"AttributeId":14948230,"AttributeName":"Countries - Burkina Faso","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946737,"AttributeId":14948231,"AttributeName":"Countries - Cambodia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946738,"AttributeId":14948232,"AttributeName":"Countries - Cameroon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946739,"AttributeId":14948233,"AttributeName":"Countries - Canada","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946740,"AttributeId":14948234,"AttributeName":"Countries - Chile","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946741,"AttributeId":14948235,"AttributeName":"Countries - China","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946745,"AttributeId":14948239,"AttributeName":"Countries - Colombia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946742,"AttributeId":14948236,"AttributeName":"Countries - Congo","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946743,"AttributeId":14948237,"AttributeName":"Countries - Croatia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946744,"AttributeId":14948238,"AttributeName":"Countries - Cuba","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946746,"AttributeId":14948240,"AttributeName":"Countries - Cyprus","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946747,"AttributeId":14948241,"AttributeName":"Countries - Czech Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946749,"AttributeId":14948243,"AttributeName":"Countries - Denmark","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946748,"AttributeId":14948242,"AttributeName":"Countries - Dominican Republic","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946751,"AttributeId":14948245,"AttributeName":"Countries - Ecuador","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946750,"AttributeId":14948244,"AttributeName":"Countries - Egypt","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946752,"AttributeId":14948246,"AttributeName":"Countries - Eritrea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946753,"AttributeId":14948247,"AttributeName":"Countries - Estonia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946755,"AttributeId":14948249,"AttributeName":"Countries - Ethiopia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946718,"AttributeId":14948212,"AttributeName":"Countries - Europe (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946754,"AttributeId":14948248,"AttributeName":"Countries - Finland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946757,"AttributeId":14948251,"AttributeName":"Countries - France","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946756,"AttributeId":14948250,"AttributeName":"Countries - Gambia, The","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946758,"AttributeId":14948252,"AttributeName":"Countries - Georgia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946760,"AttributeId":14948254,"AttributeName":"Countries - Germany","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946759,"AttributeId":14948253,"AttributeName":"Countries - Ghana","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946761,"AttributeId":14948255,"AttributeName":"Countries - Greece","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946762,"AttributeId":14948256,"AttributeName":"Countries - Guatemala","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946763,"AttributeId":14948257,"AttributeName":"Countries - Guinea-Bissau","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946764,"AttributeId":14948258,"AttributeName":"Countries - Haiti","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946765,"AttributeId":14948259,"AttributeName":"Countries - Honduras","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946766,"AttributeId":14948260,"AttributeName":"Countries - Hong Kong","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946767,"AttributeId":14948261,"AttributeName":"Countries - Hungary","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946768,"AttributeId":14948262,"AttributeName":"Countries - Iceland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946769,"AttributeId":14948263,"AttributeName":"Countries - India","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946770,"AttributeId":14948264,"AttributeName":"Countries - Indonesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946771,"AttributeId":14948265,"AttributeName":"Countries - Iran","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946772,"AttributeId":14948266,"AttributeName":"Countries - Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946773,"AttributeId":14948267,"AttributeName":"Countries - Israel","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946774,"AttributeId":14948268,"AttributeName":"Countries - Italy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946775,"AttributeId":14948269,"AttributeName":"Countries - Ivory Coast","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946782,"AttributeId":14948276,"AttributeName":"Countries - Jamaica","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946781,"AttributeId":14948275,"AttributeName":"Countries - Japan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946777,"AttributeId":14948271,"AttributeName":"Countries - Jordan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946776,"AttributeId":14948270,"AttributeName":"Countries - Kazakhstan ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946778,"AttributeId":14948272,"AttributeName":"Countries - Kenya","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946779,"AttributeId":14948273,"AttributeName":"Countries - Korea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946780,"AttributeId":14948274,"AttributeName":"Countries - Kuwait","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946783,"AttributeId":14948277,"AttributeName":"Countries - Lao","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946784,"AttributeId":14948278,"AttributeName":"Countries - Latin America (where multiple countries)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946788,"AttributeId":14948282,"AttributeName":"Countries - Latvia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946785,"AttributeId":14948279,"AttributeName":"Countries - Lebanon","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946786,"AttributeId":14948280,"AttributeName":"Countries - Lesotho","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946787,"AttributeId":14948281,"AttributeName":"Countries - Liberia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946789,"AttributeId":14948283,"AttributeName":"Countries - Lithuania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946790,"AttributeId":14948284,"AttributeName":"Countries - Luxembourg","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946792,"AttributeId":14948286,"AttributeName":"Countries - Madagascar","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946791,"AttributeId":14948285,"AttributeName":"Countries - Malawi","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946793,"AttributeId":14948287,"AttributeName":"Countries - Malaysia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946794,"AttributeId":14948288,"AttributeName":"Countries - Mali","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946797,"AttributeId":14948291,"AttributeName":"Countries - Marshall Islands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946795,"AttributeId":14948289,"AttributeName":"Countries - Mexico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946796,"AttributeId":14948290,"AttributeName":"Countries - Micronesia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946799,"AttributeId":14948293,"AttributeName":"Countries - Mongolia ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946798,"AttributeId":14948292,"AttributeName":"Countries - Mozambique","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946800,"AttributeId":14948294,"AttributeName":"Countries - Myanmar (Burma)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946801,"AttributeId":14948295,"AttributeName":"Countries - Namibia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946802,"AttributeId":14948296,"AttributeName":"Countries - Nepal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946803,"AttributeId":14948297,"AttributeName":"Countries - New Zealand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946805,"AttributeId":14948299,"AttributeName":"Countries - Nicaragua","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946806,"AttributeId":14948300,"AttributeName":"Countries - Niger","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946807,"AttributeId":14948301,"AttributeName":"Countries - Nigeria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946808,"AttributeId":14948302,"AttributeName":"Countries - Northern Ireland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946810,"AttributeId":14948304,"AttributeName":"Countries - Norway","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946809,"AttributeId":14948303,"AttributeName":"Countries - Pakistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946811,"AttributeId":14948305,"AttributeName":"Countries - Panama","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946812,"AttributeId":14948306,"AttributeName":"Countries - Papua New Guinea","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946813,"AttributeId":14948307,"AttributeName":"Countries - Peru","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946814,"AttributeId":14948308,"AttributeName":"Countries - Philippines","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946815,"AttributeId":14948309,"AttributeName":"Countries - Poland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946816,"AttributeId":14948310,"AttributeName":"Countries - Portugal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946817,"AttributeId":14948311,"AttributeName":"Countries - Puerto Rico","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946818,"AttributeId":14948312,"AttributeName":"Countries - Romania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946819,"AttributeId":14948313,"AttributeName":"Countries - Russia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946820,"AttributeId":14948314,"AttributeName":"Countries - Rwanda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946821,"AttributeId":14948315,"AttributeName":"Countries - Samoa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946822,"AttributeId":14948316,"AttributeName":"Countries - San Marino","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946823,"AttributeId":14948317,"AttributeName":"Countries - Saudi Arabia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946824,"AttributeId":14948318,"AttributeName":"Countries - Scotland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946826,"AttributeId":14948320,"AttributeName":"Countries - Senegal","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946825,"AttributeId":14948319,"AttributeName":"Countries - Serbia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946828,"AttributeId":14948322,"AttributeName":"Countries - Sierra Leone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946827,"AttributeId":14948321,"AttributeName":"Countries - Singapore","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946829,"AttributeId":14948323,"AttributeName":"Countries - Slovakia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946830,"AttributeId":14948324,"AttributeName":"Countries - Slovenia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946831,"AttributeId":14948325,"AttributeName":"Countries - South Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946832,"AttributeId":14948326,"AttributeName":"Countries - Spain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946833,"AttributeId":14948327,"AttributeName":"Countries - Sri Lanka","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946834,"AttributeId":14948328,"AttributeName":"Countries - St Lucia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946835,"AttributeId":14948329,"AttributeName":"Countries - Swaziland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946836,"AttributeId":14948330,"AttributeName":"Countries - Sweden","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946837,"AttributeId":14948331,"AttributeName":"Countries - Switzerland","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946838,"AttributeId":14948332,"AttributeName":"Countries - Syria","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946839,"AttributeId":14948333,"AttributeName":"Countries - Taiwan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946841,"AttributeId":14948335,"AttributeName":"Countries - Tanzania","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946840,"AttributeId":14948334,"AttributeName":"Countries - Thailand","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946804,"AttributeId":14948298,"AttributeName":"Countries - The Netherlands","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946842,"AttributeId":14948336,"AttributeName":"Countries - Trinidad and Tobago","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946843,"AttributeId":14948337,"AttributeName":"Countries - Tunisia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946846,"AttributeId":14948340,"AttributeName":"Countries - Turkey","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946847,"AttributeId":14948341,"AttributeName":"Countries - UK","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946848,"AttributeId":14948342,"AttributeName":"Countries - USA","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946844,"AttributeId":14948338,"AttributeName":"Countries - Uganda","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946845,"AttributeId":14948339,"AttributeName":"Countries - Ukraine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946849,"AttributeId":14948343,"AttributeName":"Countries - Uzbekistan","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946850,"AttributeId":14948344,"AttributeName":"Countries - Vanuatu","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946851,"AttributeId":14948345,"AttributeName":"Countries - Venezuela","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946852,"AttributeId":14948346,"AttributeName":"Countries - Vietnam","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946853,"AttributeId":14948347,"AttributeName":"Countries - West Indies","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946854,"AttributeId":14948348,"AttributeName":"Countries - Yemen","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946855,"AttributeId":14948349,"AttributeName":"Countries - Zambia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946856,"AttributeId":14948350,"AttributeName":"Countries - Zimbabwe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946637,"AttributeId":14948131,"AttributeName":"Interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018223,"AttributeId":15019717,"AttributeName":"Interventions - Any other interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018874,"AttributeId":15020368,"AttributeName":"Interventions - Any other interventions - Any other non-OAMT intervention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018224,"AttributeId":15019718,"AttributeName":"Interventions - Any other interventions - Medications for Chronic pain","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018225,"AttributeId":15019719,"AttributeName":"Interventions - Any other interventions - Medications for other medical conditions (HCV, HIV)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946638,"AttributeId":14948132,"AttributeName":"Interventions - MOUD","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946640,"AttributeId":14948134,"AttributeName":"Interventions - MOUD - Buprenorphine S/L, films, patch","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946641,"AttributeId":14948135,"AttributeName":"Interventions - MOUD - Long-acting buprenorphine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946639,"AttributeId":14948133,"AttributeName":"Interventions - MOUD - Methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997919,"AttributeId":14999413,"AttributeName":"Interventions - MOUD - Nalterxone injection or implant","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14997918,"AttributeId":14999412,"AttributeName":"Interventions - MOUD - Naltrexone oral","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946642,"AttributeId":14948136,"AttributeName":"Interventions - MOUD - SROM, Tincture opium, HAT, Codeine/dihydocodeine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946653,"AttributeId":14948147,"AttributeName":"Interventions - Models of OAMT delivery ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012482,"AttributeId":15013976,"AttributeName":"Interventions - Models of OAMT delivery  - Emergency based OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946656,"AttributeId":14948150,"AttributeName":"Interventions - Models of OAMT delivery  - Integrated care provision","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946657,"AttributeId":14948151,"AttributeName":"Interventions - Models of OAMT delivery  - Scale up","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15027749,"AttributeId":15029243,"AttributeName":"Interventions - Models of OAMT delivery  - Supervision or take-home ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946655,"AttributeId":14948149,"AttributeName":"Interventions - Models of OAMT delivery  - Task-shifting ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946654,"AttributeId":14948148,"AttributeName":"Interventions - Models of OAMT delivery  - Telemedicine ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018226,"AttributeId":15019720,"AttributeName":"Interventions - OAMT Discontinuation/Transfer","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018228,"AttributeId":15019722,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - BPN to NTX LAI or NTX LAI to BPN ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018229,"AttributeId":15019723,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Discontinuation of ANY OAMT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018227,"AttributeId":15019721,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - Methadone to BPN or BPN to methadone or Methadone to HAT","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018230,"AttributeId":15019724,"AttributeName":"Interventions - OAMT Discontinuation/Transfer - OAMT induction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946643,"AttributeId":14948137,"AttributeName":"Interventions - Psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946644,"AttributeId":14948138,"AttributeName":"Interventions - Psychosocial interventions - Cognitive behavior therapy","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946647,"AttributeId":14948141,"AttributeName":"Interventions - Psychosocial interventions - Contingency management","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012491,"AttributeId":15013985,"AttributeName":"Interventions - Psychosocial interventions - Other psychosocial interventions","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946646,"AttributeId":14948140,"AttributeName":"Interventions - Psychosocial interventions - Social interventions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946645,"AttributeId":14948139,"AttributeName":"Interventions - Psychosocial interventions - Third wave cognitive therapies ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946648,"AttributeId":14948142,"AttributeName":"Interventions - Withdrawal Treatment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946649,"AttributeId":14948143,"AttributeName":"Interventions - Withdrawal Treatment - Buprenorphine/methadone","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946650,"AttributeId":14948144,"AttributeName":"Interventions - Withdrawal Treatment - Clonidine/lofexedine","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15031065,"AttributeId":15032559,"AttributeName":"Interventions - Withdrawal Treatment - Oral morphine/Tincture opium/any other (for neonatal withdrawal)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946651,"AttributeId":14948145,"AttributeName":"Interventions - Withdrawal Treatment - Pregabalin, gabapentin, other medications","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15030592,"AttributeId":15032086,"AttributeName":"Interventions - Withdrawal Treatment - Rapid/ultra-rapid withdrawal/low dose NTX","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946652,"AttributeId":14948146,"AttributeName":"Interventions - Withdrawal Treatment - Transcutaneous stimulation ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007002,"AttributeId":15008496,"AttributeName":"Opioid type","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007003,"AttributeId":15008497,"AttributeName":"Opioid type - Heroin","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007005,"AttributeId":15008499,"AttributeName":"Opioid type - Opium","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007004,"AttributeId":15008498,"AttributeName":"Opioid type - Prescription opioids","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946658,"AttributeId":14948152,"AttributeName":"Outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018878,"AttributeId":15020372,"AttributeName":"Outcomes - Health systems and economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268464,"AttributeId":15269958,"AttributeName":"Outcomes - Health systems and economic outcomes - Economic outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268463,"AttributeId":15269957,"AttributeName":"Outcomes - Health systems and economic outcomes - Health services outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946669,"AttributeId":14948163,"AttributeName":"Outcomes - Illicit opioid and other substance use ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946671,"AttributeId":14948165,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Cravings","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268462,"AttributeId":15269956,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Other substance use","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946670,"AttributeId":14948164,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Use/abstinence","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15018232,"AttributeId":15019726,"AttributeName":"Outcomes - Illicit opioid and other substance use  - Withdrawal symptoms","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001474,"AttributeId":15002968,"AttributeName":"Outcomes - Other health and social outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012481,"AttributeId":15013975,"AttributeName":"Outcomes - Other health and social outcomes - Maternal and child health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001476,"AttributeId":15002970,"AttributeName":"Outcomes - Other health and social outcomes - Mental health outcomes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001477,"AttributeId":15002971,"AttributeName":"Outcomes - Other health and social outcomes - Overdose and mortality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001475,"AttributeId":15002969,"AttributeName":"Outcomes - Other health and social outcomes - Physical health outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268461,"AttributeId":15269955,"AttributeName":"Outcomes - Other health and social outcomes - Safety ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001478,"AttributeId":15002972,"AttributeName":"Outcomes - Other health and social outcomes - Social/legal outcomes ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946674,"AttributeId":14948168,"AttributeName":"Outcomes - PROM","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946677,"AttributeId":14948171,"AttributeName":"Outcomes - PROM - Patient's perception","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946675,"AttributeId":14948169,"AttributeName":"Outcomes - PROM - QoL","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946676,"AttributeId":14948170,"AttributeName":"Outcomes - PROM - Satisfaction","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15062540,"AttributeId":15064034,"AttributeName":"Outcomes - Pharmacogenetic outcome","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268466,"AttributeId":15269960,"AttributeName":"Outcomes - Pharmacogenetic outcome - Yes","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15001473,"AttributeId":15002967,"AttributeName":"Outcomes - Treatment Retention","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15268467,"AttributeId":15269961,"AttributeName":"Outcomes - Treatment Retention - Treatment retention ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946692,"AttributeId":14948186,"AttributeName":"Population category","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946695,"AttributeId":14948189,"AttributeName":"Population category - Adolescent and youth (young adults)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946698,"AttributeId":14948192,"AttributeName":"Population category - Adults (any sex)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946694,"AttributeId":14948188,"AttributeName":"Population category - Comorbid medical conditions ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946693,"AttributeId":14948187,"AttributeName":"Population category - Comorbid mental illness","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15007001,"AttributeId":15008495,"AttributeName":"Population category - Prison population","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946696,"AttributeId":14948190,"AttributeName":"Population category - Sexual or other minorities (e.g., racial)","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946697,"AttributeId":14948191,"AttributeName":"Population category - Women/Pregnancy/Neonate/Children","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946679,"AttributeId":14948173,"AttributeName":"Quality Assessment","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946682,"AttributeId":14948176,"AttributeName":"Quality Assessment - High quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946680,"AttributeId":14948174,"AttributeName":"Quality Assessment - Low quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946681,"AttributeId":14948175,"AttributeName":"Quality Assessment - Medium quality","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946699,"AttributeId":14948193,"AttributeName":"Study Design","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946700,"AttributeId":14948194,"AttributeName":"Study Design - Clinical Trials ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":15012483,"AttributeId":15013977,"AttributeName":"Study Design - Guidelines review ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946702,"AttributeId":14948196,"AttributeName":"Study Design - Metaanalysis ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946703,"AttributeId":14948197,"AttributeName":"Study Design - Systematic review protocol","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946701,"AttributeId":14948195,"AttributeName":"Study Design - Systematic reviews","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946683,"AttributeId":14948177,"AttributeName":"Study region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946684,"AttributeId":14948178,"AttributeName":"Study region - Africa","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946687,"AttributeId":14948181,"AttributeName":"Study region - Americas ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946686,"AttributeId":14948180,"AttributeName":"Study region - Eastern Mediterranean Region ","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946688,"AttributeId":14948182,"AttributeName":"Study region - Europe","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946685,"AttributeId":14948179,"AttributeName":"Study region - South East Asia","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946690,"AttributeId":14948184,"AttributeName":"Study region - Western Pacific Region","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946709,"AttributeId":14948203,"AttributeName":"Year","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946710,"AttributeId":14948204,"AttributeName":"Year - 2009-2013","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946711,"AttributeId":14948205,"AttributeName":"Year - 2014-2018","AttributeDescription":"","ExtURL":"","ExtType":""},{"AttributeSetId":14946712,"AttributeId":14948206,"AttributeName":"Year - 2019-2024","AttributeDescription":"","ExtURL":"","ExtType":""}];
  const metaProperties = ["Year"];
  const aboutContent = "<p>Controls vs. Interventions</p>";
  const aboutPopup = false;
  const studySubmissionContent = "";
  const segmentAttributes = [{"attribute":{"AttributeDescription":"","ExtURL":"","ExtType":"","OriginalAttributeID":6475238,"AttributeSetId":14946700,"AttributeId":14948194,"AttributeSetDescription":"Randomized or non-randomized clinical trials ","AttributeType":"Selectable (show checkbox)","AttributeName":"Clinical Trials "},"color":"#5CB85C","isLight":true},{"attribute":{"AttributeDescription":"","ExtURL":"","ExtType":"","OriginalAttributeID":6475239,"AttributeSetId":14946701,"AttributeId":14948195,"AttributeSetDescription":"Includes scoping reviews ","AttributeType":"Selectable (show checkbox)","AttributeName":"Systematic reviews"},"color":"#11C3D9","isLight":true},{"attribute":{"AttributeDescription":"","ExtURL":"","ExtType":"","OriginalAttributeID":6475240,"AttributeSetId":14946702,"AttributeId":14948196,"AttributeSetDescription":"Includes network metaanalysis","AttributeType":"Selectable (show checkbox)","AttributeName":"Metaanalysis "},"color":"#0275D8","isLight":false},{"attribute":{"AttributeDescription":"","ExtURL":"","ExtType":"","OriginalAttributeID":6475242,"AttributeSetId":14946703,"AttributeId":14948197,"AttributeSetDescription":"","AttributeType":"Selectable (show checkbox)","AttributeName":"Systematic review protocol"},"color":"#7002D8","isLight":false},{"attribute":{"AttributeDescription":"","ExtURL":"","ExtType":"","OriginalAttributeID":0,"AttributeSetId":15012483,"AttributeId":15013977,"AttributeSetDescription":"","AttributeType":"Selectable (show checkbox)","AttributeName":"Guidelines review "},"color":"#F0AD4E","isLight":true}];
  const referenceData = [{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948218,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288253,"Title":"A systematic review and meta-analysis of slow-release oral morphine as a maintenance therapy for opioid use disorder","ParentTitle":"","ShortTitle":"A systematic review... (Jan)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42018090782","Comments":"","TypeName":"Journal, Article","Authors":"Jan Klimas ; Lauren Gorfinkel ; Evan Wood ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jan Klimas, Lauren Gorfinkel, and Evan Wood (    ) A systematic review and meta-analysis of slow-release oral morphine as a maintenance therapy for opioid use disorder.  , "},{"Codes":[{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288262,"Title":"A systematic review of medications for opioid use disorders (MOUD) in the Arab world","ParentTitle":"","ShortTitle":"A systematic review... (Maryam)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42020222941","Comments":"","TypeName":"Journal, Article","Authors":"Maryam Kazemitabar ; Jude Alawa ; Muzz Muhammad ; Daniel Bromberg ; Kaveh Khoshnood ; Danilo Garcia ; Lilian Ghandour ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Maryam Kazemitabar, Jude Alawa, Muzz Muhammad, Daniel Bromberg, Kaveh Khoshnood, Danilo Garcia, and Lilian Ghandour (    ) A systematic review of medications for opioid use disorders (MOUD) in the Arab world.  , "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281801,"Title":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review.","ParentTitle":"Addiction science & clinical practice","ShortTitle":"Adams (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"June","StandardNumber":"1940-0632 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"16","Pages":"36","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34103087","Comments":"","TypeName":"Journal, Article","Authors":"Adams KK ; Machnicz M ; Sobieraj DM ; ","ParentAuthors":"","DOI":"10.1186/s13722-021-00244-8 ","Keywords":"Analgesics, Opioid/adverse effects\r\n*Buprenorphine/therapeutic use\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\n*Substance Withdrawal Syndrome/drug therapy/epidemiology\r\nBuprenorphine\r\nInitiation\r\nMicrodosing\r\nOpioid use disorder\r\nWithdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Adams KK, Machnicz M, and Sobieraj DM (2021) Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review.. Addiction science & clinical practice 16(1), 36 DOI: 10.1186/s13722-021-00244-8 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948339,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279805,"Title":"Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Adams (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"E. Oviedo-Joekes, St. Paul's Hospital, 575-1081 Burrard St, Vancouver, BC, Canada","Volume":"117","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2024459756&from=export http://dx.doi.org/10.1016/j.drugpo.2023.104058","OldItemId":"","Comments":"2023-05-23","TypeName":"Journal, Article","Authors":"Adams A ; Blawatt S ; MacDonald S ; Finnick R ; Lajeunesse J ; Harrison S ; Byres D ; Schechter M T; Oviedo-Joekes E ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2023.104058","Keywords":"buprenorphine\r\nmethadone\r\nopiate agonist\r\nclient centered therapy\r\nclinical protocol\r\ncoronavirus disease 2019\r\ndata base\r\ndata extraction\r\ndrug dependence treatment\r\nexperience\r\nhealth care personnel\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\npandemic\r\nprescribing practice\r\nprescription\r\nprescription drug misuse\r\nqualitative analysis\r\nqualitative research\r\nquality control\r\nrelaxing restriction on take home medication\r\nreview\r\nsafety\r\nsubstance use\r\nsystematic review\r\nthematic analysis\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter M T, and Oviedo-Joekes E (2023) Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review. International Journal of Drug Policy 117,  DOI: 10.1016/j.drugpo.2023.104058"},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283353,"Title":"Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial.","ParentTitle":"Current drug abuse reviews","ShortTitle":"Afzalimoghaddam (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1874-4737 (Linking)","City":"United Arab Emirates","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"142-147","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"28059034","Comments":"","TypeName":"Journal, Article","Authors":"Afzalimoghaddam M ; Edalatifard M ; Nejati A ; Momeni M ; Isavi N ; Karimialavijeh E ; ","ParentAuthors":"","DOI":"10.2174/1874473710666170106122455 ","Keywords":"Adult\r\nAnalgesics/administration & dosage/therapeutic use\r\nAnalgesics, Opioid/administration & dosage/therapeutic use\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nDrug Tolerance\r\nEmergency Service, Hospital\r\nFemale\r\nHaloperidol/*administration & dosage/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMidazolam/*administration & dosage/therapeutic use\r\nMiddle Aged\r\nMorphine/*administration & dosage/therapeutic use\r\nOpioid-Related Disorders/*complications\r\nPain/*drug therapy\r\nPain Measurement\r\nPilot Projects\r\nSeverity of Illness Index\r\nTreatment Outcome\r\nAnalgesia\r\nhaloperidol\r\nmidazolam\r\nmorphine\r\nopium\r\npain management","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Afzalimoghaddam M, Edalatifard M, Nejati A, Momeni M, Isavi N, and Karimialavijeh E (2016) Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial.. Current drug abuse reviews 9(2), 142-147 DOI: 10.2174/1874473710666170106122455 "},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285170,"Title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.","ParentTitle":"Pediatrics","ShortTitle":"Agthe (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"May","StandardNumber":"0031-4005 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"123","Pages":"e849-56","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"19398463","Comments":"","TypeName":"Journal, Article","Authors":"Agthe AG ; Kim GR ; Mathias KB ; Hendrix CW ; Chavez-Valdez R ; Jansson L ; Lewis TR ; Yaster M ; Gauda EB ; ","ParentAuthors":"","DOI":"10.1542/peds.2008-0978 ","Keywords":"Adrenergic alpha-Agonists/administration & dosage/*therapeutic use\r\nAnalgesics, Opioid/*administration & dosage\r\nBlood Pressure/drug effects\r\nClonidine/administration & dosage/*therapeutic use\r\nDrug Therapy, Combination\r\nFemale\r\nHeart Rate/drug effects\r\nHeroin/*adverse effects\r\nHumans\r\nInfant, Newborn\r\nMale\r\nMethadone/*adverse effects\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nOpium/*administration & dosage\r\nProspective Studies\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, Lewis TR, Yaster M, and Gauda EB (2009) Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.. Pediatrics 123(5), e849-56 DOI: 10.1542/peds.2008-0978 "},{"Codes":[],"Outcomes":[],"ItemId":98282223,"Title":"Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.","ParentTitle":"Biochemical pharmacology","ShortTitle":"Ahmad (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"July","StandardNumber":"0006-2952 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"153","Pages":"196-204","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"29458047","Comments":"","TypeName":"Journal, Article","Authors":"Ahmad T ; Valentovic MA ; Rankin GO ; ","ParentAuthors":"","DOI":"10.1016/j.bcp.2018.02.020 ","Keywords":"Analgesics, Opioid/*metabolism/therapeutic use\r\nAnimals\r\nCytochrome P-450 Enzyme System/*genetics/metabolism\r\nHumans\r\nMethadone/*metabolism/therapeutic use\r\nOpioid-Related Disorders/drug therapy/metabolism\r\nPharmacogenetics/methods/*trends\r\nPolymorphism, Single Nucleotide/*genetics\r\nCytochrome P450 (CYP)\r\nGenetic variant\r\nMethadone metabolism\r\nPharmacogenetics\r\nSingle nucleotide polymorphism (SNP)","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ahmad T, Valentovic MA, and Rankin GO (2018) Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.. Biochemical pharmacology 153, 196-204 DOI: 10.1016/j.bcp.2018.02.020 "},{"Codes":[{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281024,"Title":"The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: A randomized, double-blind, clinical trial","ParentTitle":"Trials","ShortTitle":"Ahmadi (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1745-6215","City":"","Country":"","Publisher":"","Institution":"J. Ahmadi, Shiraz University of Medical Sciences, Substance Abuse Research Center, Shiraz, Iran","Volume":"19","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L623684415&from=export http://dx.doi.org/10.1186/s13063-018-2843-9","OldItemId":"","Comments":"2018-12-20","TypeName":"Journal, Article","Authors":"Ahmadi J ; Jahromi M S; Ehsaei Z ; ","ParentAuthors":"","DOI":"10.1186/s13063-018-2843-9","Keywords":"buprenorphine\r\nadult\r\narticle\r\nBeck Scale for Suicidal Ideation\r\nclinical article\r\ncomorbidity\r\ncontrolled study\r\ndisease association\r\nDSM-5\r\nhuman\r\nmajor depression\r\nmale\r\nopiate addiction\r\nprobability\r\npsychological rating scale\r\npsychometry\r\nscoring system\r\nsingle drug dose\r\nstructured interview\r\nsuicidal ideation\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ahmadi J, Jahromi M S, and Ehsaei Z (2018) The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: A randomized, double-blind, clinical trial. Trials 19(1),  DOI: 10.1186/s13063-018-2843-9"},{"Codes":[{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"randomized","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282030,"Title":"Single high-dose buprenorphine for opioid craving during withdrawal.","ParentTitle":"Trials","ShortTitle":"Ahmadi (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"December","StandardNumber":"1745-6215 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"19","Pages":"675","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"30526648","Comments":"","TypeName":"Journal, Article","Authors":"Ahmadi J ; Jahromi MS ; Ghahremani D ; London ED ; ","ParentAuthors":"","DOI":"10.1186/s13063-018-3055-z ","Keywords":"Adult\r\nAnalgesics, Opioid/*administration & dosage/adverse effects\r\nBuprenorphine/*administration & dosage/adverse effects\r\nCraving/*drug effects\r\nDouble-Blind Method\r\nHumans\r\nInpatients\r\nIran\r\nMale\r\nOpiate Substitution Treatment/adverse effects/*methods\r\nOpioid-Related Disorders/diagnosis/psychology/*rehabilitation\r\nSubstance Withdrawal Syndrome/diagnosis/*drug therapy/psychology\r\nTime Factors\r\nTreatment Outcome\r\nBuprenorphine\r\nCraving\r\nOpioid dependence\r\nOpioid withdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ahmadi J, Jahromi MS, Ghahremani D, and London ED (2018) Single high-dose buprenorphine for opioid craving during withdrawal.. Trials 19(1), 675 DOI: 10.1186/s13063-018-3055-z "},{"Codes":[],"Outcomes":[],"ItemId":98281185,"Title":"Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial","ParentTitle":"Journal of Psychiatric Research","ShortTitle":"Ahmadpanah (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0022-3956","City":"","Country":"","Publisher":"","Institution":"S. Brand, University of Basel, Psychiatric Clinics (UPK), Center for Affective, Stress and Sleep Disorders (ZASS), Wilhelm Klein-Strasse 27, Basel, Switzerland","Volume":"94","Pages":"23-28","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L616887180&from=export http://dx.doi.org/10.1016/j.jpsychires.2017.06.004","OldItemId":"","Comments":"2020-10-08","TypeName":"Journal, Article","Authors":"Ahmadpanah M ; Reihani A ; Ghaleiha A ; Soltanian A ; Haghighi M ; Jahangard L ; Sadeghi Bahmani ; D  ; Holsboer-Trachsler E ; Brand S ; ","ParentAuthors":"","DOI":"10.1016/j.jpsychires.2017.06.004","Keywords":"IRCT20150624229001N1\r\nbuprenorphine\r\ncitalopram\r\nclomipramine\r\nescitalopram\r\nplacebo\r\nadjuvant therapy\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndouble blind procedure\r\nfemale\r\nhuman\r\nmale\r\nobsessive compulsive disorder\r\npriority journal\r\nrandomized controlled trial\r\nstatistical distribution\r\ntreatment outcome\r\ntreatment response\r\nYale Brown Obsessive Compulsive Scale","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ahmadpanah M, Reihani A, Ghaleiha A, Soltanian A, Haghighi M, Jahangard L, Sadeghi Bahmani, D , Holsboer-Trachsler E, and Brand S (2017) Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial. Journal of Psychiatric Research 94, 23-28 DOI: 10.1016/j.jpsychires.2017.06.004"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282699,"Title":"Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Ajazi (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"July","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"16","Pages":"440-446","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"35960214","Comments":"","TypeName":"Journal, Article","Authors":"Ajazi EM ; Dasgupta N ; Marshall SW ; Monaco J ; Howard AG ; Preisser JS ; Schwartz TA ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000931 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\n*Drug Overdose/drug therapy\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nRecurrence\r\nSurvival Analysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ajazi EM, Dasgupta N, Marshall SW, Monaco J, Howard AG, Preisser JS, and Schwartz TA (2022) Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis.. Journal of addiction medicine 16(4), 440-446 DOI: 10.1097/ADM.0000000000000931 "},{"Codes":[{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282358,"Title":"Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.","ParentTitle":"Annals of internal medicine","ShortTitle":"Akiyama (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"May","StandardNumber":"0003-4819 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"170","Pages":"594-603","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"30959528","Comments":"","TypeName":"Journal, Article","Authors":"Akiyama MJ ; Norton BL ; Arnsten JH ; Agyemang L ; Heo M ; Litwin AH ; ","ParentAuthors":"","DOI":"10.7326/M18-1715 ","Keywords":"Analgesics, Opioid/administration & dosage\r\nAntiviral Agents/*therapeutic use\r\n*Directly Observed Therapy\r\n*Drug Users\r\nFemale\r\nHepatitis C, Chronic/*drug therapy/epidemiology\r\nHumans\r\nMale\r\nMedication Adherence/*statistics & numerical data\r\nMethadone/administration & dosage\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/drug therapy/epidemiology\r\nSubstance Abuse, Intravenous/drug therapy/epidemiology\r\nSustained Virologic Response","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Akiyama MJ, Norton BL, Arnsten JH, Agyemang L, Heo M, and Litwin AH (2019) Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.. Annals of internal medicine 170(9), 594-603 DOI: 10.7326/M18-1715 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284207,"Title":"Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.","ParentTitle":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ShortTitle":"Akiyama (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"June","StandardNumber":"1058-4838 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"70","Pages":"2695-2702","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"31346609","Comments":"","TypeName":"Journal, Article","Authors":"Akiyama MJ ; Lipsey D ; Heo M ; Agyemang L ; Norton BL ; Hidalgo J ; Lora K ; Litwin AH ; ","ParentAuthors":"","DOI":"10.1093/cid/ciz693 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Antiviral Agents/therapeutic use\r\nFemale\r\nHepacivirus\r\n*Hepatitis C/drug therapy/epidemiology\r\n*Hepatitis C, Chronic/drug therapy\r\nHumans\r\nMale\r\nMiddle Aged\r\n*Pharmaceutical Preparations\r\nRecurrence\r\nReinfection\r\n*Substance Abuse, Intravenous/complications/drug therapy\r\nHCV\r\nDAA\r\nIDU\r\nPWID\r\nreinfection","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Akiyama MJ, Lipsey D, Heo M, Agyemang L, Norton BL, Hidalgo J, Lora K, and Litwin AH (2020) Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 70(12), 2695-2702 DOI: 10.1093/cid/ciz693 "},{"Codes":[],"Outcomes":[],"ItemId":98282079,"Title":"Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.","ParentTitle":"The Journal of clinical psychiatry","ShortTitle":"Aklin (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"August","StandardNumber":"0160-6689 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"73","Pages":"e1056-61","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"22967782","Comments":"","TypeName":"Journal, Article","Authors":"Aklin WM ; Severtson SG ; Umbricht A ; Fingerhood M ; Bigelow GE ; Lejuez CW ; Silverman K ; ","ParentAuthors":"","DOI":"10.4088/JCP.09m05807 ","Keywords":"Administration, Oral\r\nAdult\r\nBaltimore\r\nCocaine-Related Disorders/psychology/rehabilitation\r\nConditioning, Operant\r\nFemale\r\nHeroin Dependence/psychology/rehabilitation\r\nHumans\r\nMale\r\nMedication Adherence/psychology\r\nMiddle Aged\r\nNaltrexone/adverse effects/*therapeutic use\r\nNarcotic Antagonists/adverse effects/*therapeutic use\r\nOdds Ratio\r\nOpioid-Related Disorders/psychology/*rehabilitation\r\nPatient Acceptance of Health Care/*psychology\r\nPersonality Assessment/statistics & numerical data\r\nPsychometrics\r\nRehabilitation, Vocational\r\n*Risk-Taking\r\nSheltered Workshops\r\nSubstance Abuse Detection\r\nSubstance Abuse, Intravenous/psychology/rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Aklin WM, Severtson SG, Umbricht A, Fingerhood M, Bigelow GE, Lejuez CW, and Silverman K (2012) Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.. The Journal of clinical psychiatry 73(8), e1056-61 DOI: 10.4088/JCP.09m05807 "},{"Codes":[],"Outcomes":[],"ItemId":98282855,"Title":"Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.","ParentTitle":"Asian journal of psychiatry","ShortTitle":"Alammehrjerdi (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"January","StandardNumber":"1876-2018 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"31","Pages":"49-55","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"29414387","Comments":"","TypeName":"Journal, Article","Authors":"Alammehrjerdi Z ; Ezard N ; Dolan K ; ","ParentAuthors":"","DOI":"10.1016/j.ajp.2018.01.001 ","Keywords":"Adult\r\nAmphetamine-Related Disorders/*epidemiology\r\nCentral Nervous System Stimulants/*adverse effects\r\nFemale\r\nHumans\r\nIran/epidemiology\r\nMale\r\nMethadone/*therapeutic use\r\nMethamphetamine/*adverse effects\r\nMotivational Interviewing/*methods\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPsychotherapy/*methods\r\nCognitive-behavioural therapy\r\nDependence\r\nMethamphetamine\r\nTreatment\r\nWomen","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alammehrjerdi Z, Ezard N, and Dolan K (2018) Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.. Asian journal of psychiatry 31, 49-55 DOI: 10.1016/j.ajp.2018.01.001 "},{"Codes":[],"Outcomes":[],"ItemId":98284163,"Title":"A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment.","ParentTitle":"Journal of psychoactive drugs","ShortTitle":"Alammehrjerdi (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"July","StandardNumber":"0279-1072 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"51","Pages":"280-289","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"30835643","Comments":"","TypeName":"Journal, Article","Authors":"Alammehrjerdi Z ; Briggs NE ; Biglarian A ; Mokri A ; Dolan K ; ","ParentAuthors":"","DOI":"10.1080/02791072.2019.1578445 ","Keywords":"Amphetamine-Related Disorders/*rehabilitation\r\nCognitive Behavioral Therapy/*methods\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nMethadone/*administration & dosage\r\nMethamphetamine/*administration & dosage\r\nOpiate Substitution Treatment\r\nTreatment Outcome\r\nBrief cognitive behavioral therapy\r\nmethadone\r\nmethamphetamine\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alammehrjerdi Z, Briggs NE, Biglarian A, Mokri A, and Dolan K (2019) A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment.. Journal of psychoactive drugs 51(3), 280-289 DOI: 10.1080/02791072.2019.1578445 "},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948220,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948274,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948279,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948317,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280079,"Title":"Medication for opioid use disorder in the Arab World: A systematic review","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Alawa (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"L. Ghandour, Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Van Dyck Building, PO Box 11-0236, Riad El-Solh Beirut, Lebanon","Volume":"102","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2016910012&from=export http://dx.doi.org/10.1016/j.drugpo.2022.103617","OldItemId":"","Comments":"2022-03-01","TypeName":"Journal, Article","Authors":"Alawa J ; Muhammad M ; Kazemitabar M ; Bromberg D J; Garcia D ; Khoshnood K ; Ghandour L ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2022.103617","Keywords":"buprenorphine\r\nmethadone\r\nnaloxone\r\nopiate agonist\r\nadoption\r\nArab world\r\nclinical evaluation\r\ncost effectiveness analysis\r\ndisease severity\r\nevidence based practice\r\nhuman\r\nopiate addiction\r\npatient satisfaction\r\nperception\r\npolicy\r\nquality control\r\nquality of life\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alawa J, Muhammad M, Kazemitabar M, Bromberg D J, Garcia D, Khoshnood K, and Ghandour L (2022) Medication for opioid use disorder in the Arab World: A systematic review. International Journal of Drug Policy 102,  DOI: 10.1016/j.drugpo.2022.103617"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"Scoping review","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282616,"Title":"The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.","ParentTitle":"Substance abuse treatment, prevention, and policy","ShortTitle":"Alexander (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"August","StandardNumber":"1747-597X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"16","Pages":"60","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34372900","Comments":"","TypeName":"Journal, Article","Authors":"Alexander K ; Pogorzelska-Maziarz M ; Gerolamo A ; Hassen N ; Kelly EL ; Rising KL ; ","ParentAuthors":"","DOI":"10.1186/s13011-021-00395-6 ","Keywords":"Buprenorphine/therapeutic use\r\nCOVID-19/*epidemiology\r\nCross-Sectional Studies\r\nDrug Overdose/*epidemiology/ethnology/mortality\r\nEmergency Medical Services/statistics & numerical data\r\nHealth Services Accessibility/*organization & administration\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/drug therapy/*therapy\r\nPandemics\r\nPatient Satisfaction\r\nSARS-CoV-2\r\nTelemedicine/organization & administration\r\nHealthcare delivery\r\nOpioid use\r\nPandemic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alexander K, Pogorzelska-Maziarz M, Gerolamo A, Hassen N, Kelly EL, and Rising KL (2021) The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.. Substance abuse treatment, prevention, and and policy 16(1), 60 DOI: 10.1186/s13011-021-00395-6 "},{"Codes":[],"Outcomes":[],"ItemId":98281899,"Title":"The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review.","ParentTitle":"Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing","ShortTitle":"Alexander (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"May","StandardNumber":"1527-6546 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"55","Pages":"721-729","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"36458604","Comments":"","TypeName":"Journal, Article","Authors":"Alexander K ; Smith JM ; Gerolamo A ; Bernhardt J ; ","ParentAuthors":"","DOI":"10.1111/jnu.12858 ","Keywords":"Humans\r\n*Nurses\r\nQuality of Health Care\r\nNurse's Role\r\n*Opioid-Related Disorders/drug therapy\r\nOutcome Assessment, Health Care\r\nhealthcare outcomes\r\nmedication-assisted treatment\r\nmethadone\r\nnurse-led interventions\r\nnursing practice\r\nnursing role\r\nopioid use disorder\r\npatient outcomes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alexander K, Smith JM, Gerolamo A, and Bernhardt J (2023) The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review.. Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing 55(3), 721-729 DOI: 10.1111/jnu.12858 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281429,"Title":"A systematic review of the cardiotoxicity of methadone","ParentTitle":"EXCLI Journal","ShortTitle":"Alinejad (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1611-2156","City":"","Country":"","Publisher":"","Institution":"O. Mehrpour, Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Pasdaran Avenue, Birjand, Iran","Volume":"14","Pages":"577-600","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L604476540&from=export http://dx.doi.org/10.17179/excli2014-553","OldItemId":"","Comments":"2015-06-03","TypeName":"Journal, Article","Authors":"Alinejad S ; Kazemi T ; Zamani N ; Hoffman R S; Mehrpour O ; ","ParentAuthors":"","DOI":"10.17179/excli2014-553","Keywords":"buprenorphine\r\ncharcoal\r\nmagnesium\r\nmethadone\r\npotassium\r\nBrugada syndrome\r\ncardiotoxicity\r\nchildhood disease\r\ncoronary artery disease\r\ncoronary hemodynamics\r\ndefibrillation\r\ndose response\r\ndrug contraindication\r\ndrug indication\r\ndrug safety\r\nelectrocardiogram\r\nheart muscle potential\r\nheart ventricle bigeminy\r\nhuman\r\nhypokalemia\r\nnonhuman\r\nopiate addiction\r\npain\r\npregnancy\r\nQT dispersion\r\nQT interval\r\nQT prolongation\r\nreview\r\nsystematic review\r\nTakotsubo cardiomyopathy\r\ntorsade de pointes\r\nU wave","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alinejad S, Kazemi T, Zamani N, Hoffman R S, and Mehrpour O (2015) A systematic review of the cardiotoxicity of methadone. EXCLI Journal 14, 577-600 DOI: 10.17179/excli2014-553"},{"Codes":[{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280153,"Title":"The Role of Physical Activity in Opioid Substitution Therapy: A Systematic Review of Interventional and Observational Studies","ParentTitle":"Substance Abuse: Research and Treatment","ShortTitle":"Alpers (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1178-2218","City":"","Country":"","Publisher":"","Institution":"S.E. Alpers, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway","Volume":"16","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2018263593&from=export http://dx.doi.org/10.1177/11782218221111840","OldItemId":"","Comments":"2023-02-20","TypeName":"Journal, Article","Authors":"Alpers S E; Furulund E ; Pallesen S ; Mamen A ; Dyrstad S M; Fadnes L T; ","ParentAuthors":"","DOI":"10.1177/11782218221111840","Keywords":"NCT00790569\r\nNCT03022890\r\nactivity tracker\r\ncocaine\r\ndiamorphine\r\nmethadone\r\nopiate\r\naerobic exercise\r\nanxiety\r\nbadminton\r\nboxing\r\nclimbing\r\ncocaine dependence\r\ncool down\r\ndancing\r\ndepression\r\ndrug dependence\r\nfitness\r\nheroin dependence\r\nhigh intensity exercise\r\nhuman\r\nmental health\r\nmethadone treatment\r\nopiate addiction\r\nopiate substitution treatment\r\nphysical activity\r\npsychotherapy\r\nresistance training\r\nreview\r\nsubstance use\r\nsystematic review\r\nwalking\r\nyoga","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alpers S E, Furulund E, Pallesen S, Mamen A, Dyrstad S M, and Fadnes L T (2022) The Role of Physical Activity in Opioid Substitution Therapy: A Systematic Review of Interventional and Observational Studies. Substance Abuse: Research and Treatment 16,  DOI: 10.1177/11782218221111840"},{"Codes":[],"Outcomes":[],"ItemId":98282528,"Title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.","ParentTitle":"Journal of acquired immune deficiency syndromes (1999)","ShortTitle":"Altice (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"March","StandardNumber":"1525-4135 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"BHIVES Collaborative","Volume":"56 Suppl 1","Pages":"S22-32","Edition":"","Issue":"Suppl 1","Availability":"","URL":"","OldItemId":"21317590","Comments":"","TypeName":"Journal, Article","Authors":"Altice FL ; Bruce RD ; Lucas GM ; Lum PJ ; Korthuis PT ; Flanigan TP ; Cunningham CO ; Sullivan LE ; Vergara-Rodriguez P ; Fiellin DA ; Cajina A ; Botsko M ; Nandi V ; Gourevitch MN ; Finkelstein R ; ","ParentAuthors":"","DOI":"10.1097/QAI.0b013e318209751e ","Keywords":"Alcoholism\r\nAnti-HIV Agents/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination\r\nCD4 Lymphocyte Count\r\nFemale\r\nHIV Infections/*complications/drug therapy\r\nHIV-1/metabolism\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*complications/drug therapy\r\nRNA, Viral/blood\r\nRisk Factors\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, and Finkelstein R (2011) HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.. Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1(Suppl 1), S22-32 DOI: 10.1097/QAI.0b013e318209751e "},{"Codes":[],"Outcomes":[],"ItemId":98282489,"Title":"Management of women treated with buprenorphine during pregnancy.","ParentTitle":"American journal of obstetrics and gynecology","ShortTitle":"Alto (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"October","StandardNumber":"0002-9378 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"205","Pages":"302-8","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"21640969","Comments":"","TypeName":"Journal, Article","Authors":"Alto WA ; O'Connor AB ; ","ParentAuthors":"","DOI":"10.1016/j.ajog.2011.04.001 ","Keywords":"Buprenorphine/*therapeutic use\r\nFemale\r\nHumans\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Alto WA, and O'Connor AB (2011) Management of women treated with buprenorphine during pregnancy.. American journal of obstetrics and gynecology 205(4), 302-8 DOI: 10.1016/j.ajog.2011.04.001 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283187,"Title":"A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Amass (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"January","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"107","Pages":"142-51","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"21749526","Comments":"","TypeName":"Journal, Article","Authors":"Amass L ; Pukeleviciene V ; Subata E ; Almeida AR ; Pieri MC ; D'Egidio P ; Stankova Z ; Costa A ; Smyth BP ; Sakoman S ; Wei Y ; Strang J ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2011.03577.x ","Keywords":"Administration, Sublingual\r\nAdolescent\r\nAdult\r\nBuprenorphine/administration & dosage/adverse effects/*therapeutic use\r\nDrug Combinations\r\nEurope\r\nFemale\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nInduction Chemotherapy/*methods\r\nIntention to Treat Analysis\r\nMaintenance Chemotherapy\r\nMale\r\nMiddle Aged\r\nNaloxone/administration & dosage/adverse effects/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/adverse effects/*therapeutic use\r\nPatient Compliance\r\nProspective Studies\r\nSubstance Abuse, Intravenous/*prevention & control\r\nSubstance Withdrawal Syndrome/drug therapy\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Amass L, Pukeleviciene V, Subata E, Almeida AR, Pieri MC, D'Egidio P, Stankova Z, Costa A, Smyth BP, Sakoman S, Wei Y, and Strang J (2012) A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.. Addiction (Abingdon, and England) 107(1), 142-51 DOI: 10.1111/j.1360-0443.2011.03577.x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281992,"Title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Amato (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"October","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD004147","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"21975742","Comments":"","TypeName":"Journal, Article","Authors":"Amato L ; Minozzi S ; Davoli M ; Vecchi S ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD004147.pub4 ","Keywords":"Combined Modality Therapy/methods\r\nHumans\r\nNarcotics/*therapeutic use\r\nOpioid-Related Disorders/psychology/*rehabilitation\r\nPsychotherapy/*methods\r\nRandomized Controlled Trials as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Amato L, Minozzi S, Davoli M, and Vecchi S (2011) Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.. The Cochrane database of systematic reviews (10), CD004147 DOI: 10.1002/14651858.CD004147.pub4 "},{"Codes":[{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282497,"Title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Amato (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"September","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD005031","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"21901695","Comments":"","TypeName":"Journal, Article","Authors":"Amato L ; Minozzi S ; Davoli M ; Vecchi S ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD005031.pub4 ","Keywords":"Adult\r\nBuprenorphine/therapeutic use\r\nCombined Modality Therapy/methods\r\nFemale\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nNarcotics/*therapeutic use\r\nOpioid-Related Disorders/rehabilitation/*therapy\r\nPsychotherapy/*methods\r\nRandomized Controlled Trials as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Amato L, Minozzi S, Davoli M, and Vecchi S (2011) Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.. The Cochrane database of systematic reviews (9), CD005031 DOI: 10.1002/14651858.CD005031.pub4 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948326,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282487,"Title":"Methadone at tapered doses for the management of opioid withdrawal.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Amato (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"February","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"2013","Pages":"CD003409","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"23450540","Comments":"","TypeName":"Journal, Article","Authors":"Amato L ; Davoli M ; Minozzi S ; Ferroni E ; Ali R ; Ferri M ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD003409.pub4 ","Keywords":"Humans\r\nMethadone/*administration & dosage\r\nNarcotics/*administration & dosage/adverse effects\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome/*rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Amato L, Davoli M, Minozzi S, Ferroni E, Ali R, and Ferri M (2013) Methadone at tapered doses for the management of opioid withdrawal.. The Cochrane database of systematic reviews 2013(2), CD003409 DOI: 10.1002/14651858.CD003409.pub4 "},{"Codes":[{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281937,"Title":"Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Ameral (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"April","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"233","Pages":"109379","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"35255353","Comments":"","TypeName":"Journal, Article","Authors":"Ameral V ; Hocking E ; Leviyah X ; Newberger NG ; Timko C ; Livingston N ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109379 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nPatient Discharge\r\nTreatment Outcome\r\nCare continuity\r\nDetoxification\r\nOpioid use disorder\r\nTreatment engagement","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, and Livingston N (2022) Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder.. Drug and alcohol dependence 233, 109379 DOI: 10.1016/j.drugalcdep.2022.109379 "},{"Codes":[],"Outcomes":[],"ItemId":98282023,"Title":"Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment.","ParentTitle":"Substance abuse treatment, prevention, and policy","ShortTitle":"Amini (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"January","StandardNumber":"1747-597X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"18","Pages":"1","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36609286","Comments":"","TypeName":"Journal, Article","Authors":"Amini Z ; HeidariFarsani E ; ","ParentAuthors":"","DOI":"10.1186/s13011-023-00514-5 ","Keywords":"Humans\r\n*Methadone/therapeutic use\r\nMental Health\r\nOpiate Substitution Treatment/methods\r\nZinc/therapeutic use\r\nIran\r\n*Opioid-Related Disorders/complications/drug therapy\r\nDietary Supplements\r\nRecurrence\r\nMental health\r\nMethadone maintenance treatment\r\nProbability of relapse\r\nZinc supplementation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Amini Z, and HeidariFarsani E (2023) Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment.. Substance abuse treatment, prevention, and and policy 18(1), 1 DOI: 10.1186/s13011-023-00514-5 "},{"Codes":[],"Outcomes":[],"ItemId":98280164,"Title":"Use of buprenorphine microdosing for opiate dependence in the pediatric intensive care unit","ParentTitle":"Critical Care Medicine","ShortTitle":"Anderson (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1530-0293","City":"","Country":"","Publisher":"","Institution":"J. Anderson, Golisano Children's Hospital, University of Rochester, Rochester, NY, United States","Volume":"50","Pages":"432","Edition":"","Issue":"1 SUPPL","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L637188664&from=export http://dx.doi.org/10.1097/01.ccm.0000809820.27872.89","OldItemId":"","Comments":"2022-02-14","TypeName":"Journal, Article","Authors":"Anderson J ; Chen D ; Stauber S ; Schult R ; Weigand T ; Barker E ; ","ParentAuthors":"","DOI":"10.1097/01.ccm.0000809820.27872.89","Keywords":"adjuvant\r\nbuprenorphine\r\nopiate\r\nopiate agonist\r\nadult\r\nanalgesia\r\ncase report\r\nclinical article\r\nconference abstract\r\ncoronavirus disease 2019\r\ndevelopmental delay\r\ndrug megadose\r\ndrug microdose\r\ndrug therapy\r\ndrug withdrawal\r\nfemale\r\nhuman\r\ninfant\r\nintermethod comparison\r\nlow drug dose\r\nopiate addiction\r\npediatric intensive care unit\r\nrespiratory failure\r\nsedation\r\nside effect\r\ntracheostomy\r\nventilator\r\nweaning\r\nyoung adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Anderson J, Chen D, Stauber S, Schult R, Weigand T, and Barker E (2022) Use of buprenorphine microdosing for opiate dependence in the pediatric intensive care unit. Critical Care Medicine 50(1 SUPPL), 432 DOI: 10.1097/01.ccm.0000809820.27872.89"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283044,"Title":"Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.","ParentTitle":"Journal of clinical psychopharmacology","ShortTitle":"Andorn (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"May","StandardNumber":"0271-0749 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"40","Pages":"231-239","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"32282418","Comments":"","TypeName":"Journal, Article","Authors":"Andorn AC ; Haight BR ; Shinde S ; Fudala PJ ; Zhao Y ; Heidbreder C ; Learned SM ; Fox NL ; Nadipelli VR ; Hassman D ; Rutrick D ; ","ParentAuthors":"","DOI":"10.1097/JCP.0000000000001195 ","Keywords":"Adolescent\r\nAdult\r\nAged\r\nAnalgesics, Opioid/administration & dosage/adverse effects/therapeutic use\r\nBuprenorphine/*administration & dosage/adverse effects/*therapeutic use\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nInjections, Subcutaneous\r\nMale\r\nMiddle Aged\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Andorn AC, Haight BR, Shinde S, Fudala PJ, Zhao Y, Heidbreder C, Learned SM, Fox NL, Nadipelli VR, Hassman D, and Rutrick D (2020) Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.. Journal of clinical psychopharmacology 40(3), 231-239 DOI: 10.1097/JCP.0000000000001195 "},{"Codes":[],"Outcomes":[],"ItemId":98282170,"Title":"A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements.","ParentTitle":"Substance use & addiction journal","ShortTitle":"Andraka-Christou (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"April","StandardNumber":"2976-7342 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"45","Pages":"278-291","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"38288697","Comments":"","TypeName":"Journal, Article","Authors":"Andraka-Christou B ; Golan OK ; Williams M ; Buksbaum S ; Gordon AJ ; Stein BD ; ","ParentAuthors":"","DOI":"10.1177/29767342231223721 ","Keywords":"Humans\r\n*Buprenorphine\r\n*Opioid-Related Disorders/drug therapy\r\nOpiate Substitution Treatment/methods\r\nCounseling\r\n*Drug Overdose/drug therapy\r\nbuprenorphine\r\ncounseling\r\ndose\r\nlaw\r\nopioid use disorder\r\npolicy\r\nstate\r\nvisit","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Andraka-Christou B, Golan OK, Williams M, Buksbaum S, Gordon AJ, and Stein BD (2024) A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements.. Substance use & addiction journal 45(2), 278-291 DOI: 10.1177/29767342231223721 "},{"Codes":[],"Outcomes":[],"ItemId":98280125,"Title":"Efficacy of continuous theta burst stimulation - repetitive trancranial magnetic stimulation on the orbito frontal cortex as an adjunct to naltrexone in patients of opioid use disorder and its correlation with serum BDNF levels: a sham-controlled study","ParentTitle":"Journal of Addictive Diseases","ShortTitle":"Ankit (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1055-0887","City":"","Country":"","Publisher":"","Institution":"P. Dey, Central Institute of Psychiatry, Ranchi, India","Volume":"40","Pages":"373-381","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2014306568&from=export http://dx.doi.org/10.1080/10550887.2021.2007716","OldItemId":"","Comments":"2022-06-30","TypeName":"Journal, Article","Authors":"Ankit A ; Das B ; Dey P ; Kshitiz K K; Khess C R.J; ","ParentAuthors":"","DOI":"10.1080/10550887.2021.2007716","Keywords":"ELISA kit\r\nbrain derived neurotrophic factor\r\nnaltrexone\r\nadult\r\narticle\r\nbehavior disorder assessment\r\nclinical article\r\ncontinuous theta burst stimulation\r\ncontrolled study\r\ndata analysis software\r\nelectrical parameters\r\nhuman\r\nmaintenance therapy\r\nmale\r\nmental disease assessment\r\nmiddle aged\r\nobjective opioid withdrawal scale\r\nobsessive compulsive drug use scale\r\nopiate addiction\r\nopoid use disorder\r\norbital cortex\r\nprospective study\r\nprotein blood level\r\nrepetitive transcranial magnetic stimulation\r\ntherapy effect\r\nyoung adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ankit A, Das B, Dey P, Kshitiz K K, and Khess C R.J (2022) Efficacy of continuous theta burst stimulation - repetitive trancranial magnetic stimulation on the orbito frontal cortex as an adjunct to naltrexone in patients of opioid use disorder and its correlation with serum BDNF levels: a sham-controlled study. Journal of Addictive Diseases 40(3), 373-381 DOI: 10.1080/10550887.2021.2007716"},{"Codes":[],"Outcomes":[],"ItemId":98281630,"Title":"Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc Interval","ParentTitle":"Archives of Internal Medicine","ShortTitle":"Ansermot (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"","StandardNumber":"1538-3679","City":"","Country":"","Publisher":"","Institution":"C. B. Eap, Unit of Biochemistry and Clinical Psychopharmacology, Hospital of Cery, University of Lausanne, Lausanne, Switzerland","Volume":"170","Pages":"529-536","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L358645196&from=export http://dx.doi.org/10.1001/archinternmed.2010.26","OldItemId":"","Comments":"2010-04-30","TypeName":"Journal, Article","Authors":"Ansermot N ; Albayrak  ; Schlpfer J ; Crettol S ; Croquette-Krokar M ; Bourquin M ; Dglon J J; Faouzi M ; Scherbaum N ; Eap C B; ","ParentAuthors":"","DOI":"10.1001/archinternmed.2010.26","Keywords":"methadone\r\nopiate\r\nadult\r\narticle\r\ncardiotoxicity\r\nclinical article\r\ncontrolled study\r\ndrug blood level\r\ndrug substitution\r\nelectrocardiogram\r\nfemale\r\nheredity\r\nhuman\r\nmaintenance therapy\r\nmale\r\nopiate addiction\r\npharmacogenetics\r\npriority journal\r\nQT interval\r\nreal time polymerase chain reaction\r\nsudden death\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ansermot N, Albayrak , Schlpfer J, Crettol S, Croquette-Krokar M, Bourquin M, Dglon J J, Faouzi M, Scherbaum N, and Eap C B (2010) Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc Interval. Archives of Internal Medicine 170(6), 529-536 DOI: 10.1001/archinternmed.2010.26"},{"Codes":[],"Outcomes":[],"ItemId":98282800,"Title":"Problem based review: The patient taking methadone.","ParentTitle":"Acute medicine","ShortTitle":"Arora (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1747-4884 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"12","Pages":"51-4","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23539377","Comments":"","TypeName":"Journal, Article","Authors":"Arora A ; Williams K ; ","ParentAuthors":"","DOI":"","Keywords":"Adult\r\nHumans\r\nMale\r\nMethadone/administration & dosage/*therapeutic use/toxicity\r\nNaloxone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nNarcotics/administration & dosage/*therapeutic use/toxicity\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Arora A, and Williams K (2013) Problem based review: The patient taking methadone.. Acute medicine 12(1), 51-4"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280754,"Title":"Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients","ParentTitle":"Psychopharmacology","ShortTitle":"Arout (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0033-3158","City":"","Country":"","Publisher":"","Institution":"C.A. Arout, Department of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, Unit 120, New York, NY, United States","Volume":"236","Pages":"2857-2866","Edition":"","Issue":"10","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2003493507&from=export http://dx.doi.org/10.1007/s00213-018-5146-7","OldItemId":"","Comments":"2019-12-06","TypeName":"Journal, Article","Authors":"Arout C A; Waters A J; MacLean R R; Compton P ; Sofuoglu M ; ","ParentAuthors":"","DOI":"10.1007/s00213-018-5146-7","Keywords":"buprenorphine plus naloxone\r\ninterleukin 1beta\r\ninterleukin 6\r\nmethadone\r\nminocycline\r\nopiate agonist\r\nplacebo\r\ntumor necrosis factor\r\naccuracy\r\nadult\r\narticle\r\nclinical article\r\ncognition\r\ncold pressor test\r\ncontrolled study\r\ndouble blind procedure\r\ndrug craving\r\ndrug effect\r\necological momentary assessment\r\nexperimental pain\r\nfemale\r\nhuman\r\nmaintenance therapy\r\nmale\r\nnociception\r\nopiate addiction\r\npain severity\r\npain threshold\r\npriority journal\r\nprotein blood level\r\nrandomized controlled trial\r\nsingle drug dose","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Arout C A, Waters A J, MacLean R R, Compton P, and Sofuoglu M (2019) Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients. Psychopharmacology 236(10), 2857-2866 DOI: 10.1007/s00213-018-5146-7"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281989,"Title":"Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review.","ParentTitle":"Obstetrics and gynecology","ShortTitle":"Atluru (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"March","StandardNumber":"0029-7844 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"143","Pages":"403-410","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"38227945","Comments":"","TypeName":"Journal, Article","Authors":"Atluru S ; Bruehlman AK ; Vaughn P ; Schauberger CW ; Smid MC ; ","ParentAuthors":"","DOI":"10.1097/AOG.0000000000005510 ","Keywords":"Pregnancy\r\nInfant, Newborn\r\nFemale\r\nHumans\r\nMethadone/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nNaltrexone/therapeutic use\r\nProspective Studies\r\nRetrospective Studies\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\nAnalgesics, Opioid/therapeutic use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Atluru S, Bruehlman AK, Vaughn P, Schauberger CW, and Smid MC (2024) Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review.. Obstetrics and gynecology 143(3), 403-410 DOI: 10.1097/AOG.0000000000005510 "},{"Codes":[],"Outcomes":[],"ItemId":98282540,"Title":"Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.","ParentTitle":"Substance abuse treatment, prevention, and policy","ShortTitle":"Ayres (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"November","StandardNumber":"1747-597X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"44","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25407020","Comments":"","TypeName":"Journal, Article","Authors":"Ayres R ; Ingram J ; Rees A ; Neale J ; Beattie A ; Telfer M ; ","ParentAuthors":"","DOI":"10.1186/1747-597X-9-44 ","Keywords":"Adult\r\nAnalgesics, Opioid/therapeutic use\r\nBuprenorphine/*therapeutic use\r\nCognitive Dissonance\r\nEngland\r\nFeasibility Studies\r\nFemale\r\nHarm Reduction\r\nHeroin Dependence/drug therapy/psychology/*rehabilitation\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nMotivation\r\nMotivational Interviewing/methods\r\nNarcotics/therapeutic use\r\nOpiate Substitution Treatment/methods/*psychology\r\nPatient Satisfaction\r\nProgram Evaluation\r\nQualitative Research\r\nSubstance Abuse, Intravenous/drug therapy/psychology/*rehabilitation\r\nTime-to-Treatment\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ayres R, Ingram J, Rees A, Neale J, Beattie A, and Telfer M (2014) Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.. Substance abuse treatment, prevention, and and policy 9, 44 DOI: 10.1186/1747-597X-9-44 "},{"Codes":[],"Outcomes":[],"ItemId":98279746,"Title":"48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Azar (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"","StandardNumber":"1932-0620","City":"","Country":"","Publisher":"","Institution":"P. Azar, Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, DHCC, Floor 8-2775 Laurel St, Vancouver, BC, Canada","Volume":"18","Pages":"82-85","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2030264387&from=export http://dx.doi.org/10.1097/ADM.0000000000001231","OldItemId":"","Comments":"2024-04-16","TypeName":"Journal, Article","Authors":"Azar P ; Wong J S.H; Mathew N ; Ignaszewski M J; Partovi N ; Krausz R M; Ajidahun A ; Thotakura S ; Harris M ; Barrios R ; Montaner J S.G; Maharaj A R; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000001231","Keywords":"transdermal patch\r\nantibiotic agent\r\nbuprenorphine\r\ncocaine\r\nfentanyl\r\nhydromorphone\r\nmethadone\r\nmorphine\r\nnaloxone\r\nadult\r\narticle\r\ncase report\r\nclinical article\r\ndrug craving\r\ndrug withdrawal\r\nfemale\r\nfluid resuscitation\r\nhospitalization\r\nhuman\r\nopiate addiction\r\nopiate substitution treatment\r\npain\r\npancolitis\r\nsepsis\r\nsustained drug release\r\ntransdermal drug administration\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Azar P, Wong J S.H, Mathew N, Ignaszewski M J, Partovi N, Krausz R M, Ajidahun A, Thotakura S, Harris M, Barrios R, Montaner J S.G, and Maharaj A R (2024) 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine. Journal of Addiction Medicine 18(1), 82-85 DOI: 10.1097/ADM.0000000000001231"},{"Codes":[],"Outcomes":[],"ItemId":98279982,"Title":"Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection","ParentTitle":"Journal of Leukocyte Biology","ShortTitle":"Azzoni (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0741-5400","City":"","Country":"","Publisher":"","Institution":"L.J. Montaner, Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, United States","Volume":"112","Pages":"733-744","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2018390812&from=export http://dx.doi.org/10.1002/JLB.4A1221-678RR","OldItemId":"","Comments":"2022-10-11","TypeName":"Journal, Article","Authors":"Azzoni L ; Giron L B; Vadrevu S ; Zhao L ; Lalley-Chareczko L ; Hiserodt E ; Fair M ; Lynn K ; Trooskin S ; Mounzer K ; Abdel-Mohsen M ; Montaner L J; ","ParentAuthors":"","DOI":"10.1002/JLB.4A1221-678RR","Keywords":"anti human immunodeficiency virus agent\r\nbenzodiazepine derivative\r\ncannabinoid\r\nCD14 antigen\r\nimmunoglobulin G\r\ninterleukin 18\r\nmethadone\r\nnaltrexone\r\nneopterin\r\nserotonin uptake inhibitor\r\nvascular cell adhesion molecule 1\r\nadult\r\nantiretroviral therapy\r\narticle\r\ncapillary electrophoresis\r\nclinical article\r\ncohort analysis\r\ncontrolled study\r\ncross-sectional study\r\nenzyme linked immunosorbent assay\r\nfemale\r\nflow cytometry\r\nglycosylation\r\nhuman\r\nHuman immunodeficiency virus infected patient\r\nHuman immunodeficiency virus infection\r\nimmune reconstitution\r\nimmunoglobulin blood level\r\nimmunomodulation\r\ninflammation\r\nmale\r\nmiddle aged\r\nopiate addiction\r\npilot study\r\nprotein expression\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Azzoni L, Giron L B, Vadrevu S, Zhao L, Lalley-Chareczko L, Hiserodt E, Fair M, Lynn K, Trooskin S, Mounzer K, Abdel-Mohsen M, and Montaner L J (2022) Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection. Journal of Leukocyte Biology 112(4), 733-744 DOI: 10.1002/JLB.4A1221-678RR"},{"Codes":[],"Outcomes":[],"ItemId":98282295,"Title":"Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Back (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"September","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"37","Pages":"313-23","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"21854273","Comments":"","TypeName":"Journal, Article","Authors":"Back SE ; Payne RL ; Wahlquist AH ; Carter RE ; Stroud Z ; Haynes L ; Hillhouse M ; Brady KT ; Ling W ; ","ParentAuthors":"","DOI":"10.3109/00952990.2011.596982 ","Keywords":"Adult\r\nAnalgesics, Opioid/administration & dosage/adverse effects/therapeutic use\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/epidemiology/*rehabilitation\r\nSeverity of Illness Index\r\nSex Factors\r\nSubstance-Related Disorders/*epidemiology\r\nUnited States/epidemiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, and Ling W (2011) Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.. The American journal of drug and alcohol abuse 37(5), 313-23 DOI: 10.3109/00952990.2011.596982 "},{"Codes":[{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282918,"Title":"Morphine versus clonidine for neonatal abstinence syndrome.","ParentTitle":"Pediatrics","ShortTitle":"Bada (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"February","StandardNumber":"0031-4005 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"135","Pages":"e383-91","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"25624389","Comments":"","TypeName":"Journal, Article","Authors":"Bada HS ; Sithisarn T ; Gibson J ; Garlitz K ; Caldwell R ; Capilouto G ; Li Y ; Leggas M ; Breheny P ; ","ParentAuthors":"","DOI":"10.1542/peds.2014-2377 ","Keywords":"Analgesics/*therapeutic use\r\nArousal/drug effects\r\nClonidine/*therapeutic use\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMale\r\nMorphine/*therapeutic use\r\nNeonatal Abstinence Syndrome/*rehabilitation\r\nOpioid-Related Disorders/*rehabilitation\r\nPilot Projects\r\nPsychomotor Agitation/rehabilitation\r\nclonidine\r\nmorphine\r\nneonatal abstinence syndrome\r\nneurobehavioral manifestations\r\nneurobehavioral scale\r\nprenatal opiate exposure","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bada HS, Sithisarn T, Gibson J, Garlitz K, Caldwell R, Capilouto G, Li Y, Leggas M, and Breheny P (2015) Morphine versus clonidine for neonatal abstinence syndrome.. Pediatrics 135(2), e383-91 DOI: 10.1542/peds.2014-2377 "},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284529,"Title":"[Breastfeeding and rooming-in in the management of neonatal abstinence syndrome. Scoping review].","ParentTitle":"Anales del sistema sanitario de Navarra","ShortTitle":"Baeza-Gozalo (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"August","StandardNumber":"1137-6627 (Linking)","City":"Spain","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"37639321","Comments":"","TypeName":"Journal, Article","Authors":"Baeza-Gozalo P ; Sola-Ca S ; Lpez-Dicastillo O ; ","ParentAuthors":"","DOI":"10.23938/ASSN.1048 ","Keywords":"Infant\r\nInfant, Newborn\r\nFemale\r\nPregnancy\r\nHumans\r\n*Breast Feeding\r\n*Neonatal Abstinence Syndrome/therapy\r\nHospitalization\r\nLength of Stay\r\nPatient Discharge","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Baeza-Gozalo P, Sola-Ca S, and Lpez-Dicastillo O (2023) [Breastfeeding and rooming-in in the management of neonatal abstinence syndrome. Scoping review].. Anales del sistema sanitario de Navarra 46(2),  DOI: 10.23938/ASSN.1048 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284300,"Title":"Review of the assessment and management of neonatal abstinence syndrome.","ParentTitle":"Addiction science & clinical practice","ShortTitle":"Bagley (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"September","StandardNumber":"1940-0632 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"19","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"25199822","Comments":"","TypeName":"Journal, Article","Authors":"Bagley SM ; Wachman EM ; Holland E ; Brogly SB ; ","ParentAuthors":"","DOI":"10.1186/1940-0640-9-19 ","Keywords":"Breast Feeding\r\nBuprenorphine/therapeutic use\r\nClonidine/therapeutic use\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMethadone/therapeutic use\r\nNarcotics/*adverse effects\r\nNeonatal Abstinence Syndrome/*diagnosis/*therapy\r\nOpiate Substitution Treatment/methods\r\nPregnancy\r\nPregnancy Complications/diagnosis/therapy\r\nPrenatal Exposure Delayed Effects/diagnosis/therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bagley SM, Wachman EM, Holland E, and Brogly SB (2014) Review of the assessment and management of neonatal abstinence syndrome.. Addiction science & clinical practice 9(1), 19 DOI: 10.1186/1940-0640-9-19 "},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280830,"Title":"The Value of Hospitalization in the Opioid Epidemic: A Scoping Review","ParentTitle":"Canadian Journal of Addiction","ShortTitle":"Bahji (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"2368-4720","City":"","Country":"","Publisher":"","Institution":"A. Bahji, Department of Psychiatry, Queen's University, Kingston, ON, Canada","Volume":"10","Pages":"6-17","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L630965943&from=export http://dx.doi.org/10.1097/CXA.0000000000000049","OldItemId":"","Comments":"2020-02-28","TypeName":"Journal, Article","Authors":"Bahji A ; Bajaj N ; ","ParentAuthors":"","DOI":"10.1097/CXA.0000000000000049","Keywords":"buprenorphine\r\nclonidine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nbibliographic database\r\nCinahl\r\nclinical effectiveness\r\nCochrane Library\r\ncommunity\r\ndata collection method\r\ndrug dependence treatment\r\ndrug detoxification\r\ndrug overdose\r\nEmbase\r\nemergency ward\r\nepidemic\r\nevidence based medicine\r\ngeneral anesthesia\r\nhealth program\r\nhospital care\r\nhospitalization\r\nhuman\r\nintervention study\r\nlength of stay\r\nMedline\r\nmeta analysis\r\nmortality\r\nopiate addiction\r\noutcome assessment\r\npractice guideline\r\nPreferred Reporting Items for Systematic Reviews and Meta-Analyses\r\npreventive health service\r\nPsycINFO\r\nrandomized controlled trial (topic)\r\nrelapse\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bahji A, and Bajaj N (2019) The Value of Hospitalization in the Opioid Epidemic: A Scoping Review. Canadian Journal of Addiction 10(2), 6-17 DOI: 10.1097/CXA.0000000000000049"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282569,"Title":"Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis.","ParentTitle":"Acta psychiatrica Scandinavica","ShortTitle":"Bahji (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"October","StandardNumber":"0001-690X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"140","Pages":"313-339","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"31419306","Comments":"","TypeName":"Journal, Article","Authors":"Bahji A ; Cheng B ; Gray S ; Stuart H ; ","ParentAuthors":"","DOI":"10.1111/acps.13088 ","Keywords":"Adult\r\nAnalgesics, Opioid/administration & dosage/adverse effects/*agonists/therapeutic \r\n      use\r\nBuprenorphine/administration & dosage/adverse effects/therapeutic use\r\nCase-Control Studies\r\nCohort Studies\r\nDatabases, Factual\r\nDrug Overdose/*mortality\r\nDrug Tolerance\r\nFemale\r\nHumans\r\nMale\r\nMethadone/administration & dosage/adverse effects/therapeutic use\r\nMonitoring, Physiologic/methods\r\nNarcotic Antagonists/administration & dosage/adverse effects/therapeutic use\r\nOpioid-Related Disorders/*mortality/psychology/*therapy\r\nPatient Education as Topic\r\nQuality of Life\r\nRisk\r\nanalgesics\r\nbuprenorphine\r\ndrug overdose\r\nhumans\r\nmeta-analysis\r\nmethadone\r\nopioid\r\nopioid-related disorders\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bahji A, Cheng B, Gray S, and Stuart H (2019) Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis.. Acta psychiatrica Scandinavica 140(4), 313-339 DOI: 10.1111/acps.13088 "},{"Codes":[],"Outcomes":[],"ItemId":98280700,"Title":"Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review","ParentTitle":"Canadian Journal of Addiction","ShortTitle":"Bahji (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"2368-4720","City":"","Country":"","Publisher":"","Institution":"A. Bahji, Department of Public Health Sciences, Queen's University, Abramsky Hall, Room 328, 21 Arch Street, Kingston, ON, Canada","Volume":"11","Pages":"13-23","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L633085064&from=export http://dx.doi.org/10.1097/CXA.0000000000000080","OldItemId":"","Comments":"2020-11-24","TypeName":"Journal, Article","Authors":"Bahji A ; Yanagawa B ; Lamba W ; ","ParentAuthors":"","DOI":"10.1097/CXA.0000000000000080","Keywords":"needle\r\nantibiotic agent\r\nillicit drug\r\naddiction\r\nantibiotic therapy\r\nbacterial endocarditis\r\nbacterial infection\r\nCochrane Library\r\nconsultation\r\ndrug dependence\r\nEmbase\r\nfollow up\r\nharm reduction\r\nhospital patient\r\nhuman\r\nhygiene\r\ninjection drug user\r\nMedline\r\nmorbidity\r\nmortality\r\nopiate addiction\r\nPreferred Reporting Items for Systematic Reviews and Meta-Analyses\r\nPsycINFO\r\nrecurrent infection\r\nresidential care\r\nreview\r\nsex difference\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bahji A, Yanagawa B, and Lamba W (2020) Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review. Canadian Journal of Addiction 11(2), 13-23 DOI: 10.1097/CXA.0000000000000080"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282062,"Title":"Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Bahji (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"August","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"115","Pages":"1413-1425","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"31863669","Comments":"","TypeName":"Journal, Article","Authors":"Bahji A ; Carlone D ; Altomare J ; ","ParentAuthors":"","DOI":"10.1111/add.14946 ","Keywords":"Adult\r\n*Criminals\r\nDelayed-Action Preparations/therapeutic use\r\nDrug Overdose/prevention & control\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy\r\nRecurrence\r\nSecondary Prevention\r\nTreatment Outcome\r\nAnalgesics, opioid\r\ncriminal justice-involved individuals\r\ndrug overdose\r\nnaltrexone\r\nopioid-related disorders\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bahji A, Carlone D, and Altomare J (2020) Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.. Addiction (Abingdon, and England) 115(8), 1413-1425 DOI: 10.1111/add.14946 "},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279893,"Title":"Effect of add-on amantadine to clonidine on opioid withdrawal symptoms in opioid-dependent patients detoxified with buprenorphine: a randomized controlled trial","ParentTitle":"Journal of Substance Use","ShortTitle":"Bahrami (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"1465-9891","City":"","Country":"","Publisher":"","Institution":"A. Safari, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran","Volume":"28","Pages":"938-944","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2018689137&from=export http://dx.doi.org/10.1080/14659891.2022.2110954","OldItemId":"","Comments":"2023-11-24","TypeName":"Journal, Article","Authors":"Bahrami M ; Kheirabadi G ; Safari A ; Maracy M R; ","ParentAuthors":"","DOI":"10.1080/14659891.2022.2110954","Keywords":"IRCT20090801002266N15)\r\namantadine\r\nbuprenorphine\r\nclonidine\r\nopiate\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndepression\r\ndetoxification\r\ndizziness\r\ndouble blind procedure\r\ndrug dose increase\r\ndrug dose reduction\r\nDSM-5\r\nfemale\r\nflushing\r\nfollow up\r\nhuman\r\ninsomnia\r\nmale\r\nmuscle twitch\r\nopiate addiction\r\nrandomized controlled trial\r\nrestlessness\r\nrhinorrhea\r\nside effect\r\nsweating\r\nvomiting\r\nwithdrawal syndrome\r\nyawning","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bahrami M, Kheirabadi G, Safari A, and Maracy M R (2023) Effect of add-on amantadine to clonidine on opioid withdrawal symptoms in opioid-dependent patients detoxified with buprenorphine: a randomized controlled trial. Journal of Substance Use 28(6), 938-944 DOI: 10.1080/14659891.2022.2110954"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282940,"Title":"Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.","ParentTitle":"The American journal on addictions","ShortTitle":"Bakouni (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"32","Pages":"469-478","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"37308805","Comments":"","TypeName":"Journal, Article","Authors":"Bakouni H ; McAnulty C ; Tatar O ; Socias ME ; Le Foll B ; Lim R ; Ahamad K ; Jutras-Aswad D ; ","ParentAuthors":"","DOI":"10.1111/ajad.13439 ","Keywords":"Humans\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nMethadone/adverse effects\r\nAnalgesics, Opioid/adverse effects\r\nHeroin\r\nOpiate Substitution Treatment/adverse effects/methods\r\nCanada\r\n*Opioid-Related Disorders/drug therapy\r\n*Buprenorphine/adverse effects\r\nPrescriptions\r\nNarcotic Antagonists/adverse effects","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bakouni H, McAnulty C, Tatar O, Socias ME, Le Foll B, Lim R, Ahamad K, and Jutras-Aswad D (2023) Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.. The American journal on addictions 32(5), 469-478 DOI: 10.1111/ajad.13439 "},{"Codes":[],"Outcomes":[],"ItemId":98281663,"Title":"Opioid maintenance treatment during pregnancy: Occurrence and severity of neonatal abstinence syndrome","ParentTitle":"European Addiction Research","ShortTitle":"Bakstad (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"","StandardNumber":"1022-6877","City":"","Country":"","Publisher":"","Institution":"B. Bakstad, Centre for Addiction Research, Institute of Psychiatry, University of Oslo, Oslo, Norway","Volume":"15","Pages":"128-134","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L50467517&from=export http://dx.doi.org/10.1159/000210042","OldItemId":"","Comments":"2009-08-25","TypeName":"Journal, Article","Authors":"Bakstad B ; Sarfi M ; Welle-Strand G K; Ravndal E ; ","ParentAuthors":"","DOI":"10.1159/000210042","Keywords":"amphetamine\r\nbenzodiazepine\r\nbuprenorphine\r\ncannabis\r\nmethadone\r\nnicotine\r\nopiate\r\nadult\r\nApgar score\r\narticle\r\nbirth weight\r\ncesarean section\r\ncigarette smoking\r\nclinical article\r\nclinical trial\r\ncontrolled study\r\nobstetric delivery\r\ndisease severity\r\ndose response\r\ndrug dependence\r\ndrug dose reduction\r\ndrug megadose\r\ndrug use\r\nfemale\r\ngestational age\r\nhead circumference\r\nhuman\r\nmaintenance therapy\r\nmedical record\r\nmethadone treatment\r\npregnancy complication\r\npregnancy outcome\r\npregnant woman\r\nprematurity\r\nprenatal exposure\r\npriority journal\r\nprospective study\r\nquestionnaire\r\nthird trimester pregnancy\r\ntreatment duration\r\nurinalysis\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bakstad B, Sarfi M, Welle-Strand G K, and Ravndal E (2009) Opioid maintenance treatment during pregnancy: Occurrence and severity of neonatal abstinence syndrome. European Addiction Research 15(3), 128-134 DOI: 10.1159/000210042"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279902,"Title":"Prenatal exposure to opioids and neurodevelopment in infancy and childhood: A systematic review","ParentTitle":"Frontiers in Pediatrics","ShortTitle":"Balalian (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"2296-2360","City":"","Country":"","Publisher":"","Institution":"A.A. Balalian, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States","Volume":"11","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2021963548&from=export http://dx.doi.org/10.3389/fped.2023.1071889","OldItemId":"","Comments":"2023-04-03","TypeName":"Journal, Article","Authors":"Balalian A A; Graeve R ; Richter M ; Fink A ; Kielstein H ; Martins S S; Philbin M M; Factor-Litvak P ; ","ParentAuthors":"","DOI":"10.3389/fped.2023.1071889","Keywords":"alcohol\r\namphetamine derivative\r\nbarbituric acid derivative\r\nbenzodiazepine derivative\r\nbuprenorphine\r\ncannabis\r\ncocaine\r\ncodeine\r\ndiamorphine\r\nhydrocodone\r\nmethadone\r\nopiate\r\noxycodone\r\nserotonin uptake inhibitor\r\nadolescence\r\nadolescent\r\nchild\r\nchild behavior\r\nchildhood\r\ncognitive development\r\nfemale\r\nhealth practitioner\r\nhuman\r\ninfancy\r\ninfant\r\nmethadone treatment\r\nmotor development\r\nmotor performance\r\nneonatal abstinence syndrome\r\nnervous system development\r\nnewborn\r\nopiate addiction\r\npregnancy\r\npreschool child\r\nprescription\r\nproblem behavior\r\nreview\r\nschool child\r\nskill\r\nsystematic review\r\ntoddler","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Balalian A A, Graeve R, Richter M, Fink A, Kielstein H, Martins S S, Philbin M M, and Factor-Litvak P (2023) Prenatal exposure to opioids and neurodevelopment in infancy and childhood: A systematic review. Frontiers in Pediatrics 11,  DOI: 10.3389/fped.2023.1071889"},{"Codes":[],"Outcomes":[],"ItemId":98282851,"Title":"Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Bandstra (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"November","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"107 Suppl 1","Pages":"1-4","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"23106922","Comments":"","TypeName":"Journal, Article","Authors":"Bandstra ES ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2012.04059.x ","Keywords":"Adolescent\r\nAdult\r\nBuprenorphine/adverse effects/*therapeutic use\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMethadone/adverse effects/*therapeutic use\r\nNeonatal Abstinence Syndrome/drug therapy\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bandstra ES (2012) Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.. Addiction (Abingdon, and England) 107 Suppl 1, 1-4 DOI: 10.1111/j.1360-0443.2012.04059.x "},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948266,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281882,"Title":"Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review.","ParentTitle":"Harm reduction journal","ShortTitle":"Banka-Cullen (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"June","StandardNumber":"1477-7517 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"20","Pages":"78","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"37353762","Comments":"","TypeName":"Journal, Article","Authors":"Banka-Cullen SP ; Comiskey C ; Kelly P ; Zeni MB ; Gutierrez A ; Menon U ; ","ParentAuthors":"","DOI":"10.1186/s12954-023-00812-y ","Keywords":"Adolescent\r\nFemale\r\nHumans\r\nAnalgesics, Opioid/therapeutic use\r\nEducational Status\r\n*Opioid-Related Disorders/drug therapy\r\nPolicy\r\nMOUD\r\nMedication-assisted treatment\r\nNurse prescriber\r\nOpioid use disorder\r\nScoping review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Banka-Cullen SP, Comiskey C, Kelly P, Zeni MB, Gutierrez A, and Menon U (2023) Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review.. Harm reduction journal 20(1), 78 DOI: 10.1186/s12954-023-00812-y "},{"Codes":[],"Outcomes":[],"ItemId":98279851,"Title":"Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Banks (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"1932-0620","City":"","Country":"","Publisher":"","Institution":"D.E. Banks, Department of Psychological Sciences, University of Missouri - St Louis, One University Blvd, 325 Stadler Hall, St. Louis, MO, United States","Volume":"17","Pages":"356-359","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2025088696&from=export http://dx.doi.org/10.1097/ADM.0000000000001113","OldItemId":"","Comments":"2023-07-13","TypeName":"Journal, Article","Authors":"Banks D E; Fentem A ; Li X ; Paschke M ; Filiatreau L ; Woolfolk C ; Cavazos-Rehg P ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000001113","Keywords":"buprenorphine\r\nmethadone\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndemographics\r\nfamily support\r\nfemale\r\nhealth belief\r\nhelp seeking behavior\r\nhuman\r\nopiate addiction\r\npatient attitude\r\npregnancy\r\npsychopharmacotherapy\r\npuerperium\r\nself concept\r\nsocial norm\r\nstatistics\r\nstigma\r\nuncertainty","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Banks D E, Fentem A, Li X, Paschke M, Filiatreau L, Woolfolk C, and Cavazos-Rehg P (2023) Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment. Journal of Addiction Medicine 17(3), 356-359 DOI: 10.1097/ADM.0000000000001113"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281673,"Title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Bao (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"","StandardNumber":"1097-9891","City":"","Country":"","Publisher":"","Institution":"Z.-M. Liu, National Institute on Drug Dependence, Peking University, 38, Xue Yuan Road, Hai Dian District, Beijing 100083, China","Volume":"35","Pages":"28-33","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L354265361&from=export http://dx.doi.org/10.1080/00952990802342899","OldItemId":"","Comments":"2009-03-18","TypeName":"Journal, Article","Authors":"Bao Y P; Liu Z M; Epstein D H; Du C ; Shi J ; Lu L ; ","ParentAuthors":"","DOI":"10.1080/00952990802342899","Keywords":"acetylmethadol\r\nbuprenorphine\r\nmethadone\r\nopiate\r\nplacebo\r\nalternative medicine\r\narticle\r\nclinical trial\r\ndouble blind procedure\r\ndrug dose regimen\r\ndrug effect\r\nfollow up\r\nhuman\r\ninformation retrieval\r\nmaintenance therapy\r\nmeta analysis\r\nmethadone treatment\r\nopiate addiction\r\npatient compliance\r\nrandomized controlled trial\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bao Y P, Liu Z M, Epstein D H, Du C, Shi J, and Lu L (2009) A meta-analysis of retention in methadone maintenance by dose and dosing strategy. American Journal of Drug and Alcohol Abuse 35(1), 28-33 DOI: 10.1080/00952990802342899"},{"Codes":[],"Outcomes":[],"ItemId":98282419,"Title":"Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.","ParentTitle":"The Journal of the Association of Nurses in AIDS Care : JANAC","ShortTitle":"Barajas-Nava (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"1055-3290 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"28","Pages":"832-833","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"28652132","Comments":"","TypeName":"Journal, Article","Authors":"Barajas-Nava L ; ","ParentAuthors":"","DOI":"10.1016/j.jana.2017.05.009 ","Keywords":"Administration, Oral\r\nHIV Infections/*prevention & control\r\nHumans\r\nNarcotics/*administration & dosage\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*rehabilitation\r\nSubstance Abuse, Intravenous/complications/*rehabilitation\r\nhuman immunodeficiency virus\r\nopioid dependent\r\nprevention\r\nsubstitution treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Barajas-Nava L (2017) Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.. The Journal of the Association of Nurses in AIDS Care : JANAC 28(5), 832-833 DOI: 10.1016/j.jana.2017.05.009 "},{"Codes":[],"Outcomes":[],"ItemId":98283983,"Title":"The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.","ParentTitle":"Current opinion in HIV and AIDS","ShortTitle":"Baral (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"November","StandardNumber":"1746-630X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"7","Pages":"563-8","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"23076122","Comments":"","TypeName":"Journal, Article","Authors":"Baral SD ; Strmdahl S ; Beyrer C ; ","ParentAuthors":"","DOI":"10.1097/COH.0b013e328358e49e ","Keywords":"Administration, Oral\r\nAnti-HIV Agents/*administration & dosage\r\nChemoprevention/*methods\r\nClinical Trials as Topic\r\nFemale\r\nHIV Infections/*prevention & control\r\nHumans\r\nMale\r\nSubstance Abuse, Intravenous/*complications","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Baral SD, Strmdahl S, and Beyrer C (2012) The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs.. Current opinion in HIV and AIDS 7(6), 563-8 DOI: 10.1097/COH.0b013e328358e49e "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280533,"Title":"Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies","ParentTitle":"Value in Health","ShortTitle":"Barbosa (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1098-3015","City":"","Country":"","Publisher":"","Institution":"C. Barbosa, Behavioral Health Research Division, RTI International, 230 W. Monroe Street, Suite 2100, Chicago, IL, United States","Volume":"23","Pages":"1096-1108","Edition":"","Issue":"8","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007179533&from=export http://dx.doi.org/10.1016/j.jval.2020.03.015","OldItemId":"","Comments":"2020-08-27","TypeName":"Journal, Article","Authors":"Barbosa C ; Dowd W N; Zarkin G ; ","ParentAuthors":"","DOI":"10.1016/j.jval.2020.03.015","Keywords":"buprenorphine\r\ndiamorphine\r\nhydromorphone\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nbrain depth stimulation\r\ncomputer simulation\r\ncost benefit analysis\r\ndecision tree\r\ndrug intoxication\r\neconomic evaluation\r\nhealth status\r\nhuman\r\nMarkov chain\r\nmedicaid\r\nmethadone treatment\r\nopiate addiction\r\npriority journal\r\npsychosocial care\r\nquality adjusted life year\r\nreimbursement\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Barbosa C, Dowd W N, and Zarkin G (2020) Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies. Value in Health 23(8), 1096-1108 DOI: 10.1016/j.jval.2020.03.015"},{"Codes":[],"Outcomes":[],"ItemId":98280264,"Title":"Buprenorphine micro-induction in pregnancy","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Barbour (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1935-3227","City":"","Country":"","Publisher":"","Institution":"K. Barbour","Volume":"15","Pages":"E8","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L636526738&from=export http://dx.doi.org/10.1097/ADM.0000000000000902","OldItemId":"","Comments":"2021-11-30","TypeName":"Journal, Article","Authors":"Barbour K ; McQuade M ; Seligman N S; Wiegand T ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000902","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\ndexmedetomidine\r\nfentanyl\r\nmethadone\r\nmidazolam\r\nnoradrenalin\r\nopiate\r\nphenobarbital\r\nsedative agent\r\nadult\r\nadverse drug reaction\r\nagitation\r\nboy\r\nbuccal drug administration\r\ncase report\r\nclinical article\r\ncomplication\r\nconference abstract\r\ncritically ill patient\r\ndrug therapy\r\ndrug withdrawal\r\nemergency ward\r\nendocarditis\r\nextubation\r\nfeeding\r\nfemale\r\ngastrostomy\r\nhepatitis C\r\nhuman\r\nhypotension\r\ninfant\r\nlaryngomalacia\r\nmaintenance therapy\r\nmale\r\nmedical intensive care unit\r\nmental health\r\nneonatal abstinence syndrome\r\nneurosyphilis\r\nnewborn\r\nopiate addiction\r\nopiate substitution treatment\r\noutpatient\r\npregnancy\r\nrespiratory failure\r\nside effect\r\ntheoretical study\r\nvaginal delivery\r\nweaning","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Barbour K, McQuade M, Seligman N S, and Wiegand T (2021) Buprenorphine micro-induction in pregnancy. Journal of Addiction Medicine 15(5), E8 DOI: 10.1097/ADM.0000000000000902"},{"Codes":[],"Outcomes":[],"ItemId":98282563,"Title":"Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical Research.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Bardwell (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"September","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"15","Pages":"390-395","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"33177437","Comments":"","TypeName":"Journal, Article","Authors":"Bardwell G ; Jaffe K ; Korthuis PT ; Richardson L ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000772 ","Keywords":"*Alcoholism/drug therapy\r\nAnalgesics, Opioid/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nNaltrexone/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nProspective Studies","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bardwell G, Jaffe K, Korthuis PT, and Richardson L (2021) Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical Research.. Journal of addiction medicine 15(5), 390-395 DOI: 10.1097/ADM.0000000000000772 "},{"Codes":[],"Outcomes":[],"ItemId":98283273,"Title":"A Qualitative Systematic Review of Access to Substance Use Disorder Care in the United States Criminal Justice System.","ParentTitle":"International journal of environmental research and public health","ShortTitle":"Barenie (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"October","StandardNumber":"1660-4601 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"19","Pages":"","Edition":"","Issue":"19","Availability":"","URL":"","OldItemId":"36231947","Comments":"","TypeName":"Journal, Article","Authors":"Barenie RE ; Cernasev A ; Jasmin H ; Knight P ; Chisholm-Burns M ; ","ParentAuthors":"","DOI":"10.3390/ijerph191912647 ","Keywords":"*Criminal Law/methods\r\nHumans\r\nQualitative Research\r\n*Substance-Related Disorders/epidemiology/therapy\r\nUnited States\r\ncriminal justice system\r\nsubstance use disorder\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Barenie RE, Cernasev A, Jasmin H, Knight P, and Chisholm-Burns M (2022) A Qualitative Systematic Review of Access to Substance Use Disorder Care in the United States Criminal Justice System.. International journal of environmental research and public health 19(19),  DOI: 10.3390/ijerph191912647 "},{"Codes":[],"Outcomes":[],"ItemId":98280945,"Title":"Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study","ParentTitle":"Therapeutic Advances in Drug Safety","ShortTitle":"Bass (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"2042-0986","City":"","Country":"","Publisher":"","Institution":"B.K. Malhotra, Pfizer Inc, 235 East 42nd Street, New York, NY, United States","Volume":"10","Pages":"1-5","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2013212634&from=export http://dx.doi.org/10.1177/2042098618821274","OldItemId":"","Comments":"","TypeName":"Journal, Article","Authors":"Bass A ; Webster L R; Matschke K T; Malhotra B K; Wolfram G ; ","ParentAuthors":"","DOI":"10.1177/2042098618821274","Keywords":"article\r\ncapnometry\r\nclinical article\r\ncontrolled study\r\ncrossover procedure\r\ndepression\r\ndouble blind procedure\r\ndrug combination\r\ndrug overdose\r\ndrug therapy\r\nhuman\r\nintravenous drug administration\r\nopiate addiction\r\nprescription\r\nrandomized controlled trial\r\nrespiration depression\r\nnaltrexone\r\nnaltrexone plus oxycodone\r\nopiate\r\noxycodone\r\nplacebo","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bass A, Webster L R, Matschke K T, Malhotra B K, and Wolfram G (2019) Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study. Therapeutic Advances in Drug Safety 10, 1-5 DOI: 10.1177/2042098618821274"},{"Codes":[],"Outcomes":[],"ItemId":98281286,"Title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","ParentTitle":"American Journal of Obstetrics and Gynecology","ShortTitle":"Bastian (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0002-9378","City":"","Country":"","Publisher":"","Institution":"J.R. Bastian, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States","Volume":"216","Pages":"64.e1-64.e7","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L613827161&from=export http://dx.doi.org/10.1016/j.ajog.2016.09.095","OldItemId":"","Comments":"2017-03-07","TypeName":"Journal, Article","Authors":"Bastian J R; Chen H ; Zhang H ; Rothenberger S ; Tarter R ; English D ; Venkataramanan R ; Caritis S N; ","ParentAuthors":"","DOI":"10.1016/j.ajog.2016.09.095","Keywords":"albumin\r\nbuprenorphine\r\nbuprenorphine glucuronide\r\nbuprenorphine plus naloxone\r\ndrug metabolite\r\nnorbuprenorphine\r\nnorbuprenorphine glucuronide\r\nunclassified drug\r\nadult\r\narea under the curve\r\nclinical article\r\nconference paper\r\ncontrolled study\r\ndrug blood level\r\ndrug half life\r\nfemale\r\nhuman\r\nliquid chromatography-mass spectrometry\r\nmaintenance therapy\r\nmaximum plasma concentration\r\nmorning dosage\r\nopiate addiction\r\npH\r\npharmacokinetics\r\nplasma concentration-time curve\r\npregnancy\r\npregnant woman\r\npriority journal\r\npuerperium\r\ntime to maximum plasma concentration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bastian J R, Chen H, Zhang H, Rothenberger S, Tarter R, English D, Venkataramanan R, and Caritis S N (2017) Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy. American Journal of Obstetrics and Gynecology 216(1), 64.e1-64.e7 DOI: 10.1016/j.ajog.2016.09.095"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282713,"Title":"Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.","ParentTitle":"Canadian journal of psychiatry. Revue canadienne de psychiatrie","ShortTitle":"Bastien (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"August","StandardNumber":"0706-7437 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"68","Pages":"572-585","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"36519188","Comments":"","TypeName":"Journal, Article","Authors":"Bastien G ; McAnulty C ; Ledjiar O ; Socias ME ; Le Foll B ; Lim R ; Hassan AN ; Brissette S ; Marsan S ; Talbot A ; Jutras-Aswad D ; ","ParentAuthors":"","DOI":"10.1177/07067437221145013 ","Keywords":"Humans\r\nMethadone/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\nDepression/drug therapy\r\n*Buprenorphine/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\nCanada/epidemiology\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nPrescriptions\r\ncomorbidity\r\ndepressive disorders\r\ndual diagnosis\r\nmajor depressive disorder\r\nrandomised controlled trial\r\nsubstance use disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bastien G, McAnulty C, Ledjiar O, Socias ME, Le Foll B, Lim R, Hassan AN, Brissette S, Marsan S, Talbot A, and Jutras-Aswad D (2023) Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.. Canadian journal of psychiatry. Revue canadienne de psychiatrie 68(8), 572-585 DOI: 10.1177/07067437221145013 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15064034,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948218,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269960,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281451,"Title":"The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review","ParentTitle":"American Journal on Addictions","ShortTitle":"Bauer (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1055-0496","City":"","Country":"","Publisher":"","Institution":"D.A. Nielsen, 2002 Holcombe Blvd Research 151, Houston, TX, United States","Volume":"24","Pages":"15-23","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L603509051&from=export http://dx.doi.org/10.1111/ajad.12172","OldItemId":"","Comments":"2015-04-16","TypeName":"Journal, Article","Authors":"Bauer I E; Soares J C; Nielsen D A; ","ParentAuthors":"","DOI":"10.1111/ajad.12172","Keywords":"brexanolone\r\nalcohol\r\nbeta endorphin\r\nbuprenorphine plus naloxone\r\ncocaine\r\ndelta opiate receptor\r\nkappa opiate receptor\r\nmethadone\r\nmu opiate receptor\r\nnaltrexone\r\nopiate\r\nopiate antagonist\r\npsychotropic agent\r\nvaccine\r\nalcohol consumption\r\nalcoholism\r\ncocaine dependence\r\ncognitive therapy\r\nDNA polymorphism\r\ndrinking behavior\r\ngene frequency\r\ngene function\r\ngenetic variability\r\nhaplotype\r\nheroin dependence\r\nheterozygote\r\nhuman\r\nmajor depression\r\nMedline\r\nmethadone treatment\r\nmood disorder\r\nopiate addiction\r\npatient care\r\npharmacogenetics\r\nreview\r\nschizophrenia\r\nScopus\r\nself report\r\nsystematic review\r\ntreatment outcome\r\ntreatment response","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bauer I E, Soares J C, and Nielsen D A (2015) The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. American Journal on Addictions 24(1), 15-23 DOI: 10.1111/ajad.12172"},{"Codes":[],"Outcomes":[],"ItemId":98284444,"Title":"Serotonergic gene variation in substance use pharmacotherapy: a systematic review.","ParentTitle":"Pharmacogenomics","ShortTitle":"Bauer (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1462-2416 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"16","Pages":"1307-14","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"26265436","Comments":"","TypeName":"Journal, Article","Authors":"Bauer IE ; Graham DP ; Soares JC ; Nielsen DA ; ","ParentAuthors":"","DOI":"10.2217/pgs.15.72 ","Keywords":"Genetic Variation\r\nHumans\r\nSerotonin/*genetics\r\nSerotonin Agents/therapeutic use\r\nSerotonin Plasma Membrane Transport Proteins/genetics\r\nSubstance-Related Disorders/*drug therapy\r\nTryptophan Hydroxylase/genetics\r\naddiction\r\nbupropion\r\ndisulfiram\r\ngene\r\nondansetron\r\nserotonergic\r\nsertraline\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bauer IE, Graham DP, Soares JC, and Nielsen DA (2015) Serotonergic gene variation in substance use pharmacotherapy: a systematic review.. Pharmacogenomics 16(11), 1307-14 DOI: 10.2217/pgs.15.72 "},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279858,"Title":"Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials","ParentTitle":"Addictive Behaviors","ShortTitle":"Baxley (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0306-4603","City":"","Country":"","Publisher":"","Institution":"C. Baxley, San Francisco VA Health Care System (116B), 4150 Clement Street, San Francisco, CA, United States","Volume":"139","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2021886140&from=export http://dx.doi.org/10.1016/j.addbeh.2022.107589","OldItemId":"","Comments":"2023-01-10","TypeName":"Journal, Article","Authors":"Baxley C ; Borsari B ; Reavis J V; Manuel J K; Herbst E ; Becker W ; Pennington D ; Batki S L; Seal K ; ","ParentAuthors":"","DOI":"10.1016/j.addbeh.2022.107589","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nplacebo\r\nadult\r\ndrug craving\r\ndrug formulation\r\nfemale\r\nhuman\r\nmajor clinical study\r\nmale\r\nopiate addiction\r\nrandomized controlled trial (topic)\r\nreview\r\nsustained drug release\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Baxley C, Borsari B, Reavis J V, Manuel J K, Herbst E, Becker W, Pennington D, Batki S L, and Seal K (2023) Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors 139,  DOI: 10.1016/j.addbeh.2022.107589"},{"Codes":[],"Outcomes":[],"ItemId":98283302,"Title":"Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Bazazi (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"August","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"59","Pages":"1-12","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28479216","Comments":"","TypeName":"Journal, Article","Authors":"Bazazi AR ; Wickersham JA ; Wegman MP ; Culbert GJ ; Pillai V ; Shrestha R ; Al-Darraji H ; Copenhaver MM ; Kamarulzaman A ; Altice FL ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2017.05.006 ","Keywords":"Adult\r\nBehavior Therapy/*methods\r\nEvidence-Based Practice\r\nFemale\r\n*HIV Infections/etiology/psychology\r\nHumans\r\nMalaysia\r\nMale\r\nMethadone/*pharmacology\r\nNarcotics/pharmacology\r\nOpiate Substitution Treatment/*methods\r\nOutcome Assessment, Health Care\r\nPrisoners/*psychology\r\nPrisons\r\nResearch Design\r\nSubstance Abuse Treatment Centers/methods\r\n*Substance Abuse, Intravenous/complications/psychology/therapy\r\nHIV\r\nMalaysia\r\nMethadone maintenance therapy\r\nOpioid dependence\r\nPrisoner health","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bazazi AR, Wickersham JA, Wegman MP, Culbert GJ, Pillai V, Shrestha R, Al-Darraji H, Copenhaver MM, Kamarulzaman A, and Altice FL (2017) Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.. Contemporary clinical trials 59, 1-12 DOI: 10.1016/j.cct.2017.05.006 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282048,"Title":"Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.","ParentTitle":"BMC infectious diseases","ShortTitle":"Bazazi (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"November","StandardNumber":"1471-2334 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"22","Pages":"837","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36368939","Comments":"","TypeName":"Journal, Article","Authors":"Bazazi AR ; Culbert GJ ; Wegman MP ; Heimer R ; Kamarulzaman A ; Altice FL ; ","ParentAuthors":"","DOI":"10.1186/s12879-022-07804-6 ","Keywords":"Humans\r\nMale\r\nAnalgesics, Opioid/therapeutic use\r\n*HIV Infections/drug therapy\r\nMalaysia/epidemiology\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\n*Prisoners\r\nPrisons\r\nHIV\r\nMethadone\r\nMortality\r\nOpioid use disorder\r\nPrison","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bazazi AR, Culbert GJ, Wegman MP, Heimer R, Kamarulzaman A, and Altice FL (2022) Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.. BMC infectious diseases 22(1), 837 DOI: 10.1186/s12879-022-07804-6 "},{"Codes":[],"Outcomes":[],"ItemId":98282676,"Title":"State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.","ParentTitle":"Journal of opioid management","ShortTitle":"Beaudoin (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"May","StandardNumber":"1551-7489 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"12","Pages":"109-18","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"27194195","Comments":"","TypeName":"Journal, Article","Authors":"Beaudoin FL ; Banerjee GN ; Mello MJ ; ","ParentAuthors":"","DOI":"10.5055/jom.2016.0322 ","Keywords":"Analgesics, Opioid/*adverse effects\r\nCause of Death\r\nDrug Overdose/mortality/*prevention & control\r\nDrug Prescriptions\r\n*Health Policy/legislation & jurisprudence\r\nHumans\r\nInappropriate Prescribing/mortality/prevention & control\r\nModels, Organizational\r\nOpioid-Related Disorders/mortality/*prevention & control\r\nPatient Safety\r\nPolicy Making\r\nPractice Patterns, Physicians'/legislation & jurisprudence/*organization & \r\n      administration\r\nPrescription Drug Misuse/mortality/prevention & control\r\nRegional Health Planning/legislation & jurisprudence/*organization & \r\n      administration\r\nRisk Assessment\r\nRisk Factors\r\n*State Government\r\nState Health Plans/legislation & jurisprudence/*organization & administration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Beaudoin FL, Banerjee GN, and Mello MJ (2016) State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.. Journal of opioid management 12(2), 109-18 DOI: 10.5055/jom.2016.0322 "},{"Codes":[],"Outcomes":[],"ItemId":98282999,"Title":"Oral clonidine in the management of acquired opioid dependency.","ParentTitle":"Neonatal network : NN","ShortTitle":"Beaulieu (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"November","StandardNumber":"0730-0832 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"32","Pages":"419-24","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"24195803","Comments":"","TypeName":"Journal, Article","Authors":"Beaulieu MJ ; ","ParentAuthors":"","DOI":"10.1891/0730-0832.32.6.419 ","Keywords":"Administration, Oral\r\nAdult\r\nAnalgesics/administration & dosage/*therapeutic use\r\nAnalgesics, Opioid/*adverse effects\r\nChild\r\nClonidine/administration & dosage/*therapeutic use\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nPrenatal Exposure Delayed Effects/*drug therapy\r\nNAS\r\nclonidine\r\npharmacology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Beaulieu MJ (2013) Oral clonidine in the management of acquired opioid dependency.. Neonatal network : NN 32(6), 419-24 DOI: 10.1891/0730-0832.32.6.419 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280376,"Title":"Economic Evaluation in Opioid Modeling: Systematic Review","ParentTitle":"Value in Health","ShortTitle":"Beaulieu (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1098-3015","City":"","Country":"","Publisher":"","Institution":"M.S. Jalali, MGH Institute for Technology Assessment, Harvard Medical School, 101 Merrimac St., Suite 1010, Boston, MA, United States","Volume":"24","Pages":"158-173","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2008403681&from=export http://dx.doi.org/10.1016/j.jval.2020.07.013","OldItemId":"","Comments":"2021-04-09","TypeName":"Journal, Article","Authors":"Beaulieu E ; DiGennaro C ; Stringfellow E ; Connolly A ; Hamilton A ; Hyder A ; Cerd M ; Keyes K M; Jalali M S; ","ParentAuthors":"","DOI":"10.1016/j.jval.2020.07.013","Keywords":"buprenorphine\r\ndiamorphine\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nabuse deterrent formulation\r\narticle\r\ncost benefit analysis\r\ncost effectiveness analysis\r\ndrug dosage form comparison\r\ndrug overdose\r\neconomic evaluation\r\neconomic model\r\nEmbase\r\nharm reduction\r\nhuman\r\nMedline\r\nmethadone treatment\r\nmethodology\r\nopiate addiction\r\nopiate overdose\r\npriority journal\r\npublication\r\nquality control\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Beaulieu E, DiGennaro C, Stringfellow E, Connolly A, Hamilton A, Hyder A, Cerd M, Keyes K M, and Jalali M S (2021) Economic Evaluation in Opioid Modeling: Systematic Review. Value in Health 24(2), 158-173 DOI: 10.1016/j.jval.2020.07.013"},{"Codes":[{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948331,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282070,"Title":"Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Beck (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"April","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"109","Pages":"617-26","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"24304412","Comments":"","TypeName":"Journal, Article","Authors":"Beck T ; Haasen C ; Verthein U ; Walcher S ; Schuler C ; Backmund M ; Ruckes C ; Reimer J ; ","ParentAuthors":"","DOI":"10.1111/add.12440 ","Keywords":"Administration, Oral\r\nAdult\r\nCodeine/analogs & derivatives/urine\r\nCross-Over Studies\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nMaintenance Chemotherapy\r\nMale\r\nMedication Adherence\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nMorphine/*therapeutic use\r\nMorphine Derivatives/urine\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nDose-response\r\nmaintenance treatment\r\nmethadone\r\nopioid addiction\r\nretention rate\r\nslow-release oral morphine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, Ruckes C, and Reimer J (2014) Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.. Addiction (Abingdon, and England) 109(4), 617-26 DOI: 10.1111/add.12440 "},{"Codes":[],"Outcomes":[],"ItemId":98283605,"Title":"Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.","ParentTitle":"Clinical pharmacology in drug development","ShortTitle":"Bednasz (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"March","StandardNumber":"2160-763X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"6","Pages":"135-139","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"28263465","Comments":"","TypeName":"Journal, Article","Authors":"Bednasz CJ ; Venuto CS ; Ma Q ; Morse GD ; ","ParentAuthors":"","DOI":"10.1002/cpdd.313 ","Keywords":"Anti-Retroviral Agents/*pharmacokinetics/therapeutic use\r\nDrug Interactions\r\nDrug Therapy, Combination\r\nHepatitis C/drug therapy/*metabolism\r\nHumans\r\nLiver/metabolism\r\nSubstance-Related Disorders/drug therapy/*metabolism\r\nantiretroviral\r\ndirect-acting antiviral\r\ndrug-drug\r\ninteraction\r\npharmacokinetic\r\npharmacokinetic modeling","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bednasz CJ, Venuto CS, Ma Q, and Morse GD (2017) Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.. Clinical pharmacology in drug development 6(2), 135-139 DOI: 10.1002/cpdd.313 "},{"Codes":[],"Outcomes":[],"ItemId":98283659,"Title":"Treating substance use disorders in the criminal justice system.","ParentTitle":"Current psychiatry reports","ShortTitle":"Belenko (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"November","StandardNumber":"1523-3812 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"15","Pages":"414","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"24132733","Comments":"","TypeName":"Journal, Article","Authors":"Belenko S ; Hiller M ; Hamilton L ; ","ParentAuthors":"","DOI":"10.1007/s11920-013-0414-z ","Keywords":"Delivery of Health Care/*organization & administration\r\nHumans\r\nNarcotic Antagonists/*therapeutic use\r\n*Prisoners\r\n*Prisons\r\nSubstance-Related Disorders/*rehabilitation\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Belenko S, Hiller M, and Hamilton L (2013) Treating substance use disorders in the criminal justice system.. Current psychiatry reports 15(11), 414 DOI: 10.1007/s11920-013-0414-z "},{"Codes":[],"Outcomes":[],"ItemId":98282379,"Title":"Pharmacological maintenance treatments of opiate addiction.","ParentTitle":"British journal of clinical pharmacology","ShortTitle":"Bell (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"February","StandardNumber":"0306-5251 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"77","Pages":"253-63","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"23210630","Comments":"","TypeName":"Journal, Article","Authors":"Bell J ; ","ParentAuthors":"","DOI":"10.1111/bcp.12051 ","Keywords":"Buprenorphine/administration & dosage\r\nDrug Overdose\r\nHeroin/administration & dosage/adverse effects\r\nHeroin Dependence/*drug therapy/rehabilitation\r\nHumans\r\nMethadone/administration & dosage\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy/rehabilitation\r\nReinforcement, Psychology\r\nSubstance Withdrawal Syndrome/drug therapy\r\nTime Factors\r\naddiction\r\nbuprenorphine\r\ndiamorphine\r\nheroin\r\nmethadone","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bell J (2014) Pharmacological maintenance treatments of opiate addiction.. British journal of clinical pharmacology 77(2), 253-63 DOI: 10.1111/bcp.12051 "},{"Codes":[],"Outcomes":[],"ItemId":98282217,"Title":"Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.","ParentTitle":"Drugs","ShortTitle":"Bell (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"September","StandardNumber":"0012-6667 (Linking)","City":"New Zealand","Country":"","Publisher":"","Institution":"","Volume":"78","Pages":"1339-1352","Edition":"","Issue":"13","Availability":"","URL":"","OldItemId":"30132259","Comments":"","TypeName":"Journal, Article","Authors":"Bell J ; Belackova V ; Lintzeris N ; ","ParentAuthors":"","DOI":"10.1007/s40265-018-0962-y ","Keywords":"Analgesics, Opioid/administration & dosage/adverse effects/*therapeutic use\r\nDrug Overdose/prevention & control\r\nFollow-Up Studies\r\nHeroin/administration & dosage\r\nHumans\r\nMethadone/administration & dosage\r\nOpiate Substitution Treatment/adverse effects/methods\r\nOpioid-Related Disorders/drug therapy/*prevention & control\r\nRandomized Controlled Trials as Topic\r\nSubstance-Related Disorders/prevention & control\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bell J, Belackova V, and Lintzeris N (2018) Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.. Drugs 78(13), 1339-1352 DOI: 10.1007/s40265-018-0962-y "},{"Codes":[],"Outcomes":[],"ItemId":98280659,"Title":"Medication Treatment of Opioid Use Disorder","ParentTitle":"Biological Psychiatry","ShortTitle":"Bell (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0006-3223","City":"","Country":"","Publisher":"","Institution":"J. Bell, Uniting MSIC, 66 Darlinghurst Road, Kings Cross, Potts Point, NSW, Australia","Volume":"87","Pages":"82-88","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2002560169&from=export http://dx.doi.org/10.1016/j.biopsych.2019.06.020","OldItemId":"","Comments":"2019-11-28","TypeName":"Journal, Article","Authors":"Bell J ; Strang J ; ","ParentAuthors":"","DOI":"10.1016/j.biopsych.2019.06.020","Keywords":"drug implant\r\nbuprenorphine\r\nmethadone\r\nnaloxone\r\nopiate\r\nclinical outcome\r\ncomparative effectiveness\r\ndrug efficacy\r\ndrug formulation\r\ndrug overdose\r\ndrug safety\r\nheart ventricle tachycardia\r\nhuman\r\nmedication compliance\r\nopiate addiction\r\npatient compliance\r\nprescription drug diversion\r\npriority journal\r\nQT prolongation\r\nrelapse\r\nrespiration depression\r\nreview\r\nrisk benefit analysis\r\nsocial interaction\r\nstigma\r\nsystematic review\r\ntorsade de pointes\r\ntreatment duration\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bell J, and Strang J (2020) Medication Treatment of Opioid Use Disorder. Biological Psychiatry 87(1), 82-88 DOI: 10.1016/j.biopsych.2019.06.020"},{"Codes":[],"Outcomes":[],"ItemId":98283612,"Title":"Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Berg (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"September","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"481-9","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"19505589","Comments":"","TypeName":"Journal, Article","Authors":"Berg KM ; Mouriz J ; Li X ; Duggan E ; Goldberg U ; Arnsten JH ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2009.05.003 ","Keywords":"Ambulatory Care Facilities\r\nAnalgesics, Opioid/*therapeutic use\r\nAnti-HIV Agents/*therapeutic use\r\n*Directly Observed Therapy\r\nFemale\r\nHIV Infections/*drug therapy\r\nHumans\r\nMass Screening\r\nMedication Adherence/statistics & numerical data\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nSample Size\r\nSelf Administration\r\nSubstance-Related Disorders/epidemiology\r\nUnited States/epidemiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Berg KM, Mouriz J, Li X, Duggan E, Goldberg U, and Arnsten JH (2009) Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.. Contemporary clinical trials 30(5), 481-9 DOI: 10.1016/j.cct.2009.05.003 "},{"Codes":[],"Outcomes":[],"ItemId":98282336,"Title":"Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Berg (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"January","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"113","Pages":"192-9","Edition":"","Issue":"2-3","Availability":"","URL":"","OldItemId":"20832196","Comments":"","TypeName":"Journal, Article","Authors":"Berg KM ; Litwin A ; Li X ; Heo M ; Arnsten JH ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2010.07.025 ","Keywords":"Antiretroviral Therapy, Highly Active/*methods/*psychology\r\nDirectly Observed Therapy/*methods\r\nFemale\r\nHIV Infections/*drug therapy/virology\r\nHumans\r\nMale\r\nMedication Adherence/*statistics & numerical data\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/complications/drug therapy/*psychology\r\nSubstance Abuse Treatment Centers/methods\r\nViral Load/*drug effects","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Berg KM, Litwin A, Li X, Heo M, and Arnsten JH (2011) Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.. Drug and alcohol dependence 113(2-3), 192-9 DOI: 10.1016/j.drugalcdep.2010.07.025 "},{"Codes":[],"Outcomes":[],"ItemId":98281790,"Title":"A brief review of the genetics and pharmacogenetics of opioid use disorders.","ParentTitle":"Dialogues in clinical neuroscience","ShortTitle":"Berrettini (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"1294-8322 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"19","Pages":"229-236","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"29302220","Comments":"","TypeName":"Journal, Article","Authors":"Berrettini W ; ","ParentAuthors":"","DOI":"10.31887/DCNS.2017.19.3/wberrettini ","Keywords":"Buprenorphine/therapeutic use\r\nCytochrome P-450 CYP2B6/genetics/metabolism\r\nGenome-Wide Association Study\r\nHumans\r\nNarcotic Antagonists/therapeutic use\r\nOpioid-Related Disorders/*drug therapy/*genetics\r\nPharmacogenetics/*methods\r\nPolymorphism, Single Nucleotide/genetics\r\nPotassium Channels/genetics\r\nReceptors, Opioid, mu/genetics\r\naddiction\r\ndependence\r\ngenetics\r\nopioid\r\npharmacogenetics","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Berrettini W (2017) A brief review of the genetics and pharmacogenetics of opioid use disorders.. Dialogues in clinical neuroscience 19(3), 229-236 DOI: 10.31887/DCNS.2017.19.3/wberrettini "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281910,"Title":"Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder.","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Bhatraju (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"July","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"49","Pages":"511-518","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"37369019","Comments":"","TypeName":"Journal, Article","Authors":"Bhatraju EP ; Radick AC ; Leroux BG ; Kim TW ; Samet JH ; Tsui JI ; ","ParentAuthors":"","DOI":"10.1080/00952990.2023.2220876 ","Keywords":"Adult\r\nMale\r\nHumans\r\nFemale\r\n*Buprenorphine/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/urine\r\nOpiate Substitution Treatment/methods\r\nMedication adherence\r\nbuprenorphine\r\nopioid related disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bhatraju EP, Radick AC, Leroux BG, Kim TW, Samet JH, and Tsui JI (2023) Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder.. The American journal of drug and alcohol abuse 49(4), 511-518 DOI: 10.1080/00952990.2023.2220876 "},{"Codes":[],"Outcomes":[],"ItemId":98281562,"Title":"Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-course","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Bigelow (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"G.E. Bigelow, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Bayview Campus, 5510 Nathan Shock Drive, Baltimore, MD 21224, United States","Volume":"123","Pages":"57-65","Edition":"","Issue":"1-3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L51712420&from=export http://dx.doi.org/10.1016/j.drugalcdep.2011.10.018","OldItemId":"","Comments":"2012-05-31","TypeName":"Journal, Article","Authors":"Bigelow G E; Preston K L; Schmittner J ; Dong Q ; Gastfriend D R; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2011.10.018","Keywords":"hydromorphone\r\nnaltrexone\r\nadult\r\narticle\r\nclinical article\r\nclinical effectiveness\r\nclinical evaluation\r\ncontrolled release formulation\r\ncontrolled study\r\ndisease severity\r\ndose response\r\ndouble blind procedure\r\ndrug blood level\r\ndrug delivery system\r\ndrug dose comparison\r\ndrug effect\r\ndrug efficacy\r\ndrug monitoring\r\ndrug safety\r\ndrug tolerability\r\ndrug withdrawal\r\nfemale\r\nhuman\r\ninjection site contusion\r\ninjection site induration\r\ninjection site reaction\r\nmale\r\nmulticenter study\r\nopiate addiction\r\noutcome assessment\r\npriority journal\r\npupil reflex\r\nrandomized controlled trial\r\nreaction time\r\ntreatment duration\r\nvisual analog scale","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bigelow G E, Preston K L, Schmittner J, Dong Q, and Gastfriend D R (2012) Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-course. Drug and Alcohol Dependence 123(1-3), 57-65 DOI: 10.1016/j.drugalcdep.2011.10.018"},{"Codes":[],"Outcomes":[],"ItemId":98281851,"Title":"Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Bi-Mohammed (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"February","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"171","Pages":"122-131","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28086177","Comments":"","TypeName":"Journal, Article","Authors":"Bi-Mohammed Z ; Wright NM ; Hearty P ; King N ; Gavin H ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.11.032 ","Keywords":"Administration, Sublingual\r\nAnalgesics, Opioid/*adverse effects/therapeutic use\r\nBuprenorphine/adverse effects/therapeutic use\r\nDrug Prescriptions\r\nHumans\r\nIllicit Drugs/adverse effects\r\nNarcotics/adverse effects/therapeutic use\r\nOpiate Substitution Treatment/*methods/trends\r\nOpioid-Related Disorders/diagnosis/drug therapy/*epidemiology\r\nPrescription Drug Misuse/prevention & control/*trends\r\nPrevalence\r\nPrisons/*trends\r\nTreatment Outcome\r\n*Abuse\r\n*Abuse of prescribed medication\r\n*Buprenorphine\r\n*Buprenorphine/Naloxone\r\n*Diversion\r\n*Methadone\r\n*Misuse\r\n*Opioid\r\n*OxyContin\r\n*Oxycodone\r\n*Prison\r\n*Prisoner","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bi-Mohammed Z, Wright NM, Hearty P, King N, and Gavin H (2017) Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.. Drug and alcohol dependence 171, 122-131 DOI: 10.1016/j.drugalcdep.2016.11.032 "},{"Codes":[],"Outcomes":[],"ItemId":98280542,"Title":"A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?","ParentTitle":"American Journal on Addictions","ShortTitle":"Biondi (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1055-0496","City":"","Country":"","Publisher":"","Institution":"S.A. Springer, Center for Interdisciplinary Research on AIDS, Yale University School of Public Health, New Haven, CT, United States","Volume":"29","Pages":"249-267","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2004807349&from=export http://dx.doi.org/10.1111/ajad.13051","OldItemId":"","Comments":"2020-07-08","TypeName":"Journal, Article","Authors":"Biondi B E; Zheng X ; Frank C A; Petrakis I ; Springer S A; ","ParentAuthors":"","DOI":"10.1111/ajad.13051","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\ndrugs used in the treatment of addiction\r\nmethadone\r\nnaltrexone\r\nopiate\r\ndrug intoxication\r\nhuman\r\nmedication therapy management\r\nopiate addiction\r\npatient-reported outcome\r\nreview\r\nsystematic review\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Biondi B E, Zheng X, Frank C A, Petrakis I, and Springer S A (2020) A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?. American Journal on Addictions 29(4), 249-267 DOI: 10.1111/ajad.13051"},{"Codes":[],"Outcomes":[],"ItemId":98282355,"Title":"Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatment.","ParentTitle":"Substance abuse","ShortTitle":"Biondi (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0889-7077 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"42","Pages":"905-911","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"33750285","Comments":"","TypeName":"Journal, Article","Authors":"Biondi BE ; Frank CA ; Forray A ; Springer SA ; ","ParentAuthors":"","DOI":"10.1080/08897077.2021.1900984 ","Keywords":"Criminal Law\r\nDelayed-Action Preparations/therapeutic use\r\nFemale\r\n*HIV Infections/drug therapy\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nSex Factors\r\nHIV\r\nalcohol use disorder\r\ncriminal justice system\r\nextended-release naltrexone\r\nopioid use disorder\r\nwomen","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Biondi BE, Frank CA, Forray A, and Springer SA (2021) Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatment.. Substance abuse 42(4), 905-911 DOI: 10.1080/08897077.2021.1900984 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282663,"Title":"A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Bisaga (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"May","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"546-52","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"24560438","Comments":"","TypeName":"Journal, Article","Authors":"Bisaga A ; Sullivan MA ; Glass A ; Mishlen K ; Carpenter KM ; Mariani JJ ; Levin FR ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2014.01.005 ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nExcitatory Amino Acid Antagonists/administration & dosage/therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMemantine/*administration & dosage/therapeutic use\r\nMiddle Aged\r\nNaltrexone/*administration & dosage/therapeutic use\r\nNarcotic Antagonists/administration & dosage/therapeutic use\r\nOpioid-Related Disorders/*rehabilitation\r\nRecurrence\r\nSubstance Withdrawal Syndrome/*drug therapy\r\nMemantine\r\nNMDA receptors\r\nNaltrexone\r\nOpiate dependence\r\nPharmacotherapy trials","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, and Nunes EV (2014) A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.. Journal of substance abuse treatment 46(5), 546-52 DOI: 10.1016/j.jsat.2014.01.005 "},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019722,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281416,"Title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Bisaga (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"A. Bisaga, New York State Psychiatric Institute, 1051 Riverside Dr., Unit #120, New York, NY, United States","Volume":"154","Pages":"38-45","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L605571068&from=export http://dx.doi.org/10.1016/j.drugalcdep.2015.05.013","OldItemId":"","Comments":"2015-08-18","TypeName":"Journal, Article","Authors":"Bisaga A ; Sullivan M A; Glass A ; Mishlen K ; Pavlicova M ; Haney M ; Raby W N; Levin F R; Carpenter K M; Mariani J J; Nunes E V; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2015.05.013","Keywords":"dronabinol\r\nnaltrexone\r\nplacebo\r\nadult\r\nanxiety\r\narticle\r\ncannabis smoking\r\nchill\r\nclinical article\r\ncontrolled clinical trial\r\ncontrolled study\r\ndecreased appetite\r\ndetoxification\r\ndiarrhea\r\ndisease severity\r\ndose response\r\ndouble blind procedure\r\nsomnolence\r\ndrug dose increase\r\ndrug response\r\ndrug safety\r\nface edema\r\nfatigue\r\nfemale\r\ngastrointestinal symptom\r\nheadache\r\nhuman\r\nhyperhidrosis\r\nincreased appetite\r\ninsomnia\r\nmale\r\nmood change\r\nnausea\r\nopiate addiction\r\npatient compliance\r\npriority journal\r\npruritus\r\ntreatment outcome\r\nunspecified side effect\r\nvomiting\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bisaga A, Sullivan M A, Glass A, Mishlen K, Pavlicova M, Haney M, Raby W N, Levin F R, Carpenter K M, Mariani J J, and Nunes E V (2015) The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence 154, 38-45 DOI: 10.1016/j.drugalcdep.2015.05.013"},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282919,"Title":"Craving and illicit heroin use among patients in heroin-assisted treatment.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Blanken (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"January","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"120","Pages":"74-80","Edition":"","Issue":"1-3","Availability":"","URL":"","OldItemId":"21782351","Comments":"","TypeName":"Journal, Article","Authors":"Blanken P ; Hendriks VM ; Koeter MW ; van Ree JM ; van den Brink W ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2011.06.025 ","Keywords":"Adult\r\nFemale\r\nHeroin/administration & dosage/*therapeutic use\r\nHeroin Dependence/*drug therapy/psychology\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nPatient Compliance/psychology\r\nTime Factors\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Blanken P, Hendriks VM, Koeter MW, van Ree JM, and van den Brink W (2012) Craving and illicit heroin use among patients in heroin-assisted treatment.. Drug and alcohol dependence 120(1-3), 74-80 DOI: 10.1016/j.drugalcdep.2011.06.025 "},{"Codes":[{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283182,"Title":"Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Blanken (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"July","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"164","Pages":"55-63","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27177805","Comments":"","TypeName":"Journal, Article","Authors":"Blanken P ; Hendriks VM ; Huijsman IA ; van Ree JM ; van den Brink W ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.04.018 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\nCocaine/*administration & dosage\r\nCocaine-Related Disorders/*drug therapy\r\nDopamine Uptake Inhibitors/*administration & dosage\r\nDrug Therapy, Combination\r\nFemale\r\nHeroin/*therapeutic use\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nNetherlands\r\nTime Factors\r\nTreatment Outcome\r\n*Cocaine dependence\r\n*Contingency management\r\n*Heroin dependence\r\n*Heroin-assisted treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Blanken P, Hendriks VM, Huijsman IA, van Ree JM, and van den Brink W (2016) Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.. Drug and alcohol dependence 164, 55-63 DOI: 10.1016/j.drugalcdep.2016.04.018 "},{"Codes":[],"Outcomes":[],"ItemId":98281668,"Title":"Treatment of opioid dependence and ADHD/ADD with opioid maintenance and central stimulants","ParentTitle":"Heroin Addiction and Related Clinical Problems","ShortTitle":"Blix (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"","StandardNumber":"1592-1638","City":"","Country":"","Publisher":"","Institution":"O. Blix, Med. Sc., Addiction Medicine Unit, Department of Psychiatry, Ryhov County Hospital, SE-551 85 Jnkping, Sweden","Volume":"11","Pages":"5-14","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L354504860&from=export","OldItemId":"","Comments":"2009-05-12","TypeName":"Journal, Article","Authors":"Blix O ; Dalteg A ; Nilsson P ; ","ParentAuthors":"","DOI":"","Keywords":"buprenorphine\r\ncentral stimulant agent\r\nmethadone\r\nmethylphenidate\r\nmodafinil\r\nopiate\r\nadult\r\narticle\r\nattention deficit hyperactivity disorder\r\nattention disturbance\r\nclinical article\r\nclinical assessment\r\nclinical assessment tool\r\ncognition\r\ncomorbidity\r\ncontrolled study\r\ndrug megadose\r\nfemale\r\nfollow up\r\nhuman\r\ninterview\r\nlearning\r\nmale\r\nmemory\r\nmental disease\r\nnaturalistic inquiry\r\nneuropsychological assessment\r\nobsessive compulsive disorder\r\nopiate addiction\r\noutcome assessment\r\npriority journal\r\npsychotherapy\r\nquestionnaire\r\nreaction time\r\nself evaluation\r\nself report\r\nsocial support\r\nSweden\r\nsubutex","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Blix O, Dalteg A, and Nilsson P (2009) Treatment of opioid dependence and ADHD/ADD with opioid maintenance and central stimulants. Heroin Addiction and Related Clinical Problems 11(1), 5-14"},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282042,"Title":"The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type.","ParentTitle":"Epidemiologic reviews","ShortTitle":"Blondino (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"January","StandardNumber":"0193-936X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"42","Pages":"57-78","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"32944731","Comments":"","TypeName":"Journal, Article","Authors":"Blondino CT ; Gormley MA ; Taylor DDH ; Lowery E ; Clifford JS ; Burkart B ; Graves WC ; Lu J ; Prom-Wormley EC ; ","ParentAuthors":"","DOI":"10.1093/epirev/mxaa005 ","Keywords":"Humans\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\n*Substance-Related Disorders\r\nTreatment Outcome\r\nbehavioral intervention\r\nco-occurring substance use\r\nopiate treatment programs\r\nopioid abstinence\r\nopioids\r\npharmacological intervention\r\npolysubstance use\r\ntreatment retention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Blondino CT, Gormley MA, Taylor DDH, Lowery E, Clifford JS, Burkart B, Graves WC, Lu J, and Prom-Wormley EC (2020) The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type.. Epidemiologic reviews 42(1), 57-78 DOI: 10.1093/epirev/mxaa005 "},{"Codes":[{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282857,"Title":"Randomized Clinical Trial of Standard- Versus High-Calorie Formula for Methadone-Exposed Infants: A Feasibility Study.","ParentTitle":"Hospital pediatrics","ShortTitle":"Bogen (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"January","StandardNumber":"2154-1671 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"8","Pages":"7-14","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29263124","Comments":"","TypeName":"Journal, Article","Authors":"Bogen DL ; Hanusa BH ; Baker R ; Medoff-Cooper B ; Cohlan B ; ","ParentAuthors":"","DOI":"10.1542/hpeds.2017-0114 ","Keywords":"Double-Blind Method\r\n*Energy Intake\r\nFeasibility Studies\r\nFemale\r\nHumans\r\n*Infant Formula\r\nInfant, Newborn\r\nIntention to Treat Analysis\r\nMale\r\nMethadone/adverse effects\r\nNeonatal Abstinence Syndrome/*therapy\r\nOpiate Substitution Treatment/adverse effects\r\nOpioid-Related Disorders/drug therapy\r\nPilot Projects\r\nPregnancy\r\nPregnancy Complications/drug therapy\r\nPrenatal Exposure Delayed Effects\r\nTreatment Outcome\r\nWeight Gain","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bogen DL, Hanusa BH, Baker R, Medoff-Cooper B, and Cohlan B (2018) Randomized Clinical Trial of Standard- Versus High-Calorie Formula for Methadone-Exposed Infants: A Feasibility Study.. Hospital pediatrics 8(1), 7-14 DOI: 10.1542/hpeds.2017-0114 "},{"Codes":[{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281826,"Title":"A meta-analysis on the effects of incarceration-based opioid substitution treatment.","ParentTitle":"Medicine, science, and the law","ShortTitle":"Boksn (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"January","StandardNumber":"0025-8024 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"63","Pages":"53-60","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"35934979","Comments":"","TypeName":"Journal, Article","Authors":"Boksn K ; Dechant M ; Weiss M ; Hellwig A ; Stemmler M ; ","ParentAuthors":"","DOI":"10.1177/00258024221118971 ","Keywords":"Humans\r\nOpiate Substitution Treatment\r\n*Prisoners\r\n*Opioid-Related Disorders/drug therapy\r\nAnalgesics, Opioid/therapeutic use\r\nOpioid use disorder\r\nincarcerated populations\r\nmeta-analysis\r\nopioid substitution treatment\r\ntreatment of incarcerated individuals","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Boksn K, Dechant M, Weiss M, Hellwig A, and Stemmler M (2023) A meta-analysis on the effects of incarceration-based opioid substitution treatment.. Medicine, science, and and the law 63(1), 53-60 DOI: 10.1177/00258024221118971 "},{"Codes":[{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280222,"Title":"Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis","ParentTitle":"JAMA Psychiatry","ShortTitle":"Bolvar (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2168-622X","City":"","Country":"","Publisher":"","Institution":"S.T. Higgins, Department of Psychiatry, University of Vermont, 1 S Prospect St, UHC, MS482, Burlington, VT, United States","Volume":"78","Pages":"1092-1102","Edition":"","Issue":"10","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L635710735&from=export http://dx.doi.org/10.1001/jamapsychiatry.2021.1969","OldItemId":"","Comments":"2023-11-20","TypeName":"Journal, Article","Authors":"Bolvar H A; Klemperer E M; Coleman S R.M; DeSarno M ; Skelly J M; Higgins S T; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2021.1969","Keywords":"buprenorphine\r\nlevacetylmethadol\r\nmethadone\r\nnaltrexone\r\nadult\r\nbehavior change\r\ncigarette smoking\r\nCochrane Library\r\ncomorbidity\r\ncontrolled study\r\neconomic incentive\r\neffect size\r\nhuman\r\nmedication compliance\r\nMedline\r\nmeta analysis\r\nopiate addiction\r\npatient compliance\r\npractice guideline\r\nprospective study\r\nquality control\r\nreview\r\nsystematic review\r\nWeb of Science","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bolvar H A, Klemperer E M, Coleman S R.M, DeSarno M, Skelly J M, and Higgins S T (2021) Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry 78(10), 1092-1102 DOI: 10.1001/jamapsychiatry.2021.1969"},{"Codes":[],"Outcomes":[],"ItemId":98281889,"Title":"Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review.","ParentTitle":"The International journal on drug policy","ShortTitle":"Bommersbach (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"February","StandardNumber":"0955-3959 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"103931","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"36563489","Comments":"","TypeName":"Journal, Article","Authors":"Bommersbach T ; Justen M ; Bunting AM ; Funaro MC ; Winstanley EL ; Joudrey PJ ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2022.103931 ","Keywords":"Humans\r\nRural Population\r\n*COVID-19\r\nHealth Services Accessibility\r\nDatabases, Factual\r\n*Opioid-Related Disorders/epidemiology\r\n*Buprenorphine\r\nOpiate Substitution Treatment\r\nAbuse\r\nAddiction\r\nDisparities\r\nHealth services\r\nRural health\r\nSubstance use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bommersbach T, Justen M, Bunting AM, Funaro MC, Winstanley EL, and Joudrey PJ (2023) Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review.. The International journal on drug policy 112, 103931 DOI: 10.1016/j.drugpo.2022.103931 "},{"Codes":[],"Outcomes":[],"ItemId":98281199,"Title":"Opioid maintenance therapy for the treatment of opioid use disorders in outpatients with or without schizophrenia","ParentTitle":"European Neuropsychopharmacology","ShortTitle":"Bouton (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1873-7862","City":"","Country":"","Publisher":"","Institution":"J.F. Bouton, Centre Hospitalier Sainte-Anne, Service d'Addictologie, Paris, France","Volume":"27","Pages":"S1075-S1076","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L619298344&from=export","OldItemId":"","Comments":"2017-11-22","TypeName":"Journal, Article","Authors":"Bouton J F; Laqueille X ; Bourdel M C; Dervaux A ; ","ParentAuthors":"","DOI":"","Keywords":"amphetamine derivative\r\nbenzodiazepine derivative\r\nbuprenorphine\r\ncannabis\r\ncocaine\r\nmethadone\r\nopiate\r\nadult\r\nbipolar disorder\r\nchi square test\r\nclinical article\r\nclinical trial\r\ncomparative effectiveness\r\nconsultation\r\ncontrolled clinical trial\r\ncontrolled study\r\ndrug therapy\r\nDSM-5\r\nfemale\r\nFrance\r\nhuman\r\nhuman tissue\r\nmaintenance therapy\r\nmarriage\r\nmiddle aged\r\nonset age\r\nopiate addiction\r\noutpatient\r\npsychiatric treatment\r\nretrospective study\r\nschizoaffective psychosis\r\nscreening test\r\nstudent\r\nStudent t test\r\nsubstance abuse\r\ntoxicology\r\nurinalysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bouton J F, Laqueille X, Bourdel M C, and Dervaux A (2017) Opioid maintenance therapy for the treatment of opioid use disorders in outpatients with or without schizophrenia. European Neuropsychopharmacology 27, S1075-S1076"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"Mindfulness Based Relapse Prevention","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"Mixed methods study","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281231,"Title":"Mindfulness-based relapse prevention for methadone maintenance: A feasibility trial","ParentTitle":"Journal of Alternative and Complementary Medicine","ShortTitle":"Bowen (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1075-5535","City":"","Country":"","Publisher":"","Institution":"S. Bowen, Pacific University School of Graduate Psychology, 190 SE 8th Avenue, Hillsboro, OR, United States","Volume":"23","Pages":"541-544","Edition":"","Issue":"7","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L617434153&from=export http://dx.doi.org/10.1089/acm.2016.0417","OldItemId":"","Comments":"2017-07-31","TypeName":"Journal, Article","Authors":"Bowen S ; Somohano V C; Rutkie R E; Manuel J A; Rehder K L; ","ParentAuthors":"","DOI":"10.1089/acm.2016.0417","Keywords":"methadone\r\nadult\r\naged\r\nanxiety\r\narticle\r\navoidance behavior\r\nclinical article\r\ncraving\r\ndepression\r\nfeasibility study\r\nfemale\r\nhuman\r\ninformation processing\r\nmale\r\nmethadone treatment\r\nmindfulness\r\nmindfulness based relapse prevention\r\nopiate addiction\r\noutcome assessment\r\npatient attitude\r\npatient satisfaction\r\npilot study\r\nposttraumatic stress disorder\r\npriority journal\r\nquality of life\r\nrelapse\r\nself care\r\nself report\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bowen S, Somohano V C, Rutkie R E, Manuel J A, and Rehder K L (2017) Mindfulness-based relapse prevention for methadone maintenance: A feasibility trial. Journal of Alternative and Complementary Medicine 23(7), 541-544 DOI: 10.1089/acm.2016.0417"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282290,"Title":"Potential uses of naltrexone in emergency department patients with opioid use disorder.","ParentTitle":"Clinical toxicology (Philadelphia, Pa.)","ShortTitle":"Bradley (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"September","StandardNumber":"1556-3650 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"57","Pages":"753-759","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"30831039","Comments":"","TypeName":"Journal, Article","Authors":"Bradley ES ; Liss D ; Carreiro SP ; Brush DE ; Babu K ; ","ParentAuthors":"","DOI":"10.1080/15563650.2019.1583342 ","Keywords":"Analgesics, Opioid/poisoning\r\nDrug Overdose/drug therapy\r\n*Emergency Service, Hospital\r\nHumans\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpioid-Related Disorders/drug therapy\r\nNaltrexone\r\nabstinence\r\naddiction\r\nmedication-assisted therapy\r\noverdose","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bradley ES, Liss D, Carreiro SP, Brush DE, and Babu K (2019) Potential uses of naltrexone in emergency department patients with opioid use disorder.. Clinical toxicology (Philadelphia, and Pa.) 57(9), 753-759 DOI: 10.1080/15563650.2019.1583342 "},{"Codes":[],"Outcomes":[],"ItemId":98280545,"Title":"Sustained-release Oral Hydromorphone for the Treatment of Opioid Use Disorder","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Braithwaite (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1932-0620","City":"","Country":"","Publisher":"","Institution":"S. Nolan, University of British Columbia, Clinician Scientist, British Columbia Centre on Substance Use, 553B-1081 Burrard Street, Vancouver, BC, Canada","Volume":"14","Pages":"345-347","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2024431365&from=export http://dx.doi.org/10.1097/ADM.0000000000000585","OldItemId":"","Comments":"","TypeName":"Journal, Article","Authors":"Braithwaite V ; Fairgrieve C ; Nolan S ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000585","Keywords":"adult\r\nalcohol intoxication\r\narticle\r\nCanada\r\ncase report\r\nclinical article\r\nclinical trial\r\ncraving\r\ndrug therapy\r\nfirst-line treatment\r\nhuman\r\nhyponatremia\r\nmale\r\nmiddle aged\r\nmyoclonus\r\nQT prolongation\r\nQTc interval\r\nside effect\r\nsustained drug release\r\ntorsade de pointes\r\nurban hospital\r\nhydromorphone\r\nmethadone\r\nmorphine\r\nopiate\r\nopiate agonist","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Braithwaite V, Fairgrieve C, and Nolan S (2020) Sustained-release Oral Hydromorphone for the Treatment of Opioid Use Disorder. Journal of Addiction Medicine 14(4), 345-347 DOI: 10.1097/ADM.0000000000000585"},{"Codes":[],"Outcomes":[],"ItemId":98279958,"Title":"A review of the safety of buprenorphine in special populations","ParentTitle":"American Journal of the Medical Sciences","ShortTitle":"Brandt (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0002-9629","City":"","Country":"","Publisher":"","Institution":"C. Brandt, Tennessee Valley Healthcare System, 3400 Lebanon Pike, Murfreesboro, TN, United States","Volume":"364","Pages":"675-684","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2020139975&from=export http://dx.doi.org/10.1016/j.amjms.2022.06.025","OldItemId":"","Comments":"2023-02-22","TypeName":"Journal, Article","Authors":"Brandt C ; Atkinson T J; ","ParentAuthors":"","DOI":"10.1016/j.amjms.2022.06.025","Keywords":"buprenorphine\r\nefavirenz\r\nnorbuprenorphine\r\ndepression\r\ndrug absorption\r\ndrug bioavailability\r\ndrug efficacy\r\ndrug formulation\r\ndrug metabolism\r\ndrug safety\r\ndrug tolerability\r\nheart rate\r\nhemodialysis\r\nhighly active antiretroviral therapy\r\nintoxication\r\nkidney disease\r\nlactation\r\nliver failure\r\nmaximum plasma concentration\r\nopiate addiction\r\npolypharmacy\r\npregnancy\r\npregnant woman\r\nprescription\r\nrespiration depression\r\nreview\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Brandt C, and Atkinson T J (2022) A review of the safety of buprenorphine in special populations. American Journal of the Medical Sciences 364(6), 675-684 DOI: 10.1016/j.amjms.2022.06.025"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281243,"Title":"Quality of life as an outcome of opioid use disorder treatment: A systematic review","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Bray (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"J.W. Bray, Department of Economics, The University of North Carolina at Greensboro, PO Box 26170, Greensboro, NC, United States","Volume":"76","Pages":"88-93","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L614390381&from=export http://dx.doi.org/10.1016/j.jsat.2017.01.019","OldItemId":"","Comments":"2017-04-11","TypeName":"Journal, Article","Authors":"Bray J W; Aden B ; Eggman A A; Hellerstein L ; Wittenberg E ; Nosyk B ; Stribling J C; Schackman B R; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2017.01.019","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nmethadone\r\nAddiction Severity Index\r\narticle\r\nclinical outcome\r\nhuman\r\nopiate addiction\r\nopiate substitution treatment\r\npriority journal\r\npsychopharmacotherapy\r\nquality adjusted life year\r\nquality of life\r\nSymptom Checklist 90\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bray J W, Aden B, Eggman A A, Hellerstein L, Wittenberg E, Nosyk B, Stribling J C, and Schackman B R (2017) Quality of life as an outcome of opioid use disorder treatment: A systematic review. Journal of Substance Abuse Treatment 76, 88-93 DOI: 10.1016/j.jsat.2017.01.019"},{"Codes":[],"Outcomes":[],"ItemId":98282206,"Title":"Medications for Opioid Use Disorder in Rural United States: A Critical Review of the Literature, 2004-2021.","ParentTitle":"Substance use & misuse","ShortTitle":"Bresett (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"1082-6084 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"58","Pages":"111-118","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36420639","Comments":"","TypeName":"Journal, Article","Authors":"Bresett JW ; Kruse-Diehr AJ ; ","ParentAuthors":"","DOI":"10.1080/10826084.2022.2149244 ","Keywords":"Humans\r\nUnited States\r\nOpiate Substitution Treatment/methods\r\n*Buprenorphine/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\n*Physicians\r\nAnalgesics, Opioid/therapeutic use\r\nMOUD\r\nopioids\r\nrural","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bresett JW, and Kruse-Diehr AJ (2023) Medications for Opioid Use Disorder in Rural United States: A Critical Review of the Literature, 2004-2021.. Substance use & misuse 58(1), 111-118 DOI: 10.1080/10826084.2022.2149244 "},{"Codes":[{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282159,"Title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Brinkley-Rubinstein (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"March","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"184","Pages":"57-63","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"29402680","Comments":"","TypeName":"Journal, Article","Authors":"Brinkley-Rubinstein L ; McKenzie M ; Macmadu A ; Larney S ; Zaller N ; Dauria E ; Rich J ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2017.11.023 ","Keywords":"Adult\r\nAnalgesics, Opioid/adverse effects/therapeutic use\r\nFemale\r\nFollow-Up Studies\r\nHeroin Dependence/epidemiology/prevention & control/psychology\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nOpiate Substitution Treatment/methods/psychology/*trends\r\nOpioid-Related Disorders/*drug therapy/epidemiology/psychology\r\n*Prisoners/psychology\r\nPrisons/*trends\r\nRandom Allocation\r\nRhode Island/epidemiology\r\nSubstance Abuse, Intravenous/epidemiology/prevention & control/psychology\r\n*Substance Withdrawal Syndrome/epidemiology/psychology\r\nTime Factors\r\nUnited States\r\nIncarceration\r\nMethadone maintenance treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, and Rich J (2018) A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.. Drug and alcohol dependence 184, 57-63 DOI: 10.1016/j.drugalcdep.2017.11.023 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281510,"Title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: Systematic review and meta-analysis","ParentTitle":"American Journal of Epidemiology","ShortTitle":"Brogly (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"0002-9262","City":"","Country":"","Publisher":"","Institution":"S.B. Brogly, Department of Epidemiology, Boston University, School of Public Health, 715 Albany Street, Talbot 419-E, Boston, MA, United States","Volume":"180","Pages":"673-686","Edition":"","Issue":"7","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L604736065&from=export http://dx.doi.org/10.1093/aje/kwu190","OldItemId":"","Comments":"2015-06-18","TypeName":"Journal, Article","Authors":"Brogly S B; Saia K A; Walley A Y; Du H M; Sebastiani P ; ","ParentAuthors":"","DOI":"10.1093/aje/kwu190","Keywords":"buprenorphine\r\nillicit drug\r\nmethadone\r\nmorphine\r\nbirth weight\r\nbody height\r\nfemale\r\ngestational age\r\nhead circumference\r\nhospitalization\r\nhuman\r\nlength of stay\r\nmeta analysis\r\nmethadone treatment\r\nopiate addiction\r\npregnancy outcome\r\npremature labor\r\nprenatal drug exposure\r\npublishing\r\nquality control\r\nrandomized controlled trial (topic)\r\nreview\r\nsystematic review\r\ntreatment duration\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Brogly S B, Saia K A, Walley A Y, Du H M, and Sebastiani P (2014) Prenatal buprenorphine versus methadone exposure and neonatal outcomes: Systematic review and meta-analysis. American Journal of Epidemiology 180(7), 673-686 DOI: 10.1093/aje/kwu190"},{"Codes":[{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281909,"Title":"The perioperative management of patients maintained on medications used to manage opioid addiction.","ParentTitle":"Current opinion in anaesthesiology","ShortTitle":"Bryson (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"June","StandardNumber":"0952-7907 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"27","Pages":"359-64","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"24500338","Comments":"","TypeName":"Journal, Article","Authors":"Bryson EO ; ","ParentAuthors":"","DOI":"10.1097/ACO.0000000000000052 ","Keywords":"Analgesics, Opioid\r\nHumans\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*therapy\r\nPain Management/methods\r\nPerioperative Care/*methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Bryson EO (2014) The perioperative management of patients maintained on medications used to manage opioid addiction.. Current opinion in anaesthesiology 27(3), 359-64 DOI: 10.1097/ACO.0000000000000052 "},{"Codes":[],"Outcomes":[],"ItemId":98281704,"Title":"Treatment of opioid use disorder in primary care.","ParentTitle":"BMJ (Clinical research ed.)","ShortTitle":"Buresh (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"May","StandardNumber":"0959-8138 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"373","Pages":"n784","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34011512","Comments":"","TypeName":"Journal, Article","Authors":"Buresh M ; Stern R ; Rastegar D ; ","ParentAuthors":"","DOI":"10.1136/bmj.n784 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nBehavior Therapy\r\nCombined Modality Therapy\r\nCounseling\r\nCrisis Intervention\r\nGlobal Health\r\nHealth Status Disparities\r\nHumans\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/diagnosis/*drug therapy/epidemiology/therapy\r\nPrimary Health Care/*methods\r\nPsychiatric Rehabilitation/methods\r\nTreatment Outcome\r\nUnited States/epidemiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Buresh M, Stern R, and Rastegar D (2021) Treatment of opioid use disorder in primary care.. BMJ (Clinical research ed.) 373, n784 DOI: 10.1136/bmj.n784 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281951,"Title":"Cost-effectiveness of emergency department-initiated treatment for opioid dependence.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Busch (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"November","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"2002-2010","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"28815789","Comments":"","TypeName":"Journal, Article","Authors":"Busch SH ; Fiellin DA ; Chawarski MC ; Owens PH ; Pantalon MV ; Hawk K ; Bernstein SL ; O'Connor PG ; D'Onofrio G ; ","ParentAuthors":"","DOI":"10.1111/add.13900 ","Keywords":"*Aftercare\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nCost-Benefit Analysis\r\n*Emergency Service, Hospital\r\nHealth Services/economics/*statistics & numerical data\r\nHumans\r\nOpiate Substitution Treatment/economics/*methods\r\nOpioid-Related Disorders/economics/*therapy\r\nPatient Participation\r\n*Primary Health Care\r\nReferral and Consultation\r\nUnited States\r\nBuprenorphine\r\ncost analysis\r\nemergency department\r\nhealth services research\r\nopiates\r\nscreening","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Busch SH, Fiellin DA, Chawarski MC, Owens PH, Pantalon MV, Hawk K, Bernstein SL, O'Connor PG, and D'Onofrio G (2017) Cost-effectiveness of emergency department-initiated treatment for opioid dependence.. Addiction (Abingdon, and England) 112(11), 2002-2010 DOI: 10.1111/add.13900 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283232,"Title":"Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.","ParentTitle":"The British journal of psychiatry : the journal of mental science","ShortTitle":"Byford (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"November","StandardNumber":"0007-1250 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"203","Pages":"341-9","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"24029536","Comments":"","TypeName":"Journal, Article","Authors":"Byford S ; Barrett B ; Metrebian N ; Groshkova T ; Cary M ; Charles V ; Lintzeris N ; Strang J ; ","ParentAuthors":"","DOI":"10.1192/bjp.bp.112.111583 ","Keywords":"Adolescent\r\nAdult\r\nAged\r\nAnalgesics, Opioid/administration & dosage/*economics\r\nChronic Disease\r\nCost Savings\r\nCost-Benefit Analysis/statistics & numerical data\r\nCrime/economics/statistics & numerical data\r\nHealth Care Costs/statistics & numerical data\r\nHeroin/administration & dosage/*economics\r\nHeroin Dependence/economics/*rehabilitation\r\nHumans\r\nInjections/economics\r\nIntention to Treat Analysis\r\nMethadone/administration & dosage/*economics\r\nMiddle Aged\r\nOpiate Substitution Treatment/*economics/methods\r\nOutcome Assessment, Health Care/economics/*statistics & numerical data\r\nPatient Compliance\r\nQuality-Adjusted Life Years\r\nUnited Kingdom\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, and Strang J (2013) Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.. The British journal of psychiatry : the journal of mental science 203(5), 341-9 DOI: 10.1192/bjp.bp.112.111583 "},{"Codes":[],"Outcomes":[],"ItemId":98284206,"Title":"Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial.","ParentTitle":"Alimentary pharmacology & therapeutics","ShortTitle":"Byrne (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"June","StandardNumber":"0269-2813 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"55","Pages":"1512-1523","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"35538396","Comments":"","TypeName":"Journal, Article","Authors":"Byrne CJ ; Radley A ; Inglis SK ; Beer L ; Palmer N ; Duc Pham M; Allardice K ; Wang H ; Robinson E ; Hermansson M ; Semizarov D ; Healy B ; Doyle JS ; Dillon JF ; ","ParentAuthors":"","DOI":"10.1111/apt.16953 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nAntiviral Agents/therapeutic use\r\nHepacivirus\r\n*Hepatitis C/drug therapy\r\n*Hepatitis C, Chronic/diagnosis/drug therapy\r\nHumans\r\n*Pharmacies\r\nRNA/therapeutic use\r\n*Substance Abuse, Intravenous/drug therapy/epidemiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Byrne CJ, Radley A, Inglis SK, Beer L, Palmer N, Duc Pham M, Allardice K, Wang H, Robinson E, Hermansson M, Semizarov D, Healy B, Doyle JS, and Dillon JF (2022) Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial.. Alimentary pharmacology & therapeutics 55(12), 1512-1523 DOI: 10.1111/apt.16953 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280674,"Title":"Prescribing buprenorphine for opioid use disorders in the ed: A review of best practices, barriers, and future directions","ParentTitle":"Open Access Emergency Medicine","ShortTitle":"Cao (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1179-1500","City":"","Country":"","Publisher":"","Institution":"S.A. Simpson, Denver Health Medical Center, 777 Bannock St, MC 0116, Denver, CO, United States","Volume":"12","Pages":"261-274","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2005631610&from=export http://dx.doi.org/10.2147/OAEM.S267416","OldItemId":"","Comments":"2021-04-06","TypeName":"Journal, Article","Authors":"Cao S S; Dunham S I; Simpson S A; ","ParentAuthors":"","DOI":"10.2147/OAEM.S267416","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nclonidine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nclinical protocol\r\nconstipation\r\nsomnolence\r\ndrug efficacy\r\ndrug overdose\r\ndrug safety\r\ndrug tolerability\r\nemergency ward\r\nevidence based medicine\r\nfollow up\r\nheadache\r\nhealth program\r\nhuman\r\nmedical care need\r\nmedical practice\r\nnausea\r\nopiate addiction\r\npatient assessment\r\npatient care\r\npatient compliance\r\npractice guideline\r\nprescription\r\nreview\r\nrisk factor\r\nsystematic review\r\nvomiting","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cao S S, Dunham S I, and Simpson S A (2020) Prescribing buprenorphine for opioid use disorders in the ed: A review of best practices, barriers, and future directions. Open Access Emergency Medicine 12, 261-274 DOI: 10.2147/OAEM.S267416"},{"Codes":[],"Outcomes":[],"ItemId":98282508,"Title":"Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.","ParentTitle":"Pediatrics in review","ShortTitle":"Carney (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"January","StandardNumber":"0191-9601 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"39","Pages":"43-45","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29292291","Comments":"","TypeName":"Journal, Article","Authors":"Carney BL ; Hadland SE ; Bagley SM ; ","ParentAuthors":"","DOI":"10.1542/pir.2017-0153 ","Keywords":"Adolescent\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nClinical Protocols\r\nHumans\r\nMethadone/*therapeutic use\r\nNaltrexone/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nPrimary Health Care/*methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Carney BL, Hadland SE, and Bagley SM (2018) Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.. Pediatrics in review 39(1), 43-45 DOI: 10.1542/pir.2017-0153 "},{"Codes":[{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280643,"Title":"Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Carney (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1469-493X","City":"","Country":"","Publisher":"","Institution":"T. Carney, South African Medical Research Council, Alcohol, Tobacco and Other Drug Research Unit, Francie Van Zijl Drive, Tygerberg, Western Cape, South Africa","Volume":"2020","Pages":"","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L630960221&from=export http://dx.doi.org/10.1002/14651858.CD012254.pub2","OldItemId":"","Comments":"2020-03-04","TypeName":"Journal, Article","Authors":"Carney T ; Van Hout M C; Norman I ; Dada S ; Siegfried N ; Parry C D.H; ","ParentAuthors":"","DOI":"10.1002/14651858.CD012254.pub2","Keywords":"buprenorphine\r\ndihydrocodeine\r\nmethadone\r\ndrug dependence\r\ndrug detoxification\r\ndrug traffic\r\nfinancial management\r\nfollow up\r\ngroups by age\r\nhealth status\r\nhuman\r\nmaintenance therapy\r\nopiate addiction\r\nopiate substitution treatment\r\npriority journal\r\nrandomized controlled trial (topic)\r\nreview\r\nself report\r\nsystematic review\r\ntherapy effect\r\ntreatment duration\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Carney T, Van Hout M C, Norman I, Dada S, Siegfried N, and Parry C D.H (2020) Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders. Cochrane Database of Systematic Reviews 2020(2),  DOI: 10.1002/14651858.CD012254.pub2"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948251,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282154,"Title":"Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).","ParentTitle":"PloS one","ShortTitle":"Carrieri (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1932-6203 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"Methaville Study Group","Volume":"9","Pages":"e112328","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"25393311","Comments":"","TypeName":"Journal, Article","Authors":"Carrieri PM ; Michel L ; Lions C ; Cohen J ; Vray M ; Mora M ; Marcellin F ; Spire B ; Morel A ; Roux P ; ","ParentAuthors":"","DOI":"10.1371/journal.pone.0112328 ","Keywords":"Adult\r\nFemale\r\nFrance\r\nHumans\r\n*Induction Chemotherapy\r\nMale\r\nMethadone/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\n*Primary Health Care","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, Marcellin F, Spire B, Morel A, and Roux P (2014) Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).. PloS one 9(11), e112328 DOI: 10.1371/journal.pone.0112328 "},{"Codes":[],"Outcomes":[],"ItemId":98281786,"Title":"Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.","ParentTitle":"Hospital practice (1995)","ShortTitle":"Carswell (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"October","StandardNumber":"2154-8331 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"50","Pages":"251-258","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"35837678","Comments":"","TypeName":"Journal, Article","Authors":"Carswell N ; Angermaier G ; Castaneda C ; Delgado F ; ","ParentAuthors":"","DOI":"10.1080/21548331.2022.2102776 ","Keywords":"Analgesics, Opioid/adverse effects\r\n*Antiemetics/therapeutic use\r\nBenzodiazepines/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nHospitals\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/diagnosis/drug therapy/epidemiology\r\nRecurrence\r\n*Substance Withdrawal Syndrome/drug therapy\r\nUnited States\r\nAddiction\r\nbuprenorphine\r\ninpatient\r\nmethadone\r\nmicroinduction\r\nopioid\r\nopioid use disorder\r\nopioid-related disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Carswell N, Angermaier G, Castaneda C, and Delgado F (2022) Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.. Hospital practice (1995) 50(4), 251-258 DOI: 10.1080/21548331.2022.2102776 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281268,"Title":"Economic analysis of buprenorphine subdermal implant versus standards of care for primarily treatment-naive primarily heroin-addicted patients with opioid use disorder","ParentTitle":"Journal of Managed Care and Specialty Pharmacy","ShortTitle":"Carter (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"2376-1032","City":"","Country":"","Publisher":"","Institution":"J. Carter, EPI-Q, 11315 W 22nd St, Oak Brook, IL, United States","Volume":"23","Pages":"S51-S52","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L624716686&from=export","OldItemId":"","Comments":"2018-11-06","TypeName":"Journal, Article","Authors":"Carter J ; Dammerman R ; Frost M ; ","ParentAuthors":"","DOI":"","Keywords":"buprenorphine\r\ndiamorphine\r\nmethadone\r\nopiate\r\nabstinence\r\nbudget\r\nchild\r\nclinical trial (topic)\r\nconference abstract\r\ndeath\r\ndisease simulation\r\ndriver\r\ndrug efficacy\r\ndrug therapy\r\ndrug withdrawal\r\neconomic model\r\nemergency ward\r\nepidemic\r\nfemale\r\nhealth status\r\nhigh risk patient\r\nhospitalization\r\nhuman\r\nimplant\r\nmale\r\nmeta analysis\r\nnetwork meta-analysis\r\nopiate addiction\r\nrelapse\r\nrisk assessment\r\nsensitivity analysis\r\nsystematic review\r\nuncertainty","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Carter J, Dammerman R, and Frost M (2017) Economic analysis of buprenorphine subdermal implant versus standards of care for primarily treatment-naive primarily heroin-addicted patients with opioid use disorder. Journal of Managed Care and Specialty Pharmacy 23, S51-S52"},{"Codes":[],"Outcomes":[],"ItemId":98280622,"Title":"Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach","ParentTitle":"BMJ Case Reports","ShortTitle":"Caulfield (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1757-790X","City":"","Country":"","Publisher":"","Institution":"M.D.G. Caulfield, Department of Family Medicine, University of Calgary, Calgary, AB, Canada","Volume":"13","Pages":"","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L631368634&from=export http://dx.doi.org/10.1136/bcr-2019-233715","OldItemId":"","Comments":"2020-04-22","TypeName":"Journal, Article","Authors":"Caulfield M D.G; Brar R ; Sutherland C ; Nolan S ; ","ParentAuthors":"","DOI":"10.1136/bcr-2019-233715","Keywords":"buprenorphine plus naloxone\r\ncocaine\r\ndiamorphine\r\nhydromorphone\r\nmethadone\r\nmethamphetamine\r\nmorphine\r\nadult\r\narticle\r\nbody weight gain\r\ncase report\r\nclinical article\r\ncocaine dependence\r\ndepression\r\ndisease severity\r\ndrug dose increase\r\ndrug dose titration\r\ndrug microdose\r\ndrug withdrawal\r\nheroin dependence\r\nhuman\r\ninsomnia\r\nlow drug dose\r\nmale\r\nmethamphetamine dependence\r\nmiddle aged\r\npriority journal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Caulfield M D.G, Brar R, Sutherland C, and Nolan S (2020) Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach. BMJ Case Reports 13(3),  DOI: 10.1136/bcr-2019-233715"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283179,"Title":"Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Chakrabarti (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"March","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"107","Pages":"253-6","Edition":"","Issue":"2-3","Availability":"","URL":"","OldItemId":"19948382","Comments":"","TypeName":"Journal, Article","Authors":"Chakrabarti A ; Woody GE ; Griffin ML ; Subramaniam G ; Weiss RD ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2009.10.014 ","Keywords":"Adolescent\r\nAge Factors\r\nBuprenorphine/administration & dosage/adverse effects/*therapeutic use\r\nData Interpretation, Statistical\r\nDose-Response Relationship, Drug\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nMale\r\nNaloxone/administration & dosage/adverse effects/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nNarcotics/*therapeutic use\r\nNational Institute on Drug Abuse (U.S.)\r\nOpioid-Related Disorders/*drug therapy\r\nOutpatients\r\nPain/chemically induced\r\nPain Measurement\r\nSocioeconomic Factors\r\nSubstance Withdrawal Syndrome/prevention & control\r\nTime Factors\r\nTreatment Outcome\r\nUnited States\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, and Weiss RD (2010) Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.. Drug and alcohol dependence 107(2-3), 253-6 DOI: 10.1016/j.drugalcdep.2009.10.014 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281718,"Title":"Opioid treatment programs, telemedicine and COVID-19: A scoping review.","ParentTitle":"Substance abuse","ShortTitle":"Chan (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0889-7077 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"43","Pages":"539-546","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34520702","Comments":"","TypeName":"Journal, Article","Authors":"Chan B ; Bougatsos C ; Priest KC ; McCarty D ; Grusing S ; Chou R ; ","ParentAuthors":"","DOI":"10.1080/08897077.2021.1967836 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nFemale\r\nHumans\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy/epidemiology\r\nPandemics\r\nPregnancy\r\n*Pregnancy Complications, Infectious\r\nSARS-CoV-2\r\nSystematic Reviews as Topic\r\n*Telemedicine\r\nUnited States\r\n*COVID-19 Drug Treatment\r\nCOVID-19\r\nTelemedicine\r\nbuprenorphine\r\nmethadone\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chan B, Bougatsos C, Priest KC, McCarty D, Grusing S, and Chou R (2022) Opioid treatment programs, telemedicine and COVID-19: A scoping review.. Substance abuse 43(1), 539-546 DOI: 10.1080/08897077.2021.1967836 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282392,"Title":"Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.","ParentTitle":"HIV research & clinical practice","ShortTitle":"Chandra (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"February","StandardNumber":"2578-7470 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"20","Pages":"12-23","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"31303149","Comments":"","TypeName":"Journal, Article","Authors":"Chandra DK ; Bazazi AR ; Nahaboo Solim MA; Kamarulzaman A ; Altice FL ; Culbert GJ ; ","ParentAuthors":"","DOI":"10.1080/15284336.2019.1603433 ","Keywords":"Adult\r\nBehavior Therapy\r\n*Clinical Trials as Topic\r\nHIV Infections/drug therapy/*epidemiology\r\nHumans\r\nMalaysia/epidemiology\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/drug therapy/*epidemiology\r\nPrisoners/*statistics & numerical data\r\nPrisons/statistics & numerical data\r\nRetention in Care/standards/*statistics & numerical data\r\nSurveys and Questionnaires\r\nClinical trials\r\nHIV\r\ncriminal justice\r\nprisoners\r\nstudy retention\r\nsubstance use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chandra DK, Bazazi AR, Nahaboo Solim MA, Kamarulzaman A, Altice FL, and Culbert GJ (2019) Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.. HIV research & clinical practice 20(1), 12-23 DOI: 10.1080/15284336.2019.1603433 "},{"Codes":[],"Outcomes":[],"ItemId":98279965,"Title":"Transitioning patients with opioid use disorder from methadone to buprenorphine","ParentTitle":"Current Psychiatry","ShortTitle":"Chaney (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1537-8276","City":"","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"23-24 and 28","Edition":"","Issue":"12","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2026546066&from=export http://dx.doi.org/10.12788/cp.0305","OldItemId":"","Comments":"2023-09-12","TypeName":"Journal, Article","Authors":"Chaney L ; Mathia C ; Cole T ; ","ParentAuthors":"","DOI":"10.12788/cp.0305","Keywords":"transdermal patch\r\nbuprenorphine\r\nmethadone\r\nadult\r\narticle\r\ncase report\r\nclinical article\r\ndrug dose increase\r\ndrug dose reduction\r\ndrug microdose\r\ndrug therapeutic index\r\nhuman\r\nmale\r\nmethadone treatment\r\nmiddle aged\r\nopiate addiction\r\nopiate substitution treatment\r\noutpatient care\r\npartial agonism\r\npatient preference\r\npatient safety\r\ntreatment duration\r\ntreatment outcome\r\ntreatment switching","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chaney L, Mathia C, and Cole T (2022) Transitioning patients with opioid use disorder from methadone to buprenorphine. Current Psychiatry 21(12), 23-24 and 28 DOI: 10.12788/cp.0305"},{"Codes":[],"Outcomes":[],"ItemId":98281735,"Title":"Buprenorphine implants in medical treatment of opioid addiction.","ParentTitle":"Expert review of clinical pharmacology","ShortTitle":"Chavoustie (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"August","StandardNumber":"1751-2433 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"10","Pages":"799-807","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"28571505","Comments":"","TypeName":"Journal, Article","Authors":"Chavoustie S ; Frost M ; Snyder O ; Owen J ; Darwish M ; Dammerman R ; Sanjurjo V ; ","ParentAuthors":"","DOI":"10.1080/17512433.2017.1336434 ","Keywords":"Analgesics, Opioid/administration & dosage/adverse effects\r\nBuprenorphine/*administration & dosage/adverse effects\r\nDelayed-Action Preparations\r\nDrug Implants\r\nHumans\r\nMethadone/administration & dosage\r\nNarcotic Antagonists/administration & dosage/adverse effects\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nBuprenorphine implant\r\nopioid dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chavoustie S, Frost M, Snyder O, Owen J, Darwish M, Dammerman R, and Sanjurjo V (2017) Buprenorphine implants in medical treatment of opioid addiction.. Expert review of clinical pharmacology 10(8), 799-807 DOI: 10.1080/17512433.2017.1336434 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948197,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15064034,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269960,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280528,"Title":"GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: A systematic review and meta-analysis protocol","ParentTitle":"Systematic Reviews","ShortTitle":"Chawar (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"2046-4053","City":"","Country":"","Publisher":"","Institution":"Z. Samaan, Department of Psychiatry and Behavioural Neurosciences, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada","Volume":"9","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L632723360&from=export http://dx.doi.org/10.1186/s13643-020-01461-z","OldItemId":"","Comments":"2020-11-30","TypeName":"Journal, Article","Authors":"Chawar C ; Hillmer A ; Sanger S ; D'Elia A ; Panesar B ; Guan L ; Xie D X; Bansal N ; Abdullah A ; Kapczinski F ; Pare G ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.1186/s13643-020-01461-z","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nclonidine\r\ndiamorphine\r\nfentanyl\r\nhydromorphone\r\nmorphine\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nabstinence\r\nall cause mortality\r\nblood level\r\ndrug megadose\r\ndrug therapy\r\nfollow up\r\ngenetic association\r\ngenetic variability\r\ngenome-wide association study\r\ngenotype\r\nhigh risk behavior\r\nhospitalization\r\nhuman\r\nmedical record\r\nmedication assisted treatment\r\nmental disease\r\nmeta analysis\r\nmortality rate\r\nopiate addiction\r\npharmacogenomics\r\nphenotype\r\npriority journal\r\nrelapse\r\nretention time\r\nreview\r\nself report\r\nsubstance use\r\nsystematic review\r\ntreatment outcome\r\nurinalysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chawar C, Hillmer A, Sanger S, D'Elia A, Panesar B, Guan L, Xie D X, Bansal N, Abdullah A, Kapczinski F, Pare G, Thabane L, and Samaan Z (2020) GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: A systematic review and meta-analysis protocol. Systematic Reviews 9(1),  DOI: 10.1186/s13643-020-01461-z"},{"Codes":[{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282878,"Title":"Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.","ParentTitle":"Journal of opioid management","ShortTitle":"Chawla (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"January","StandardNumber":"1551-7489 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"35-41","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23709302","Comments":"","TypeName":"Journal, Article","Authors":"Chawla JM ; Pal H ; Lal R ; Jain R ; Schooler N ; Balhara YP ; ","ParentAuthors":"","DOI":"10.5055/jom.2013.0145 ","Keywords":"Adult\r\nAnalgesics, Opioid/adverse effects/*therapeutic use\r\nBuprenorphine/adverse effects/*therapeutic use\r\nChecklist\r\nChi-Square Distribution\r\nDouble-Blind Method\r\nHeroin Dependence/diagnosis/*rehabilitation\r\nHumans\r\nIndia\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/adverse effects/*methods\r\nPain Measurement\r\nPilot Projects\r\nSeverity of Illness Index\r\nSubstance Withdrawal Syndrome/diagnosis/*rehabilitation\r\nSurveys and Questionnaires\r\nTime Factors\r\nTramadol/adverse effects/*therapeutic use\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chawla JM, Pal H, Lal R, Jain R, Schooler N, and Balhara YP (2013) Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.. Journal of opioid management 9(1), 35-41 DOI: 10.5055/jom.2013.0145 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282144,"Title":"Effectiveness of prize-based contingency management in a methadone maintenance program in China.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Chen (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"November","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"133","Pages":"270-4","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23831409","Comments":"","TypeName":"Journal, Article","Authors":"Chen W ; Hong Y ; Zou X ; McLaughlin MM ; Xia Y ; Ling L ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.05.028 ","Keywords":"Adult\r\nBehavior Therapy\r\nChina\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*psychology\r\nOpioid-Related Disorders/drug therapy/psychology/therapy\r\nPatient Compliance/*psychology\r\n*Reward\r\nAbstinence\r\nChina\r\nContingency management\r\nMethadone maintenance treatment\r\nTreatment attendance","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chen W, Hong Y, Zou X, McLaughlin MM, Xia Y, and Ling L (2013) Effectiveness of prize-based contingency management in a methadone maintenance program in China.. Drug and alcohol dependence 133(1), 270-4 DOI: 10.1016/j.drugalcdep.2013.05.028 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948297,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948346,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281970,"Title":"A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.","ParentTitle":"Addiction science & clinical practice","ShortTitle":"Chetty (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"February","StandardNumber":"1940-0632 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"12","Pages":"6","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"28235415","Comments":"","TypeName":"Journal, Article","Authors":"Chetty M ; Kenworthy JJ ; Langham S ; Walker A ; Dunlop WC ; ","ParentAuthors":"","DOI":"10.1186/s13722-017-0071-3 ","Keywords":"Buprenorphine/*economics\r\nCost-Benefit Analysis\r\nDrug Overdose/*economics/therapy\r\nHumans\r\n*Models, Economic\r\nNarcotic Antagonists/*economics\r\nNonprescription Drugs/*economics\r\nOpioid-Related Disorders/*economics/therapy\r\nEconomic evaluation\r\nNon-prescription opioid dependence\r\nOpioid agonist maintenance therapy\r\nSystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chetty M, Kenworthy JJ, Langham S, Walker A, and Dunlop WC (2017) A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.. Addiction science & clinical practice 12(1), 6 DOI: 10.1186/s13722-017-0071-3 "},{"Codes":[],"Outcomes":[],"ItemId":98281484,"Title":"Methadone safety: A clinical practice guideline from the american pain society and college on problems of drug dependence, in collaboration with the heart rhythm society","ParentTitle":"Journal of Pain","ShortTitle":"Chou (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1526-5900","City":"","Country":"","Publisher":"","Institution":"R. Chou, Mail Code BICC, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States","Volume":"15","Pages":"321-337","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L372731985&from=export http://dx.doi.org/10.1016/j.jpain.2014.01.494","OldItemId":"","Comments":"2014-04-15","TypeName":"Journal, Article","Authors":"Chou R ; Cruciani R A; Fiellin D A; Compton P ; Farrar J T; Haigney M C; Inturrisi C ; Knight J R; Otis-Green S ; Marcus S M; Mehta D ; Meyer M C; Portenoy R ; Savage S ; Strain E ; Walsh S ; Zeltzer L ; ","ParentAuthors":"","DOI":"10.1016/j.jpain.2014.01.494","Keywords":"anti human immunodeficiency virus agent\r\nantiarrhythmic agent\r\nantibiotic agent\r\nanticonvulsive agent\r\nantihistaminic agent\r\natypical antipsychotic agent\r\nbarbituric acid derivative\r\ncitalopram\r\nmethadone\r\nopiate derivative\r\nquinolone derivative\r\nserotonin uptake inhibitor\r\ntricyclic antidepressant agent\r\narticle\r\nchronic pain\r\ndrug dose increase\r\ndrug dose titration\r\ndrug monitoring\r\ndrug overdose\r\ndrug safety\r\nelectrocardiography\r\nfollow up\r\nheart arrhythmia\r\nheart ventricle arrhythmia\r\nhigh risk patient\r\nhuman\r\nloading drug dose\r\nmedical society\r\nopiate addiction\r\npatient counseling\r\npatient education\r\npractice guideline\r\nQT prolongation\r\nrecommended drug dose\r\nrespiration depression\r\nsedation\r\nside effect\r\nsystematic review\r\ntorsade de pointes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chou R, Cruciani R A, Fiellin D A, Compton P, Farrar J T, Haigney M C, Inturrisi C, Knight J R, Otis-Green S, Marcus S M, Mehta D, Meyer M C, Portenoy R, Savage S, Strain E, Walsh S, and Zeltzer L (2014) Methadone safety: A clinical practice guideline from the american pain society and college on problems of drug dependence, in collaboration with the heart rhythm society. Journal of Pain 15(4), 321-337 DOI: 10.1016/j.jpain.2014.01.494"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281485,"Title":"Methadone overdose and cardiac arrhythmia potential: Findings from a review of the evidence for an american pain society and college on problems of drug dependence clinical practice guideline","ParentTitle":"Journal of Pain","ShortTitle":"Chou (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1526-5900","City":"","Country":"","Publisher":"","Institution":"R. Chou, Mail Code BICC, 3181 SW Sam Jackson Park Road, Portland, OR 97239, United States","Volume":"15","Pages":"338-365","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L372731986&from=export http://dx.doi.org/10.1016/j.jpain.2014.01.495","OldItemId":"","Comments":"2014-04-15","TypeName":"Journal, Article","Authors":"Chou R ; Weimer M B; Dana T ; ","ParentAuthors":"","DOI":"10.1016/j.jpain.2014.01.495","Keywords":"benzodiazepine\r\nillicit drug\r\nmethadone\r\nopiate\r\nadverse outcome\r\narticle\r\ncancer pain\r\nchronic pain\r\nclinical practice\r\ndrug dependence\r\ndrug dependence treatment\r\ndrug overdose\r\ndrug safety\r\nECG abnormality\r\nelectrocardiography monitoring\r\nevidence based medicine\r\nfollow up\r\nharm reduction\r\nheart arrhythmia\r\nhuman\r\nmedical society\r\nmethadone treatment\r\nmortality\r\nopiate addiction\r\npractice guideline\r\nQT prolongation\r\nrandomized controlled trial (topic)\r\nrisk factor\r\nrisk management\r\nsudden death\r\nsystematic review\r\ntorsade de pointes\r\ntreatment outcome\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chou R, Weimer M B, and Dana T (2014) Methadone overdose and cardiac arrhythmia potential: Findings from a review of the evidence for an american pain society and college on problems of drug dependence clinical practice guideline. Journal of Pain 15(4), 338-365 DOI: 10.1016/j.jpain.2014.01.495"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285097,"Title":"Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings","ParentTitle":"AHRQ Comparative Effectiveness Technical Briefs","ShortTitle":"Chou (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"December","StandardNumber":"28045474","City":"Rockville (MD)","Country":"","Publisher":"Agency for Healthcare Research and Quality (US)","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28045474","Comments":"","TypeName":"Book, Whole","Authors":"Chou R ; Korthuis PT ; Weimer M ; Bougatsos C ; Blazina I ; Zakher B ; Grusing S ; Devine B ; McCarty D ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chou R, Korthuis PT, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, and McCarty D (2016) Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. Rockville (MD): Agency for Healthcare Research and Quality (US)"},{"Codes":[{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282263,"Title":"Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence.","ParentTitle":"Journal of consulting and clinical psychology","ShortTitle":"Christensen (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"December","StandardNumber":"0022-006X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"82","Pages":"964-72","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"25090043","Comments":"","TypeName":"Journal, Article","Authors":"Christensen DR ; Landes RD ; Jackson L ; Marsch LA ; Mancino MJ ; Chopra MP ; Bickel WK ; ","ParentAuthors":"","DOI":"10.1037/a0037496 ","Keywords":"Adult\r\nAged\r\nAnalgesics, Opioid/administration & dosage\r\nBuprenorphine/administration & dosage\r\nCognitive Behavioral Therapy/*methods\r\nCombined Modality Therapy\r\nFemale\r\nHumans\r\n*Internet\r\nMale\r\nMiddle Aged\r\n*Motivation\r\nNarcotic Antagonists/administration & dosage\r\n*Opiate Substitution Treatment/methods\r\nOpioid-Related Disorders/drug therapy/*therapy\r\n*Reinforcement, Psychology\r\nResidence Characteristics\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Christensen DR, Landes RD, Jackson L, Marsch LA, Mancino MJ, Chopra MP, and Bickel WK (2014) Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence.. Journal of consulting and clinical psychology 82(6), 964-72 DOI: 10.1037/a0037496 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282199,"Title":"A Meta-Analysis of Breastfeeding Effects for Infants With Neonatal Abstinence Syndrome.","ParentTitle":"Nursing research","ShortTitle":"Chu (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"January","StandardNumber":"0029-6562 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"71","Pages":"54-65","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34596065","Comments":"","TypeName":"Journal, Article","Authors":"Chu L ; McGrath JM ; Qiao J ; Brownell E ; Recto P ; Cleveland LM ; Lopez E ; Gelfond J ; Crawford A ; McGlothen-Bell K ; ","ParentAuthors":"","DOI":"10.1097/NNR.0000000000000555 ","Keywords":"Breast Feeding/*adverse effects\r\nFemale\r\nHumans\r\nInfant\r\nInfant, Newborn\r\nMale\r\nNeonatal Abstinence Syndrome/*complications/physiopathology\r\nOpioid-Related Disorders/complications/physiopathology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Chu L, McGrath JM, Qiao J, Brownell E, Recto P, Cleveland LM, Lopez E, Gelfond J, Crawford A, and McGlothen-Bell K (2022) A Meta-Analysis of Breastfeeding Effects for Infants With Neonatal Abstinence Syndrome.. Nursing research 71(1), 54-65 DOI: 10.1097/NNR.0000000000000555 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280457,"Title":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Cioe (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"S.A. Springer, Yale University School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, 135 College St., Suite 323, New Haven, CT, United States","Volume":"119","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2008036603&from=export http://dx.doi.org/10.1016/j.jsat.2020.108146","OldItemId":"","Comments":"2020-12-15","TypeName":"Journal, Article","Authors":"Cioe K ; Biondi B E; Easly R ; Simard A ; Zheng X ; Springer S A; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2020.108146","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\narticle\r\nattitude to health\r\nclinical practice\r\ndisease severity\r\nepidemic\r\nhealth education\r\nhuman\r\nmedical decision making\r\nmisinformation\r\nopiate addiction\r\noutcome assessment\r\nprescription\r\npriority journal\r\nsocial stigma\r\nstigma\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cioe K, Biondi B E, Easly R, Simard A, Zheng X, and Springer S A (2020) A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment 119,  DOI: 10.1016/j.jsat.2020.108146"},{"Codes":[],"Outcomes":[],"ItemId":98282266,"Title":"Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.","ParentTitle":"The American journal of emergency medicine","ShortTitle":"Cisewski (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"January","StandardNumber":"0735-6757 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"37","Pages":"143-150","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"30355476","Comments":"","TypeName":"Journal, Article","Authors":"Cisewski DH ; Santos C ; Koyfman A ; Long B ; ","ParentAuthors":"","DOI":"10.1016/j.ajem.2018.10.013 ","Keywords":"Behavior Therapy\r\nBuprenorphine/adverse effects/pharmacokinetics/pharmacology/*therapeutic use\r\nCombined Modality Therapy\r\nDirective Counseling\r\nDosage Forms\r\n*Emergency Service, Hospital\r\nHumans\r\nNarcotic Antagonists/adverse effects/pharmacokinetics/pharmacology/*therapeutic \r\n      use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Withdrawal Syndrome/*drug therapy\r\nAddiction\r\nBuprenorphine\r\nMultimodal medication-assisted treatment\r\nOpioid\r\nWithdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cisewski DH, Santos C, Koyfman A, and Long B (2019) Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.. The American journal of emergency medicine 37(1), 143-150 DOI: 10.1016/j.ajem.2018.10.013 "},{"Codes":[{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280792,"Title":"Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice","ParentTitle":"Journal of Midwifery and Women's Health","ShortTitle":"Clark (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1526-9523","City":"","Country":"","Publisher":"","Institution":"R.R.S. Clark, Department of Community and Public Health, Johns Hopkins University, Baltimore, MD, United States","Volume":"64","Pages":"545-558","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L628491039&from=export http://dx.doi.org/10.1111/jmwh.12982","OldItemId":"","Comments":"2019-10-25","TypeName":"Journal, Article","Authors":"Clark R R.S; ","ParentAuthors":"","DOI":"10.1111/jmwh.12982","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nAfrican American\r\nbreast feeding\r\nclinical outcome\r\nclinical practice\r\nhealth care facility\r\nhealth care personnel\r\nhealth care policy\r\nhealth education\r\nhuman\r\nHuman immunodeficiency virus infection\r\nmaintenance therapy\r\nneonatal abstinence syndrome\r\nnurse\r\nopiate addiction\r\npopulation research\r\nprenatal care\r\npriority journal\r\nqualitative research\r\nquantitative study\r\nreview\r\nrisk factor\r\nrural population\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Clark R R.S (2019) Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice. Journal of Midwifery and Women's Health 64(5), 545-558 DOI: 10.1111/jmwh.12982"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019722,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282852,"Title":"Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.","ParentTitle":"The American journal on addictions","ShortTitle":"Comer (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"July","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"29","Pages":"313-322","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"32246728","Comments":"","TypeName":"Journal, Article","Authors":"Comer SD ; Mannelli P ; Alam D ; Douaihy A ; Nangia N ; Akerman SC ; Zavod A ; Silverman BL ; Sullivan MA ; ","ParentAuthors":"","DOI":"10.1111/ajad.13024 ","Keywords":"Adult\r\n*Buprenorphine/administration & dosage/adverse effects\r\nDelayed-Action Preparations\r\nDose-Response Relationship, Drug\r\nDrug Monitoring/methods\r\n*Drug Substitution/adverse effects/methods\r\nFemale\r\nHumans\r\nMale\r\n*Naltrexone/administration & dosage/adverse effects\r\nNarcotic Antagonists/administration & dosage/adverse effects\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Withdrawal Syndrome/etiology/therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Comer SD, Mannelli P, Alam D, Douaihy A, Nangia N, Akerman SC, Zavod A, Silverman BL, and Sullivan MA (2020) Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.. The American journal on addictions 29(4), 313-322 DOI: 10.1111/ajad.13024 "},{"Codes":[],"Outcomes":[],"ItemId":98288264,"Title":"Comparative efficacy and safety of opioid receptor modulators for the treatment of opioid use disorder: a systematic review and network meta-analysis","ParentTitle":"","ShortTitle":"Comparative efficacy... (Anees)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42021276305","Comments":"","TypeName":"Journal, Article","Authors":"Anees Bahji ; Dan Devoe ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Anees Bahji, and Dan Devoe (    ) Comparative efficacy and safety of opioid receptor modulators for the treatment of opioid use disorder: a systematic review and network meta-analysis.  , "},{"Codes":[],"Outcomes":[],"ItemId":98281772,"Title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.","ParentTitle":"Harvard review of psychiatry","ShortTitle":"Connery (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"March","StandardNumber":"1067-3229 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"23","Pages":"63-75","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"25747920","Comments":"","TypeName":"Journal, Article","Authors":"Connery HS ; ","ParentAuthors":"","DOI":"10.1097/HRP.0000000000000075 ","Keywords":"Buprenorphine/*therapeutic use\r\nFemale\r\nForecasting\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nRandomized Controlled Trials as Topic\r\nRisk Factors\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Connery HS (2015) Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.. Harvard review of psychiatry 23(2), 63-75 DOI: 10.1097/HRP.0000000000000075 "},{"Codes":[{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288251,"Title":"Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy","ParentTitle":"","ShortTitle":"Continuation of Buprenorphine... (Disha)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42016042095","Comments":"","TypeName":"Journal, Article","Authors":"Disha Mehta ; Vinod Thomas ; Landon Berger ; Sandra Cortina ; Jacinta Johnson ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Disha Mehta, Vinod Thomas, Landon Berger, Sandra Cortina, and Jacinta Johnson (    ) Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.  , "},{"Codes":[],"Outcomes":[],"ItemId":98282039,"Title":"Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.","ParentTitle":"Addiction science & clinical practice","ShortTitle":"Cook (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"February","StandardNumber":"1940-0632 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"18","Pages":"11","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36788634","Comments":"","TypeName":"Journal, Article","Authors":"Cook RR ; Foot C ; Arah OA ; Humphreys K ; Rudolph KE ; Luo SX ; Tsui JI ; Levander XA ; Korthuis PT ; ","ParentAuthors":"","DOI":"10.1186/s13722-023-00364-3 ","Keywords":"Adult\r\nHumans\r\nMale\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/epidemiology\r\nBuprenorphine\r\nCocaine\r\nExtended-release naltrexone\r\nGeneralizability\r\nMedications for opioid use disorder\r\nMethamphetamine\r\nStimulants\r\nTransportability","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cook RR, Foot C, Arah OA, Humphreys K, Rudolph KE, Luo SX, Tsui JI, Levander XA, and Korthuis PT (2023) Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.. Addiction science & clinical practice 18(1), 11 DOI: 10.1186/s13722-023-00364-3 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279923,"Title":"Meta-analysis of primary care delivered buprenorphine treatment retention outcomes","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Cooper (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0095-2990","City":"","Country":"","Publisher":"","Institution":"A. Ramesh, Department of Biochemistry, Cancer Biology, Neuroscience & Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd, Nashville, TN, United States","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2025537103&from=export http://dx.doi.org/10.1080/00952990.2023.2251653","OldItemId":"","Comments":"","TypeName":"Journal, Article","Authors":"Cooper R L; Edgerton R D; Watson J ; Conley N ; Agee W A; Wilus D M; MacMaster S A; Bell L ; Patel P ; Godbole A ; Bass-Thomas C ; Ramesh A ; Tabatabai M ; ","ParentAuthors":"","DOI":"10.1080/00952990.2023.2251653","Keywords":"adult\r\narticle\r\ncounseling\r\ndrug efficacy\r\ndrug therapy\r\nfemale\r\nhuman\r\nmale\r\nmeta analysis\r\nopiate addiction\r\noutcome assessment\r\nprimary medical care\r\nrace\r\nretention in care\r\nsystematic review\r\nbuprenorphine\r\nopiate","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cooper R L, Edgerton R D, Watson J, Conley N, Agee W A, Wilus D M, MacMaster S A, Bell L, Patel P, Godbole A, Bass-Thomas C, Ramesh A, and Tabatabai M (2023) Meta-analysis of primary care delivered buprenorphine treatment retention outcomes. American Journal of Drug and Alcohol Abuse ,  DOI: 10.1080/00952990.2023.2251653"},{"Codes":[],"Outcomes":[],"ItemId":98284711,"Title":"Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.","ParentTitle":"AIDS care","ShortTitle":"Cooperman (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"0954-0121 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"828-35","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"22272732","Comments":"","TypeName":"Journal, Article","Authors":"Cooperman NA ; Heo M ; Berg KM ; Li X ; Litwin AH ; Nahvi S ; Arnsten JH ; ","ParentAuthors":"","DOI":"10.1080/09540121.2011.644231 ","Keywords":"Anti-HIV Agents/*administration & dosage\r\nCognitive Behavioral Therapy/*methods\r\n*Directly Observed Therapy\r\nDrug Users\r\nFemale\r\nHIV Seropositivity/*drug therapy/epidemiology/psychology\r\nHumans\r\nMale\r\nMedication Adherence/psychology/*statistics & numerical data\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nSubstance-Related Disorders/*drug therapy\r\nTreatment Outcome\r\n*Viral Load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cooperman NA, Heo M, Berg KM, Li X, Litwin AH, Nahvi S, and Arnsten JH (2012) Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.. AIDS care 24(7), 828-35 DOI: 10.1080/09540121.2011.644231 "},{"Codes":[{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282069,"Title":"Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.","ParentTitle":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","ShortTitle":"Cooperman (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"August","StandardNumber":"1462-2203 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"20","Pages":"1152-1156","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"29059389","Comments":"","TypeName":"Journal, Article","Authors":"Cooperman NA ; Lu SE ; Richter KP ; Bernstein SL ; Williams JM ; ","ParentAuthors":"","DOI":"10.1093/ntr/ntx189 ","Keywords":"Adult\r\nAnalgesics, Opioid/adverse effects\r\nBehavior Therapy/methods\r\nFemale\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nNicotine/administration & dosage\r\nOpiate Substitution Treatment/*methods/psychology\r\nOpioid-Related Disorders/*epidemiology/psychology/*therapy\r\nPilot Projects\r\nSmokers/psychology\r\nSmoking Cessation/*methods/psychology\r\nTobacco Use Cessation Devices\r\nTobacco Use Disorder/*epidemiology/psychology/*therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cooperman NA, Lu SE, Richter KP, Bernstein SL, and Williams JM (2018) Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20(9), 1152-1156 DOI: 10.1093/ntr/ntx189 "},{"Codes":[],"Outcomes":[],"ItemId":98280932,"Title":"Field Test of a Dialectical Behavior Therapy Skills TrainingBased Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment","ParentTitle":"Journal of Dual Diagnosis","ShortTitle":"Cooperman (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1550-4263","City":"","Country":"","Publisher":"","Institution":"N.A. Cooperman, Rutgers Robert Wood Johnson Medical School, Division of Addiction Psychiatry, Rutgers Cancer Institute of New Jersey, 317 George Street, Suite 105, New Brunswick, NJ, United States","Volume":"15","Pages":"67-73","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L626013428&from=export http://dx.doi.org/10.1080/15504263.2018.1548719","OldItemId":"","Comments":"2019-06-21","TypeName":"Journal, Article","Authors":"Cooperman N A; Rizvi S L; Hughes C D; Williams J M; ","ParentAuthors":"","DOI":"10.1080/15504263.2018.1548719","Keywords":"methadone\r\nnicotine patch\r\nopiate\r\nadult\r\narticle\r\nclinical article\r\ndialectical behavior therapy\r\ndistress syndrome\r\nemotionality\r\nfemale\r\nfollow up\r\nhuman\r\nmethadone treatment\r\nmindfulness\r\nopiate addiction\r\nrelapse\r\nsmoking cessation\r\ntobacco dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cooperman N A, Rizvi S L, Hughes C D, and Williams J M (2019) Field Test of a Dialectical Behavior Therapy Skills TrainingBased Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment. Journal of Dual Diagnosis 15(1), 67-73 DOI: 10.1080/15504263.2018.1548719"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282300,"Title":"A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Cooperman (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"August","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"127","Pages":"108468","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34134880","Comments":"","TypeName":"Journal, Article","Authors":"Cooperman NA ; Hanley AW ; Kline A ; Garland EL ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2021.108468 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Chronic Pain/drug therapy\r\nHumans\r\n*Illicit Drugs\r\nMethadone/therapeutic use\r\n*Mindfulness\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nPilot Projects\r\nChronic pain\r\nMORE\r\nMethadone\r\nMindfulness\r\nOpioid\r\nSavoring","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cooperman NA, Hanley AW, Kline A, and Garland EL (2021) A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.. Journal of substance abuse treatment 127, 108468 DOI: 10.1016/j.jsat.2021.108468 "},{"Codes":[],"Outcomes":[],"ItemId":98281887,"Title":"Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.","ParentTitle":"Adolescent medicine: state of the art reviews","ShortTitle":"Cottrill (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"August","StandardNumber":"1934-4287 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"25","Pages":"251-65","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"27132312","Comments":"","TypeName":"Journal, Article","Authors":"Cottrill CB ; Matson SC ; ","ParentAuthors":"","DOI":"","Keywords":"Administration, Sublingual\r\nAdolescent\r\nAdolescent Health\r\nAnalgesics, Opioid/metabolism\r\nBehavior, Addictive/therapy\r\nBuprenorphine/administration & dosage/adverse effects/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/administration & dosage/adverse \r\n      effects/*therapeutic use\r\nDose-Response Relationship, Drug\r\nDrug Overdose/prevention & control\r\nHumans\r\nNarcotic Antagonists/administration & dosage/adverse effects/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/diagnosis/*drug therapy/therapy\r\nPatient Care Team\r\nPatient Compliance\r\nPractice Guidelines as Topic\r\nReceptors, Opioid, mu/metabolism\r\nSubstance Abuse Detection","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cottrill CB, and Matson SC (2014) Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.. Adolescent medicine: state of the art reviews 25(2), 251-65"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282169,"Title":"A randomized trial of oral naltrexone for treating opioid-dependent offenders.","ParentTitle":"The American journal on addictions","ShortTitle":"Coviello (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"19","Pages":"422-32","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"20716305","Comments":"","TypeName":"Journal, Article","Authors":"Coviello DM ; Cornish JW ; Lynch KG ; Alterman AI ; O'Brien CP ; ","ParentAuthors":"","DOI":"10.1111/j.1521-0391.2010.00070.x ","Keywords":"Administration, Oral\r\nAdolescent\r\nAdult\r\nCriminals/*psychology\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaltrexone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy/*therapy\r\nPsychotherapy/*methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Coviello DM, Cornish JW, Lynch KG, Alterman AI, and O'Brien CP (2010) A randomized trial of oral naltrexone for treating opioid-dependent offenders.. The American journal on addictions 19(5), 422-32 DOI: 10.1111/j.1521-0391.2010.00070.x "},{"Codes":[{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283104,"Title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Coyle (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"November","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"107 Suppl 1","Pages":"63-73","Edition":"","Issue":"0 1","Availability":"","URL":"","OldItemId":"23106928","Comments":"","TypeName":"Journal, Article","Authors":"Coyle MG ; Salisbury AL ; Lester BM ; Jones HE ; Lin H ; Graf-Rohrmeister K ; Fischer G ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2012.04040.x ","Keywords":"Adolescent\r\nAdult\r\nAnalgesics, Opioid/*adverse effects\r\nBuprenorphine/*adverse effects\r\nFemale\r\nHumans\r\nInfant Behavior/*drug effects\r\nInfant, Newborn\r\nLinear Models\r\nMale\r\nMethadone/*adverse effects\r\nMorphine/administration & dosage/therapeutic use\r\nNeonatal Abstinence Syndrome/drug therapy/*physiopathology\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nPregnancy Complications/drug therapy\r\nPrenatal Exposure Delayed Effects\r\nSeverity of Illness Index\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, and Fischer G (2012) Neonatal neurobehavior effects following buprenorphine versus methadone exposure.. Addiction (Abingdon, and England) 107 Suppl 1(0 1), 63-73 DOI: 10.1111/j.1360-0443.2012.04040.x "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281581,"Title":"Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Cropsey (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"K.L. Cropsey, University of Alabama at Birmingham, Department of Psychiatry, 401 Beacon Parkway West, Birmingham, AL 35209, United States","Volume":"119","Pages":"172-178","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L51534559&from=export http://dx.doi.org/10.1016/j.drugalcdep.2011.06.021","OldItemId":"","Comments":"2012-02-16","TypeName":"Journal, Article","Authors":"Cropsey K L; Lane P S; Hale G J; Jackson D O; Clark C B; Ingersoll K S; Islam M A; Stitzer M L; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2011.06.021","Keywords":"buprenorphine\r\nplacebo\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ncriminal justice\r\ndrug dose titration\r\ndrug efficacy\r\ndrug screening\r\neducational status\r\nfemale\r\nfollow up\r\nhealth care facility\r\nhuman\r\nintention to treat analysis\r\nlegal aspect\r\nlow drug dose\r\nmarriage\r\nopiate addiction\r\npilot study\r\npriority journal\r\nrandomized controlled trial\r\ntreatment duration\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cropsey K L, Lane P S, Hale G J, Jackson D O, Clark C B, Ingersoll K S, Islam M A, and Stitzer M L (2011) Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system. Drug and Alcohol Dependence 119(3), 172-178 DOI: 10.1016/j.drugalcdep.2011.06.021"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948266,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948311,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281262,"Title":"Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: A systematic review","ParentTitle":"Heroin Addiction and Related Clinical Problems","ShortTitle":"Crowley (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1592-1638","City":"","Country":"","Publisher":"","Institution":"M.C. Van Hout, School of Health Sciences, Waterford Institute of Technology, Ireland","Volume":"19","Pages":"25-42","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L615327047&from=export","OldItemId":"","Comments":"2017-05-08","TypeName":"Journal, Article","Authors":"Crowley D ; Van Hout M C; ","ParentAuthors":"","DOI":"","Keywords":"benzodiazepine\r\nbuprenorphine\r\ncocaine\r\nillicit drug\r\nlevacetylmethadol\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nplacebo\r\ntricyclic antidepressant agent\r\ncommunity integration\r\ndrug bioavailability\r\ndrug efficacy\r\ndrug fatality\r\ndrug overdose\r\nheart arrhythmia\r\nheroin dependence\r\nhuman\r\nmortality risk\r\nopiate addiction\r\nprisoner\r\nQT prolongation\r\nreview\r\nrisk reduction\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Crowley D, and Van Hout M C (2017) Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: A systematic review. Heroin Addiction and Related Clinical Problems 19(2), 25-42"},{"Codes":[],"Outcomes":[],"ItemId":98282205,"Title":"Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.","ParentTitle":"The American journal on addictions","ShortTitle":"Cunningham (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"July","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"22","Pages":"352-7","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"23795874","Comments":"","TypeName":"Journal, Article","Authors":"Cunningham CO ; Giovanniello A ; Kunins HV ; Roose RJ ; Fox AD ; Sohler NL ; ","ParentAuthors":"","DOI":"10.1111/j.1521-0391.2013.12032.x ","Keywords":"Adult\r\nBuprenorphine/*therapeutic use\r\nCocaine-Related Disorders/complications/drug therapy\r\nFemale\r\nHumans\r\nLongitudinal Studies\r\nMale\r\nMedication Adherence/*psychology\r\nOpiate Substitution Treatment/*psychology\r\nOpioid-Related Disorders/complications/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cunningham CO, Giovanniello A, Kunins HV, Roose RJ, Fox AD, and Sohler NL (2013) Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.. The American journal on addictions 22(4), 352-7 DOI: 10.1111/j.1521-0391.2013.12032.x "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282165,"Title":"Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Cushman (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"September","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"68","Pages":"68-73","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27431049","Comments":"","TypeName":"Journal, Article","Authors":"Cushman PA ; Liebschutz JM ; Anderson BJ ; Moreau MR ; Stein MD ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2016.06.003 ","Keywords":"Adult\r\nAmbulatory Care/*methods\r\nBuprenorphine/*administration & dosage\r\nFemale\r\nFollow-Up Studies\r\nHospitalization\r\nHumans\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy/epidemiology\r\nPatient Transfer/organization & administration\r\nReferral and Consultation\r\nSafety-net Providers\r\nSubstance Abuse, Intravenous/*drug therapy/epidemiology\r\nTime Factors\r\nTreatment Outcome\r\nBuprenorphine\r\nHospitalization\r\nInjection drug use\r\nOpioid use disorder\r\nTransitions of care","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, and Stein MD (2016) Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.. Journal of substance abuse treatment 68, 68-73 DOI: 10.1016/j.jsat.2016.06.003 "},{"Codes":[],"Outcomes":[],"ItemId":98285148,"Title":"Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Dalgard (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"July","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"CO-STAR Investigators","Volume":"41","Pages":"213-224","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"35920743","Comments":"","TypeName":"Journal, Article","Authors":"Dalgard O ; Litwin AH ; Shibolet O ; Grebely J ; Nahass R ; Altice FL ; Conway B ; Gane EJ ; Luetkemeyer AF ; Peng CY ; Iser D ; Gendrano IN ; Kelly MM ; Haber BA ; Platt H ; Puenpatom A ; ","ParentAuthors":"","DOI":"10.1080/10550887.2022.2088978 ","Keywords":"Adult\r\nHumans\r\n*Antiviral Agents/therapeutic use\r\n*Hepatitis C, Chronic/drug therapy/complications\r\nHepacivirus\r\nAnalgesics, Opioid/therapeutic use\r\nAmides/therapeutic use\r\nQuality of Life\r\nHepatitis C virus\r\nopioid agonist therapy\r\nquality of life\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dalgard O, Litwin AH, Shibolet O, Grebely J, Nahass R, Altice FL, Conway B, Gane EJ, Luetkemeyer AF, Peng CY, Iser D, Gendrano IN, Kelly MM, Haber BA, Platt H, and Puenpatom A (2023) Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection.. Journal of addictive diseases 41(3), 213-224 DOI: 10.1080/10550887.2022.2088978 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282349,"Title":"Does the Addition of Naloxone in Buprenorphine/Naloxone Affect Retention in Treatment in Opioid Replacement Therapy?: A Systematic Review and Meta-Analysis.","ParentTitle":"Journal of addictions nursing","ShortTitle":"Dalton (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"October","StandardNumber":"1088-4602 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"254-260","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"31800516","Comments":"","TypeName":"Journal, Article","Authors":"Dalton K ; Butt N ; ","ParentAuthors":"","DOI":"10.1097/JAN.0000000000000308 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/*therapeutic use\r\nHumans\r\nNarcotic Antagonists/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/nursing\r\n*Patient Compliance\r\nQuality of Life\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dalton K, and Butt N (2019) Does the Addition of Naloxone in Buprenorphine/Naloxone Affect Retention in Treatment in Opioid Replacement Therapy?: A Systematic Review and Meta-Analysis.. Journal of addictions nursing 30(4), 254-260 DOI: 10.1097/JAN.0000000000000308 "},{"Codes":[],"Outcomes":[],"ItemId":98281578,"Title":"Non-attendance at counselling therapy in cocaine-using methadone-maintained patients: Lessons learnt from an abandoned randomised controlled trial","ParentTitle":"Irish Journal of Medical Science","ShortTitle":"Darker (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"0021-1265","City":"","Country":"","Publisher":"","Institution":"C. Darker, Department of Public Health and Primary Care, Adelaide and Meath Hospital Dublin, Incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland","Volume":"181","Pages":"483-489","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L51809072&from=export http://dx.doi.org/10.1007/s11845-011-0803-4","OldItemId":"","Comments":"2019-05-31","TypeName":"Journal, Article","Authors":"Darker C ; Sweeney B ; El Hassan H ; Kelly A ; Connor S ; Smyth B ; Barry J ; ","ParentAuthors":"","DOI":"10.1007/s11845-011-0803-4","Keywords":"cocaine\r\nmethadone\r\nadult\r\narticle\r\nclinical article\r\ncocaine dependence\r\ncognitive therapy\r\ncohort analysis\r\ncoping\r\ndrug misuse\r\nfemale\r\nhuman\r\nhuman relation\r\nmale\r\nmethadone treatment\r\nmotivation\r\nopiate addiction\r\npatient counseling\r\nrandomized controlled trial (topic)\r\nstaff","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Darker C, Sweeney B, El Hassan H, Kelly A, Connor S, Smyth B, and Barry J (2012) Non-attendance at counselling therapy in cocaine-using methadone-maintained patients: Lessons learnt from an abandoned randomised controlled trial. Irish Journal of Medical Science 181(4), 483-489 DOI: 10.1007/s11845-011-0803-4"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285212,"Title":"Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.","ParentTitle":"JAMA pediatrics","ShortTitle":"Davis (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"August","StandardNumber":"2168-6203 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"172","Pages":"741-748","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"29913015","Comments":"","TypeName":"Journal, Article","Authors":"Davis JM ; Shenberger J ; Terrin N ; Breeze JL ; Hudak M ; Wachman EM ; Marro P ; Oliveira EL ; Harvey-Wilkes K ; Czynski A ; Engelhardt B ; D'Apolito K ; Bogen D ; Lester B ; ","ParentAuthors":"","DOI":"10.1001/jamapediatrics.2018.1307 ","Keywords":"Analgesics, Opioid/adverse effects/*therapeutic use\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nIntention to Treat Analysis\r\nMale\r\nMethadone/adverse effects/*therapeutic use\r\nMorphine/adverse effects/*therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, and Lester B (2018) Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.. JAMA pediatrics 172(8), 741-748 DOI: 10.1001/jamapediatrics.2018.1307 "},{"Codes":[],"Outcomes":[],"ItemId":98282100,"Title":"Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism?","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Day (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"August","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"1329-1336","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"28044376","Comments":"","TypeName":"Journal, Article","Authors":"Day E ; Mitcheson L ; ","ParentAuthors":"","DOI":"10.1111/add.13644 ","Keywords":"Humans\r\nOpiate Substitution Treatment/*methods/*psychology\r\nOpioid-Related Disorders/*psychology/*therapy\r\n*Psychosocial Support Systems\r\nEvidence-based practice\r\nopiate\r\nopiate substitution treatment\r\npsychosocial intervention\r\ntraining\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Day E, and Mitcheson L (2017) Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism?. Addiction (Abingdon, and England) 112(8), 1329-1336 DOI: 10.1111/add.13644 "},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280290,"Title":"Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development","ParentTitle":"Addiction Biology","ShortTitle":"De Aquino (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1355-6215","City":"","Country":"","Publisher":"","Institution":"J.P. De Aquino, VA Connecticut Healthcare System, West Haven, CT, United States","Volume":"26","Pages":"","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2006785299&from=export http://dx.doi.org/10.1111/adb.12964","OldItemId":"","Comments":"2020-09-29","TypeName":"Journal, Article","Authors":"De Aquino J P; Flores J M; Avila-Quintero V J; Compton P ; Sofuoglu M ; ","ParentAuthors":"","DOI":"10.1111/adb.12964","Keywords":"4 aminobutyric acid receptor stimulating agent\r\nalpha 2 adrenergic receptor stimulating agent\r\nanalgesic agent\r\nbiological marker\r\nbuprenorphine\r\nbuprenorphine plus naloxone\r\ncannabinoid\r\ncholecystokinin receptor blocking agent\r\ndextromethorphan\r\ngabapentin\r\nglial activation inhibitor\r\nketamine\r\nmethadone\r\nmidazolam\r\nminocycline\r\nn methyl dextro aspartic acid receptor blocking agent\r\nnaltrexone\r\nopiate antagonist\r\nplacebo\r\nunclassified drug\r\nadverse event\r\nanalgesic activity\r\narticle\r\ncentral nervous system\r\ncholinergic system\r\nchronic pain\r\nclinical feature\r\ndisease association\r\ndrug response\r\ndrug targeting\r\nhuman\r\nmeta analysis\r\nneurobiology\r\nnociception\r\nnonhuman\r\nopiate addiction\r\noutcome assessment\r\npain\r\npain assessment\r\nreward\r\nsensitization\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"De Aquino J P, Flores J M, Avila-Quintero V J, Compton P, and Sofuoglu M (2021) Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development. Addiction Biology 26(4),  DOI: 10.1111/adb.12964"},{"Codes":[],"Outcomes":[],"ItemId":98281864,"Title":"Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"De Aquino (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"228","Pages":"109097","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34601272","Comments":"","TypeName":"Journal, Article","Authors":"De Aquino JP ; Parida S ; Avila-Quintero VJ ; Flores J ; Compton P ; Hickey T ; Gmez O ; Sofuoglu M ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.109097 ","Keywords":"*Acute Pain/drug therapy\r\n*Analgesia\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/complications/drug therapy\r\nAntinociception\r\nDrug development\r\nOpioid addiction\r\nOpioids\r\nPain tolerance","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gmez O, and Sofuoglu M (2021) Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.. Drug and alcohol dependence 228, 109097 DOI: 10.1016/j.drugalcdep.2021.109097 "},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279963,"Title":"Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"De Aquino (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"J.P. De Aquino, VA Connecticut Healthcare System, 950 Campbell Avenue (151D), West Haven, CT, United States","Volume":"241","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2021313427&from=export http://dx.doi.org/10.1016/j.drugalcdep.2022.109702","OldItemId":"","Comments":"2022-12-07","TypeName":"Journal, Article","Authors":"De Aquino J P; Bahji A ; Gmez O ; Sofuoglu M ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109702","Keywords":"buprenorphine\r\ncannabis\r\nclonazepam\r\nclonidine\r\ndronabinol\r\nmethadone\r\nnaltrexone\r\noxycodone\r\nplacebo\r\nzolpidem\r\ncannabis use\r\ndisease exacerbation\r\ndose response\r\ndrug craving\r\ndrug safety\r\ndrug withdrawal\r\ndysphoria\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\nrandomized controlled trial (topic)\r\nreview\r\nside effect\r\nsystematic review\r\ntachycardia\r\ntherapeutic index\r\nvisual analog scale\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"De Aquino J P, Bahji A, Gmez O, and Sofuoglu M (2022) Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies. Drug and Alcohol Dependence 241,  DOI: 10.1016/j.drugalcdep.2022.109702"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279788,"Title":"Delta-9-tetrahydrocannabinolmodulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study","ParentTitle":"Addiction Biology","ShortTitle":"De Aquino (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"1355-6215","City":"","Country":"","Publisher":"","Institution":"J.P. De Aquino, Department of Psychiatry, Yale School of Medicine, 950 Campbell Avenue, 151D, West Haven, CT, United States","Volume":"28","Pages":"","Edition":"","Issue":"9","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2024756503&from=export http://dx.doi.org/10.1111/adb.13317","OldItemId":"","Comments":"2023-09-28","TypeName":"Journal, Article","Authors":"De Aquino J P; Meyerovich J ; Xie C Z; Ranganathan M ; Compton P ; Pittman B ; Rogan M ; Sofuoglu M ; ","ParentAuthors":"","DOI":"10.1111/adb.13317","Keywords":"alcohol\r\ncannabis\r\ncocaine\r\ndronabinol\r\nmethadone\r\nplacebo\r\nsedative agent\r\nadult\r\naged\r\narticle\r\nclinical article\r\nclinical laboratory\r\ncontrolled study\r\ncrossover procedure\r\ndose response\r\ndrug dose comparison\r\ndrug effect\r\nexperimental study\r\nfemale\r\nhuman\r\nlow drug dose\r\nmale\r\nmental performance\r\nmixed effects model\r\nneuromodulation\r\nnociception\r\nopiate addiction\r\npain\r\nrandomized controlled trial\r\nrisk benefit analysis\r\nself report\r\nsingle drug dose\r\nstatistical model\r\ntobacco","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"De Aquino J P, Meyerovich J, Xie C Z, Ranganathan M, Compton P, Pittman B, Rogan M, and Sofuoglu M (2023) Delta-9-tetrahydrocannabinolmodulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study. Addiction Biology 28(9),  DOI: 10.1111/adb.13317"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281576,"Title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"DeFulio (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"K. Silverman, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, 5200 Eastern Avenue, Ste. W142, Baltimore, MD 21224, United States","Volume":"120","Pages":"48-54","Edition":"","Issue":"1-3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L51532943&from=export http://dx.doi.org/10.1016/j.drugalcdep.2011.06.023","OldItemId":"","Comments":"2012-02-01","TypeName":"Journal, Article","Authors":"DeFulio A ; Everly J J; Leoutsakos J M.S; Umbricht A ; Fingerhood M ; Bigelow G E; Silverman K ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2011.06.023","Keywords":"NCT00684788\r\ncocaine\r\nnaltrexone\r\nopiate\r\nadult\r\narticle\r\nclinical article\r\ncontrolled release formulation\r\ncontrolled study\r\nemployment\r\nextended release formulation\r\nfemale\r\nFood and Drug Administration\r\nhealth behavior\r\nhuman\r\nmale\r\nopiate addiction\r\npatient compliance\r\nprescription\r\npriority journal\r\nrandomized controlled trial\r\nreinforcement (psychology)\r\nworkplace","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"DeFulio A, Everly J J, Leoutsakos J M.S, Umbricht A, Fingerhood M, Bigelow G E, and Silverman K (2012) Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial. Drug and Alcohol Dependence 120(1-3), 48-54 DOI: 10.1016/j.drugalcdep.2011.06.023"},{"Codes":[{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279826,"Title":"Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies","ParentTitle":"The Lancet Psychiatry","ShortTitle":"Degenhardt (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"2215-0366","City":"","Country":"","Publisher":"","Institution":"L. Degenhardt, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia","Volume":"10","Pages":"386-402","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2024541381&from=export http://dx.doi.org/10.1016/S2215-0366(23)00095-0","OldItemId":"","Comments":"2024-03-19","TypeName":"Journal, Article","Authors":"Degenhardt L ; Clark B ; Macpherson G ; Leppan O ; Nielsen S ; Zahra E ; Larance B ; Kimber J ; Martino-Burke D ; Hickman M ; Farrell M ; ","ParentAuthors":"","DOI":"10.1016/S2215-0366(23)00095-0","Keywords":"amphetamine derivative\r\nbenzodiazepine derivative\r\nbuprenorphine\r\ncannabis\r\ncocaine\r\ndiamorphine\r\nfentanyl\r\nmethadone\r\nopiate agonist\r\nadult\r\nalcohol consumption\r\nalcohol withdrawal syndrome\r\nanxiety\r\narticle\r\nAustralia and New Zealand\r\nautomutilation\r\ncentral Asia\r\nCochrane Library\r\ncohort analysis\r\ncrime\r\ncriminal justice\r\ndrug craving\r\ndrug dependence treatment\r\ndrug safety\r\nEmbase\r\nFar East\r\nfemale\r\ngender\r\nheart disease\r\nhuman\r\ninformation processing\r\nmale\r\nMedline\r\nmeta analysis\r\nmethadone treatment\r\nMiddle East\r\nNorth America\r\nobservational study\r\nopiate addiction\r\npain\r\npatient compliance\r\npatient preference\r\npatient satisfaction\r\nphysical well-being\r\nPreferred Reporting Items for Systematic Reviews and Meta-Analyses\r\nprescription\r\nprevalence\r\npsychological well-being\r\nPsycINFO\r\nself report\r\nsleep\r\nSoutheast Asia\r\nsuicidal behavior\r\nsystematic review\r\ntreatment duration\r\ntreatment outcome\r\nurinalysis\r\nurine sampling\r\nWestern Europe","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Degenhardt L, Clark B, Macpherson G, Leppan O, Nielsen S, Zahra E, Larance B, Kimber J, Martino-Burke D, Hickman M, and Farrell M (2023) Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry 10(6), 386-402 DOI: 10.1016/S2215-0366(23)00095-0"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281175,"Title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","ParentTitle":"Expert Opinion on Pharmacotherapy","ShortTitle":"Dematteis (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1465-6566","City":"","Country":"","Publisher":"","Institution":"M. Dematteis, Department of Addiction Medicine, Grenoble Alpes University Hospital, Grenoble Cedex 09, France","Volume":"18","Pages":"1987-1999","Edition":"","Issue":"18","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L619676423&from=export http://dx.doi.org/10.1080/14656566.2017.1409722","OldItemId":"","Comments":"2017-12-20","TypeName":"Journal, Article","Authors":"Dematteis M ; Auriacombe M ; DAgnone O ; Somaini L ; Szerman N ; Littlewood R ; Alam F ; Alho H ; Benyamina A ; Bobes J ; Daulouede J P; Leonardi C ; Maremmani I ; Torrens M ; Walcher S ; Soyka M ; ","ParentAuthors":"","DOI":"10.1080/14656566.2017.1409722","Keywords":"buprenorphine\r\nmethadone\r\nalcoholism\r\nclinical decision making\r\ndrug craving\r\ndrug cross tolerance\r\ndrug efficacy\r\ndrug intoxication\r\ndrug metabolism\r\ndrug safety\r\nhuman\r\nmortality\r\nopiate addiction\r\npain\r\npatient preference\r\npharmaceutical care\r\npractice guideline\r\npregnant woman\r\nprisoner\r\nquality of life\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dematteis M, Auriacombe M, DAgnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede J P, Leonardi C, Maremmani I, Torrens M, Walcher S, and Soyka M (2017) Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy 18(18), 1987-1999 DOI: 10.1080/14656566.2017.1409722"},{"Codes":[],"Outcomes":[],"ItemId":98281463,"Title":"The effectiveness of opioid substitution treatments for patients with opioid dependence: A systematic review and multiple treatment comparison protocol","ParentTitle":"Systematic Reviews","ShortTitle":"Dennis (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"2046-4053","City":"","Country":"","Publisher":"","Institution":"L. Thabane, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada","Volume":"3","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L603849695&from=export http://dx.doi.org/10.1186/2046-4053-3-105","OldItemId":"","Comments":"2015-04-30","TypeName":"Journal, Article","Authors":"Dennis B B; Naji L ; Bawor M ; Bonner A ; Varenbut M ; Daiter J ; Plater C ; Pare G ; Marsh D C; Worster A ; Desai D ; Samaan Z ; Thabane L ; ","ParentAuthors":"","DOI":"10.1186/2046-4053-3-105","Keywords":"buprenorphine\r\ndiamorphine\r\nmethadone\r\nnaltrexone\r\narticle\r\nbibliographic database\r\nclinical effectiveness\r\nevidence based practice\r\nhuman\r\nimmune response\r\ninformation processing\r\nintervention study\r\nmeta analysis (topic)\r\nopiate addiction\r\nopiate substitution treatment\r\nprevalence\r\npriority journal\r\nprotocol compliance\r\npublic health\r\npublication\r\nsystematic review\r\ntreatment planning\r\nvaccination","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis B B, Naji L, Bawor M, Bonner A, Varenbut M, Daiter J, Plater C, Pare G, Marsh D C, Worster A, Desai D, Samaan Z, and Thabane L (2014) The effectiveness of opioid substitution treatments for patients with opioid dependence: A systematic review and multiple treatment comparison protocol. Systematic Reviews 3(1),  DOI: 10.1186/2046-4053-3-105"},{"Codes":[],"Outcomes":[],"ItemId":98281411,"Title":"Opioid substitution and antagonist therapy trials exclude the common addiction patient: A systematic review and analysis of eligibility criteria","ParentTitle":"Trials","ShortTitle":"Dennis (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1745-6215","City":"","Country":"","Publisher":"","Institution":"L. Thabane, McMaster University, Department of Clinical Epidemiology and Biostatistics, 1280 Main Street West, Hamilton, ON, Canada","Volume":"16","Pages":"1","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L606486559&from=export http://dx.doi.org/10.1186/s13063-015-0942-4","OldItemId":"","Comments":"2015-11-03","TypeName":"Journal, Article","Authors":"Dennis B B; Roshanov P S; Naji L ; Bawor M ; Paul J ; Plater C ; Pare G ; Worster A ; Varenbut M ; Daiter J ; Marsh D C; Desai D ; Samaan Z ; Thabane L ; ","ParentAuthors":"","DOI":"10.1186/s13063-015-0942-4","Keywords":"buprenorphine\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\nopiate\r\npsychotropic agent\r\nalcohol abuse\r\narticle\r\nclinical assessment\r\ncohort analysis\r\ncomorbidity\r\nhuman\r\nmaintenance therapy\r\nmeta analysis\r\nobservational study\r\nopiate addiction\r\nprevalence\r\nprospective study\r\npsychological well-being\r\nsubstance abuse\r\nsystematic review\r\nWorld Health Organization","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis B B, Roshanov P S, Naji L, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh D C, Desai D, Samaan Z, and Thabane L (2015) Opioid substitution and antagonist therapy trials exclude the common addiction patient: A systematic review and analysis of eligibility criteria. Trials 16(1), 1 DOI: 10.1186/s13063-015-0942-4"},{"Codes":[],"Outcomes":[],"ItemId":98281432,"Title":"The impact of chronic pain on opioid addiction treatment: A systematic review protocol","ParentTitle":"Systematic Reviews","ShortTitle":"Dennis (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"2046-4053","City":"","Country":"","Publisher":"","Institution":"Z. Samaan, McMaster University, Department of Clinical Epidemiology and Biostatistics, 1280 Main Street West, Hamilton, ON, Canada","Volume":"4","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L605592894&from=export http://dx.doi.org/10.1186/s13643-015-0042-2","OldItemId":"","Comments":"2015-08-20","TypeName":"Journal, Article","Authors":"Dennis B B; Bawor M ; Paul J ; Varenbut M ; Daiter J ; Plater C ; Pare G ; Marsh D C; Worster A ; Desai D ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.1186/s13643-015-0042-2","Keywords":"buprenorphine\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\narticle\r\nbibliographic database\r\ncardiovascular disease\r\nchronic pain\r\nclinical assessment\r\nclinical practice\r\ndrug overdose\r\nevidence based practice\r\nhuman\r\ninformation processing\r\nmeta analysis\r\nmortality\r\nopiate addiction\r\nopiate substitution treatment\r\npractice guideline\r\npriority journal\r\nsystematic review\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis B B, Bawor M, Paul J, Varenbut M, Daiter J, Plater C, Pare G, Marsh D C, Worster A, Desai D, Thabane L, and Samaan Z (2015) The impact of chronic pain on opioid addiction treatment: A systematic review protocol. Systematic Reviews 4(1),  DOI: 10.1186/s13643-015-0042-2"},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284460,"Title":"Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis.","ParentTitle":"Substance abuse : research and treatment","ShortTitle":"Dennis (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1178-2218 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"59-80","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"26417202","Comments":"","TypeName":"Journal, Article","Authors":"Dennis BB ; Bawor M ; Naji L ; Chan CK ; Varenbut J ; Paul J ; Varenbut M ; Daiter J ; Plater C ; Pare G ; Marsh DC ; Worster A ; Desai D ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.4137/SART.S30120 ","Keywords":"chronic pain\r\nguidelines\r\nmeta-analysis\r\nopioid substitution therapy\r\nopioid use disorder\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis BB, Bawor M, Naji L, Chan CK, Varenbut J, Paul J, Varenbut M, Daiter J, Plater C, Pare G, Marsh DC, Worster A, Desai D, Thabane L, and Samaan Z (2015) Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis.. Substance abuse : research and treatment 9, 59-80 DOI: 10.4137/SART.S30120 "},{"Codes":[],"Outcomes":[],"ItemId":98281384,"Title":"Pain and opioid addiction: A systematic review and evaluation of pain measurement in patients with opioid dependence on methadone maintenance Treatment","ParentTitle":"Current Drug Abuse Reviews","ShortTitle":"Dennis (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1874-4737","City":"","Country":"","Publisher":"","Institution":"Z. Samaan, Department of Psychiatry and Behavioural Neuroscience, McMaster University, 1280 Main Street West, Hamilton, ON, Canada","Volume":"9","Pages":"49-60","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L609719444&from=export http://dx.doi.org/10.2174/187447370901160321102837","OldItemId":"","Comments":"2016-04-27","TypeName":"Journal, Article","Authors":"Dennis B B; Bawor M ; Paul J ; Plater C ; Pare G ; Worster A ; Varenbut M ; Daiter J ; Marsh D C; Desai D ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.2174/187447370901160321102837","Keywords":"article\r\nBrief Pain Inventory\r\nchronic pain\r\ncomorbidity\r\ndiagnostic value\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\noutcome assessment\r\nprescription\r\npriority journal\r\nprognostic value\r\nquality control\r\nquestionnaire\r\nreceiver operating characteristic\r\nsensitivity and specificity\r\nsystematic review\r\ntreatment response\r\nvalidation process","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis B B, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh D C, Desai D, Thabane L, and Samaan Z (2016) Pain and opioid addiction: A systematic review and evaluation of pain measurement in patients with opioid dependence on methadone maintenance Treatment. Current Drug Abuse Reviews 9(1), 49-60 DOI: 10.2174/187447370901160321102837"},{"Codes":[],"Outcomes":[],"ItemId":98280658,"Title":"A call for consensus in defining efficacy in clinical trials for opioid addiction: Combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder","ParentTitle":"Trials","ShortTitle":"Dennis (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1745-6215","City":"","Country":"","Publisher":"","Institution":"Z. Samaan, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada","Volume":"21","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L630520591&from=export http://dx.doi.org/10.1186/s13063-019-3995-y","OldItemId":"","Comments":"2020-01-31","TypeName":"Journal, Article","Authors":"Dennis B B; Sanger N ; Bawor M ; Naji L ; Plater C ; Worster A ; Woo J ; Bhalerao A ; Baptist-Mohseni N ; Hillmer A ; Rice D ; Corace K ; Hutton B ; Tugwell P ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.1186/s13063-019-3995-y","Keywords":"methadone\r\nanalgesia\r\narticle\r\nclinical effectiveness\r\nclinical outcome\r\nclinical trial (topic)\r\ndrug craving\r\ndrug withdrawal\r\nemployment status\r\nhealth status\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\nopiate substitution treatment\r\npatient decision making\r\npatient-reported outcome\r\nqualitative research\r\nsemi structured interview\r\nsocioeconomics\r\nsubstance abuse\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dennis B B, Sanger N, Bawor M, Naji L, Plater C, Worster A, Woo J, Bhalerao A, Baptist-Mohseni N, Hillmer A, Rice D, Corace K, Hutton B, Tugwell P, Thabane L, and Samaan Z (2020) A call for consensus in defining efficacy in clinical trials for opioid addiction: Combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials 21(1),  DOI: 10.1186/s13063-019-3995-y"},{"Codes":[{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284947,"Title":"Scoping Review of Barriers and Facilitators of Breastfeeding in Women on Opioid Maintenance Therapy.","ParentTitle":"Journal of obstetric, gynecologic, and neonatal nursing : JOGNN","ShortTitle":"Doerzbacher (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"January","StandardNumber":"0090-0311 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"51","Pages":"29-40","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34655544","Comments":"","TypeName":"Journal, Article","Authors":"Doerzbacher M ; Sperlich M ; Hequembourg A ; Chang YP ; ","ParentAuthors":"","DOI":"10.1016/j.jogn.2021.09.004 ","Keywords":"*Analgesics, Opioid/therapeutic use\r\n*Breast Feeding\r\nFemale\r\nHumans\r\nOpiate Substitution Treatment\r\nPostpartum Period\r\nRetrospective Studies\r\nbreastfeeding\r\nneonatal abstinence syndrome\r\nopioid maintenance therapy\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Doerzbacher M, Sperlich M, Hequembourg A, and Chang YP (2022) Scoping Review of Barriers and Facilitators of Breastfeeding in Women on Opioid Maintenance Therapy.. Journal of obstetric, gynecologic, and and neonatal nursing : JOGNN 51(1), 29-40 DOI: 10.1016/j.jogn.2021.09.004 "},{"Codes":[{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282000,"Title":"Supervised Dosing With a Long-Acting Opioid Medication in the Management of Opioid Dependence.","ParentTitle":"Clinical nurse specialist CNS","ShortTitle":"Dover (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"November","StandardNumber":"0887-6274 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"34","Pages":"261-262","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"33009112","Comments":"","TypeName":"Journal, Article","Authors":"Dover J ; Scruth E ; ","ParentAuthors":"","DOI":"10.1097/NUR.0000000000000552 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nDelayed-Action Preparations\r\n*Directly Observed Therapy\r\nHumans\r\nOpioid-Related Disorders/*nursing\r\nRandomized Controlled Trials as Topic\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dover J, and Scruth E (2020) Supervised Dosing With a Long-Acting Opioid Medication in the Management of Opioid Dependence.. Clinical nurse specialist CNS 34(6), 261-262 DOI: 10.1097/NUR.0000000000000552 "},{"Codes":[],"Outcomes":[],"ItemId":98283435,"Title":"CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.","ParentTitle":"JAMA","ShortTitle":"Dowell (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"April","StandardNumber":"0098-7484 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"315","Pages":"1624-45","Edition":"","Issue":"15","Availability":"","URL":"","OldItemId":"26977696","Comments":"","TypeName":"Journal, Article","Authors":"Dowell D ; Haegerich TM ; Chou R ; ","ParentAuthors":"","DOI":"10.1001/jama.2016.1464 ","Keywords":"Acute Pain/drug therapy\r\nAdult\r\nAnalgesics, Opioid/administration & dosage/adverse effects/*therapeutic use\r\nBenzodiazepines/therapeutic use\r\n*Centers for Disease Control and Prevention, U.S.\r\nChronic Pain/*drug therapy\r\nCommunication\r\nContraindications\r\nDrug Prescriptions/*standards\r\nDrug Therapy, Combination\r\nGoals\r\nHumans\r\nObservational Studies as Topic\r\nPrescription Drug Misuse/prevention & control\r\nPrimary Health Care/standards\r\nRandomized Controlled Trials as Topic\r\nTreatment Outcome\r\nUnited States\r\nWithholding Treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dowell D, Haegerich TM, and Chou R (2016) CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.. JAMA 315(15), 1624-45 DOI: 10.1001/jama.2016.1464 "},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282742,"Title":"Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.","ParentTitle":"JAMA psychiatry","ShortTitle":"Dunn (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"2168-622X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"74","Pages":"885-893","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"28700791","Comments":"","TypeName":"Journal, Article","Authors":"Dunn KE ; Tompkins DA ; Bigelow GE ; Strain EC ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2017.1838 ","Keywords":"Adult\r\nAnalgesics/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\nBuprenorphine/therapeutic use\r\nClonidine/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Withdrawal Syndrome/*drug therapy\r\nTramadol/*therapeutic use\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dunn KE, Tompkins DA, Bigelow GE, and Strain EC (2017) Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.. JAMA psychiatry 74(9), 885-893 DOI: 10.1001/jamapsychiatry.2017.1838 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282034,"Title":"Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Dunn (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"February","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"121","Pages":"108197","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"33357606","Comments":"","TypeName":"Journal, Article","Authors":"Dunn KE ; Brooner RK ; Stoller KB ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2020.108197 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\n*COVID-19\r\nFemale\r\nHumans\r\nMale\r\nMedication Adherence\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*rehabilitation\r\n*Self-Help Devices\r\nSurveys and Questionnaires\r\nCOVID-19\r\nMethadone\r\nOpioid use disorder\r\nPain\r\nTake-home\r\nTechnology-assisted","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Dunn KE, Brooner RK, and Stoller KB (2021) Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.. Journal of substance abuse treatment 121, 108197 DOI: 10.1016/j.jsat.2020.108197 "},{"Codes":[],"Outcomes":[],"ItemId":98281293,"Title":"Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals with Opioid Dependence","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Earley (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1932-0620","City":"","Country":"","Publisher":"","Institution":"P.H. Earley, Earley Consultancy LLC, 675 Seminole Ave, Atlanta, GA, United States","Volume":"11","Pages":"224-230","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L616769037&from=export http://dx.doi.org/10.1097/ADM.0000000000000302","OldItemId":"","Comments":"2017-06-22","TypeName":"Journal, Article","Authors":"Earley P H; Zummo J ; Memisoglu A ; Silverman B L; Gastfriend D R; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000302","Keywords":"naltrexone\r\nabstinence\r\nadult\r\nanxiety\r\narthralgia\r\narticle\r\nbronchitis\r\nclinical article\r\ncontrolled release formulation\r\ncounseling\r\ndecreased appetite\r\ndepersonalization\r\ndepression\r\ndetoxification\r\ndiarrhea\r\ndizziness\r\ndrug craving\r\ndrug dependence treatment\r\ndrug safety\r\ndrug tolerability\r\ndrug withdrawal\r\nextended release formulation\r\nfatigue\r\nfemale\r\nhuman\r\ninjection site mass\r\ninjection site pain\r\nmale\r\nmedication compliance\r\nmulticenter study\r\nnausea\r\nneuralgia\r\nnurse\r\nnursing assistant\r\nopen study\r\nopiate addiction\r\noutpatient care\r\npriority journal\r\nquality of life\r\nShort Form 36\r\nside effect\r\nsinusitis\r\nupper respiratory tract infection\r\nurinalysis\r\nvomiting\r\nwork resumption\r\nvivitrol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Earley P H, Zummo J, Memisoglu A, Silverman B L, and Gastfriend D R (2017) Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals with Opioid Dependence. Journal of Addiction Medicine 11(3), 224-230 DOI: 10.1097/ADM.0000000000000302"},{"Codes":[],"Outcomes":[],"ItemId":98281524,"Title":"Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs","ParentTitle":"Evidence-Based Medicine","ShortTitle":"Edelman (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1473-6810","City":"","Country":"","Publisher":"","Institution":"L.E. Fiellin, Yale Medical Group, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, United States","Volume":"18","Pages":"177-178","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52404211&from=export http://dx.doi.org/10.1136/eb-2012-101125","OldItemId":"","Comments":"2014-01-22","TypeName":"Journal, Article","Authors":"Edelman E J; Fiellin L E; ","ParentAuthors":"","DOI":"10.1136/eb-2012-101125","Keywords":"methadone\r\nopiate agonist\r\nCochrane Library\r\ndrug use\r\nEmbase\r\nfollow up\r\nhuman\r\nHuman immunodeficiency virus infection\r\nincidence\r\ninfection prevention\r\ninfection risk\r\ninjection drug use\r\nMedline\r\nmeta analysis\r\nmethadone treatment\r\nnote\r\nopiate addiction\r\nopiate substitution treatment\r\nPsycINFO\r\nrandomized controlled trial (topic)\r\nrisk reduction\r\nsexual behavior\r\nsystematic review\r\nvirus transmission","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Edelman E J, and Fiellin L E (2013) Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs. Evidence-Based Medicine 18(5), 177-178 DOI: 10.1136/eb-2012-101125"},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280715,"Title":"Adjunctive memantine for opioid use disorder treatment: A systematic review","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Elias (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"A.M. Elias, Pharmacy Department (119), Durham VA Medical Center, 508 Fulton St., Durham, NC, United States","Volume":"107","Pages":"38-43","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2003527685&from=export http://dx.doi.org/10.1016/j.jsat.2019.10.003","OldItemId":"","Comments":"2019-11-28","TypeName":"Journal, Article","Authors":"Elias A M; Pepin M J; Brown J N; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2019.10.003","Keywords":"buprenorphine\r\nmemantine\r\nmethadone\r\nnaltrexone\r\narticle\r\nclinical assessment\r\nclinical evaluation\r\ncognition\r\ndrug craving\r\ndrug efficacy\r\ndrug mechanism\r\ndrug safety\r\nhuman\r\nmonotherapy\r\nopiate addiction\r\nopiate substitution treatment\r\npriority journal\r\nrandomized controlled trial (topic)\r\nsystematic review\r\nvisual analog scale\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Elias A M, Pepin M J, and Brown J N (2019) Adjunctive memantine for opioid use disorder treatment: A systematic review. Journal of Substance Abuse Treatment 107, 38-43 DOI: 10.1016/j.jsat.2019.10.003"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282179,"Title":"Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Enns (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"June","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"247","Pages":"109893","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37120920","Comments":"","TypeName":"Journal, Article","Authors":"Enns B ; Krebs E ; Whitehurst DGT ; Jutras-Aswad D ; Le Foll B ; Socias ME ; Nosyk B ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2023.109893 ","Keywords":"Humans\r\nMethadone/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nCost-Benefit Analysis\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy\r\nPrescriptions\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nBuprenorphine\r\nCost-effectiveness\r\nEconomics\r\nMethadone\r\nOpioid agonist therapy\r\nOpioid treatment\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Enns B, Krebs E, Whitehurst DGT, Jutras-Aswad D, Le Foll B, Socias ME, and Nosyk B (2023) Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder.. Drug and alcohol dependence 247, 109893 DOI: 10.1016/j.drugalcdep.2023.109893 "},{"Codes":[],"Outcomes":[],"ItemId":98281120,"Title":"Effectiveness of mindfulness-based cognitive group therapy on cognitive emotion regulation of patients under treatment with methadone","ParentTitle":"Journal of Substance Use","ShortTitle":"Esmaeili (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1465-9891","City":"","Country":"","Publisher":"","Institution":"M.R. Miri, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran","Volume":"23","Pages":"58-62","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L618079203&from=export http://dx.doi.org/10.1080/14659891.2017.1348553","OldItemId":"","Comments":"2018-02-05","TypeName":"Journal, Article","Authors":"Esmaeili A ; Khodadadi M ; Norozi E ; Miri M R; ","ParentAuthors":"","DOI":"10.1080/14659891.2017.1348553","Keywords":"methadone\r\nadult\r\narticle\r\nclinical article\r\nclinical effectiveness\r\ncognition\r\ncognitive therapy\r\ncontrolled study\r\ndrug dependence\r\nemotionality\r\ngroup therapy\r\nhuman\r\nIranian (citizen)\r\nmale\r\nmethadone treatment\r\nmindfulness\r\npretest posttest control group design\r\npriority journal\r\nquasi experimental study\r\nrandomized controlled trial\r\ntherapy effect","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Esmaeili A, Khodadadi M, Norozi E, and Miri M R (2018) Effectiveness of mindfulness-based cognitive group therapy on cognitive emotion regulation of patients under treatment with methadone. Journal of Substance Use 23(1), 58-62 DOI: 10.1080/14659891.2017.1348553"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283627,"Title":"Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).","ParentTitle":"PLoS medicine","ShortTitle":"Fadnes (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"June","StandardNumber":"1549-1277 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"INTRO-HCV Study Group","Volume":"18","Pages":"e1003653","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"34061883","Comments":"","TypeName":"Journal, Article","Authors":"Fadnes LT ; Aas CF ; Vold JH ; Leiva RA ; Ohldieck C ; Chalabianloo F ; Skurtveit S ; Lygren OJ ; Dalgrd O ; Vickerman P ; Midgard H ; Lberg EM ; Johansson KA ; ","ParentAuthors":"","DOI":"10.1371/journal.pmed.1003653 ","Keywords":"Adult\r\nAntiviral Agents/*therapeutic use\r\n*Delivery of Health Care, Integrated\r\n*Drug Users\r\nFemale\r\nHepatitis C, Chronic/complications/diagnosis/*drug therapy\r\nHumans\r\nMale\r\nMiddle Aged\r\nNorway\r\n*Opiate Substitution Treatment\r\nSubstance Abuse, Intravenous/complications/diagnosis/*rehabilitation\r\nSustained Virologic Response\r\nTime Factors\r\nTreatment Outcome\r\nViral Load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgrd O, Vickerman P, Midgard H, Lberg EM, and Johansson KA (2021) Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).. PLoS medicine 18(6), e1003653 DOI: 10.1371/journal.pmed.1003653 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948329,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282935,"Title":"Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.","ParentTitle":"Journal of clinical psychopharmacology","ShortTitle":"Falcato (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"April","StandardNumber":"0271-0749 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"35","Pages":"150-7","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"25679130","Comments":"","TypeName":"Journal, Article","Authors":"Falcato L ; Beck T ; Reimer J ; Verthein U ; ","ParentAuthors":"","DOI":"10.1097/JCP.0000000000000288 ","Keywords":"Adult\r\nCocaine-Related Disorders/*psychology/*rehabilitation\r\nCross-Over Studies\r\nFemale\r\nHeroin Dependence/*psychology/*rehabilitation\r\nHumans\r\nMale\r\nMethadone/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nMorphine/administration & dosage/*therapeutic use\r\nNarcotics/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment/psychology\r\nSubstance Withdrawal Syndrome/*psychology\r\nSurveys and Questionnaires\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Falcato L, Beck T, Reimer J, and Verthein U (2015) Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.. Journal of clinical psychopharmacology 35(2), 150-7 DOI: 10.1097/JCP.0000000000000288 "},{"Codes":[],"Outcomes":[],"ItemId":98281898,"Title":"Injectable pharmacotherapy for opioid use disorders (IPOD).","ParentTitle":"Contemporary clinical trials","ShortTitle":"Farabee (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"July","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"49","Pages":"70-7","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27282118","Comments":"","TypeName":"Journal, Article","Authors":"Farabee D ; Hillhouse M ; Condon T ; McCrady B ; McCollister K ; Ling W ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2016.06.003 ","Keywords":"Delayed-Action Preparations\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy/rehabilitation\r\nPatient Navigation/*methods\r\n*Prisoners\r\n*Prisons\r\nExperimental\r\nExtended release naltrexone\r\nInjectable naltrexone\r\nJail inmates\r\nOpioid dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Farabee D, Hillhouse M, Condon T, McCrady B, McCollister K, and Ling W (2016) Injectable pharmacotherapy for opioid use disorders (IPOD).. Contemporary clinical trials 49, 70-7 DOI: 10.1016/j.cct.2016.06.003 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282101,"Title":"A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Farabee (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"October","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"117","Pages":"108076","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"32811623","Comments":"","TypeName":"Journal, Article","Authors":"Farabee D ; Condon T ; Hallgren KA ; McCrady B ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2020.108076 ","Keywords":"Adult\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\n*Patient Navigation\r\n*Prisoners\r\nExperimental\r\nExtended release naltrexone\r\nInjectable naltrexone\r\nJail inmates\r\nOpioid dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Farabee D, Condon T, Hallgren KA, and McCrady B (2020) A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder.. Journal of substance abuse treatment 117, 108076 DOI: 10.1016/j.jsat.2020.108076 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282332,"Title":"Heroin anticraving medications: a systematic review.","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Fareed (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"November","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"36","Pages":"332-41","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"20955107","Comments":"","TypeName":"Journal, Article","Authors":"Fareed A ; Vayalapalli S ; Casarella J ; Amar R ; Drexler K ; ","ParentAuthors":"","DOI":"10.3109/00952990.2010.505991 ","Keywords":"Buprenorphine/*therapeutic use\r\nHeroin\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/rehabilitation\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome/*drug therapy/rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fareed A, Vayalapalli S, Casarella J, Amar R, and Drexler K (2010) Heroin anticraving medications: a systematic review.. The American journal of drug and alcohol abuse 36(6), 332-41 DOI: 10.3109/00952990.2010.505991 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282772,"Title":"Methadone maintenance dosing guideline for opioid dependence, a literature review.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Fareed (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"January","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"29","Pages":"1-14","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"20390694","Comments":"","TypeName":"Journal, Article","Authors":"Fareed A ; Casarella J ; Amar R ; Vayalapalli S ; Drexler K ; ","ParentAuthors":"","DOI":"10.1080/10550880903436010 ","Keywords":"Dose-Response Relationship, Drug\r\nDrug Administration Schedule\r\nHumans\r\nMethadone/*administration & dosage/adverse effects\r\nNarcotics/*administration & dosage/adverse effects\r\nObservation\r\nOpioid-Related Disorders/*drug therapy\r\nPractice Guidelines as Topic\r\nRandomized Controlled Trials as Topic\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fareed A, Casarella J, Amar R, Vayalapalli S, and Drexler K (2010) Methadone maintenance dosing guideline for opioid dependence, a literature review.. Journal of addictive diseases 29(1), 1-14 DOI: 10.1080/10550880903436010 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282248,"Title":"Effect of methadone maintenance treatment on heroin craving, a literature review.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Fareed (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"January","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"27-38","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"21218308","Comments":"","TypeName":"Journal, Article","Authors":"Fareed A ; Vayalapalli S ; Stout S ; Casarella J ; Drexler K ; Bailey SP ; ","ParentAuthors":"","DOI":"10.1080/10550887.2010.531672 ","Keywords":"Behavior, Addictive/*drug therapy\r\nHeroin Dependence/*drug therapy/*psychology\r\nHumans\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fareed A, Vayalapalli S, Stout S, Casarella J, Drexler K, and Bailey SP (2011) Effect of methadone maintenance treatment on heroin craving, a literature review.. Journal of addictive diseases 30(1), 27-38 DOI: 10.1080/10550887.2010.531672 "},{"Codes":[],"Outcomes":[],"ItemId":98281824,"Title":"Comorbid posttraumatic stress disorder and opiate addiction: a literature review.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Fareed (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"32","Pages":"168-79","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"23815424","Comments":"","TypeName":"Journal, Article","Authors":"Fareed A ; Eilender P ; Haber M ; Bremner J ; Whitfield N ; Drexler K ; ","ParentAuthors":"","DOI":"10.1080/10550887.2013.795467 ","Keywords":"Cognitive Behavioral Therapy\r\nCombined Modality Therapy\r\nComorbidity\r\nDiagnosis, Differential\r\nEvidence-Based Medicine\r\nHumans\r\nNarcotics/adverse effects\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*epidemiology/psychology/*rehabilitation\r\nPrognosis\r\nStress Disorders, Post-Traumatic/*epidemiology/psychology/*rehabilitation\r\nSubstance Withdrawal Syndrome/epidemiology/psychology/rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fareed A, Eilender P, Haber M, Bremner J, Whitfield N, and Drexler K (2013) Comorbid posttraumatic stress disorder and opiate addiction: a literature review.. Journal of addictive diseases 32(2), 168-79 DOI: 10.1080/10550887.2013.795467 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281178,"Title":"Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy results from a double-blind, randomized, and placebo-controlled trial","ParentTitle":"Journal of Psychiatric Research","ShortTitle":"Farnia (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0022-3956","City":"","Country":"","Publisher":"","Institution":"S. Brand, University of Basel, Psychiatric Clinics (UPK), Center for Affective, Stress and Sleep Disorders (ZASS), Wilhelm Klein-Strasse 27, Basel, Switzerland","Volume":"95","Pages":"260-268","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L618285048&from=export http://dx.doi.org/10.1016/j.jpsychires.2017.08.011","OldItemId":"","Comments":"2020-10-08","TypeName":"Journal, Article","Authors":"Farnia V ; Tatari F ; Alikhani M ; Yazdchi K ; Taghizadeh M ; Sadeghi Bahmani ; D  ; Karbasizadeh H ; Holsboer-Trachsler E ; Brand S ; ","ParentAuthors":"","DOI":"10.1016/j.jpsychires.2017.08.011","Keywords":"IRCT2015091523705N2\r\nagents acting on the genital system\r\nessential oil\r\nestradiol\r\nliothyronine\r\nmethadone\r\nplacebo\r\nprogesterone\r\nprolactin\r\nRosa damascena essential oil\r\nthyroid hormone\r\nthyrotropin\r\nthyroxine\r\nunclassified drug\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndouble blind procedure\r\nestradiol blood level\r\nfemale\r\nfemale sexual dysfunction\r\nhuman\r\nliothyronine blood level\r\nmethadone treatment\r\nopiate addiction\r\norgasm\r\npriority journal\r\nprogesterone blood level\r\nprolactin blood level\r\nquestionnaire\r\nrandomized controlled trial\r\nRosa damascena\r\nself evaluation\r\nsexual function\r\nsexual satisfaction\r\nthyroid hormone blood level\r\nthyrotropin blood level\r\nthyroxine blood level\r\nvaginal lubrication","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Farnia V, Tatari F, Alikhani M, Yazdchi K, Taghizadeh M, Sadeghi Bahmani, D , Karbasizadeh H, Holsboer-Trachsler E, and Brand S (2017) Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy results from a double-blind, randomized, and placebo-controlled trial. Journal of Psychiatric Research 95, 260-268 DOI: 10.1016/j.jpsychires.2017.08.011"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282397,"Title":"Ginseng treatment improves the sexual side effects of methadone maintenance treatment.","ParentTitle":"Psychiatry research","ShortTitle":"Farnia (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"June","StandardNumber":"0165-1781 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"276","Pages":"142-150","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"31082749","Comments":"","TypeName":"Journal, Article","Authors":"Farnia V ; Alikhani M ; Ebrahimi A ; Golshani S ; Sadeghi Bahmani D; Brand S ; ","ParentAuthors":"","DOI":"10.1016/j.psychres.2019.05.004 ","Keywords":"Adult\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/*adverse effects\r\nOpioid-Related Disorders/*drug therapy\r\n*Panax\r\nPlant Extracts/*therapeutic use\r\nSexual Behavior/drug effects\r\nSexual Dysfunction, Physiological/chemically induced/*drug therapy\r\nGinseng\r\nMethadone maintenance therapy\r\nMethadone-related sexual dysfunction\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Farnia V, Alikhani M, Ebrahimi A, Golshani S, Sadeghi Bahmani D, and Brand S (2019) Ginseng treatment improves the sexual side effects of methadone maintenance treatment.. Psychiatry research 276, 142-150 DOI: 10.1016/j.psychres.2019.05.004 "},{"Codes":[{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283004,"Title":"Heroin maintenance for chronic heroin-dependent individuals.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Ferri (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"August","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD003410","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"20687073","Comments":"","TypeName":"Journal, Article","Authors":"Ferri M ; Davoli M ; Perucci CA ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD003410.pub3 ","Keywords":"Adult\r\nCrime/statistics & numerical data\r\nHeroin/*therapeutic use\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotics/*therapeutic use\r\nRandomized Controlled Trials as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ferri M, Davoli M, and Perucci CA (2010) Heroin maintenance for chronic heroin-dependent individuals.. The Cochrane database of systematic reviews (8), CD003410 DOI: 10.1002/14651858.CD003410.pub3 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283068,"Title":"Heroin maintenance for chronic heroin-dependent individuals.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Ferri (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"December","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"2011","Pages":"CD003410","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"22161378","Comments":"","TypeName":"Journal, Article","Authors":"Ferri M ; Davoli M ; Perucci CA ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD003410.pub4 ","Keywords":"Adult\r\nCrime/prevention & control\r\nHeroin/*therapeutic use\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotics/*therapeutic use\r\nPatient Compliance\r\nRandomized Controlled Trials as Topic\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ferri M, Davoli M, and Perucci CA (2011) Heroin maintenance for chronic heroin-dependent individuals.. The Cochrane database of systematic reviews 2011(12), CD003410 DOI: 10.1002/14651858.CD003410.pub4 "},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948218,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282884,"Title":"Slow-release oral morphine as maintenance therapy for opioid dependence.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Ferri (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"June","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD009879","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"23740540","Comments":"","TypeName":"Journal, Article","Authors":"Ferri M ; Minozzi S ; Bo A ; Amato L ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD009879.pub2 ","Keywords":"Administration, Oral\r\nDelayed-Action Preparations/administration & dosage/adverse effects\r\nHumans\r\nMorphine/*administration & dosage/adverse effects\r\nNarcotics/*administration & dosage/adverse effects\r\nOpiate Substitution Treatment/adverse effects/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nQuality of Life\r\nRandomized Controlled Trials as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ferri M, Minozzi S, Bo A, and Amato L (2013) Slow-release oral morphine as maintenance therapy for opioid dependence.. The Cochrane database of systematic reviews (6), CD009879 DOI: 10.1002/14651858.CD009879.pub2 "},{"Codes":[],"Outcomes":[],"ItemId":98282418,"Title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.","ParentTitle":"Journal of acquired immune deficiency syndromes (1999)","ShortTitle":"Fiellin (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"March","StandardNumber":"1525-4135 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"BHIVES Collaborative","Volume":"56 Suppl 1","Pages":"S33-8","Edition":"","Issue":"0 1","Availability":"","URL":"","OldItemId":"21317592","Comments":"","TypeName":"Journal, Article","Authors":"Fiellin DA ; Weiss L ; Botsko M ; Egan JE ; Altice FL ; Bazerman LB ; Chaudhry A ; Cunningham CO ; Gourevitch MN ; Lum PJ ; Sullivan LE ; Schottenfeld RS ; O'Connor PG ; ","ParentAuthors":"","DOI":"10.1097/QAI.0b013e3182097537 ","Keywords":"Buprenorphine/administration & dosage/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination\r\nFemale\r\nHIV Infections/*complications\r\nHumans\r\nMale\r\nNaloxone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOdds Ratio\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*complications/*drug therapy\r\nProspective Studies\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, and O'Connor PG (2011) Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.. Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1(0 1), S33-8 DOI: 10.1097/QAI.0b013e3182097537 "},{"Codes":[{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282424,"Title":"A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.","ParentTitle":"The American journal of medicine","ShortTitle":"Fiellin (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"January","StandardNumber":"0002-9343 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"126","Pages":"74.e11-7","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23260506","Comments":"","TypeName":"Journal, Article","Authors":"Fiellin DA ; Barry DT ; Sullivan LE ; Cutter CJ ; Moore BA ; O'Connor PG ; Schottenfeld RS ; ","ParentAuthors":"","DOI":"10.1016/j.amjmed.2012.07.005 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\n*Cognitive Behavioral Therapy\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Compliance\r\n*Primary Health Care\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, and Schottenfeld RS (2013) A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.. The American journal of medicine 126(1), 74.e11-7 DOI: 10.1016/j.amjmed.2012.07.005 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282129,"Title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.","ParentTitle":"JAMA internal medicine","ShortTitle":"Fiellin (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"December","StandardNumber":"2168-6106 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"174","Pages":"1947-54","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"25330017","Comments":"","TypeName":"Journal, Article","Authors":"Fiellin DA ; Schottenfeld RS ; Cutter CJ ; Moore BA ; Barry DT ; O'Connor PG ; ","ParentAuthors":"","DOI":"10.1001/jamainternmed.2014.5302 ","Keywords":"Adult\r\nAnalgesics, Opioid/urine\r\nBuprenorphine/*administration & dosage\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\nMale\r\nNarcotic Antagonists/*administration & dosage\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy/urine\r\n*Prescription Drugs\r\nPrimary Health Care/*methods\r\nRecurrence\r\nSubstance Withdrawal Syndrome/*prevention & control\r\nTreatment Outcome\r\nUrinalysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, and O'Connor PG (2014) Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.. JAMA internal medicine 174(12), 1947-54 DOI: 10.1001/jamainternmed.2014.5302 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282460,"Title":"Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.","ParentTitle":"The American journal on addictions","ShortTitle":"Fishman (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"433-444","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"34075644","Comments":"","TypeName":"Journal, Article","Authors":"Fishman M ; Wenzel K ; Scodes J ; Pavlicova M ; Campbell ANC ; Rotrosen J ; Nunes E ; ","ParentAuthors":"","DOI":"10.1111/ajad.13176 ","Keywords":"Aged\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nNaltrexone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fishman M, Wenzel K, Scodes J, Pavlicova M, Campbell ANC, Rotrosen J, and Nunes E (2021) Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.. The American journal on addictions 30(5), 433-444 DOI: 10.1111/ajad.13176 "},{"Codes":[{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280632,"Title":"Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Fluyau (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"D. Fluyau, Emory University School of Medicine, 201 Dowman Dr, Atlanta, GA, United States","Volume":"208","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2004670288&from=export http://dx.doi.org/10.1016/j.drugalcdep.2020.107845","OldItemId":"","Comments":"2020-02-03","TypeName":"Journal, Article","Authors":"Fluyau D ; Revadigar N ; Pierre C G; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2020.107845","Keywords":"amantadine\r\nbuprenorphine\r\ndextromethorphan\r\nketamine\r\nmemantine\r\nmethadone\r\nn methyl dextro aspartic acid receptor blocking agent\r\nnaloxone\r\nplacebo\r\ncombination drug therapy\r\ndetoxification\r\ndisease severity\r\ndrug dose reduction\r\ndrug effect\r\ndrug efficacy\r\ndrug safety\r\ndrug targeting\r\nED50\r\nfollow up\r\nhuman\r\nmaintenance therapy\r\nmeta analysis\r\nnonhuman\r\nopiate addiction\r\npatient dropout\r\npriority journal\r\nqualitative analysis\r\nreview\r\nrisk assessment\r\nrisk factor\r\nside effect\r\nsystematic review\r\ntherapy effect\r\ntreatment outcome\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fluyau D, Revadigar N, and Pierre C G (2020) Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review. Drug and Alcohol Dependence 208,  DOI: 10.1016/j.drugalcdep.2020.107845"},{"Codes":[],"Outcomes":[],"ItemId":98284866,"Title":"Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.","ParentTitle":"Annals of internal medicine","ShortTitle":"Frank (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"August","StandardNumber":"0003-4819 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"167","Pages":"181-191","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"28715848","Comments":"","TypeName":"Journal, Article","Authors":"Frank JW ; Lovejoy TI ; Becker WC ; Morasco BJ ; Koenig CJ ; Hoffecker L ; Dischinger HR ; Dobscha SK ; Krebs EE ; ","ParentAuthors":"","DOI":"10.7326/M17-0598 ","Keywords":"Analgesics, Opioid/administration & dosage/adverse effects/*therapeutic use\r\nChronic Pain/*drug therapy\r\nDrug Administration Schedule\r\nHumans\r\nQuality of Life\r\nSeverity of Illness Index\r\nSubstance Withdrawal Syndrome/etiology\r\nTreatment Outcome\r\nWithholding Treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, Dischinger HR, Dobscha SK, and Krebs EE (2017) Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.. Annals of internal medicine 167(3), 181-191 DOI: 10.7326/M17-0598 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282043,"Title":"Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Friedmann (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"February","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"85","Pages":"45-48","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28527855","Comments":"","TypeName":"Journal, Article","Authors":"Friedmann PD ; Wilson D ; Hoskinson R Jr; Poshkus M ; Clarke JG ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2017.04.010 ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMedication Adherence/*statistics & numerical data\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nPilot Projects\r\n*Prisoners\r\nRecurrence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Friedmann PD, Wilson D, Hoskinson R Jr, Poshkus M, and Clarke JG (2018) Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison.. Journal of substance abuse treatment 85, 45-48 DOI: 10.1016/j.jsat.2017.04.010 "},{"Codes":[{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282279,"Title":"Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Friedmann (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"February","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"85","Pages":"61-65","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28236511","Comments":"","TypeName":"Journal, Article","Authors":"Friedmann PD ; Wilson D ; Nunes EV ; Hoskinson R Jr; Lee JD ; Gordon M ; Murphy SM ; Bonnie RJ ; Chen DT ; Boney TY ; O'Brien CP ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2017.01.018 ","Keywords":"Adult\r\nAlcoholic Intoxication/complications\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nQuality of Life\r\n*Secondary Prevention\r\nTime Factors","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Friedmann PD, Wilson D, Nunes EV, Hoskinson R Jr, Lee JD, Gordon M, Murphy SM, Bonnie RJ, Chen DT, Boney TY, and O'Brien CP (2018) Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?. Journal of substance abuse treatment 85, 61-65 DOI: 10.1016/j.jsat.2017.01.018 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282853,"Title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Frost (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"August","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"114","Pages":"1416-1426","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"31013390","Comments":"","TypeName":"Journal, Article","Authors":"Frost M ; Bailey GL ; Lintzeris N ; Strang J ; Dunlop A ; Nunes EV ; Jansen JB ; Frey LC ; Weber B ; Haber P ; Oosman S ; Kim S ; Tiberg F ; ","ParentAuthors":"","DOI":"10.1111/add.14636 ","Keywords":"Adult\r\nAged\r\nAnalgesics, Opioid/*administration & dosage\r\nAustralia\r\nBuprenorphine/*administration & dosage\r\nDelayed-Action Preparations/*administration & dosage\r\nDenmark\r\nDrug Monitoring\r\nFemale\r\nGermany\r\nHumans\r\nHungary\r\nInjections, Subcutaneous\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nOutpatients/psychology\r\nPatient Safety\r\nPatient Satisfaction\r\nSweden\r\nUnited Kingdom\r\nUnited States\r\nBuprenorphine\r\nCAM2038\r\nPhase 3 trial\r\ndepot\r\nlong-term safety\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Frost M, Bailey GL, Lintzeris N, Strang J, Dunlop A, Nunes EV, Jansen JB, Frey LC, Weber B, Haber P, Oosman S, Kim S, and Tiberg F (2019) Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.. Addiction (Abingdon, and England) 114(8), 1416-1426 DOI: 10.1111/add.14636 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281477,"Title":"Medication-assisted treatment with methadone: Assessing the evidence","ParentTitle":"Psychiatric Services","ShortTitle":"Fullerton (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1557-9700","City":"","Country":"","Publisher":"","Institution":"C.A. Fullerton, Truven Health Analytics, Cambridge, MA, United States","Volume":"65","Pages":"146-157","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L372333625&from=export http://dx.doi.org/10.1176/appi.ps.201300235","OldItemId":"","Comments":"2014-02-21","TypeName":"Journal, Article","Authors":"Fullerton C A; Kim M ; Thomas C P; Lyman D R; Montejano L B; Dougherty R H; Daniels A S; Ghose S S; Delphin-Rittmon M E; ","ParentAuthors":"","DOI":"10.1176/appi.ps.201300235","Keywords":"methadone\r\nplacebo\r\narticle\r\nclinical effectiveness\r\ncriminal behavior\r\ndisease association\r\ndrug efficacy\r\nfetus outcome\r\nhealth care delivery\r\nhuman\r\nHuman immunodeficiency virus infection\r\ninfection risk\r\nMedline\r\nmental health service\r\nmeta analysis\r\nmethadone treatment\r\nmortality\r\nopiate addiction\r\noutcome assessment\r\npatient monitoring\r\npregnancy\r\npregnancy outcome\r\npregnant woman\r\npsychosocial care\r\nPsycINFO\r\nrandomized controlled trial (topic)\r\nsystematic review\r\nunspecified side effect\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Fullerton C A, Kim M, Thomas C P, Lyman D R, Montejano L B, Dougherty R H, Daniels A S, Ghose S S, and Delphin-Rittmon M E (2014) Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services 65(2), 146-157 DOI: 10.1176/appi.ps.201300235"},{"Codes":[],"Outcomes":[],"ItemId":98279770,"Title":"Buprenorphine Extended-Release Treatment for Opioid Use Disorder in the Postpartum Period","ParentTitle":"Obstetrics and Gynecology","ShortTitle":"Galati (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0029-7844","City":"","Country":"","Publisher":"","Institution":"B.M. Galati, Department of Psychiatry, Washington University School of Medicine in St. Louis, St. Louis, MO, United States","Volume":"142","Pages":"1148-1152","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2028057332&from=export http://dx.doi.org/10.1097/AOG.0000000000005319","OldItemId":"","Comments":"2023-11-07","TypeName":"Journal, Article","Authors":"Galati B M; Wenzinger M ; Rogers C E; Cooke E ; Kelly J C; ","ParentAuthors":"","DOI":"10.1097/AOG.0000000000005319","Keywords":"ice pack\r\namphetamine\r\nbenzodiazepine\r\nbuprenorphine\r\ncannabis\r\ncocaine\r\nlidocaine\r\nmethamphetamine\r\nnicotine\r\nadult\r\narticle\r\nclinical article\r\ncraving\r\ndrug dependence\r\ndrug withdrawal\r\nfemale\r\nfollow up\r\ngastrointestinal symptom\r\nhigh risk population\r\nhuman\r\nliquid chromatography\r\nliquid chromatography-mass spectrometry\r\nloading drug dose\r\nmaintenance drug dose\r\nmiddle aged\r\nopiate addiction\r\npregnancy\r\npregnancy test\r\npruritus\r\npuerperium\r\nretrospective study\r\nteratogenicity\r\ntoxicology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Galati B M, Wenzinger M, Rogers C E, Cooke E, and Kelly J C (2023) Buprenorphine Extended-Release Treatment for Opioid Use Disorder in the Postpartum Period. Obstetrics and Gynecology 142(5), 1148-1152 DOI: 10.1097/AOG.0000000000005319"},{"Codes":[],"Outcomes":[],"ItemId":98282249,"Title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.","ParentTitle":"Progress in neuro-psychopharmacology & biological psychiatry","ShortTitle":"Gerra (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"March","StandardNumber":"0278-5846 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"35","Pages":"483-9","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"21147192","Comments":"","TypeName":"Journal, Article","Authors":"Gerra G ; Saenz E ; Busse A ; Maremmani I ; Ciccocioppo R ; Zaimovic A ; Gerra ML ; Amore M ; Manfredini M ; Donnini C ; Somaini L ; ","ParentAuthors":"","DOI":"10.1016/j.pnpbp.2010.12.002 ","Keywords":"Analgesics, Opioid/*administration & dosage/therapeutic use\r\nComorbidity\r\nCrime\r\nDrug Administration Schedule\r\nFemale\r\n*Heroin\r\nHeroin Dependence/epidemiology/*rehabilitation\r\nHumans\r\nInterview, Psychological\r\nMale\r\nMental Disorders/*epidemiology\r\nMethadone/*administration & dosage/therapeutic use\r\nMotivation\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/epidemiology/rehabilitation\r\nPatient Compliance\r\nSelf Report\r\n*Substance Abuse Detection\r\nSubstance-Related Disorders\r\nTreatment Outcome\r\nViolence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, and Somaini L (2011) Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.. Progress in neuro-psychopharmacology & biological psychiatry 35(2), 483-9 DOI: 10.1016/j.pnpbp.2010.12.002 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281700,"Title":"Review of medication-assisted treatment for opioid use disorder.","ParentTitle":"Journal of osteopathic medicine","ShortTitle":"Ghanem (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"March","StandardNumber":"2702-3648 (Linking)","City":"Germany","Country":"","Publisher":"","Institution":"","Volume":"122","Pages":"367-374","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"35285220","Comments":"","TypeName":"Journal, Article","Authors":"Ghanem N ; Dromgoole D ; Hussein A ; Jermyn RT ; ","ParentAuthors":"","DOI":"10.1515/jom-2021-0163 ","Keywords":"*Buprenorphine/therapeutic use\r\n*COVID-19/epidemiology\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy/epidemiology/rehabilitation\r\nUnited States\r\n*COVID-19 Drug Treatment\r\nOUD\r\nmedication-assisted treatment\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ghanem N, Dromgoole D, Hussein A, and Jermyn RT (2022) Review of medication-assisted treatment for opioid use disorder.. Journal of osteopathic medicine 122(7), 367-374 DOI: 10.1515/jom-2021-0163 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284312,"Title":"Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.","ParentTitle":"Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences","ShortTitle":"Ghazanfarpour (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"June","StandardNumber":"1560-8115 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"27","Pages":"423-431","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"31093953","Comments":"","TypeName":"Journal, Article","Authors":"Ghazanfarpour M ; Najafi MN ; Roozbeh N ; Mashhadi ME ; Keramat-Roudi A ; Mgarbane B ; Tsatsakis A ; Moghaddam MMM ; Rezaee R ; ","ParentAuthors":"","DOI":"10.1007/s40199-019-00266-3 ","Keywords":"Analgesics, Opioid/*adverse effects\r\nBuprenorphine/therapeutic use\r\nClonidine/therapeutic use\r\nDrug Therapy, Combination\r\nHumans\r\nInfant, Newborn\r\nLength of Stay\r\nMethadone/therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nOpiate Substitution Treatment/*methods\r\nRandomized Controlled Trials as Topic\r\nTime Factors\r\nTreatment Outcome\r\nClonidine\r\nMethadone\r\nMorphine\r\nNeonatal abstinence syndrome\r\nNeonatal passive addiction\r\nNeonatal withdrawal syndrome\r\nOpioid\r\nOpium\r\nWithdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ghazanfarpour M, Najafi MN, Roozbeh N, Mashhadi ME, Keramat-Roudi A, Mgarbane B, Tsatsakis A, Moghaddam MMM, and Rezaee R (2019) Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.. Daru : journal of Faculty of Pharmacy, and Tehran University of Medical Sciences 27(1), 423-431 DOI: 10.1007/s40199-019-00266-3 "},{"Codes":[{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280722,"Title":"A Review of Novel Methods to Support the Transition from Methadone and Other Full Agonist Opioids to Buprenorphine/Naloxone Sublingual in Both Community and Acute Care Settings","ParentTitle":"Canadian Journal of Addiction","ShortTitle":"Ghosh (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"2368-4720","City":"","Country":"","Publisher":"","Institution":"S.M. Ghosh, Department of General Internal Medicine, University of Alberta, Edmonton, AB, Canada","Volume":"10","Pages":"41-50","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L630600432&from=export http://dx.doi.org/10.1097/CXA.0000000000000072","OldItemId":"","Comments":"2020-01-23","TypeName":"Journal, Article","Authors":"Ghosh S M; Klaire S ; Tanguay R ; Manek M ; Azar P ; ","ParentAuthors":"","DOI":"10.1097/CXA.0000000000000072","Keywords":"transdermal patch\r\nbuprenorphine\r\nbuprenorphine plus naloxone\r\nfentanyl\r\nmethadone\r\nmorphine\r\nopiate agonist\r\nclinical protocol\r\nCochrane Library\r\ncommunity care\r\ndata base\r\ndrug substitution\r\ndrug withdrawal\r\nEmbase\r\nemergency care\r\nhuman\r\nintermethod comparison\r\nMedline\r\nopiate addiction\r\nopiate substitution treatment\r\noutpatient\r\npeer review\r\npublication\r\nreview\r\nscientific literature\r\nsystematic review\r\nbutrans","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ghosh S M, Klaire S, Tanguay R, Manek M, and Azar P (2019) A Review of Novel Methods to Support the Transition from Methadone and Other Full Agonist Opioids to Buprenorphine/Naloxone Sublingual in Both Community and Acute Care Settings. Canadian Journal of Addiction 10(4), 41-50 DOI: 10.1097/CXA.0000000000000072"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281912,"Title":"Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Golan (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"June","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"235","Pages":"109445","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"35430522","Comments":"","TypeName":"Journal, Article","Authors":"Golan OK ; Totaram R ; Perry E ; Fortson K ; Rivera-Atilano R ; Entress R ; Golan M ; Andraka-Christou B ; Whitaker D ; Pigott T ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109445 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nCognition\r\nHumans\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy\r\nQuality of Life\r\nBuprenorphine\r\nMeta-analysis\r\nOpioid Use Disorder\r\nQuality of life\r\nReview","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Golan OK, Totaram R, Perry E, Fortson K, Rivera-Atilano R, Entress R, Golan M, Andraka-Christou B, Whitaker D, and Pigott T (2022) Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder.. Drug and alcohol dependence 235, 109445 DOI: 10.1016/j.drugalcdep.2022.109445 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281458,"Title":"A Phase 4, Pilot, Open-Label Study of VIVITROL (Extended-Release Naltrexone XR-NTX) for Prisoners","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Gordon (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"M.S. Gordon, Friends Research Institute Inc., 1040 Park Avenue Suite 103, Baltimore, MD, United States","Volume":"59","Pages":"52-58","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L606596989&from=export http://dx.doi.org/10.1016/j.jsat.2015.07.005","OldItemId":"","Comments":"2015-11-04","TypeName":"Journal, Article","Authors":"Gordon M S; Kinlock T W; Vocci F J; Fitzgerald T T; Memisoglu A ; Silverman B ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2015.07.005","Keywords":"cocaine\r\nnaltrexone\r\nopiate\r\nadult\r\narticle\r\nclinical article\r\ncocaine dependence\r\ncommunity\r\ndrug formulation\r\ndrug screening\r\nfeasibility study\r\nfemale\r\nfollow up\r\nhuman\r\ninjection\r\nmale\r\nmedical history\r\noffender\r\nopen study\r\nopiate addiction\r\nphase 4 clinical trial\r\npilot study\r\npriority journal\r\ncorrectional facility\r\nprisoner\r\nrecidivism\r\nurinalysis\r\nvivitrol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gordon M S, Kinlock T W, Vocci F J, Fitzgerald T T, Memisoglu A, and Silverman B (2015) A Phase 4, Pilot, Open-Label Study of VIVITROL (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment 59, 52-58 DOI: 10.1016/j.jsat.2015.07.005"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282640,"Title":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Gordon (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"March","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"172","Pages":"34-42","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28107680","Comments":"","TypeName":"Journal, Article","Authors":"Gordon MS ; Kinlock TW ; Schwartz RP ; O'Grady KE ; Fitzgerald TT ; Vocci FJ ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.11.037 ","Keywords":"Adult\r\nBuprenorphine/adverse effects/*therapeutic use\r\nCocaine-Related Disorders/epidemiology/urine\r\nCounseling\r\nCrime/statistics & numerical data\r\nFemale\r\nFollow-Up Studies\r\nHeroin Dependence/rehabilitation\r\nHumans\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/adverse effects/*therapeutic use\r\nOpioid-Related Disorders/*prevention & control/*rehabilitation\r\n*Prisoners\r\nRecurrence\r\nSex Characteristics\r\nTreatment Outcome\r\nYoung Adult\r\n*Buprenorphine\r\n*Heroin addiction\r\n*Opioid substitution therapy\r\n*Prisoners","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE, Fitzgerald TT, and Vocci FJ (2017) A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.. Drug and alcohol dependence 172, 34-42 DOI: 10.1016/j.drugalcdep.2016.11.037 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282715,"Title":"Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Gordon (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"February","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"53","Pages":"130-136","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28011389","Comments":"","TypeName":"Journal, Article","Authors":"Gordon MS ; Vocci FJ ; Fitzgerald TT ; O'Grady KE ; O'Brien CP ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2016.12.015 ","Keywords":"Crime/statistics & numerical data\r\nDelayed-Action Preparations\r\nDelivery of Health Care/*methods\r\nFemale\r\nHIV Infections\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMedication Adherence\r\n*Mobile Health Units\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\n*Prisoners\r\n*Prisons\r\nRecurrence\r\nRisk-Taking\r\n*Substance Abuse Treatment Centers\r\nUnited States\r\nCriminal justice\r\nLong-acting naltrexone\r\nMedical mobile treatment\r\nPrisoners","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gordon MS, Vocci FJ, Fitzgerald TT, O'Grady KE, and O'Brien CP (2017) Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.. Contemporary clinical trials 53, 130-136 DOI: 10.1016/j.cct.2016.12.015 "},{"Codes":[{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280188,"Title":"Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Gormley (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"M.A. Gormley, Clemson University College of Behavioral, Social, and Health Science, Department of Public Health Services, 605 Grove Rd, Greenville, SC, United States","Volume":"229","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2015239346&from=export http://dx.doi.org/10.1016/j.drugalcdep.2021.109123","OldItemId":"","Comments":"2022-03-25","TypeName":"Journal, Article","Authors":"Gormley M A; Pericot-Valverde I ; Diaz L ; Coleman A ; Lancaster J ; Ortiz E ; Moschella P ; Heo M ; Litwin A H; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.109123","Keywords":"clinical effectiveness\r\nclinical outcome\r\nconvalescence\r\nfollow up\r\nhealth care utilization\r\nhealth service\r\nhuman\r\ninformation dissemination\r\nmedical research\r\nopiate addiction\r\npeer group\r\npeer recovery support service\r\npolypharmacy\r\nremission\r\nreview\r\nsystematic review\r\ntherapy effect","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gormley M A, Pericot-Valverde I, Diaz L, Coleman A, Lancaster J, Ortiz E, Moschella P, Heo M, and Litwin A H (2021) Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: A systematic review. Drug and Alcohol Dependence 229,  DOI: 10.1016/j.drugalcdep.2021.109123"},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288052,"Title":"Alpha2adrenergic agonists for the management of opioid withdrawal","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Gowing (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1465-1858","City":"","Country":"","Publisher":"John Wiley & Sons, Ltd","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"5","Availability":"","URL":"http://dx.doi.org/10.1002/14651858.CD002024.pub5","OldItemId":"","Comments":"[Drugs and Alcohol]","TypeName":"Journal, Article","Authors":"Gowing L ; Farrell M ; Ali R ; White JM ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD002024.pub5","Keywords":"Acute Disease\r\nAdrenergic alpha2 Receptor Agonists [*therapeutic use]\r\nClonidine [analogs & derivatives, therapeutic use]\r\nControlled Clinical Trials as Topic\r\nHumans\r\nMethadone [administration & dosage, therapeutic use]\r\nOpiate Substitution Treatment [methods]\r\nOpioidRelated Disorders [*complications]\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome [*rehabilitation]","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gowing L, Farrell M, Ali R, and White JM (2016) Alpha2adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews (5),  DOI: 10.1002/14651858.CD002024.pub5"},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032086,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281241,"Title":"Opioid antagonists with minimal sedation for opioid withdrawal","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Gowing (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1465-1858","City":"","Country":"","Publisher":"","Institution":"L. Gowing, University of Adelaide, Discipline of Pharmacology, Frome Road, Adelaide, SA, Australia","Volume":"2017","Pages":"","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L616443030&from=export http://dx.doi.org/10.1002/14651858.CD002021.pub4","OldItemId":"","Comments":"2022-07-19","TypeName":"Journal, Article","Authors":"Gowing L ; Ali R ; White J M; ","ParentAuthors":"","DOI":"10.1002/14651858.CD002021.pub4","Keywords":"adrenergic receptor stimulating agent\r\nbuprenorphine\r\nclonidine\r\nlofexidine\r\nmethadone\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nopiate antagonist\r\nplacebo\r\ncohort analysis\r\nconfusion\r\nday care\r\ndelirium\r\ndisease severity\r\ndrug detoxification\r\nevidence based medicine\r\nhuman\r\nopiate addiction\r\noutcome assessment\r\noutpatient care\r\npriority journal\r\nprospective study\r\nrandomized controlled trial (topic)\r\nreview\r\nsedation\r\nsystematic review\r\ntreatment duration\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gowing L, Ali R, and White J M (2017) Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews 2017(5),  DOI: 10.1002/14651858.CD002021.pub4"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282844,"Title":"Buprenorphine for managing opioid withdrawal.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Gowing (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"February","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"2","Pages":"CD002025","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"28220474","Comments":"","TypeName":"Journal, Article","Authors":"Gowing L ; Ali R ; White JM ; Mbewe D ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD002025.pub5 ","Keywords":"Acute Disease\r\nBuprenorphine/administration & dosage/adverse effects/*therapeutic use\r\nClonidine/analogs & derivatives/therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMethadone/administration & dosage/adverse effects\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/complications/*drug therapy\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gowing L, Ali R, White JM, and Mbewe D (2017) Buprenorphine for managing opioid withdrawal.. The Cochrane database of systematic reviews 2(2), CD002025 DOI: 10.1002/14651858.CD002025.pub5 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284112,"Title":"Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis.","ParentTitle":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ShortTitle":"Grebely (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"July","StandardNumber":"1058-4838 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"73","Pages":"e107-e118","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"32447375","Comments":"","TypeName":"Journal, Article","Authors":"Grebely J ; Tran L ; Degenhardt L ; Dowell-Day A ; Santo T ; Larney S ; Hickman M ; Vickerman P ; French C ; Butler K ; Gibbs D ; Valerio H ; Read P ; Dore GJ ; Hajarizadeh B ; ","ParentAuthors":"","DOI":"10.1093/cid/ciaa612 ","Keywords":"Analgesics, Opioid\r\nAntiviral Agents/therapeutic use\r\nAustralia/epidemiology\r\nEurope\r\n*Hepatitis C/drug therapy\r\n*Hepatitis C, Chronic/drug therapy\r\nHumans\r\nNorth America\r\n*Pharmaceutical Preparations\r\n*Substance Abuse, Intravenous/complications/drug therapy\r\nThailand\r\nTreatment Outcome\r\nHCV\r\nIDU\r\nPWID\r\ncare cascade\r\ninjecting drug use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Grebely J, Tran L, Degenhardt L, Dowell-Day A, Santo T, Larney S, Hickman M, Vickerman P, French C, Butler K, Gibbs D, Valerio H, Read P, Dore GJ, and Hajarizadeh B (2021) Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73(1), e107-e118 DOI: 10.1093/cid/ciaa612 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285009,"Title":"Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.","ParentTitle":"Cureus","ShortTitle":"Gregory (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"2168-8184 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"13","Pages":"e19870","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"34976492","Comments":"","TypeName":"Journal, Article","Authors":"Gregory HM ; Hill VM ; Parker RW ; ","ParentAuthors":"","DOI":"10.7759/cureus.19870 ","Keywords":"buprenorphine\r\ndea waiver\r\nmedication assisted treatment (mat)\r\nmedications for opioid use disorder (moud)\r\nnaloxone\r\nopioid agonist\r\nopioid medication\r\nopioid use disorder (oud)\r\nrural health\r\nsuboxone","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gregory HM, Hill VM, and Parker RW (2021) Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.. Cureus 13(11), e19870 DOI: 10.7759/cureus.19870 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282794,"Title":"A randomized controlled trial to evaluate the relative efficacy of the addition of a psycho-social intervention to standard-of-care services in reducing attrition and improving attendance among first-time users of methadone maintenance treatment in China.","ParentTitle":"AIDS and behavior","ShortTitle":"Gu (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"July","StandardNumber":"1090-7165 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"17","Pages":"2002-10","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"23413126","Comments":"","TypeName":"Journal, Article","Authors":"Gu J ; Lau JT ; Xu H ; Zhong Y ; Hao Y ; Zhao Y ; Fan L ; Ling W ; ","ParentAuthors":"","DOI":"10.1007/s10461-012-0393-9 ","Keywords":"Adult\r\nChina\r\nFemale\r\nHIV Infections/prevention & control\r\nHeroin Dependence/*drug therapy/psychology\r\nHumans\r\nMale\r\n*Medication Adherence\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nPatient Education as Topic/*methods\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gu J, Lau JT, Xu H, Zhong Y, Hao Y, Zhao Y, Fan L, and Ling W (2013) A randomized controlled trial to evaluate the relative efficacy of the addition of a psycho-social intervention to standard-of-care services in reducing attrition and improving attendance among first-time users of methadone maintenance treatment in China.. AIDS and behavior 17(6), 2002-10 DOI: 10.1007/s10461-012-0393-9 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281833,"Title":"Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review.","ParentTitle":"Telemedicine journal and e-health : the official journal of the American Telemedicine Association","ShortTitle":"Guillen (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"June","StandardNumber":"1530-5627 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"28","Pages":"761-767","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"34714172","Comments":"","TypeName":"Journal, Article","Authors":"Guillen AG ; Reddy M ; Saadat S ; Chakravarthy B ; ","ParentAuthors":"","DOI":"10.1089/tmj.2021.0308 ","Keywords":"*Buprenorphine/therapeutic use\r\nHumans\r\n*Opioid-Related Disorders/drug therapy\r\nPandemics\r\n*Telemedicine/methods\r\n*COVID-19 Drug Treatment\r\nbuprenorphine\r\nopioid use disorder\r\ntelehealth\r\ntelemedicine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Guillen AG, Reddy M, Saadat S, and Chakravarthy B (2022) Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review.. Telemedicine journal and e-health : the official journal of the American Telemedicine Association 28(6), 761-767 DOI: 10.1089/tmj.2021.0308 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283746,"Title":"Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.","ParentTitle":"AIDS care","ShortTitle":"Guise (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"0954-0121 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"29","Pages":"1119-1128","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"28281354","Comments":"","TypeName":"Journal, Article","Authors":"Guise A ; Seguin M ; Mburu G ; McLean S ; Grenfell P ; Islam Z ; Filippovych S ; Assan H ; Low A ; Vickerman P ; Rhodes T ; ","ParentAuthors":"","DOI":"10.1080/09540121.2017.1300634 ","Keywords":"Anti-Retroviral Agents/*therapeutic use\r\nDelivery of Health Care/organization & administration\r\nHIV Infections/*drug therapy/prevention & control/psychology\r\nHumans\r\n*Opiate Substitution Treatment\r\nPreventive Health Services/*organization & administration\r\nPrimary Health Care/*methods\r\nSocial Stigma\r\nSubstance-Related Disorders/*drug therapy/psychology\r\nART\r\nHIV\r\nOST\r\nPeople who inject drugs\r\nintegration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Guise A, Seguin M, Mburu G, McLean S, Grenfell P, Islam Z, Filippovych S, Assan H, Low A, Vickerman P, and Rhodes T (2017) Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.. AIDS care 29(9), 1119-1128 DOI: 10.1080/09540121.2017.1300634 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283405,"Title":"Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Gunderson (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"March","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"10","Pages":"124-30","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"26918662","Comments":"","TypeName":"Journal, Article","Authors":"Gunderson EW ; Sumner M ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000201 ","Keywords":"Administration, Sublingual\r\nAdolescent\r\nAdult\r\nAged\r\nAnalgesics, Opioid/administration & dosage/adverse effects/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/*administration & dosage/adverse \r\n      effects/*therapeutic use\r\nCraving/drug effects\r\n*Dosage Forms\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/administration & dosage/adverse effects/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Compliance\r\nPatient Preference\r\nSingle-Blind Method\r\nSubstance Withdrawal Syndrome/drug therapy\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gunderson EW, and Sumner M (2016) Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film.. Journal of addiction medicine 10(2), 124-30 DOI: 10.1097/ADM.0000000000000201 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282041,"Title":"Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial.","ParentTitle":"The American journal of psychiatry","ShortTitle":"Gustafson (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"February","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"181","Pages":"115-124","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"37789744","Comments":"","TypeName":"Journal, Article","Authors":"Gustafson DH ; Landucci G ; Vjorn OJ ; Gicquelais RE ; Goldberg SB ; Johnston DC ; Curtin JJ ; Bailey GL ; Shah DV ; Pe-Romashko K ; Gustafson DH ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.20230055 ","Keywords":"Humans\r\nAnalgesics, Opioid/therapeutic use\r\nQuality of Life\r\nOpiate Substitution Treatment/adverse effects\r\n*Opioid-Related Disorders/drug therapy\r\n*Buprenorphine/therapeutic use\r\nMethadone/therapeutic use\r\n*Substance Withdrawal Syndrome/etiology\r\n*Telemedicine\r\nBuprenorphine\r\nMedications for Opioid Use Disorder\r\nMethadone\r\nOpioid Use Disorder\r\nSubstance-Related and Addictive Disorders\r\nmHealth","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Gustafson DH, Landucci G, Vjorn OJ, Gicquelais RE, Goldberg SB, Johnston DC, Curtin JJ, Bailey GL, Shah DV, Pe-Romashko K, and Gustafson DH (2024) Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial.. The American journal of psychiatry 181(2), 115-124 DOI: 10.1176/appi.ajp.20230055 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282341,"Title":"Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults.","ParentTitle":"Addictive behaviors","ShortTitle":"Haeny (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"November","StandardNumber":"0306-4603 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"110","Pages":"106514","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"32619868","Comments":"","TypeName":"Journal, Article","Authors":"Haeny AM ; Montgomery L ; Burlew AK ; Campbell ANC ; Scodes J ; Pavlicova M ; Rotrosen J ; Nunes E ; ","ParentAuthors":"","DOI":"10.1016/j.addbeh.2020.106514 ","Keywords":"Adult\r\nBlack or African American\r\n*Buprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nBlack/African American\r\nBuprenorphine\r\nNaltrexone\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Haeny AM, Montgomery L, Burlew AK, Campbell ANC, Scodes J, Pavlicova M, Rotrosen J, and Nunes E (2020) Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults.. Addictive behaviors 110, 106514 DOI: 10.1016/j.addbeh.2020.106514 "},{"Codes":[],"Outcomes":[],"ItemId":98281020,"Title":"A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder","ParentTitle":"International Clinical Psychopharmacology","ShortTitle":"Hage (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"0268-1315","City":"","Country":"","Publisher":"","Institution":"D. Jutras-Aswad, Research Center, Centre Hospitalier de l'Universit de Montrel (CR-CHUM), Viger Tower, 900 St-Denis Street, Montreal, QC, Canada","Volume":"33","Pages":"268-273","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L623431224&from=export http://dx.doi.org/10.1097/YIC.0000000000000223","OldItemId":"","Comments":"2018-08-16","TypeName":"Journal, Article","Authors":"Hage C E; Ghabrash M F; Dubreucq S ; Brissette S ; Lesprance F ; Lesprance P ; Ouellet-Plamondon C ; Bruneau J ; Jutras-Aswad D ; ","ParentAuthors":"","DOI":"10.1097/YIC.0000000000000223","Keywords":"NCT02200406\r\nantidepressant agent\r\ndesvenlafaxine\r\ndiamorphine\r\nmethadone\r\nopiate\r\nserotonin noradrenalin reuptake inhibitor\r\nadult\r\naged\r\nanxiety\r\nanxiety disorder\r\narticle\r\ncardiotoxicity\r\nclinical article\r\nClinical Global Impression scale\r\nColumbia suicide severity rating scale\r\nconstipation\r\ndepression\r\ndisease severity\r\ndrug craving\r\ndrug efficacy\r\ndrug safety\r\ndrug tolerability\r\ndrug urine level\r\nelectrocardiogram\r\nfatigue\r\nfemale\r\nHamilton Anxiety Scale\r\nheadache\r\nHeroin Craving Questionnaire\r\nhuman\r\nmajor depression\r\nmale\r\nmethadone treatment\r\nMontgomery Asberg Depression Rating Scale\r\nnausea\r\nopen study\r\nopiate addiction\r\noutcomes research\r\npatient compliance\r\npilot study\r\npreliminary data\r\npriority journal\r\npsychological rating scale\r\nQT interval\r\nquality of life\r\nquestionnaire\r\nself report\r\nStructured Clinical Interview for DSM Disorders\r\nsuicidal ideation\r\nsymptom\r\ntreatment outcome\r\nvomiting\r\npristiq","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hage C E, Ghabrash M F, Dubreucq S, Brissette S, Lesprance F, Lesprance P, Ouellet-Plamondon C, Bruneau J, and Jutras-Aswad D (2018) A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder. International Clinical Psychopharmacology 33(5), 268-273 DOI: 10.1097/YIC.0000000000000223"},{"Codes":[{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282432,"Title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis.","ParentTitle":"The lancet. Gastroenterology & hepatology","ShortTitle":"Hajarizadeh (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"November","StandardNumber":"2468-1253 (Electronic)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"3","Pages":"754-767","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"30245064","Comments":"","TypeName":"Journal, Article","Authors":"Hajarizadeh B ; Cunningham EB ; Reid H ; Law M ; Dore GJ ; Grebely J ; ","ParentAuthors":"","DOI":"10.1016/S2468-1253(18)30304-2 ","Keywords":"Antiviral Agents/*therapeutic use\r\nHepatitis C, Chronic/*complications/*drug therapy\r\nHumans\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*complications/drug therapy\r\nSubstance Abuse, Intravenous/*complications/drug therapy\r\nSustained Virologic Response","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hajarizadeh B, Cunningham EB, Reid H, Law M, Dore GJ, and Grebely J (2018) Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis.. The lancet. Gastroenterology & hepatology 3(11), 754-767 DOI: 10.1016/S2468-1253(18)30304-2 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282485,"Title":"Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.","ParentTitle":"Journal of hepatology","ShortTitle":"Hajarizadeh (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"April","StandardNumber":"0168-8278 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"72","Pages":"643-657","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"31785345","Comments":"","TypeName":"Journal, Article","Authors":"Hajarizadeh B ; Cunningham EB ; Valerio H ; Martinello M ; Law M ; Janjua NZ ; Midgard H ; Dalgard O ; Dillon J ; Hickman M ; Bruneau J ; Dore GJ ; Grebely J ; ","ParentAuthors":"","DOI":"10.1016/j.jhep.2019.11.012 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nAntiviral Agents/*therapeutic use\r\nFemale\r\n*Hepacivirus\r\nHepatitis C, Chronic/*complications/*drug therapy/virology\r\nHumans\r\nIncidence\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*complications/drug therapy\r\nReinfection/*epidemiology/virology\r\nRisk\r\nSubstance Abuse, Intravenous/*complications\r\nSustained Virologic Response\r\nDAA\r\nFollow-up\r\nHCV\r\nMeta-regression\r\nOAT\r\nOpioid agonist therapy\r\nPWID\r\nReinfection\r\nSVR\r\nSustained virological response\r\nSystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hajarizadeh B, Cunningham EB, Valerio H, Martinello M, Law M, Janjua NZ, Midgard H, Dalgard O, Dillon J, Hickman M, Bruneau J, Dore GJ, and Grebely J (2020) Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.. Journal of hepatology 72(4), 643-657 DOI: 10.1016/j.jhep.2019.11.012 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280343,"Title":"Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Hall (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"N.Y. Hall, School of Health and Social Development, Deakin University, 221 Burwood Highway, Burwood, Victoria, Australia","Volume":"221","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2011194769&from=export http://dx.doi.org/10.1016/j.drugalcdep.2021.108651","OldItemId":"","Comments":"2021-08-13","TypeName":"Journal, Article","Authors":"Hall N Y; Le L ; Majmudar I ; Mihalopoulos C ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.108651","Keywords":"methadone\r\nattitude to health\r\nclinical practice\r\nDSM-IV\r\nevidence based medicine\r\nhealth care access\r\nhealth care cost\r\nhealth care disparity\r\nhealth literacy\r\nhealth program\r\nhuman\r\nmeta analysis\r\nopiate addiction\r\nopiate substitution treatment\r\npatient attitude\r\npractice guideline\r\nqualitative analysis\r\nquantitative analysis\r\nreview\r\nself report\r\nsocial aspect\r\nsocial stigma\r\nsystematic review\r\nthematic analysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hall N Y, Le L, Majmudar I, and Mihalopoulos C (2021) Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence 221,  DOI: 10.1016/j.drugalcdep.2021.108651"},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948331,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282609,"Title":"Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Hmmig (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"October","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"47","Pages":"275-81","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"25064422","Comments":"","TypeName":"Journal, Article","Authors":"Hmmig R ; Khler W ; Bonorden-Kleij K ; Weber B ; Lebentrau K ; Berthel T ; Babic-Hohnjec L ; Vollmert C ; Hpner D ; Gholami N ; Verthein U ; Haasen C ; Reimer J ; Ruckes C ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2014.05.012 ","Keywords":"Administration, Oral\r\nAdult\r\nCross-Over Studies\r\nDelayed-Action Preparations\r\nEurope\r\nFemale\r\nHumans\r\nInternational Cooperation\r\nMale\r\nMethadone/administration & dosage/adverse effects/*therapeutic use\r\nMorphine/administration & dosage/adverse effects/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nOpioid dependence\r\nOpioid substitution treatment\r\nQTc-interval\r\nSafety\r\nSlow-release oral morphine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hmmig R, Khler W, Bonorden-Kleij K, Weber B, Lebentrau K, Berthel T, Babic-Hohnjec L, Vollmert C, Hpner D, Gholami N, Verthein U, Haasen C, Reimer J, and Ruckes C (2014) Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.. Journal of substance abuse treatment 47(4), 275-81 DOI: 10.1016/j.jsat.2014.05.012 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281502,"Title":"Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Hartung (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"D.M. Hartung, Oregon State University, Oregon Health and Science University College of Pharmacy, 3303 SW Bond Avenue, CH12C, Portland OR 97239, United States","Volume":"47","Pages":"113-121","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L53138516&from=export http://dx.doi.org/10.1016/j.jsat.2014.03.007","OldItemId":"","Comments":"2014-07-07","TypeName":"Journal, Article","Authors":"Hartung D M; McCarty D ; Fu R ; Wiest K ; Chalk M ; Gastfriend D R; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2014.03.007","Keywords":"alcohol\r\nnaltrexone\r\nalcoholism\r\narticle\r\nCinahl\r\ncost benefit analysis\r\ndetoxification\r\nhealth care utilization\r\nhospital patient\r\nhuman\r\nMedline\r\nmeta analysis\r\nobservational study\r\nopiate addiction\r\npriority journal\r\nsubstance abuse\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hartung D M, McCarty D, Fu R, Wiest K, Chalk M, and Gastfriend D R (2014) Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies. Journal of Substance Abuse Treatment 47(2), 113-121 DOI: 10.1016/j.jsat.2014.03.007"},{"Codes":[],"Outcomes":[],"ItemId":98279894,"Title":"Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Hassman (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0095-2990","City":"","Country":"","Publisher":"","Institution":"S. Strafford, Indivior Inc, 10710 Midlothian Turnpike, Suite 125, North Chesterfield, VA, United States","Volume":"49","Pages":"43-52","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2018755541&from=export http://dx.doi.org/10.1080/00952990.2022.2106574","OldItemId":"","Comments":"2023-03-13","TypeName":"Journal, Article","Authors":"Hassman H ; Strafford S ; Shinde S N; Heath A ; Boyett B ; Dobbins R L; ","ParentAuthors":"","DOI":"10.1080/00952990.2022.2106574","Keywords":"NCT03993392\r\nNCT04060654\r\nbuprenorphine\r\ncannabinoid\r\nclonidine\r\nfentanyl\r\nibuprofen\r\nondansetron\r\noxycodone\r\ntrazodone\r\nadult\r\nanxiety disorder\r\narticle\r\nchill\r\nclinical article\r\nclinical assessment\r\ncontrolled study\r\ndemographics\r\ndrug safety\r\ndrug tolerability\r\nDSM-5\r\nfemale\r\nhuman\r\ninjection site contusion\r\ninjection site pain\r\ninsomnia\r\nirritability\r\nmale\r\nnausea\r\nopiate addiction\r\npain\r\npilot study\r\nsingle drug dose\r\nsustained drug release\r\ntreatment outcome\r\nvisual analog scale\r\nvomiting\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hassman H, Strafford S, Shinde S N, Heath A, Boyett B, and Dobbins R L (2023) Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection. American Journal of Drug and Alcohol Abuse 49(1), 43-52 DOI: 10.1080/00952990.2022.2106574"},{"Codes":[],"Outcomes":[],"ItemId":98281847,"Title":"Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.","ParentTitle":"BMC public health","ShortTitle":"Henderson (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"July","StandardNumber":"1471-2458 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"1471","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34320954","Comments":"","TypeName":"Journal, Article","Authors":"Henderson R ; McInnes A ; Mackey L ; Bruised Head M; Crowshoe L ; Hann J ; Hayward J ; Holroyd BR ; Lang E ; Larson B ; Leonard AJ ; Persaud S ; Raghavji K ; Sarin C ; Virani H ; Wadsworth IW ; Whitman S ; McLane P ; ","ParentAuthors":"","DOI":"10.1186/s12889-021-11495-0 ","Keywords":"Alberta\r\n*COVID-19\r\n*Disasters\r\nEmergencies\r\nHumans\r\n*Opioid-Related Disorders/epidemiology/therapy\r\nPandemics/prevention & control\r\nPublic Health\r\nSARS-CoV-2\r\nCoronavirus\r\nDisaster planning\r\nEmergency\r\nHealth services\r\nMedication assisted treatment\r\nOpioid agonist treatment\r\nOpioid epidemic\r\nReview","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Henderson R, McInnes A, Mackey L, Bruised Head M, Crowshoe L, Hann J, Hayward J, Holroyd BR, Lang E, Larson B, Leonard AJ, Persaud S, Raghavji K, Sarin C, Virani H, Wadsworth IW, Whitman S, and McLane P (2021) Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.. BMC public health 21(1), 1471 DOI: 10.1186/s12889-021-11495-0 "},{"Codes":[],"Outcomes":[],"ItemId":98283551,"Title":"Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms.","ParentTitle":"The American journal on addictions","ShortTitle":"Hess (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"20","Pages":"480-1","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"21838850","Comments":"","TypeName":"Journal, Article","Authors":"Hess M ; Boesch L ; Leisinger R ; Stohler R ; ","ParentAuthors":"","DOI":"10.1111/j.1521-0391.2011.00159.x ","Keywords":"Administration, Cutaneous\r\nAdministration, Sublingual\r\nAdult\r\nBuprenorphine/*administration & dosage/therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMethadone/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nSeverity of Illness Index\r\nSubstance Withdrawal Syndrome/drug therapy/*prevention & control","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hess M, Boesch L, Leisinger R, and Stohler R (2011) Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms.. The American journal on addictions 20(5), 480-1 DOI: 10.1111/j.1521-0391.2011.00159.x "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281999,"Title":"Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.","ParentTitle":"Drug development and industrial pharmacy","ShortTitle":"Hjelmstrm (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"January","StandardNumber":"0363-9045 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"1-7","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"31914818","Comments":"","TypeName":"Journal, Article","Authors":"Hjelmstrm P ; Banke Nordbeck E; Tiberg F ; ","ParentAuthors":"","DOI":"10.1080/03639045.2019.1706552 ","Keywords":"Buprenorphine/*administration & dosage/pharmacology\r\nDose-Response Relationship, Drug\r\nHumans\r\nNarcotic Antagonists/administration & dosage/pharmacology\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nOpioid dependence\r\nbuprenorphine\r\ndose\r\nillicit opioid use\r\nopioid receptor blockade\r\nopioid use disorder\r\ntreatment retention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hjelmstrm P, Banke Nordbeck E, and Tiberg F (2020) Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.. Drug development and industrial pharmacy 46(1), 1-7 DOI: 10.1080/03639045.2019.1706552 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284778,"Title":"Telehealth-Delivered Opioid Agonist Therapy for the Treatment of Adults with Opioid Use Disorder: Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines","ParentTitle":"CADTH Rapid Response Reports","ShortTitle":"Ho (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"October","StandardNumber":"30817107","City":"Ottawa (ON)","Country":"","Publisher":"Canadian Agency for Drugs and Technologies in Health","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"30817107","Comments":"","TypeName":"Book, Whole","Authors":"Ho C ; Argez C ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ho C, and Argez C (2018) Telehealth-Delivered Opioid Agonist Therapy for the Treatment of Adults with Opioid Use Disorder: Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health"},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280128,"Title":"Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States","ParentTitle":"Addictive Behaviors","ShortTitle":"Hochheimer (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0306-4603","City":"","Country":"","Publisher":"","Institution":"M. Hochheimer, School of Social Work, University of Maryland, Baltimore, 525 W. Redwood Street, Baltimore, MD, United States","Volume":"124","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2014617539&from=export http://dx.doi.org/10.1016/j.addbeh.2021.107113","OldItemId":"","Comments":"2021-10-05","TypeName":"Journal, Article","Authors":"Hochheimer M ; Unick G J; ","ParentAuthors":"","DOI":"10.1016/j.addbeh.2021.107113","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nAfrican American\r\ncultural factor\r\ndrug dependence treatment\r\nethnicity\r\ngender\r\nhuman\r\nmedication compliance\r\nmeta analysis\r\nmethadone treatment\r\nopiate addiction\r\noutcome assessment\r\noutcome variable\r\npatient counseling\r\npsychosocial intervention\r\nrace\r\nretention in care\r\nreview\r\nsex difference\r\nsocial aspect\r\nsystematic review\r\ntreatment duration\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hochheimer M, and Unick G J (2022) Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States. Addictive Behaviors 124,  DOI: 10.1016/j.addbeh.2021.107113"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283115,"Title":"A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.","ParentTitle":"Drug and alcohol review","ShortTitle":"Holland (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"June","StandardNumber":"0959-5236 (Linking)","City":"Australia","Country":"","Publisher":"","Institution":"","Volume":"31","Pages":"483-91","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"22150819","Comments":"","TypeName":"Journal, Article","Authors":"Holland R ; Matheson C ; Anthony G ; Roberts K ; Priyardarshi S ; Macrae A ; Whitelaw E ; Appavoo S ; Bond C ; ","ParentAuthors":"","DOI":"10.1111/j.1465-3362.2011.00394.x ","Keywords":"Adult\r\nDrug Administration Schedule\r\nFemale\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMale\r\n*Medication Adherence\r\nMethadone/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nPilot Projects\r\nScotland\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Holland R, Matheson C, Anthony G, Roberts K, Priyardarshi S, Macrae A, Whitelaw E, Appavoo S, and Bond C (2012) A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.. Drug and alcohol review 31(4), 483-91 DOI: 10.1111/j.1465-3362.2011.00394.x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282405,"Title":"Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Holland (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"April","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"109","Pages":"596-607","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"24304349","Comments":"","TypeName":"Journal, Article","Authors":"Holland R ; Maskrey V ; Swift L ; Notley C ; Robinson A ; Nagar J ; Gale T ; Kouimtsidis C ; ","ParentAuthors":"","DOI":"10.1111/add.12439 ","Keywords":"Adult\r\nBuprenorphine/*therapeutic use\r\nCrime/statistics & numerical data\r\nFemale\r\nHumans\r\nMaintenance Chemotherapy\r\nMale\r\nMedication Adherence/*statistics & numerical data\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods/psychology\r\nOpioid-Related Disorders/*drug therapy/psychology\r\nProportional Hazards Models\r\nQuality of Life/psychology\r\nTreatment Outcome\r\nUnited Kingdom\r\nBuprenorphine\r\ncapability index\r\nconsumption\r\ncriminality\r\nillicit drug use\r\nopiate maintenance treatment\r\nquality of life\r\nrandomized controlled trial\r\nsupervised methadone\r\ntreatment retention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J, Gale T, and Kouimtsidis C (2014) Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.. Addiction (Abingdon, and England) 109(4), 596-607 DOI: 10.1111/add.12439 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282594,"Title":"Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Hser (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"October","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"106","Pages":"1801-9","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"21793958","Comments":"","TypeName":"Journal, Article","Authors":"Hser YI ; Li J ; Jiang H ; Zhang R ; Du J ; Zhang C ; Zhang B ; Evans E ; Wu F ; Chang YJ ; Peng C ; Huang D ; Stitzer ML ; Roll J ; Zhao M ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2011.03490.x ","Keywords":"Adult\r\nAnalysis of Variance\r\nChina\r\nFemale\r\nHIV Infections/epidemiology/prevention & control\r\nHumans\r\nMale\r\nMethadone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/psychology/*rehabilitation/urine\r\nPatient Compliance/*statistics & numerical data\r\nPatient Dropouts/statistics & numerical data\r\nRecurrence\r\nReward\r\nSubstance Abuse, Intravenous/psychology/*rehabilitation/urine\r\nTime Factors\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hser YI, Li J, Jiang H, Zhang R, Du J, Zhang C, Zhang B, Evans E, Wu F, Chang YJ, Peng C, Huang D, Stitzer ML, Roll J, and Zhao M (2011) Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.. Addiction (Abingdon, and England) 106(10), 1801-9 DOI: 10.1111/j.1360-0443.2011.03490.x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282805,"Title":"Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Hser (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"January","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"109","Pages":"79-87","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23961726","Comments":"","TypeName":"Journal, Article","Authors":"Hser YI ; Saxon AJ ; Huang D ; Hasson A ; Thomas C ; Hillhouse M ; Jacobs P ; Teruya C ; McLaughlin P ; Wiest K ; Cohen A ; Ling W ; ","ParentAuthors":"","DOI":"10.1111/add.12333 ","Keywords":"Adolescent\r\nAdult\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination\r\nFemale\r\nHumans\r\nMale\r\nMedication Adherence/*statistics & numerical data\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nTreatment Outcome\r\nYoung Adult\r\nBuprenorphine\r\nmethadone\r\nopiate dependence\r\ntreatment outcomes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, and Ling W (2014) Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.. Addiction (Abingdon, and England) 109(1), 79-87 DOI: 10.1111/add.12333 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282656,"Title":"Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Hser (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"April","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"111","Pages":"695-705","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"26599131","Comments":"","TypeName":"Journal, Article","Authors":"Hser YI ; Evans E ; Huang D ; Weiss R ; Saxon A ; Carroll KM ; Woody G ; Liu D ; Wakim P ; Matthews AG ; Hatch-Maillette M ; Jelstrom E ; Wiest K ; McLaughlin P ; Ling W ; ","ParentAuthors":"","DOI":"10.1111/add.13238 ","Keywords":"Adolescent\r\nAdult\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/*therapeutic use\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nRandom Allocation\r\nTreatment Outcome\r\nYoung Adult\r\nBuprenorphine\r\nlongitudinal\r\nmethadone\r\nmortality\r\nopioid dependence\r\nopioid use\r\noutcomes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M, Jelstrom E, Wiest K, McLaughlin P, and Ling W (2016) Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.. Addiction (Abingdon, and England) 111(4), 695-705 DOI: 10.1111/add.13238 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282018,"Title":"Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Hser (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"January","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"117","Pages":"151-161","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34105213","Comments":"","TypeName":"Journal, Article","Authors":"Hser YI ; Zhu Y ; Fei Z ; Mooney LJ ; Evans EA ; Kelleghan A ; Matthews A ; Yoo C ; Saxon AJ ; ","ParentAuthors":"","DOI":"10.1111/add.15594 ","Keywords":"Adult\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nFollow-Up Studies\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy/epidemiology\r\nBuprenorphine\r\ncomorbidity\r\nlongitudinal\r\nmental health disorder\r\nmethadone\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hser YI, Zhu Y, Fei Z, Mooney LJ, Evans EA, Kelleghan A, Matthews A, Yoo C, and Saxon AJ (2022) Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.. Addiction (Abingdon, and England) 117(1), 151-161 DOI: 10.1111/add.15594 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280808,"Title":"Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder","ParentTitle":"American Journal on Addictions","ShortTitle":"Huhn (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1055-0496","City":"","Country":"","Publisher":"","Institution":"A.S. Huhn, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States","Volume":"28","Pages":"246-261","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L628250696&from=export http://dx.doi.org/10.1111/ajad.12921","OldItemId":"","Comments":"","TypeName":"Journal, Article","Authors":"Huhn A S; Berry M S; Dunn K E; ","ParentAuthors":"","DOI":"10.1111/ajad.12921","Keywords":"adult\r\nattention\r\nclinical trial (topic)\r\ncohort analysis\r\ndepression\r\ndrug dependence\r\ndrug therapy\r\nfemale\r\nfunding\r\ngender\r\nhuman\r\nmale\r\nMedline\r\nmental health\r\nmental stress\r\nmeta analysis\r\nPreferred Reporting Items for Systematic Reviews and Meta-Analyses\r\nprospective study\r\nremission\r\nreview\r\nsystematic review\r\nbuprenorphine\r\nopiate","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Huhn A S, Berry M S, and Dunn K E (2019) Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder. American Journal on Addictions 28(4), 246-261 DOI: 10.1111/ajad.12921"},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280037,"Title":"Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper","ParentTitle":"Science Translational Medicine","ShortTitle":"Huhn (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1946-6234","City":"","Country":"","Publisher":"","Institution":"A.S. Huhn, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States","Volume":"14","Pages":"","Edition":"","Issue":"650","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2019775461&from=export http://dx.doi.org/10.1126/scitranslmed.abn8238","OldItemId":"","Comments":"2023-01-17","TypeName":"Journal, Article","Authors":"Huhn A S; Finan P H; Gamaldo C E; Hammond A S; Umbricht A ; Bergeria C L; Strain E C; Dunn K E; ","ParentAuthors":"","DOI":"10.1126/scitranslmed.abn8238","Keywords":"buprenorphine plus naloxone\r\nopiate\r\nplacebo\r\nsuvorexant\r\nactimetry\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndrug craving\r\ndrug dose reduction\r\ndrug withdrawal\r\nelectroencephalography\r\nfemale\r\nhuman\r\nintention to treat analysis\r\nmale\r\nopiate addiction\r\nrandomized controlled trial\r\nsleep disorder\r\nsleep time\r\nvisual analog scale\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Huhn A S, Finan P H, Gamaldo C E, Hammond A S, Umbricht A, Bergeria C L, Strain E C, and Dunn K E (2022) Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper. Science Translational Medicine 14(650),  DOI: 10.1126/scitranslmed.abn8238"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283064,"Title":"Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.","ParentTitle":"Archives of general psychiatry","ShortTitle":"Hulse (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"October","StandardNumber":"0003-990X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"66","Pages":"1108-15","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"19805701","Comments":"","TypeName":"Journal, Article","Authors":"Hulse GK ; Morris N ; Arnold-Reed D ; Tait RJ ; ","ParentAuthors":"","DOI":"10.1001/archgenpsychiatry.2009.130 ","Keywords":"Administration, Oral\r\nAdult\r\nDrug Implants\r\nFemale\r\nFollow-Up Studies\r\nHeroin Dependence/blood/*drug therapy/prevention & control\r\nHumans\r\nMale\r\nNaltrexone/*administration & dosage/blood/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/blood/therapeutic use\r\nRecurrence\r\nSubstance Abuse Detection\r\nTablets\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Hulse GK, Morris N, Arnold-Reed D, and Tait RJ (2009) Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.. Archives of general psychiatry 66(10), 1108-15 DOI: 10.1001/archgenpsychiatry.2009.130 "},{"Codes":[],"Outcomes":[],"ItemId":98283336,"Title":"A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.","ParentTitle":"Journal of opioid management","ShortTitle":"Jain (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"January","StandardNumber":"1551-7489 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"7","Pages":"11-20","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"21434580","Comments":"","TypeName":"Journal, Article","Authors":"Jain K ; Jain R ; Dhawan A ; ","ParentAuthors":"","DOI":"10.5055/jom.2011.0044 ","Keywords":"Acute Disease\r\nAdolescent\r\nAdult\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nHeroin/administration & dosage/adverse effects\r\nHeroin Dependence/*drug therapy/metabolism\r\nHumans\r\nMale\r\nMemantine/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nNaloxone/administration & dosage/adverse effects/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/adverse effects/*therapeutic use\r\nReceptors, N-Methyl-D-Aspartate/antagonists & inhibitors\r\nSubstance Withdrawal Syndrome/*drug therapy/etiology/metabolism\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jain K, Jain R, and Dhawan A (2011) A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.. Journal of opioid management 7(1), 11-20 DOI: 10.5055/jom.2011.0044 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282151,"Title":"The Effectiveness of Group Spiritual Intervention on Self-esteem and Happiness Among Men Undergoing Methadone Maintenance Treatment.","ParentTitle":"Current drug research reviews","ShortTitle":"Jalali (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"2589-9775 (Linking)","City":"United Arab Emirates","Country":"","Publisher":"","Institution":"","Volume":"11","Pages":"67-72","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29749316","Comments":"","TypeName":"Journal, Article","Authors":"Jalali A ; Behrouzi MK ; Salari N ; Bazrafshan MR ; Rahmati M ; ","ParentAuthors":"","DOI":"10.2174/1874473711666180510164420 ","Keywords":"Adult\r\n*Happiness\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment/*psychology\r\nOpioid-Related Disorders/psychology/rehabilitation/*therapy\r\nPersonal Satisfaction\r\nPsychotherapy, Group/*methods\r\n*Self Concept\r\n*Spirituality\r\nTreatment Outcome\r\nHappiness\r\ndrug user\r\nmale\r\nmethadone maintenance therapy\r\nself-esteem\r\nspiritual intervention.","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jalali A, Behrouzi MK, Salari N, Bazrafshan MR, and Rahmati M (2019) The Effectiveness of Group Spiritual Intervention on Self-esteem and Happiness Among Men Undergoing Methadone Maintenance Treatment.. Current drug research reviews 11(1), 67-72 DOI: 10.2174/1874473711666180510164420 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948213,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948221,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948227,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948252,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948263,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948264,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948333,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948334,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948335,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948339,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948346,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281517,"Title":"Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries","ParentTitle":"Journal of Food and Drug Analysis","ShortTitle":"Jarlais (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1021-9498","City":"","Country":"","Publisher":"","Institution":"D.C.D. Jarlais, Beth Israel Medical Center, 160 Water Street FL 24, New York, NY 10038, United States","Volume":"21","Pages":"S59-S61","Edition":"","Issue":"4 SUPPL.","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52852290&from=export http://dx.doi.org/10.1016/j.jfda.2013.09.035","OldItemId":"","Comments":"2014-04-04","TypeName":"Journal, Article","Authors":"Jarlais D C.D; ","ParentAuthors":"","DOI":"10.1016/j.jfda.2013.09.035","Keywords":"methadone\r\nBangladesh\r\nBrazil\r\nChina\r\nconference paper\r\nEstonia\r\nharm reduction\r\nhealth program\r\nhepatitis C\r\nhigh risk behavior\r\nhuman\r\nHuman immunodeficiency virus infection\r\nincidence\r\nincome\r\ninfection risk\r\nintravenous drug abuse\r\nIran\r\nLithuania\r\nlowest income group\r\nmiddle income group\r\nopiate addiction\r\nopiate substitution treatment\r\nprevalence\r\nquality of life\r\nrisk reduction\r\nscale up\r\nsystematic review\r\nTaiwan\r\nThailand\r\nViet Nam\r\nvirus transmission","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jarlais D C.D (2013) Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries. Journal of Food and Drug Analysis 21(4 SUPPL.), S59-S61 DOI: 10.1016/j.jfda.2013.09.035"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282186,"Title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Jarvis (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"July","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"113","Pages":"1188-1209","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"29396985","Comments":"","TypeName":"Journal, Article","Authors":"Jarvis BP ; Holtyn AF ; Subramaniam S ; Tompkins DA ; Oga EA ; Bigelow GE ; Silverman K ; ","ParentAuthors":"","DOI":"10.1111/add.14180 ","Keywords":"Analgesics, Opioid/poisoning\r\nDelayed-Action Preparations\r\nDrug Overdose\r\nHumans\r\nInjections, Intramuscular\r\nMedication Adherence\r\nNaltrexone/*administration & dosage/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nExtended-release\r\nheroin\r\ninjectable\r\nmedication-assisted treatment\r\nnaltrexone\r\nopioid use disorder\r\nprescription opioids","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow GE, and Silverman K (2018) Extended-release injectable naltrexone for opioid use disorder: a systematic review.. Addiction (Abingdon, and England) 113(7), 1188-1209 DOI: 10.1111/add.14180 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282319,"Title":"The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Jarvis (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"April","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"197","Pages":"220-227","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"30852374","Comments":"","TypeName":"Journal, Article","Authors":"Jarvis BP ; Holtyn AF ; DeFulio A ; Koffarnus MN ; Leoutsakos JS ; Umbricht A ; Fingerhood M ; Bigelow GE ; Silverman K ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2018.12.026 ","Keywords":"Adult\r\nBlack or African American/psychology\r\nCocaine/*urine\r\nDelayed-Action Preparations/administration & dosage\r\nFemale\r\nHeroin/*urine\r\nHumans\r\nInjections\r\nMale\r\nMiddle Aged\r\nMotivation\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy/ethnology/psychology\r\nSubstance Abuse Detection\r\nWorkplace\r\nContingency management\r\nEmployment-based reinforcement\r\nExtended-release naltrexone\r\nHeroin\r\nIncentives\r\nOpioid use disorder\r\nTherapeutic workplace\r\nTreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jarvis BP, Holtyn AF, DeFulio A, Koffarnus MN, Leoutsakos JS, Umbricht A, Fingerhood M, Bigelow GE, and Silverman K (2019) The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial.. Drug and alcohol dependence 197, 220-227 DOI: 10.1016/j.drugalcdep.2018.12.026 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281997,"Title":"Slow-release oral morphine for opioid maintenance treatment: a systematic review.","ParentTitle":"British journal of clinical pharmacology","ShortTitle":"Jegu (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"June","StandardNumber":"0306-5251 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"71","Pages":"832-43","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"21265874","Comments":"","TypeName":"Journal, Article","Authors":"Jegu J ; Gallini A ; Soler P ; Montastruc JL ; Lapeyre-Mestre M ; ","ParentAuthors":"","DOI":"10.1111/j.1365-2125.2011.03923.x ","Keywords":"Administration, Oral\r\nAnalgesics, Opioid/*therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nMorphine/*therapeutic use\r\nOpioid-Related Disorders/drug therapy/*rehabilitation\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome/drug therapy/*rehabilitation\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jegu J, Gallini A, Soler P, Montastruc JL, and Lapeyre-Mestre M (2011) Slow-release oral morphine for opioid maintenance treatment: a systematic review.. British journal of clinical pharmacology 71(6), 832-43 DOI: 10.1111/j.1365-2125.2011.03923.x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281956,"Title":"Systematic review on the clinical management of chronic pain and comorbid opioid use disorder.","ParentTitle":"Adicciones","ShortTitle":"Jimnez-Fernndez (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"July","StandardNumber":"0214-4840 (Linking)","City":"Spain","Country":"","Publisher":"","Institution":"","Volume":"35","Pages":"197-212","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"35472158","Comments":"","TypeName":"Journal, Article","Authors":"Jimnez-Fernndez B ; Calomarde-Gmez C ; Lpez-Lazcano A ; Lligoa A ; Gual A ; Lpez-Pelayo H ; ","ParentAuthors":"","DOI":"10.20882/adicciones.1680 ","Keywords":"Humans\r\n*Chronic Pain/complications/drug therapy\r\n*Opioid-Related Disorders/complications/epidemiology/therapy\r\nAnalgesics, Opioid/therapeutic use/adverse effects\r\nMethadone\r\n*Buprenorphine/therapeutic use\r\nOpiate Substitution Treatment/adverse effects/methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jimnez-Fernndez B, Calomarde-Gmez C, Lpez-Lazcano A, Lligoa A, Gual A, and Lpez-Pelayo H (2023) Systematic review on the clinical management of chronic pain and comorbid opioid use disorder.. Adicciones 35(2), 197-212 DOI: 10.20882/adicciones.1680 "},{"Codes":[],"Outcomes":[],"ItemId":98281779,"Title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy.","ParentTitle":"Drugs","ShortTitle":"Jones (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"April","StandardNumber":"0012-6667 (Linking)","City":"New Zealand","Country":"","Publisher":"","Institution":"","Volume":"72","Pages":"747-57","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"22512363","Comments":"","TypeName":"Journal, Article","Authors":"Jones HE ; Finnegan LP ; Kaltenbach K ; ","ParentAuthors":"","DOI":"10.2165/11632820-000000000-00000 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMethadone/*therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy/prevention & control\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nRandomized Controlled Trials as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jones HE, Finnegan LP, and Kaltenbach K (2012) Methadone and buprenorphine for the management of opioid dependence in pregnancy.. Drugs 72(6), 747-57 DOI: 10.2165/11632820-000000000-00000 "},{"Codes":[],"Outcomes":[],"ItemId":98283015,"Title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Jones (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"November","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"107 Suppl 1","Pages":"5-27","Edition":"","Issue":"0 1","Availability":"","URL":"","OldItemId":"23106923","Comments":"","TypeName":"Journal, Article","Authors":"Jones HE ; Heil SH ; Baewert A ; Arria AM ; Kaltenbach K ; Martin PR ; Coyle MG ; Selby P ; Stine SM ; Fischer G ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2012.04035.x ","Keywords":"Buprenorphine/adverse effects/pharmacology/*therapeutic use\r\nChild Development/drug effects\r\nFemale\r\nFetus/drug effects\r\nHumans\r\nInfant, Newborn\r\nLength of Stay\r\nMethadone/therapeutic use\r\nMilk, Human/chemistry\r\nMorphine/therapeutic use\r\nNarcotic Antagonists/adverse effects/pharmacology/*therapeutic use\r\nNeonatal Abstinence Syndrome/drug therapy\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/urine\r\nPain Management/methods\r\nPatient Dropouts\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nPrenatal Exposure Delayed Effects/therapy\r\nRandomized Controlled Trials as Topic\r\n*Substance Abuse Detection\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, and Fischer G (2012) Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.. Addiction (Abingdon, and England) 107 Suppl 1(0 1), 5-27 DOI: 10.1111/j.1360-0443.2012.04035.x "},{"Codes":[],"Outcomes":[],"ItemId":98281905,"Title":"Bridging the Macro-micro Divide: A Qualitative Meta-synthesis on the Perspectives and Experiences of Health Care Providers on the Extramedical Use and Diversion of Buprenorphine.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Kankanam (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"January","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"17","Pages":"e1-e10","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"35914107","Comments":"","TypeName":"Journal, Article","Authors":"Kankanam Gamage K; Tejpar S ; Majid U ; Dixon K ; Sabioni P ; Sud A ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000001020 ","Keywords":"Humans\r\n*Buprenorphine/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nOpiate Substitution Treatment/methods\r\nHealth Personnel","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kankanam Gamage K, Tejpar S, Majid U, Dixon K, Sabioni P, and Sud A (2023) Bridging the Macro-micro Divide: A Qualitative Meta-synthesis on the Perspectives and Experiences of Health Care Providers on the Extramedical Use and Diversion of Buprenorphine.. Journal of addiction medicine 17(1), e1-e10 DOI: 10.1097/ADM.0000000000001020 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282155,"Title":"Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Karow (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"December","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"209-15","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"20728288","Comments":"","TypeName":"Journal, Article","Authors":"Karow A ; Reimer J ; Schfer I ; Krausz M ; Haasen C ; Verthein U ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2010.06.009 ","Keywords":"Adult\r\nAged\r\nAged, 80 and over\r\nCase Management\r\nCounseling\r\nEducation\r\nFemale\r\nHeroin/*therapeutic use\r\nHeroin Dependence/drug therapy/psychology/*rehabilitation\r\nHumans\r\nInterview, Psychological\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/drug therapy/psychology/*rehabilitation\r\nPsychiatric Status Rating Scales\r\n*Quality of Life\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Karow A, Reimer J, Schfer I, Krausz M, Haasen C, and Verthein U (2010) Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.. Drug and alcohol dependence 112(3), 209-15 DOI: 10.1016/j.drugalcdep.2010.06.009 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15064034,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269960,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282109,"Title":"Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone.","ParentTitle":"Clinical pharmacology and therapeutics","ShortTitle":"Kazi (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"March","StandardNumber":"0009-9236 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"115","Pages":"506-514","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"38009933","Comments":"","TypeName":"Journal, Article","Authors":"Kazi I ; Chenoweth MJ ; Jutras-Aswad D ; Ahamad K ; Socias ME ; Le Foll B ; Tyndale RF ; ","ParentAuthors":"","DOI":"10.1002/cpt.3112 ","Keywords":"Humans\r\nMethadone/therapeutic use\r\nAnalgesics, Opioid/adverse effects\r\nPharmacogenetics\r\nCytochrome P-450 CYP3A\r\nNarcotic Antagonists/adverse effects\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\n*Buprenorphine/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/genetics\r\nOpiate Substitution Treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kazi I, Chenoweth MJ, Jutras-Aswad D, Ahamad K, Socias ME, Le Foll B, and Tyndale RF (2024) Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone.. Clinical pharmacology and therapeutics 115(3), 506-514 DOI: 10.1002/cpt.3112 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283451,"Title":"Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Kelly (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"June","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"6","Pages":"145-52","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"22134175","Comments":"","TypeName":"Journal, Article","Authors":"Kelly SM ; Schwartz RP ; Ogrady KE ; Gandhi D ; Jaffe JH ; ","ParentAuthors":"","DOI":"10.1097/ADM.0b013e31823ae556 ","Keywords":"Adult\r\nBaltimore\r\nCombined Modality Therapy\r\n*Counseling\r\nCrisis Intervention\r\nDose-Response Relationship, Drug\r\nFemale\r\nFollow-Up Studies\r\nHIV Infections/*prevention & control/psychology/*transmission\r\nHealth Knowledge, Attitudes, Practice\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\nPatient Education as Topic/methods\r\nUnsafe Sex/prevention & control/psychology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kelly SM, Schwartz RP, Ogrady KE, Gandhi D, and Jaffe JH (2012) Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.. Journal of addiction medicine 6(2), 145-52 DOI: 10.1097/ADM.0b013e31823ae556 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281930,"Title":"Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review.","ParentTitle":"Journal of general internal medicine","ShortTitle":"Kennedy (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"February","StandardNumber":"0884-8734 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"37","Pages":"332-340","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"33469778","Comments":"","TypeName":"Journal, Article","Authors":"Kennedy AJ ; Wessel CB ; Levine R ; Downer K ; Raymond M ; Osakue D ; Hassan I ; Merlin JS ; Liebschutz JM ; ","ParentAuthors":"","DOI":"10.1007/s11606-020-06448-z ","Keywords":"*Behavior, Addictive\r\n*Buprenorphine/therapeutic use\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\n*buprenorphine\r\n*long-term\r\n*opioid use disorder\r\n*retention\r\n*systematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kennedy AJ, Wessel CB, Levine R, Downer K, Raymond M, Osakue D, Hassan I, Merlin JS, and Liebschutz JM (2022) Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review.. Journal of general internal medicine 37(2), 332-340 DOI: 10.1007/s11606-020-06448-z "},{"Codes":[{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279837,"Title":"Side Effects of Chronic Methadone Use in Opioid Addiction: A Scoping Review on Hematological Derangements","ParentTitle":"Current Drug Safety","ShortTitle":"Khalid (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"1574-8863","City":"","Country":"","Publisher":"","Institution":"K. Khalid, Clinical Research Centre, Hospital Tuanku Fauziah, Ministry of Health Malaysia, Perlis, Malaysia","Volume":"18","Pages":"167-174","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2019067697&from=export http://dx.doi.org/10.2174/1574886317666220514154931","OldItemId":"","Comments":"2023-02-03","TypeName":"Journal, Article","Authors":"Khalid K ; Anuar A ; Ang W C; Jamaluddin R ; ","ParentAuthors":"","DOI":"10.2174/1574886317666220514154931","Keywords":"hydrocortisone\r\nleptin\r\nmethadone\r\nadult\r\nblood viscosity\r\ncentral nervous system\r\ncognitive defect\r\nconstipation\r\ndaytime somnolence\r\nendocrine system\r\nfemale\r\nharm reduction\r\nhealth hazard\r\nhormone blood level\r\nhuman\r\nhuman cell\r\nhyperprolactinemia\r\nhypogonadotropic hypogonadism\r\nmale\r\nmethadone treatment\r\nopiate addiction\r\nopiate substitution treatment\r\norgan systems\r\nrespiration depression\r\nreview\r\nside effect\r\nsubstitution reaction\r\nsystematic review\r\ntorsade de pointes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Khalid K, Anuar A, Ang W C, and Jamaluddin R (2023) Side Effects of Chronic Methadone Use in Opioid Addiction: A Scoping Review on Hematological Derangements. Current Drug Safety 18(2), 167-174 DOI: 10.2174/1574886317666220514154931"},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281139,"Title":"Gabapentin, Pregabalin, and Placebo in Reducing Opioid Withdrawal Symptoms in Opioid-dependent Individuals: A Randomized-controlled Trial","ParentTitle":"Addictive Disorders and their Treatment","ShortTitle":"Kheirabadi (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1531-5754","City":"","Country":"","Publisher":"","Institution":"M. Bahrami, Behavioral Sciences Research Center, Khorshid Hospital, Ostandari St, Post Code: 8145831451, Isfahan, Iran","Volume":"17","Pages":"55-64","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622342495&from=export http://dx.doi.org/10.1097/ADT.0000000000000127","OldItemId":"","Comments":"2018-06-06","TypeName":"Journal, Article","Authors":"Kheirabadi G R; Salehi M ; Bahrami M ; Maracy M R; ","ParentAuthors":"","DOI":"10.1097/ADT.0000000000000127","Keywords":"IRCT201707252266N7\r\nbuprenorphine\r\ngabapentin\r\nopiate\r\nplacebo\r\npregabalin\r\nadult\r\narticle\r\nclinical article\r\ncontrolled study\r\ndouble blind procedure\r\ndrug detoxification\r\ndrug dose increase\r\nDSM-5\r\nfemale\r\nhuman\r\nIran\r\nmale\r\nopiate addiction\r\npriority journal\r\npsychopharmacotherapy\r\nrandomized controlled trial\r\nrating scale\r\nShort Opioid Withdrawal Scale\r\nsymptom\r\nunspecified side effect\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kheirabadi G R, Salehi M, Bahrami M, and Maracy M R (2018) Gabapentin, Pregabalin, and Placebo in Reducing Opioid Withdrawal Symptoms in Opioid-dependent Individuals: A Randomized-controlled Trial. Addictive Disorders and their Treatment 17(2), 55-64 DOI: 10.1097/ADT.0000000000000127"},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282900,"Title":"The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.","ParentTitle":"Journal of clinical psychopharmacology","ShortTitle":"Kheirabadi (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"0271-0749 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"41","Pages":"644-649","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"34559090","Comments":"","TypeName":"Journal, Article","Authors":"Kheirabadi G ; Najafian N ; Khodadadi F ; ","ParentAuthors":"","DOI":"10.1097/JCP.0000000000001466 ","Keywords":"Adrenergic alpha-2 Receptor Agonists/administration & dosage/*pharmacology\r\nAdult\r\nBuprenorphine/administration & dosage/*pharmacology\r\nClonidine/administration & dosage/*pharmacology\r\nDouble-Blind Method\r\nExcitatory Amino Acid Antagonists/administration & dosage/*pharmacology\r\nFemale\r\nHumans\r\nMale\r\nMemantine/administration & dosage/*pharmacology\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/complications/*drug therapy\r\nOutcome Assessment, Health Care\r\nSubstance Withdrawal Syndrome/*drug therapy/etiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kheirabadi G, Najafian N, and Khodadadi F (2021) The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.. Journal of clinical psychopharmacology 41(6), 644-649 DOI: 10.1097/JCP.0000000000001466 "},{"Codes":[{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282116,"Title":"Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Kidorf (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"June","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"187","Pages":"343-350","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"29709732","Comments":"","TypeName":"Journal, Article","Authors":"Kidorf M ; Brooner RK ; Leoutsakos JM ; Peirce J ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2018.03.009 ","Keywords":"Adult\r\nAnalgesics, Opioid/*administration & dosage\r\nCounseling\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nMotivation\r\nNeedle-Exchange Programs\r\nOpiate Substitution Treatment/*methods/psychology\r\nOpioid-Related Disorders/*drug therapy/psychology\r\nPatient Compliance/*psychology\r\nReferral and Consultation\r\nReinforcement, Psychology\r\nTreatment Outcome\r\nMethadone maintenance\r\nSyringe exchange\r\nTreatment initiation\r\nTreatment retention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kidorf M, Brooner RK, Leoutsakos JM, and Peirce J (2018) Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial.. Drug and alcohol dependence 187, 343-350 DOI: 10.1016/j.drugalcdep.2018.03.009 "},{"Codes":[{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282091,"Title":"Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Kim (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"August","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"249","Pages":"110874","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37402335","Comments":"","TypeName":"Journal, Article","Authors":"Kim JJ ; Nikoo M ; Nikoo N ; Javidanbardan S ; Kazemi A ; Choi F ; Gholami A ; Lafooraki NY ; Vogel M ; Rezazadeh-Azar P ; Meyer M ; Cabanis M ; Jang K ; Aknondzadeh S ; Krausz M ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2023.110874 ","Keywords":"Female\r\nHumans\r\nMale\r\n*Methadone/therapeutic use\r\nOpium/therapeutic use\r\nQuality of Life/psychology\r\n*Opioid-Related Disorders/drug therapy/psychology\r\nOpiate Substitution Treatment/psychology\r\nIran\r\nMethadone\r\nOpioid agonist treatment\r\nOpioid use disorder\r\nOpium tincture\r\nQuality of life","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kim JJ, Nikoo M, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Gholami A, Lafooraki NY, Vogel M, Rezazadeh-Azar P, Meyer M, Cabanis M, Jang K, Aknondzadeh S, and Krausz M (2023) Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial.. Drug and alcohol dependence 249, 110874 DOI: 10.1016/j.drugalcdep.2023.110874 "},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282253,"Title":"Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.","ParentTitle":"Substance use & misuse","ShortTitle":"Kinsella (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1082-6084 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"57","Pages":"1400-1416","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"35758300","Comments":"","TypeName":"Journal, Article","Authors":"Kinsella M ; Halliday LOE ; Shaw M ; Capel Y ; Nelson SM ; Kearns RJ ; ","ParentAuthors":"","DOI":"10.1080/10826084.2022.2083174 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nChild\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\nPregnancy\r\nMethadone\r\nbuprenorphine\r\nopioid replacement\r\npregnancy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kinsella M, Halliday LOE, Shaw M, Capel Y, Nelson SM, and Kearns RJ (2022) Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.. Substance use & misuse 57(9), 1400-1416 DOI: 10.1080/10826084.2022.2083174 "},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282636,"Title":"An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department.","ParentTitle":"Clinical toxicology (Philadelphia, Pa.)","ShortTitle":"Klein (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"August","StandardNumber":"1556-3650 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"57","Pages":"697-702","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"30712404","Comments":"","TypeName":"Journal, Article","Authors":"Klein LR ; Cole JB ; Driver BE ; Miner JR ; Laes JR ; Fagerstrom E ; L Martel M; ","ParentAuthors":"","DOI":"10.1080/15563650.2018.1547828 ","Keywords":"Administration, Oral\r\nAdult\r\nAged\r\nClonidine/administration & dosage/*therapeutic use\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nOlanzapine/administration & dosage/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nProspective Studies\r\nSeverity of Illness Index\r\nSubstance Withdrawal Syndrome/diagnosis/*prevention & control\r\nTreatment Outcome\r\nYoung Adult\r\nOlanzapine\r\nclonidine\r\nopioid withdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Klein LR, Cole JB, Driver BE, Miner JR, Laes JR, Fagerstrom E, and L Martel M (2019) An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department.. Clinical toxicology (Philadelphia, and Pa.) 57(8), 697-702 DOI: 10.1080/15563650.2018.1547828 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282848,"Title":"Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.","ParentTitle":"Systematic reviews","ShortTitle":"Klimas (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"August","StandardNumber":"2046-4053 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"10","Pages":"216","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"34362464","Comments":"","TypeName":"Journal, Article","Authors":"Klimas J ; Hamilton MA ; Gorfinkel L ; Adam A ; Cullen W ; Wood E ; ","ParentAuthors":"","DOI":"10.1186/s13643-021-01764-9 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nHumans\r\nMethadone/therapeutic use\r\nObservational Studies as Topic\r\n*Opioid-Related Disorders/drug therapy\r\nRandomized Controlled Trials as Topic\r\nOpioid agonist treatment\r\nRandomization\r\nRapid review\r\nRetention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Klimas J, Hamilton MA, Gorfinkel L, Adam A, Cullen W, and Wood E (2021) Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.. Systematic reviews 10(1), 216 DOI: 10.1186/s13643-021-01764-9 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948264,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280400,"Title":"A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in PRISONS","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Komalasari (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"R. Komalasari, University of stirling, University of Yarsi, Indonesia","Volume":"87","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2008404211&from=export http://dx.doi.org/10.1016/j.drugpo.2020.102978","OldItemId":"","Comments":"2020-11-30","TypeName":"Journal, Article","Authors":"Komalasari R ; Wilson S ; Haw S ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2020.102978","Keywords":"opiate agonist\r\ndata base\r\nevidence based medicine\r\nhealth care personnel\r\nhealth care policy\r\nhealth program\r\nhuman\r\nIndonesia\r\nIran\r\nKyrgyzstan\r\nmanagement\r\nopiate addiction\r\npersonal experience\r\npriority journal\r\ncorrectional facility\r\nqualitative research\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Komalasari R, Wilson S, and Haw S (2021) A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in PRISONS. International Journal of Drug Policy 87,  DOI: 10.1016/j.drugpo.2020.102978"},{"Codes":[],"Outcomes":[],"ItemId":98282602,"Title":"Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.","ParentTitle":"Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence","ShortTitle":"Konijnenberg (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"","StandardNumber":"0929-7049 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"17","Pages":"495-519","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"21480011","Comments":"","TypeName":"Journal, Article","Authors":"Konijnenberg C ; Melinder A ; ","ParentAuthors":"","DOI":"10.1080/09297049.2011.553591 ","Keywords":"Analgesics, Opioid/*pharmacology/therapeutic use\r\nBuprenorphine/*pharmacology/therapeutic use\r\nChild\r\nChild Development/*drug effects\r\nCognition/*drug effects\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*pharmacology/therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/rehabilitation\r\nPregnancy\r\nPrenatal Exposure Delayed Effects/*psychology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Konijnenberg C, and Melinder A (2011) Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence 17(5), 495-519 DOI: 10.1080/09297049.2011.553591 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282305,"Title":"Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.","ParentTitle":"Canadian family physician Medecin de famille canadien","ShortTitle":"Korownyk (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"May","StandardNumber":"0008-350X (Linking)","City":"Canada","Country":"","Publisher":"","Institution":"","Volume":"65","Pages":"e194-e206","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"31088885","Comments":"","TypeName":"Journal, Article","Authors":"Korownyk C ; Perry D ; Ton J ; Kolber MR ; Garrison S ; Thomas B ; Allan GM ; Dugr N ; Finley CR ; Ting R ; Yang PR ; Vandermeer B ; Lindblad AJ ; ","ParentAuthors":"","DOI":"","Keywords":"Analgesics, Opioid/adverse effects\r\nBuprenorphine/therapeutic use\r\nCounseling\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*diagnosis/*drug therapy\r\nPrimary Health Care/*methods\r\nRandomized Controlled Trials as Topic\r\nSystematic Reviews as Topic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Korownyk C, Perry D, Ton J, Kolber MR, Garrison S, Thomas B, Allan GM, Dugr N, Finley CR, Ting R, Yang PR, Vandermeer B, and Lindblad AJ (2019) Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.. Canadian family physician Medecin de famille canadien 65(5), e194-e206"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281849,"Title":"Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.","ParentTitle":"Annals of internal medicine","ShortTitle":"Korthuis (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"February","StandardNumber":"0003-4819 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"166","Pages":"268-278","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"27919103","Comments":"","TypeName":"Journal, Article","Authors":"Korthuis PT ; McCarty D ; Weimer M ; Bougatsos C ; Blazina I ; Zakher B ; Grusing S ; Devine B ; Chou R ; ","ParentAuthors":"","DOI":"10.7326/M16-2149 ","Keywords":"Buprenorphine/therapeutic use\r\nCombined Modality Therapy\r\nEducation, Medical, Continuing\r\nHealth Education\r\nHumans\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPrimary Health Care/*organization & administration\r\nPsychotherapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, and Chou R (2017) Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.. Annals of internal medicine 166(4), 268-278 DOI: 10.7326/M16-2149 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282363,"Title":"Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Korthuis (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"June","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"CTN-0055 CHOICES Investigators","Volume":"112","Pages":"1036-1044","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"28061017","Comments":"","TypeName":"Journal, Article","Authors":"Korthuis PT ; Lum PJ ; Vergara-Rodriguez P ; Ahamad K ; Wood E ; Kunkel LE ; Oden NL ; Lindblad R ; Sorensen JL ; Arenas V ; Ha D ; Mandler RN ; McCarty D ; ","ParentAuthors":"","DOI":"10.1111/add.13753 ","Keywords":"Alcoholism/complications/*drug therapy\r\nBritish Columbia\r\nChicago\r\nDelayed-Action Preparations/adverse effects/therapeutic use\r\nFeasibility Studies\r\nFemale\r\nHIV Infections/*complications\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaltrexone/adverse effects/*therapeutic use\r\nNarcotic Antagonists/adverse effects/*therapeutic use\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPilot Projects\r\nTreatment Outcome\r\nAlcohol\r\nHIV\r\nextended-release naltrexone\r\ninjection drug use\r\nopioid-related disorders\r\nrandomized clinical trial","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, and McCarty D (2017) Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.. Addiction (Abingdon, and England) 112(6), 1036-1044 DOI: 10.1111/add.13753 "},{"Codes":[],"Outcomes":[],"ItemId":98281684,"Title":"Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.","ParentTitle":"The American journal on addictions","ShortTitle":"Kosten (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"February","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"28","Pages":"55-62","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"30701615","Comments":"","TypeName":"Journal, Article","Authors":"Kosten TR ; Baxter LE ; ","ParentAuthors":"","DOI":"10.1111/ajad.12862 ","Keywords":"Analgesics, Opioid/*pharmacology\r\nBehavior, Addictive\r\n*Cost of Illness\r\nHumans\r\nOpiate Substitution Treatment/*adverse effects/methods\r\nOpioid-Related Disorders/psychology/therapy\r\nSecondary Prevention\r\n*Substance Withdrawal Syndrome/etiology/psychology/therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kosten TR, and Baxter LE (2019) Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.. The American journal on addictions 28(2), 55-62 DOI: 10.1111/ajad.12862 "},{"Codes":[],"Outcomes":[],"ItemId":98282057,"Title":"Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Kowalczyk (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"44","Pages":"502-511","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"29634425","Comments":"","TypeName":"Journal, Article","Authors":"Kowalczyk WJ ; Moran LM ; Bertz JW ; Phillips KA ; Ghitza UE ; Vahabzadeh M ; Lin JL ; Epstein DH ; Preston KL ; ","ParentAuthors":"","DOI":"10.1080/00952990.2018.1454933 ","Keywords":"Adrenergic alpha-2 Receptor Agonists/administration & dosage\r\nAdult\r\nAffect/drug effects\r\nBuprenorphine/*administration & dosage\r\nClonidine/*administration & dosage\r\nCraving/drug effects\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\n*Ecological Momentary Assessment\r\nFemale\r\nHumans\r\nLinear Models\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/administration & dosage\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy/psychology\r\nEcological momentary assessment\r\nabstinence\r\nclonidine\r\ncraving\r\nopioid-agonist therapy\r\nstress","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kowalczyk WJ, Moran LM, Bertz JW, Phillips KA, Ghitza UE, Vahabzadeh M, Lin JL, Epstein DH, and Preston KL (2018) Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.. The American journal of drug and alcohol abuse 44(5), 502-511 DOI: 10.1080/00952990.2018.1454933 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284639,"Title":"Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.","ParentTitle":"The New England journal of medicine","ShortTitle":"Kraft (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"June","StandardNumber":"0028-4793 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"376","Pages":"2341-2348","Edition":"","Issue":"24","Availability":"","URL":"","OldItemId":"28468518","Comments":"","TypeName":"Journal, Article","Authors":"Kraft WK ; Adeniyi-Jones SC ; Chervoneva I ; Greenspan JS ; Abatemarco D ; Kaltenbach K ; Ehrlich ME ; ","ParentAuthors":"","DOI":"10.1056/NEJMoa1614835 ","Keywords":"Administration, Oral\r\nAdministration, Sublingual\r\nAnalgesics, Opioid/*adverse effects/*therapeutic use\r\nBuprenorphine/adverse effects/*therapeutic use\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nHypnotics and Sedatives/therapeutic use\r\nInfant, Newborn\r\nLength of Stay\r\nMale\r\nMorphine/adverse effects/therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy\r\n*Opiate Substitution Treatment\r\nPhenobarbital/therapeutic use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, and Ehrlich ME (2017) Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.. The New England journal of medicine 376(24), 2341-2348 DOI: 10.1056/NEJMoa1614835 "},{"Codes":[],"Outcomes":[],"ItemId":98283230,"Title":"Buprenorphine in Neonatal Abstinence Syndrome.","ParentTitle":"Clinical pharmacology and therapeutics","ShortTitle":"Kraft (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"January","StandardNumber":"0009-9236 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"103","Pages":"112-119","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29105752","Comments":"","TypeName":"Journal, Article","Authors":"Kraft WK ; ","ParentAuthors":"","DOI":"10.1002/cpt.930 ","Keywords":"Buprenorphine/*pharmacology\r\nDrug Dosage Calculations\r\nHumans\r\nInfant, Newborn\r\nNarcotic Antagonists/pharmacology\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nOpiate Substitution Treatment/methods\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kraft WK (2018) Buprenorphine in Neonatal Abstinence Syndrome.. Clinical pharmacology and therapeutics 103(1), 112-119 DOI: 10.1002/cpt.930 "},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283118,"Title":"[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].","ParentTitle":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","ShortTitle":"Krupitski (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"","StandardNumber":"1997-7298 (Linking)","City":"Russia (Federation)","Country":"","Publisher":"","Institution":"","Volume":"110","Pages":"44-54","Edition":"","Issue":"5 Pt 2","Availability":"","URL":"","OldItemId":"21322147","Comments":"","TypeName":"Journal, Article","Authors":"Krupitski EM ; Zvartau EE ; Tso-Podosenin MV ; Masalov DV ; Burakov AM ; Egorova VIu ; Didenko TIu ; Romanova TN ; Ivanova EB ; Bespalov AIu ; Verbitskaia EV ; Neznanov NG ; Grineneko AIa ; O'Brien C ; Woody D ; ","ParentAuthors":"","DOI":"","Keywords":"Adolescent\r\nAdult\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nFemale\r\nFluoxetine/*therapeutic use\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMale\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nPlacebos\r\nRemission Induction\r\nSelective Serotonin Reuptake Inhibitors/*therapeutic use\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitski EM, Zvartau EE, Tso-Podosenin MV, Masalov DV, Burakov AM, Egorova VIu, Didenko TIu, Romanova TN, Ivanova EB, Bespalov AIu, Verbitskaia EV, Neznanov NG, Grineneko AIa, O'Brien C, and Woody D (2010) [Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 110(5 Pt 2), 44-54"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282734,"Title":"[Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].","ParentTitle":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","ShortTitle":"Krupitski (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1997-7298 (Linking)","City":"Russia (Federation)","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"3-11","Edition":"","Issue":"5 Pt 2","Availability":"","URL":"","OldItemId":"22951790","Comments":"","TypeName":"Journal, Article","Authors":"Krupitski EM ; Nunes EV ; Ling W ; Illeperuma A ; Gastfriend DR ; Blokhina EA ; Silverman BL ; ","ParentAuthors":"","DOI":"","Keywords":"Adult\r\nDelayed-Action Preparations/administration & dosage\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitski EM, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Blokhina EA, and Silverman BL (2012) [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 112(5 Pt 2), 3-11"},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281187,"Title":"A Randomized Controlled Study of the Efficacy of Pregabalin in the Treatment of Opiate Withdrawal Syndrome","ParentTitle":"Neuroscience and Behavioral Physiology","ShortTitle":"Krupitskii (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0097-0549","City":"","Country":"","Publisher":"","Institution":"E.M. Krupitskii, Bekhterev St. Petersburg Research Psychoneurology Institute, St. Petersburg, Russian Federation","Volume":"47","Pages":"1094-1101","Edition":"","Issue":"9","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L619310663&from=export http://dx.doi.org/10.1007/s11055-017-0517-9","OldItemId":"","Comments":"2017-12-21","TypeName":"Journal, Article","Authors":"Krupitskii E M; Ilyuk R D; Mikhailov A D; Kazankov K A; Rybakova K V; Skurat E P; Grishina O G; Zaplatkin I A; Vetrova M V; Neznanov N G; ","ParentAuthors":"","DOI":"10.1007/s11055-017-0517-9","Keywords":"clonidine\r\ndonormil\r\ndoxylamine\r\nketorolac\r\nketorolac trometamol\r\nloperamide\r\nmetoclopramide\r\nnaftizin\r\nnaphazoline\r\nphenazepam\r\npregabalin\r\nadult\r\nanxiety\r\narticle\r\nasthenia\r\nclinical article\r\nconstipation\r\ncontrolled study\r\ndepression\r\ndisease severity\r\ndrug craving\r\ndrug efficacy\r\ndrug safety\r\ndrug tolerability\r\nfemale\r\nhuman\r\nmale\r\nopiate addiction\r\nopioid withdrawal syndrome\r\npain\r\npsychomotor disorder\r\nrandomized controlled trial\r\nrhinorrhea\r\nside effect\r\nsingle drug dose\r\nsleep disorder\r\ntreatment outcome\r\nvomiting\r\nwellbeing\r\nwithdrawal syndrome\r\ncerucal\r\nclofelin\r\ndonormil\r\nimodium\r\nketanov\r\nlyrica\r\nnaftizin\r\nsanorin","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitskii E M, Ilyuk R D, Mikhailov A D, Kazankov K A, Rybakova K V, Skurat E P, Grishina O G, Zaplatkin I A, Vetrova M V, and Neznanov N G (2017) A Randomized Controlled Study of the Efficacy of Pregabalin in the Treatment of Opiate Withdrawal Syndrome. Neuroscience and Behavioral Physiology 47(9), 1094-1101 DOI: 10.1007/s11055-017-0517-9"},{"Codes":[],"Outcomes":[],"ItemId":98282969,"Title":"Long-acting depot formulations of naltrexone for heroin dependence: a review.","ParentTitle":"Current opinion in psychiatry","ShortTitle":"Krupitsky (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"May","StandardNumber":"0951-7367 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"23","Pages":"210-4","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"20224403","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky EM ; Blokhina EA ; ","ParentAuthors":"","DOI":"10.1097/YCO.0b013e3283386578 ","Keywords":"Delayed-Action Preparations\r\nDrug Implants\r\nHeroin Dependence/psychology/*rehabilitation\r\nHumans\r\nInjections, Intramuscular\r\nMedication Adherence/psychology\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nSecondary Prevention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky EM, and Blokhina EA (2010) Long-acting depot formulations of naltrexone for heroin dependence: a review.. Current opinion in psychiatry 23(3), 210-4 DOI: 10.1097/YCO.0b013e3283386578 "},{"Codes":[{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282143,"Title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.","ParentTitle":"Lancet (London, England)","ShortTitle":"Krupitsky (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"April","StandardNumber":"0140-6736 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"377","Pages":"1506-13","Edition":"","Issue":"9776","Availability":"","URL":"","OldItemId":"21529928","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky E ; Nunes EV ; Ling W ; Illeperuma A ; Gastfriend DR ; Silverman BL ; ","ParentAuthors":"","DOI":"10.1016/S0140-6736(11)60358-9 ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nFemale\r\nHIV Seropositivity/complications\r\nHumans\r\nInjections\r\nMale\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nOpioid-Related Disorders/*rehabilitation/virology\r\nSubstance Abuse Detection","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, and Silverman BL (2011) Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.. Lancet (London, and England) 377(9776), 1506-13 DOI: 10.1016/S0140-6736(11)60358-9 "},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282956,"Title":"Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.","ParentTitle":"Archives of general psychiatry","ShortTitle":"Krupitsky (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"September","StandardNumber":"0003-990X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"69","Pages":"973-81","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"22945623","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky E ; Zvartau E ; Blokhina E ; Verbitskaya E ; Wahlgren V ; Tsoy-Podosenin M ; Bushara N ; Burakov A ; Masalov D ; Romanova T ; Tyurina A ; Palatkin V ; Slavina T ; Pecoraro A ; Woody GE ; ","ParentAuthors":"","DOI":"10.1001/archgenpsychiatry.2012.1a ","Keywords":"Administration, Oral\r\nAdolescent\r\nAdult\r\nCombined Modality Therapy\r\nCounseling\r\nDelayed-Action Preparations\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nDrug Implants\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nRussia\r\nSecondary Prevention\r\nSubstance Abuse Detection\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Slavina T, Pecoraro A, and Woody GE (2012) Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.. Archives of general psychiatry 69(9), 973-81 DOI: 10.1001/archgenpsychiatry.2012.1a "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282775,"Title":"Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Krupitsky (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"September","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"108","Pages":"1628-37","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"23701526","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky E ; Nunes EV ; Ling W ; Gastfriend DR ; Memisoglu A ; Silverman BL ; ","ParentAuthors":"","DOI":"10.1111/add.12208 ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMedication Adherence\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nOpioid-Related Disorders/*rehabilitation\r\nSecondary Prevention\r\nSelf Report\r\nCraving\r\ndepot naltrexone\r\nextended-release naltrexone\r\nheroin dependence\r\ninjectable naltrexone\r\nlong-term safety\r\nnaltrexone\r\nopioid dependence\r\nsustained release formulations","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, and Silverman BL (2013) Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.. Addiction (Abingdon, and England) 108(9), 1628-37 DOI: 10.1111/add.12208 "},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282811,"Title":"Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Krupitsky (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"October","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"132","Pages":"674-80","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"23683793","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky E ; Zvartau E ; Blokhina E ; Verbitskaya E ; Tsoy M ; Wahlgren V ; Burakov A ; Masalov D ; Romanova TN ; Palatkin V ; Tyurina A ; Yaroslavtseva T ; Sinha R ; Kosten TR ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.04.021 ","Keywords":"Adolescent\r\nAdrenergic alpha-2 Receptor Agonists/*administration & dosage\r\nAdult\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nFemale\r\nFollow-Up Studies\r\nGuanfacine/*administration & dosage\r\nHumans\r\nMale\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy/*epidemiology\r\nRussia/epidemiology\r\nSecondary Prevention\r\nYoung Adult\r\nClinical trial\r\nGuanfacine\r\nNaltrexone\r\nOpiate dependence\r\nStress","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova TN, Palatkin V, Tyurina A, Yaroslavtseva T, Sinha R, and Kosten TR (2013) Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.. Drug and alcohol dependence 132(3), 674-80 DOI: 10.1016/j.drugalcdep.2013.04.021 "},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282710,"Title":"[A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].","ParentTitle":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","ShortTitle":"Krupitsky (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1997-7298 (Linking)","City":"Russia (Federation)","Country":"","Publisher":"","Institution":"","Volume":"115","Pages":"39-46","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"26525620","Comments":"","TypeName":"Journal, Article","Authors":"Krupitsky EM ; Blokhina EA ; Zvartau EE ; Verbitskaya VE ; Bushara EM ; Tiurina AA ; Palatkin VY ; Yaroslavtseva TS ; Burakov AM ; Masalov DV ; Romanova TN ; Grininko AY ; Sinha R ; Kosten T ; ","ParentAuthors":"","DOI":"10.17116/jnevro201511510139-46 ","Keywords":"Adolescent\r\nAdrenergic alpha-2 Receptor Agonists/*therapeutic use\r\nAdult\r\nAnalgesics, Opioid/adverse effects\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nFemale\r\nGuanfacine/*therapeutic use\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy/prevention & control\r\nRecurrence\r\nSecondary Prevention\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Krupitsky EM, Blokhina EA, Zvartau EE, Verbitskaya VE, Bushara EM, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Burakov AM, Masalov DV, Romanova TN, Grininko AY, Sinha R, and Kosten T (2015) [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 115(10), 39-46 DOI: 10.17116/jnevro201511510139-46 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280676,"Title":"Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial","ParentTitle":"Substance Abuse: Research and Treatment","ShortTitle":"Kumar (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1178-2218","City":"","Country":"","Publisher":"","Institution":"N. Kumar, Department of Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, United States","Volume":"14","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007347905&from=export http://dx.doi.org/10.1177/1178221820970926","OldItemId":"","Comments":"2021-02-16","TypeName":"Journal, Article","Authors":"Kumar N ; Mancino M J; Thostenson J D; McGaugh J ; Oliveto A H; ","ParentAuthors":"","DOI":"10.1177/1178221820970926","Keywords":"NCT01895270\r\nbuprenorphine\r\nisradipine\r\nmethadone\r\nplacebo\r\nabdominal pain\r\nadult\r\narticle\r\nburning sensation\r\nclinical article\r\nconstipation\r\ncontrolled study\r\ndetoxification\r\ndizziness\r\nsomnolence\r\ndrug craving\r\ndrug dose increase\r\ndrug dose reduction\r\ndrug efficacy\r\ndrug tolerability\r\nfatigue\r\nfeasibility study\r\nfemale\r\nflushing\r\ngastrointestinal disease\r\nheadache\r\nhuman\r\nkidney disease\r\nleg swelling\r\nlethargy\r\nlimb swelling\r\nmaintenance drug dose\r\nmale\r\nmedication compliance\r\nmethadone treatment\r\nmicturition\r\nneurologic disease\r\nopiate addiction\r\noutpatient care\r\nparesthesia\r\npatient compliance\r\npilot study\r\npruritus\r\nrandomized controlled trial\r\nrash\r\nside effect\r\nskin disease\r\nsomnolence\r\ntreatment outcome\r\nurinalysis\r\nurinary tract disease\r\nurine color\r\nvascular disease\r\nvomiting","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Kumar N, Mancino M J, Thostenson J D, McGaugh J, and Oliveto A H (2020) Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial. Substance Abuse: Research and Treatment 14,  DOI: 10.1177/1178221820970926"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948297,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948346,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281409,"Title":"A systematic review of model-based economic evaluations of drug substitution therapies in maintenance treatment of non-prescription opioid dependence","ParentTitle":"Value in Health","ShortTitle":"Langham (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"1098-3015","City":"","Country":"","Publisher":"","Institution":"S. Langham, PHMR, London, United Kingdom","Volume":"18","Pages":"A411","Edition":"","Issue":"7","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L72083262&from=export","OldItemId":"","Comments":"2015-11-27","TypeName":"Journal, Article","Authors":"Langham S ; Kenworthy J J; Dunlop W ; Chetty M ; ","ParentAuthors":"","DOI":"","Keywords":"opiate\r\nplacebo\r\nmodel\r\neconomic evaluation\r\ndrug substitution\r\nsubstitution therapy\r\nmaintenance therapy\r\nprescription\r\nopiate addiction\r\nEuropean\r\nsystematic review\r\nMonte Carlo method\r\nhealth\r\ndecision tree\r\ndata base\r\nstatistical model\r\ncost benefit analysis\r\nopiate substitution treatment\r\nNew Zealand\r\ncost effectiveness analysis\r\ncost utility analysis\r\npopulation\r\nlifespan\r\nsensitivity analysis\r\nquality adjusted life year\r\ntechnology\r\nsimulation\r\nbudget\r\nUnited Kingdom\r\nSpain\r\nViet Nam\r\nhealth care system","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Langham S, Kenworthy J J, Dunlop W, and Chetty M (2015) A systematic review of model-based economic evaluations of drug substitution therapies in maintenance treatment of non-prescription opioid dependence. Value in Health 18(7), A411"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281482,"Title":"A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence","ParentTitle":"Drug and Alcohol Review","ShortTitle":"Larney (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"0959-5236","City":"","Country":"","Publisher":"","Institution":"S. Larney","Volume":"33","Pages":"115-128","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L1052901265&from=export http://dx.doi.org/10.1111/dar.12095","OldItemId":"","Comments":"2014-11-03","TypeName":"Journal, Article","Authors":"Larney S ; Gowing L ; Mattick R P; Farrell M ; Hall W ; Degenhardt L ; ","ParentAuthors":"","DOI":"10.1111/dar.12095","Keywords":"diamorphine\r\nnaltrexone\r\nnarcotic antagonist\r\ndrug implant\r\nhuman\r\nexperimental therapy\r\nmeta analysis\r\nopiate addiction\r\nreview\r\nsystematic review\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Larney S, Gowing L, Mattick R P, Farrell M, Hall W, and Degenhardt L (2014) A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence. Drug and Alcohol Review 33(2), 115-128 DOI: 10.1111/dar.12095"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019722,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283126,"Title":"No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.","ParentTitle":"The American journal on addictions","ShortTitle":"Latif (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"February","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"28","Pages":"77-85","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"30701613","Comments":"","TypeName":"Journal, Article","Authors":"Latif ZE ; Solli KK ; Opheim A ; Kunoe N ; Benth J ; Krajci P ; Sharma-Haase K ; Tanum L ; ","ParentAuthors":"","DOI":"10.1111/ajad.12859 ","Keywords":"Adult\r\n*Buprenorphine, Naloxone Drug Combination/administration & dosage/adverse effects\r\nChronic Pain/*diagnosis\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\n*Naltrexone/administration & dosage/adverse effects\r\nNarcotic Antagonists/therapeutic use\r\nNorway\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/drug therapy\r\nPain Measurement","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Latif ZE, Solli KK, Opheim A, Kunoe N, Benth J, Krajci P, Sharma-Haase K, and Tanum L (2019) No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.. The American journal on addictions 28(2), 77-85 DOI: 10.1111/ajad.12859 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282917,"Title":"Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.","ParentTitle":"Journal of psychopharmacology (Oxford, England)","ShortTitle":"Law (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"August","StandardNumber":"0269-8811 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"31","Pages":"1046-1055","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"28631527","Comments":"","TypeName":"Journal, Article","Authors":"Law FD ; Diaper AM ; Melichar JK ; Coulton S ; Nutt DJ ; Myles JS ; ","ParentAuthors":"","DOI":"10.1177/0269881117711710 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/*therapeutic use\r\nClonidine/*analogs & derivatives/therapeutic use\r\nCraving/drug effects\r\nDouble-Blind Method\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Withdrawal Syndrome/drug therapy\r\nTreatment Outcome\r\nYoung Adult\r\nBuprenorphine\r\ndetoxification\r\nlofexidine\r\nmethadone\r\nopiate withdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Law FD, Diaper AM, Melichar JK, Coulton S, Nutt DJ, and Myles JS (2017) Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.. Journal of psychopharmacology (Oxford, and England) 31(8), 1046-1055 DOI: 10.1177/0269881117711710 "},{"Codes":[],"Outcomes":[],"ItemId":98282291,"Title":"Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Lee (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"March","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"41","Pages":"110-7","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25602580","Comments":"","TypeName":"Journal, Article","Authors":"Lee JD ; Friedmann PD ; Boney TY ; Hoskinson RA Jr; McDonald R ; Gordon M ; Fishman M ; Chen DT ; Bonnie RJ ; Kinlock TW ; Nunes EV ; Cornish JW ; O'Brien CP ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2015.01.005 ","Keywords":"Adult\r\nCriminal Law\r\n*Criminals\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\n*Secondary Prevention\r\nCriminal justice\r\nExtended-release naltrexone\r\nNaltrexone\r\nOpioid relapse prevention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee JD, Friedmann PD, Boney TY, Hoskinson RA Jr, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, and O'Brien CP (2015) Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.. Contemporary clinical trials 41, 110-7 DOI: 10.1016/j.cct.2015.01.005 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282536,"Title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Lee (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"June","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"110","Pages":"1008-14","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"25703440","Comments":"","TypeName":"Journal, Article","Authors":"Lee JD ; McDonald R ; Grossman E ; McNeely J ; Laska E ; Rotrosen J ; Gourevitch MN ; ","ParentAuthors":"","DOI":"10.1111/add.12894 ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nNew York City\r\nOpioid-Related Disorders/*rehabilitation\r\nPilot Projects\r\n*Prisoners\r\nRecurrence\r\nTreatment Outcome\r\nExtended-release naltrexone\r\nVivitrol\r\njail\r\nopioid dependence\r\nprisoners\r\nrandomized controlled trial\r\nrelapse prevention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee JD, McDonald R, Grossman E, McNeely J, Laska E, Rotrosen J, and Gourevitch MN (2015) Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.. Addiction (Abingdon, and England) 110(6), 1008-14 DOI: 10.1111/add.12894 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282953,"Title":"A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.","ParentTitle":"The international journal of neuropsychopharmacology","ShortTitle":"Lee (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"February","StandardNumber":"1461-1457 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"18","Pages":"pyv008","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"25716777","Comments":"","TypeName":"Journal, Article","Authors":"Lee SY ; Chen SL ; Chang YH ; Chu CH ; Chen SH ; Chen PS ; Huang SY ; Tzeng NS ; Wang LJ ; Lee IH ; Wang TY ; Chen KC ; Yang YK ; Hong JS ; Lu RB ; ","ParentAuthors":"","DOI":"10.1093/ijnp/pyv008 ","Keywords":"Adult\r\nAnalgesics, Opioid/toxicity\r\nBrain-Derived Neurotrophic Factor/blood\r\nC-Reactive Protein\r\nDextromethorphan/administration & dosage/*therapeutic use\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Therapy, Combination/methods\r\nExcitatory Amino Acid Antagonists/administration & dosage/therapeutic use\r\nFemale\r\nHumans\r\nInterleukin-6/blood\r\nInterleukin-8/blood\r\nMale\r\nMethadone/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nMorphine/*toxicity\r\nOpioid-Related Disorders/blood/*drug therapy/psychology\r\nRetention, Psychology/*drug effects\r\nTime Factors\r\nTransforming Growth Factor beta1/blood\r\nTreatment Outcome\r\nTumor Necrosis Factor-alpha/blood\r\nCytokines\r\nDextromethorphan\r\nHeroin\r\ncytokine\r\ndextromethorphan\r\nmethadone maintenance therapy\r\nopioid dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee SY, Chen SL, Chang YH, Chu CH, Chen SH, Chen PS, Huang SY, Tzeng NS, Wang LJ, Lee IH, Wang TY, Chen KC, Yang YK, Hong JS, and Lu RB (2015) A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.. The international journal of neuropsychopharmacology 18(7), pyv008 DOI: 10.1093/ijnp/pyv008 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948333,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283195,"Title":"Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.","ParentTitle":"Scientific reports","ShortTitle":"Lee (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"May","StandardNumber":"2045-2322 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"5","Pages":"10140","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25988317","Comments":"","TypeName":"Journal, Article","Authors":"Lee SY ; Chen SL ; Chang YH ; Chen PS ; Huang SY ; Tzeng NS ; Wang LJ ; Lee IH ; Wang TY ; Chen KC ; Yang YK ; Hong JS ; Lu RB ; ","ParentAuthors":"","DOI":"10.1038/srep10140 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nBrain-Derived Neurotrophic Factor/blood\r\nC-Reactive Protein/metabolism\r\nDopamine Agents/therapeutic use\r\nDouble-Blind Method\r\nDrug Therapy, Combination/*methods\r\nHumans\r\nInterleukin-6/blood\r\nInterleukin-8/blood\r\nMemantine/*therapeutic use\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*therapy\r\nPlacebos/therapeutic use\r\nTransforming Growth Factor beta/blood\r\nTreatment Outcome\r\nTumor Necrosis Factor-alpha/blood","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, Wang LJ, Lee IH, Wang TY, Chen KC, Yang YK, Hong JS, and Lu RB (2015) Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.. Scientific reports 5, 10140 DOI: 10.1038/srep10140 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282092,"Title":"Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.","ParentTitle":"The New England journal of medicine","ShortTitle":"Lee (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"March","StandardNumber":"0028-4793 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"374","Pages":"1232-42","Edition":"","Issue":"13","Availability":"","URL":"","OldItemId":"27028913","Comments":"","TypeName":"Journal, Article","Authors":"Lee JD ; Friedmann PD ; Kinlock TW ; Nunes EV ; Boney TY ; Hoskinson RA Jr; Wilson D ; McDonald R ; Rotrosen J ; Gourevitch MN ; Gordon M ; Fishman M ; Chen DT ; Bonnie RJ ; Cornish JW ; Murphy SM ; O'Brien CP ; ","ParentAuthors":"","DOI":"10.1056/NEJMoa1505409 ","Keywords":"Adult\r\nCommunity Health Services\r\nCounseling\r\n*Criminals\r\nDelayed-Action Preparations\r\nDrug Overdose\r\nFemale\r\nHumans\r\nKaplan-Meier Estimate\r\nMale\r\nMiddle Aged\r\nNaltrexone/*administration & dosage/adverse effects\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nOpioid-Related Disorders/complications/*drug therapy/therapy\r\nSecondary Prevention\r\nSubstance Abuse, Intravenous/complications","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA Jr, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, and O'Brien CP (2016) Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.. The New England journal of medicine 374(13), 1232-42 DOI: 10.1056/NEJMoa1505409 "},{"Codes":[{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284429,"Title":"Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.","ParentTitle":"Journal of perinatology : official journal of the California Perinatal Association","ShortTitle":"Lee (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"November","StandardNumber":"0743-8346 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"39","Pages":"1535-1545","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"31316147","Comments":"","TypeName":"Journal, Article","Authors":"Lee JJ ; Chen J ; Eisler L ; Li G ; Davis JM ; Sun LS ; ","ParentAuthors":"","DOI":"10.1038/s41372-019-0437-3 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nBuprenorphine/*therapeutic use\r\nHumans\r\nInfant, Newborn\r\nLength of Stay/*statistics & numerical data\r\nMethadone/*therapeutic use\r\nMorphine/*therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy\r\n*Opiate Substitution Treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee JJ, Chen J, Eisler L, Li G, Davis JM, and Sun LS (2019) Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.. Journal of perinatology : official journal of the California Perinatal Association 39(11), 1535-1545 DOI: 10.1038/s41372-019-0437-3 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282695,"Title":"Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail.","ParentTitle":"JAMA network open","ShortTitle":"Lee (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"September","StandardNumber":"2574-3805 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"4","Pages":"e2123032","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"34495340","Comments":"","TypeName":"Journal, Article","Authors":"Lee JD ; Malone M ; McDonald R ; Cheng A ; Vasudevan K ; Tofighi B ; Garment A ; Porter B ; Goldfeld KS ; Matteo M ; Mangat J ; Katyal M ; Giftos J ; MacDonald R ; ","ParentAuthors":"","DOI":"10.1001/jamanetworkopen.2021.23032 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/administration & dosage/*therapeutic use\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nMale\r\n*Medication Adherence\r\nOpioid-Related Disorders/*drug therapy\r\nPilot Projects\r\n*Prisoners\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lee JD, Malone M, McDonald R, Cheng A, Vasudevan K, Tofighi B, Garment A, Porter B, Goldfeld KS, Matteo M, Mangat J, Katyal M, Giftos J, and MacDonald R (2021) Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail.. JAMA network open 4(9), e2123032 DOI: 10.1001/jamanetworkopen.2021.23032 "},{"Codes":[],"Outcomes":[],"ItemId":98282150,"Title":"Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.","ParentTitle":"The American journal on addictions","ShortTitle":"Leslie (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"April","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"265-270","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"25655226","Comments":"","TypeName":"Journal, Article","Authors":"Leslie DL ; Milchak W ; Gastfriend DR ; Herschman PL ; Bixler EO ; Velott DL ; Meyer RE ; ","ParentAuthors":"","DOI":"10.1111/ajad.12182 ","Keywords":"Adult\r\nCohort Studies\r\nDelayed-Action Preparations/administration & dosage\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/psychology/*rehabilitation\r\nPennsylvania\r\nRehabilitation Centers\r\nWithholding Treatment\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Leslie DL, Milchak W, Gastfriend DR, Herschman PL, Bixler EO, Velott DL, and Meyer RE (2015) Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.. The American journal on addictions 24(3), 265-270 DOI: 10.1111/ajad.12182 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282833,"Title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.","ParentTitle":"JAMA internal medicine","ShortTitle":"Liebschutz (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"August","StandardNumber":"2168-6106 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"174","Pages":"1369-76","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"25090173","Comments":"","TypeName":"Journal, Article","Authors":"Liebschutz JM ; Crooks D ; Herman D ; Anderson B ; Tsui J ; Meshesha LZ ; Dossabhoy S ; Stein M ; ","ParentAuthors":"","DOI":"10.1001/jamainternmed.2014.2556 ","Keywords":"Adult\r\nAmbulatory Care/*statistics & numerical data\r\nBuprenorphine/*therapeutic use\r\nFemale\r\n*Hospitalization\r\nHumans\r\nMale\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Discharge\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, and Stein M (2014) Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.. JAMA internal medicine 174(8), 1369-76 DOI: 10.1001/jamainternmed.2014.2556 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282826,"Title":"Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Lier (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"November","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"142","Pages":"108852","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"35988513","Comments":"","TypeName":"Journal, Article","Authors":"Lier AJ ; Seval N ; Vander Wyk B; Di Paola A ; Springer SA ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2022.108852 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\n*HIV Infections/drug therapy\r\n*Hepatitis C/complications/drug therapy\r\nHumans\r\nInjections, Intramuscular\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/rehabilitation\r\nRNA/therapeutic use\r\nSocial Justice\r\nExtended-release naltrexone\r\nHIV\r\nHepatitis C virus\r\nInjection drug use\r\nMedications for opioid use disorder\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lier AJ, Seval N, Vander Wyk B, Di Paola A, and Springer SA (2022) Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.. Journal of substance abuse treatment 142, 108852 DOI: 10.1016/j.jsat.2022.108852 "},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280101,"Title":"Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials","ParentTitle":"PLoS ONE","ShortTitle":"Lim (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1932-6203","City":"","Country":"","Publisher":"","Institution":"D. Panagiotoglou, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada","Volume":"17","Pages":"","Edition":"","Issue":"3 March","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2017548424&from=export http://dx.doi.org/10.1371/journal.pone.0266142","OldItemId":"","Comments":"2022-04-27","TypeName":"Journal, Article","Authors":"Lim J ; Farhat I ; Douros A ; Panagiotoglou D ; ","ParentAuthors":"","DOI":"10.1371/journal.pone.0266142","Keywords":"buprenorphine\r\nmethadone\r\nmorphine\r\nnaltrexone\r\narticle\r\nclinical outcome\r\nclinical protocol\r\ndrug efficacy\r\ndrug use\r\nhealth care practice\r\nhuman\r\nmeta analysis\r\nopiate addiction\r\nprescription\r\nrandomized controlled trial (topic)\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lim J, Farhat I, Douros A, and Panagiotoglou D (2022) Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials. PLoS ONE 17(3 March),  DOI: 10.1371/journal.pone.0266142"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282790,"Title":"Buprenorphine tapering schedule and illicit opioid use.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Ling (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"February","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"104","Pages":"256-65","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"19149822","Comments":"","TypeName":"Journal, Article","Authors":"Ling W ; Hillhouse M ; Domier C ; Doraimani G ; Hunter J ; Thomas C ; Jenkins J ; Hasson A ; Annon J ; Saxon A ; Selzer J ; Boverman J ; Bilangi R ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2008.02455.x ","Keywords":"Adolescent\r\nAdult\r\nAged\r\nAged, 80 and over\r\nBuprenorphine/*administration & dosage\r\nBuprenorphine, Naloxone Drug Combination\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Abuse Detection\r\nSubstance Withdrawal Syndrome/etiology\r\nTime Factors\r\nUnited States\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, and Bilangi R (2009) Buprenorphine tapering schedule and illicit opioid use.. Addiction (Abingdon, and England) 104(2), 256-65 DOI: 10.1111/j.1360-0443.2008.02455.x "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282201,"Title":"Comparison of behavioral treatment conditions in buprenorphine maintenance.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Ling (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"October","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"108","Pages":"1788-98","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"23734858","Comments":"","TypeName":"Journal, Article","Authors":"Ling W ; Hillhouse M ; Ang A ; Jenkins J ; Fahey J ; ","ParentAuthors":"","DOI":"10.1111/add.12266 ","Keywords":"Adult\r\nAnalgesics, Opioid/urine\r\nBuprenorphine/adverse effects/*therapeutic use\r\n*Cognitive Behavioral Therapy\r\nCombined Modality Therapy/methods\r\nFemale\r\nHumans\r\nLos Angeles\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/adverse effects/*therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/drug therapy/*psychology/*therapy\r\nOutpatients\r\nSubstance Withdrawal Syndrome/etiology\r\nTreatment Outcome\r\nYoung Adult\r\nBehavioral treatment\r\nbuprenorphine\r\ncognitive behavioral therapy\r\ncontingency management\r\nmedication management\r\nopiates\r\nopioids","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ling W, Hillhouse M, Ang A, Jenkins J, and Fahey J (2013) Comparison of behavioral treatment conditions in buprenorphine maintenance.. Addiction (Abingdon, and England) 108(10), 1788-98 DOI: 10.1111/add.12266 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948334,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282107,"Title":"A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Ling (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"April","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"197","Pages":"168-182","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"30831429","Comments":"","TypeName":"Journal, Article","Authors":"Ling S ; Mangaoil R ; Cleverley K ; Sproule B ; Puts M ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2019.02.007 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nClinical Trials as Topic/methods\r\nFemale\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nNorth America/epidemiology\r\nOpiate Substitution Treatment/*methods/psychology\r\nOpioid-Related Disorders/*drug therapy/epidemiology/psychology\r\nQuality of Life/psychology\r\n*Sex Characteristics\r\nTreatment Outcome\r\nBuprenorphine\r\nBuprenorphine/naloxone\r\nGender differences\r\nMedication assisted treatment\r\nMethadone\r\nOpioid maintenance treatment\r\nOpioid use disorder\r\nRetention\r\nSex differences","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ling S, Mangaoil R, Cleverley K, Sproule B, and Puts M (2019) A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.. Drug and alcohol dependence 197, 168-182 DOI: 10.1016/j.drugalcdep.2019.02.007 "},{"Codes":[{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283239,"Title":"Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Ling (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"November","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"13","Pages":"442-449","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"30844878","Comments":"","TypeName":"Journal, Article","Authors":"Ling W ; Nadipelli VR ; Solem CT ; Ronquest NA ; Yeh YC ; Learned SM ; Mehra V ; Heidbreder C ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000517 ","Keywords":"Adult\r\nAnalgesics, Opioid/blood/urine\r\nBuprenorphine/*administration & dosage/adverse effects\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nEmployment\r\nFemale\r\nHumans\r\nInjections, Subcutaneous\r\nInsurance, Health/economics\r\nLogistic Models\r\nMale\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Acceptance of Health Care\r\nPatient Compliance\r\nPatient Satisfaction/*statistics & numerical data\r\nPatient-Centered Care\r\n*Quality of Life\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ling W, Nadipelli VR, Solem CT, Ronquest NA, Yeh YC, Learned SM, Mehra V, and Heidbreder C (2019) Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study.. Journal of addiction medicine 13(6), 442-449 DOI: 10.1097/ADM.0000000000000517 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948241,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283670,"Title":"Buprenorphine-naloxone use in pregnancy: asystematic review and metaanalysis.","ParentTitle":"American journal of obstetrics & gynecology MFM","ShortTitle":"Link (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"August","StandardNumber":"2589-9333 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"2","Pages":"100179","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"33345863","Comments":"","TypeName":"Journal, Article","Authors":"Link HM ; Jones H ; Miller L ; Kaltenbach K ; Seligman N ; ","ParentAuthors":"","DOI":"10.1016/j.ajogmf.2020.100179 ","Keywords":"*Buprenorphine/adverse effects\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nFemale\r\nHumans\r\nInfant\r\nInfant, Newborn\r\nOpiate Substitution Treatment\r\nPregnancy\r\n*Pregnancy Complications/drug therapy\r\nPregnancy Outcome\r\nbuprenorphine\r\nbuprenorphine-naloxone\r\nmedication-assisted treatment\r\nmethadone\r\nneonatal abstinence syndrome\r\nopioid use disorder\r\npregnancy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Link HM, Jones H, Miller L, Kaltenbach K, and Seligman N (2020) Buprenorphine-naloxone use in pregnancy: asystematic review and metaanalysis.. American journal of obstetrics & gynecology MFM 2(3), 100179 DOI: 10.1016/j.ajogmf.2020.100179 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282156,"Title":"A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Lintzeris (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"July","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"131","Pages":"119-26","Edition":"","Issue":"1-2","Availability":"","URL":"","OldItemId":"23317685","Comments":"","TypeName":"Journal, Article","Authors":"Lintzeris N ; Leung SY ; Dunlop AJ ; Larance B ; White N ; Rivas GR ; Holland RM ; Degenhardt L ; Muhleisen P ; Hurley M ; Ali R ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2012.12.009 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine/*administration & dosage/*blood\r\nChemistry, Pharmaceutical\r\nDisease Management\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*administration & dosage/*blood\r\nOpioid-Related Disorders/*blood/*drug therapy\r\nTablets\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lintzeris N, Leung SY, Dunlop AJ, Larance B, White N, Rivas GR, Holland RM, Degenhardt L, Muhleisen P, Hurley M, and Ali R (2013) A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence.. Drug and alcohol dependence 131(1-2), 119-26 DOI: 10.1016/j.drugalcdep.2012.12.009 "},{"Codes":[],"Outcomes":[],"ItemId":98281140,"Title":"Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines","ParentTitle":"Journal of Addiction Medicine","ShortTitle":"Lintzeris (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1932-0620","City":"","Country":"","Publisher":"","Institution":"N. Lintzeris, South Eastern Sydney LocalHealthDistrict (SESLHD), NSW Health, Surry Hills, NSW, Australia","Volume":"12","Pages":"234-240","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622503213&from=export http://dx.doi.org/10.1097/ADM.0000000000000396","OldItemId":"","Comments":"2019-10-11","TypeName":"Journal, Article","Authors":"Lintzeris N ; Monds L A; Rivas C ; Leung S ; Dunlop A ; Newcombe D ; Walters C ; Galea S ; White N ; Montebello M ; Demirkol A ; Swanson N ; Ali R ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000396","Keywords":"buprenorphine\r\nmethadone\r\nadult\r\narticle\r\nAustralia\r\nclinical article\r\ncohort analysis\r\ndrug safety\r\ndrug substitution\r\ndrug withdrawal\r\nfeasibility study\r\nfemale\r\nhuman\r\nmale\r\nmedical record\r\nmulticenter study\r\nNew Zealand\r\nopiate addiction\r\noutcome assessment\r\npatient satisfaction\r\npractice guideline\r\npriority journal\r\nprotocol compliance\r\nsubstance use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lintzeris N, Monds L A, Rivas C, Leung S, Dunlop A, Newcombe D, Walters C, Galea S, White N, Montebello M, Demirkol A, Swanson N, and Ali R (2018) Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. Journal of Addiction Medicine 12(3), 234-240 DOI: 10.1097/ADM.0000000000000396"},{"Codes":[{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282510,"Title":"Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.","ParentTitle":"JAMA network open","ShortTitle":"Lintzeris (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"May","StandardNumber":"2574-3805 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"4","Pages":"e219041","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"33970256","Comments":"","TypeName":"Journal, Article","Authors":"Lintzeris N ; Dunlop AJ ; Haber PS ; Lubman DI ; Graham R ; Hutchinson S ; Arunogiri S ; Hayes V ; Hjelmstrm P ; Svedberg A ; Peterson S ; Tiberg F ; ","ParentAuthors":"","DOI":"10.1001/jamanetworkopen.2021.9041 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Subcutaneous\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Reported Outcome Measures\r\nSurveys and Questionnaires","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lintzeris N, Dunlop AJ, Haber PS, Lubman DI, Graham R, Hutchinson S, Arunogiri S, Hayes V, Hjelmstrm P, Svedberg A, Peterson S, and Tiberg F (2021) Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.. JAMA network open 4(5), e219041 DOI: 10.1001/jamanetworkopen.2021.9041 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280571,"Title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Lister (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0095-2990","City":"","Country":"","Publisher":"","Institution":"J.J. Lister, Rutgers, The State University of New Jersey, School of Social Work, 120 Albany Street, New Brunswick, NJ, United States","Volume":"46","Pages":"273-288","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2003857806&from=export http://dx.doi.org/10.1080/00952990.2019.1694536","OldItemId":"","Comments":"2020-07-01","TypeName":"Journal, Article","Authors":"Lister J J; Weaver A ; Ellis J D; Himle J A; Ledgerwood D M; ","ParentAuthors":"","DOI":"10.1080/00952990.2019.1694536","Keywords":"consumer\r\nhealth care access\r\nhealth care cost\r\nhealth personnel attitude\r\nhuman\r\nopiate addiction\r\noutpatient care\r\nperception\r\npharmaceutical care\r\nprogram acceptability\r\nreview\r\nrural population\r\nsystematic review\r\ntravel\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lister J J, Weaver A, Ellis J D, Himle J A, and Ledgerwood D M (2020) A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. American Journal of Drug and Alcohol Abuse 46(3), 273-288 DOI: 10.1080/00952990.2019.1694536"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281582,"Title":"Naltrexone depot formulations for opioid and alcohol dependence: A systematic review","ParentTitle":"CNS Neuroscience and Therapeutics","ShortTitle":"Lobmaier (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"","StandardNumber":"1755-5949","City":"","Country":"","Publisher":"","Institution":"P.P. Lobmaier, Norwegian Centre for Addiction Research, Kirkeveien 166, Building 45, 0407 Oslo, Norway","Volume":"17","Pages":"629-636","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L363008438&from=export http://dx.doi.org/10.1111/j.1755-5949.2010.00194.x","OldItemId":"","Comments":"2011-12-07","TypeName":"Journal, Article","Authors":"Lobmaier P P; Kune N ; Gossop M ; Waal H ; ","ParentAuthors":"","DOI":"10.1111/j.1755-5949.2010.00194.x","Keywords":"naltrexone\r\noneil implant\r\nplacebo\r\nprodetoxon\r\nunclassified drug\r\nwedgewood implant\r\nalcoholism\r\nallergy\r\napplication site infection\r\napplication site inflammation\r\napplication site pain\r\ncognitive defect\r\ndrug formulation\r\ndrug implant\r\ndrug mechanism\r\ndrug metabolism\r\ndrug release\r\ndrug safety\r\ndrug tolerability\r\nheadache\r\nhuman\r\nmuscle twitch\r\nnausea\r\nopiate addiction\r\npatient compliance\r\npsychosocial care\r\nquality of life\r\nrandomized controlled trial (topic)\r\nreview\r\nside effect\r\nsystematic review\r\ntreatment outcome\r\nvomiting\r\noneil implant\r\nprodetoxon\r\nvivitrol\r\nwedgewood implant","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lobmaier P P, Kune N, Gossop M, and Waal H (2011) Naltrexone depot formulations for opioid and alcohol dependence: A systematic review. CNS Neuroscience and Therapeutics 17(6), 629-636 DOI: 10.1111/j.1755-5949.2010.00194.x"},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281521,"Title":"Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Lofwall (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"M.R. Lofwall, University of Kentucky, Center on Drug and Alcohol Research, 515 Oldham Court, Lexington, KY 40502, United States","Volume":"133","Pages":"188-197","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52615534&from=export http://dx.doi.org/10.1016/j.drugalcdep.2013.05.010","OldItemId":"","Comments":"2013-10-15","TypeName":"Journal, Article","Authors":"Lofwall M R; Babalonis S ; Nuzzo P A; Siegel A ; Campbell C ; Walsh S L; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.05.010","Keywords":"NCT00980044\r\nhydrocortisone\r\nplacebo\r\ntramadol\r\nabdominal pain\r\nadult\r\narticle\r\nclinical article\r\nclinical feature\r\ncontrolled drug release\r\ncontrolled study\r\ncrossover procedure\r\ndepression\r\ndouble blind procedure\r\ndrug cost\r\ndrug dose comparison\r\ndrug efficacy\r\ndrug response\r\ndrug safety\r\ndrug tolerability\r\ndrug withdrawal\r\nsustained drug release\r\nfemale\r\nflank pain\r\ngroup B streptococcal infection\r\nhot flush\r\nhuman\r\ninsomnia\r\nirritability\r\nlacrimation\r\nmale\r\nmuscle tone\r\nopiate addiction\r\noutcome assessment\r\nphase 1 clinical trial\r\nphase 2 clinical trial\r\nprescription\r\npriority journal\r\nrandomized controlled trial\r\nrash\r\nrhinorrhea\r\nsneezing\r\nsore throat\r\ntachycardia\r\nthorax pain\r\nurine retention\r\nwithdrawal syndrome\r\nultram er","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lofwall M R, Babalonis S, Nuzzo P A, Siegel A, Campbell C, and Walsh S L (2013) Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial. Drug and Alcohol Dependence 133(1), 188-197 DOI: 10.1016/j.drugalcdep.2013.05.010"},{"Codes":[{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281360,"Title":"Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Lofwall (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"M.R. Lofwall, Center on Drug and Alcohol Research, 845 Angliana Ave., Lexington, KY, United States","Volume":"164","Pages":"143-150","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L610558033&from=export http://dx.doi.org/10.1016/j.drugalcdep.2016.05.002","OldItemId":"","Comments":"2016-06-09","TypeName":"Journal, Article","Authors":"Lofwall M R; Babalonis S ; Nuzzo P A; Elayi S C; Walsh S L; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.05.002","Keywords":"cannabinoid 1 receptor\r\ncannabis\r\ndronabinol\r\nopiate\r\noxycodone\r\nplacebo\r\nadult\r\nanxiety\r\narticle\r\nbackache\r\nclinical article\r\ncognitive defect\r\ncontrolled study\r\ndisease exacerbation\r\ndose response\r\ndouble blind procedure\r\ndrug dose comparison\r\ndrug dose reduction\r\ndrug effect\r\ndrug efficacy\r\ndrug tolerability\r\nepiphora\r\neye disease\r\nfemale\r\nhospital patient\r\nhuman\r\nmaintenance therapy\r\nmale\r\nmuscle disease\r\nmuscle tone\r\nnervousness\r\nopiate addiction\r\noutcome assessment\r\npanic\r\npriority journal\r\npsychomotor performance\r\nrandomized controlled trial\r\nrhinorrhea\r\nrunny eye\r\nrunny eye\r\nsedation\r\nside effect\r\nsinus tachycardia\r\ntachycardia\r\nvisual analog scale\r\nwithdrawal syndrome\r\nyawning\r\nmarinol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lofwall M R, Babalonis S, Nuzzo P A, Elayi S C, and Walsh S L (2016) Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans. Drug and Alcohol Dependence 164, 143-150 DOI: 10.1016/j.drugalcdep.2016.05.002"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282720,"Title":"Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.","ParentTitle":"JAMA internal medicine","ShortTitle":"Lofwall (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"June","StandardNumber":"2168-6106 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"178","Pages":"764-773","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"29799968","Comments":"","TypeName":"Journal, Article","Authors":"Lofwall MR ; Walsh SL ; Nunes EV ; Bailey GL ; Sigmon SC ; Kampman KM ; Frost M ; Tiberg F ; Linden M ; Sheldon B ; Oosman S ; Peterson S ; Chen M ; Kim S ; ","ParentAuthors":"","DOI":"10.1001/jamainternmed.2018.1052 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine/*administration & dosage/adverse effects\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nInjections, Subcutaneous/adverse effects\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/*administration & dosage/adverse effects\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Frost M, Tiberg F, Linden M, Sheldon B, Oosman S, Peterson S, Chen M, and Kim S (2018) Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.. JAMA internal medicine 178(6), 764-773 DOI: 10.1001/jamainternmed.2018.1052 "},{"Codes":[{"AttributeId":14948264,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948346,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279886,"Title":"Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Loh (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"M.-C. Van Hout, Professor of International Public Health Policy and Practice, Public Health Institute, Faculty of Health, Liverpool John Moore's University, 3rd Floor, Exchange Station, Tithebarn Street, Liverpool, United Kingdom","Volume":"112","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2022311851&from=export http://dx.doi.org/10.1016/j.drugpo.2023.103957","OldItemId":"","Comments":"2023-07-05","TypeName":"Journal, Article","Authors":"Loh D A; Plugge E ; Van Hout M C; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2023.103957","Keywords":"methadone\r\ncommunity\r\ncommunity reintegration\r\ncorrectional facility\r\ndrug effect\r\nfamily support\r\ngovernment\r\ngrey literature\r\nhuman\r\nIndonesia\r\nMalay-Indonesian\r\nMalaysia\r\nopiate addiction\r\nopiate substitution treatment\r\nparity\r\npractice guideline\r\nreview\r\nsocial welfare\r\nSoutheast Asia\r\nstigma\r\nsystematic review\r\nViet Nam","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Loh D A, Plugge E, and Van Hout M C (2023) Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review. International Journal of Drug Policy 112,  DOI: 10.1016/j.drugpo.2023.103957"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282232,"Title":"Individual Placement and Support (IPS) for Methadone Maintenance Therapy Patients: A Pilot Randomized Controlled Trial.","ParentTitle":"Administration and policy in mental health","ShortTitle":"Lones (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"May","StandardNumber":"0894-587X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"44","Pages":"359-364","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"28213673","Comments":"","TypeName":"Journal, Article","Authors":"Lones CE ; Bond GR ; McGovern MP ; Carr K ; Leckron-Myers T ; Hartnett T ; Becker DR ; ","ParentAuthors":"","DOI":"10.1007/s10488-017-0793-2 ","Keywords":"Adult\r\nEmployment, Supported/*organization & administration\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPilot Projects\r\nSocioeconomic Factors\r\nMethadone\r\nOpioid use disorder\r\nSupported employment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lones CE, Bond GR, McGovern MP, Carr K, Leckron-Myers T, Hartnett T, and Becker DR (2017) Individual Placement and Support (IPS) for Methadone Maintenance Therapy Patients: A Pilot Randomized Controlled Trial.. Administration and policy in mental health 44(3), 359-364 DOI: 10.1007/s10488-017-0793-2 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948264,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281336,"Title":"Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis","ParentTitle":"Clinical Infectious Diseases","ShortTitle":"Low (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1058-4838","City":"","Country":"","Publisher":"","Institution":"A.J. Low, School of Social and Community Medicine, University of Bristol, 722 W 168th, New York, NY, United Kingdom","Volume":"63","Pages":"1094-1104","Edition":"","Issue":"8","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L612673552&from=export http://dx.doi.org/10.1093/cid/ciw416","OldItemId":"","Comments":"2019-09-20","TypeName":"Journal, Article","Authors":"Low A J; Mburu G ; Welton N J; May M T; Davies C F; French C ; Turner K M; Looker K J; Christensen H ; McLean S ; Rhodes T ; Platt L ; Hickman M ; Guise A ; Vickerman P ; ","ParentAuthors":"","DOI":"10.1093/cid/ciw416","Keywords":"antiretrovirus agent\r\nantiretroviral therapy\r\nantiviral therapy\r\narticle\r\nCD4 lymphocyte count\r\nChina\r\nEurope\r\nhuman\r\nHuman immunodeficiency virus infection\r\nIndonesia\r\nintravenous drug abuse\r\nmeta analysis\r\nmortality\r\nNorth America\r\nopiate substitution treatment\r\noutcome assessment\r\npatient care\r\npatient compliance\r\npriority journal\r\nsystematic review\r\ntreatment withdrawal\r\nvirus inhibition","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Low A J, Mburu G, Welton N J, May M T, Davies C F, French C, Turner K M, Looker K J, Christensen H, McLean S, Rhodes T, Platt L, Hickman M, Guise A, and Vickerman P (2016) Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 63(8), 1094-1104 DOI: 10.1093/cid/ciw416"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282803,"Title":"Methadone maintenance treatment versus methadone maintenance treatment plus auricular acupuncture: impacts on patient satisfaction and coping mechanism.","ParentTitle":"Journal of pharmacy practice","ShortTitle":"Lua (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"December","StandardNumber":"0897-1900 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"26","Pages":"541-50","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"23764566","Comments":"","TypeName":"Journal, Article","Authors":"Lua PL ; Talib NS ; Ismail Z ; ","ParentAuthors":"","DOI":"10.1177/0897190013489574 ","Keywords":"Acupuncture, Ear/*methods\r\n*Adaptation, Psychological\r\nAdult\r\nCombined Modality Therapy\r\nHumans\r\nLongitudinal Studies\r\nMalaysia\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*rehabilitation\r\nPatient Satisfaction\r\nProspective Studies\r\nYoung Adult\r\nauricular acupuncture\r\ncoping\r\ndrug addiction\r\nmethadone\r\nsatisfaction","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lua PL, Talib NS, and Ismail Z (2013) Methadone maintenance treatment versus methadone maintenance treatment plus auricular acupuncture: impacts on patient satisfaction and coping mechanism.. Journal of pharmacy practice 26(6), 541-50 DOI: 10.1177/0897190013489574 "},{"Codes":[{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282126,"Title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.","ParentTitle":"Annals of internal medicine","ShortTitle":"Lucas (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"June","StandardNumber":"0003-4819 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"152","Pages":"704-11","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"20513828","Comments":"","TypeName":"Journal, Article","Authors":"Lucas GM ; Chaudhry A ; Hsu J ; Woodson T ; Lau B ; Olsen Y ; Keruly JC ; Fiellin DA ; Finkelstein R ; Barditch-Crovo P ; Cook K ; Moore RD ; ","ParentAuthors":"","DOI":"10.7326/0003-4819-152-11-201006010-00003 ","Keywords":"Anti-HIV Agents/therapeutic use\r\nBaltimore\r\nBuprenorphine/*therapeutic use\r\nCommunity Health Services/*standards\r\nDrug Therapy, Combination\r\nHIV Infections/*complications/drug therapy\r\nHumans\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpioid-Related Disorders/complications/*drug therapy\r\nOutcome Assessment, Health Care\r\nReferral and Consultation\r\nSubstance Abuse Treatment Centers/standards\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, and Moore RD (2010) Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.. Annals of internal medicine 152(11), 704-11 DOI: 10.7326/0003-4819-152-11-201006010-00003 "},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281182,"Title":"Effects of opiate substitution treatment on mortality for opioids users: A systematic review and meta-analysis","ParentTitle":"The Lancet","ShortTitle":"Ma (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1474-547X","City":"","Country":"","Publisher":"","Institution":"Y.-P. Bao, National Institute on Drug Dependence, Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China","Volume":"390","Pages":"56","Edition":"","Issue":"SPEC.ISS 1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L621512901&from=export","OldItemId":"","Comments":"2018-04-06","TypeName":"Journal, Article","Authors":"Ma J ; Wang R J; Su M F; Liu M X; Shi J ; Lu L ; Bao Y P; ","ParentAuthors":"","DOI":"","Keywords":"buprenorphine\r\nmethadone\r\nadult\r\nall cause mortality\r\ncohort analysis\r\nconference abstract\r\ncontrolled study\r\ndrug overdose\r\nEmbase\r\nfemale\r\nfollow up\r\nhuman\r\nmale\r\nMedline\r\nmeta analysis\r\nmortality rate\r\nmortality risk\r\nopiate substitution treatment\r\nprevention\r\nrisk assessment\r\nrisk factor\r\nsubstitution reaction\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ma J, Wang R J, Su M F, Liu M X, Shi J, Lu L, and Bao Y P (2017) Effects of opiate substitution treatment on mortality for opioids users: A systematic review and meta-analysis. The Lancet 390(SPEC.ISS 1), 56"},{"Codes":[{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280720,"Title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","ParentTitle":"Molecular Psychiatry","ShortTitle":"Ma (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1359-4184","City":"","Country":"","Publisher":"","Institution":"Y.-P. Bao, National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China","Volume":"24","Pages":"1868-1883","Edition":"","Issue":"12","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622683280&from=export http://dx.doi.org/10.1038/s41380-018-0094-5","OldItemId":"","Comments":"2018-06-28","TypeName":"Journal, Article","Authors":"Ma J ; Bao Y P; Wang R J; Su M F; Liu M X; Li J Q; Degenhardt L ; Farrell M ; Blow F C; Ilgen M ; Shi J ; Lu L ; ","ParentAuthors":"","DOI":"10.1038/s41380-018-0094-5","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nall cause mortality\r\narticle\r\ncrude mortality rate\r\ndrug dependence treatment\r\nevidence based medicine\r\nfollow up\r\nhigh risk population\r\nhuman\r\nmedication assisted treatment\r\nmedication compliance\r\nmeta analysis\r\nmortality\r\nmortality risk\r\nopiate addiction\r\npremature mortality\r\npriority journal\r\nprotection\r\nretention time\r\nrisk factor\r\nsystematic review\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ma J, Bao Y P, Wang R J, Su M F, Liu M X, Li J Q, Degenhardt L, Farrell M, Blow F C, Ilgen M, Shi J, and Lu L (2019) Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry 24(12), 1868-1883 DOI: 10.1038/s41380-018-0094-5"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281551,"Title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","ParentTitle":"BMJ (Online)","ShortTitle":"MacArthur (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1756-1833","City":"","Country":"","Publisher":"","Institution":"G.J. MacArthur, School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, United Kingdom","Volume":"345","Pages":"","Edition":"","Issue":"7879","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L365897976&from=export http://dx.doi.org/10.1136/bmj.e5945","OldItemId":"","Comments":"2012-11-07","TypeName":"Journal, Article","Authors":"MacArthur G J; Minozzi S ; Martin N ; Vickerman P ; Deren S ; Bruneau J ; Degenhardt L ; Hickman M ; ","ParentAuthors":"","DOI":"10.1136/bmj.e5945","Keywords":"buprenorphine\r\nmethadone\r\nadult\r\nbehavior change\r\nclinical effectiveness\r\ndetoxification\r\nfollow up\r\nhigh risk behavior\r\nhuman\r\nHuman immunodeficiency virus infection\r\nincidence\r\ninfection prevention\r\ninfection risk\r\nintravenous drug abuse\r\nmajor clinical study\r\nmeta analysis\r\nmethadone treatment\r\nopiate addiction\r\nopiate substitution treatment\r\npriority journal\r\nreview\r\nrisk reduction\r\nsystematic review\r\nvirus transmission","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"MacArthur G J, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, and Hickman M (2012) Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ (Online) 345(7879),  DOI: 10.1136/bmj.e5945"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284035,"Title":"Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.","ParentTitle":"The International journal on drug policy","ShortTitle":"MacArthur (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"January","StandardNumber":"0955-3959 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"25","Pages":"34-52","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23973009","Comments":"","TypeName":"Journal, Article","Authors":"MacArthur GJ ; van Velzen E ; Palmateer N ; Kimber J ; Pharris A ; Hope V ; Taylor A ; Roy K ; Aspinall E ; Goldberg D ; Rhodes T ; Hedrich D ; Salminen M ; Hickman M ; Hutchinson SJ ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2013.07.001 ","Keywords":"HIV Infections/complications/*prevention & control\r\n*Harm Reduction\r\nHepatitis C/complications/*prevention & control\r\nHumans\r\nNeedle-Exchange Programs\r\nOpiate Substitution Treatment\r\nRisk-Taking\r\nSubstance Abuse, Intravenous/*complications/prevention & control/psychology\r\nHIV\r\nHarm reduction\r\nHepatitis C\r\nPeople who inject drugs\r\nReview","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, and Hutchinson SJ (2014) Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.. The International journal on drug policy 25(1), 34-52 DOI: 10.1016/j.drugpo.2013.07.001 "},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280452,"Title":"Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review","ParentTitle":"Journal of General Internal Medicine","ShortTitle":"Mackey (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0884-8734","City":"","Country":"","Publisher":"","Institution":"K. Mackey, Evidence Synthesis Program (ESP) Coordinating Center, VA Portland Health Care System, Portland, OR, United States","Volume":"35","Pages":"954-963","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007149867&from=export http://dx.doi.org/10.1007/s11606-020-06257-4","OldItemId":"","Comments":"2020-11-09","TypeName":"Journal, Article","Authors":"Mackey K ; Veazie S ; Anderson J ; Bourne D ; Peterson K ; ","ParentAuthors":"","DOI":"10.1007/s11606-020-06257-4","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nnaltrexone\r\nopiate derivative\r\nbibliographic database\r\ndrug use\r\neducational status\r\nevidence based medicine\r\nhealth belief\r\nhealth care cost\r\nhealth care personnel\r\nhealth insurance\r\nhuman\r\nknowledge\r\nopiate addiction\r\npeer group\r\npersonal experience\r\nprescription\r\nprospective study\r\nquality control\r\nreview\r\nrisk assessment\r\nrisk factor\r\nsocial stigma\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mackey K, Veazie S, Anderson J, Bourne D, and Peterson K (2020) Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of General Internal Medicine 35, 954-963 DOI: 10.1007/s11606-020-06257-4"},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282315,"Title":"Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.","ParentTitle":"Substance use & misuse","ShortTitle":"Madden (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1082-6084 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"56","Pages":"2181-2201","Edition":"","Issue":"14","Availability":"","URL":"","OldItemId":"34538213","Comments":"","TypeName":"Journal, Article","Authors":"Madden EF ; Prevedel S ; Light T ; Sulzer SH ; ","ParentAuthors":"","DOI":"10.1080/10826084.2021.1975749 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy\r\nStigma\r\nbuprenorphine\r\nmedications for addiction treatment\r\nmethadone\r\nopioid use disorder\r\npharmacotherapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Madden EF, Prevedel S, Light T, and Sulzer SH (2021) Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.. Substance use & misuse 56(14), 2181-2201 DOI: 10.1080/10826084.2021.1975749 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282958,"Title":"A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Madlung-Kratzer (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"September","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"104","Pages":"1549-57","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"19686525","Comments":"","TypeName":"Journal, Article","Authors":"Madlung-Kratzer E ; Spitzer B ; Brosch R ; Dunkel D ; Haring C ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2009.02653.x ","Keywords":"Adult\r\nDelayed-Action Preparations/administration & dosage\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nMorphine/*administration & dosage\r\nNarcotics/*administration & dosage\r\nOpioid-Related Disorders/*rehabilitation\r\nSubstance Withdrawal Syndrome/*prevention & control\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Madlung-Kratzer E, Spitzer B, Brosch R, Dunkel D, and Haring C (2009) A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.. Addiction (Abingdon, and England) 104(9), 1549-57 DOI: 10.1111/j.1360-0443.2009.02653.x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281724,"Title":"Inequities in the treatment of opioid use disorder: A scoping review.","ParentTitle":"Journal of substance use and addiction treatment","ShortTitle":"Magee (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"September","StandardNumber":"2949-8759 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"152","Pages":"209082","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37271346","Comments":"","TypeName":"Journal, Article","Authors":"Magee T ; Peters C ; Jacobsen SM ; Nees D ; Dunford B ; Ford AI ; Vassar M ; ","ParentAuthors":"","DOI":"10.1016/j.josat.2023.209082 ","Keywords":"Humans\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy\r\n*Drug Overdose/drug therapy\r\nPatient-Centered Care\r\nHealth inequities\r\nOUD treatment\r\nOpioid dependence\r\nOpioid use disorder\r\nSubstance use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Magee T, Peters C, Jacobsen SM, Nees D, Dunford B, Ford AI, and Vassar M (2023) Inequities in the treatment of opioid use disorder: A scoping review.. Journal of substance use and addiction treatment 152, 209082 DOI: 10.1016/j.josat.2023.209082 "},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281041,"Title":"Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Maglione (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"M.A. Maglione, RAND Corporation, 1776 Main Street, Santa Monica, CA, United States","Volume":"89","Pages":"28-51","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2000620359&from=export http://dx.doi.org/10.1016/j.jsat.2018.03.001","OldItemId":"","Comments":"2018-04-19","TypeName":"Journal, Article","Authors":"Maglione M A; Raaen L ; Chen C ; Azhar G ; Shahidinia N ; Shen M ; Maksabedian E ; Shanman R M; Newberry S ; Hempel S ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2018.03.001","Keywords":"buprenorphine\r\nmethadone\r\narticle\r\nattention\r\nbody equilibrium\r\ncognition\r\ncrime\r\ndrug dependence\r\ndrug therapy\r\nevidence based medicine\r\nfatigue\r\nfunctional assessment\r\nhuman\r\ninsomnia\r\nmedical history\r\nmedication assisted treatment\r\nmemory\r\nneurology\r\noccupation\r\nopiate addiction\r\npriority journal\r\nrandomized controlled trial (topic)\r\nreturn to work\r\nsocial behavior\r\nsystematic review\r\ntherapy effect\r\ntraffic accident\r\nvision\r\nworking memory","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Maglione M A, Raaen L, Chen C, Azhar G, Shahidinia N, Shen M, Maksabedian E, Shanman R M, Newberry S, and Hempel S (2018) Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review. Journal of Substance Abuse Treatment 89, 28-51 DOI: 10.1016/j.jsat.2018.03.001"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285036,"Title":"Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.","ParentTitle":"Rand health quarterly","ShortTitle":"Maglione (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"June","StandardNumber":"2162-8254 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"8","Pages":"","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"32582471","Comments":"","TypeName":"Journal, Article","Authors":"Maglione MA ; Laura R ; Christine C ; Azhar GS ; Nima S ; Mimi S ; Hernandez EJM ; Shanman RM ; Susanne H ; ","ParentAuthors":"","DOI":"","Keywords":"Military Health and Health Care\r\nOpioids\r\nPharmaceutical Drugs\r\nSubstance Abuse Treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Maglione MA, Laura R, Christine C, Azhar GS, Nima S, Mimi S, Hernandez EJM, Shanman RM, and Susanne H (2020) Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.. Rand health quarterly 8(4), "},{"Codes":[{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281799,"Title":"Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments.","ParentTitle":"Current psychiatry reports","ShortTitle":"Mahmoud (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"September","StandardNumber":"1523-3812 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"375-386","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"35895282","Comments":"","TypeName":"Journal, Article","Authors":"Mahmoud H ; Naal H ; Whaibeh E ; Smith A ; ","ParentAuthors":"","DOI":"10.1007/s11920-022-01346-z ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*COVID-19\r\nHumans\r\n*Opioid-Related Disorders/drug therapy\r\nPandemics\r\n*Telemedicine\r\nCOVID-19\r\nMedication-assisted treatment\r\nOpioid use disorder\r\nTelebehavioral health\r\nTelehealth","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mahmoud H, Naal H, Whaibeh E, and Smith A (2022) Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments.. Current psychiatry reports 24(9), 375-386 DOI: 10.1007/s11920-022-01346-z "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281391,"Title":"Systematic literature review on buprenorphine/naloxone use in outpatient opioid dependence treatment","ParentTitle":"Canadian Journal of Addiction","ShortTitle":"Main (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"2368-4720","City":"","Country":"","Publisher":"","Institution":"L. Kelly, Box 489, Sioux Lookout, ON, Canada","Volume":"7","Pages":"12-18","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L618653470&from=export","OldItemId":"","Comments":"2017-10-17","TypeName":"Journal, Article","Authors":"Main F ; Kelly L ; ","ParentAuthors":"","DOI":"","Keywords":"buprenorphine plus naloxone\r\nabstinence\r\narticle\r\nCanada\r\ndrug efficacy\r\ndrug safety\r\nfollow up\r\nhuman\r\nmortality\r\nNorth America\r\nopiate addiction\r\noutpatient department\r\npredictor variable\r\nprimary medical care\r\nquality of life\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Main F, and Kelly L (2016) Systematic literature review on buprenorphine/naloxone use in outpatient opioid dependence treatment. Canadian Journal of Addiction 7(1), 12-18"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280944,"Title":"Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review","ParentTitle":"PLoS Medicine","ShortTitle":"Malta (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1549-1277","City":"","Country":"","Publisher":"","Institution":"M. Malta, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada","Volume":"16","Pages":"","Edition":"","Issue":"12","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2004611778&from=export http://dx.doi.org/10.1371/journal.pmed.1003002","OldItemId":"","Comments":"2020-01-31","TypeName":"Journal, Article","Authors":"Malta M ; Varatharajan T ; Russell C ; Pang M ; Bonato S ; Fischer B ; ","ParentAuthors":"","DOI":"10.1371/journal.pmed.1003002","Keywords":"buprenorphine\r\nmethadone\r\nnaloxone\r\nopiate\r\nopiate agonist\r\narticle\r\ncost effectiveness analysis\r\nDiagnostic and Statistical Manual of Mental Disorders\r\nfollow up\r\nhuman\r\nintoxication\r\nmaintenance therapy\r\nmethadone treatment\r\nmortality\r\nopiate addiction\r\nopiate substitution treatment\r\nprisoner\r\nrandomized controlled trial (topic)\r\nrisk factor\r\nsystematic review\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Malta M, Varatharajan T, Russell C, Pang M, Bonato S, and Fischer B (2019) Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLoS Medicine 16(12),  DOI: 10.1371/journal.pmed.1003002"},{"Codes":[{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948197,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288269,"Title":"Management of opioid use disorders: An update to the national clinical practice guideline","ParentTitle":"","ShortTitle":"Management of opioid... (Igor)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42023398663","Comments":"","TypeName":"Journal, Article","Authors":"Igor Yakovenko ; Yvette Mukaneza ; Katuschia Germ ; Jacob Belliveau ; Paxton Bach ; Thomas Brothers ; Peter Selby ; Ginette Poulin ; Marie-ve Goyer ; Julie Bruneau ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Igor Yakovenko, Yvette Mukaneza, Katuschia Germ, Jacob Belliveau, Paxton Bach, Thomas Brothers, Peter Selby, Ginette Poulin, Marie-ve Goyer, and Julie Bruneau (    ) Management of opioid use disorders: An update to the national clinical practice guideline.  , "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948268,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282705,"Title":"Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users: A Randomized Clinical Trial.","ParentTitle":"European addiction research","ShortTitle":"Mannaioni (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1022-6877 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"9-18","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29393208","Comments":"","TypeName":"Journal, Article","Authors":"Mannaioni G ; Lanzi C ; Lotti M ; Galli V ; Totti A ; Pacileo I ; Sili M ; Pracucci C ; Dilaghi A ; Bertieri L ; Quaranta M ; Orsini F ; Occupati B ; Michahelles A ; Ciuti R ; Bianchini E ; Fabbro G ; Biggeri A ; Masini E ; Moroni F ; ","ParentAuthors":"","DOI":"10.1159/000485029 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nMethadone/blood/*therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy\r\nTime Factors\r\nTreatment Outcome\r\nHeroin use disorders\r\nMethadone dose\r\nMethadone maintenance treatment\r\nR-methadone plasma levels\r\nRetention in treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mannaioni G, Lanzi C, Lotti M, Galli V, Totti A, Pacileo I, Sili M, Pracucci C, Dilaghi A, Bertieri L, Quaranta M, Orsini F, Occupati B, Michahelles A, Ciuti R, Bianchini E, Fabbro G, Biggeri A, Masini E, and Moroni F (2018) Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users: A Randomized Clinical Trial.. European addiction research 24(1), 9-18 DOI: 10.1159/000485029 "},{"Codes":[{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032086,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282828,"Title":"Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.","ParentTitle":"Addiction biology","ShortTitle":"Mannelli (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"April","StandardNumber":"1355-6215 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"14","Pages":"204-13","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"18715283","Comments":"","TypeName":"Journal, Article","Authors":"Mannelli P ; Patkar AA ; Peindl K ; Gorelick DA ; Wu LT ; Gottheil E ; ","ParentAuthors":"","DOI":"10.1111/j.1369-1600.2008.00119.x ","Keywords":"Adult\r\nAnalgesics, Opioid/*adverse effects\r\nCommunity Mental Health Services/*statistics & numerical data\r\nDisruptive, Impulse Control, and Conduct Disorders/prevention & control\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\n*Inactivation, Metabolic\r\nMale\r\nMethadone/therapeutic use\r\nNaltrexone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nProgram Development\r\nSubstance Withdrawal Syndrome/*etiology/*rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mannelli P, Patkar AA, Peindl K, Gorelick DA, Wu LT, and Gottheil E (2009) Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.. Addiction biology 14(2), 204-13 DOI: 10.1111/j.1369-1600.2008.00119.x "},{"Codes":[],"Outcomes":[],"ItemId":98281019,"Title":"Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone","ParentTitle":"American Journal on Addictions","ShortTitle":"Mannelli (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1055-0496","City":"","Country":"","Publisher":"","Institution":"P. Mannelli, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States","Volume":"27","Pages":"471-476","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L623220518&from=export http://dx.doi.org/10.1111/ajad.12763","OldItemId":"","Comments":"2018-09-06","TypeName":"Journal, Article","Authors":"Mannelli P ; Swartz M ; Wu L T; ","ParentAuthors":"","DOI":"10.1111/ajad.12763","Keywords":"NCT01690546\r\namphetamine\r\nbarbituric acid derivative\r\nbenzodiazepine derivative\r\nbuprenorphine\r\nbuprenorphine plus naloxone\r\nclonidine\r\ncocaine\r\ncyclobenzaprine\r\ndextropropoxyphene\r\ndiamorphine\r\nhydroxyzine\r\nibuprofen\r\nloperamide\r\nlorazepam\r\nmethamphetamine\r\nnaloxone\r\nnaltrexone\r\nopiate\r\nparacetamol\r\nphencyclidine\r\npromethazine\r\ntetrahydrocannabinol\r\ntrazodone\r\nadult\r\naged\r\narticle\r\nclinical article\r\nclinical trial\r\ncontrolled study\r\ndemography\r\ndisease control\r\ndisease severity\r\ndrug dose increase\r\ndrug release\r\ndrug safety\r\ndrug screening\r\ndrug tolerability\r\ndrug withdrawal\r\nDSM-5\r\nfemale\r\nheroin dependence\r\nhuman\r\ninjection drug user\r\nlow drug dose\r\nmale\r\nopen study\r\nopiate addiction\r\nopioid use disorder\r\noutcome assessment\r\noutpatient department\r\nsocial aspect\r\nsymptom\r\ntreatment duration\r\ntreatment response\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mannelli P, Swartz M, and Wu L T (2018) Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone. American Journal on Addictions 27(6), 471-476 DOI: 10.1111/ajad.12763"},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282700,"Title":"Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Marsch (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"January","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"43-51","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"24060350","Comments":"","TypeName":"Journal, Article","Authors":"Marsch LA ; Guarino H ; Acosta M ; Aponte-Melendez Y ; Cleland C ; Grabinski M ; Brady R ; Edwards J ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2013.08.012 ","Keywords":"Adult\r\nBehavior Therapy/*methods\r\nCommunity Health Services/methods\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\n*Internet\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*rehabilitation\r\nSubstance Abuse Detection/methods\r\nBehavioral therapy\r\nComputer\r\nInternet\r\nOpioid\r\nTreatment\r\nWeb","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, and Edwards J (2014) Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment.. Journal of substance abuse treatment 46(1), 43-51 DOI: 10.1016/j.jsat.2013.08.012 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282120,"Title":"Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.","ParentTitle":"The lancet. Psychiatry","ShortTitle":"Marsden (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"May","StandardNumber":"2215-0366 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"6","Pages":"391-402","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"30952568","Comments":"","TypeName":"Journal, Article","Authors":"Marsden J ; Stillwell G ; James K ; Shearer J ; Byford S ; Hellier J ; Kelleher M ; Kelly J ; Murphy C ; Mitcheson L ; ","ParentAuthors":"","DOI":"10.1016/S2215-0366(19)30097-5 ","Keywords":"Adult\r\nAnalgesics, Opioid/agonists\r\nCognitive Behavioral Therapy/economics/*methods\r\nCombined Modality Therapy/*economics\r\nCost-Benefit Analysis\r\nFemale\r\nHumans\r\nIntention to Treat Analysis\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/economics/*methods\r\nOpioid-Related Disorders/economics/*therapy\r\nPrecision Medicine\r\nQuality-Adjusted Life Years\r\nTreatment Outcome\r\nUnited Kingdom","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Marsden J, Stillwell G, James K, Shearer J, Byford S, Hellier J, Kelleher M, Kelly J, Murphy C, and Mitcheson L (2019) Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.. The lancet. Psychiatry 6(5), 391-402 DOI: 10.1016/S2215-0366(19)30097-5 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948260,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948330,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948334,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281648,"Title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Mattick (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"","StandardNumber":"1469-493X","City":"","Country":"","Publisher":"","Institution":"R. P. Mattick, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia","Volume":"","Pages":"","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L355236719&from=export http://dx.doi.org/10.1002/14651858.CD002209.pub2","OldItemId":"","Comments":"2009-11-04","TypeName":"Journal, Article","Authors":"Mattick R P; Breen C ; Kimber J ; Davoli M ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD002209.pub2","Keywords":"methadone\r\nmorphine\r\nopiate\r\nplacebo\r\nclinical trial\r\ncontrolled clinical trial\r\ncriminal behavior\r\ndetoxification\r\ndrug dependence\r\ndrug dependence treatment\r\ndrug efficacy\r\nhair analysis\r\nheroin dependence\r\nhuman\r\nmaintenance therapy\r\nmortality\r\npublishing\r\nrandomized controlled trial\r\nreview\r\nself report\r\nsystematic review\r\ntreatment duration\r\nurinalysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mattick R P, Breen C, Kimber J, and Davoli M (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews (3),  DOI: 10.1002/14651858.CD002209.pub2"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281476,"Title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Mattick (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1469-493X","City":"","Country":"","Publisher":"","Institution":"R.P. Mattick, University of New South Wales, National Drug and Alcohol Research Centre, Sydney, NSW, Australia","Volume":"2014","Pages":"","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L620551420&from=export http://dx.doi.org/10.1002/14651858.CD002207.pub4","OldItemId":"","Comments":"2018-02-22","TypeName":"Journal, Article","Authors":"Mattick R P; Breen C ; Kimber J ; Davoli M ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD002207.pub4","Keywords":"benzodiazepine\r\nbuprenorphine\r\ncocaine\r\ndiamorphine\r\nmethadone\r\nmorphine\r\nplacebo\r\nclinical effectiveness\r\nclinical evaluation\r\ncriminal behavior\r\ndose response\r\ndrug efficacy\r\ndrug megadose\r\ndrug safety\r\nhuman\r\nlow drug dose\r\nmeta analysis\r\nmethadone treatment\r\nmortality\r\nopiate addiction\r\noutcome assessment\r\npriority journal\r\nrandomized controlled trial (topic)\r\nreview\r\nsedation\r\nself report\r\nsubstance use\r\nsystematic review\r\ntreatment planning\r\nurinalysis","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mattick R P, Breen C, Kimber J, and Davoli M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2014(2),  DOI: 10.1002/14651858.CD002207.pub4"},{"Codes":[],"Outcomes":[],"ItemId":98281469,"Title":"Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence","ParentTitle":"Neuropsychiatric Disease and Treatment","ShortTitle":"Mauger (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1176-6328","City":"","Country":"","Publisher":"","Institution":"R. Fraser, Addictions Unit, McGill University Health Centre, 1547 Pine Avenue West, Montreal, QC H3G 1B3, Canada","Volume":"10","Pages":"587-598","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L372789191&from=export http://dx.doi.org/10.2147/NDT.S39692","OldItemId":"","Comments":"2014-04-28","TypeName":"Journal, Article","Authors":"Mauger S ; Fraser R ; Gill K ; ","ParentAuthors":"","DOI":"10.2147/NDT.S39692","Keywords":"alanine aminotransferase\r\naspartate aminotransferase\r\nbuprenorphine plus naloxone\r\ndiamorphine\r\nillicit drug\r\nmethadone\r\nmorphine\r\nopiate\r\noxycodone\r\nplacebo\r\nalanine aminotransferase blood level\r\narticle\r\naspartate aminotransferase blood level\r\nconstipation\r\ndiaphoresis\r\ndiarrhea\r\ndizziness\r\ndrug bioavailability\r\ndrug blood level\r\ndrug dependence\r\ndrug dependence treatment\r\ndrug detoxification\r\ndrug distribution\r\ndrug dose titration\r\ndrug efficacy\r\ndrug half life\r\ndrug mechanism\r\ndrug safety\r\nfatigue\r\nfirst pass effect\r\nheadache\r\nhepatitis C\r\nhuman\r\nHuman immunodeficiency virus infection\r\ninsomnia\r\nmydriasis\r\nnausea\r\nopiate addiction\r\noutcome assessment\r\npain\r\npatient care\r\npatient monitoring\r\nQT prolongation\r\nrandomized controlled trial (topic)\r\nreflex\r\nrespiration depression\r\nrisk assessment\r\nrisk benefit analysis\r\nrisk factor\r\nrisk reduction\r\nside effect\r\nsweating\r\nsystematic review\r\nvirus transmission\r\nvomiting\r\nwithdrawal syndrome\r\nyawning\r\nsuboxone\r\nzubsolv","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mauger S, Fraser R, and Gill K (2014) Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence. Neuropsychiatric Disease and Treatment 10, 587-598 DOI: 10.2147/NDT.S39692"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282200,"Title":"Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"McAnulty (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"October","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"239","Pages":"109604","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"36037586","Comments":"","TypeName":"Journal, Article","Authors":"McAnulty C ; Bastien G ; Eugenia Socias M; Bruneau J ; Foll BL ; Lim R ; Brissette S ; Ledjiar O ; Marsan S ; Talbot A ; Jutras-Aswad D ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109604 ","Keywords":"*Buprenorphine/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nCraving\r\nHumans\r\nMethadone/therapeutic use\r\nNaloxone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\nPrescriptions\r\nBuprenorphine/naloxone\r\nCraving\r\nMethadone\r\nOpioid\r\nOpioid-related disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Foll BL, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, and Jutras-Aswad D (2022) Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.. Drug and alcohol dependence 239, 109604 DOI: 10.1016/j.drugalcdep.2022.109604 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282128,"Title":"Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial.","ParentTitle":"Addictive behaviors","ShortTitle":"McAnulty (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"July","StandardNumber":"0306-4603 (Linking)","City":"England","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"154","Pages":"108023","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"38579594","Comments":"","TypeName":"Journal, Article","Authors":"McAnulty C ; Bastien G ; Ledjiar O ; Eugenia Socias M; Le Foll B ; Lim R ; Jutras-Aswad D ; ","ParentAuthors":"","DOI":"10.1016/j.addbeh.2024.108023 ","Keywords":"Female\r\nHumans\r\nAnalgesics, Opioid/therapeutic use\r\nCraving\r\nOpiate Substitution Treatment/methods\r\nCanada/epidemiology\r\n*Opioid-Related Disorders/psychology\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nMethadone/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nAddiction\r\nBuprenorphine\r\nCraving\r\nDependence\r\nMethadone\r\nOpioid","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McAnulty C, Bastien G, Ledjiar O, Eugenia Socias M, Le Foll B, Lim R, and Jutras-Aswad D (2024) Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial.. Addictive behaviors 154, 108023 DOI: 10.1016/j.addbeh.2024.108023 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281868,"Title":"Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.","ParentTitle":"The American journal of psychiatry","ShortTitle":"McCarty (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"September","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"178","Pages":"804-817","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"34315284","Comments":"","TypeName":"Journal, Article","Authors":"McCarty D ; Bougatsos C ; Chan B ; Hoffman KA ; Priest KC ; Grusing S ; Chou R ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.2021.20101548 ","Keywords":"Drug Prescriptions\r\nHumans\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nPharmacies\r\nMethadone Therapy\r\nOffice-Based Methadone\r\nOpioid Use Disorder\r\nPharmacy Methadone Dispensing","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McCarty D, Bougatsos C, Chan B, Hoffman KA, Priest KC, Grusing S, and Chou R (2021) Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.. The American journal of psychiatry 178(9), 804-817 DOI: 10.1176/appi.ajp.2021.20101548 "},{"Codes":[{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282273,"Title":"Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review.","ParentTitle":"Journal of addiction medicine","ShortTitle":"McCarty (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"May","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"16","Pages":"e157-e164","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"34282085","Comments":"","TypeName":"Journal, Article","Authors":"McCarty D ; Chan B ; Buchheit BM ; Bougatsos C ; Grusing S ; Chou R ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000898 ","Keywords":"Adolescent\r\nAged\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nHealth Services Accessibility\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nRetrospective Studies\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McCarty D, Chan B, Buchheit BM, Bougatsos C, Grusing S, and Chou R (2022) Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review.. Journal of addiction medicine 16(3), e157-e164 DOI: 10.1097/ADM.0000000000000898 "},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282251,"Title":"Extended-release naltrexone opioid treatment at jail reentry (XOR).","ParentTitle":"Contemporary clinical trials","ShortTitle":"McDonald (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"July","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"49","Pages":"57-64","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27178765","Comments":"","TypeName":"Journal, Article","Authors":"McDonald RD ; Tofighi B ; Laska E ; Goldfeld K ; Bonilla W ; Flannery M ; Santana-Correa N ; Johnson CW ; Leibowitz N ; Rotrosen J ; Gourevitch MN ; Lee JD ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2016.05.002 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nCause of Death\r\nDelayed-Action Preparations\r\nDrug Overdose/prevention & control\r\nHumans\r\nInjections, Intramuscular\r\nMethadone/therapeutic use\r\nMortality\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/rehabilitation\r\nPatient Participation\r\n*Prisons\r\nSecondary Prevention\r\nCriminal justice\r\nExtended-release naltrexone\r\nJail\r\nNaltrexone\r\nOpioid relapse prevention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McDonald RD, Tofighi B, Laska E, Goldfeld K, Bonilla W, Flannery M, Santana-Correa N, Johnson CW, Leibowitz N, Rotrosen J, Gourevitch MN, and Lee JD (2016) Extended-release naltrexone opioid treatment at jail reentry (XOR).. Contemporary clinical trials 49, 57-64 DOI: 10.1016/j.cct.2016.05.002 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281823,"Title":"Opioid use disorder treatment for people experiencing homelessness: A scoping review.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"McLaughlin (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"July","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"224","Pages":"108717","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"33985863","Comments":"","TypeName":"Journal, Article","Authors":"McLaughlin MF ; Li R ; Carrero ND ; Bain PA ; Chatterjee A ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.108717 ","Keywords":"Buprenorphine/therapeutic use\r\n*Health Services Accessibility\r\n*Health Services Misuse\r\n*Ill-Housed Persons\r\nHumans\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*epidemiology/*therapy\r\nUnited States/epidemiology\r\nHealthcare for the homeless\r\nHomelessness\r\nMOUD\r\nOpioid use disorder\r\nSubstance use treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"McLaughlin MF, Li R, Carrero ND, Bain PA, and Chatterjee A (2021) Opioid use disorder treatment for people experiencing homelessness: A scoping review.. Drug and alcohol dependence 224, 108717 DOI: 10.1016/j.drugalcdep.2021.108717 "},{"Codes":[{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280284,"Title":"A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes","ParentTitle":"Open Forum Infectious Diseases","ShortTitle":"Mcnamara (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2328-8957","City":"","Country":"","Publisher":"","Institution":"S.A. Springer, Yale AIDS Program, Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, United States","Volume":"8","Pages":"","Edition":"","Issue":"8","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2015306300&from=export http://dx.doi.org/10.1093/ofid/ofab289","OldItemId":"","Comments":"2021-11-16","TypeName":"Journal, Article","Authors":"Mcnamara K F; Biondi B E; Hernndez-Ramrez R U; Taweh N ; Grimshaw A A; Springer S A; ","ParentAuthors":"","DOI":"10.1093/ofid/ofab289","Keywords":"buprenorphine\r\ncocaine\r\nfentanyl\r\nicosapentaenoic acid\r\nmethamphetamine\r\nnaloxone\r\nnaltrexone\r\nribavirin\r\nsofosbuvir\r\nantiretroviral therapy\r\nbacterial endocarditis\r\nCD4 lymphocyte count\r\nClinical Global Impression scale\r\ncommunicable disease\r\nepidemic\r\nhealth care policy\r\nhepatitis B\r\nhepatitis C\r\nHepatitis C virus\r\nhospital readmission\r\nhospitalization\r\nhuman\r\nHuman immunodeficiency virus\r\nHuman immunodeficiency virus infection\r\nlimit of detection\r\nliver cirrhosis\r\nmedication compliance\r\nmeta analysis\r\nopiate addiction\r\nquestionnaire\r\nrandomized controlled trial (topic)\r\nreinfection\r\nreview\r\nsexual transmission\r\nsustained virologic response\r\nsystematic review\r\nvirus load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mcnamara K F, Biondi B E, Hernndez-Ramrez R U, Taweh N, Grimshaw A A, and Springer S A (2021) A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes. Open Forum Infectious Diseases 8(8),  DOI: 10.1093/ofid/ofab289"},{"Codes":[{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283080,"Title":"A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Meade (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"January","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"38","Pages":"12-21","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"19574017","Comments":"","TypeName":"Journal, Article","Authors":"Meade CS ; Lukas SE ; McDonald LJ ; Fitzmaurice GM ; Eldridge JA ; Merrill N ; Weiss RD ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2009.05.010 ","Keywords":"*Acupuncture Points\r\nAdolescent\r\nAdult\r\nAnalgesics, Opioid/adverse effects\r\nAnalysis of Variance\r\nBuprenorphine/*therapeutic use\r\nChi-Square Distribution\r\nCombined Modality Therapy\r\nDrug Administration Schedule\r\nFemale\r\nHealth Status\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpioid-Related Disorders/*therapy\r\nPain/etiology\r\nPatient Selection\r\nSubstance Withdrawal Syndrome\r\nSurvival Analysis\r\nTime Factors\r\nTranscutaneous Electric Nerve Stimulation/*methods","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Meade CS, Lukas SE, McDonald LJ, Fitzmaurice GM, Eldridge JA, Merrill N, and Weiss RD (2010) A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.. Journal of substance abuse treatment 38(1), 12-21 DOI: 10.1016/j.jsat.2009.05.010 "},{"Codes":[],"Outcomes":[],"ItemId":98283490,"Title":"A review of the existing literature on buprenorphine pharmacogenomics.","ParentTitle":"The pharmacogenomics journal","ShortTitle":"Meaden (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"April","StandardNumber":"1470-269X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"128-139","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"33154520","Comments":"","TypeName":"Journal, Article","Authors":"Meaden CW ; Mozeika A ; Asri R ; Santos CD ; ","ParentAuthors":"","DOI":"10.1038/s41397-020-00198-1 ","Keywords":"Animals\r\nBuprenorphine/*therapeutic use\r\nGenotype\r\nHumans\r\nPharmacogenetics/methods\r\nPolymorphism, Single Nucleotide/genetics\r\nReceptors, Opioid, mu/genetics","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Meaden CW, Mozeika A, Asri R, and Santos CD (2021) A review of the existing literature on buprenorphine pharmacogenomics.. The pharmacogenomics journal 21(2), 128-139 DOI: 10.1038/s41397-020-00198-1 "},{"Codes":[],"Outcomes":[],"ItemId":98281741,"Title":"Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.","ParentTitle":"Pediatrics","ShortTitle":"Medication-Assisted... (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"September","StandardNumber":"0031-4005 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"COMMITTEE ON SUBSTANCE USE AND PREVENTION","Volume":"138","Pages":"","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"27550978","Comments":"","TypeName":"Journal, Article","Authors":"","ParentAuthors":"","DOI":"10.1542/peds.2016-1893 ","Keywords":"Adolescent\r\nBuprenorphine/therapeutic use\r\nHumans\r\nMedication Adherence\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":" (2016) Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.. Pediatrics 138(3),  DOI: 10.1542/peds.2016-1893 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282187,"Title":"User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.","ParentTitle":"BMJ (Clinical research ed.)","ShortTitle":"Melnick (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"June","StandardNumber":"0959-8138 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"377","Pages":"e069271","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"35760423","Comments":"","TypeName":"Journal, Article","Authors":"Melnick ER ; Nath B ; Dziura JD ; Casey MF ; Jeffery MM ; Paek H ; Soares WE 3rd; Hoppe JA ; Rajeevan H ; Li F ; Skains RM ; Walter LA ; Patel MD ; Chari SV ; Platts-Mills TF ; Hess EP ; D'Onofrio G ; ","ParentAuthors":"","DOI":"10.1136/bmj-2021-069271 ","Keywords":"Adult\r\n*Buprenorphine/therapeutic use\r\n*Decision Support Systems, Clinical\r\nEmergency Service, Hospital\r\nHumans\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Melnick ER, Nath B, Dziura JD, Casey MF, Jeffery MM, Paek H, Soares WE 3rd, Hoppe JA, Rajeevan H, Li F, Skains RM, Walter LA, Patel MD, Chari SV, Platts-Mills TF, Hess EP, and D'Onofrio G (2022) User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.. BMJ (Clinical research ed.) 377, e069271 DOI: 10.1136/bmj-2021-069271 "},{"Codes":[{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282645,"Title":"Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Metrebian (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"March","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"110","Pages":"479-90","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"25251885","Comments":"","TypeName":"Journal, Article","Authors":"Metrebian N ; Groshkova T ; Hellier J ; Charles V ; Martin A ; Forzisi L ; Lintzeris N ; Zador D ; Williams H ; Carnwath T ; Mayet S ; Strang J ; ","ParentAuthors":"","DOI":"10.1111/add.12748 ","Keywords":"Administration, Oral\r\nAdult\r\nAlcohol Drinking/epidemiology\r\nAnalgesics, Opioid/*administration & dosage\r\nCocaine-Related Disorders/epidemiology\r\nComorbidity\r\nCrime/statistics & numerical data\r\nEmployment/statistics & numerical data\r\nEngland\r\nFemale\r\nHealth Status\r\nHeroin/administration & dosage\r\nHeroin Dependence/epidemiology/psychology/*rehabilitation\r\nHousing/statistics & numerical data\r\nHumans\r\nIllicit Drugs\r\nInjections, Intravenous\r\nInterpersonal Relations\r\nLinear Models\r\nMale\r\nMethadone/administration & dosage\r\nNeedle-Exchange Programs\r\nOpiate Substitution Treatment/*methods\r\nSubstance Abuse, Intravenous/epidemiology/psychology/*rehabilitation\r\nTreatment Outcome\r\nAddiction\r\ndiamorphine\r\nheroin\r\ninjectable opiate treatment\r\nmethadone\r\nopiates\r\nsubstance misuse","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Metrebian N, Groshkova T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S, and Strang J (2015) Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).. Addiction (Abingdon, and England) 110(3), 479-90 DOI: 10.1111/add.12748 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280179,"Title":"Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES)","ParentTitle":"Pilot and Feasibility Studies","ShortTitle":"Metrebian (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2055-5784","City":"","Country":"","Publisher":"","Institution":"N. Metrebian, Kings College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom","Volume":"7","Pages":"","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2010122433&from=export http://dx.doi.org/10.1186/s40814-020-00761-4","OldItemId":"","Comments":"2021-03-05","TypeName":"Journal, Article","Authors":"Metrebian N ; Carr E ; Goldsmith K ; Weaver T ; Pilling S ; Shearer J ; Woolston-Thomas K ; Tas B ; Cooper C ; Getty C A; van der Waal R ; Kelleher M ; Finch E ; Bijral P ; Taylor D ; Scott J ; Strang J ; ","ParentAuthors":"","DOI":"10.1186/s40814-020-00761-4","Keywords":"mobile phone\r\ntablet computer\r\nmethadone\r\nadult\r\narticle\r\nclinical article\r\nclinical effectiveness\r\ncontrolled study\r\ncost effectiveness analysis\r\ndrug use\r\nfeasibility study\r\nfemale\r\nfollow up\r\nhuman\r\nmale\r\nmedication compliance\r\nopiate addiction\r\npatient compliance\r\npharmacist\r\npharmacy (shop)\r\nrandomized controlled trial","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Metrebian N, Carr E, Goldsmith K, Weaver T, Pilling S, Shearer J, Woolston-Thomas K, Tas B, Cooper C, Getty C A, van der Waal R, Kelleher M, Finch E, Bijral P, Taylor D, Scott J, and Strang J (2021) Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES). Pilot and Feasibility Studies 7(1),  DOI: 10.1186/s40814-020-00761-4"},{"Codes":[{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948218,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282898,"Title":"Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.","ParentTitle":"Human psychopharmacology","ShortTitle":"Metz (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"August","StandardNumber":"0885-6222 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"26","Pages":"412-21","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"21823171","Comments":"","TypeName":"Journal, Article","Authors":"Metz V ; Jagsch R ; Ebner N ; Wrzl J ; Pribasnig A ; Aschauer C ; Fischer G ; ","ParentAuthors":"","DOI":"10.1002/hup.1224 ","Keywords":"Adult\r\nAustria\r\nBirth Weight\r\nBuprenorphine/*administration & dosage/adverse effects\r\nDouble-Blind Method\r\nFemale\r\nGestational Age\r\nHumans\r\nInfant, Newborn\r\nLength of Stay\r\nMale\r\nMethadone/*administration & dosage/adverse effects\r\nMorphine/administration & dosage\r\nNeonatal Abstinence Syndrome/drug therapy/epidemiology\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nPregnancy Outcome\r\nPregnancy Trimester, Third\r\nProspective Studies\r\nTime Factors\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Metz V, Jagsch R, Ebner N, Wrzl J, Pribasnig A, Aschauer C, and Fischer G (2011) Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.. Human psychopharmacology 26(6), 412-21 DOI: 10.1002/hup.1224 "},{"Codes":[],"Outcomes":[],"ItemId":98281271,"Title":"Maternal and fetal methadone exposure: Associations with neonatal abstinence syndrome","ParentTitle":"Clinical Pharmacology and Therapeutics","ShortTitle":"Metzger (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1532-6535","City":"","Country":"","Publisher":"","Institution":"I.F. Metzger, Indiana University School of Medicine, Indianapolis, IN, United States","Volume":"101","Pages":"S99","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L614166276&from=export http://dx.doi.org/10.1002/cpt.570","OldItemId":"","Comments":"2017-01-26","TypeName":"Journal, Article","Authors":"Metzger I F; Schwartz A E; Haneline L S; Haas D M; Evrard C A; Yeley B C; Jones D R; Masters A R; Renbarger J L; Quinney S K; ","ParentAuthors":"","DOI":"10.1002/cpt.570","Keywords":"methadone\r\nmorphine\r\nadverse drug reaction\r\nblood level\r\nclinical article\r\nclinical trial\r\ndrug megadose\r\nfemale\r\nfetus\r\nhuman\r\nhuman tissue\r\ninfant\r\nlength of stay\r\nliquid chromatography-mass spectrometry\r\nmaternal exposure\r\nmaximum permissible dose\r\nmethadone treatment\r\nneonatal abstinence syndrome\r\nnewborn\r\npilot study\r\npregnant woman\r\nside effect\r\numbilical cord blood","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Metzger I F, Schwartz A E, Haneline L S, Haas D M, Evrard C A, Yeley B C, Jones D R, Masters A R, Renbarger J L, and Quinney S K (2017) Maternal and fetal methadone exposure: Associations with neonatal abstinence syndrome. Clinical Pharmacology and Therapeutics 101, S99 DOI: 10.1002/cpt.570"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282443,"Title":"Oral naltrexone maintenance treatment for opioid dependence.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Minozzi (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"February","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD001333","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"21328250","Comments":"","TypeName":"Journal, Article","Authors":"Minozzi S ; Amato L ; Vecchi S ; Davoli M ; Kirchmayer U ; Verster A ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD001333.pub3 ","Keywords":"Administration, Oral\r\nControlled Clinical Trials as Topic\r\nFemale\r\nHumans\r\nMale\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, and Verster A (2011) Oral naltrexone maintenance treatment for opioid dependence.. The Cochrane database of systematic reviews (2), CD001333 DOI: 10.1002/14651858.CD001333.pub3 "},{"Codes":[{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281468,"Title":"Detoxification treatments for opiate dependent adolescents","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Minozzi (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1469-493X","City":"","Country":"","Publisher":"","Institution":"S. Minozzi, Lazio Regional Health Service, Department of Epidemiology, Via di Santa Costanza, 53, Rome, Italy","Volume":"2014","Pages":"","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L620551187&from=export http://dx.doi.org/10.1002/14651858.CD006749.pub3","OldItemId":"","Comments":"2018-02-21","TypeName":"Journal, Article","Authors":"Minozzi S ; Amato L ; Bellisario C ; Davoli M ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD006749.pub3","Keywords":"alcohol\r\nbuprenorphine\r\nbuprenorphine plus naloxone\r\ncannabis\r\nclonidine\r\ncocaine\r\nopiate\r\nadolescent\r\nalcoholism\r\ncannabis addiction\r\ncocaine dependence\r\ndrug detoxification\r\nfollow up\r\nheadache\r\nhealth status\r\nhuman\r\nmeta analysis\r\nopiate addiction\r\noutcome assessment\r\npriority journal\r\npsychosocial care\r\nreview\r\nself report\r\nsocial status\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Minozzi S, Amato L, Bellisario C, and Davoli M (2014) Detoxification treatments for opiate dependent adolescents. Cochrane Database of Systematic Reviews 2014(4),  DOI: 10.1002/14651858.CD006749.pub3"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948218,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280471,"Title":"Maintenance agonist treatments for opiate-dependent pregnant women","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Minozzi (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1465-1858","City":"","Country":"","Publisher":"","Institution":"S. Minozzi, Department of Epidemiology, Lazio Regional Health Service, Rome, Italy","Volume":"2020","Pages":"","Edition":"","Issue":"11","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L634383699&from=export http://dx.doi.org/10.1002/14651858.CD006318.pub4","OldItemId":"","Comments":"2021-05-11","TypeName":"Journal, Article","Authors":"Minozzi S ; Amato L ; Jahanfar S ; Bellisario C ; Ferri M ; Davoli M ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD006318.pub4","Keywords":"NCT03098407\r\nbuprenorphine\r\ncodeine\r\ndiamorphine\r\nlevacetylmethadol\r\nmethadone\r\nmorphine\r\nnicotine\r\nApgar score\r\nbirth weight\r\nbleeding\r\nbreast feeding\r\nbreathing rate\r\ncentral sleep apnea syndrome\r\ncesarean section\r\nchild health\r\nclinical effectiveness\r\ncombination chemotherapy\r\ndrug efficacy\r\ndrug release\r\ndrug safety\r\nDSM-IV\r\nevidence based practice\r\nfetus distress\r\nfollow up\r\ngrimace\r\nhealth status\r\nhuman\r\nmaintenance therapy\r\nmalpresentation\r\nmeconium aspiration\r\nmeta analysis\r\nmonotherapy\r\nmorbidity\r\nneonatal abstinence syndrome\r\nnewborn mortality\r\nopiate addiction\r\nphysical activity\r\nphysical appearance\r\npregnant woman\r\npremature labor\r\npriority journal\r\npsychosocial intervention\r\npuerperal morbidity\r\npulse rate\r\nrandomized controlled trial (topic)\r\nreview\r\nrisk factor\r\nsensitivity analysis\r\nsleep apnea syndromes\r\nsystematic review\r\nthird trimester pregnancy\r\ntreatment duration\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, and Davoli M (2020) Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database of Systematic Reviews 2020(11),  DOI: 10.1002/14651858.CD006318.pub4"},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282173,"Title":"A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Mitchell (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"March","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"128","Pages":"222-9","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"22999817","Comments":"","TypeName":"Journal, Article","Authors":"Mitchell SG ; Gryczynski J ; Schwartz RP ; O'Grady KE ; Olsen YK ; Jaffe JH ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2012.08.027 ","Keywords":"Black or African American/*psychology\r\nAmbulatory Care/*methods\r\nBaltimore\r\nBuprenorphine/*administration & dosage\r\nCocaine-Related Disorders/diagnosis/therapy\r\nCounseling/*methods\r\nFemale\r\nHumans\r\nMale\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/diagnosis/*therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mitchell SG, Gryczynski J, Schwartz RP, O'Grady KE, Olsen YK, and Jaffe JH (2013) A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans.. Drug and alcohol dependence 128(3), 222-9 DOI: 10.1016/j.drugalcdep.2012.08.027 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282239,"Title":"Extended-release naltrexone for youth with opioid use disorder.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Mitchell (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"130","Pages":"108407","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34118699","Comments":"","TypeName":"Journal, Article","Authors":"Mitchell SG ; Monico LB ; Gryczynski J ; Fishman MJ ; O'Grady KE ; Schwartz RP ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2021.108407 ","Keywords":"Adolescent\r\nAdult\r\nAftercare\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\n*Naltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nPatient Discharge\r\nYoung Adult\r\nAdolescent\r\nExtended-release naltrexone\r\nNaltrexone\r\nOpioid use disorder\r\nTreatment\r\nYoung adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mitchell SG, Monico LB, Gryczynski J, Fishman MJ, O'Grady KE, and Schwartz RP (2021) Extended-release naltrexone for youth with opioid use disorder.. Journal of substance abuse treatment 130, 108407 DOI: 10.1016/j.jsat.2021.108407 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281946,"Title":"Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Mocanu (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"July","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse","Volume":"248","Pages":"109932","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37224674","Comments":"","TypeName":"Journal, Article","Authors":"Mocanu V ; Bozinoff N ; Wood E ; Jutras-Aswad D ; Le Foll B ; Lim R ; Cheol Choi J; Yin Mok W; Eugenia Socias M; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2023.109932 ","Keywords":"Humans\r\nAnalgesics, Opioid/therapeutic use\r\nOpiate Substitution Treatment/methods\r\nCanada\r\n*Opioid-Related Disorders/drug therapy/complications\r\nMethadone/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nPrescriptions\r\n*Buprenorphine/therapeutic use\r\nBuprenorphine\r\nMethadone\r\nOpioid agonist therapy\r\nOpioid use disorder\r\nPrescription opioids\r\nRotation\r\nSwitching","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Cheol Choi J, Yin Mok W, and Eugenia Socias M (2023) Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial.. Drug and alcohol dependence 248, 109932 DOI: 10.1016/j.drugalcdep.2023.109932 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280454,"Title":"Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol","ParentTitle":"Addictive Behaviors","ShortTitle":"Moe (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0306-4603","City":"","Country":"","Publisher":"","Institution":"J. Moe, Department of Emergency Medicine, Vancouver General Hospital, 920 West 10th Avenue, Vancouver, BC, Canada","Volume":"111","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007257018&from=export http://dx.doi.org/10.1016/j.addbeh.2020.106551","OldItemId":"","Comments":"2020-08-19","TypeName":"Journal, Article","Authors":"Moe J ; Doyle-Waters M M; O'Sullivan F ; Hohl C M; Azar P ; ","ParentAuthors":"","DOI":"10.1016/j.addbeh.2020.106551","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nadverse outcome\r\narticle\r\nclinical effectiveness\r\nclinical outcome\r\nclinical protocol\r\ndrug delivery system\r\ndrug dose regimen\r\ndrug efficacy\r\ndrug retention\r\ndrug safety\r\nhuman\r\nmedication compliance\r\nmicro induction\r\nopiate addiction\r\npatient comfort\r\npractice guideline\r\nprescription\r\nsocial status\r\nsystematic review\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Moe J, Doyle-Waters M M, O'Sullivan F, Hohl C M, and Azar P (2020) Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol. Addictive Behaviors 111,  DOI: 10.1016/j.addbeh.2020.106551"},{"Codes":[{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282723,"Title":"The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.","ParentTitle":"European addiction research","ShortTitle":"Moeini (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1022-6877 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"25","Pages":"41-47","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"30630161","Comments":"","TypeName":"Journal, Article","Authors":"Moeini M ; Omidi A ; Sehat M ; Banafshe HR ; ","ParentAuthors":"","DOI":"10.1159/000496194 ","Keywords":"Administration, Intranasal\r\nAdult\r\nAnxiety/complications/drug therapy\r\nCraving/*drug effects\r\nDehydroepiandrosterone Sulfate/blood\r\nDouble-Blind Method\r\nHeroin Dependence/blood/*complications/*drug therapy\r\nHumans\r\nHydrocortisone/blood\r\nMale\r\nOxytocin/administration & dosage/*pharmacology/*therapeutic use\r\nStress, Psychological/complications/*drug therapy\r\nSubstance Withdrawal Syndrome/complications/*drug therapy\r\nYoung Adult\r\nCortisol\r\nCraving\r\nHeroin\r\nOxytocin\r\nWithdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Moeini M, Omidi A, Sehat M, and Banafshe HR (2019) The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.. European addiction research 25(1), 41-47 DOI: 10.1159/000496194 "},{"Codes":[{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280752,"Title":"A systematic review of methadone maintenance therapy studies in preventing relapses in addiction: Evidence from asean countries","ParentTitle":"Heroin Addiction and Related Clinical Problems","ShortTitle":"Mohd (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1592-1638","City":"","Country":"","Publisher":"","Institution":"N. Muhammad, Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia","Volume":"21","Pages":"15-32","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2003248957&from=export","OldItemId":"","Comments":"","TypeName":"Journal, Article","Authors":"Mohd Fahami ; N A ; Shuid A N; Abdullah A ; Naina-Mohamed I ; Chin K Y; Mohamed N ; Masbah N ; Mohd Saad ; Q H ; Kamisah Y ; Muhammad N ; ","ParentAuthors":"","DOI":"","Keywords":"adult\r\ndrug megadose\r\ndrug therapy\r\ndrug withdrawal\r\nfemale\r\nharm reduction\r\nhuman\r\nlow drug dose\r\nmale\r\nMedline\r\nmethadone treatment\r\noccupation\r\nopiate addiction\r\nprevention\r\nrelapse\r\nreview\r\nScopus\r\nsubstance abuse\r\nsystematic review\r\nWeb of Science\r\nillicit drug\r\nmethadone\r\nopiate","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Mohd Fahami, N A, Shuid A N, Abdullah A, Naina-Mohamed I, Chin K Y, Mohamed N, Masbah N, Mohd Saad, Q H, Kamisah Y, and Muhammad N (2019) A systematic review of methadone maintenance therapy studies in preventing relapses in addiction: Evidence from asean countries. Heroin Addiction and Related Clinical Problems 21(5), 15-32"},{"Codes":[],"Outcomes":[],"ItemId":98282228,"Title":"Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Montgomery (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"130","Pages":"108489","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34118716","Comments":"","TypeName":"Journal, Article","Authors":"Montgomery L ; Winhusen T ; Scodes J ; Pavlicova M ; Twitty D ; Campbell ANC ; Wang AL ; Nunes EV ; Rotrosen J ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2021.108489 ","Keywords":"Adult\r\n*Buprenorphine/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nTobacco Use\r\nBuprenorphine\r\nCigarettes\r\nNaltrexone\r\nOpioid use disorder\r\nSmoking","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Montgomery L, Winhusen T, Scodes J, Pavlicova M, Twitty D, Campbell ANC, Wang AL, Nunes EV, and Rotrosen J (2021) Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network.. Journal of substance abuse treatment 130, 108489 DOI: 10.1016/j.jsat.2021.108489 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282620,"Title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Moore (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"April","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"99","Pages":"32-43","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"30797392","Comments":"","TypeName":"Journal, Article","Authors":"Moore KE ; Roberts W ; Reid HH ; Smith KMZ ; Oberleitner LMS ; McKee SA ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2018.12.003 ","Keywords":"Buprenorphine/administration & dosage\r\nHumans\r\nMethadone/administration & dosage\r\nNaltrexone/administration & dosage\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\n*Prisons\r\n*Randomized Controlled Trials as Topic\r\nRecidivism/statistics & numerical data\r\nRisk-Taking\r\nBuprenorphine\r\nIncarceration\r\nMedication assisted treatment\r\nMethadone\r\nNaltrexone","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, and McKee SA (2019) Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.. Journal of substance abuse treatment 99, 32-43 DOI: 10.1016/j.jsat.2018.12.003 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283440,"Title":"A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Moore (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"February","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"97","Pages":"68-74","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"30577901","Comments":"","TypeName":"Journal, Article","Authors":"Moore BA ; Buono FD ; Lloyd DP ; Printz DMB ; Fiellin DA ; Barry DT ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2018.11.011 ","Keywords":"Adult\r\n*Cognitive Behavioral Therapy\r\nCombined Modality Therapy\r\nFemale\r\nHumans\r\nIllicit Drugs\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\n*Opiate Substitution Treatment\r\n*Outcome and Process Assessment, Health Care\r\nSelf Report\r\n*Self-Help Groups\r\n*Self-Management\r\n*Substance Abuse Detection\r\nSubstance-Related Disorders/drug therapy/*therapy\r\nTelephone\r\nComputer-based treatment\r\nIVR\r\nMethadone treatment\r\nOpioid-related disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Moore BA, Buono FD, Lloyd DP, Printz DMB, Fiellin DA, and Barry DT (2019) A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.. Journal of substance abuse treatment 97, 68-74 DOI: 10.1016/j.jsat.2018.11.011 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948264,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281760,"Title":"Economic Evaluations of Opioid Use Disorder Interventions.","ParentTitle":"PharmacoEconomics","ShortTitle":"Murphy (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"September","StandardNumber":"1170-7690 (Linking)","City":"New Zealand","Country":"","Publisher":"","Institution":"","Volume":"34","Pages":"863-87","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"27002518","Comments":"","TypeName":"Journal, Article","Authors":"Murphy SM ; Polsky D ; ","ParentAuthors":"","DOI":"10.1007/s40273-016-0400-5 ","Keywords":"Cost-Benefit Analysis\r\nHumans\r\nMethadone/*administration & dosage/economics\r\nOpiate Substitution Treatment/economics/*methods\r\nOpioid-Related Disorders/economics/*rehabilitation\r\nResearch Design","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Murphy SM, and Polsky D (2016) Economic Evaluations of Opioid Use Disorder Interventions.. PharmacoEconomics 34(9), 863-87 DOI: 10.1007/s40273-016-0400-5 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282608,"Title":"Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.","ParentTitle":"Annals of internal medicine","ShortTitle":"Murphy (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"January","StandardNumber":"0003-4819 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"170","Pages":"90-98","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"30557443","Comments":"","TypeName":"Journal, Article","Authors":"Murphy SM ; McCollister KE ; Leff JA ; Yang X ; Jeng PJ ; Lee JD ; Nunes EV ; Novo P ; Rotrosen J ; Schackman BR ; ","ParentAuthors":"","DOI":"10.7326/M18-0227 ","Keywords":"Adult\r\nBuprenorphine/administration & dosage/economics/*therapeutic use\r\nCost-Benefit Analysis\r\nDelayed-Action Preparations/economics\r\nDrug Therapy, Combination/economics\r\nFemale\r\nHealth Care Costs\r\nHumans\r\nMale\r\nNaloxone/administration & dosage/economics/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/economics/*therapeutic use\r\nOpiate Substitution Treatment/economics/*methods\r\nOpioid-Related Disorders/economics/*prevention & control\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, and Schackman BR (2019) Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.. Annals of internal medicine 170(2), 90-98 DOI: 10.7326/M18-0227 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282072,"Title":"Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Murphy (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"December","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"116","Pages":"3444-3453","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"33950535","Comments":"","TypeName":"Journal, Article","Authors":"Murphy SM ; Jeng PJ ; McCollister KE ; Leff JA ; Jalali A ; Shulman M ; Lee JD ; Nunes EV ; Novo P ; Rotrosen J ; Schackman BR ; ","ParentAuthors":"","DOI":"10.1111/add.15531 ","Keywords":"Cost-Benefit Analysis\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\n*Naltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nRetrospective Studies\r\nUnited States\r\nBuprenorphine-naloxone\r\ncost-effectiveness\r\nefficiency\r\nextended-release naltrexone\r\ninduction\r\nopioid detoxification\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Murphy SM, Jeng PJ, McCollister KE, Leff JA, Jalali A, Shulman M, Lee JD, Nunes EV, Novo P, Rotrosen J, and Schackman BR (2021) Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.. Addiction (Abingdon, and England) 116(12), 3444-3453 DOI: 10.1111/add.15531 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280347,"Title":"Effectiveness of medication-assisted therapy in Malaysia. A systematic review and meta-analysis after a decade","ParentTitle":"Heroin Addiction and Related Clinical Problems","ShortTitle":"Musa (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1592-1638","City":"","Country":"","Publisher":"","Institution":"A. Yee, Department of Psychological Medicine, University of Malaya Center for Addiction Sciences (UM-CAS), Faculty of Medicine, University of Malaya, Kuala Lumpur, Selangor, Malaysia","Volume":"23","Pages":"13-27","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2014015547&from=export","OldItemId":"","Comments":"2021-10-27","TypeName":"Journal, Article","Authors":"Musa R ; Yee A ; ","ParentAuthors":"","DOI":"","Keywords":"methadone\r\ncost effectiveness analysis\r\nemployment\r\nenvironment\r\nhealth\r\nhigh risk behavior\r\nhuman\r\nHuman immunodeficiency virus infection\r\nMalaysia\r\nmeta analysis\r\nmethadone maintenance therapy\r\nmethadone treatment\r\nopiate addiction\r\nopiate treatment index\r\noutcome assessment\r\npsychoanalysis\r\npsychological health\r\nquality of life\r\nquantitative analysis\r\nreview\r\nscoring system\r\nsocial interaction\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Musa R, and Yee A (2021) Effectiveness of medication-assisted therapy in Malaysia. A systematic review and meta-analysis after a decade. Heroin Addiction and Related Clinical Problems 23(2), 13-27"},{"Codes":[],"Outcomes":[],"ItemId":98284832,"Title":"Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Nahvi (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"September","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"109","Pages":"1554-63","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"24862167","Comments":"","TypeName":"Journal, Article","Authors":"Nahvi S ; Ning Y ; Segal KS ; Richter KP ; Arnsten JH ; ","ParentAuthors":"","DOI":"10.1111/add.12631 ","Keywords":"Benzazepines/*therapeutic use\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nNew York City\r\nNicotinic Agonists/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nQuinoxalines/*therapeutic use\r\nSmoking/*therapy\r\nSmoking Cessation/*methods\r\nTreatment Outcome\r\nVarenicline\r\nOpioid dependence\r\nmethadone maintenance\r\nsmoking cessation\r\nvarenicline","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nahvi S, Ning Y, Segal KS, Richter KP, and Arnsten JH (2014) Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.. Addiction (Abingdon, and England) 109(9), 1554-63 DOI: 10.1111/add.12631 "},{"Codes":[],"Outcomes":[],"ItemId":98280429,"Title":"Fentanyl versus Methadone in Management of Withdrawal Syndrome in Opioid Addicted Patients; a Pilot Clinical Trial","ParentTitle":"Archives of Academic Emergency Medicine","ShortTitle":"Najafi (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2645-4904","City":"","Country":"","Publisher":"","Institution":"N. Zamani, Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran","Volume":"9","Pages":"1-4","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2014566238&from=export http://dx.doi.org/10.22037/aaem.v9i1.1384","OldItemId":"","Comments":"2022-01-25","TypeName":"Journal, Article","Authors":"Najafi B ; Shadnia S ; Hassanian-Moghaddam H ; Heydarian A ; Mahdavinejad A ; Zamani N ; ","ParentAuthors":"","DOI":"10.22037/aaem.v9i1.1384","Keywords":"IRCT20150110020624N2\r\nclonidine\r\nfentanyl\r\nmethadone\r\nsedative agent\r\nacute kidney tubule necrosis\r\nadolescent\r\nadult\r\nadult respiratory distress syndrome\r\naged\r\nagitation\r\narticle\r\naspiration pneumonia\r\nclinical article\r\nClinical Opiate Withdrawal Score\r\ncontrolled clinical trial\r\ncontrolled study\r\ndecubitus\r\ndrug dose increase\r\ndrug dose reduction\r\ndrug therapy\r\nhuman\r\nintensive care unit\r\nintubation\r\nlength of stay\r\nmiddle aged\r\nopiate addiction\r\npain\r\npatient care\r\npilot study\r\nprospective study\r\nrhabdomyolysis\r\nscoring system\r\nSimplified Acute Physiology Score\r\nsingle blind procedure\r\ntreatment duration\r\ntreatment outcome\r\nwithdrawal syndrome\r\nyoung adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Najafi B, Shadnia S, Hassanian-Moghaddam H, Heydarian A, Mahdavinejad A, and Zamani N (2021) Fentanyl versus Methadone in Management of Withdrawal Syndrome in Opioid Addicted Patients; a Pilot Clinical Trial. Archives of Academic Emergency Medicine 9(1), 1-4 DOI: 10.22037/aaem.v9i1.1384"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280419,"Title":"Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review","ParentTitle":"Experimental and Clinical Psychopharmacology","ShortTitle":"Nalven (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1064-1297","City":"","Country":"","Publisher":"","Institution":"T. Nalven, Department of Psychology, University of Rhode Island, United States","Volume":"29","Pages":"524-538","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2013527617&from=export http://dx.doi.org/10.1037/pha0000510","OldItemId":"","Comments":"2021-11-30","TypeName":"Journal, Article","Authors":"Nalven T ; Spillane N S; Schick M R; Weyandt L L; ","ParentAuthors":"","DOI":"10.1037/pha0000510","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nAlaska Native\r\nAmerican Indian\r\narticle\r\nAsian\r\nbiodiversity\r\nBlack person\r\ndrug efficacy\r\nepidemic\r\nethnicity\r\ngender\r\nhealth disparity\r\nhuman\r\ninformation processing\r\npeople of mixed ancestry\r\nNative Hawaiian\r\nopiate addiction\r\nPacific Islander\r\npatient care\r\npharmacological parameters\r\nrace\r\nrandomized controlled trial (topic)\r\nrisk assessment\r\nstudy design\r\nsystematic review\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nalven T, Spillane N S, Schick M R, and Weyandt L L (2021) Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review. Experimental and Clinical Psychopharmacology 29(5), 524-538 DOI: 10.1037/pha0000510"},{"Codes":[],"Outcomes":[],"ItemId":98280538,"Title":"Neonatal abstinence syndrome in a newborn delivered by an opioid-dependent mother using methadone substitution therapy during pregnancy","ParentTitle":"Palliative Medicine in Practice","ShortTitle":"Napieralska (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"2545-0425","City":"","Country":"","Publisher":"","Institution":"I. Pawowska, Department of Pharmacology, Medical University of Gdask, Poland","Volume":"14","Pages":"124-129","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007446103&from=export http://dx.doi.org/10.5603/PMPI.2020.0012","OldItemId":"","Comments":"2020-09-18","TypeName":"Journal, Article","Authors":"Napieralska M ; Pawowska I ; Krzyaniak N ; ","ParentAuthors":"","DOI":"10.5603/PMPI.2020.0012","Keywords":"neonatal incubator\r\nantibiotic agent\r\ndiamorphine\r\nmethadone\r\nmorphine\r\nagitation\r\nantibiotic prophylaxis\r\nApgar score\r\narticle\r\nbottle feeding\r\nbradycardia\r\nbreast milk\r\ncase report\r\nclinical article\r\nclinical feature\r\nclonus\r\nconsultation\r\ncontinuous positive airway pressure\r\ncrying\r\ncyanosis\r\ndrug dose increase\r\ndrug dose reduction\r\nfeeding difficulty\r\nfemale\r\nfinnegan neonatal abstinence score\r\ngroup B streptococcal infection\r\nHepatitis C virus\r\nhospital discharge\r\nhuman\r\nhypoxemia\r\nlimb tremor\r\nloose feces\r\nmale\r\nmother\r\nneonatal abstinence syndrome\r\nneurologic disease\r\nnewborn\r\nopiate addiction\r\nopiate substitution treatment\r\noxygenation\r\nparenteral nutrition\r\nperinatal period\r\npregnancy\r\npregnancy complication\r\nrespiratory acidosis\r\nscoring system\r\nsport nutrition\r\nsucking\r\nsyrup\r\nthorax radiography\r\ntremor\r\nvaginal delivery\r\nvaginitis\r\nvirus carrier","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Napieralska M, Pawowska I, and Krzyaniak N (2020) Neonatal abstinence syndrome in a newborn delivered by an opioid-dependent mother using methadone substitution therapy during pregnancy. Palliative Medicine in Practice 14(2), 124-129 DOI: 10.5603/PMPI.2020.0012"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282984,"Title":"Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.","ParentTitle":"JAMA network open","ShortTitle":"Nelson (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"March","StandardNumber":"2574-3805 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"3","Pages":"e201195","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"32186745","Comments":"","TypeName":"Journal, Article","Authors":"Nelson LF ; Yocum VK ; Patel KD ; Qeadan F ; Hsi A ; Weitzen S ; ","ParentAuthors":"","DOI":"10.1001/jamanetworkopen.2020.1195 ","Keywords":"Analgesics, Opioid/*adverse effects\r\nBuprenorphine/adverse effects\r\nChild Development/drug effects\r\nChild, Preschool\r\nCognition/drug effects\r\nCognitive Dysfunction/*chemically induced\r\nFemale\r\nHumans\r\nInfant\r\nInfant, Newborn\r\nMale\r\nMaternal Exposure/*adverse effects\r\nMethadone/adverse effects\r\nOpiate Substitution Treatment/*adverse effects\r\nOpioid-Related Disorders/drug therapy\r\nPregnancy\r\nPregnancy Complications/drug therapy\r\nPrenatal Exposure Delayed Effects/*psychology\r\nRisk Factors","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nelson LF, Yocum VK, Patel KD, Qeadan F, Hsi A, and Weitzen S (2020) Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.. JAMA network open 3(3), e201195 DOI: 10.1001/jamanetworkopen.2020.1195 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948190,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280269,"Title":"Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: A systematic review","ParentTitle":"JBI Evidence Synthesis","ShortTitle":"Nguemo (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2689-8381","City":"","Country":"","Publisher":"","Institution":"J.B. Nguemo Djiometio, Daphne Cockwell School of Nursing, Faculty of Community Services, Ryerson University, Toronto, ON, Canada","Volume":"19","Pages":"1887-1914","Edition":"","Issue":"8","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2015250050&from=export http://dx.doi.org/10.11124/JBIES-20-00223","OldItemId":"","Comments":"2022-02-25","TypeName":"Journal, Article","Authors":"Nguemo Djiometio ; J B ; Buzuayew A ; Mohamud H ; Njoroge I ; Kahan M ; Nelson L E; ","ParentAuthors":"","DOI":"10.11124/JBIES-20-00223","Keywords":"buprenorphine\r\nmethadone\r\nadult\r\nAfrican\r\nBlack person\r\nCaribbean (person)\r\ncondom use\r\ndrug efficacy\r\nfemale\r\nhigh risk behavior\r\nhuman\r\nHuman immunodeficiency virus infection\r\nmale\r\nmeta analysis\r\nmethadone treatment\r\nopiate addiction\r\nopiate substitution treatment\r\nprostitution\r\nrandomized controlled trial (topic)\r\nreview\r\nsexual intercourse\r\nsystematic review\r\nunsafe sex","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nguemo Djiometio, J B, Buzuayew A, Mohamud H, Njoroge I, Kahan M, and Nelson L E (2021) Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: A systematic review. JBI Evidence Synthesis 19(8), 1887-1914 DOI: 10.11124/JBIES-20-00223"},{"Codes":[],"Outcomes":[],"ItemId":98282471,"Title":"Comparing buprenorphine induction experience with heroin and prescription opioid users.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Nielsen (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"October","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"43","Pages":"285-90","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"22301084","Comments":"","TypeName":"Journal, Article","Authors":"Nielsen S ; Hillhouse M ; Mooney L ; Fahey J ; Ling W ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2011.12.009 ","Keywords":"Adult\r\nAged\r\nBuprenorphine/*administration & dosage\r\nFemale\r\nFollow-Up Studies\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPrescription Drugs/adverse effects\r\nSubstance Withdrawal Syndrome/drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nielsen S, Hillhouse M, Mooney L, Fahey J, and Ling W (2012) Comparing buprenorphine induction experience with heroin and prescription opioid users.. Journal of substance abuse treatment 43(3), 285-90 DOI: 10.1016/j.jsat.2011.12.009 "},{"Codes":[{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283359,"Title":"A comparison of buprenorphine taper outcomes between prescription opioid and heroin users.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Nielsen (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"January","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"7","Pages":"33-8","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23222095","Comments":"","TypeName":"Journal, Article","Authors":"Nielsen S ; Hillhouse M ; Thomas C ; Hasson A ; Ling W ; ","ParentAuthors":"","DOI":"10.1097/ADM.0b013e318277e92e ","Keywords":"Adult\r\nBuprenorphine/*administration & dosage\r\nDemography\r\nDose-Response Relationship, Drug\r\nDrug Administration Schedule\r\nFemale\r\nHeroin/*pharmacology\r\nHumans\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/administration & dosage\r\nNarcotics/pharmacology\r\n*Opiate Substitution Treatment/methods/statistics & numerical data\r\nSubstance Abuse Detection/methods\r\n*Substance-Related Disorders/diagnosis/drug therapy/epidemiology\r\nTreatment Outcome\r\nUnited States/epidemiology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nielsen S, Hillhouse M, Thomas C, Hasson A, and Ling W (2013) A comparison of buprenorphine taper outcomes between prescription opioid and heroin users.. Journal of addiction medicine 7(1), 33-8 DOI: 10.1097/ADM.0b013e318277e92e "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282575,"Title":"Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Nielsen (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"January","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"48","Pages":"70-6","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"25065489","Comments":"","TypeName":"Journal, Article","Authors":"Nielsen S ; Hillhouse M ; Mooney L ; Ang A ; Ling W ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2014.06.006 ","Keywords":"Adult\r\nAnalgesics, Opioid/administration & dosage/*pharmacology\r\nBehavior Therapy/methods\r\nBuprenorphine/administration & dosage/*pharmacology\r\nBuprenorphine, Naloxone Drug Combination\r\nFemale\r\nHeroin Dependence/drug therapy/therapy\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/administration & dosage/pharmacology\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/drug therapy/*therapy\r\n*Prescription Drug Misuse\r\nTreatment Outcome\r\nBuprenorphine\r\nPrescription opioid\r\nTreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nielsen S, Hillhouse M, Mooney L, Ang A, and Ling W (2015) Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.. Journal of substance abuse treatment 48(1), 70-6 DOI: 10.1016/j.jsat.2014.06.006 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281280,"Title":"A systematic review of opioid agonist treatments for pharmaceutical opioid dependence","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Nielsen (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0376-8716","City":"","Country":"","Publisher":"","Institution":"S. Nielsen, South Eastern Sydney Local Health District, Sydney, NSW, Australia","Volume":"171","Pages":"e152-e153","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L618520991&from=export http://dx.doi.org/10.1016/j.drugalcdep.2016.08.421","OldItemId":"","Comments":"2017-10-06","TypeName":"Journal, Article","Authors":"Nielsen S ; Larance B ; Degenhardt L ; Gowing L ; Lintzeris N ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.08.421","Keywords":"buprenorphine\r\nmethadone\r\nopiate\r\nplacebo\r\nagonist\r\ncontrolled study\r\ndetoxification\r\ndrug therapy\r\nEmbase\r\nfemale\r\nhuman\r\nhuman tissue\r\nmaintenance therapy\r\nmale\r\nMedline\r\nopiate addiction\r\nPsycINFO\r\nrandomized controlled trial (topic)\r\nsystematic review\r\nurine\r\nWeb of Science","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nielsen S, Larance B, Degenhardt L, Gowing L, and Lintzeris N (2017) A systematic review of opioid agonist treatments for pharmaceutical opioid dependence. Drug and Alcohol Dependence 171, e152-e153 DOI: 10.1016/j.drugalcdep.2016.08.421"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281038,"Title":"Identifying and treating codeine dependence: A systematic review","ParentTitle":"Medical Journal of Australia","ShortTitle":"Nielsen (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"0025-729X","City":"","Country":"","Publisher":"","Institution":"S. Nielsen, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia","Volume":"208","Pages":"451-461","Edition":"","Issue":"10","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622526922&from=export http://dx.doi.org/10.5694/mja17.00749","OldItemId":"","Comments":"2018-06-21","TypeName":"Journal, Article","Authors":"Nielsen S ; Macdonald T ; Johnson J L; ","ParentAuthors":"","DOI":"10.5694/mja17.00749","Keywords":"analgesic agent\r\ncodeine\r\ncytochrome P450 inhibitor\r\ndrugs used in the treatment of addiction\r\nopiate agonist\r\nbehavior therapy\r\ncase control study\r\ncase report\r\ncase study\r\ncodeine dependence\r\ncomorbidity\r\ndata extraction\r\ndisease association\r\ndrug dependence treatment\r\ndrug efficacy\r\nEmbase\r\nempirical research\r\nevidence based practice\r\nhospital patient\r\nhuman\r\nmedical decision making\r\nmedical record review\r\nmedication overuse\r\nMedline\r\nmental disease\r\nnarcotic dependence\r\nopen study\r\nperception\r\npublication\r\nqualitative research\r\nquality control\r\nquantitative analysis\r\nrandomized controlled trial (topic)\r\nretrospective study\r\nreview\r\nstandardization\r\nsystematic review\r\ntreatment outcome\r\ntreatment response","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nielsen S, Macdonald T, and Johnson J L (2018) Identifying and treating codeine dependence: A systematic review. Medical Journal of Australia 208(10), 451-461 DOI: 10.5694/mja17.00749"},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281866,"Title":"Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Nikoo (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"March","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"415-429","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"27740713","Comments":"","TypeName":"Journal, Article","Authors":"Nikoo M ; Nikoo N ; Anbardan SJ ; Amiri A ; Vogel M ; Choi F ; Sepehry AA ; Bagheri Valoojerdi AH; Jang K ; Schtz C ; Akhondzadeh S ; Krausz M ; ","ParentAuthors":"","DOI":"10.1111/add.13628 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nHumans\r\nOpioid-Related Disorders/*drug therapy\r\nOpium/*therapeutic use\r\nTreatment Outcome\r\nMedication-assisted treatment\r\nopiate dependence\r\nopioid dependence\r\nopium\r\nreview\r\nsubstance use\r\ntincture of opium\r\ntreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nikoo M, Nikoo N, Anbardan SJ, Amiri A, Vogel M, Choi F, Sepehry AA, Bagheri Valoojerdi AH, Jang K, Schtz C, Akhondzadeh S, and Krausz M (2017) Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy.. Addiction (Abingdon, and England) 112(3), 415-429 DOI: 10.1111/add.13628 "},{"Codes":[],"Outcomes":[],"ItemId":98282059,"Title":"Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.","ParentTitle":"International journal of methods in psychiatric research","ShortTitle":"Nikoo (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"March","StandardNumber":"1049-8931 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"28","Pages":"e1768","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"30714249","Comments":"","TypeName":"Journal, Article","Authors":"Nikoo M ; Moazen-Zadeh E ; Nikoo N ; Javidanbardan S ; Kazemi A ; Choi F ; Vogel M ; Gholami A ; Tavakoli S ; Givaki R ; Jazani M ; Mohammadian F ; Markazi Moghaddam N; Goudarzi N ; Schutz C ; Jang K ; Akhondzadeh S ; Krausz M ; ","ParentAuthors":"","DOI":"10.1002/mpr.1768 ","Keywords":"Adult\r\nClinical Protocols\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nOpium/*therapeutic use\r\nclinical trial\r\nmethadone\r\nopioid\r\nopium\r\nsubstance use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nikoo M, Moazen-Zadeh E, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Vogel M, Gholami A, Tavakoli S, Givaki R, Jazani M, Mohammadian F, Markazi Moghaddam N, Goudarzi N, Schutz C, Jang K, Akhondzadeh S, and Krausz M (2019) Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.. International journal of methods in psychiatric research 28(1), e1768 DOI: 10.1002/mpr.1768 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281841,"Title":"Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Nikoo (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"February","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"118","Pages":"284-294","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"35971297","Comments":"","TypeName":"Journal, Article","Authors":"Nikoo M ; Kianpoor K ; Nikoo N ; Javidanbardan S ; Kazemi A ; Choi F ; Vogel M ; Gholami A ; Tavakoli S ; Wong JSH ; Moazen-Zadeh E ; Givaki R ; Jazani M ; Mohammadian F ; Moghaddam NM ; Schtz C ; Jang K ; Akhondzadeh S ; Krausz M ; ","ParentAuthors":"","DOI":"10.1111/add.16030 ","Keywords":"Humans\r\nFemale\r\n*Methadone/therapeutic use\r\nOpium/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\nDouble-Blind Method\r\nOpiate Substitution Treatment/methods\r\nClinical trial\r\nmethadone\r\nopioid agonist treatment\r\nopioid substitution treatment\r\nopium\r\nopium tincture\r\nretention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nikoo M, Kianpoor K, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Vogel M, Gholami A, Tavakoli S, Wong JSH, Moazen-Zadeh E, Givaki R, Jazani M, Mohammadian F, Moghaddam NM, Schtz C, Jang K, Akhondzadeh S, and Krausz M (2023) Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.. Addiction (Abingdon, and England) 118(2), 284-294 DOI: 10.1111/add.16030 "},{"Codes":[],"Outcomes":[],"ItemId":98282858,"Title":"Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.","ParentTitle":"The Annals of pharmacotherapy","ShortTitle":"Noormohammadi (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"August","StandardNumber":"1060-0280 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"50","Pages":"666-72","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"27199497","Comments":"","TypeName":"Journal, Article","Authors":"Noormohammadi A ; Forinash A ; Yancey A ; Crannage E ; Campbell K ; Shyken J ; ","ParentAuthors":"","DOI":"10.1177/1060028016648367 ","Keywords":"Buprenorphine/administration & dosage/adverse effects/*therapeutic use\r\nFemale\r\nHumans\r\nInfant\r\nInfant, Newborn\r\nLength of Stay\r\nMethadone/administration & dosage/adverse effects/*therapeutic use\r\nNeonatal Abstinence Syndrome/*prevention & control\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nRandomized Controlled Trials as Topic\r\nalcohol\r\nand substance abuse\r\ndrug\r\nobstetrics/gynecology\r\npregnancy/drug effects\r\nsubstance abuse\r\nwomens health","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Noormohammadi A, Forinash A, Yancey A, Crannage E, Campbell K, and Shyken J (2016) Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.. The Annals of pharmacotherapy 50(8), 666-72 DOI: 10.1177/1060028016648367 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280209,"Title":"Opium tincture-assisted treatment for opioid use disorder: A systematic review","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Noroozi (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0740-5472","City":"","Country":"","Publisher":"","Institution":"M. Karamouzian, School of Population and Public Health, Faculty of Medicine, University of British Columbia, 2206 E Mall, Vancouver, BC, Canada","Volume":"129","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2012932298&from=export http://dx.doi.org/10.1016/j.jsat.2021.108519","OldItemId":"","Comments":"2021-12-13","TypeName":"Journal, Article","Authors":"Noroozi A ; Kebriaeezadeh A ; Mirrahimi B ; Armoon B ; Ahounbar E ; Narenjiha H ; Salehi M ; Karamouzian M ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2021.108519","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nmethadone\r\nopiate\r\nabstinence\r\nanxiety\r\ncognition\r\ndepression\r\ndrug dose reduction\r\ndrug efficacy\r\ndrug safety\r\nGeneral Health Questionnaire-28\r\nhuman\r\nlow drug dose\r\nmaintenance therapy\r\nmethadone treatment\r\nMontreal cognitive assessment\r\nopiate addiction\r\npsychological well-being\r\nquality of life\r\nrandomized controlled trial (topic)\r\nreview\r\nRosenberg Self-Esteem Scale\r\nself esteem\r\nShort Form 36\r\nsleep quality\r\nsocial disability\r\nsystematic review\r\ntreatment withdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Noroozi A, Kebriaeezadeh A, Mirrahimi B, Armoon B, Ahounbar E, Narenjiha H, Salehi M, and Karamouzian M (2021) Opium tincture-assisted treatment for opioid use disorder: A systematic review. Journal of Substance Abuse Treatment 129,  DOI: 10.1016/j.jsat.2021.108519"},{"Codes":[],"Outcomes":[],"ItemId":98283788,"Title":"The 'Expanded HIV care in opioid substitution treatment' (EHOST) cluster-randomized, stepped-wedge trial: A study protocol.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Nosyk (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"November","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"45","Pages":"201-209","Edition":"","Issue":"Pt B","Availability":"","URL":"","OldItemId":"26342295","Comments":"","TypeName":"Journal, Article","Authors":"Nosyk B ; Krebs E ; Min JE ; Ahamad K ; Buxton J ; Goldsmith C ; Hull M ; Joe R ; Krajden M ; Lima VD ; Olding M ; Wood E ; Montaner JSG ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2015.08.020 ","Keywords":"Anti-HIV Agents/administration & dosage/*therapeutic use\r\nBritish Columbia\r\nHIV Infections/*diagnosis/*drug therapy\r\nHumans\r\nMass Screening\r\nMedication Adherence\r\nOpiate Substitution Treatment/*statistics & numerical data\r\nPractice Patterns, Physicians'\r\nResearch Design\r\nSubstance Abuse, Intravenous/*drug therapy\r\nAntiretroviral treatment\r\nCluster-randomized\r\nHIV\r\nOpioid Agonist Treatment\r\nStepped-wedge","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nosyk B, Krebs E, Min JE, Ahamad K, Buxton J, Goldsmith C, Hull M, Joe R, Krajden M, Lima VD, Olding M, Wood E, and Montaner JSG (2015) The 'Expanded HIV care in opioid substitution treatment' (EHOST) cluster-randomized, stepped-wedge trial: A study protocol.. Contemporary clinical trials 45(Pt B), 201-209 DOI: 10.1016/j.cct.2015.08.020 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282148,"Title":"The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.","ParentTitle":"European addiction research","ShortTitle":"Notley (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1022-6877 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"19","Pages":"287-98","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"23652159","Comments":"","TypeName":"Journal, Article","Authors":"Notley C ; Blyth A ; Maskrey V ; Craig J ; Holland R ; ","ParentAuthors":"","DOI":"10.1159/000346674 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nHumans\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*methods/trends\r\nOpioid-Related Disorders/diagnosis/*drug therapy/psychology\r\nRegistries\r\nTime Factors","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Notley C, Blyth A, Maskrey V, Craig J, and Holland R (2013) The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.. European addiction research 19(6), 287-98 DOI: 10.1159/000346674 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282860,"Title":"Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.","ParentTitle":"The American journal of psychiatry","ShortTitle":"Nunes (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"July","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"178","Pages":"660-671","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"34170188","Comments":"","TypeName":"Journal, Article","Authors":"Nunes EV Jr; Scodes JM ; Pavlicova M ; Lee JD ; Novo P ; Campbell ANC ; Rotrosen J ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.2020.20060816 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine, Naloxone Drug Combination/*administration & dosage/therapeutic use\r\nDelayed-Action Preparations/*administration & dosage/therapeutic use\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nNaltrexone/*administration & dosage/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nYoung Adult\r\nBuprenorphine\r\nCriminal Justice\r\nExtended-Release Injection Naltrexone\r\nHomelessness\r\nNaltrexone Induction\r\nOpioid Use Disorder\r\nRelapse","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Nunes EV Jr, Scodes JM, Pavlicova M, Lee JD, Novo P, Campbell ANC, and Rotrosen J (2021) Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.. The American journal of psychiatry 178(7), 660-671 DOI: 10.1176/appi.ajp.2020.20060816 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948266,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280583,"Title":"Retention of patients in opioid substitution treatment: A systematic review","ParentTitle":"PLoS ONE","ShortTitle":"OConnor (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1932-6203","City":"","Country":"","Publisher":"","Institution":"G. Cousins, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland","Volume":"15","Pages":"","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2005887396&from=export http://dx.doi.org/10.1371/journal.pone.0232086","OldItemId":"","Comments":"2020-06-01","TypeName":"Journal, Article","Authors":"OConnor A M; Cousins G ; Durand L ; Barry J ; Boland F ; ","ParentAuthors":"","DOI":"10.1371/journal.pone.0232086","Keywords":"buprenorphine\r\ncocaine\r\nmethadone\r\nopiate\r\nadult\r\ncause of death\r\ncohort analysis\r\ndrug retention\r\nfemale\r\nhuman\r\nmaintenance therapy\r\nmajor clinical study\r\nmale\r\nmeta analysis\r\nmortality\r\nobservational study\r\nopiate addiction\r\nopiate substitution treatment\r\npatient dropout\r\npublic health\r\nrandomized controlled trial\r\nreview\r\nrisk assessment\r\nrisk factor\r\nrisk reduction\r\nsocial psychology\r\nsubstance use\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"OConnor A M, Cousins G, Durand L, Barry J, and Boland F (2020) Retention of patients in opioid substitution treatment: A systematic review. PLoS ONE 15(5),  DOI: 10.1371/journal.pone.0232086"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282622,"Title":"Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial.","ParentTitle":"The American journal on addictions","ShortTitle":"Opheim (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"453-460","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"34487395","Comments":"","TypeName":"Journal, Article","Authors":"Opheim A ; Gaulen Z ; Solli KK ; Latif ZE ; Fadnes LT ; Benth J ; Kune N ; Tanum L ; ","ParentAuthors":"","DOI":"10.1111/ajad.13151 ","Keywords":"Adult\r\nAnalgesics, Opioid/therapeutic use\r\n*Buprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nRecurrence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Opheim A, Gaulen Z, Solli KK, Latif ZE, Fadnes LT, Benth J, Kune N, and Tanum L (2021) Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial.. The American journal on addictions 30(5), 453-460 DOI: 10.1111/ajad.13151 "},{"Codes":[{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282562,"Title":"Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Opheim (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"December","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"135","Pages":"107360","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37865138","Comments":"","TypeName":"Journal, Article","Authors":"Opheim A ; Benth J ; Solli KK ; Kloster PS ; Fadnes LT ; Kune N ; Gaulen Z ; Tanum L ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2023.107360 ","Keywords":"Male\r\nHumans\r\nFemale\r\nNarcotic Antagonists/therapeutic use\r\nNaltrexone/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\n*Buprenorphine\r\nChronic Disease\r\nRecurrence\r\nDelayed-Action Preparations/therapeutic use\r\nInjections, Intramuscular\r\nBuprenorphine-naloxone\r\nExtended-release naltrexone\r\nOpioid dependence\r\nRelapse to non-opioid addictive substances","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Opheim A, Benth J, Solli KK, Kloster PS, Fadnes LT, Kune N, Gaulen Z, and Tanum L (2023) Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial.. Contemporary clinical trials 135, 107360 DOI: 10.1016/j.cct.2023.107360 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288249,"Title":"Opioid analgesics to treat chronic noncancer pain among patients prescribed opioid agonist therapy or with opioid use disorder","ParentTitle":"","ShortTitle":"Opioid analgesics to... (Vahid)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42023475381","Comments":"","TypeName":"Journal, Article","Authors":"Vahid Ashoorion ; Abhimanyu Sud ; Jason Busse ; Danielle Rice ; Jaris Swidrovich ; Umair Majid ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Vahid Ashoorion, Abhimanyu Sud, Jason Busse, Danielle Rice, Jaris Swidrovich, and Umair Majid (    ) Opioid analgesics to treat chronic noncancer pain among patients prescribed opioid agonist therapy or with opioid use disorder.  , "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948211,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279869,"Title":"Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature","ParentTitle":"Pathophysiology","ShortTitle":"Ordean (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0928-4680","City":"","Country":"","Publisher":"","Institution":"A. Ordean, Department of Family Medicine, St. Josephs Health Centre, Unity Health Toronto, Toronto, ON, Canada","Volume":"30","Pages":"27-36","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2022268535&from=export http://dx.doi.org/10.3390/pathophysiology30010004","OldItemId":"","Comments":"2023-04-12","TypeName":"Journal, Article","Authors":"Ordean A ; Tubman-Broeren M ; ","ParentAuthors":"","DOI":"10.3390/pathophysiology30010004","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\ncannabis\r\nillicit drug\r\nmethadone\r\nnaloxone\r\nopiate\r\nadult\r\nalcohol consumption\r\nbirth length\r\nbirth weight\r\nCanada\r\ncannabis use\r\nclinical decision making\r\nCochrane Library\r\ncommunity care\r\ncomparative study\r\ncongenital malformation\r\ndata analysis\r\ndata extraction\r\ndemographics\r\ndrug efficacy\r\ndrug safety\r\ndrug screening\r\ndrug urine level\r\nEmbase\r\nfemale\r\ngestational age\r\nhead circumference\r\nhuman\r\ninformation retrieval\r\nlength of stay\r\nMedline\r\nmonotherapy\r\nneonatal abstinence syndrome\r\nobservational study\r\nobstetric delivery\r\nopiate addiction\r\noutcome assessment\r\noutpatient care\r\nparity\r\npatient counseling\r\npharmaceutical care\r\npractice guideline\r\npregnancy\r\npregnancy outcome\r\npregnant woman\r\npremature labor\r\nprevalence\r\nretrospective study\r\nreview\r\nrisk benefit analysis\r\nselection bias\r\nsubstance use\r\nsystematic review\r\ntobacco use\r\ntreatment duration\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ordean A, and Tubman-Broeren M (2023) Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature. Pathophysiology 30(1), 27-36 DOI: 10.3390/pathophysiology30010004"},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282135,"Title":"The effect of methadone on the hypothalamic pituitary gonadal axis and sexual function: A systematic review.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Ortman (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"February","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"207","Pages":"107823","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"31901578","Comments":"","TypeName":"Journal, Article","Authors":"Ortman HA ; Siegel JA ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2019.107823 ","Keywords":"Analgesics, Opioid/*adverse effects\r\nAnimals\r\nChronic Pain/drug therapy\r\nFemale\r\nGonadal Disorders/*chemically induced\r\nHumans\r\nHypothalamo-Hypophyseal System/*drug effects\r\nMale\r\nMethadone/*adverse effects\r\nOpiate Substitution Treatment/adverse effects\r\nOpioid-Related Disorders/drug therapy\r\nSexual Dysfunction, Physiological/*chemically induced\r\nEstrogens\r\nHPG axis\r\nMethadone\r\nOpioids\r\nSexual function\r\nTestosterone","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ortman HA, and Siegel JA (2020) The effect of methadone on the hypothalamic pituitary gonadal axis and sexual function: A systematic review.. Drug and alcohol dependence 207, 107823 DOI: 10.1016/j.drugalcdep.2019.107823 "},{"Codes":[{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948252,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282766,"Title":"Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Otiashvili (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"December","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"133","Pages":"376-82","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"23916321","Comments":"","TypeName":"Journal, Article","Authors":"Otiashvili D ; Piralishvili G ; Sikharulidze Z ; Kamkamidze G ; Poole S ; Woody GE ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.06.024 ","Keywords":"Adult\r\nBuprenorphine/*therapeutic use\r\nFemale\r\nGeorgia (Republic)/epidemiology\r\nHIV Infections/*psychology/transmission\r\nHepatitis C/epidemiology\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nNeedle Sharing/statistics & numerical data\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\n*Risk-Taking\r\nSubstance Abuse Detection\r\nSubstance Abuse, Intravenous/drug therapy/psychology\r\nTreatment Outcome\r\nBuprenorphine abuse\r\nRepublic of Georgia\r\nTreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Otiashvili D, Piralishvili G, Sikharulidze Z, Kamkamidze G, Poole S, and Woody GE (2013) Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.. Drug and alcohol dependence 133(2), 376-82 DOI: 10.1016/j.drugalcdep.2013.06.024 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15064034,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948333,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269960,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281419,"Title":"Genetic polymorphisms of OPRM1 gene and their impact on methadone maintenance treatment in opioid addicts: A systematic review of the literature","ParentTitle":"European Neuropsychopharmacology","ShortTitle":"Oueslati (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"0924-977X","City":"","Country":"","Publisher":"","Institution":"B. Oueslati, Razi Hospital, Psychiatry Department B, Manouba, Tunisia","Volume":"25","Pages":"S275","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L72129413&from=export","OldItemId":"","Comments":"2016-01-15","TypeName":"Journal, Article","Authors":"Oueslati B ; Moula O ; Chebli S ; Smari N ; Triki R ; Ghachem R ; ","ParentAuthors":"","DOI":"","Keywords":"opiate\r\nmethadone\r\nopiate receptor\r\ngenetic polymorphism\r\ngene\r\nmethadone treatment\r\nmaintenance therapy\r\ndrug dependence\r\nsystematic review\r\nEuropean\r\ncollege\r\npsychopharmacology\r\nallele\r\ngenotype\r\nethnic group\r\nhuman\r\nsingle nucleotide polymorphism\r\naddiction\r\nagonist\r\nTaiwan\r\npharmacodynamics\r\nArab","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Oueslati B, Moula O, Chebli S, Smari N, Triki R, and Ghachem R (2015) Genetic polymorphisms of OPRM1 gene and their impact on methadone maintenance treatment in opioid addicts: A systematic review of the literature. European Neuropsychopharmacology 25, S275"},{"Codes":[{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15064034,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269960,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281138,"Title":"The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: A systematic review","ParentTitle":"Pharmacogenomics","ShortTitle":"Oueslati (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1462-2416","City":"","Country":"","Publisher":"","Institution":"B. Oueslati, Psychiatry Department, Razi Hospital, Manouba, Tunisia","Volume":"19","Pages":"741-747","Edition":"","Issue":"8","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622340387&from=export http://dx.doi.org/10.2217/pgs-2018-0017","OldItemId":"","Comments":"2018-06-08","TypeName":"Journal, Article","Authors":"Oueslati B ; Moula O ; Ghachem R ; ","ParentAuthors":"","DOI":"10.2217/pgs-2018-0017","Keywords":"methadone\r\nmu opiate receptor\r\nallele\r\ndisease severity\r\ndrug efficacy\r\ngenetic association\r\ngenetic variation\r\ngenotype\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\nOPRM1 gene\r\noutcome assessment\r\nreview\r\nsingle nucleotide polymorphism\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Oueslati B, Moula O, and Ghachem R (2018) The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: A systematic review. Pharmacogenomics 19(8), 741-747 DOI: 10.2217/pgs-2018-0017"},{"Codes":[{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282782,"Title":"Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Oviedo-Joekes (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"September","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"111","Pages":"50-7","Edition":"","Issue":"1-2","Availability":"","URL":"","OldItemId":"20510551","Comments":"","TypeName":"Journal, Article","Authors":"Oviedo-Joekes E ; Guh D ; Brissette S ; Marchand K ; Marsh D ; Chettiar J ; Nosyk B ; Krausz M ; Anis A ; Schechter MT ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2010.03.016 ","Keywords":"Administration, Oral\r\nAdult\r\nFemale\r\nHealth Status\r\nHeroin/administration & dosage/*therapeutic use\r\nHumans\r\nInjections\r\nMale\r\nMethadone/administration & dosage/*therapeutic use\r\nMiddle Aged\r\nNarcotics/therapeutic use\r\nOpioid-Related Disorders/*therapy\r\nPsychotherapy\r\nQuality of Life\r\nSex Factors\r\nStatistics, Nonparametric\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, and Schechter MT (2010) Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.. Drug and alcohol dependence 111(1-2), 50-7 DOI: 10.1016/j.drugalcdep.2010.03.016 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282977,"Title":"Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.","ParentTitle":"JAMA psychiatry","ShortTitle":"Oviedo-Joekes (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"May","StandardNumber":"2168-622X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"73","Pages":"447-55","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"27049826","Comments":"","TypeName":"Journal, Article","Authors":"Oviedo-Joekes E ; Guh D ; Brissette S ; Marchand K ; MacDonald S ; Lock K ; Harrison S ; Janmohamed A ; Anis AH ; Krausz M ; Marsh DC ; Schechter MT ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2016.0109 ","Keywords":"Adult\r\nBritish Columbia\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nFemale\r\nFollow-Up Studies\r\nHeroin/adverse effects/*therapeutic use\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nHydromorphone/adverse effects/*therapeutic use\r\n*Illicit Drugs\r\nInjections, Intravenous\r\nIntention to Treat Analysis\r\nLong-Term Care\r\nMale\r\nMiddle Aged\r\nNeedle-Exchange Programs\r\nSubstance Abuse Detection","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, and Schechter MT (2016) Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.. JAMA psychiatry 73(5), 447-55 DOI: 10.1001/jamapsychiatry.2016.0109 "},{"Codes":[],"Outcomes":[],"ItemId":98281773,"Title":"Pharmacogenomics of methadone: a narrative review of the literature.","ParentTitle":"Pharmacogenomics","ShortTitle":"Packiasabapathy (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"August","StandardNumber":"1462-2416 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"871-887","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"32705966","Comments":"","TypeName":"Journal, Article","Authors":"Packiasabapathy S ; Aruldhas BW ; Horn N ; Overholser BR ; Quinney SK ; Renschler JS ; Sadhasivam S ; ","ParentAuthors":"","DOI":"10.2217/pgs-2020-0040 ","Keywords":"Analgesics, Opioid/administration & dosage/*adverse effects\r\nAnimals\r\nGenetic Variation/*genetics\r\nHumans\r\nMethadone/administration & dosage/*adverse effects\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/drug therapy/*genetics\r\nPharmacogenetics/*methods\r\ngene variants\r\nmethadone\r\nopioid\r\nopioid maintenance therapy\r\npersonalized analgesia\r\npharmacodynamics\r\npharmacogenetics\r\npharmacogenomics\r\npharmacokinetics\r\npolymorphism","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Packiasabapathy S, Aruldhas BW, Horn N, Overholser BR, Quinney SK, Renschler JS, and Sadhasivam S (2020) Pharmacogenomics of methadone: a narrative review of the literature.. Pharmacogenomics 21(12), 871-887 DOI: 10.2217/pgs-2020-0040 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282593,"Title":"Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.","ParentTitle":"The American journal on addictions","ShortTitle":"Paschen-Wolff (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"November","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"32","Pages":"584-592","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"37583120","Comments":"","TypeName":"Journal, Article","Authors":"Paschen-Wolff M ; Greenfield SF ; Kathryn McHugh R; Burlew K ; Pavlicova M ; Choo TH ; Barbosa-Leiker C ; Ruglass LM ; Mennenga S ; Rotrosen J ; Nunes EV ; Campbell ANC ; ","ParentAuthors":"","DOI":"10.1111/ajad.13463 ","Keywords":"Female\r\nHumans\r\nMale\r\n*Buprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\n*Naltrexone/pharmacology/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker C, Ruglass LM, Mennenga S, Rotrosen J, Nunes EV, and Campbell ANC (2023) Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.. The American journal on addictions 32(6), 584-592 DOI: 10.1111/ajad.13463 "},{"Codes":[],"Outcomes":[],"ItemId":98279883,"Title":"Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy","ParentTitle":"AJP Reports","ShortTitle":"Patel (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"2157-6998","City":"","Country":"","Publisher":"","Institution":"B.V. Parilla, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Kentucky, College of Medicine, 800 Rose St, C-368, Lexington, KY, United States","Volume":"14","Pages":"E88-E90","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2030032206&from=export http://dx.doi.org/10.1055/a-2250-6419","OldItemId":"","Comments":"2024-03-07","TypeName":"Journal, Article","Authors":"Patel N B; Parilla B V; ","ParentAuthors":"","DOI":"10.1055/a-2250-6419","Keywords":"buprenorphine\r\nmethadone\r\nnonsteroid antiinflammatory agent\r\nparacetamol\r\ntetrahydrocannabinol\r\nadult\r\nanxiety disorder\r\nApgar score\r\narticle\r\ncase report\r\nclinical article\r\ndepression\r\ndrug dose increase\r\ndrug dose reduction\r\ndrug microdose\r\ndrug substitution\r\ndrug withdrawal\r\nfemale\r\nfollow up\r\nhepatitis C\r\nhuman\r\nnausea and vomiting\r\nneonatal abstinence syndrome\r\nopiate addiction\r\npregnancy\r\nprescription\r\nthird trimester pregnancy\r\ntobacco use\r\nvaginal delivery\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Patel N B, and Parilla B V (2023) Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy. AJP Reports 14(1), E88-E90 DOI: 10.1055/a-2250-6419"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282013,"Title":"Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder.","ParentTitle":"Trials","ShortTitle":"Peter (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"March","StandardNumber":"1745-6215 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"237","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36991453","Comments":"","TypeName":"Journal, Article","Authors":"Peter SC ; Murphy JG ; Witkiewitz K ; Hand SB ; Thomas F ; Johnson KC ; Cowan R ; Harris M ; Derefinko KJ ; ","ParentAuthors":"","DOI":"10.1186/s13063-023-07102-9 ","Keywords":"Adult\r\nHumans\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nNarcotic Antagonists/adverse effects\r\n*Mindfulness\r\nEconomics, Behavioral\r\n*Opioid-Related Disorders/diagnosis/drug therapy/psychology\r\n*Buprenorphine/therapeutic use\r\nMedication Adherence\r\nOpiate Substitution Treatment/methods\r\nBehavioral economics\r\nBrief motivational intervention\r\nContingency management\r\nOpioid use disorder\r\nSequential Multiple Assignment Randomized Trial\r\nSubstance-free activities","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Peter SC, Murphy JG, Witkiewitz K, Hand SB, Thomas F, Johnson KC, Cowan R, Harris M, and Derefinko KJ (2023) Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder.. Trials 24(1), 237 DOI: 10.1186/s13063-023-07102-9 "},{"Codes":[],"Outcomes":[],"ItemId":98280777,"Title":"Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder","ParentTitle":"Annals of Emergency Medicine","ShortTitle":"Phillips (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0196-0644","City":"","Country":"","Publisher":"","Institution":"R.H. Phillips, Cooper University Hospital Emergency Department, Camden, NJ, United States","Volume":"74","Pages":"430-432","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2001573297&from=export http://dx.doi.org/10.1016/j.annemergmed.2019.01.006","OldItemId":"","Comments":"2019-09-02","TypeName":"Journal, Article","Authors":"Phillips R H; Salzman M ; Haroz R ; Rafeq R ; Mazzarelli A J; Pelletier-Bui A ; ","ParentAuthors":"","DOI":"10.1016/j.annemergmed.2019.01.006","Keywords":"antibiotic agent\r\nbuprenorphine\r\ndiamorphine\r\nmethadone\r\nnaloxone\r\nondansetron\r\nopiate\r\nadult\r\nantibiotic therapy\r\narticle\r\ncase report\r\ncellulitis\r\nclinical article\r\nClinical Opiate Withdrawal Scale Score\r\ncocaine dependence\r\ndrug dose increase\r\nelectrocardiogram\r\nhospital discharge\r\nhuman\r\nintravenous drug abuse\r\nleg swelling\r\nmale\r\nopiate addiction\r\nopiate substitution treatment\r\nphysical examination\r\npriority journal\r\npulse oximetry\r\nrehabilitation care\r\nscoring system\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Phillips R H, Salzman M, Haroz R, Rafeq R, Mazzarelli A J, and Pelletier-Bui A (2019) Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder. Annals of Emergency Medicine 74(3), 430-432 DOI: 10.1016/j.annemergmed.2019.01.006"},{"Codes":[],"Outcomes":[],"ItemId":98282376,"Title":"Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.","ParentTitle":"Substance abuse treatment, prevention, and policy","ShortTitle":"Pijl (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"August","StandardNumber":"1747-597X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"17","Pages":"62","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36028837","Comments":"","TypeName":"Journal, Article","Authors":"Pijl EM ; Alraja A ; Duff E ; Cooke C ; Dash S ; Nayak N ; Lamoureux J ; Poulin G ; Knight E ; Fry B ; ","ParentAuthors":"","DOI":"10.1186/s13011-022-00463-5 ","Keywords":"*Analgesics, Opioid\r\nCanada\r\nHumans\r\n*Opioid-Related Disorders\r\nPopulation Groups\r\nRural Population\r\nCommunity health services\r\nIntegrative review\r\nOpioid agonist\r\nOpioid epidemic\r\nOpioid-related disorders\r\nRural population","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Pijl EM, Alraja A, Duff E, Cooke C, Dash S, Nayak N, Lamoureux J, Poulin G, Knight E, and Fry B (2022) Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.. Substance abuse treatment, prevention, and and policy 17(1), 62 DOI: 10.1186/s13011-022-00463-5 "},{"Codes":[],"Outcomes":[],"ItemId":98282463,"Title":"The effectiveness of acupuncture on HPA functional in depressed patients under methadone maintenance treatment, a randomized double-blind sham-controlled trial.","ParentTitle":"Asian journal of psychiatry","ShortTitle":"Pirnia (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"August","StandardNumber":"1876-2018 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"36","Pages":"62-63","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"29966889","Comments":"","TypeName":"Journal, Article","Authors":"Pirnia B ; Pirnia K ; Mohammadpour S ; Malekanmehr P ; Soleimani A ; Mahmoodi Z ; Soleimani AA ; Zahiroddin A ; ","ParentAuthors":"","DOI":"10.1016/j.ajp.2018.06.008 ","Keywords":"*Acupuncture Therapy\r\nAdult\r\nDepressive Disorder/complications/physiopathology/*therapy\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nHydrocortisone/*analysis\r\nHypothalamo-Hypophyseal System/*physiopathology\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nNarcotics/therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/complications/drug therapy/physiopathology\r\nPituitary-Adrenal System/*physiopathology\r\nSaliva/chemistry\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Pirnia B, Pirnia K, Mohammadpour S, Malekanmehr P, Soleimani A, Mahmoodi Z, Soleimani AA, and Zahiroddin A (2018) The effectiveness of acupuncture on HPA functional in depressed patients under methadone maintenance treatment, a randomized double-blind sham-controlled trial.. Asian journal of psychiatry 36, 62-63 DOI: 10.1016/j.ajp.2018.06.008 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284872,"Title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Platt (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"March","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"113","Pages":"545-563","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"28891267","Comments":"","TypeName":"Journal, Article","Authors":"Platt L ; Minozzi S ; Reed J ; Vickerman P ; Hagan H ; French C ; Jordan A ; Degenhardt L ; Hope V ; Hutchinson S ; Maher L ; Palmateer N ; Taylor A ; Bruneau J ; Hickman M ; ","ParentAuthors":"","DOI":"10.1111/add.14012 ","Keywords":"Australia/epidemiology\r\nChina/epidemiology\r\nComorbidity\r\nDatabases, Factual\r\nEurope/epidemiology\r\nHepatitis C/*epidemiology/*prevention & control\r\nHumans\r\nInternationality\r\nNeedle-Exchange Programs/*statistics & numerical data\r\nNorth America/epidemiology\r\nOpiate Substitution Treatment/*statistics & numerical data\r\nSubstance Abuse, Intravenous/*epidemiology\r\nTreatment Outcome\r\nUnited Kingdom/epidemiology\r\nCochrane\r\nharm reduction\r\nhepatitis C\r\nincidence\r\nmeta-analysis\r\nneedle and syringe programmes\r\nopioid substitution therapy\r\nreview\r\nsubstance use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, and Hickman M (2018) Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.. Addiction (Abingdon, and England) 113(3), 545-563 DOI: 10.1111/add.14012 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282812,"Title":"Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).","ParentTitle":"Journal of studies on alcohol and drugs","ShortTitle":"Potter (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"July","StandardNumber":"1937-1888 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"74","Pages":"605-13","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"23739025","Comments":"","TypeName":"Journal, Article","Authors":"Potter JS ; Marino EN ; Hillhouse MP ; Nielsen S ; Wiest K ; Canamar CP ; Martin JA ; Ang A ; Baker R ; Saxon AJ ; Ling W ; ","ParentAuthors":"","DOI":"10.15288/jsad.2013.74.605 ","Keywords":"Adult\r\nBuprenorphine/*administration & dosage\r\nBuprenorphine, Naloxone Drug Combination\r\nFemale\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nNaloxone/*administration & dosage\r\nNarcotic Antagonists/administration & dosage\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*rehabilitation\r\nSeverity of Illness Index\r\nSubstance Abuse, Intravenous/epidemiology/rehabilitation\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, and Ling W (2013) Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).. Journal of studies on alcohol and drugs 74(4), 605-13 DOI: 10.15288/jsad.2013.74.605 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98284663,"Title":"DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.","ParentTitle":"The International journal on drug policy","ShortTitle":"Radley (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"0955-3959 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"47","Pages":"126-136","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28647161","Comments":"","TypeName":"Journal, Article","Authors":"Radley A ; Tait J ; Dillon JF ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2017.05.042 ","Keywords":"Adult\r\nAged\r\nAnalgesics, Opioid/therapeutic use\r\nAntiviral Agents/*therapeutic use\r\nCommunity Pharmacy Services/*statistics & numerical data\r\nFeasibility Studies\r\nFemale\r\nHepatitis C/blood/*complications/*drug therapy\r\nHepatitis C Antibodies/blood\r\nHumans\r\nInterferon-alpha/therapeutic use\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/*statistics & numerical data\r\nPharmacists\r\nRibavirin/*therapeutic use\r\nSubstance Abuse, Intravenous/blood/*complications/*drug therapy\r\nYoung Adult\r\nClinical pathways\r\nCommunity pharmacy\r\nDirectly acting antiviral drugs\r\nFeasibility trial\r\nHepatitis C","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Radley A, Tait J, and Dillon JF (2017) DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.. The International journal on drug policy 47, 126-136 DOI: 10.1016/j.drugpo.2017.05.042 "},{"Codes":[],"Outcomes":[],"ItemId":98282595,"Title":"Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.","ParentTitle":"BMJ open","ShortTitle":"Radley (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"December","StandardNumber":"2044-6055 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"8","Pages":"e021443","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"30552244","Comments":"","TypeName":"Journal, Article","Authors":"Radley A ; de Bruin M ; Inglis SK ; Donnan PT ; Dillon JF ; ","ParentAuthors":"","DOI":"10.1136/bmjopen-2017-021443 ","Keywords":"Adult\r\nAntiviral Agents/economics/*therapeutic use\r\nCluster Analysis\r\nCost-Benefit Analysis\r\nFemale\r\nHepatitis C/diagnosis/economics/epidemiology/*rehabilitation\r\nHumans\r\nMale\r\nMiddle Aged\r\n*Opiate Substitution Treatment/economics\r\nOpioid-Related Disorders/economics/epidemiology/*rehabilitation\r\nPatient Acceptance of Health Care\r\n*Pharmaceutical Services/economics\r\nQualitative Research\r\nScotland\r\nTreatment Outcome\r\nYoung Adult\r\nclinical pathways\r\ncommunity pharmacy\r\ndirect-acting antivirals\r\nhepatitis c\r\nrandomised controlled trial","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Radley A, de Bruin M, Inglis SK, Donnan PT, and Dillon JF (2018) Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.. BMJ open 8(12), e021443 DOI: 10.1136/bmjopen-2017-021443 "},{"Codes":[{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008499,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282631,"Title":"Pharmacological therapies for maintenance treatments of opium dependence.","ParentTitle":"The Cochrane database of systematic reviews","ShortTitle":"Rahimi-Movaghar (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"January","StandardNumber":"1361-6137 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"CD007775","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23440817","Comments":"","TypeName":"Journal, Article","Authors":"Rahimi-Movaghar A ; Amin-Esmaeili M ; Hefazi M ; Yousefi-Nooraie R ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD007775.pub2 ","Keywords":"Baclofen/administration & dosage\r\nBuprenorphine/administration & dosage\r\nDrug Administration Schedule\r\nHumans\r\nMaintenance Chemotherapy/*methods\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nRandomized Controlled Trials as Topic\r\nSubstance Withdrawal Syndrome/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rahimi-Movaghar A, Amin-Esmaeili M, Hefazi M, and Yousefi-Nooraie R (2013) Pharmacological therapies for maintenance treatments of opium dependence.. The Cochrane database of systematic reviews (1), CD007775 DOI: 10.1002/14651858.CD007775.pub2 "},{"Codes":[],"Outcomes":[],"ItemId":98281557,"Title":"Efficacy of naltrexone in preventing relapse in opioid dependent patients","ParentTitle":"Pakistan Journal of Medical and Health Sciences","ShortTitle":"Rashid (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1996-7195","City":"","Country":"","Publisher":"","Institution":"S. Rashid, Department of Psychiatry FJMC, Sir Ganga Ram Hospital, Lahore, Pakistan","Volume":"6","Pages":"549-551","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L365901270&from=export","OldItemId":"","Comments":"2012-11-02","TypeName":"Journal, Article","Authors":"Rashid S ; Saleem F ; Hanif S ; Imam H ; Omer S M; Farooq M ; Waris A A; Rashid M H; ","ParentAuthors":"","DOI":"","Keywords":"naltrexone\r\nadult\r\nanxiety disorder\r\narticle\r\nclinical article\r\nclinical trial\r\ndrug efficacy\r\ndrug induced headache\r\nfollow up\r\nhuman\r\nintervention study\r\nmale\r\nopen study\r\nopiate addiction\r\nprospective study\r\nrelapse\r\nthin layer chromatography","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rashid S, Saleem F, Hanif S, Imam H, Omer S M, Farooq M, Waris A A, and Rashid M H (2012) Efficacy of naltrexone in preventing relapse in opioid dependent patients. Pakistan Journal of Medical and Health Sciences 6(3), 549-551"},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282565,"Title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Reimer (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"September","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"106","Pages":"1647-55","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"21489005","Comments":"","TypeName":"Journal, Article","Authors":"Reimer J ; Verthein U ; Karow A ; Schfer I ; Naber D ; Haasen C ; ","ParentAuthors":"","DOI":"10.1111/j.1360-0443.2011.03463.x ","Keywords":"Adult\r\nAnalgesics, Opioid/adverse effects/*therapeutic use\r\nAnalysis of Variance\r\nBody Mass Index\r\nEchocardiography\r\nElectrocardiography\r\nFemale\r\nGermany\r\nHealth Status\r\nHealth Status Indicators\r\nHeroin/adverse effects/therapeutic use\r\nHumans\r\nMale\r\nMental Health/*statistics & numerical data\r\nMethadone/adverse effects/therapeutic use\r\nOpiate Substitution Treatment/adverse effects/*methods\r\nOpioid-Related Disorders/epidemiology/psychology/*rehabilitation\r\nQuality of Life/psychology\r\nSerologic Tests\r\nSeverity of Illness Index\r\nSubstance Abuse Treatment Centers\r\nSubstance Abuse, Intravenous/epidemiology/psychology/*rehabilitation\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Reimer J, Verthein U, Karow A, Schfer I, Naber D, and Haasen C (2011) Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.. Addiction (Abingdon, and England) 106(9), 1647-55 DOI: 10.1111/j.1360-0443.2011.03463.x "},{"Codes":[],"Outcomes":[],"ItemId":98284727,"Title":"Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.","ParentTitle":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","ShortTitle":"Reimer (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"August","StandardNumber":"1058-4838 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"57 Suppl 2","Pages":"S97-104","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"23884073","Comments":"","TypeName":"Journal, Article","Authors":"Reimer J ; Schmidt CS ; Schulte B ; Gansefort D ; Glz J ; Gerken G ; Scherbaum N ; Verthein U ; Backmund M ; ","ParentAuthors":"","DOI":"10.1093/cid/cit307 ","Keywords":"Adolescent\r\nAdult\r\nAged\r\nAntiviral Agents/administration & dosage\r\nBehavior Therapy/*methods\r\nFemale\r\nGermany\r\nHepatitis C/*drug therapy\r\nHumans\r\nInterferon-alpha/administration & dosage\r\nMale\r\nMedication Adherence\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nPolyethylene Glycols/administration & dosage\r\nProspective Studies\r\nRecombinant Proteins/administration & dosage\r\nRibavirin/administration & dosage\r\nSubstance Abuse, Intravenous/*complications/*drug therapy\r\nTreatment Outcome\r\nViral Load\r\nYoung Adult\r\nantiviral treatment\r\nhepatitis C\r\ninjection drug users\r\npsychoeducation\r\nretention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Reimer J, Schmidt CS, Schulte B, Gansefort D, Glz J, Gerken G, Scherbaum N, Verthein U, and Backmund M (2013) Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 57 Suppl 2, S97-104 DOI: 10.1093/cid/cit307 "},{"Codes":[],"Outcomes":[],"ItemId":98281939,"Title":"The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.","ParentTitle":"European addiction research","ShortTitle":"Reimer (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1022-6877 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"22","Pages":"99-106","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"26426530","Comments":"","TypeName":"Journal, Article","Authors":"Reimer J ; Wright N ; Somaini L ; Roncero C ; Maremmani I ; McKeganey N ; Littlewood R ; Krajci P ; Alho H ; D'Agnone O ; ","ParentAuthors":"","DOI":"10.1159/000438988 ","Keywords":"Consensus\r\nHumans\r\nOpiate Substitution Treatment/*adverse effects\r\nOpioid-Related Disorders/drug therapy\r\nPrescription Drug Diversion/*economics\r\nPrescription Drug Misuse/*adverse effects/*economics","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Reimer J, Wright N, Somaini L, Roncero C, Maremmani I, McKeganey N, Littlewood R, Krajci P, Alho H, and D'Agnone O (2016) The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.. European addiction research 22(2), 99-106 DOI: 10.1159/000438988 "},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288248,"Title":"Retention in Opioid Agonist Treatment: A Systematic Review and Meta-analysis comparing Observational Studies and Randomized Controlled Trials","ParentTitle":"","ShortTitle":"Retention in Opioid... (Jan)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42018104452","Comments":"","TypeName":"Journal, Article","Authors":"Jan Klimas ; Ahmed Adam ; Lauren Gorfinkel ; Michee-Ana Hamilton ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Jan Klimas, Ahmed Adam, Lauren Gorfinkel, and Michee-Ana Hamilton (    ) Retention in Opioid Agonist Treatment: A Systematic Review and Meta-analysis comparing Observational Studies and Randomized Controlled Trials.  , "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282375,"Title":"Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.","ParentTitle":"PloS one","ShortTitle":"Rice (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1932-6203 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"15","Pages":"e0244401","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"33370393","Comments":"","TypeName":"Journal, Article","Authors":"Rice D ; Corace K ; Wolfe D ; Esmaeilisaraji L ; Michaud A ; Grima A ; Austin B ; Douma R ; Barbeau P ; Butler C ; Willows M ; Poulin PA ; Sproule BA ; Porath A ; Garber G ; Taha S ; Garner G ; Skidmore B ; Moher D ; Thavorn K ; Hutton B ; ","ParentAuthors":"","DOI":"10.1371/journal.pone.0244401 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nCombined Modality Therapy\r\nHumans\r\nNetwork Meta-Analysis\r\nOpioid-Related Disorders/*therapy\r\nPractice Guidelines as Topic\r\nPsychosocial Intervention/*methods\r\nRandomized Controlled Trials as Topic\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rice D, Corace K, Wolfe D, Esmaeilisaraji L, Michaud A, Grima A, Austin B, Douma R, Barbeau P, Butler C, Willows M, Poulin PA, Sproule BA, Porath A, Garber G, Taha S, Garner G, Skidmore B, Moher D, Thavorn K, and Hutton B (2020) Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.. PloS one 15(12), e0244401 DOI: 10.1371/journal.pone.0244401 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282364,"Title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.","ParentTitle":"Lancet (London, England)","ShortTitle":"Rich (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"July","StandardNumber":"0140-6736 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"386","Pages":"350-9","Edition":"","Issue":"9991","Availability":"","URL":"","OldItemId":"26028120","Comments":"","TypeName":"Journal, Article","Authors":"Rich JD ; McKenzie M ; Larney S ; Wong JB ; Tran L ; Clarke J ; Noska A ; Reddy M ; Zaller N ; ","ParentAuthors":"","DOI":"10.1016/S0140-6736(14)62338-2 ","Keywords":"Adult\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*administration & dosage/therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPatient Acceptance of Health Care/statistics & numerical data\r\nPrisoners/*psychology\r\nPrisons\r\nRhode Island\r\nSubstance Abuse Treatment Centers/statistics & numerical data","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, and Zaller N (2015) Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.. Lancet (London, and England) 386(9991), 350-9 DOI: 10.1016/S0140-6736(14)62338-2 "},{"Codes":[],"Outcomes":[],"ItemId":98280383,"Title":"Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence","ParentTitle":"Journal of the American Board of Family Medicine","ShortTitle":"Robbins (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"1557-2625","City":"","Country":"","Publisher":"","Institution":"J.L. Robbins, Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Mail Code L-475, 3181 SW Sam Jackson Park Road, Portland, OR, United States","Volume":"34","Pages":"S141-S146","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2011504241&from=export http://dx.doi.org/10.3122/JABFM.2021.S1.200236","OldItemId":"","Comments":"2021-04-08","TypeName":"Journal, Article","Authors":"Robbins J L; Englander H ; Gregg J ; ","ParentAuthors":"","DOI":"10.3122/JABFM.2021.S1.200236","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nfentanyl\r\nhydrocodone\r\nhydromorphone\r\nmethadone\r\nmorphine\r\noxycodone\r\nparacetamol\r\nadult\r\naged\r\nalcoholism\r\nanalgesia\r\narticle\r\nclinical article\r\ncombination drug therapy\r\ncomorbidity\r\ncontrolled study\r\ndrug dose reduction\r\ndrug microdose\r\ndrug tolerability\r\nfemale\r\nhealth insurance\r\nhuman\r\nmale\r\nmedicaid\r\nmedicare\r\nmiddle aged\r\nnausea\r\nopiate addiction\r\npractice guideline\r\nprescription\r\nsocial distancing\r\ntelemedicine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Robbins J L, Englander H, and Gregg J (2021) Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence. Journal of the American Board of Family Medicine 34, S141-S146 DOI: 10.3122/JABFM.2021.S1.200236"},{"Codes":[{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283704,"Title":"A systematic review of interventions to increase the uptake of opiate substitution therapy in injecting drug users.","ParentTitle":"Journal of public health (Oxford, England)","ShortTitle":"Roberts (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"September","StandardNumber":"1741-3842 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"33","Pages":"378-84","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"21047870","Comments":"","TypeName":"Journal, Article","Authors":"Roberts J ; Annett H ; Hickman M ; ","ParentAuthors":"","DOI":"10.1093/pubmed/fdq088 ","Keywords":"Cognitive Behavioral Therapy/*methods\r\nHealth Services Research\r\nHumans\r\n*Motivation\r\nOpiate Substitution Treatment/*methods\r\nSubstance Abuse, Intravenous/*rehabilitation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Roberts J, Annett H, and Hickman M (2011) A systematic review of interventions to increase the uptake of opiate substitution therapy in injecting drug users.. Journal of public health (Oxford, and England) 33(3), 378-84 DOI: 10.1093/pubmed/fdq088 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282658,"Title":"Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.","ParentTitle":"JAMA","ShortTitle":"Rosenthal (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"July","StandardNumber":"0098-7484 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"PRO-814 Study Group","Volume":"316","Pages":"282-90","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"27434441","Comments":"","TypeName":"Journal, Article","Authors":"Rosenthal RN ; Lofwall MR ; Kim S ; Chen M ; Beebe KL ; Vocci FJ ; ","ParentAuthors":"","DOI":"10.1001/jama.2016.9382 ","Keywords":"Administration, Sublingual\r\nAdult\r\nAnalgesics, Opioid/blood\r\nBuprenorphine/*administration & dosage\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nDrug Implants\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nSelf Report","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, and Vocci FJ (2016) Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.. JAMA 316(3), 282-90 DOI: 10.1001/jama.2016.9382 "},{"Codes":[],"Outcomes":[],"ItemId":98282011,"Title":"Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Rossom (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"January","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"124","Pages":"107012","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"36402275","Comments":"","TypeName":"Journal, Article","Authors":"Rossom RC ; Crain AL ; O'Connor PJ ; Wright E ; Haller IV ; Hooker SA ; Sperl-Hillen JM ; Olson A ; Romagnoli K ; Solberg L ; Dehmer SP ; Haapala J ; Borgert-Spaniol C ; Tusing L ; Muegge J ; Allen C ; Ekstrom H ; Huntley K ; McCormack J ; Bart G ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2022.107012 ","Keywords":"Humans\r\nOpiate Substitution Treatment/methods\r\n*Opioid-Related Disorders/drug therapy\r\n*Buprenorphine/therapeutic use\r\nAnalgesics, Opioid/therapeutic use\r\nPrimary Health Care\r\nOpioid overdose\r\nOpioid use disorder\r\nPragmatic clinical trial\r\nPrimary care\r\nShared decision-making","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rossom RC, Crain AL, O'Connor PJ, Wright E, Haller IV, Hooker SA, Sperl-Hillen JM, Olson A, Romagnoli K, Solberg L, Dehmer SP, Haapala J, Borgert-Spaniol C, Tusing L, Muegge J, Allen C, Ekstrom H, Huntley K, McCormack J, and Bart G (2023) Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.. Contemporary clinical trials 124, 107012 DOI: 10.1016/j.cct.2022.107012 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280113,"Title":"Public health risks associated with methadone in Iran: A systematic review and meta-analysis","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Rostam-Abadi (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"A. Rahimi-Movaghar, Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran","Volume":"100","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2015709365&from=export http://dx.doi.org/10.1016/j.drugpo.2021.103529","OldItemId":"","Comments":"2022-03-25","TypeName":"Journal, Article","Authors":"Rostam-Abadi Y ; Gholami J ; Noroozi A ; Ansari M ; Baheshmat S ; Hamzehzadeh M ; Ghadirzadeh M R; Vahdani B ; Ekhtiari H ; Mojtabai R ; Rahimi-Movaghar A ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2021.103529","Keywords":"methadone\r\nage distribution\r\ncause of death\r\nchronic pain\r\nconfidence interval\r\ndata base\r\ndata extraction\r\ndetoxification\r\ndrug dependence\r\ngender\r\nhealth hazard\r\nhelp seeking behavior\r\nhigh risk population\r\nhuman\r\nintoxication\r\nIran\r\nmeta analysis\r\nmethadone poisoning\r\nmethadone treatment\r\nmethadone use disorder\r\nopiate addiction\r\npopulation research\r\nprescription\r\nprevalence\r\npublic health\r\nquality control\r\nreview\r\nstatistical analysis\r\nsystematic review\r\ntrend study\r\nuniversity student","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M R, Vahdani B, Ekhtiari H, Mojtabai R, and Rahimi-Movaghar A (2022) Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal of Drug Policy 100,  DOI: 10.1016/j.drugpo.2021.103529"},{"Codes":[],"Outcomes":[],"ItemId":98282552,"Title":"Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.","ParentTitle":"BMC public health","ShortTitle":"Roux (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"June","StandardNumber":"1471-2458 (Linking)","City":"England","Country":"","Publisher":"","Institution":"ANRS Methaville Study Group","Volume":"12","Pages":"488","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"22741944","Comments":"","TypeName":"Journal, Article","Authors":"Roux P ; Michel L ; Cohen J ; Mora M ; Morel A ; Aubertin JF ; Desenclos JC ; Spire B ; Carrieri PM ; ","ParentAuthors":"","DOI":"10.1186/1471-2458-12-488 ","Keywords":"Follow-Up Studies\r\nFrance\r\nHumans\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nPrimary Health Care/*organization & administration\r\nSubstance Abuse Treatment Centers\r\nTime Factors\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, Desenclos JC, Spire B, and Carrieri PM (2012) Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.. BMC public health 12, 488 DOI: 10.1186/1471-2458-12-488 "},{"Codes":[{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279709,"Title":"Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review","ParentTitle":"International Journal of Drug Policy","ShortTitle":"Russell (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"","StandardNumber":"0955-3959","City":"","Country":"","Publisher":"","Institution":"C. Russell, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada","Volume":"127","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2031330015&from=export http://dx.doi.org/10.1016/j.drugpo.2024.104343","OldItemId":"","Comments":"2024-04-09","TypeName":"Journal, Article","Authors":"Russell C ; Ashley J ; Ali F ; Bozinoff N ; Corace K ; Marsh D C; Mushquash C ; Wyman J ; Zhang M ; Lange S ; ","ParentAuthors":"","DOI":"10.1016/j.drugpo.2024.104343","Keywords":"buprenorphine plus naloxone\r\nmethadone\r\nopiate\r\nopiate agonist\r\naccess to medication\r\nage\r\nclinical feature\r\ncoronavirus disease 2019\r\ndisease association\r\nemployment\r\nethnicity\r\ngender\r\nhealth care utilization\r\nhome care\r\nhousing\r\nhuman\r\nincome\r\nisolation\r\nmarriage\r\nmedical decision making\r\nmedication compliance\r\nneighborhood\r\nopiate addiction\r\npractice guideline\r\npsychosis\r\nreview\r\nsleep quality\r\nsocial distancing\r\nsuicidal ideation\r\nsystematic review\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Russell C, Ashley J, Ali F, Bozinoff N, Corace K, Marsh D C, Mushquash C, Wyman J, Zhang M, and Lange S (2024) Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review. International Journal of Drug Policy 127,  DOI: 10.1016/j.drugpo.2024.104343"},{"Codes":[{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282633,"Title":"18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.","ParentTitle":"Journal of substance use and addiction treatment","ShortTitle":"Rutrick (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"November","StandardNumber":"2949-8759 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"154","Pages":"209155","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"37657559","Comments":"","TypeName":"Journal, Article","Authors":"Rutrick D ; Learned SM ; Boyett B ; Hassman D ; Shinde S ; Zhao Y ; ","ParentAuthors":"","DOI":"10.1016/j.josat.2023.209155 ","Keywords":"Humans\r\n*Buprenorphine/adverse effects\r\nAnalgesics, Opioid/adverse effects\r\nNarcotic Antagonists/adverse effects\r\nNaltrexone\r\n*Opioid-Related Disorders/drug therapy\r\nInjections, Subcutaneous\r\nExtended-release buprenorphine\r\nIntegrated analysis\r\nLong-term safety and efficacy\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Rutrick D, Learned SM, Boyett B, Hassman D, Shinde S, and Zhao Y (2023) 18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.. Journal of substance use and addiction treatment 154, 209155 DOI: 10.1016/j.josat.2023.209155 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281852,"Title":"Review article: Rapid review of the emergency department-initiated buprenorphine for opioid use disorder.","ParentTitle":"Emergency medicine Australasia : EMA","ShortTitle":"Salter (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"December","StandardNumber":"1742-6723 (Linking)","City":"Australia","Country":"","Publisher":"","Institution":"","Volume":"32","Pages":"924-934","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"33089635","Comments":"","TypeName":"Journal, Article","Authors":"Salter H ; Hutton J ; Cantwell K ; Dietze P ; Higgs P ; Straub A ; Zordan R ; Lloyd-Jones M ; ","ParentAuthors":"","DOI":"10.1111/1742-6723.13654 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nEmergency Service, Hospital\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nbuprenorphine\r\nemergency\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Salter H, Hutton J, Cantwell K, Dietze P, Higgs P, Straub A, Zordan R, and Lloyd-Jones M (2020) Review article: Rapid review of the emergency department-initiated buprenorphine for opioid use disorder.. Emergency medicine Australasia : EMA 32(6), 924-934 DOI: 10.1111/1742-6723.13654 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283010,"Title":"Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.","ParentTitle":"Experimental and clinical psychopharmacology","ShortTitle":"Sanders (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"August","StandardNumber":"1064-1297 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"294-302","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"23855333","Comments":"","TypeName":"Journal, Article","Authors":"Sanders NC ; Mancino MJ ; Gentry WB ; Guise JB ; Bickel WK ; Thostenson J ; Oliveto AH ; ","ParentAuthors":"","DOI":"10.1037/a0033724 ","Keywords":"Adult\r\nAmines/administration & dosage/adverse effects/*therapeutic use\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nCyclohexanecarboxylic Acids/administration & dosage/adverse effects/*therapeutic \r\n      use\r\nDiagnostic and Statistical Manual of Mental Disorders\r\nDirectly Observed Therapy\r\nDouble-Blind Method\r\nExcitatory Amino Acid Antagonists/administration & dosage/adverse \r\n      effects/*therapeutic use\r\nFemale\r\nGabapentin\r\nHumans\r\nInduction Chemotherapy\r\nMaintenance Chemotherapy\r\nMale\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy/prevention & control\r\nPatient Dropouts\r\nPilot Projects\r\nSecondary Prevention\r\nSeverity of Illness Index\r\nSubstance Withdrawal Syndrome/physiopathology/*prevention & control/urine\r\ngamma-Aminobutyric Acid/administration & dosage/adverse effects/*therapeutic use","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, and Oliveto AH (2013) Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.. Experimental and clinical psychopharmacology 21(4), 294-302 DOI: 10.1037/a0033724 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285162,"Title":"Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis.","ParentTitle":"Frontiers in psychiatry","ShortTitle":"Sanger (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"1664-0640 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"11","Pages":"812","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"33005151","Comments":"","TypeName":"Journal, Article","Authors":"Sanger N ; Bhatt M ; Singhal N ; Panesar B ; D'Elia A ; Trottier M ; Shahid H ; Hillmer A ; Baptist-Mohseni N ; Roczyki V ; Soni D ; Brush M ; Lovell E ; Sanger S ; Samaan MC ; de Souza RJ ; Thabane L ; Samaan Z ; ","ParentAuthors":"","DOI":"10.3389/fpsyt.2020.00812 ","Keywords":"meta-analysis\r\nopioid use disorder\r\nopioids\r\nprescription\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sanger N, Bhatt M, Singhal N, Panesar B, D'Elia A, Trottier M, Shahid H, Hillmer A, Baptist-Mohseni N, Roczyki V, Soni D, Brush M, Lovell E, Sanger S, Samaan MC, de Souza RJ, Thabane L, and Samaan Z (2020) Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis.. Frontiers in psychiatry 11, 812 DOI: 10.3389/fpsyt.2020.00812 "},{"Codes":[{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280242,"Title":"Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis","ParentTitle":"JAMA Psychiatry","ShortTitle":"Santo (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2168-622X","City":"","Country":"","Publisher":"","Institution":"T. Santo, National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King St, Randwick, NSW, Australia","Volume":"78","Pages":"979-993","Edition":"","Issue":"9","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L635274939&from=export http://dx.doi.org/10.1001/jamapsychiatry.2021.0976","OldItemId":"","Comments":"2023-10-04","TypeName":"Journal, Article","Authors":"Santo T ; Clark B ; Hickman M ; Grebely J ; Campbell G ; Sordo L ; Chen A ; Tran L T; Bharat C ; Padmanathan P ; Cousins G ; Dupouy J ; Kelty E ; Muga R ; Nosyk B ; Min J ; Pavarin R ; Farrell M ; Degenhardt L ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2021.0976","Keywords":"alcohol\r\nbuprenorphine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nopiate agonist\r\nadult\r\nall cause mortality\r\ncancer risk\r\ncardiovascular mortality\r\ncause of death\r\ndrug intoxication\r\nfemale\r\nhepatitis virus\r\nhuman\r\nincarceration\r\ninjury\r\nmale\r\nmeta analysis\r\nmethadone treatment\r\nmortality rate\r\nmortality risk\r\nopiate addiction\r\nPreferred Reporting Items for Systematic Reviews and Meta-Analyses\r\nrandomized controlled trial (topic)\r\nreview\r\nsuicide\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran L T, Bharat C, Padmanathan P, Cousins G, Dupouy J, Kelty E, Muga R, Nosyk B, Min J, Pavarin R, Farrell M, and Degenhardt L (2021) Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis. JAMA Psychiatry 78(9), 979-993 DOI: 10.1001/jamapsychiatry.2021.0976"},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281256,"Title":"Supervised dosing with a long-acting opioid medication in the management of opioid dependence","ParentTitle":"Cochrane Database of Systematic Reviews","ShortTitle":"Saulle (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1469-493X","City":"","Country":"","Publisher":"","Institution":"S. Vecchi, Lazio Regional Health Service, Department of Epidemiology, Via di S. Costanza, Rome, Italy","Volume":"2017","Pages":"","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L615667851&from=export http://dx.doi.org/10.1002/14651858.CD011983.pub2","OldItemId":"","Comments":"2017-05-09","TypeName":"Journal, Article","Authors":"Saulle R ; Vecchi S ; Gowing L ; ","ParentAuthors":"","DOI":"10.1002/14651858.CD011983.pub2","Keywords":"buprenorphine\r\ndiamorphine\r\nlong acting drug\r\nmethadone\r\nnarcotic analgesic agent\r\nclinical effectiveness\r\nclinical supervision\r\ndrug craving\r\nhuman\r\nmotivation\r\nopiate addiction\r\nopiate substitution treatment\r\nprescription drug diversion\r\npriority journal\r\nrandomized controlled trial (topic)\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Saulle R, Vecchi S, and Gowing L (2017) Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database of Systematic Reviews 2017(4),  DOI: 10.1002/14651858.CD011983.pub2"},{"Codes":[{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282119,"Title":"The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.","ParentTitle":"The American journal on addictions","ShortTitle":"Saunders (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"December","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"722-31","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"26388539","Comments":"","TypeName":"Journal, Article","Authors":"Saunders EC ; McGovern MP ; Lambert-Harris C ; Meier A ; McLeman B ; Xie H ; ","ParentAuthors":"","DOI":"10.1111/ajad.12292 ","Keywords":"Adult\r\n*Cognitive Behavioral Therapy\r\nCombined Modality Therapy\r\nCounseling\r\nDiagnosis, Dual (Psychiatry)\r\nFemale\r\nHumans\r\nMale\r\nOpioid-Related Disorders/complications/*drug therapy/*therapy\r\nPatient Acceptance of Health Care\r\nPsychotropic Drugs/*therapeutic use\r\nStress Disorders, Post-Traumatic/complications/*drug therapy/*therapy\r\nTreatment Outcome\r\nYoung Adult\r\nco-occurring disorders\r\nintegrated treatment\r\nmedication-assisted treatment\r\nopioid dependence\r\nposttraumatic stress disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Saunders EC, McGovern MP, Lambert-Harris C, Meier A, McLeman B, and Xie H (2015) The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.. The American journal on addictions 24(8), 722-31 DOI: 10.1111/ajad.12292 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948298,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280270,"Title":"Beneficial effects of opioid rotation to buprenorphine/naloxone on opioid misuse, craving, mental health, and pain control in chronic non-cancer pain patients with opioid use disorder","ParentTitle":"Journal of Clinical Medicine","ShortTitle":"Schellekens (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"2077-0383","City":"","Country":"","Publisher":"","Institution":"S.E. Veldman, Department of Psychiatry, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, Netherlands","Volume":"10","Pages":"","Edition":"","Issue":"16","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2013494414&from=export http://dx.doi.org/10.3390/jcm10163727","OldItemId":"","Comments":"2021-10-01","TypeName":"Journal, Article","Authors":"Schellekens A F.A; Veldman S E; Suranto E S.D; van Rijswijk S M; van der Wal S E.I; Schene A H; van Beek M H.C.T; ","ParentAuthors":"","DOI":"10.3390/jcm10163727","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nclonidine\r\nfentanyl\r\nloperamide\r\nmethadone\r\nmetoclopramide\r\nmu opiate receptor agonist\r\nnonsteroid antiinflammatory agent\r\nopiate\r\noxycodone\r\nparacetamol\r\npregabalin\r\nadd on therapy\r\nadult\r\naged\r\narticle\r\ncancer pain\r\nchronic pain\r\nclinical article\r\ncontrolled study\r\nDepression, Anxiety and Stress Scale\r\ndisease severity\r\ndrug craving\r\ndrug withdrawal\r\nDSM-5\r\nDSM-IV-TR\r\nfemale\r\nfollow up\r\nhuman\r\nmale\r\nmental health\r\nmini international neuropsychiatric interview\r\nnociception\r\nnumeric rating scale\r\nobservational study\r\nopiate addiction\r\npain assessment\r\npain severity\r\nprospective study\r\npsychometry\r\nquestionnaire\r\nself report\r\nvisual analog scale","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schellekens A F.A, Veldman S E, Suranto E S.D, van Rijswijk S M, van der Wal S E.I, Schene A H, and van Beek M H.C.T (2021) Beneficial effects of opioid rotation to buprenorphine/naloxone on opioid misuse, craving, mental health, and pain control in chronic non-cancer pain patients with opioid use disorder. Journal of Clinical Medicine 10(16),  DOI: 10.3390/jcm10163727"},{"Codes":[],"Outcomes":[],"ItemId":98282877,"Title":"Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.","ParentTitle":"International review of psychiatry (Abingdon, England)","ShortTitle":"Schlienz (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"October","StandardNumber":"0954-0261 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"30","Pages":"147-154","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"30398080","Comments":"","TypeName":"Journal, Article","Authors":"Schlienz NJ ; Huhn AS ; Speed TJ ; Sweeney MM ; Antoine DG ; ","ParentAuthors":"","DOI":"10.1080/09540261.2018.1509843 ","Keywords":"Body Weight Maintenance/*drug effects\r\n*Diagnosis, Dual (Psychiatry)\r\nHumans\r\nMethadone/*adverse effects\r\nNarcotics/*adverse effects\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPsychotropic Drugs/*adverse effects\r\nWeight Gain/*drug effects\r\nOpioids\r\ndual diagnosis\r\nmethadone\r\nobesity\r\nweight gain","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schlienz NJ, Huhn AS, Speed TJ, Sweeney MM, and Antoine DG (2018) Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.. International review of psychiatry (Abingdon, and England) 30(5), 147-154 DOI: 10.1080/09540261.2018.1509843 "},{"Codes":[],"Outcomes":[],"ItemId":98282370,"Title":"Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.","ParentTitle":"Addiction science & clinical practice","ShortTitle":"Schramm (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"July","StandardNumber":"1940-0632 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"15","Pages":"30","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"32736660","Comments":"","TypeName":"Journal, Article","Authors":"Schramm ZA ; Leroux BG ; Radick AC ; Ventura AS ; Klein JW ; Samet JH ; Saxon AJ ; Kim TW ; Tsui JI ; ","ParentAuthors":"","DOI":"10.1186/s13722-020-00203-9 ","Keywords":"Adult\r\nBuprenorphine/*therapeutic use\r\n*Directly Observed Therapy\r\nFemale\r\nHumans\r\nMale\r\n*Medication Adherence\r\n*Mobile Applications\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPilot Projects\r\nSelf Report\r\n*Telemedicine\r\nTreatment Outcome\r\nBuprenorphine\r\nDirectly observed therapy\r\nMedication adherence\r\nMobile health\r\nOpioid related disorders\r\nmHealth","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schramm ZA, Leroux BG, Radick AC, Ventura AS, Klein JW, Samet JH, Saxon AJ, Kim TW, and Tsui JI (2020) Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.. Addiction science & clinical practice 15(1), 30 DOI: 10.1186/s13722-020-00203-9 "},{"Codes":[],"Outcomes":[],"ItemId":98282821,"Title":"Interim methadone treatment: impact on arrests.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Schwartz (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"August","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"103","Pages":"148-54","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"19443133","Comments":"","TypeName":"Journal, Article","Authors":"Schwartz RP ; Jaffe JH ; O'Grady KE ; Kinlock TW ; Gordon MS ; Kelly SM ; Wilson ME ; Ahmed A ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2009.03.007 ","Keywords":"Adult\r\nCrime/*statistics & numerical data\r\nDrug Administration Schedule\r\nFemale\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMale\r\nMethadone/*administration & dosage\r\nTime Factors\r\nWaiting Lists","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schwartz RP, Jaffe JH, O'Grady KE, Kinlock TW, Gordon MS, Kelly SM, Wilson ME, and Ahmed A (2009) Interim methadone treatment: impact on arrests.. Drug and alcohol dependence 103(3), 148-54 DOI: 10.1016/j.drugalcdep.2009.03.007 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282906,"Title":"Interim versus standard methadone treatment: a benefit-cost analysis.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Schwartz (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"March","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"306-14","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"24239030","Comments":"","TypeName":"Journal, Article","Authors":"Schwartz RP ; Alexandre PK ; Kelly SM ; O'Grady KE ; Gryczynski J ; Jaffe JH ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2013.10.003 ","Keywords":"Adult\r\nCost-Benefit Analysis\r\nCounseling/economics\r\nFemale\r\nHealth Care Costs\r\nHumans\r\nMale\r\nMethadone/economics/*therapeutic use\r\nMiddle Aged\r\nOpioid-Related Disorders/*drug therapy\r\nBenefitcost\r\nInterim methadone\r\nMethadone treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schwartz RP, Alexandre PK, Kelly SM, O'Grady KE, Gryczynski J, and Jaffe JH (2014) Interim versus standard methadone treatment: a benefit-cost analysis.. Journal of substance abuse treatment 46(3), 306-14 DOI: 10.1016/j.jsat.2013.10.003 "},{"Codes":[],"Outcomes":[],"ItemId":98282132,"Title":"Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Schwartz (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"July","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"49","Pages":"21-8","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27282117","Comments":"","TypeName":"Journal, Article","Authors":"Schwartz RP ; Kelly SM ; Mitchell SG ; Dunlap L ; Zarkin GA ; Sharma A ; O'Grady KE ; Jaffe JH ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2016.06.002 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\n*Community Health Services\r\nCost-Benefit Analysis\r\nCosts and Cost Analysis\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/economics/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Navigation/economics/*methods\r\nPatient Transfer\r\n*Prisons\r\nUnited States\r\nCriminal justice\r\nInterim methadone\r\nJail\r\nMethadone treatment\r\nPatient navigation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O'Grady KE, and Jaffe JH (2016) Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.. Contemporary clinical trials 49, 21-8 DOI: 10.1016/j.cct.2016.06.002 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282219,"Title":"Methadone treatment of arrestees: A randomized clinical trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Schwartz (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"January","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"206","Pages":"107680","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"31753737","Comments":"","TypeName":"Journal, Article","Authors":"Schwartz RP ; Kelly SM ; Mitchell SG ; O'Grady KE ; Sharma A ; Jaffe JH ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2019.107680 ","Keywords":"Adult\r\nAnalgesics, Opioid/therapeutic use\r\nBaltimore/epidemiology\r\nDrug Overdose/*epidemiology\r\nFemale\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Acceptance of Health Care/statistics & numerical data\r\nPrisoners/*statistics & numerical data\r\nTreatment Outcome\r\nCriminal justice\r\nInterim methadone treatment\r\nJail\r\nOpioid use disorder\r\nOverdose death\r\nPatient navigation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Schwartz RP, Kelly SM, Mitchell SG, O'Grady KE, Sharma A, and Jaffe JH (2020) Methadone treatment of arrestees: A randomized clinical trial.. Drug and alcohol dependence 206, 107680 DOI: 10.1016/j.drugalcdep.2019.107680 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280521,"Title":"The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review","ParentTitle":"Infectious Disease Clinics of North America","ShortTitle":"Seval (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0891-5520","City":"","Country":"","Publisher":"","Institution":"N. Seval, Department of Internal Medicine, Section of Infectious Disease, Yale AIDS Program, 135 College Street, Suite 323, New Haven, CT, United States","Volume":"34","Pages":"559-584","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2007390461&from=export http://dx.doi.org/10.1016/j.idc.2020.06.011","OldItemId":"","Comments":"2020-09-10","TypeName":"Journal, Article","Authors":"Seval N ; Wurcel A ; Gunderson C G; Grimshaw A ; Springer S A; ","ParentAuthors":"","DOI":"10.1016/j.idc.2020.06.011","Keywords":"Australia\r\nDenmark\r\ndisease association\r\nDSM-5\r\nfollow up\r\nharm reduction\r\nhazard ratio\r\nhealth program\r\nhealth service\r\nhepatitis C\r\nhuman\r\nmethadone treatment\r\nopiate addiction\r\npeer review\r\npolymerase chain reaction\r\npopulation research\r\nprisoner\r\nquantitative analysis\r\nreinfection\r\nreview\r\nrisk assessment\r\nrisk factor\r\nScotland\r\nSpain\r\nsubstance use\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Seval N, Wurcel A, Gunderson C G, Grimshaw A, and Springer S A (2020) The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review. Infectious Disease Clinics of North America 34(3), 559-584 DOI: 10.1016/j.idc.2020.06.011"},{"Codes":[],"Outcomes":[],"ItemId":98282075,"Title":"Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Seval (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"June","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"105","Pages":"106394","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"33838307","Comments":"","TypeName":"Journal, Article","Authors":"Seval N ; Frank CA ; Litwin AH ; Roth P ; Schade MA ; Pavlicova M ; Levin FR ; Brady KT ; Nunes EV ; Springer SA ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2021.106394 ","Keywords":"Adult\r\n*Buprenorphine/therapeutic use\r\n*Delivery of Health Care, Integrated\r\nHumans\r\nNeoplasm Recurrence, Local\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nBuprenorphine\r\nHospital\r\nInfectious disease\r\nOpioid use disorder\r\nRandomized controlled trial","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Seval N, Frank CA, Litwin AH, Roth P, Schade MA, Pavlicova M, Levin FR, Brady KT, Nunes EV, and Springer SA (2021) Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.. Contemporary clinical trials 105, 106394 DOI: 10.1016/j.cct.2021.106394 "},{"Codes":[{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283050,"Title":"The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.","ParentTitle":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research","ShortTitle":"Shearer (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"May","StandardNumber":"1098-3015 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"26","Pages":"658-665","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"36509367","Comments":"","TypeName":"Journal, Article","Authors":"Shearer J ; Metrebian N ; Weaver T ; Goldsmith K ; Strang J ; Pilling S ; Mitcheson L ; Day E ; Dunn J ; Glasper A ; Akhtar S ; Bajaria J ; Charles V ; Desai R ; Haque F ; Little N ; McKechnie H ; Mosler F ; Mutz J ; Poovendran D ; Byford S ; ","ParentAuthors":"","DOI":"10.1016/j.jval.2022.11.021 ","Keywords":"Humans\r\n*Heroin/therapeutic use\r\nCost-Benefit Analysis\r\nMotivation\r\nAnalgesics, Opioid/therapeutic use\r\n*Heroin Dependence\r\ncluster randomized trial\r\ncontingency management\r\ncost-effectiveness analysis\r\nopioid agonist treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Shearer J, Metrebian N, Weaver T, Goldsmith K, Strang J, Pilling S, Mitcheson L, Day E, Dunn J, Glasper A, Akhtar S, Bajaria J, Charles V, Desai R, Haque F, Little N, McKechnie H, Mosler F, Mutz J, Poovendran D, and Byford S (2023) The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 26(5), 658-665 DOI: 10.1016/j.jval.2022.11.021 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282517,"Title":"Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance.","ParentTitle":"Substance abuse","ShortTitle":"Shi (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0889-7077 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"40","Pages":"132-135","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"30714880","Comments":"","TypeName":"Journal, Article","Authors":"Shi JM ; Henry SP ; Dwy SL ; Orazietti SA ; Carroll KM ; ","ParentAuthors":"","DOI":"10.1080/08897077.2019.1569192 ","Keywords":"Adult\r\nAmbulatory Care\r\nAnalgesics, Opioid/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nCognitive Behavioral Therapy/*methods\r\nCombined Modality Therapy\r\nFemale\r\nHumans\r\n*Internet-Based Intervention\r\nMale\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*therapy\r\nPilot Projects\r\n*Retention in Care\r\nTreatment Outcome\r\nBehavioral interventions\r\nbuprenorphine\r\nweb-based interventions","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Shi JM, Henry SP, Dwy SL, Orazietti SA, and Carroll KM (2019) Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance.. Substance abuse 40(2), 132-135 DOI: 10.1080/08897077.2019.1569192 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282694,"Title":"Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Shulman (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"September","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"14","Pages":"e188-e194","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"32039934","Comments":"","TypeName":"Journal, Article","Authors":"Shulman M ; Luo SX ; Campbell ANC ; Scodes J ; Pavlicova M ; Broffman A ; Saxon AJ ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000630 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nPain/drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Shulman M, Luo SX, Campbell ANC, Scodes J, Pavlicova M, Broffman A, Saxon AJ, and Nunes EV (2020) Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder.. Journal of addiction medicine 14(5), e188-e194 DOI: 10.1097/ADM.0000000000000630 "},{"Codes":[],"Outcomes":[],"ItemId":98280572,"Title":"A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Sibai (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0095-2990","City":"","Country":"","Publisher":"","Institution":"A. Bisaga, New York State Psychiatric Institute, Department of Psychology, 1051 Riverside Drive, Unit 120, New York, NY, United States","Volume":"46","Pages":"289-296","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2003917747&from=export http://dx.doi.org/10.1080/00952990.2019.1700265","OldItemId":"","Comments":"2019-12-31","TypeName":"Journal, Article","Authors":"Sibai M ; Mishlen K ; Nunes E V; Levin F R; Mariani J J; Bisaga A ; ","ParentAuthors":"","DOI":"10.1080/00952990.2019.1700265","Keywords":"buprenorphine\r\nclonazepam\r\nclonidine\r\ndiamorphine\r\nnaltrexone\r\nopiate\r\nprochlorperazine\r\ntrazodone\r\nzolpidem\r\nadult\r\narticle\r\nclinical article\r\nclinical outcome\r\ndrug craving\r\ndrug safety\r\ndrug tolerability\r\nfeasibility study\r\nfemale\r\nheroin dependence\r\nhuman\r\nmale\r\nopen study\r\nopiate addiction\r\noutpatient care\r\noutpatient department\r\nwithdrawal syndrome\r\nvivitrol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sibai M, Mishlen K, Nunes E V, Levin F R, Mariani J J, and Bisaga A (2020) A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. American Journal of Drug and Alcohol Abuse 46(3), 289-296 DOI: 10.1080/00952990.2019.1700265"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282514,"Title":"A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.","ParentTitle":"JAMA psychiatry","ShortTitle":"Sigmon (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"December","StandardNumber":"2168-622X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"70","Pages":"1347-54","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"24153411","Comments":"","TypeName":"Journal, Article","Authors":"Sigmon SC ; Dunn KE ; Saulsgiver K ; Patrick ME ; Badger GJ ; Heil SH ; Brooklyn JR ; Higgins ST ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2013.2216 ","Keywords":"Adult\r\nBuprenorphine/*administration & dosage/pharmacology\r\nCognitive Behavioral Therapy/methods\r\nCombined Modality Therapy\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nFemale\r\nHumans\r\nMale\r\nNaloxone/therapeutic use\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/pharmacology\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy/psychology/urine\r\nPsychiatric Status Rating Scales\r\nSeverity of Illness Index\r\nTime Factors\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, and Higgins ST (2013) A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.. JAMA psychiatry 70(12), 1347-54 DOI: 10.1001/jamapsychiatry.2013.2216 "},{"Codes":[],"Outcomes":[],"ItemId":98281066,"Title":"Maternal and neonatal outcomes following methadone taper for opiate detoxification","ParentTitle":"Obstetrics and Gynecology","ShortTitle":"Smallwood (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1873-233X","City":"","Country":"","Publisher":"","Institution":"P.T. Smallwood, University of Kentucky, Department of Obstetrics and Gynecology, Lexington, KY, United States","Volume":"131","Pages":"70S","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622555310&from=export","OldItemId":"","Comments":"2018-06-19","TypeName":"Journal, Article","Authors":"Smallwood P T; Williams C M; McQuerry K J; Critchfield A S; ","ParentAuthors":"","DOI":"","Keywords":"methadone\r\nmorphine\r\nopiate\r\nadult\r\nclinical article\r\nconference abstract\r\ncontrolled study\r\ndetoxification\r\ndrug megadose\r\ndrug therapy\r\ndrug withdrawal\r\nfemale\r\nhospital patient\r\nhuman\r\nhuman tissue\r\nincidence\r\nlength of stay\r\nmaintenance therapy\r\nmedical record review\r\nneonatal abstinence syndrome\r\nnewborn\r\npregnant woman\r\nretrospective study\r\nurine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Smallwood P T, Williams C M, McQuerry K J, and Critchfield A S (2018) Maternal and neonatal outcomes following methadone taper for opiate detoxification. Obstetrics and Gynecology 131, 70S"},{"Codes":[],"Outcomes":[],"ItemId":98282390,"Title":"Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial.","ParentTitle":"European addiction research","ShortTitle":"Solli (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"1022-6877 (Linking)","City":"Switzerland","Country":"","Publisher":"","Institution":"","Volume":"25","Pages":"303-309","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"31340204","Comments":"","TypeName":"Journal, Article","Authors":"Solli KK ; Kunoe N ; Latif ZE ; Sharma-Haase K ; Opheim A ; Krajci P ; Gaulen Z ; altyt Benth J; Tanum L ; ","ParentAuthors":"","DOI":"10.1159/000501931 ","Keywords":"Adult\r\nDelayed-Action Preparations/therapeutic use\r\nFemale\r\nHumans\r\nMale\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Acceptance of Health Care/*statistics & numerical data\r\nYoung Adult\r\nExtended-release naltrexone\r\nMaintenance treatment program\r\nNaltrexone\r\nOpioid dependency\r\nOpioid maintenance treatment\r\nTreatment of opioid dependence","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Solli KK, Kunoe N, Latif ZE, Sharma-Haase K, Opheim A, Krajci P, Gaulen Z, altyt Benth J, and Tanum L (2019) Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial.. European addiction research 25(6), 303-309 DOI: 10.1159/000501931 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282749,"Title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","ParentTitle":"BMJ (Clinical research ed.)","ShortTitle":"Sordo (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"April","StandardNumber":"0959-8138 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"357","Pages":"j1550","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"28446428","Comments":"","TypeName":"Journal, Article","Authors":"Sordo L ; Barrio G ; Bravo MJ ; Indave BI ; Degenhardt L ; Wiessing L ; Ferri M ; Pastor-Barriuso R ; ","ParentAuthors":"","DOI":"10.1136/bmj.j1550 ","Keywords":"Buprenorphine/*adverse effects/therapeutic use\r\nDrug Overdose/*mortality\r\nHumans\r\nMethadone/*adverse effects/therapeutic use\r\nNarcotics/*adverse effects/therapeutic use\r\nOpiate Substitution Treatment/*adverse effects\r\nOpioid-Related Disorders/*mortality\r\nRisk","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, and Pastor-Barriuso R (2017) Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.. BMJ (Clinical research ed.) 357, j1550 DOI: 10.1136/bmj.j1550 "},{"Codes":[],"Outcomes":[],"ItemId":98283011,"Title":"Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence.","ParentTitle":"Expert opinion on drug delivery","ShortTitle":"Soyka (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"November","StandardNumber":"1742-5247 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"9","Pages":"1409-17","Edition":"","Issue":"11","Availability":"","URL":"","OldItemId":"23013384","Comments":"","TypeName":"Journal, Article","Authors":"Soyka M ; ","ParentAuthors":"","DOI":"10.1517/17425247.2012.729574 ","Keywords":"Animals\r\nBuprenorphine/*administration & dosage/pharmacokinetics\r\nBuprenorphine, Naloxone Drug Combination\r\nDrug Carriers\r\nDrug Combinations\r\nDrug Compounding\r\nHumans\r\nNaloxone/*administration & dosage/pharmacokinetics\r\nNarcotic Antagonists/*administration & dosage/pharmacokinetics\r\nOpioid-Related Disorders/*drug therapy\r\nTablets","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Soyka M (2012) Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence.. Expert opinion on drug delivery 9(11), 1409-17 DOI: 10.1517/17425247.2012.729574 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282380,"Title":"Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment?","ParentTitle":"Annali dell'Istituto superiore di sanita","ShortTitle":"Specka (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"0021-2571 (Linking)","City":"Italy","Country":"","Publisher":"","Institution":"","Volume":"49","Pages":"358-64","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"24334780","Comments":"","TypeName":"Journal, Article","Authors":"Specka M ; Bning A ; Kluwig J ; Schifano F ; Banger M ; Lange W ; Lax H ; Marrziniak B ; Schngel C ; Scherbaum N ; ","ParentAuthors":"","DOI":"10.4415/ANN_13_04_07 ","Keywords":"Adult\r\nAge Factors\r\nFemale\r\nHumans\r\nMale\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPatient Compliance\r\n*Reinforcement, Psychology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Specka M, Bning A, Kluwig J, Schifano F, Banger M, Lange W, Lax H, Marrziniak B, Schngel C, and Scherbaum N (2013) Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment?. Annali dell'Istituto superiore di sanita 49(4), 358-64 DOI: 10.4415/ANN_13_04_07 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280058,"Title":"Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review","ParentTitle":"Pharmacotherapy","ShortTitle":"Spreen (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"0277-0008","City":"","Country":"","Publisher":"","Institution":"M.A. Smith, Department of Pharmacy Services, University of Michigan Health, Ann Arbor, MI, United States","Volume":"42","Pages":"411-427","Edition":"","Issue":"5","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2015408917&from=export http://dx.doi.org/10.1002/phar.2676","OldItemId":"","Comments":"2022-05-30","TypeName":"Journal, Article","Authors":"Spreen L A; Dittmar E N; Quirk K C; Smith M A; ","ParentAuthors":"","DOI":"10.1002/phar.2676","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\ndynorphin\r\nfentanyl\r\nhydromorphone\r\nkappa opiate receptor\r\nmethadone\r\nmorphine\r\nmu opiate receptor\r\nopiate\r\noxycodone\r\nadolescent\r\nadult\r\naged\r\nagitation\r\nanalgesia\r\nanimal experiment\r\nanimal model\r\nanxiety\r\nanxiety disorder\r\narthralgia\r\nbinding affinity\r\nchronic pain\r\ncohort analysis\r\nconstipation\r\ncontrolled study\r\ndiaphoresis\r\ndiarrhea\r\ndisease severity\r\ndrug microdose\r\ndrug withdrawal\r\nfeasibility study\r\nfemale\r\nhuman\r\nlow back pain\r\nmajor clinical study\r\nmale\r\nmeta analysis\r\nmouse\r\nmyalgia\r\nnonhuman\r\nobservational study\r\nopiate addiction\r\npain\r\npractice guideline\r\npsychological aspect\r\nrespiration depression\r\nrestlessness\r\nreview\r\nrisk assessment\r\nsystematic review\r\ntreatment failure\r\ntremor\r\nvery elderly\r\nvomiting\r\nbelbuca\r\nbuprenex\r\nbuprex\r\nbutrans\r\nprefin\r\nprobuphine\r\nsublocade\r\nsuboxone\r\nsubutex\r\ntemgesic","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Spreen L A, Dittmar E N, Quirk K C, and Smith M A (2022) Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy 42(5), 411-427 DOI: 10.1002/phar.2676"},{"Codes":[],"Outcomes":[],"ItemId":98283393,"Title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.","ParentTitle":"Journal of urban health : bulletin of the New York Academy of Medicine","ShortTitle":"Springer (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"July","StandardNumber":"1099-3460 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"87","Pages":"592-602","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"20177974","Comments":"","TypeName":"Journal, Article","Authors":"Springer SA ; Chen S ; Altice FL ; ","ParentAuthors":"","DOI":"10.1007/s11524-010-9438-4 ","Keywords":"Anti-Retroviral Agents/*therapeutic use\r\nBuprenorphine/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination\r\nCD4 Lymphocyte Count\r\nFemale\r\nHIV Infections/*drug therapy\r\nHumans\r\nMale\r\nMental Disorders/complications\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nNarcotics/therapeutic use\r\n*Prisoners\r\nSubstance-Related Disorders/complications/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Springer SA, Chen S, and Altice FL (2010) Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.. Journal of urban health : bulletin of the New York Academy of Medicine 87(4), 592-602 DOI: 10.1007/s11524-010-9438-4 "},{"Codes":[],"Outcomes":[],"ItemId":98285172,"Title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.","ParentTitle":"Contemporary clinical trials","ShortTitle":"Springer (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"March","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"37","Pages":"209-18","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"24384538","Comments":"","TypeName":"Journal, Article","Authors":"Springer SA ; Altice FL ; Herme M ; Di Paola A ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2013.12.006 ","Keywords":"Adult\r\nAlcoholism/*drug therapy\r\nAnti-Retroviral Agents/administration & dosage/*therapeutic use\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nHIV Infections/*drug therapy\r\nHealth Status\r\nHumans\r\nMedication Adherence\r\nMental Health\r\nNaltrexone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\n*Prisoners\r\nResearch Design\r\nRisk-Taking\r\nSecondary Prevention\r\nSocioeconomic Factors\r\nAlcohol use disorder\r\nExtended-release naltrexone\r\nHIV\r\nHazardous drinking\r\nPrisoners\r\nRandomized controlled trial","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Springer SA, Altice FL, Herme M, and Di Paola A (2014) Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.. Contemporary clinical trials 37(2), 209-18 DOI: 10.1016/j.cct.2013.12.006 "},{"Codes":[],"Outcomes":[],"ItemId":98282268,"Title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Springer (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"December","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"157","Pages":"158-65","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"26560326","Comments":"","TypeName":"Journal, Article","Authors":"Springer SA ; Brown SE ; Di Paola A ; Altice FL ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2015.10.023 ","Keywords":"Adult\r\nCriminals/*psychology\r\nDelayed-Action Preparations/administration & dosage\r\nDouble-Blind Method\r\nFemale\r\nHIV Infections/drug therapy/*psychology\r\nHumans\r\nInjections/psychology\r\nMale\r\nMiddle Aged\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpiate Substitution Treatment/methods/*psychology\r\nOpioid-Related Disorders/drug therapy/psychology/urine\r\nPatient Compliance/*psychology\r\n*Transitional Care\r\nAlcohol use disorders\r\nCriminal justice system\r\nExtended-release naltrexone\r\nHIV\r\nOpioid use disorders\r\nVivitrol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Springer SA, Brown SE, Di Paola A, and Altice FL (2015) Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.. Drug and alcohol dependence 157, 158-65 DOI: 10.1016/j.drugalcdep.2015.10.023 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282952,"Title":"Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.","ParentTitle":"Journal of acquired immune deficiency syndromes (1999)","ShortTitle":"Springer (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"May","StandardNumber":"1525-4135 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"78","Pages":"43-53","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29373393","Comments":"","TypeName":"Journal, Article","Authors":"Springer SA ; Di Paola A ; Azar MM ; Barbour R ; Biondi BE ; Desabrais M ; Lincoln T ; Skiest DJ ; Altice FL ; ","ParentAuthors":"","DOI":"10.1097/QAI.0000000000001634 ","Keywords":"Adult\r\nCriminal Law\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nFemale\r\nFollow-Up Studies\r\nHIV Infections/complications/*drug therapy\r\nHIV-1\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nMultivariate Analysis\r\nNaltrexone/administration & dosage/adverse effects/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/adverse effects/*therapeutic use\r\nOpioid-Related Disorders/complications/*drug therapy\r\n*Prisoners\r\nProspective Studies\r\nRNA, Viral\r\nResearch Design\r\nTime Factors\r\nTreatment Outcome\r\nViral Load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, and Altice FL (2018) Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.. Journal of acquired immune deficiency syndromes (1999) 78(1), 43-53 DOI: 10.1097/QAI.0000000000001634 "},{"Codes":[],"Outcomes":[],"ItemId":98282995,"Title":"Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.","ParentTitle":"Journal of acquired immune deficiency syndromes (1999)","ShortTitle":"Springer (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"September","StandardNumber":"1525-4135 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"79","Pages":"92-100","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"29781884","Comments":"","TypeName":"Journal, Article","Authors":"Springer SA ; Di Paola A ; Barbour R ; Azar MM ; Altice FL ; ","ParentAuthors":"","DOI":"10.1097/QAI.0000000000001759 ","Keywords":"Adult\r\nAlcohol Deterrents/*administration & dosage\r\nAlcoholism/complications/*drug therapy\r\nDelayed-Action Preparations/*administration & dosage\r\nDouble-Blind Method\r\nFemale\r\nHIV Infections/complications/*virology\r\nHIV-1/genetics/isolation & purification\r\nHumans\r\nMale\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPlacebos\r\n*Prisoners\r\nRNA, Viral/blood\r\n*Viral Load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Springer SA, Di Paola A, Barbour R, Azar MM, and Altice FL (2018) Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.. Journal of acquired immune deficiency syndromes (1999) 79(1), 92-100 DOI: 10.1097/QAI.0000000000001759 "},{"Codes":[{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013976,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019724,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282726,"Title":"Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.","ParentTitle":"Canadian family physician Medecin de famille canadien","ShortTitle":"Srivastava (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"May","StandardNumber":"0008-350X (Linking)","City":"Canada","Country":"","Publisher":"","Institution":"","Volume":"65","Pages":"e214-e220","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"31088887","Comments":"","TypeName":"Journal, Article","Authors":"Srivastava A ; Kahan M ; Njoroge I ; Sommer LZ ; ","ParentAuthors":"","DOI":"","Keywords":"Adult\r\nBuprenorphine/*therapeutic use\r\nClonidine/*therapeutic use\r\nEmergency Service, Hospital\r\nFemale\r\nHumans\r\nMale\r\nNarcotic Antagonists/therapeutic use\r\nOntario\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nProspective Studies\r\nSubstance Withdrawal Syndrome/*drug therapy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Srivastava A, Kahan M, Njoroge I, and Sommer LZ (2019) Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.. Canadian family physician Medecin de famille canadien 65(5), e214-e220"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948297,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282031,"Title":"Patient's and healthcare provider's experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis.","ParentTitle":"BMC health services research","ShortTitle":"Steiro (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"March","StandardNumber":"1472-6963 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"24","Pages":"333","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"38481254","Comments":"","TypeName":"Journal, Article","Authors":"Steiro A ; Hestevik CH ; Muller AE ; ","ParentAuthors":"","DOI":"10.1186/s12913-024-10778-7 ","Keywords":"Humans\r\n*Opiate Substitution Treatment\r\nDelivery of Health Care\r\nFamily\r\nHealth Personnel\r\nQualitative Research\r\n*Opioid-Related Disorders/drug therapy\r\nHealth policy\r\nOpioid maintenance treatment\r\nOpioid-related disorders\r\nPatient and health providers\r\nQualitative evidence synthesis\r\nUser experience","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Steiro A, Hestevik CH, and Muller AE (2024) Patient's and healthcare provider's experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis.. BMC health services research 24(1), 333 DOI: 10.1186/s12913-024-10778-7 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283160,"Title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.","ParentTitle":"Lancet (London, England)","ShortTitle":"Strang (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"May","StandardNumber":"0140-6736 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"375","Pages":"1885-95","Edition":"","Issue":"9729","Availability":"","URL":"","OldItemId":"20511018","Comments":"","TypeName":"Journal, Article","Authors":"Strang J ; Metrebian N ; Lintzeris N ; Potts L ; Carnwath T ; Mayet S ; Williams H ; Zador D ; Evers R ; Groshkova T ; Charles V ; Martin A ; Forzisi L ; ","ParentAuthors":"","DOI":"10.1016/S0140-6736(10)60349-2 ","Keywords":"Administration, Oral\r\nAdolescent\r\nAdult\r\nAged\r\nEngland\r\nFemale\r\nHeroin/*administration & dosage\r\nHeroin Dependence/*rehabilitation\r\nHumans\r\nIllicit Drugs\r\nInjections\r\nMale\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nNarcotics/*administration & dosage\r\nPrescription Drugs/*administration & dosage\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, Williams H, Zador D, Evers R, Groshkova T, Charles V, Martin A, and Forzisi L (2010) Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.. Lancet (London, and England) 375(9729), 1885-95 DOI: 10.1016/S0140-6736(10)60349-2 "},{"Codes":[{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948298,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948326,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948331,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283229,"Title":"Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction.","ParentTitle":"The British journal of psychiatry : the journal of mental science","ShortTitle":"Strang (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"July","StandardNumber":"0007-1250 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"207","Pages":"5-14","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"26135571","Comments":"","TypeName":"Journal, Article","Authors":"Strang J ; Groshkova T ; Uchtenhagen A ; van den Brink W ; Haasen C ; Schechter MT ; Lintzeris N ; Bell J ; Pirona A ; Oviedo-Joekes E ; Simon R ; Metrebian N ; ","ParentAuthors":"","DOI":"10.1192/bjp.bp.114.149195 ","Keywords":"Heroin/*administration & dosage/*adverse effects\r\nHeroin Dependence/*drug therapy\r\nHumans\r\nMethadone/*administration & dosage/adverse effects\r\nOpiate Substitution Treatment\r\nRandomized Controlled Trials as Topic\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, and Metrebian N (2015) Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction.. The British journal of psychiatry : the journal of mental science 207(1), 5-14 DOI: 10.1192/bjp.bp.114.149195 "},{"Codes":[],"Outcomes":[],"ItemId":98281245,"Title":"Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study","ParentTitle":"European Addiction Research","ShortTitle":"Strang (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"1022-6877","City":"","Country":"","Publisher":"","Institution":"","Volume":"23","Pages":"61-70","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L614917944&from=export http://dx.doi.org/10.1159/000456612","OldItemId":"","Comments":"2017-05-19","TypeName":"Journal, Article","Authors":"Strang J ; Reed K ; Bogdanowicz K ; Bell J ; Van Der Waal R ; Keen J ; Beavan P ; Baillie S ; Knight A ; ","ParentAuthors":"","DOI":"10.1159/000456612","Keywords":"alcohol\r\nbenzodiazepine derivative\r\nbuprenorphine\r\ncocaine\r\nmethadone\r\nnorbuprenorphine\r\nopiate\r\nadolescent\r\nadult\r\nalcohol consumption\r\narthralgia\r\narticle\r\nbioavailability\r\nbreathing rate\r\nchild\r\nclinical article\r\ncomparative study\r\ncontrolled study\r\ncrossover procedure\r\ndrug blood level\r\ndrug craving\r\ndrug dose titration\r\ndrug formulation\r\ndrug retention\r\ndrug safety\r\ndrug solubility\r\ndrug use\r\nfemale\r\nheadache\r\nhuman\r\nhyperhidrosis\r\nhypesthesia\r\nlyophilisate\r\nmaintenance therapy\r\nmale\r\nnausea\r\nopiate addiction\r\nphase 2 clinical trial\r\nphysical disease by body function\r\npriority journal\r\nrandomized controlled trial\r\nrespiration depression\r\nrespiratory function\r\ntablet disintegration\r\nvomiting\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Strang J, Reed K, Bogdanowicz K, Bell J, Van Der Waal R, Keen J, Beavan P, Baillie S, and Knight A (2017) Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study. European Addiction Research 23(2), 61-70 DOI: 10.1159/000456612"},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282398,"Title":"Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.","ParentTitle":"Health technology assessment (Winchester, England)","ShortTitle":"Strang (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"January","StandardNumber":"1366-5278 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"23","Pages":"1-72","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"30702059","Comments":"","TypeName":"Journal, Article","Authors":"Strang J ; Kelleher M ; Mayet S ; Day E ; Hellier J ; Byford S ; Murphy C ; McLennan B ; Shearer J ; Ryan E ; Marsden J ; ","ParentAuthors":"","DOI":"10.3310/hta23030 ","Keywords":"*Administration, Oral\r\nAdult\r\nDelayed-Action Preparations/*administration & dosage\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nLongitudinal Studies\r\nMale\r\nNaltrexone/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nPlacebos/*administration & dosage\r\nUnited Kingdom","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Strang J, Kelleher M, Mayet S, Day E, Hellier J, Byford S, Murphy C, McLennan B, Shearer J, Ryan E, and Marsden J (2019) Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.. Health technology assessment (Winchester, and England) 23(3), 1-72 DOI: 10.3310/hta23030 "},{"Codes":[],"Outcomes":[],"ItemId":98281615,"Title":"Effects of a single 50% extra dose of methadone on heroin craving and mood in lower-versus higher-dose methadone patients","ParentTitle":"Journal of Clinical Psychopharmacology","ShortTitle":"Strasser (2010)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2010","Month":"","StandardNumber":"0271-0749","City":"","Country":"","Publisher":"","Institution":"J. Strasser, Psychiatric Hospital, University of Basel, Wilhelm Klein-Strasse 27, CH-4025 Basel, Switzerland","Volume":"30","Pages":"450-454","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L50965989&from=export http://dx.doi.org/10.1097/JCP.0b013e3181e6df49","OldItemId":"","Comments":"2010-08-26","TypeName":"Journal, Article","Authors":"Strasser J ; Wiesbeck G A; Meier N ; Stohler R ; Drsteler-Macfarland K M; ","ParentAuthors":"","DOI":"10.1097/JCP.0b013e3181e6df49","Keywords":"methadone\r\nadult\r\narticle\r\nclinical article\r\nclinical trial\r\ncontrolled clinical trial\r\ncontrolled study\r\ndouble blind procedure\r\ndrug megadose\r\ndrug safety\r\ndrug withdrawal\r\nfemale\r\nheroin dependence\r\nhuman\r\nlow drug dose\r\nmale\r\nmood\r\npriority journal\r\nquestionnaire\r\nrandomized controlled trial\r\nself report\r\nvisual analog scale","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Strasser J, Wiesbeck G A, Meier N, Stohler R, and Drsteler-Macfarland K M (2010) Effects of a single 50% extra dose of methadone on heroin craving and mood in lower-versus higher-dose methadone patients. Journal of Clinical Psychopharmacology 30(4), 450-454 DOI: 10.1097/JCP.0b013e3181e6df49"},{"Codes":[],"Outcomes":[],"ItemId":98281756,"Title":"Opioid Use Disorder Treatments: An Evidence Map.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Sugarman (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"December","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"241","Pages":"109657","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"36332588","Comments":"","TypeName":"Journal, Article","Authors":"Sugarman A ; Vittitow A ; Cheng A ; Malone M ; McDonald R ; Pace N ; Williams O ; Tofighi B ; McNeely J ; Schatz D ; Roberts T ; Hey SP ; Garrity K ; Lindquist K ; Lee JD ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109657 ","Keywords":"Humans\r\nOpiate Substitution Treatment/methods\r\nAnalgesics, Opioid/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\n*Buprenorphine/therapeutic use\r\nMethadone/therapeutic use\r\nNaltrexone/therapeutic use\r\nBuprenorphine\r\nEvidence map\r\nMethadone\r\nOpioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sugarman A, Vittitow A, Cheng A, Malone M, McDonald R, Pace N, Williams O, Tofighi B, McNeely J, Schatz D, Roberts T, Hey SP, Garrity K, Lindquist K, and Lee JD (2022) Opioid Use Disorder Treatments: An Evidence Map.. Drug and alcohol dependence 241, 109657 DOI: 10.1016/j.drugalcdep.2022.109657 "},{"Codes":[],"Outcomes":[],"ItemId":98282901,"Title":"Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Sullivan (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"November","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"133","Pages":"80-5","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"23827259","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan MA ; Bisaga A ; Mariani JJ ; Glass A ; Levin FR ; Comer SD ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.05.030 ","Keywords":"Adolescent\r\nAdult\r\nDelayed-Action Preparations\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaltrexone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Dropouts/statistics & numerical data\r\nProportional Hazards Models\r\nLong-acting injectable naltrexone\r\nOpiate dependence\r\nOpioid antagonist\r\nTreatment retention\r\nUrine toxicology","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan MA, Bisaga A, Mariani JJ, Glass A, Levin FR, Comer SD, and Nunes EV (2013) Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?. Drug and alcohol dependence 133(1), 80-5 DOI: 10.1016/j.drugalcdep.2013.05.030 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282046,"Title":"Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Sullivan (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"February","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"147","Pages":"122-9","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25555621","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan MA ; Bisaga A ; Glass A ; Mishlen K ; Pavlicova M ; Carpenter KM ; Mariani JJ ; Levin FR ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2014.11.028 ","Keywords":"Administration, Oral\r\nAdult\r\n*Behavior Therapy/methods\r\nDelayed-Action Preparations/administration & dosage\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nInjections, Intravenous\r\nMale\r\nMiddle Aged\r\nNaltrexone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*diagnosis/psychology/*therapy\r\nPatient Compliance/psychology\r\n*Patient Dropouts/psychology\r\nInjection naltrexone\r\nOpiate dependence treatment\r\nOpioid antagonist\r\nOral naltrexone\r\nPharmacotherapy trials","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan MA, Bisaga A, Glass A, Mishlen K, Pavlicova M, Carpenter KM, Mariani JJ, Levin FR, and Nunes EV (2015) Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.. Drug and alcohol dependence 147, 122-9 DOI: 10.1016/j.drugalcdep.2014.11.028 "},{"Codes":[],"Outcomes":[],"ItemId":98282308,"Title":"Novel Buccal Film Formulation of Buprenorphine-Naloxone for the Maintenance Treatment of Opioid Dependence: A 12-Week Conversion Study.","ParentTitle":"Clinical therapeutics","ShortTitle":"Sullivan (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"May","StandardNumber":"0149-2918 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"37","Pages":"1064-75","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"25823919","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan JG ; Webster L ; ","ParentAuthors":"","DOI":"10.1016/j.clinthera.2015.02.027 ","Keywords":"Administration, Buccal\r\nAdministration, Sublingual\r\nAdult\r\nAnalgesics, Opioid/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/*administration & dosage/adverse \r\n      effects/therapeutic use\r\nChemistry, Pharmaceutical\r\nDrug Substitution\r\nFemale\r\nHumans\r\nMale\r\nMedication Adherence/statistics & numerical data\r\nMiddle Aged\r\nNarcotic Antagonists/*administration & dosage/adverse effects/therapeutic use\r\nOpioid-Related Disorders/*rehabilitation\r\nSubstance Withdrawal Syndrome\r\nTreatment Outcome\r\nYoung Adult\r\nbuccal\r\nbuprenorphine\r\ndependence\r\nnaloxone\r\nopioid\r\nsafety","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan JG, and Webster L (2015) Novel Buccal Film Formulation of Buprenorphine-Naloxone for the Maintenance Treatment of Opioid Dependence: A 12-Week Conversion Study.. Clinical therapeutics 37(5), 1064-75 DOI: 10.1016/j.clinthera.2015.02.027 "},{"Codes":[],"Outcomes":[],"ItemId":98282185,"Title":"Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.","ParentTitle":"The journal of pain","ShortTitle":"Sullivan (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"March","StandardNumber":"1526-5900 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"18","Pages":"308-318","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"27908840","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan MD ; Turner JA ; DiLodovico C ; D'Appollonio A ; Stephens K ; Chan YF ; ","ParentAuthors":"","DOI":"10.1016/j.jpain.2016.11.003 ","Keywords":"Adult\r\nAged\r\nAnalgesics, Opioid/*therapeutic use\r\nAnxiety Disorders/etiology\r\nChronic Pain/*drug therapy/psychology\r\nDrug Administration Schedule\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/drug therapy/prevention & control/psychology\r\nOutcome Assessment, Health Care\r\n*Outpatients\r\nPain Measurement\r\nPilot Projects\r\nPrescription Drug Misuse/statistics & numerical data\r\nSelf Care/*methods\r\nTreatment Outcome\r\nChronic opioid therapy\r\nopioid dose taper\r\npain intensity\r\npain interference\r\npain self-management","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan MD, Turner JA, DiLodovico C, D'Appollonio A, Stephens K, and Chan YF (2017) Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.. The journal of pain 18(3), 308-318 DOI: 10.1016/j.jpain.2016.11.003 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032086,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282522,"Title":"Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.","ParentTitle":"The American journal of psychiatry","ShortTitle":"Sullivan (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"May","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"174","Pages":"459-467","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"28068780","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan M ; Bisaga A ; Pavlicova M ; Choi CJ ; Mishlen K ; Carpenter KM ; Levin FR ; Dakwar E ; Mariani JJ ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.2016.16050548 ","Keywords":"Administration, Oral\r\nAdolescent\r\nAdult\r\n*Ambulatory Care\r\nBehavior Therapy\r\nBuprenorphine/*administration & dosage\r\nClonidine/administration & dosage\r\nCombined Modality Therapy\r\nDelayed-Action Preparations\r\nDose-Response Relationship, Drug\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nNaltrexone/*administration & dosage\r\nOpioid-Related Disorders/*rehabilitation\r\nRemission Induction\r\nSecondary Prevention\r\nYoung Adult\r\nBuprenorphine\r\nDetoxification\r\nInjectable Naltrexone\r\nNaltrexone\r\nOpioid Dependence\r\nOutpatient","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, and Nunes EV (2017) Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.. The American journal of psychiatry 174(5), 459-467 DOI: 10.1176/appi.ajp.2016.16050548 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948266,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15032086,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281151,"Title":"Outpatient transition to extended-release naltrexone in patients with opioid-use disorder","ParentTitle":"American Journal on Addictions","ShortTitle":"Sullivan (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1521-0391","City":"","Country":"","Publisher":"","Institution":"M. Sullivan, Alkermes, Ireland","Volume":"27","Pages":"323","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L623398556&from=export http://dx.doi.org/10.1111/ajad.12753","OldItemId":"","Comments":"2018-08-14","TypeName":"Journal, Article","Authors":"Sullivan M ; Mannelli P ; Yu M ; Nangia N ; Graham C ; Webster I ; Andrew Tompkins ; D  ; Kosten T ; Akerman S ; Silverman B ; ","ParentAuthors":"","DOI":"10.1111/ajad.12753","Keywords":"buprenorphine\r\nclonazepam\r\nclonidine\r\nnaltrexone\r\nopiate\r\nplacebo\r\ntrazodone\r\nadult\r\nadverse event\r\nanxiety\r\nconference abstract\r\nconsensus\r\ncontrolled study\r\ncounseling\r\ndetoxification\r\ndiarrhea\r\ndouble blind procedure\r\ndrug combination\r\ndrug safety\r\ndrug therapy\r\ndrug withdrawal\r\nfemale\r\nfollow up\r\nhuman\r\nhuman tissue\r\ninjection\r\nmale\r\nnausea\r\nopiate addiction\r\noutpatient\r\npharmacokinetics\r\nphase 3 clinical trial (topic)\r\npotential difference\r\nrandomized controlled trial (topic)\r\nrelapse\r\nsubstance use\r\nsystematic review\r\ntitrimetry\r\nurine sampling\r\nvisually impaired person\r\nvital sign\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan M, Mannelli P, Yu M, Nangia N, Graham C, Webster I, Andrew Tompkins, D , Kosten T, Akerman S, and Silverman B (2018) Outpatient transition to extended-release naltrexone in patients with opioid-use disorder. American Journal on Addictions 27(4), 323 DOI: 10.1111/ajad.12753"},{"Codes":[{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282553,"Title":"A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.","ParentTitle":"The American journal of psychiatry","ShortTitle":"Sullivan (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"February","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"176","Pages":"129-137","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"30336703","Comments":"","TypeName":"Journal, Article","Authors":"Sullivan MA ; Bisaga A ; Pavlicova M ; Carpenter KM ; Choi CJ ; Mishlen K ; Levin FR ; Mariani JJ ; Nunes EV ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.2018.17070732 ","Keywords":"Administration, Oral\r\nAdult\r\n*Behavior Therapy\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMedication Adherence\r\nMiddle Aged\r\nNaltrexone/*administration & dosage/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/therapeutic use\r\nOpioid-Related Disorders/*rehabilitation\r\nRecurrence\r\nTreatment Outcome\r\nInjection Naltrexone\r\nOpioid Antagonist\r\nOpioid Use Disorder\r\nOral Naltrexone\r\nTreatment Retention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, and Nunes EV (2019) A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.. The American journal of psychiatry 176(2), 129-137 DOI: 10.1176/appi.ajp.2018.17070732 "},{"Codes":[{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282692,"Title":"Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis.","ParentTitle":"BMJ open","ShortTitle":"Sun (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"January","StandardNumber":"2044-6055 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"5","Pages":"e005997","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"25573521","Comments":"","TypeName":"Journal, Article","Authors":"Sun HM ; Li XY ; Chow EP ; Li T ; Xian Y ; Lu YH ; Tian T ; Zhuang X ; Zhang L ; ","ParentAuthors":"","DOI":"10.1136/bmjopen-2014-005997 ","Keywords":"Adolescent\r\nAdult\r\nChina\r\nCrime/*statistics & numerical data\r\nDrug Users/*psychology\r\nEmployment/statistics & numerical data\r\nFemale\r\nHumans\r\nInterpersonal Relations\r\n*Maintenance Chemotherapy\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nSocial Skills\r\nYoung Adult\r\nPUBLIC HEALTH","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Sun HM, Li XY, Chow EP, Li T, Xian Y, Lu YH, Tian T, Zhuang X, and Zhang L (2015) Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis.. BMJ open 5(1), e005997 DOI: 10.1136/bmjopen-2014-005997 "},{"Codes":[{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98285178,"Title":"Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial.","ParentTitle":"Journal of perinatology : official journal of the California Perinatal Association","ShortTitle":"Surran (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"December","StandardNumber":"0743-8346 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"33","Pages":"954-9","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"23949834","Comments":"","TypeName":"Journal, Article","Authors":"Surran B ; Visintainer P ; Chamberlain S ; Kopcza K ; Shah B ; Singh R ; ","ParentAuthors":"","DOI":"10.1038/jp.2013.95 ","Keywords":"Adrenergic alpha-2 Receptor Agonists/administration & dosage/*therapeutic use\r\nAnalgesics, Opioid/administration & dosage/*adverse effects\r\nAnalysis of Variance\r\nClonidine/administration & dosage/*therapeutic use\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMale\r\nMorphine/*administration & dosage\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nPhenobarbital/*therapeutic use\r\nProspective Studies","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Surran B, Visintainer P, Chamberlain S, Kopcza K, Shah B, and Singh R (2013) Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial.. Journal of perinatology : official journal of the California Perinatal Association 33(12), 954-9 DOI: 10.1038/jp.2013.95 "},{"Codes":[],"Outcomes":[],"ItemId":98282191,"Title":"Extended-release intramuscular naltrexone (VIVITROL): a review of its use in the prevention of relapse to opioid dependence in detoxified patients.","ParentTitle":"CNS drugs","ShortTitle":"Syed (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"October","StandardNumber":"1172-7047 (Linking)","City":"New Zealand","Country":"","Publisher":"","Institution":"","Volume":"27","Pages":"851-61","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"24018540","Comments":"","TypeName":"Journal, Article","Authors":"Syed YY ; Keating GM ; ","ParentAuthors":"","DOI":"10.1007/s40263-013-0110-x ","Keywords":"Adult\r\nDelayed-Action Preparations\r\nDrug Administration Schedule\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/*administration & dosage/pharmacokinetics/*therapeutic use\r\nNarcotic Antagonists/*administration & dosage/pharmacokinetics/*therapeutic use\r\nOpioid-Related Disorders/drug therapy/*prevention & control\r\nSecondary Prevention","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Syed YY, and Keating GM (2013) Extended-release intramuscular naltrexone (VIVITROL): a review of its use in the prevention of relapse to opioid dependence in detoxified patients.. CNS drugs 27(10), 851-61 DOI: 10.1007/s40263-013-0110-x "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948197,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288267,"Title":"Systematic review and Meta-analysis: Comparative Efficacy and Tolerability of Medications for Opioid Use Disorder in Youth","ParentTitle":"","ShortTitle":"Systematic review and... (Ozge)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42023389609","Comments":"","TypeName":"Journal, Article","Authors":"Ozge Amuk Williams; Sadiq Naveed ; Nauman Ashraf ; Sahar Ashraf ; Aliza Bukhari ; Mohsan Ali ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ozge Amuk Williams, Sadiq Naveed, Nauman Ashraf, Sahar Ashraf, Aliza Bukhari, and Mohsan Ali (    ) Systematic review and Meta-analysis: Comparative Efficacy and Tolerability of Medications for Opioid Use Disorder in Youth.  , "},{"Codes":[{"AttributeId":14948197,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288265,"Title":"Systematic Review of the Impact of Opioid Agonist Therapies on Pregnancy Outcomes for Pregnant People with Opioid Use Disorder","ParentTitle":"","ShortTitle":"Systematic Review of... (Lindsay)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42022332082","Comments":"","TypeName":"Journal, Article","Authors":"Lindsay Wilson ; Preet Gandhi ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Lindsay Wilson, and Preet Gandhi (    ) Systematic Review of the Impact of Opioid Agonist Therapies on Pregnancy Outcomes for Pregnant People with Opioid Use Disorder.  , "},{"Codes":[],"Outcomes":[],"ItemId":98283078,"Title":"A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.","ParentTitle":"Journal of opioid management","ShortTitle":"Tacke (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"November","StandardNumber":"1551-7489 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"5","Pages":"321-9","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"20073406","Comments":"","TypeName":"Journal, Article","Authors":"Tacke U ; Uosukainen H ; Kananen M ; Kontra K ; Pentiknen H ; ","ParentAuthors":"","DOI":"10.5055/jom.2009.0032 ","Keywords":"Adult\r\nAmbulatory Care\r\nAnalgesics, Opioid/*administration & dosage\r\nBuprenorphine/*administration & dosage\r\nBuprenorphine, Naloxone Drug Combination\r\nCost-Benefit Analysis\r\nCounseling\r\nDrug Administration Schedule\r\nDrug Therapy, Computer-Assisted/*economics/methods\r\nElectronics, Medical/*economics\r\nFeasibility Studies\r\nFemale\r\nHumans\r\nMale\r\n*Medication Adherence\r\nNaloxone/*administration & dosage\r\nNarcotic Antagonists/*administration & dosage\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Satisfaction\r\nPilot Projects\r\nSurveys and Questionnaires\r\nTime Factors\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tacke U, Uosukainen H, Kananen M, Kontra K, and Pentiknen H (2009) A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination.. Journal of opioid management 5(6), 321-9 DOI: 10.5055/jom.2009.0032 "},{"Codes":[{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282490,"Title":"Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).","ParentTitle":"Contemporary clinical trials","ShortTitle":"Talal (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"January","StandardNumber":"1551-7144 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"112","Pages":"106632","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34813962","Comments":"","TypeName":"Journal, Article","Authors":"Talal AH ; Markatou M ; Sofikitou EM ; Brown LS ; Perumalswami P ; Dinani A ; Tobin JN ; ","ParentAuthors":"","DOI":"10.1016/j.cct.2021.106632 ","Keywords":"Antiviral Agents/therapeutic use\r\nHepacivirus/genetics\r\n*Hepatitis C/drug therapy/epidemiology\r\n*Hepatitis C, Chronic/drug therapy/epidemiology\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/complications/drug therapy\r\nPatient-Centered Care\r\nProspective Studies\r\n*Telemedicine\r\nHepatitis C virus\r\nPersons with opioid use disorder\r\nPragmatic clinical trial\r\nStepped-wedge design\r\nTelemedicine","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, and Tobin JN (2022) Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).. Contemporary clinical trials 112, 106632 DOI: 10.1016/j.cct.2021.106632 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948304,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282657,"Title":"Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.","ParentTitle":"JAMA psychiatry","ShortTitle":"Tanum (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"December","StandardNumber":"2168-622X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"74","Pages":"1197-1205","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"29049469","Comments":"","TypeName":"Journal, Article","Authors":"Tanum L ; Solli KK ; Latif ZE ; Benth J ; Opheim A ; Sharma-Haase K ; Krajci P ; Kune N ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2017.3206 ","Keywords":"Administration, Oral\r\nAdult\r\n*Buprenorphine, Naloxone Drug Combination/administration & \r\n      dosage/pharmacokinetics\r\nDelayed-Action Preparations\r\nDiagnostic and Statistical Manual of Mental Disorders\r\nDrug Monitoring/methods\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\n*Naloxone/administration & dosage/pharmacokinetics\r\nNarcotic Antagonists/administration & dosage/pharmacokinetics\r\nOpiate Substitution Treatment/*methods\r\n*Opioid-Related Disorders/diagnosis/drug therapy\r\nPsychiatric Status Rating Scales\r\nSubstance Abuse Detection/methods\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tanum L, Solli KK, Latif ZE, Benth J, Opheim A, Sharma-Haase K, Krajci P, and Kune N (2017) Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.. JAMA psychiatry 74(12), 1197-1205 DOI: 10.1001/jamapsychiatry.2017.3206 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281944,"Title":"Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature.","ParentTitle":"BMJ supportive & palliative care","ShortTitle":"Taveros (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"December","StandardNumber":"2045-435X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"7","Pages":"383-389","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"27566722","Comments":"","TypeName":"Journal, Article","Authors":"Taveros MC ; Chuang EJ ; ","ParentAuthors":"","DOI":"10.1136/bmjspcare-2016-001126 ","Keywords":"Analgesics, Opioid/*therapeutic use\r\nHumans\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/drug therapy\r\nPain Management/*methods\r\nCancer\r\nMethadone maintenance\r\nPain\r\nopioid addiction\r\npalliative care","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Taveros MC, and Chuang EJ (2017) Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature.. BMJ supportive & palliative care 7(4), 383-389 DOI: 10.1136/bmjspcare-2016-001126 "},{"Codes":[],"Outcomes":[],"ItemId":98281592,"Title":"Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Taylor (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"L.E. Taylor, The Warren Alpert Medical School of Brown University, The Miriam Hospital, Center for AIDS Research, Building 156, 164 Summit Avenue, Providence, RI 02906, United States","Volume":"116","Pages":"233-237","Edition":"","Issue":"1-3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L51199239&from=export http://dx.doi.org/10.1016/j.drugalcdep.2010.11.016","OldItemId":"","Comments":"2011-06-14","TypeName":"Journal, Article","Authors":"Taylor L E; Bowman S E; Chapman S ; Zaller N ; Stein M D; Cioe P A; Maynard M A; McGovern B H; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2010.11.016","Keywords":"methadone\r\npeginterferon alpha2a\r\npsychotropic agent\r\nribavirin\r\nvirus RNA\r\nzidovudine\r\nadult\r\nanemia\r\nanxiety disorder\r\narticle\r\nCD4 lymphocyte count\r\nclinical article\r\nclinical trial\r\ndrug dependence\r\ndrug efficacy\r\ndrug withdrawal\r\nevening dosage\r\nfemale\r\ngenotype\r\nhepatitis C\r\nhighly active antiretroviral therapy\r\nhuman\r\nHuman immunodeficiency virus infection\r\nliver fibrosis\r\nmale\r\nmania\r\nmental disease\r\nmethadone treatment\r\ncoinfection\r\nmorning dosage\r\nmulticenter study\r\npatient compliance\r\npneumonia\r\npriority journal\r\nprospective study\r\nretinopathy\r\nsubstance abuse\r\nsuicidal ideation\r\ncopegus\r\npegasys","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Taylor L E, Bowman S E, Chapman S, Zaller N, Stein M D, Cioe P A, Maynard M A, and McGovern B H (2011) Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug and Alcohol Dependence 116(1-3), 233-237 DOI: 10.1016/j.drugalcdep.2010.11.016"},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948145,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282007,"Title":"Opioid Detoxification During Pregnancy: A Systematic Review.","ParentTitle":"Obstetrics and gynecology","ShortTitle":"Terplan (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"May","StandardNumber":"0029-7844 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"131","Pages":"803-814","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"29630016","Comments":"","TypeName":"Journal, Article","Authors":"Terplan M ; Laird HJ ; Hand DJ ; Wright TE ; Premkumar A ; Martin CE ; Meyer MC ; Jones HE ; Krans EE ; ","ParentAuthors":"","DOI":"10.1097/AOG.0000000000002562 ","Keywords":"Female\r\nHumans\r\nInfant, Newborn\r\n*Opiate Substitution Treatment/adverse effects/methods/statistics & numerical \r\n      data\r\nOpioid-Related Disorders/*therapy\r\nPregnancy\r\nPregnancy Complications/*therapy\r\nPregnancy Outcome\r\nPrenatal Care/*methods\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, and Krans EE (2018) Opioid Detoxification During Pregnancy: A Systematic Review.. Obstetrics and gynecology 131(5), 803-814 DOI: 10.1097/AOG.0000000000002562 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019719,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281547,"Title":"Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Tetrault (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"","StandardNumber":"1873-6483","City":"","Country":"","Publisher":"","Institution":"J.M. Tetrault, Yale University School of Medicine, Section of General Internal Medicine, 367 Cedar Street, New Haven, CT 06510, United States","Volume":"43","Pages":"433-439","Edition":"","Issue":"4","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52181936&from=export http://dx.doi.org/10.1016/j.jsat.2012.07.011","OldItemId":"","Comments":"2012-11-12","TypeName":"Journal, Article","Authors":"Tetrault J M; Moore B A; Barry D T; O'Connor P G; Schottenfeld R ; Fiellin D A; Fiellin L E; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2012.07.011","Keywords":"NCT00317460\r\nantiretrovirus agent\r\nbuprenorphine plus naloxone\r\nadult\r\narticle\r\nCD4 lymphocyte count\r\nclinical article\r\ncontrolled study\r\ncounseling\r\ndisease duration\r\ndrug abuse\r\nfemale\r\nfollow up\r\nhighly active antiretroviral therapy\r\nhuman\r\nHuman immunodeficiency virus\r\nHuman immunodeficiency virus infected patient\r\nHuman immunodeficiency virus infection\r\nmale\r\nopiate addiction\r\npatient compliance\r\npriority journal\r\nrandomized controlled trial\r\nvirus load","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tetrault J M, Moore B A, Barry D T, O'Connor P G, Schottenfeld R, Fiellin D A, and Fiellin L E (2012) Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal of Substance Abuse Treatment 43(4), 433-439 DOI: 10.1016/j.jsat.2012.07.011"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948318,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948139,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98288252,"Title":"The comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder","ParentTitle":"","ShortTitle":"The comparative effectiveness... (Danielle)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"    ","Month":"","StandardNumber":"","City":"","Country":"","Publisher":"","Institution":"","Volume":"","Pages":"","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"CRD42018090761","Comments":"","TypeName":"Journal, Article","Authors":"Danielle Rice ; Kimberly Corace ; Beth Sproule ; Patricia Poulin ; Becky Skidmore ; Leila Esmaeilisaraji ; Fatemeh Yazadi ; David Moher ; Brian Hutton ; Gary Garber ; Sheena Taha ; Amy Porath ; Melanie Willows ; Gordon Garner ; Donna May ; ","ParentAuthors":"","DOI":"","Keywords":"","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Danielle Rice, Kimberly Corace, Beth Sproule, Patricia Poulin, Becky Skidmore, Leila Esmaeilisaraji, Fatemeh Yazadi, David Moher, Brian Hutton, Gary Garber, Sheena Taha, Amy Porath, Melanie Willows, Gordon Garner, and Donna May (    ) The comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder.  , "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948135,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281478,"Title":"Medication-assisted treatment with buprenorphine: Assessing the evidence","ParentTitle":"Psychiatric Services","ShortTitle":"Thomas (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1557-9700","City":"","Country":"","Publisher":"","Institution":"C.P. Thomas, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States","Volume":"65","Pages":"158-170","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L372333626&from=export http://dx.doi.org/10.1176/appi.ps.201300256","OldItemId":"","Comments":"2014-02-21","TypeName":"Journal, Article","Authors":"Thomas C P; Fullerton C A; Kim M ; Montejano L ; Lyman D R; Dougherty R H; Daniels A S; Ghose S S; Delphin-Rittmon M E; ","ParentAuthors":"","DOI":"10.1176/appi.ps.201300256","Keywords":"buprenorphine\r\nmethadone\r\nnaloxone\r\nopiate\r\nplacebo\r\narticle\r\nbehavior therapy\r\ncrossover procedure\r\nfetus outcome\r\nfollow up\r\nhuman\r\nmaintenance therapy\r\nMedline\r\nmethadone treatment\r\nopiate addiction\r\npatient satisfaction\r\nposttraumatic stress disorder\r\npregnancy\r\nPsycINFO\r\nquasi experimental study\r\nrandomized controlled trial (topic)\r\nsocial work\r\nsociology\r\nsystematic review\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Thomas C P, Fullerton C A, Kim M, Montejano L, Lyman D R, Dougherty R H, Daniels A S, Ghose S S, and Delphin-Rittmon M E (2014) Medication-assisted treatment with buprenorphine: Assessing the evidence. Psychiatric Services 65(2), 158-170 DOI: 10.1176/appi.ps.201300256"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948148,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282053,"Title":"The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder.","ParentTitle":"Journal of managed care & specialty pharmacy","ShortTitle":"Tice (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"April","StandardNumber":"2376-0540 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"27","Pages":"528-532","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"33769860","Comments":"","TypeName":"Journal, Article","Authors":"Tice JA ; Whittington MD ; Campbell JD ; Pearson SD ; ","ParentAuthors":"","DOI":"10.18553/jmcp.2021.27.4.528 ","Keywords":"Cost-Benefit Analysis\r\nHumans\r\nModels, Economic\r\nOpiate Substitution Treatment/*economics\r\nOpioid-Related Disorders/*drug therapy/economics\r\nTelemedicine/*economics\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tice JA, Whittington MD, Campbell JD, and Pearson SD (2021) The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder.. Journal of managed care & specialty pharmacy 27(4), 528-532 DOI: 10.18553/jmcp.2021.27.4.528 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282809,"Title":"Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.","ParentTitle":"The American journal of psychiatry","ShortTitle":"Tiihonen (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"May","StandardNumber":"0002-953X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"169","Pages":"531-6","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"22764364","Comments":"","TypeName":"Journal, Article","Authors":"Tiihonen J ; Krupitsky E ; Verbitskaya E ; Blokhina E ; Mamontova O ; Fhr J ; Tuomola P ; Kuoppasalmi K ; Kiviniemi V ; Zwartau E ; ","ParentAuthors":"","DOI":"10.1176/appi.ajp.2011.11071121 ","Keywords":"Adult\r\nAmphetamine-Related Disorders/complications/drug therapy\r\nDouble-Blind Method\r\nDrug Implants\r\nFemale\r\nHeroin Dependence/complications/drug therapy\r\nHumans\r\nMale\r\nNaltrexone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nSubstance-Related Disorders/*drug therapy\r\nTreatment Outcome\r\nUnsafe Sex/drug effects","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Fhr J, Tuomola P, Kuoppasalmi K, Kiviniemi V, and Zwartau E (2012) Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.. The American journal of psychiatry 169(5), 531-6 DOI: 10.1176/appi.ajp.2011.11071121 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948287,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948313,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281393,"Title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","ParentTitle":"Journal of Addictive Diseases","ShortTitle":"Timko (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"","StandardNumber":"1055-0887","City":"","Country":"","Publisher":"","Institution":"C. Timko, Center for Innovation to Implementation, VA Health Care System (152-MPD), 795 Willow Road, Menlo Park, CA, United States","Volume":"35","Pages":"22-35","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L607321703&from=export http://dx.doi.org/10.1080/10550887.2016.1100960","OldItemId":"","Comments":"2016-02-04","TypeName":"Journal, Article","Authors":"Timko C ; Schultz N R; Cucciare M A; Vittorio L ; Garrison-Diehn C ; ","ParentAuthors":"","DOI":"10.1080/10550887.2016.1100960","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nmethadone\r\nnaltrexone\r\nplacebo\r\nbehavior therapy\r\nChinese medicine\r\ncognitive therapy\r\ncounseling\r\nfollow up\r\nhuman\r\nopiate addiction\r\nreview\r\nsystematic review\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Timko C, Schultz N R, Cucciare M A, Vittorio L, and Garrison-Diehn C (2016) Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases 35(1), 22-35 DOI: 10.1080/10550887.2016.1100960"},{"Codes":[],"Outcomes":[],"ItemId":98279903,"Title":"Patient satisfaction with buprenorphine or methadone for treatment of opioid use disorder during obstetric care","ParentTitle":"American Journal of Obstetrics and Gynecology","ShortTitle":"Trammel (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"","StandardNumber":"0002-9378","City":"","Country":"","Publisher":"","Institution":"","Volume":"228","Pages":"S284-S285","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2022102044&from=export http://dx.doi.org/10.1016/j.ajog.2022.11.506","OldItemId":"","Comments":"2023-01-12","TypeName":"Journal, Article","Authors":"Trammel C ; Lawlor M L; Jacobsen H ; Mills M ; Krauss M ; Galati B ; Raghuraman N ; Carter E B; Odibo A O; Kelly J C; ","ParentAuthors":"","DOI":"10.1016/j.ajog.2022.11.506","Keywords":"buprenorphine\r\nmethadone\r\nopiate\r\nadult\r\nadverse drug reaction\r\nclinical article\r\nconference abstract\r\ncontrolled study\r\ndemographics\r\ndrug therapy\r\nfemale\r\nhuman\r\nLikert scale\r\nobstetric procedure\r\nopiate addiction\r\npatient satisfaction\r\npregnancy\r\npuerperium\r\nside effect\r\ntitrimetry","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Trammel C, Lawlor M L, Jacobsen H, Mills M, Krauss M, Galati B, Raghuraman N, Carter E B, Odibo A O, and Kelly J C (2023) Patient satisfaction with buprenorphine or methadone for treatment of opioid use disorder during obstetric care. American Journal of Obstetrics and Gynecology 228(1), S284-S285 DOI: 10.1016/j.ajog.2022.11.506"},{"Codes":[],"Outcomes":[],"ItemId":98281230,"Title":"Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women","ParentTitle":"Pharmacotherapy","ShortTitle":"Tran (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"","StandardNumber":"0277-0008","City":"","Country":"","Publisher":"","Institution":"T.H. Tran, Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL, United States","Volume":"37","Pages":"824-839","Edition":"","Issue":"7","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L617183348&from=export http://dx.doi.org/10.1002/phar.1958","OldItemId":"","Comments":"2017-08-01","TypeName":"Journal, Article","Authors":"Tran T H; Griffin B L; Stone R H; Vest K M; Todd T J; ","ParentAuthors":"","DOI":"10.1002/phar.1958","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nopiate\r\nbehavior\r\nbreast feeding\r\nclinical study\r\ndevelopment\r\ndrug efficacy\r\nfemale\r\nFood and Drug Administration\r\nhuman\r\nmeta analysis\r\nneonatal abstinence syndrome\r\nnonhuman\r\nopiate addiction\r\npregnancy\r\npregnant woman\r\nrandomized controlled trial (topic)\r\nreview\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tran T H, Griffin B L, Stone R H, Vest K M, and Todd T J (2017) Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Pharmacotherapy 37(7), 824-839 DOI: 10.1002/phar.1958"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280401,"Title":"Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy","ParentTitle":"American Journal of Drug and Alcohol Abuse","ShortTitle":"Tsai (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"","StandardNumber":"0095-2990","City":"","Country":"","Publisher":"","Institution":"T.-Y. Wang, Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan","Volume":"47","Pages":"330-343","Edition":"","Issue":"3","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2010152590&from=export http://dx.doi.org/10.1080/00952990.2020.1849247","OldItemId":"","Comments":"2021-01-20","TypeName":"Journal, Article","Authors":"Tsai T Y; Wang T Y; Liu Y C; Lee P W; Chang W H; Lu T H; Tseng H H; Lee S Y; Chang Y H; Yang Y ; Chen P S; Chen K C; Yang Y K; Lu R B; ","ParentAuthors":"","DOI":"10.1080/00952990.2020.1849247","Keywords":"NCT03229642\r\ndrug rapid test\r\ndiamorphine\r\nmethadone\r\narticle\r\nattention\r\nBarratt Impulsiveness Scale\r\nclinical article\r\nclinical outcome\r\ncontinuous performance test\r\ndepression\r\ndorsolateral prefrontal cortex\r\ndouble blind procedure\r\ndrug craving\r\ndrug metabolism\r\ndrug urine level\r\nfemale\r\nfollow up\r\nHamilton Depression Rating Scale\r\nheroin dependence\r\nhuman\r\nimpulsiveness\r\nmale\r\nmethadone treatment\r\nopiate addiction\r\npilot study\r\nquestionnaire\r\nrepetitive transcranial magnetic stimulation\r\nside effect\r\ntreatment outcome\r\nurinalysis\r\nvisual analog scale","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tsai T Y, Wang T Y, Liu Y C, Lee P W, Chang W H, Lu T H, Tseng H H, Lee S Y, Chang Y H, Yang Y, Chen P S, Chen K C, Yang Y K, and Lu R B (2021) Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy. American Journal of Drug and Alcohol Abuse 47(3), 330-343 DOI: 10.1080/00952990.2020.1849247"},{"Codes":[{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281871,"Title":"A qualitative meta-synthesis of pregnant women's experiences of accessing and receiving treatment for opioid use disorder.","ParentTitle":"Drug and alcohol review","ShortTitle":"Tsuda-McCaie (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"May","StandardNumber":"0959-5236 (Linking)","City":"Australia","Country":"","Publisher":"","Institution":"","Volume":"41","Pages":"851-862","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"35038366","Comments":"","TypeName":"Journal, Article","Authors":"Tsuda-McCaie F ; Kotera Y ; ","ParentAuthors":"","DOI":"10.1111/dar.13421 ","Keywords":"Female\r\nHumans\r\nMothers\r\n*Opioid-Related Disorders/therapy\r\nPregnancy\r\n*Pregnant Women/psychology\r\nQualitative Research\r\nSocial Stigma\r\nmedication-assisted treatment\r\nmeta-analysis\r\nopioid use disorder\r\npregnancy\r\nsubstance use treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tsuda-McCaie F, and Kotera Y (2022) A qualitative meta-synthesis of pregnant women's experiences of accessing and receiving treatment for opioid use disorder.. Drug and alcohol review 41(4), 851-862 DOI: 10.1111/dar.13421 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282411,"Title":"Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Tsui (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"October","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"227","Pages":"108917","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34399136","Comments":"","TypeName":"Journal, Article","Authors":"Tsui JI ; Leroux BG ; Radick AC ; Schramm ZA ; Blalock K ; Labelle C ; Heerema M ; Klein JW ; Merrill JO ; Saxon AJ ; Samet JH ; Kim TW ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.108917 ","Keywords":"Adult\r\n*Buprenorphine/therapeutic use\r\nDirectly Observed Therapy\r\nFemale\r\nHumans\r\nMale\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nPilot Projects\r\nBuprenorphine\r\nDirectly-observed therapy\r\nMedication adherence\r\nMobile health\r\nOpioid related disorders\r\nmHealth","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tsui JI, Leroux BG, Radick AC, Schramm ZA, Blalock K, Labelle C, Heerema M, Klein JW, Merrill JO, Saxon AJ, Samet JH, and Kim TW (2021) Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial.. Drug and alcohol dependence 227, 108917 DOI: 10.1016/j.drugalcdep.2021.108917 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282519,"Title":"Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Tsui (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"July","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"236","Pages":"109469","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"35605529","Comments":"","TypeName":"Journal, Article","Authors":"Tsui JI ; Campbell ANC ; Pavlicova M ; Choo TH ; Lee JD ; Cook RR ; Shulman M ; Nunes EV ; Rotrosen J ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2022.109469 ","Keywords":"*Buprenorphine/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\n*Methamphetamine/adverse effects\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nAmphetamine use\r\nMethamphetamine use\r\nOpioid use disorder\r\nSubstance use treatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Tsui JI, Campbell ANC, Pavlicova M, Choo TH, Lee JD, Cook RR, Shulman M, Nunes EV, and Rotrosen J (2022) Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.. Drug and alcohol dependence 236, 109469 DOI: 10.1016/j.drugalcdep.2022.109469 "},{"Codes":[{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948254,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019721,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282632,"Title":"Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.","ParentTitle":"Substance use & misuse","ShortTitle":"Verthein (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"","StandardNumber":"1082-6084 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"980-91","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"21235340","Comments":"","TypeName":"Journal, Article","Authors":"Verthein U ; Haasen C ; Reimer J ; ","ParentAuthors":"","DOI":"10.3109/10826084.2010.540624 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\nDrug Substitution\r\nFemale\r\nHeroin/*therapeutic use\r\nHeroin Dependence/*drug therapy/rehabilitation\r\nHumans\r\nMale\r\nMethadone/*therapeutic use\r\nMiddle Aged\r\nNarcotics/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Verthein U, Haasen C, and Reimer J (2011) Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.. Substance use & misuse 46(8), 980-91 DOI: 10.3109/10826084.2010.540624 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948263,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280683,"Title":"Adherence to and Retention in Medications for Opioid Use Disorder among Adolescents and Young Adults","ParentTitle":"Epidemiologic Reviews","ShortTitle":"Viera (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"","StandardNumber":"0193-936X","City":"","Country":"","Publisher":"","Institution":"A. Viera, Yale School of Public Health, Department of Social and Behavioral Sciences, 60 College Street, New Haven, CT, United States","Volume":"42","Pages":"41-56","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2011810561&from=export http://dx.doi.org/10.1093/epirev/mxaa001","OldItemId":"","Comments":"2021-09-28","TypeName":"Journal, Article","Authors":"Viera A ; Bromberg D J; Whittaker S ; Refsland B M; Stanojlovi M ; Nyhan K ; Altice F L; ","ParentAuthors":"","DOI":"10.1093/epirev/mxaa001","Keywords":"buprenorphine\r\nmethadone\r\nnaltrexone\r\nadolescent\r\nadult\r\nchild\r\ncontrolled study\r\nfamily conflict\r\nhuman\r\nmedication compliance\r\nopiate addiction\r\noutcome variable\r\npatient compliance\r\npriority journal\r\npublication bias\r\nquality control\r\nreview\r\nsystematic review\r\nyoung adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Viera A, Bromberg D J, Whittaker S, Refsland B M, Stanojlovi M, Nyhan K, and Altice F L (2020) Adherence to and Retention in Medications for Opioid Use Disorder among Adolescents and Young Adults. Epidemiologic Reviews 42(1), 41-56 DOI: 10.1093/epirev/mxaa001"},{"Codes":[],"Outcomes":[],"ItemId":98283426,"Title":"The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial.","ParentTitle":"Substance abuse treatment, prevention, and policy","ShortTitle":"Vold (2023)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2023","Month":"April","StandardNumber":"1747-597X (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"18","Pages":"25","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"37095561","Comments":"","TypeName":"Journal, Article","Authors":"Vold JH ; Chalabianloo F ; Lberg EM ; Aas CF ; Lim AG ; Vickerman P ; Johansson KA ; Fadnes LT ; ","ParentAuthors":"","DOI":"10.1186/s13011-023-00534-1 ","Keywords":"Humans\r\nHepacivirus\r\n*Hepatitis C, Chronic/drug therapy\r\nAntiviral Agents\r\n*Drug Users\r\nOpiate Substitution Treatment\r\n*Hepatitis C/complications\r\nFatigue\r\n*Substance Abuse, Intravenous/complications\r\nFatigue\r\nHepatitis C virus infection\r\nIntegrated treatment\r\nOpioid agonist therapy\r\nSubstance-related disorders","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Vold JH, Chalabianloo F, Lberg EM, Aas CF, Lim AG, Vickerman P, Johansson KA, and Fadnes LT (2023) The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial.. Substance abuse treatment, prevention, and and policy 18(1), 25 DOI: 10.1186/s13011-023-00534-1 "},{"Codes":[],"Outcomes":[],"ItemId":98282846,"Title":"Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Walsh (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"May","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"162","Pages":"190-8","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"27012435","Comments":"","TypeName":"Journal, Article","Authors":"Walsh SL ; Nuzzo PA ; Babalonis S ; Casselton V ; Lofwall MR ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2016.03.005 ","Keywords":"Administration, Intranasal\r\nAdolescent\r\nAdult\r\nAnalgesics, Opioid\r\nBuprenorphine/*pharmacology\r\nBuprenorphine, Naloxone Drug Combination/*pharmacology\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*pharmacology\r\nNarcotic Antagonists/*pharmacology\r\nNarcotics\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*drug therapy\r\nOxycodone/pharmacology\r\nReinforcement, Psychology\r\nSelf Administration\r\nSubstance Withdrawal Syndrome/drug therapy\r\nYoung Adult\r\nAbuse\r\nBuprenorphine\r\nMisuse\r\nMu agonist\r\nOpioid\r\nOpioid withdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Walsh SL, Nuzzo PA, Babalonis S, Casselton V, and Lofwall MR (2016) Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.. Drug and alcohol dependence 162, 190-8 DOI: 10.1016/j.drugalcdep.2016.03.005 "},{"Codes":[],"Outcomes":[],"ItemId":98283001,"Title":"Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.","ParentTitle":"JAMA psychiatry","ShortTitle":"Walsh (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"September","StandardNumber":"2168-622X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"74","Pages":"894-902","Edition":"","Issue":"9","Availability":"","URL":"","OldItemId":"28655025","Comments":"","TypeName":"Journal, Article","Authors":"Walsh SL ; Comer SD ; Lofwall MR ; Vince B ; Levy-Cooperman N ; Kelsh D ; Coe MA ; Jones JD ; Nuzzo PA ; Tiberg F ; Sheldon B ; Kim S ; ","ParentAuthors":"","DOI":"10.1001/jamapsychiatry.2017.1874 ","Keywords":"Adolescent\r\nAdult\r\nAnalgesics, Opioid/antagonists & inhibitors\r\nBuprenorphine/adverse effects/pharmacokinetics/*therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nHydromorphone/*antagonists & inhibitors\r\nMale\r\nMiddle Aged\r\nNarcotic Antagonists/therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nSubstance Withdrawal Syndrome/drug therapy\r\nTreatment Outcome\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Walsh SL, Comer SD, Lofwall MR, Vince B, Levy-Cooperman N, Kelsh D, Coe MA, Jones JD, Nuzzo PA, Tiberg F, Sheldon B, and Kim S (2017) Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.. JAMA psychiatry 74(9), 894-902 DOI: 10.1001/jamapsychiatry.2017.1874 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282686,"Title":"Methadone maintenance treatment and cognitive function: a systematic review.","ParentTitle":"Current drug abuse reviews","ShortTitle":"Wang (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"September","StandardNumber":"1874-4737 (Linking)","City":"United Arab Emirates","Country":"","Publisher":"","Institution":"","Volume":"6","Pages":"220-30","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"23773088","Comments":"","TypeName":"Journal, Article","Authors":"Wang GY ; Wouldes TA ; Russell BR ; ","ParentAuthors":"","DOI":"10.2174/18744737112059990020 ","Keywords":"Cognition/*drug effects\r\nCognition Disorders/*chemically induced\r\nDose-Response Relationship, Drug\r\nHumans\r\nMethadone/administration & dosage/*adverse effects/pharmacokinetics\r\nOpiate Substitution Treatment/adverse effects/methods\r\nOpioid-Related Disorders/rehabilitation\r\nTime Factors","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang GY, Wouldes TA, and Russell BR (2013) Methadone maintenance treatment and cognitive function: a systematic review.. Current drug abuse reviews 6(3), 220-30 DOI: 10.2174/18744737112059990020 "},{"Codes":[{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281069,"Title":"Opioid detoxification during pregnancy: Systematic review and meta-analysis of maternal and neonatal outcomes","ParentTitle":"Obstetrics and Gynecology","ShortTitle":"Wang (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1873-233X","City":"","Country":"","Publisher":"","Institution":"M. Wang, University of Alabama at Birmingham, Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, Birmingham, AL, United States","Volume":"131","Pages":"197S","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L622555587&from=export","OldItemId":"","Comments":"2018-06-19","TypeName":"Journal, Article","Authors":"Wang M ; Kuper S ; Sims B ; Paddock C ; Williams-Glass T ; Harper L ; ","ParentAuthors":"","DOI":"","Keywords":"buprenorphine\r\nmethadone\r\nopiate\r\nadult\r\nCochrane Library\r\ncohort analysis\r\ncomparative effectiveness\r\nconference abstract\r\ncontrolled study\r\ndetoxification\r\ndrug efficacy\r\ndrug safety\r\ndrug therapy\r\nEmbase\r\nepidemic\r\nfemale\r\nhospital patient\r\nhuman\r\nmaintenance therapy\r\nMedline\r\nneonatal abstinence syndrome\r\nnewborn\r\noutpatient\r\npharmacokinetics\r\npregnancy disorder\r\npregnant woman\r\nprematurity\r\npublishing\r\nrandomized controlled trial (topic)\r\nrelapse\r\nrisk assessment\r\nrisk factor\r\nstillbirth\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang M, Kuper S, Sims B, Paddock C, Williams-Glass T, and Harper L (2018) Opioid detoxification during pregnancy: Systematic review and meta-analysis of maternal and neonatal outcomes. Obstetrics and Gynecology 131, 197S"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98280958,"Title":"Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes","ParentTitle":"American Journal of Perinatology","ShortTitle":"Wang (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0735-1631","City":"","Country":"","Publisher":"","Institution":"M.J. Wang, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, 1700 6th Avenue South Street 10270, Birmingham, AL, United States","Volume":"36","Pages":"581-587","Edition":"","Issue":"6","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L627444298&from=export http://dx.doi.org/10.1055/s-0038-1670680","OldItemId":"","Comments":"2019-05-20","TypeName":"Journal, Article","Authors":"Wang M J; Kuper S G; Sims B ; Paddock C S; Dantzler J ; Muir S ; Harper L M; ","ParentAuthors":"","DOI":"10.1055/s-0038-1670680","Keywords":"methadone\r\nopiate\r\nabstinence\r\nclinical effectiveness\r\ncomparative effectiveness\r\ndrug abuse\r\ndrug detoxification\r\nfailure to thrive\r\nhospital patient\r\nhuman\r\nintermethod comparison\r\nirritability\r\nmaintenance therapy\r\nmaternal abstinence\r\nmeta analysis\r\nneonatal abstinence syndrome\r\nopiate addiction\r\nopiate substitution treatment\r\noutpatient\r\nparameters concerning the fetus, newborn and pregnancy\r\npatient safety\r\nperinatal outcome\r\npregnancy\r\npremature labor\r\npriority journal\r\nrecurrence risk\r\nreview\r\nstillbirth\r\nsystematic review\r\ntreatment outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang M J, Kuper S G, Sims B, Paddock C S, Dantzler J, Muir S, and Harper L M (2019) Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes. American Journal of Perinatology 36(6), 581-587 DOI: 10.1055/s-0038-1670680"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15029243,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283045,"Title":"Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.","ParentTitle":"Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists","ShortTitle":"Wang (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"March","StandardNumber":"1758-5864 (Linking)","City":"Australia","Country":"","Publisher":"","Institution":"","Volume":"11","Pages":"e12344","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"30460781","Comments":"","TypeName":"Journal, Article","Authors":"Wang X ; Jiang H ; Zhao M ; Li J ; Gray F ; Sheng L ; Li Y ; Li X ; Ling W ; Li W ; Hao W ; ","ParentAuthors":"","DOI":"10.1111/appy.12344 ","Keywords":"Administration, Sublingual\r\nAdolescent\r\nAdult\r\nAnalgesics, Opioid/administration & dosage/adverse effects/*pharmacology\r\nBuprenorphine, Naloxone Drug Combination/administration & dosage/adverse \r\n      effects/*pharmacology\r\nChina\r\nDouble-Blind Method\r\nFemale\r\nHumans\r\nMale\r\nMiddle Aged\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\n*Outcome Assessment, Health Care\r\nYoung Adult\r\nPeople's Republic of China\r\nbuprenorphine-naloxone\r\nopiate dependence\r\nopiate substitution treatment\r\ntreatment efficacy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang X, Jiang H, Zhao M, Li J, Gray F, Sheng L, Li Y, Li X, Ling W, Li W, and Hao W (2019) Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists 11(1), e12344 DOI: 10.1111/appy.12344 "},{"Codes":[],"Outcomes":[],"ItemId":98281962,"Title":"Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder.","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Wang (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"July","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"472-477","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"32379516","Comments":"","TypeName":"Journal, Article","Authors":"Wang AL ; Shi Z ; Elman I ; Langleben DD ; ","ParentAuthors":"","DOI":"10.1080/00952990.2020.1741001 ","Keywords":"Adult\r\nAnalgesics, Opioid\r\nCigarette Smoking/*epidemiology\r\nCraving\r\nDelayed-Action Preparations\r\nFemale\r\nHumans\r\nInjections, Intramuscular\r\nMale\r\nMiddle Aged\r\nNaltrexone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nOpioid-Related Disorders/*drug therapy\r\nRecurrence\r\nRetrospective Studies\r\nTobacco Products\r\nYoung Adult\r\nOpioids\r\ncomorbid\r\nextended-release injectable naltrexone\r\nnicotine\r\nopioid addiction\r\nopioid antagonist\r\nsmoking","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang AL, Shi Z, Elman I, and Langleben DD (2020) Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder.. The American journal of drug and alcohol abuse 46(4), 472-477 DOI: 10.1080/00952990.2020.1741001 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282542,"Title":"Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.","ParentTitle":"Addiction biology","ShortTitle":"Wang (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"March","StandardNumber":"1355-6215 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"27","Pages":"e13112","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"34877769","Comments":"","TypeName":"Journal, Article","Authors":"Wang AL ; Shulman M ; Choo TH ; Pavlicova M ; Langleben DD ; Nunes EV ; Rotrosen J ; ","ParentAuthors":"","DOI":"10.1111/adb.13112 ","Keywords":"Buprenorphine, Naloxone Drug Combination/therapeutic use\r\n*Chronic Pain/drug therapy\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\nProspective Studies\r\nbuprenorphine-naloxone\r\ninjectable extended-release naltrexone\r\npain","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang AL, Shulman M, Choo TH, Pavlicova M, Langleben DD, Nunes EV, and Rotrosen J (2022) Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.. Addiction biology 27(2), e13112 DOI: 10.1111/adb.13112 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282068,"Title":"Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Wang (2024)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2024","Month":"January","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"42","Pages":"33-44","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"36655851","Comments":"","TypeName":"Journal, Article","Authors":"Wang K ; Shafique S ; Xiao D ; Walter SM ; Liu Y ; Piamjariyakul U ; Xie C ; ","ParentAuthors":"","DOI":"10.1080/10550887.2022.2131957 ","Keywords":"Humans\r\nFemale\r\nMale\r\n*Buprenorphine/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nNaloxone/therapeutic use\r\n*Opioid-Related Disorders/drug therapy/rehabilitation\r\nOpiate Substitution Treatment\r\nSex Characteristics\r\n*Depressive Disorder, Major\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nMethadone/therapeutic use\r\n*Substance Withdrawal Syndrome/drug therapy\r\nOpioid use disorder\r\nbuprenorphine\r\nclinical opiate withdrawal scale\r\nlinear mixed model\r\nmethadone\r\nsex differences","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wang K, Shafique S, Xiao D, Walter SM, Liu Y, Piamjariyakul U, and Xie C (2024) Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences.. Journal of addictive diseases 42(1), 33-44 DOI: 10.1080/10550887.2022.2131957 "},{"Codes":[{"AttributeId":15013977,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948325,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948136,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948138,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948140,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948141,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281980,"Title":"Methodological quality of guidelines for the management of opioid use disorder: A systematic review.","ParentTitle":"Journal of clinical pharmacy and therapeutics","ShortTitle":"Watan (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"December","StandardNumber":"0269-4727 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"46","Pages":"1531-1548","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"34159618","Comments":"","TypeName":"Journal, Article","Authors":"Watan Pal A; Aziz Z ; Kamarulzaman A ; ","ParentAuthors":"","DOI":"10.1111/jcpt.13449 ","Keywords":"Cognitive Behavioral Therapy/standards\r\nContinuity of Patient Care/standards\r\nHumans\r\nOpiate Substitution Treatment/methods/standards\r\nOpioid-Related Disorders/diagnosis/*therapy\r\nPatient Education as Topic/standards\r\nPractice Guidelines as Topic/*standards\r\nAGREE-II instrument\r\nclinical recommendations\r\nopioid dependence\r\npractice guideline\r\npsychosocial management\r\nquality appraisal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Watan Pal A, Aziz Z, and Kamarulzaman A (2021) Methodological quality of guidelines for the management of opioid use disorder: A systematic review.. Journal of clinical pharmacy and therapeutics 46(6), 1531-1548 DOI: 10.1111/jcpt.13449 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948150,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948169,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283969,"Title":"Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial.","ParentTitle":"JAMA internal medicine","ShortTitle":"Watkins (2017)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2017","Month":"October","StandardNumber":"2168-6106 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"177","Pages":"1480-1488","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"28846769","Comments":"","TypeName":"Journal, Article","Authors":"Watkins KE ; Ober AJ ; Lamp K ; Lind M ; Setodji C ; Osilla KC ; Hunter SB ; McCullough CM ; Becker K ; Iyiewuare PO ; Diamant A ; Heinzerling K ; Pincus HA ; ","ParentAuthors":"","DOI":"10.1001/jamainternmed.2017.3947 ","Keywords":"Adult\r\nAnalgesics, Opioid/*adverse effects\r\n*Disease Management\r\nEthanol/*adverse effects\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nMale\r\n*Patient Care Team\r\nPrimary Health Care/*methods\r\nQuality of Life\r\n*Referral and Consultation\r\nRetrospective Studies\r\nSelf Report\r\nSubstance-Related Disorders/psychology/*therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Watkins KE, Ober AJ, Lamp K, Lind M, Setodji C, Osilla KC, Hunter SB, McCullough CM, Becker K, Iyiewuare PO, Diamant A, Heinzerling K, and Pincus HA (2017) Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial.. JAMA internal medicine 177(10), 1480-1488 DOI: 10.1001/jamainternmed.2017.3947 "},{"Codes":[],"Outcomes":[],"ItemId":98282735,"Title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial.","ParentTitle":"Lancet (London, England)","ShortTitle":"Weaver (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"July","StandardNumber":"0140-6736 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"384","Pages":"153-63","Edition":"","Issue":"9938","Availability":"","URL":"","OldItemId":"24725468","Comments":"","TypeName":"Journal, Article","Authors":"Weaver T ; Metrebian N ; Hellier J ; Pilling S ; Charles V ; Little N ; Poovendran D ; Mitcheson L ; Ryan F ; Bowden-Jones O ; Dunn J ; Glasper A ; Finch E ; Strang J ; ","ParentAuthors":"","DOI":"10.1016/S0140-6736(14)60196-3 ","Keywords":"Adolescent\r\nAdult\r\nFemale\r\nHepatitis B/*prevention & control/psychology\r\nHepatitis B Vaccines/*administration & dosage\r\nHeroin Dependence/psychology/*rehabilitation\r\nHumans\r\nMale\r\nMedication Adherence\r\nMiddle Aged\r\nMotivation\r\n*Opiate Substitution Treatment/psychology\r\nVaccination/methods\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, and Strang J (2014) Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial.. Lancet (London, and England) 384(9938), 153-63 DOI: 10.1016/S0140-6736(14)60196-3 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283061,"Title":"Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.","ParentTitle":"Journal of addictive diseases","ShortTitle":"Webster (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"October","StandardNumber":"1055-0887 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"35","Pages":"325-338","Edition":"","Issue":"4","Availability":"","URL":"","OldItemId":"27267785","Comments":"","TypeName":"Journal, Article","Authors":"Webster L ; Hjelmstrm P ; Sumner M ; Gunderson EW ; ","ParentAuthors":"","DOI":"10.1080/10550887.2016.1195608 ","Keywords":"Administration, Sublingual\r\nAdult\r\nBuprenorphine/*administration & dosage/adverse effects/therapeutic use\r\nDouble-Blind Method\r\nDrug Combinations\r\nFemale\r\nHumans\r\nMale\r\nNaloxone/*administration & dosage/adverse effects/therapeutic use\r\nNarcotic Antagonists/*administration & dosage/therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*drug therapy\r\nTablets\r\nTreatment Outcome\r\nOpioid-related disorders\r\nbuprenorphine\r\nnaloxone\r\nsubstance-related disorders\r\n-opioid receptor","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Webster L, Hjelmstrm P, Sumner M, and Gunderson EW (2016) Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.. Journal of addictive diseases 35(4), 325-338 DOI: 10.1080/10550887.2016.1195608 "},{"Codes":[{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282226,"Title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.","ParentTitle":"Archives of general psychiatry","ShortTitle":"Weiss (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"December","StandardNumber":"0003-990X (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"68","Pages":"1238-46","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"22065255","Comments":"","TypeName":"Journal, Article","Authors":"Weiss RD ; Potter JS ; Fiellin DA ; Byrne M ; Connery HS ; Dickinson W ; Gardin J ; Griffin ML ; Gourevitch MN ; Haller DL ; Hasson AL ; Huang Z ; Jacobs P ; Kosinski AS ; Lindblad R ; McCance-Katz EF ; Provost SE ; Selzer J ; Somoza EC ; Sonne SC ; Ling W ; ","ParentAuthors":"","DOI":"10.1001/archgenpsychiatry.2011.121 ","Keywords":"Adult\r\nBuprenorphine/administration & dosage/*therapeutic use\r\nCombined Modality Therapy\r\n*Counseling\r\nDrug Therapy, Combination\r\nFemale\r\nHumans\r\nInterview, Psychological\r\nMale\r\nNaloxone/administration & dosage/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/drug therapy/*therapy\r\nPsychiatric Status Rating Scales\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, and Ling W (2011) Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.. Archives of general psychiatry 68(12), 1238-46 DOI: 10.1001/archgenpsychiatry.2011.121 "},{"Codes":[],"Outcomes":[],"ItemId":98282586,"Title":"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.","ParentTitle":"Journal of acquired immune deficiency syndromes (1999)","ShortTitle":"Weiss (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"March","StandardNumber":"1525-4135 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"56 Suppl 1","Pages":"S7-13","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"21317598","Comments":"","TypeName":"Journal, Article","Authors":"Weiss L ; Egan JE ; Botsko M ; Netherland J ; Fiellin DA ; Finkelstein R ; ","ParentAuthors":"","DOI":"10.1097/QAI.0b013e3182097426 ","Keywords":"Ambulatory Care/organization & administration\r\nBuprenorphine/*therapeutic use\r\nBuprenorphine, Naloxone Drug Combination\r\nHIV Infections/*complications\r\nHumans\r\nMethadone/therapeutic use\r\nMulticenter Studies as Topic/*methods\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/administration & dosage/*therapeutic use\r\nOpiate Substitution Treatment\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPilot Projects\r\nUnited States","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Weiss L, Egan JE, Botsko M, Netherland J, Fiellin DA, and Finkelstein R (2011) The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.. Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1, S7-13 DOI: 10.1097/QAI.0b013e3182097426 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282122,"Title":"Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Weiss (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"May","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"150","Pages":"112-9","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25818060","Comments":"","TypeName":"Journal, Article","Authors":"Weiss RD ; Potter JS ; Griffin ML ; Provost SE ; Fitzmaurice GM ; McDermott KA ; Srisarajivakul EN ; Dodd DR ; Dreifuss JA ; McHugh RK ; Carroll KM ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2015.02.030 ","Keywords":"Adult\r\nAnalgesics, Opioid/*therapeutic use\r\nBehavior, Addictive/drug therapy/psychology/*therapy\r\n*Counseling\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nMale\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/drug therapy/psychology/*therapy\r\nTreatment Outcome\r\nYoung Adult\r\nAddiction\r\nFollow-up\r\nHeroin\r\nOpioids\r\nPrescription opioids\r\nTreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, and Carroll KM (2015) Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.. Drug and alcohol dependence 150, 112-9 DOI: 10.1016/j.drugalcdep.2015.02.030 "},{"Codes":[],"Outcomes":[],"ItemId":98281527,"Title":"Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia","ParentTitle":"Drug and Alcohol Dependence","ShortTitle":"Wickersham (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1879-0046","City":"","Country":"","Publisher":"","Institution":"J.A. Wickersham, Yale University School of Medicine, Department of Medicine, Section of Infectious Diseases, AIDS Program, 135 College St. Suite 323, New Haven, CT 06510-2283, United States","Volume":"132","Pages":"378-382","Edition":"","Issue":"1-2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52440318&from=export http://dx.doi.org/10.1016/j.drugalcdep.2013.01.005","OldItemId":"","Comments":"2013-09-17","TypeName":"Journal, Article","Authors":"Wickersham J A; Zahari M M; Azar M M; Kamarulzaman A ; Altice F L; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2013.01.005","Keywords":"methadone\r\nadult\r\narticle\r\nclinical article\r\ncommunity assessment\r\ndose response\r\ndrug dose escalation\r\ndrug dose increase\r\ndrug efficacy\r\nfollow up\r\nhealth program\r\nhuman\r\nHuman immunodeficiency virus infected patient\r\nmaintenance drug dose\r\nmaintenance therapy\r\nMalaysia\r\nmale\r\nmethadone treatment\r\nopiate addiction\r\npatient compliance\r\npilot study\r\npriority journal\r\nprisoner\r\ntreatment duration\r\nwithdrawal syndrome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wickersham J A, Zahari M M, Azar M M, Kamarulzaman A, and Altice F L (2013) Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug and Alcohol Dependence 132(1-2), 378-382 DOI: 10.1016/j.drugalcdep.2013.01.005"},{"Codes":[],"Outcomes":[],"ItemId":98281162,"Title":"Buprenorphine Induction Via Telemedicine to Emergency Department Patients","ParentTitle":"Clinical Toxicology","ShortTitle":"Wiegand (2018)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2018","Month":"","StandardNumber":"1556-9519","City":"","Country":"","Publisher":"","Institution":"T. Wiegand, Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, United States","Volume":"56","Pages":"982-983","Edition":"","Issue":"10","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L624641736&from=export http://dx.doi.org/10.1080/15563650.2018.1506610","OldItemId":"","Comments":"2018-11-02","TypeName":"Journal, Article","Authors":"Wiegand T ; Crane P ; ","ParentAuthors":"","DOI":"10.1080/15563650.2018.1506610","Keywords":"buprenorphine\r\nbuprenorphine plus naloxone\r\nopiate\r\nadult\r\nasthenia\r\ncase report\r\ncellulitis\r\nclinical article\r\ncomplication\r\nconference abstract\r\nconsultation\r\ndiagnosis\r\ndrug overdose\r\ndrug therapy\r\ndrug withdrawal\r\nemergency medicine\r\nemergency ward\r\nendocarditis\r\nfemale\r\nfever\r\nhospital care\r\nhuman\r\nmale\r\nopiate addiction\r\nreimbursement\r\nresident\r\nrural area\r\nskill\r\nsoftware\r\ntablet computer\r\ntelemedicine\r\ntoxicology\r\ntravel\r\nvideorecording","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wiegand T, and Crane P (2018) Buprenorphine Induction Via Telemedicine to Emergency Department Patients. Clinical Toxicology 56(10), 982-983 DOI: 10.1080/15563650.2018.1506610"},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948267,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019723,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281797,"Title":"Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Wilder (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"April","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"149","Pages":"225-31","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"25735465","Comments":"","TypeName":"Journal, Article","Authors":"Wilder C ; Lewis D ; Winhusen T ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2015.02.012 ","Keywords":"Buprenorphine/therapeutic use\r\nFemale\r\nHumans\r\nKaplan-Meier Estimate\r\nMethadone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nNarcotics/therapeutic use\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*drug therapy\r\nPatient Dropouts/*statistics & numerical data\r\n*Postpartum Period\r\nPregnancy\r\nPregnancy Complications/*drug therapy\r\nPregnancy Outcome\r\nRetrospective Studies\r\nMedication assisted treatment\r\nMethadone\r\nOpioid use disorder\r\nPatient dropout\r\nPostpartum\r\nPregnancy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wilder C, Lewis D, and Winhusen T (2015) Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.. Drug and alcohol dependence 149, 225-31 DOI: 10.1016/j.drugalcdep.2015.02.012 "},{"Codes":[],"Outcomes":[],"ItemId":98281816,"Title":"Pharmacological Management of Opioid Use Disorder in Pregnant Women.","ParentTitle":"CNS drugs","ShortTitle":"Wilder (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"August","StandardNumber":"1172-7047 (Linking)","City":"New Zealand","Country":"","Publisher":"","Institution":"","Volume":"29","Pages":"625-36","Edition":"","Issue":"8","Availability":"","URL":"","OldItemId":"26315948","Comments":"","TypeName":"Journal, Article","Authors":"Wilder CM ; Winhusen T ; ","ParentAuthors":"","DOI":"10.1007/s40263-015-0273-8 ","Keywords":"Analgesics, Opioid/administration & dosage/adverse effects\r\nAnimals\r\nBuprenorphine/administration & dosage\r\nFemale\r\nHumans\r\nInfant, Newborn\r\nMethadone/administration & dosage\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/complications/*drug therapy\r\nPregnancy\r\nPregnancy Complications/*drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wilder CM, and Winhusen T (2015) Pharmacological Management of Opioid Use Disorder in Pregnant Women.. CNS drugs 29(8), 625-36 DOI: 10.1007/s40263-015-0273-8 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281965,"Title":"A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem.","ParentTitle":"Sleep medicine","ShortTitle":"Wilkerson (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"August","StandardNumber":"1389-9457 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"84","Pages":"142-153","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34153796","Comments":"","TypeName":"Journal, Article","Authors":"Wilkerson AK ; McRae-Clark AL ; ","ParentAuthors":"","DOI":"10.1016/j.sleep.2021.05.021 ","Keywords":"Adult\r\nComorbidity\r\nHumans\r\n*Opioid-Related Disorders/drug therapy/epidemiology\r\nSelf Report\r\nSleep\r\n*Sleep Wake Disorders/epidemiology\r\nAddiction\r\nAssessment\r\nMedication assisted treatment\r\nOpioid use disorder\r\nSleep","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wilkerson AK, and McRae-Clark AL (2021) A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem.. Sleep medicine 84, 142-153 DOI: 10.1016/j.sleep.2021.05.021 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282765,"Title":"Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.","ParentTitle":"The American journal on addictions","ShortTitle":"Wilson (2012)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2012","Month":"September","StandardNumber":"1055-0496 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"21","Pages":"476-87","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"22882399","Comments":"","TypeName":"Journal, Article","Authors":"Wilson ME ; Kinlock TW ; Gordon MS ; O'Grady KE ; Schwartz RP ; ","ParentAuthors":"","DOI":"10.1111/j.1521-0391.2012.00250.x ","Keywords":"Adult\r\n*HIV Infections\r\nHumans\r\nLinear Models\r\nMale\r\nMethadone/*therapeutic use\r\nNarcotics/*therapeutic use\r\nNeedle Sharing/statistics & numerical data\r\n*Opiate Substitution Treatment\r\nOpioid-Related Disorders/*therapy\r\n*Prisoners\r\n*Risk Reduction Behavior\r\nUnited States\r\nUnsafe Sex/statistics & numerical data","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wilson ME, Kinlock TW, Gordon MS, O'Grady KE, and Schwartz RP (2012) Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.. The American journal on addictions 21(5), 476-87 DOI: 10.1111/j.1521-0391.2012.00250.x "},{"Codes":[{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948233,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948325,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019718,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948178,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948188,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948195,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008498,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281933,"Title":"Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners' experience.","ParentTitle":"Australian journal of general practice","ShortTitle":"Wilson (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"October","StandardNumber":"2208-7958 (Electronic)","City":"Australia","Country":"","Publisher":"","Institution":"","Volume":"51","Pages":"804-811","Edition":"","Issue":"10","Availability":"","URL":"","OldItemId":"36184866","Comments":"","TypeName":"Journal, Article","Authors":"Wilson H ; Harris-Roxas B ; Lintzeris N ; Harris M ; ","ParentAuthors":"","DOI":"10.31128/AJGP-10-21-6201 ","Keywords":"Analgesics, Opioid/adverse effects\r\n*Chronic Pain/drug therapy\r\nDrug Prescriptions\r\n*General Practitioners\r\nHumans\r\n*Opioid-Related Disorders/drug therapy/therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wilson H, Harris-Roxas B, Lintzeris N, and Harris M (2022) Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners' experience.. Australian journal of general practice 51(10), 804-811 DOI: 10.31128/AJGP-10-21-6201 "},{"Codes":[],"Outcomes":[],"ItemId":98282384,"Title":"A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Winstanley (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"April","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"40","Pages":"255-64","Edition":"","Issue":"3","Availability":"","URL":"","OldItemId":"21266301","Comments":"","TypeName":"Journal, Article","Authors":"Winstanley EL ; Bigelow GE ; Silverman K ; Johnson RE ; Strain EC ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2010.11.010 ","Keywords":"Adult\r\nCocaine-Related Disorders/complications/*drug therapy\r\nDouble-Blind Method\r\nFemale\r\nFluoxetine/*therapeutic use\r\nHumans\r\nMale\r\nMethadone/therapeutic use\r\nMiddle Aged\r\nMotivation\r\nNarcotics/therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/complications/*rehabilitation\r\nSelective Serotonin Reuptake Inhibitors/*therapeutic use\r\nSubstance Abuse Detection\r\nTime Factors\r\nToken Economy\r\nTreatment Outcome","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Winstanley EL, Bigelow GE, Silverman K, Johnson RE, and Strain EC (2011) A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.. Journal of substance abuse treatment 40(3), 255-64 DOI: 10.1016/j.jsat.2010.11.010 "},{"Codes":[{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948163,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013985,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282639,"Title":"Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison.","ParentTitle":"Journal of substance abuse treatment","ShortTitle":"Woody (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"August","StandardNumber":"0740-5472 (Linking)","City":"United States","Country":"","Publisher":"","Institution":"","Volume":"127","Pages":"108355","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34134881","Comments":"","TypeName":"Journal, Article","Authors":"Woody GE ; Poole S ; Yu E ; Carroll J ; Lynch KG ; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2021.108355 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nDelayed-Action Preparations/therapeutic use\r\nHumans\r\nInjections, Intramuscular\r\nNaltrexone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\n*Opioid-Related Disorders/drug therapy\r\n*Prisoners\r\nPrisons\r\nNaltrexone\r\nOpioids\r\nPrisoners\r\nTreatment","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Woody GE, Poole S, Yu E, Carroll J, and Lynch KG (2021) Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison.. Journal of substance abuse treatment 127, 108355 DOI: 10.1016/j.jsat.2021.108355 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948341,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002971,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002972,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282717,"Title":"Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.","ParentTitle":"The British journal of general practice : the journal of the Royal College of General Practitioners","ShortTitle":"Wright (2011)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2011","Month":"December","StandardNumber":"0960-1643 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"61","Pages":"e772-80","Edition":"","Issue":"593","Availability":"","URL":"","OldItemId":"22137413","Comments":"","TypeName":"Journal, Article","Authors":"Wright NM ; Sheard L ; Adams CE ; Rushforth BJ ; Harrison W ; Bound N ; Hart R ; Tompkins CN ; ","ParentAuthors":"","DOI":"10.3399/bjgp11X613106 ","Keywords":"Administration, Oral\r\nAdministration, Sublingual\r\nAdult\r\nAged\r\nBuprenorphine/*administration & dosage\r\nHumans\r\nMethadone/*administration & dosage\r\nMiddle Aged\r\nNarcotic Antagonists/*administration & dosage\r\nOpiate Substitution Treatment/*methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPrisoners/statistics & numerical data\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wright NM, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, Hart R, and Tompkins CN (2011) Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.. The British journal of general practice : the journal of the Royal College of General Practitioners 61(593), e772-80 DOI: 10.3399/bjgp11X613106 "},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948151,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948149,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948165,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948170,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948171,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948174,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282028,"Title":"Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Wu (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"July","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"Pharm-OUD-Care Collaborative Investigators","Volume":"116","Pages":"1805-1816","Edition":"","Issue":"7","Availability":"","URL":"","OldItemId":"33428284","Comments":"","TypeName":"Journal, Article","Authors":"Wu LT ; John WS ; Ghitza UE ; Wahle A ; Matthews AG ; Lewis M ; Hart B ; Hubbard Z ; Bowlby LA ; Greenblatt LH ; Mannelli P ; ","ParentAuthors":"","DOI":"10.1111/add.15353 ","Keywords":"*Buprenorphine/therapeutic use\r\nHumans\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\nPharmacists\r\n*Physicians\r\nUnited States\r\nBuprenorphine collaborative care\r\noffice-based buprenorphine treatment\r\nopioid use disorder\r\npharmacist-provided care\r\npharmacy practice\r\nprimary care","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wu LT, John WS, Ghitza UE, Wahle A, Matthews AG, Lewis M, Hart B, Hubbard Z, Bowlby LA, Greenblatt LH, and Mannelli P (2021) Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.. Addiction (Abingdon, and England) 116(7), 1805-1816 DOI: 10.1111/add.15353 "},{"Codes":[],"Outcomes":[],"ItemId":98281897,"Title":"Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Wu (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"February","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"117","Pages":"444-456","Edition":"","Issue":"2","Availability":"","URL":"","OldItemId":"34286886","Comments":"","TypeName":"Journal, Article","Authors":"Wu LT ; John WS ; Morse ED ; Adkins S ; Pippin J ; Brooner RK ; Schwartz RP ; ","ParentAuthors":"","DOI":"10.1111/add.15641 ","Keywords":"Analgesics, Opioid/therapeutic use\r\nFeasibility Studies\r\nHumans\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy\r\n*Pharmacies\r\n*Pharmacy\r\nCollaborative care\r\ncommunity pharmacy\r\nmethadone maintenance treatment\r\nmethadone prescribing\r\nopioid treatment program\r\nopioid use disorder","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wu LT, John WS, Morse ED, Adkins S, Pippin J, Brooner RK, and Schwartz RP (2022) Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.. Addiction (Abingdon, and England) 117(2), 444-456 DOI: 10.1111/add.15641 "},{"Codes":[],"Outcomes":[],"ItemId":98280723,"Title":"Treatment for Individuals with Severe Mental Illness Who Use Illicit Drugs while Maintained on Methadone: Mindfulness and Modification Therapy","ParentTitle":"Journal of Nervous and Mental Disease","ShortTitle":"Wupperman (2019)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2019","Month":"","StandardNumber":"0022-3018","City":"","Country":"","Publisher":"","Institution":"P. Wupperman, 524 W 59th St, New York, NY, United States","Volume":"207","Pages":"1005-1011","Edition":"","Issue":"12","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L630822826&from=export http://dx.doi.org/10.1097/NMD.0000000000001066","OldItemId":"","Comments":"2020-02-17","TypeName":"Journal, Article","Authors":"Wupperman P ; Burns N ; Pugach C P; Edwards E ; ","ParentAuthors":"","DOI":"10.1097/NMD.0000000000001066","Keywords":"illicit drug\r\nmethadone\r\nadult\r\narticle\r\nclinical article\r\ndisease severity\r\ndrug use\r\nfeasibility study\r\nfemale\r\nfollow up\r\ngroup therapy\r\nhuman\r\nmale\r\nmental disease\r\nmethadone treatment\r\nmindfulness\r\nmodification therapy\r\npilot study\r\ntreatment response","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Wupperman P, Burns N, Pugach C P, and Edwards E (2019) Treatment for Individuals with Severe Mental Illness Who Use Illicit Drugs while Maintained on Methadone: Mindfulness and Modification Therapy. Journal of Nervous and Mental Disease 207(12), 1005-1011 DOI: 10.1097/NMD.0000000000001066"},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281473,"Title":"Phase i study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence","ParentTitle":"American Journal on Addictions","ShortTitle":"Xuyi (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1521-0391","City":"","Country":"","Publisher":"","Institution":"L. Jin, Beijing Institute of Pharmacology and Toxicology, No. 27, Taiping Road, Beijing, China","Volume":"23","Pages":"162-169","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52811625&from=export http://dx.doi.org/10.1111/j.1521-0391.2013.12085.x","OldItemId":"","Comments":"2014-02-25","TypeName":"Journal, Article","Authors":"Xuyi W ; Juelu W ; Xiaojun X ; Haiyan L ; Zheyuan L ; Zhehui G ; Guoming D ; Gang L ; Jin L ; Wei H ; ","ParentAuthors":"","DOI":"10.1111/j.1521-0391.2013.12085.x","Keywords":"alanine aminotransferase\r\nnaltrexone\r\ntriacylglycerol\r\nadult\r\nalanine aminotransferase blood level\r\nanorexia\r\narticle\r\nclinical article\r\ncontrolled study\r\ndisease severity\r\ndizziness\r\ndouble blind procedure\r\ndrug blood level\r\ndrug megadose\r\ndrug safety\r\ndrug tolerability\r\nfemale\r\nhuman\r\ninjection site induration\r\nlow drug dose\r\nmale\r\nnausea\r\nopiate addiction\r\nrandomized controlled trial\r\nrelapse\r\ntonsillitis\r\ntriacylglycerol blood level\r\nunspecified side effect","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Xuyi W, Juelu W, Xiaojun X, Haiyan L, Zheyuan L, Zhehui G, Guoming D, Gang L, Jin L, and Wei H (2014) Phase i study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence. American Journal on Addictions 23(2), 162-169 DOI: 10.1111/j.1521-0391.2013.12085.x"},{"Codes":[{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948184,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98281497,"Title":"The Prevalence of Sexual Dysfunction among Male Patients on Methadone and Buprenorphine Treatments: A Meta-Analysis Study","ParentTitle":"Journal of Sexual Medicine","ShortTitle":"Yee (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"","StandardNumber":"1743-6095","City":"","Country":"","Publisher":"","Institution":"H.S. Loh, FRACGP, Clinical Academic Unit (Family Medicine), Newcastle University of Medicine, Johor 79200, Malaysia","Volume":"11","Pages":"22-32","Edition":"","Issue":"1","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52842187&from=export http://dx.doi.org/10.1111/jsm.12352","OldItemId":"","Comments":"2020-10-23","TypeName":"Journal, Article","Authors":"Yee A ; Loh H S; Hisham Hashim ; H M B; Ng C G; ","ParentAuthors":"","DOI":"10.1111/jsm.12352","Keywords":"buprenorphine\r\nmethadone\r\narticle\r\nbuprenorphine treatment\r\ndrug dependence treatment\r\nhuman\r\nmale sexual dysfunction\r\nmeta analysis\r\nmethadone treatment\r\npriority journal\r\nrisk\r\nsexual dysfunction\r\nsystematic review","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Yee A, Loh H S, Hisham Hashim, H M B, and Ng C G (2014) The Prevalence of Sexual Dysfunction among Male Patients on Methadone and Buprenorphine Treatments: A Meta-Analysis Study. Journal of Sexual Medicine 11(1), 22-32 DOI: 10.1111/jsm.12352"},{"Codes":[{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948212,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948217,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948235,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282456,"Title":"Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.","ParentTitle":"International journal of impotence research","ShortTitle":"Yee (2014)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2014","Month":"September","StandardNumber":"0955-9930 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"26","Pages":"161-6","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"24990199","Comments":"","TypeName":"Journal, Article","Authors":"Yee A ; Loh HS ; Hisham Hashim HM; Ng CG ; ","ParentAuthors":"","DOI":"10.1038/ijir.2014.18 ","Keywords":"Adult\r\nAnalgesics, Opioid/*adverse effects/therapeutic use\r\nBuprenorphine/*adverse effects/therapeutic use\r\nHumans\r\nMale\r\nMethadone/*adverse effects/therapeutic use\r\nOpiate Substitution Treatment/*adverse effects\r\nOpioid-Related Disorders/complications/rehabilitation\r\nSexual Dysfunction, Physiological/*chemically induced","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Yee A, Loh HS, Hisham Hashim HM, and Ng CG (2014) Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.. International journal of impotence research 26(5), 161-6 DOI: 10.1038/ijir.2014.18 "},{"Codes":[],"Outcomes":[],"ItemId":98281435,"Title":"Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients","ParentTitle":"Psychopharmacology","ShortTitle":"Zaaijer (2015)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2015","Month":"","StandardNumber":"0033-3158","City":"","Country":"","Publisher":"","Institution":"E.R. Zaaijer, Department of Psychiatry, Academic Medical Center, University of Amsterdam, PO Box 22660, Amsterdam, Netherlands","Volume":"232","Pages":"2597-2607","Edition":"","Issue":"14","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L602897857&from=export http://dx.doi.org/10.1007/s00213-015-3891-4","OldItemId":"","Comments":"2015-07-06","TypeName":"Journal, Article","Authors":"Zaaijer E R; Van Dijk L ; De Bruin K ; Goudriaan A E; Lammers L A; Koeter M W.J; Van Den Brink W ; Booij J ; ","ParentAuthors":"","DOI":"10.1007/s00213-015-3891-4","Keywords":"6 beta naltrexol\r\ncocaine\r\ndopamine transporter\r\niodine 123\r\nnaltrexone\r\nopiate\r\nunclassified drug\r\nadult\r\nanhedonia\r\narticle\r\nBeck Depression Inventory\r\nbinding affinity\r\nclinical article\r\ncomparative study\r\ncontrolled study\r\ndepression\r\ndetoxification\r\ndisease association\r\ndrug blood level\r\ndrug effect\r\ndrug metabolism\r\ndrug release\r\nfemale\r\nheroin dependence\r\nhuman\r\nmale\r\npost hoc analysis\r\npriority journal\r\npsychometry\r\nputamen\r\nsingle photon emission computed tomography\r\nSnaith Hamilton Pleasure Scale\r\nstriate cortex\r\nsymptomatology\r\ntreatment duration\r\nurinalysis\r\nvivitrol","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zaaijer E R, Van Dijk L, De Bruin K, Goudriaan A E, Lammers L A, Koeter M W.J, Van Den Brink W, and Booij J (2015) Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. Psychopharmacology 232(14), 2597-2607 DOI: 10.1007/s00213-015-3891-4"},{"Codes":[],"Outcomes":[],"ItemId":98285165,"Title":"Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).","ParentTitle":"The American journal of drug and alcohol abuse","ShortTitle":"Zahari (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"September","StandardNumber":"0095-2990 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"42","Pages":"587-596","Edition":"","Issue":"5","Availability":"","URL":"","OldItemId":"27284701","Comments":"","TypeName":"Journal, Article","Authors":"Zahari Z ; Lee CS ; Ibrahim MA ; Musa N ; Mohd Yasin MA; Lee YY ; Tan SC ; Mohamad N ; Ismail R ; ","ParentAuthors":"","DOI":"10.3109/00952990.2016.1172078 ","Keywords":"ATP Binding Cassette Transporter, Subfamily B/genetics\r\nAdult\r\nCross-Sectional Studies\r\nGenotype\r\nHumans\r\nMale\r\nMethadone/*blood/pharmacokinetics/*therapeutic use\r\nMiddle Aged\r\n*Opiate Substitution Treatment\r\nPolymorphism, Single Nucleotide/*genetics\r\nABCB1\r\nMDR1\r\nP-glycoprotein (P-gp)\r\nmethadone maintenance therapy (MMT)\r\nopioid dependence\r\nserum methadone concentration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, and Ismail R (2016) Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).. The American journal of drug and alcohol abuse 42(5), 587-596 DOI: 10.3109/00952990.2016.1172078 "},{"Codes":[],"Outcomes":[],"ItemId":98281529,"Title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","ParentTitle":"Journal of Substance Abuse Treatment","ShortTitle":"Zaller (2013)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2013","Month":"","StandardNumber":"1873-6483","City":"","Country":"","Publisher":"","Institution":"N. Zaller, The Miriam Hospital, Providence, RI, United States","Volume":"45","Pages":"222-226","Edition":"","Issue":"2","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L52510017&from=export http://dx.doi.org/10.1016/j.jsat.2013.02.005","OldItemId":"","Comments":"2013-07-02","TypeName":"Journal, Article","Authors":"Zaller N ; McKenzie M ; Friedmann P D; Green T C; McGowan S ; Rich J D; ","ParentAuthors":"","DOI":"10.1016/j.jsat.2013.02.005","Keywords":"buprenorphine plus naloxone\r\nmethadone\r\nadult\r\narticle\r\nclinical article\r\ncommunity care\r\nfeasibility study\r\nfemale\r\nhuman\r\nHuman immunodeficiency virus infection\r\ninfection risk\r\nmale\r\nmethadone treatment\r\nopiate addiction\r\nprescription\r\npriority journal\r\nprisoner\r\nsurvival rate\r\ntreatment duration\r\ntreatment outcome\r\nsuboxone","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zaller N, McKenzie M, Friedmann P D, Green T C, McGowan S, and Rich J D (2013) Initiation of buprenorphine during incarceration and retention in treatment upon release. Journal of Substance Abuse Treatment 45(2), 222-226 DOI: 10.1016/j.jsat.2013.02.005"},{"Codes":[{"AttributeId":14999412,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948265,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948179,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948180,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14999413,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013983,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98279995,"Title":"The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis","ParentTitle":"Frontiers in Psychiatry","ShortTitle":"Zangiabadian (2022)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2022","Month":"","StandardNumber":"1664-0640","City":"","Country":"","Publisher":"","Institution":"M. Sadeghian, Department of Psychiatry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran","Volume":"13","Pages":"","Edition":"","Issue":"","Availability":"","URL":"https://www.embase.com/search/results?subaction=viewrecord&id=L2019463751&from=export http://dx.doi.org/10.3389/fpsyt.2022.1003257","OldItemId":"","Comments":"2022-11-01","TypeName":"Journal, Article","Authors":"Zangiabadian M ; Golmohammadi S ; Nejadghaderi S A; Zahmatkesh M M; Nasiri M J; Sadeghian M ; ","ParentAuthors":"","DOI":"10.3389/fpsyt.2022.1003257","Keywords":"naltrexone\r\nclinical effectiveness\r\ndose\r\ndrug administration route\r\ndrug dose escalation\r\ndrug efficacy\r\nhuman\r\nmedication compliance\r\nmeta analysis\r\nopiate addiction\r\nrelapse\r\nreview\r\nsystematic review\r\ntreatment duration","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zangiabadian M, Golmohammadi S, Nejadghaderi S A, Zahmatkesh M M, Nasiri M J, and Sadeghian M (2022) The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis. Frontiers in Psychiatry 13,  DOI: 10.3389/fpsyt.2022.1003257"},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008495,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15008497,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269958,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282286,"Title":"Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Zarkin (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"December","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"217","Pages":"108292","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"32992151","Comments":"","TypeName":"Journal, Article","Authors":"Zarkin GA ; Orme S ; Dunlap LJ ; Kelly SM ; Mitchell SG ; O'Grady KE ; Schwartz RP ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2020.108292 ","Keywords":"Adult\r\nAnalgesics, Opioid/economics/therapeutic use\r\n*Cost-Benefit Analysis/methods\r\nFemale\r\nHumans\r\nJails/*economics\r\nMale\r\nMethadone/*economics/therapeutic use\r\nMiddle Aged\r\nOpiate Substitution Treatment/*economics/methods\r\nOpioid-Related Disorders/drug therapy/*economics\r\nPatient Acceptance of Health Care\r\nPatient Navigation/*economics/methods\r\nTreatment Outcome\r\nCost-effectiveness\r\nJail-Based\r\nMethadone\r\nOpioids\r\nPatient navigation","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zarkin GA, Orme S, Dunlap LJ, Kelly SM, Mitchell SG, O'Grady KE, and Schwartz RP (2020) Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.. Drug and alcohol dependence 217, 108292 DOI: 10.1016/j.drugalcdep.2020.108292 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948196,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948205,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283025,"Title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.","ParentTitle":"Addiction (Abingdon, England)","ShortTitle":"Zedler (2016)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2016","Month":"December","StandardNumber":"0965-2140 (Linking)","City":"England","Country":"","Publisher":"","Institution":"","Volume":"111","Pages":"2115-2128","Edition":"","Issue":"12","Availability":"","URL":"","OldItemId":"27223595","Comments":"","TypeName":"Journal, Article","Authors":"Zedler BK ; Mann AL ; Kim MM ; Amick HR ; Joyce AR ; Murrelle EL ; Jones HE ; ","ParentAuthors":"","DOI":"10.1111/add.13462 ","Keywords":"Abnormalities, Drug-Induced/prevention & control\r\nAnalgesics, Opioid/*therapeutic use\r\nBirth Weight/physiology\r\nBuprenorphine/*therapeutic use\r\nFemale\r\nFetal Death/prevention & control\r\nFetal Development/drug effects\r\nHumans\r\nInfant, Newborn\r\nMethadone/*therapeutic use\r\nOpiate Substitution Treatment/methods\r\nOpioid-Related Disorders/*rehabilitation\r\nPatient Safety\r\nPregnancy\r\nPregnancy Complications/*rehabilitation\r\nPregnancy Outcome\r\nPremature Birth/prevention & control\r\nPrenatal Care/methods\r\nRandomized Controlled Trials as Topic\r\nSudden Infant Death/prevention & control\r\nBuprenorphine\r\ndependence\r\nfetus\r\nharm\r\nmethadone\r\nopioid use disorder\r\npregnancy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, and Jones HE (2016) Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.. Addiction (Abingdon, and England) 111(12), 2115-2128 DOI: 10.1111/add.13462 "},{"Codes":[{"AttributeId":14948133,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948134,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948187,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002969,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002970,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948175,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948342,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269956,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282035,"Title":"Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Zhu (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"228","Pages":"108996","Edition":"","Issue":"","Availability":"","URL":"","OldItemId":"34555691","Comments":"","TypeName":"Journal, Article","Authors":"Zhu Y ; Mooney LJ ; Yoo C ; Evans EA ; Kelleghan A ; Saxon AJ ; Curtis ME ; Hser YI ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2021.108996 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nBuprenorphine, Naloxone Drug Combination/therapeutic use\r\nComorbidity\r\n*Depressive Disorder, Major\r\nFollow-Up Studies\r\nHumans\r\nMethadone/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/complications/drug therapy/epidemiology\r\nTreatment Outcome\r\nBuprenorphine-naloxone\r\nMethadone\r\nOpioid use disorder\r\nProspective cohort study\r\nPsychiatric comorbidity\r\nTreatment outcomes","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, and Hser YI (2021) Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.. Drug and alcohol dependence 228, 108996 DOI: 10.1016/j.drugalcdep.2021.108996 "},{"Codes":[{"AttributeId":14948143,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948144,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948192,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948164,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948189,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948204,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948266,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15002967,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948181,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269961,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98282605,"Title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.","ParentTitle":"Drug and alcohol dependence","ShortTitle":"Ziedonis (2009)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2009","Month":"January","StandardNumber":"0376-8716 (Linking)","City":"Ireland","Country":"","Publisher":"","Institution":"","Volume":"99","Pages":"28-36","Edition":"","Issue":"1-3","Availability":"","URL":"","OldItemId":"18805656","Comments":"","TypeName":"Journal, Article","Authors":"Ziedonis DM ; Amass L ; Steinberg M ; Woody G ; Krejci J ; Annon JJ ; Cohen AJ ; Waite-O'Brien N ; Stine SM ; McCarty D ; Reid MS ; Brown LS Jr; Maslansky R ; Winhusen T ; Babcock D ; Brigham G ; Muir J ; Orr D ; Buchan BJ ; Horton T ; Ling W ; ","ParentAuthors":"","DOI":"10.1016/j.drugalcdep.2008.06.016 ","Keywords":"Adrenergic alpha-Agonists/*therapeutic use\r\nAdult\r\nAged\r\nAnxiety/psychology\r\nBuprenorphine/*therapeutic use\r\nClonidine/*therapeutic use\r\nData Interpretation, Statistical\r\nDepression/psychology\r\nDrug Therapy, Combination\r\nFemale\r\nHeroin Dependence/psychology/rehabilitation\r\nHumans\r\nMale\r\nMiddle Aged\r\nNaloxone/*therapeutic use\r\nNarcotic Antagonists/*therapeutic use\r\nNational Institute on Alcohol Abuse and Alcoholism (U.S.)\r\nOpioid-Related Disorders/*rehabilitation\r\nPrognosis\r\nSmoking/psychology\r\nSocioeconomic Factors\r\nSubstance Abuse Detection\r\nSubstance Withdrawal Syndrome/*drug therapy/psychology\r\nTreatment Outcome\r\nUnited States\r\nYoung Adult","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, and Ling W (2009) Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.. Drug and alcohol dependence 99(1-3), 28-36 DOI: 10.1016/j.drugalcdep.2008.06.016 "},{"Codes":[{"AttributeId":15032559,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020368,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15020372,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948182,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948191,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948194,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948206,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948331,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013975,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":14948176,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15013984,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15019726,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269955,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]},{"AttributeId":15269957,"AdditionalText":"","ArmId":0,"ArmTitle":"","ItemAttributeFullTextDetails":[]}],"Outcomes":[],"ItemId":98283903,"Title":"Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial.","ParentTitle":"European journal of pediatrics","ShortTitle":"Zimmermann (2020)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2020","Month":"January","StandardNumber":"0340-6199 (Linking)","City":"Germany","Country":"","Publisher":"","Institution":"Swiss neonatal abstinence syndrome study group","Volume":"179","Pages":"141-149","Edition":"","Issue":"1","Availability":"","URL":"","OldItemId":"31691849","Comments":"","TypeName":"Journal, Article","Authors":"Zimmermann U ; Rudin C ; Du A ; Held L ; Bucher HU ; ","ParentAuthors":"","DOI":"10.1007/s00431-019-03486-6 ","Keywords":"Analgesics, Opioid/*adverse effects/therapeutic use\r\nChlorpromazine/*therapeutic use\r\nDopamine Antagonists/*therapeutic use\r\nDose-Response Relationship, Drug\r\nDouble-Blind Method\r\nDrug Administration Schedule\r\nDrug Therapy, Combination\r\nFemale\r\nFollow-Up Studies\r\nHumans\r\nHypnotics and Sedatives/*therapeutic use\r\nInfant, Newborn\r\nMale\r\nMorphine/*therapeutic use\r\nNeonatal Abstinence Syndrome/*drug therapy\r\nPhenobarbital/*therapeutic use\r\nProspective Studies\r\nTreatment Outcome\r\nChlorpromazine\r\nMorphine\r\nNeonate\r\nOpioids\r\nPharmacological treatment\r\nPhenobarbital\r\nWithdrawal","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zimmermann U, Rudin C, Du A, Held L, and Bucher HU (2020) Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial.. European journal of pediatrics 179(1), 141-149 DOI: 10.1007/s00431-019-03486-6 "},{"Codes":[],"Outcomes":[],"ItemId":98282284,"Title":"Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.","ParentTitle":"Journal of addiction medicine","ShortTitle":"Zweben (2021)","DateCreated":"17/04/2024","CreatedBy":"Abhishek Ghosh","DateEdited":"17/04/2024","EditedBy":"Abhishek Ghosh","Year":"2021","Month":"November","StandardNumber":"1932-0620 (Linking)","City":"Netherlands","Country":"","Publisher":"","Institution":"","Volume":"15","Pages":"454-460","Edition":"","Issue":"6","Availability":"","URL":"","OldItemId":"33323695","Comments":"","TypeName":"Journal, Article","Authors":"Zweben JE ; Sorensen JL ; Shingle M ; Blazes CK ; ","ParentAuthors":"","DOI":"10.1097/ADM.0000000000000789 ","Keywords":"Analgesics, Opioid/therapeutic use\r\n*Buprenorphine/therapeutic use\r\nHumans\r\nMethadone/therapeutic use\r\nNarcotic Antagonists/therapeutic use\r\nOpiate Substitution Treatment\r\n*Opioid-Related Disorders/drug therapy","ItemStatus":"I","ItemStatusTooltip":"Included in review","QuickCitation":"Zweben JE, Sorensen JL, Shingle M, and Blazes CK (2021) Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.. Journal of addiction medicine 15(6), 454-460 DOI: 10.1097/ADM.0000000000000789 "}];
  const summaryAttribute = "";
  const checkboxCheckedSvg = '<svg id="checked" fill="#000000" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M0 0h24v24H0z" fill="none"/>' +
    '<path d="M19 3H5c-1.11 0-2 .9-2 2v14c0 1.1.89 2 2 2h14c1.11 0 2-.9 2-2V5c0-1.1-.89-2-2-2zm-9 14l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9 9z"/>' +
    '</svg>';
  const checkboxUncheckedSvg = '<svg id="unchecked" fill="#000000" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M19 5v14H5V5h14m0-2H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2z"/>' +
    '<path d="M0 0h24v24H0z" fill="none"/>' +
    '</svg>';
  const checkboxIndeterminateSvg = '<svg id="indeterminate" fill="#000000" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">' +
    '<defs>' +
    '<path d="M0 0h24v24H0z" id="a"/>' +
    '</defs>' +
    '<clipPath id="b">' +
    '<use overflow="visible" xlink:href="#a"/>' +
    '</clipPath>' +
    '<path clip-path="url(#b)" d="M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm-2 10H7v-2h10v2z"/>' +
    '</svg>';
  const radioCheckedSvg = '<svg id="checked" fill="#000000" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M12 7c-2.76 0-5 2.24-5 5s2.24 5 5 5 5-2.24 5-5-2.24-5-5-5zm0-5C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z"/>' +
    '<path d="M0 0h24v24H0z" fill="none"/>' +
    '</svg>';
  const radioUncheckedSvg = '<svg id="unchecked" fill="#000000" height="24" viewBox="0 0 24 24" width="24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z"/>' +
    '<path d="M0 0h24v24H0z" fill="none"/>' +
    '</svg>';
  const arrowUpSvg = '<svg class="btnRowCollapse arrowUp" id="arrowUp" fill="#000000" width="18" height="18" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M20.24 18.804c0 0.116-0.058 0.247-0.145 0.334l-0.725 0.725c-0.087 0.087-0.203 0.145-0.334 0.145-0.116 0-0.247-0.058-0.334-0.145l-5.702-5.702-5.702 5.702c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-0.725-0.725c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l6.761-6.761c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l6.761 6.761c0.087 0.087 0.145 0.218 0.145 0.334zM20.24 13.232c0 0.116-0.058 0.247-0.145 0.334l-0.725 0.725c-0.087 0.087-0.203 0.145-0.334 0.145-0.116 0-0.247-0.058-0.334-0.145l-5.702-5.702-5.702 5.702c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-0.725-0.725c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l6.761-6.761c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l6.761 6.761c0.087 0.087 0.145 0.218 0.145 0.334z"/>' +
    '<path d="M0 0h24v24H0z" fill="none"/>' +
    '</svg>';
  const arrowDownSvg = '<svg class="btnRowCollapse arrowDown" id="arrowDown" fill="#000000" width="18" height="18" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M20.24 12.768c0 0.116-0.058 0.247-0.145 0.334l-6.761 6.761c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-6.761-6.761c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l0.725-0.725c0.087-0.087 0.203-0.145 0.334-0.145 0.116 0 0.247 0.058 0.334 0.145l5.702 5.702 5.702-5.702c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l0.725 0.725c0.087 0.087 0.145 0.218 0.145 0.334zM20.24 7.196c0 0.116-0.058 0.247-0.145 0.334l-6.761 6.761c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-6.761-6.761c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l0.725-0.725c0.087-0.087 0.203-0.145 0.334-0.145 0.116 0 0.247 0.058 0.334 0.145l5.702 5.702 5.702-5.702c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l0.725 0.725c0.087 0.087 0.145 0.218 0.145 0.334z"/>' +
    '<path fill="none" d="M0 0h24v24H0V0z"/>' +
    '</svg>';
  const arrowLeftSvg = '<svg class="btnColCollapse arrowLeft" id="arrowLeft" fill="#000000" width="18" height="18" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M14.436 19.036c0 0.116-0.058 0.247-0.145 0.334l-0.725 0.725c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-6.761-6.761c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l6.761-6.761c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l0.725 0.725c0.087 0.087 0.145 0.218 0.145 0.334s-0.058 0.247-0.145 0.334l-5.702 5.702 5.702 5.702c0.087 0.087 0.145 0.218 0.145 0.334zM20.008 19.036c0 0.116-0.058 0.247-0.145 0.334l-0.725 0.725c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-6.761-6.761c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l6.761-6.761c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l0.725 0.725c0.087 0.087 0.145 0.218 0.145 0.334s-0.058 0.247-0.145 0.334l-5.702 5.702 5.702 5.702c0.087 0.087 0.145 0.218 0.145 0.334z"/>' +
    '<path fill="none" d="M0 0h24v24H0V0z"/>' +
    '</svg>';
  const arrowRightSvg = '<svg class="btnColCollapse arrowRight" id="arrowRight" fill="#000000" width="18" height="18" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">' +
    '<path d="M14.436 13c0 0.116-0.058 0.247-0.145 0.334l-6.761 6.761c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-0.725-0.725c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l5.702-5.702-5.702-5.702c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l0.725-0.725c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l6.761 6.761c0.087 0.087 0.145 0.218 0.145 0.334zM20.008 13c0 0.116-0.058 0.247-0.145 0.334l-6.761 6.761c-0.087 0.087-0.218 0.145-0.334 0.145s-0.247-0.058-0.334-0.145l-0.725-0.725c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l5.702-5.702-5.702-5.702c-0.087-0.087-0.145-0.218-0.145-0.334s0.058-0.247 0.145-0.334l0.725-0.725c0.087-0.087 0.218-0.145 0.334-0.145s0.247 0.058 0.334 0.145l6.761 6.761c0.087 0.087 0.145 0.218 0.145 0.334z"/>' +
    '<path fill="none" d="M0 0h24v24H0V0z"/>' +
    '</svg>';
  const refreshSvg = '<svg class="btnRefresh" id="refresh" fill="#000000" width="18" height="18" viewBox="0 0 24 24" width="24"><path d="M0 0h24v24H0z" fill="none"/><path d="M17.65 6.35C16.2 4.9 14.21 4 12 4c-4.42 0-7.99 3.58-7.99 8s3.57 8 7.99 8c3.73 0 6.84-2.55 7.73-6h-2.08c-.82 2.33-3.04 4-5.65 4-3.31 0-6-2.69-6-6s2.69-6 6-6c1.66 0 3.14.69 4.22 1.78L13 11h7V4l-2.35 2.35z"/></svg>';
  const topHeaderColors = ["#555555","#5a5a5a","#646464","#747474"];
  const topHeaderFontColor = "#FFFFFF";
  const sideHeaderColors = ["#555555","#5a5a5a","#646464","#747474"];
  const sideHeaderFontColor = "#FFFFFF";
  const dataColor = "#0275d8";
  const collapseColumnHeaders = undefined;
  const collapseRowHeaders = undefined;
  const allowRISDownload = true;
  const showRecordCount = false;
  const showColumnDescriptions = false;
  const showRowDescriptions = false;

  const $window = $(window);
  const $announce = $('#announce');
  const $pivotTable = $('.pivot-table');
  const $pivotBody = $('.body');
  const $textualBody = $('.textual-body');
  const $topHead = $('.top-head');
  const $textWrapp = $('.text-wrapp');
  const $topHeadTable = $('table', $topHead);
  const $topHeadWrapper = $('.top-head-wrapper');
  const $sideHead = $('.side-head');
  const $leftTable = $('.left-table');
  const $sideHeadTable = $('table', $sideHead);
  const $footer = $('.footer');
  const $menu = $('.menu');
  const $veil = $('.veil');
  const $reader = $('.reader');
  const $accessibility = $('.accessibility');
  const $attributeTooltip = $('.attribute-tooltip');
  const $attributeTooltipContent = $('.attribute-tooltip .content')
  const $recordCount = $('.record-count');

  let $header = $('.header');
  let chartType = 'bubble';
  let filterMode = 'default';

  //On page load force focus
  $(".menu").focus();
  $(document).ready(function () {
    var inputs = $('.menu').find('button').filter(':visible');

    var firstInput = inputs.first();
    var lastInput = inputs.last();

    /*set focus on first input*/
    firstInput.focus();

    /*redirect last tab to first input*/
    lastInput.on('keydown', function (e) {
      if ((e.which === 9 && !e.shiftKey)) {
        e.preventDefault();
        firstInput.focus();
      }
    });

    /*redirect first shift+tab to last input*/
    firstInput.on('keydown', function (e) {
      if ((e.which === 9 && e.shiftKey)) {
        e.preventDefault();
        lastInput.focus();
      }
    });
  });

  /**
   * @param {String} value
   */
  function safeParseInt(value) {
    const parsed = parseInt(value, 10);
    if (isNaN(parsed)) {
      return 0;
    }
    return parsed;
  }

  /**
   * Convert reference object from the eppi mapper to a RIS entry
   * @param referenceItem
   */
  function exportItemToRIS(reference, selectedKeywords) {
    const calend = [
      'Jan',
      'Feb',
      'Mar',
      'Apr',
      'May',
      'Jun',
      'Jul',
      'Aug',
      'Sep',
      'Oct',
      'Nov',
      'Dec',
    ];
    const newLine = '\r\n';
    let res = 'TY  - ';
    let tmp = '';
    switch (reference.TypeId) {
      case 14:
        res += 'JOUR' + newLine;
        break;
      case 1:
        res += 'RPRT' + newLine;
        break;
      case 2:
        res += 'BOOK' + newLine;
        break;
      case 3:
        res += 'CHAP' + newLine;
        break;
      case 4:
        res += 'THES' + newLine;
        break;
      case 5:
        res += 'CONF' + newLine;
        break;
      case 6:
        res += 'ELEC' + newLine;
        break;
      case 7:
        res += 'ELEC' + newLine;
        break;
      case 8:
        res += 'ADVS' + newLine;
        break;
      case 10:
        res += 'MGZN' + newLine;
        break;
      default:
        res += 'GEN' + newLine;
        break;
    }
    res += 'T1  - ' + reference.Title + newLine;
    if (reference.TypeId == 10 || reference.TypeId == 14)
      res += 'JF  - ' + reference.ParentTitle + newLine;
    else res += 'T2  - ' + reference.ParentTitle + newLine;
    for (let au of reference.Authors.split(';')) {
      tmp = au.trim();
      if (tmp != '') res += 'A1  - ' + tmp + newLine;
    }
    for (let au of reference.ParentAuthors.split(';')) {
      tmp = au.trim();
      if (tmp != '') res += 'A2  - ' + tmp + newLine;
    }
    res +=
      'KW  - eppi-reviewer4' +
      newLine +
      (reference.Keywords != null && reference.Keywords.length > 2
        ? reference.Keywords.trim() + newLine
        : '');
    let tmpDate = '';
    let Month = safeParseInt(reference.Month);

    if (!Month || Month < 1 || Month > 12) {
      Month =
        1 + reference.Month.length > 2
          ? calend.indexOf(reference.Month.substring(0, 3)) + 1
          : 0;
    }
    let yr = safeParseInt(reference.Year);
    if (reference.Year !== '' && yr) {
      if (yr > 0) {
        if (yr < 20) yr += 1900;
        else if (yr < 100) yr += 2000;
        if (yr.toString().length == 4) {
          res += 'PY  - ' + yr.toString() + newLine;
          if (Month != 0) {
            tmpDate +=
            reference.Year +
              '/' +
              (Month.toString().length == 1
                ? '0' + Month.toString()
                : Month.toString()) +
              '//';
          } else {
            tmpDate += reference.Year + '///' + reference.Month; //"y1  - "
          }
        }
      }
    }
    if (tmpDate.length > 0) {
      res += 'DA  - ' + tmpDate + newLine;
      res += 'Y1  - ' + tmpDate;

      //little trick: edition information is supposed to be the additional info at the end of the
      //Y1 filed. For Thesis pubtype (4) we use the edition field to hold the thesys type,
      //the following finishes up the Y1 field keeping all this into account

      if (reference.TypeId == 4 && reference.Edition.length > 0)
        res += newLine + 'KW  - ' + reference.Edition + newLine;
      else if (reference.Edition.length > 0) res += ' ' + reference.Edition + newLine;
      else res += newLine;
    } else if (reference.TypeId == 4 && reference.Edition.length > 0) {
      res += newLine + 'KW  - ' + reference.Edition + newLine;
    } //end of little trick

    res += 'AB  - ' + reference.Abstract + newLine;
    if (reference.DOI.length > 0) res += 'DO  - ' + reference.DOI + newLine;
    res += 'VL  - ' + reference.Volume + newLine;
    res += 'IS  - ' + reference.Issue + newLine;
    let split = '-';
    Yr = reference.Pages.indexOf(split);
    if (Yr > 0) {
      let pgs = reference.Pages.split(split);
      res += 'SP  - ' + pgs[0] + newLine;
      res += 'EP  - ' + pgs[1] + newLine;
    } else if (reference.Pages.length > 0) res += 'SP  - ' + reference.Pages + newLine;
    res +=
      'CY  - ' +
      reference.City +
      (reference.Country.length > 0 ? ' ' + reference.Country : '') +
      newLine;
    if (reference.URL.length > 0) res += 'UR  - ' + reference.URL + newLine;
    if (reference.Availability.length > 0) res += 'AV  - ' + reference.Availability + newLine;
    if (reference.Publisher.length > 0) res += 'PB  - ' + reference.Publisher + newLine;
    if (reference.StandardNumber.length > 0)
      res += 'SN  - ' + reference.StandardNumber + newLine;
    res += 'U1  - ' + reference.ItemId.toString() + newLine;
    res += 'U2  - ' + selectedKeywords + newLine;
    if (reference.OldItemId.length > 0) res += 'U3  - ' + reference.OldItemId + newLine;

    res += 'N1  - ' + reference.Comments + newLine;

    res += 'ER  - ' + newLine + newLine;

    res = res.replace('     ', ' ');
    res = res.replace('    ', ' ');
    res = res.replace('   ', ' ');
    res = res.replace('   ', ' ');
    return res;
  }

  /**
   *
   * @param {Array} references - array of eppi reference objects
   */
  function handleRisDownloadButtonClick(references){
    const $downloadButton = $('#risDownload');
    const selectedKeywords = $('li.checked', '.reader-filter').map(function() { return $(this).text().trim() }).get().join('; ');

    // remove existing onclick handlers
    $downloadButton.unbind();
    $downloadButton.on('click', (e) => {
      const fileBlob = createRISFile(references, selectedKeywords);
      downloadRISFile(fileBlob);
    });
  }

  /**
   * Create a RIS file blcb from the given references.
   * @param selectedReferences - list of references to create a RIS file from
   * @returns {Blob}
   */
  function createRISFile(selectedReferences, selectedKeywords){
    const len = selectedReferences.length;
    let risData = '';
    for(let i = 0; i < len; i++){
      risData += exportItemToRIS(selectedReferences[i], selectedKeywords);
    }
    return new Blob([risData], { type: 'text/plain' });

  }

  /**
   * Download the File blob of the references.
   * @param {Blob} file
  */
  function downloadRISFile(file){
    const blobUrl = URL.createObjectURL(file);
    // Save the need for file-save.js
    const link = document.createElement("a");
    link.href = blobUrl;
    link.download = `references.ris`;
    link.click();
  }

  /**
   * Gets the colour for the headings.
   * @param stepNumber
   * @returns {number}
   */
  function getColor(side, stepNumber) {
    // let base = 24;
    // let steps = 5;
    // let step = 8;
    //
    // // stops a step being greater than 5
    // stepNumber = stepNumber % steps;
    // return base + (step * stepNumber);
    stepNumber = stepNumber % 4;
    if (side)
      return sideHeaderColors[stepNumber];
    else
      return topHeaderColors[stepNumber];
  }

  /**
   * Builds the table used as the column headers of the pivot table.
   */
  function buildTableColHead() {
    let tableHeadHtml = '';
    let rowClass = '';
    let styles = [];

    for (let i = 0; i < csvData.totalColDepth; i++) {
      let cellClass = '';

      if (i > 0 && (i + 1) < csvData.totalColDepth) {
        rowClass = 'header-can-hide'
      } else if ((i + 1) === csvData.totalColDepth) {
        cellClass = 'clickable-col'
        rowClass = ''
      } else {
        rowClass = ''
      }

      const row = csvData.rows[i];
      tableHeadHtml += '<tr class="' + rowClass + '">';

      for (let j = 0; j < row.length; j++) {
        const col = row[j];

        const colSpan = i === 0 && j === 0 ? csvData.totalColBreadth : col.span;

        let style = '';
        let title = '';

        if (i === 0) {
          style = 'style="background-color:' + getColor(false, 0) + ';color:' + topHeaderFontColor + ';"';
        }

        if (i === 1) {
          style = 'style="background-color:' + getColor(false, j) + ';color:' + topHeaderFontColor + ';"';

          for (let k = 0; k < colSpan; k++)
          {
            styles.push(style);
          }
        }

        if (i > 1) {
          style = styles[j];
        }
        
        if (showColumnDescriptions && col.setDescription.length > 0) {
          title = col.setDescription;
        }

        tableHeadHtml += '<th class="level-' + i + ' ' + cellClass + '" colspan="' + colSpan + '" title="' + title + '" ' + style + ' data-id="' + col.id + '">';
        tableHeadHtml += '<div>';

        if (i === 1) {
          tableHeadHtml += arrowLeftSvg;
          tableHeadHtml += arrowRightSvg;
          tableHeadHtml += refreshSvg;
        }

        tableHeadHtml += '<span>';
        tableHeadHtml += col.title;
        tableHeadHtml += '</span></div>';
        tableHeadHtml += '</th>'
      }

      tableHeadHtml += '</tr>';
    }

    $('table thead', $topHead).append(tableHeadHtml);
    topColHeight = $('table', $topHead).height();
    $('table', $topHead).height(topColHeight);
  }

  /*
  Build text view table headers
  */
  function buildTextHeaderTable() {
    let textHead = '';
    let rowClass = '';
    let styles = [];

    for (let i = 0; i < csvData.totalColDepth; i++) {
      let cellClass = '';

      if (i > 0 && (i + 1) < csvData.totalColDepth) {
        rowClass = 'header-can-hide'
      } else if ((i + 1) === csvData.totalColDepth) {
        cellClass = 'clickable-col'
        rowClass = ''
      } else {
        rowClass = ''
      }

      const row = csvData.rows[i];
      textHead += '<tr class="' + rowClass + '">';

      for (let j = 0; j < row.length; j++) {
        const col = row[j];
        const colSpan = i === 0 && j === 0 ? csvData.totalColBreadth : col.span;

        let style = '';
        let title = '';

        if (i === 0) {
          style = 'style="background-color:' + getColor(false, 0) + ';color:' + topHeaderFontColor + ';"';
        }

        if (i === 1) {
          style = 'style="background-color:' + getColor(false, j) + ';color:' + topHeaderFontColor + ';"';

          for (let k = 0; k < colSpan; k++) {
            styles.push(style);
          }
        }

        if (i > 1) {
          style = styles[j];
        }

        if (showColumnDescriptions && col.setDescription.length > 0) {
          title = col.setDescription;
        }

        textHead += '<th class="table-width level-' + i + ' ' + cellClass + '" colspan="' + colSpan + '" title="' + title + '" ' + style + ' data-id="' + col.id + '">';
        textHead += '<div>';

        textHead += '<span>';
        textHead += col.title;
        textHead += '</span></div>';
        textHead += '</th>'
      }

      textHead += '</tr>';
    }

    $('table thead', $textWrapp).append(textHead);
    topColHeight = $('table', $textWrapp).height();
    $('table', $textWrapp).height(topColHeight);
  }

  /**
   * Builds the table used as the row headers of the pivot table.
   */
  function buildTableRowHead() {
    let tableHeadHtml = '';
    let rowClass = '';
    let lightnessLevel = 0;
    let backgroundStyle = '';

    for (let i = csvData.totalColDepth; i < csvData.rows.length; i++) {
      const row = csvData.rows[i];
      tableHeadHtml += '<tr>';

      for (let j = 0; j < row.length; j++) {
        const col = row[j];
        const rowSpan = i === csvData.totalColDepth && j === 0 ? csvData.totalRowBreadth : col.span;
        const level = csvData.totalColDepth - row.length + j;

        let title = '';

        if (level <= 0) {
          backgroundStyle = 'background-color:' + getColor(true, 0) + ';color:' + sideHeaderFontColor + ';';
        }

        if (level === 1) {
          backgroundStyle = 'background-color:' + getColor(true, lightnessLevel) + ';color:' + sideHeaderFontColor + ';';
          lightnessLevel += 1;
        }

        if (level > 0 && (level + 1) < csvData.totalColDepth) {
          rowClass = 'header-can-hide'
        } else if ((level + 1) === csvData.totalColDepth) {
          rowClass = 'clickable-row'
        }

        if (showRowDescriptions && col.setDescription.length > 0) {
          title = col.setDescription;
        }

        tableHeadHtml += '<th class="level-' + level + ' ' + rowClass + '" rowspan="' + rowSpan + '" title="' + title + '" style="' + backgroundStyle + '" data-id="' + col.id + '">';
        tableHeadHtml += '<div>';

        if (level === 1) {
          tableHeadHtml += arrowUpSvg;
          tableHeadHtml += arrowDownSvg;
          tableHeadHtml += refreshSvg;
        }

        tableHeadHtml += '<span>';
        tableHeadHtml += col.title;
        tableHeadHtml += '</span></div>';
        tableHeadHtml += '</th>'
      }

      tableHeadHtml += '</tr>';
    }

    $('table tbody', $sideHead).append(tableHeadHtml);
    sideColWidth = $('table', $sideHead).width();
    $('table', $sideHead).width(sideColWidth);
  }

  /**
   * Creates the table columns of a row for the pivot table.
   */
  function buildTableColumns(cols, $colHeaders, rowIds) {
    let colIndex = 0;
    let tableColHtml = '';

    $colHeaders.each(function(colHeaderIndex, colHeader) {
      const $colHeader = $(colHeader);
      const colSpan = parseInt($colHeader.attr('colspan'));

      if ($colHeader.hasClass('collapsed')) {
        const colIds = [];

        for (let i = 0; i < colSpan; i++) {
          colIds.push(cols[colIndex].id);
          colIndex++;
        }

        tableColHtml += '<td class="cell" ' +
          'data-colid="' + colIds.join(',') + '" ' +
          'data-rowid="' + rowIds.join(',') + '">' +
          '</td>';
      } else {
        for (let i = 0; i < colSpan; i++) {
          tableColHtml += '<td class="cell" ' +
            'data-colid="' + cols[colIndex].id + '" ' +
            'data-rowid="' + rowIds.join(',') + '">' +
            '</td>';
          colIndex++;
        }
      }
    });

    return tableColHtml;
  }

  /**
   * Creates the table rows of the pivot table.
   */
  function buildTableRows() {
    let tableRowHtml = '';
    let rowIndex = csvData.totalColDepth;

    const cols = csvData.rows[csvData.totalColDepth - 1];
    const $colHeaders = $('.top-head .level-1');
    const $rowHeaders = $('.side-head .level-1');

    $rowHeaders.each(function(rowHeaderIndex, rowHeader) {
      const rowIds = [];
      const $rowHeader = $(rowHeader);
      const rowSpan = parseInt($rowHeader.attr('rowspan'));

      if ($rowHeader.hasClass('collapsed')) {
        tableRowHtml += '<tr>';
        for (let i = 0; i < rowSpan; i++) {
          const row = csvData.rows[rowIndex];
          rowIds.push(row[row.length - 1].id);
          rowIndex++;
        }
        tableRowHtml += buildTableColumns(cols, $colHeaders, rowIds);
        tableRowHtml += '</tr>';
      } else {
        tableRowHtml += '<tr>';
        for (let i = 0; i < rowSpan; i++) {
          const row = csvData.rows[rowIndex];
          tableRowHtml += buildTableColumns(cols, $colHeaders, [row[row.length - 1].id]);
          rowIndex++;
          tableRowHtml += '</tr>';
        }
      }
    });

    $('table tbody', $pivotBody).html(tableRowHtml);
  }

  /**
   * Gets references that match the given row and column lists.
   * @param rowIdList
   * @param colIdList
   * @returns {Array}
   * @constructor
   */
  function getFilteredReferences(rowIdList, colIdList) {
    const references = [];
    const refMatches = referenceData
      .filter((reference) => {
        if (!reference.hasOwnProperty('Codes')) return false;

        //#region This Code Does All The Reader Filtering
        if (rowIdList.length > 0 && colIdList.length > 0) { // if we have selection in both column and row....
          for (const rowId of rowIdList) {  // for each row in the list of rows
            for (const colId of colIdList) {  // get a column in the list of columns
              if (reference.Codes // of the references that have codes,, does this particular reference have at least 2 codes that match rowid and colid
                .filter((code) => code.AttributeId === rowId || code.AttributeId === colId).length >= 2){
                  return true;
                }
            }
          }
        } else {
          for (const code of reference.Codes) {
            if (rowIdList.length === 0) {  // No row intersections to check for.
              if (colIdList.indexOf(code.AttributeId) >= 0) return true;
            } else if (colIdList.length === 0) {  // No column intersections to check for.
              if (rowIdList.indexOf(code.AttributeId) >= 0) return true;
            }
          }
        }
        //#endregion

        return false;
      });

    for (const reference of refMatches) {
      //#region does filtering in the settings menu (affects map display)
      if (filterMode === 'default'){
        //#region Check all the filters. (Parent AND > Child OR)
        const parentFilters = filters.filter((item) => item.checked);
        let refMatchesFilter = parentFilters.length === 0;

        for (const parentFilter of parentFilters) {
          refMatchesFilter = false;

          for (const childFilter of parentFilter.children.filter((item) => item.checked)) {
            const childFilterMatch = reference.Codes.filter((code) => code.AttributeId === childFilter.id).length > 0;

            if (childFilterMatch) {
              refMatchesFilter = true;
              break; // exit this loop --> immediately goes into execution of the parentFilter loop; leaves childfilter loops
                      // result is we end up not checking each selected child item for a match,, resulting in an "OR" condition; "AND" condition would include all selected child items
            }
          }

          // if we do not match in the child filters, then we know it's not AND and we
          // can break.
          if (!refMatchesFilter) break;
        }

        // if we do not match all active parent filters then we do not count this.
        if (!refMatchesFilter) continue;

        references.push(reference);
        //#endregion
      } else if (filterMode === 'and') {
        //#region Check all the filters. (Parent AND == Child AND)
        const parentFilters = filters.filter((item) => item.checked);
        let refMatchesFilter = parentFilters.length === 0;

        for (const parentFilter of parentFilters) { // when checking each parent filter item,
          refMatchesFilter = false; // reset match to false
          const childFilters = parentFilter.children.filter((item) => item.checked);  // filter out child filter items

          for (const childFilter of childFilters) { // each child filter item
            refMatchesFilter = false; // reset match to false
            const childFilterMatch = reference.Codes.filter((code) => code.AttributeId === childFilter.id).length > 0;  // check if child filter item's code matches any reference code

            if (childFilterMatch) { // if child filter item matches at least 1 reference code,
              refMatchesFilter = true;  // set match to true
              // continue this loop --> we do not immediately go into execution of the parentFilter loop; stay in childfilter loops
              // result is we check each selected child item for a match, returning only references which do match, resulting in an "AND" condition
            } else {
              // refMatchesFilter = false;
              break;
            }
          }

          if (!refMatchesFilter) break;
        }

        if (!refMatchesFilter) continue;

        references.push(reference);
        //#endregion
      } else if (filterMode === 'or') {
        //#region Check all the filters. (Parent OR == Child OR)
        const parentFilters = filters.filter((item) => item.checked);
        let refMatchesFilter = parentFilters.length === 0;

        for (const parentFilter of parentFilters) {
          const childFilters = parentFilter.children.filter((item) => item.checked);

          for (const childFilter of childFilters) {
            const childFilterMatch = reference.Codes.filter((code) => code.AttributeId === childFilter.id).length > 0;

            if (childFilterMatch) {
              refMatchesFilter = true;
              break;
            }
          }

          if (!refMatchesFilter) continue;
        }

        if (!refMatchesFilter){
        } else {
          references.push(reference);
        }
        //#endregion
      }
      //#endregion
    }

    return references;
  }

  /**
   * Builds the legend.
   */
  function buildLegend() {
    if (segmentAttributes === null) return;

    let legendHtml = '';

    segmentAttributes.forEach((segment) => {
      legendHtml += '<span class="legend-item" data-description="' + segment.attribute.AttributeSetDescription + '">' +
          '<span class="dot" style="background-color: ' + segment.color + '"></span>' +
          '<span class="label">' + segment.attribute.AttributeName + '</span></span>'
    })

    $('.legend').html(legendHtml);
  }

  /**
   * Creates a pie png image as a data url.
   */
  function createPiePng(counts) {
    let currentPoint = 0;
    let conicGrad = '';

    for (const count of counts) {
      currentPoint += count.width;
      if (conicGrad.length > 0) conicGrad += ', ';
      conicGrad += count.color + ' 0 ' + currentPoint + '%';
    }

    if (currentPoint < 100) {
      if (conicGrad.length > 0) conicGrad += ', ';
      conicGrad += '#eeeeee 0';
    }

    const gradient = new ConicGradient({
      stops: conicGrad,
      size: 97
    });

    const png = gradient.png;

    // Clean up memory issues once we have our PNG.
    $(gradient.canvas).empty().remove();
    delete gradient.canvas;

    return png;
  }

  /**
   * Create the mosiac svg
   *
   * @param {Number} dimension
   * @param {Array} references
   */
  function createMosaic(dimension, references) {
    let x = 0;
    let y = 0;

    let html = `<svg width="100" height="100" xmlns="http://www.w3.org/2000/svg">
   <defs>
   <pattern id="grid" width="${dimension}" height="${dimension}" patternUnits="userSpaceOnUse">
   <path d="M ${dimension} 0 L 0 0 0 ${dimension}" fill="none" stroke="white" stroke-width="0.5" />
   </pattern>
   </defs >
    <rect width="100%" height="100%" fill="url(#grid)" />`;

    for (const ref of references) {
      html += `<rect width="${dimension}" height="${dimension}" fill="${ref}" x="${x}" y="${y}" stroke="white" stroke-width="0.5" />`;
      x += dimension;

      if (x > 90) {
        x = 0;
        y += dimension
      }
    }

    html += '</svg >';


    return html;
  }

  /**
   * Creates the initial zero counts for the block.
   * @param rowIds
   * @param colIds
   */
  function createInitialCounts(rowIds, colIds) {
    let counts = [];

    if (segmentAttributes.length === 0) {
      counts.push({
        id: rowIds.join('_') + '-' + colIds.join('_'),
        attribute: null,
        color: dataColor,
        count: 0,
        width: 0,
        size: 0
      })
    } else {
      for (const segment of segmentAttributes) {
        counts.push({
          id: segment.attribute.AttributeId,
          attribute: segment.attribute,
          color: segment.color,
          isLight: segment.isLight,
          count: 0,
          width: 0,
          size: 0
        })
      }
    }

    return counts
  }

  /**
   * Calculate the dimensions of the blocks that will go in the svg grid
   *
   * @param {Number} minRequiredBlocks minimum required mosiac tiles (equal to max number of references)
   * @param {Number} containerDimension dimensions of the container
   */
  function getBlockSize(minRequiredBlocks, containerDimension) {
    let number = Math.round(Math.sqrt(minRequiredBlocks));
    while (containerDimension % number != 0 && number < containerDimension) {
      number = number + 1;
    }
    return containerDimension / number;
  }

  /**
   * Updates all the reference counts and creates the visuals.
   */
  function updateReferenceCounts() {
    let maxCount = 0;

    // Remove old html and detach events.
    $('.cell', $pivotBody).off();
    $('.pie-wrapper').off().detach().remove();
    $('.data-wrapper').off().detach().remove();

    $('.cell', $pivotBody).each((index, cell) => {
      const $cell = $(cell);
      let colIds = $cell.data('colid')
      let rowIds = $cell.data('rowid');

      if (isNaN(colIds)) {
        colIds = colIds.split(',').map(id => parseInt(id));
      } else {
        colIds = [colIds]
      }

      if (isNaN(rowIds)) {
        rowIds = rowIds.split(',').map(id => parseInt(id));
      } else {
        rowIds = [rowIds]
      }

      const references = getFilteredReferences(rowIds, colIds);
      const counts = createInitialCounts(rowIds, colIds);

      let totalCount = 0;

      for (const reference of references) {
        for (const count of counts) {
          if (count.attribute === null) {
            totalCount += 1;
            count.count += 1;
            continue;
          }

          const countMatched = reference.Codes
            .filter((code) => code.AttributeId === count.id).length > 0

          if (countMatched) {
            count.count += 1;
            totalCount += 1;
          }
        }
      }

      if (totalCount === 0) {
        $cell.addClass('none');
      } else {
        $cell.removeClass('none');
      }

      if (totalCount > maxCount) {
        maxCount = totalCount
      }

      for (const count of counts) {
        count.width = totalCount === 0 || count.count === 0 ? 0 : Math.round(count.count / totalCount * 100);

        // Check if the count is a sane amount to see, if not, make it the minimum.
        if (count.width < 8 && count.count !== 0) count.width = 8
      }

      // Sort counts descending.
      counts.sort(function(a, b) { return b.count - a.count});

      $cell.data('totalSize', 0);
      $cell.data('totalCount', totalCount);
      $cell.data('counts', counts);

      let wrapper = '';

      if (counts.length > 0) {
        switch (chartType) {
          case 'bubble':
          case 'heat':
          case 'text':
            wrapper = '<div class="data-wrapper">'

            let counter = 1;

            for (const count of counts) {
              if (count.count === 0) continue;

              let style = 'background-color:' + count.color + ';';

              if (!count.isLight) {
                style += 'color:#ffffff;';
              }

              wrapper += '<div id="' + count.id + '" ' +
                'class="data" ' +
                'style="' + style + '">';

              if (chartType === 'text') {
                if (count.attribute !== null) {
                  wrapper += `<span class="count">${count.count}</span><span class="name">${count.attribute.AttributeName}</span>`;
                } else if (count.count > 1) {
                  wrapper += `<span class="count">${count.count}</span><span class="name">Records</span>`;
                } else {
                  wrapper += `<span class="count">${count.count}</span><span class="name">Record</span>`;
                }
              }

              wrapper += '</div>';

              if (chartType !== 'text' && counter % 2 === 0) {
                wrapper += '<div class="break"></div>'
              }

              counter ++;
            }

            wrapper += '</div>'

            break;
          case 'mosaic':
            wrapper = '<div class="mosaic-wrapper"></div>'
            break;
          case 'donut':
            const png = createPiePng(counts);
            const piePngStyle = png.length > 0 ? ' style="background-image: url(' + png + ')"' : '';
            wrapper = `<div class="pie-wrapper"><div class="pie"${piePngStyle}></div><div class="pie-hole"></div></div>`
            break;
        }
      }

      $cell.html(wrapper);
    });

    // Update the size of the chart elements.
    $('.cell', $pivotBody).each((index, cell) => {
      const $cell = $(cell);
      const totalCount = $cell.data('totalCount');
      const counts = $cell.data('counts');

      for (const count of counts) {
        count.size = count.count === 0 ? 0 : Math.round(count.count / maxCount * 100);
        // Check if the count is a sane amount to see, if not, make it the minimum.
        if (count.size < 8 && count.count !== 0) count.size = 8
      }

      let totalSize = totalCount === 0 ? 0 : Math.round(totalCount / maxCount * 100);
      // Check if the count is a sane amount to see, if not, make it the minimum.
      if (totalSize < 8 && totalCount !== 0) totalSize = 8

      $cell.data('counts', counts);
      $cell.data('totalSize', totalSize);
      $cell.data('maxCount', maxCount);
    });

    // Setup events.
    setupTooltips();
    handleTableClick();
  }

  /**
   * Switches between the bubble and heat-map views.
   */
  function updateTableDataView() {
    $('.cell', $pivotBody).each((index, cell) => {
      const $cell = $(cell);
      const counts = $cell.data('counts');
      const totalSize = $cell.data('totalSize');
      const totalWidth = $cell.data('totalWidth');
      const maxCount = $cell.data('maxCount');
      const blockSize = 100;

      switch (chartType) {
        case 'bubble':
          $('.data-wrapper', $cell).css({
            'display': 'flex'
          });
          $('.data', $cell).css({
            'border-radius': '100%'
          });
          break;
        case 'heat':
          $('.data-wrapper', $cell).css({
            'display': 'flex',
            'opacity': (totalSize / 100)
          });
          break;
        case 'mosaic':
          $('.mosaic-wrapper', $cell).css({
            'display': 'block'
          });
          const dimension = getBlockSize(maxCount, 100);
          // Get colours from segments
          const referenceColours = counts.map(x => new Array(x.count).fill(x.color));
          const references = [].concat.apply([], referenceColours);
          let mosaic = createMosaic(dimension, references);
          $('.mosaic-wrapper', $cell).html(mosaic)
          break;
        case 'donut':
          const circleSize = (blockSize * totalSize / 100);
          let holeSize = totalSize - (circleSize / blockSize * 24);
          if (holeSize < 0) holeSize = 0;

          $('.pie-wrapper', $cell).css({
            'display': 'block'
          });

          $('.pie', $cell).css({
            'width': circleSize + '%',
            'height': circleSize + '%'
          });

          $('.pie-hole', $cell).css({
            'width': holeSize + '%',
            'height': holeSize + '%'
          });
          break;
        case 'text':
          break;
      }

      if (chartType !== 'text') {
        let maxBlockSize = blockSize;

        if (segmentAttributes.length > 1) {
          maxBlockSize = blockSize / (segmentAttributes.length / 2);
        }

        for (const [index, count] of counts.entries()) {
          let size = blockSize * count.size / 100;

          // Check if the count is a sane amount to see, if not, make it the minimum.
          if (size < 8 && count.count !== 0) size = 8;
          else if (size > maxBlockSize && count.count !== 0) size = maxBlockSize;

          $('#' + count.id, $cell).css({
            'height': chartType === 'bubble' ? size + 'px' : '100%',
            'width': chartType === 'bubble' ? size + 'px' : count.width + '%'
          });
        }

        setTimeout(function () {
          $('.data-wrapper', $cell).css({
            'opacity': chartType === 'heat' ? totalWidth / 100 : 1
          });
        }, 500);
      }
    });
  }

  /**
   * Cross browser functionality to request full screen access.
   * https://developer.mozilla.org/en-US/docs/Web/API/Fullscreen_API#Toggling_fullscreen_mode
   */
  function toggleFullScreen() {
    if (!document.fullscreenElement &&    // alternative standard method
      !document.mozFullScreenElement && !document.webkitFullscreenElement && !document.msFullscreenElement ) {  // current working methods
      if (document.documentElement.requestFullscreen) {
        document.documentElement.requestFullscreen();
      } else if (document.documentElement.msRequestFullscreen) {
        document.documentElement.msRequestFullscreen();
      } else if (document.documentElement.mozRequestFullScreen) {
        document.documentElement.mozRequestFullScreen();
      } else if (document.documentElement.webkitRequestFullscreen) {
        document.documentElement.webkitRequestFullscreen(Element.ALLOW_KEYBOARD_INPUT);
      }
    } else {
      if (document.exitFullscreen) {
        document.exitFullscreen();
      } else if (document.msExitFullscreen) {
        document.msExitFullscreen();
      } else if (document.mozCancelFullScreen) {
        document.mozCancelFullScreen();
      } else if (document.webkitExitFullscreen) {
        document.webkitExitFullscreen();
      }
    }
  }

  /**
   * Helper function to build the full table.
   */
  function buildTable() {
    buildTableColHead();
    buildTextHeaderTable();
    buildTableRowHead();
    buildTableRows();

    // Update data in the table.
    updateReferenceCounts();
    updateTableDataView();
  }

  /**
   * Sets the filter state of the the given filter ID by either adding it or
   * removing it from a list of unchecked filter IDs.
   * @param checkFilters
   * @param filterId
   * @param klass
   */
  function setFilterState(checkFilters, filterId, klass) {
    for (const filter of checkFilters) {
      if (filterId === filter.id) {
        filter.checked = klass === 'checked' || klass === 'indeterminate';
      }

      if (filter.children.length > 0) {
        setFilterState(filter.children, filterId, klass);
      }
    }
  }

  /**
   * Updates the filter's parent node's state.
   * @param $target
   */
  function updateFilterParentNodeCheckedState($target) {
    let hasChecked = false;
    let hasUnchecked = false;
    let hasIndeterminate = false;

    $target.next().children().each(function () {
      const klass = $(this).attr('class');

      if (klass === 'checked') {
        hasChecked = true;
      } else if (klass === 'unchecked') {
        hasUnchecked = true;
      } else {
        hasIndeterminate = true;
      }
    })

    let klass = '';

    if (hasChecked && !hasUnchecked && !hasIndeterminate) {
      klass = 'checked'
    } else if (!hasChecked && hasUnchecked && !hasIndeterminate) {
      klass = 'unchecked'
    } else if ((hasChecked && hasUnchecked && !hasIndeterminate) ||
      (hasChecked && !hasUnchecked && hasIndeterminate) ||
      (!hasChecked && hasUnchecked && hasIndeterminate) ||
      (hasChecked && hasUnchecked && hasIndeterminate)) {
      klass = 'indeterminate'
    }

    if (klass.length > 0) {
      const filterId = $target.data('id');
      setFilterState(filters, filterId, klass);

      $target
        .removeClass($target.attr('class'))
        .addClass(klass);
    }
  }

  /**
   * Updates the filter's node state and calls it's children r
   * recursively.
   * @param $target
   * @param newKlass
   */
  function updateFilterNodeCheckedState($target, newKlass = '') {
    const klass = $target.attr('class');
    $('#filterClearButton').attr('disabled',false);

    if (newKlass.length === 0) {
      if (klass === 'checked') {
        newKlass = 'unchecked';
      } else {
        newKlass = 'checked';
      }
    }

    const $next = $target.next();

    if ($next.is('ul')) {
      $next.children().each(function () {
        updateFilterNodeCheckedState($(this), newKlass);
      })
    }

    if ($target.is('li')) {
      const filterId = $target.data('id');
      setFilterState(filters, filterId, newKlass);

      $target
        .removeClass(klass)
        .addClass(newKlass);

      const $parent = $target.parent().prev();
      updateFilterParentNodeCheckedState($parent);
    }
  }

  /**
   * Update's the filter type and the checked state of the radios.
   * @param $filters
   * @param $target
   */
  function updateFilterMode($filters, $target) {
    const klass = $target.attr('class');
    if (klass === 'checked') return;

    filterMode = $target.data('id');

    $('.filter-type-wrapper li', $filters)
        .removeClass('checked')
        .addClass('unchecked');
    $target
        .removeClass('unchecked')
        .addClass('checked');
  }

  /**
   * Creates a filter node recursively.
   * @param filters
   * @returns {string}
   */
  function createFilterNode(filters) {
    let filterHtml = '<ul>';

    for (const filter of filters) {
      filterHtml += '<li class="unchecked" data-id="' + filter.id + '">' +
        checkboxCheckedSvg +
        checkboxUncheckedSvg +
        checkboxIndeterminateSvg +
        ' <span>' + filter.label + '</span></li>';

      if (filter.children.length > 0) filterHtml += createFilterNode(filter.children);
    }

    filterHtml += '</ul>';
    return filterHtml;
  }

  /**
   * Creates the elements for the settings panel and hooks up
   * the events.
   */
  function createSettingsPanel() {
    const $filters = $('.settings');

    // Open filter if it should be auto open.
    if (autoOpenFilter) {
      $filters.css({display: 'block'});
      $filters.addClass('open');
      $veil.addClass('open');
      settingsFocusTrap.activate();
    }

    let settingsHtml = '<div class="title clearfix">' +
      '<span id="settingsTitle">Filters</span>' +
      '<button class="btnSettings right" id="close" role="button" aria-label="Close filters">close</button>' +
      '<button class="btnSettings left disabled" id="update" role="button" aria-label="Update filters">update</button>' +
      '</div>';
    settingsHtml += createFiltersPanel();

    $filters.html(settingsHtml);

    $('.filter-type-wrapper li', $filters).on('click', (e) => {
      updateFilterMode($filters, $(e.currentTarget));
      $('.disabled').removeClass('disabled');
      $('#update', $filters).on('click', handleUpdate);
    });

    $('.filter-wrapper li', $filters).on('click', (e) => {
      updateFilterNodeCheckedState($(e.currentTarget));
      $('.disabled').removeClass('disabled');
      $('#update', $filters).on('click', handleUpdate);
    });

    $('.menu-settings').on('click', function () {
      $filters.css({display: 'block'});
      $filters.addClass('open');
      $veil.addClass('open');
      $filters.focus();
      settingsFocusTrap.activate();
    });    

    $('#filterClearButton').on('click', function () {
      const $filterButton = $('#filterClearButton');
      const $filteritems = $('.filter-wrapper ul > li');

      for (const item of $filteritems) {
        const $item = $(item);
        updateFilterNodeCheckedState($item, 'unchecked');
      }
      $filterButton.attr('disabled', true);
      $('.disabled').removeClass('disabled');
      $('#update', $filters).on('click', handleUpdate);
    })

    $('#close', $filters).on('click', function () {
      if (!$('#update', $filters).hasClass('disabled')) {
        if (!confirm('You have not updated the map with your changes. Are you sure you want to close?')) {
          return;
        }
      }

      $filters.removeClass('open');
      $veil.removeClass('open');
      $filters.css({display: 'none'});
      settingsFocusTrap.deactivate();
      $('.menu-settings').focus();
    });

    // Close modal on escape key
    $filters.on('keydown', function (event) {
      if (event.key === "Escape") {
        if (!$('#update', $filters).hasClass('disabled')) {
          if (!confirm('You have not updated the map with your changes. Are you sure you want to close?')) {
            return;
          }
        }
  
        $filters.removeClass('open');
        $veil.removeClass('open');
        $filters.css({display: 'none'});
        settingsFocusTrap.deactivate();
        $('.menu-settings').focus();
      }
    });

    function handleUpdate() {
      const $update = $(this);
      $update.addClass('busy');

      setTimeout(() => {
        updateReferenceCounts();
        updateTableDataView();
        UpdateRecordCount();

        $filters.removeClass('open');
        $veil.removeClass('open');
        $update.removeClass('busy')
          .addClass('disabled');
        $update.off('click');
        $filters.css({display: 'none'});
        settingsFocusTrap.deactivate();
        $('.menu-settings').focus();
      }, 300);
    }
  }

  /**
   * Creates the filter section elements for the settings panel.
   * @returns {string}
   */
  function createFiltersPanel() {
    let filterHtml = `<div class="filter-type-wrapper">
        <h2>Filter mode</h2>
        <ul>
          <li class="${filterMode === 'default' ? 'checked': 'unchecked'}" data-id="default">
            ${radioCheckedSvg}
            ${radioUncheckedSvg}
            <span>Default <small>(OR within sections, AND across sections)</small></span>
          </li> 
          <li class="${filterMode === 'and' ? 'checked': 'unchecked'}" data-id="and">
            ${radioCheckedSvg}
            ${radioUncheckedSvg}
            <span>And</span>
          </li> 
          <li class="${filterMode === 'or' ? 'checked': 'unchecked'}" data-id="or">
            ${radioCheckedSvg}
            ${radioUncheckedSvg}
            <span>Or</span>
          </li> 
        </ul>
      </div>
      <div class="filter-wrapper">
        <h2>Filters</h2>`;
      filterHtml +=
      '<button id="filterClearButton">Clear Filter</button>';
    filterHtml += createFilterNode(filters);
    filterHtml +=
    '</div>';

    return filterHtml;
  }

  function handleStyleClicked(e) {
    const styleButtons = document.querySelectorAll('button[data-style]');

    chartType = e.currentTarget.dataset.style;

    for (var i = 0; i < styleButtons.length; i++) {
      styleButtons[i].ariaChecked = false;
    }

    e.currentTarget.ariaChecked = true;

    if (chartType === 'text') {
      $pivotTable.addClass('text-view');

      if (segmentAttributes.length > 4) {
        $pivotTable.addClass('text-view-large');
      }
    } else {
      $pivotTable.removeClass('text-view');
      $pivotTable.removeClass('text-view-large');
    }

    adjustTable();
    updateReferenceCounts();
    updateTableDataView();

    $announce.html('Map changed to ' + chartType + 'view.');
  }

  function setupStyleSwitch() {
    var styleButtons = document.querySelectorAll('button[data-style]');
    var donutStyleButton = document.querySelectorAll('button[data-style="donut"]');

    for (var i = 0; i < styleButtons.length; i++) {
      styleButtons[i].onclick = handleStyleClicked;
    }

    if (segmentAttributes.length === 0 && donutStyleButton.length > 0) {
      donutStyleButton[0].style.display = 'none';
    }
  }

  /**
   * Creates the tooltip for the cell as it's hovered over.
   */
  function setupTooltips() {
    $('.cell').hover((e) => {
      if (chartType === 'text') return;

      // Hover.
      const $target = $(e.currentTarget);
      const totalCount = $target.data('totalCount');

      if (totalCount <= 0) {
        return
      }

      const counts = $target.data('counts');

      let tooltipHtml = '<div class="tooltip">';

      for (const count of counts) {
        if (count.count === 0) continue;

        let title = 'Record';

        if (count.count > 1) {
          title = 'Records';
        }

        if (count.attribute !== null) {
          title = count.attribute.AttributeName
        }

        tooltipHtml += '<div class="count">' +
          '<span style="background-color: ' + count.color + ';">' + count.count + '</span> ' +
          title +
          '</div>';
      }

      tooltipHtml += '</div>';

      $(tooltipHtml)
        .appendTo('body')
        .fadeIn('fast');
    }, (e) => {
      // Hover out.
      $('.tooltip').remove();
      delete $('.tooltip');
    }).mousemove((e) => {
      $('.tooltip')
        .css({
          top: e.pageY + 10,
          left: e.pageX + 10
        });
    });
  }

  /**
   * Creates the meta item in the reader for the reference key
   * passed in.
   * @param key
   * @param reference
   * @returns {string}
   */
  function createMetaItem(key, reference) {
    let metaItem = '';
    const renameKeys = {
      'Journal': 'ParentTitle'
    }
    let tempKey = renameKeys[key];
    if (reference[tempKey] == undefined) {
      tempKey = key
    }

    if (tempKey !== summaryAttribute && reference[tempKey] !== undefined && reference[tempKey].length > 0) {

      let label = '';
      label = key

      metaItem += '<div class="meta-data-item clearfix ' + tempKey + '">';
      metaItem += '<label>' + label.replace(/([^A-Z])([A-Z])/g, '$1 $2') + '</label>';
      metaItem += '<span>' + reference[tempKey] + '</span>';
      metaItem += '</div>'
    }

    return metaItem;
  }

  /**
   * Creates the elements to read a review.
   * @param refId
   */
  function selectReference(refId) {
    const references = referenceData.filter((reference) => {
      return reference.ItemId === refId;
    });

    if (references.length === 0) {
      $('.read').html('');
      return;
    }

    const reference = references[0];
    let refHtml = '<h2>' + reference.Title + '</h2>';
    refHtml += '<hr>';

    if (reference.Abstract !== undefined && reference.Abstract.length > 0) {
      refHtml += '<p>' + reference.Abstract.replace(/\r/g, '<br>') + '</p>';
      refHtml += '<hr>';
    } else if (summaryAttribute.length > 0 && reference[summaryAttribute] !== undefined && reference[summaryAttribute].length > 0) {
      refHtml += '<p>' + reference[summaryAttribute].replace(/\r/g, '<br>') + '</p>';
      refHtml += '<hr>';
    }

    if (reference.URL !== undefined && reference.URL.length > 0) {
      refHtml += '<ol class="refs">';
      refHtml += '<li><a class="small" href="' + reference.URL + '" target="_blank"> Read full article:' + reference.Title + '</a></li>';

      if (reference.DOI === undefined || reference.DOI.length === 0) {
        refHtml += '</ol>';
        refHtml += '<hr>';
      }
    }

    if (reference.DOI !== undefined && reference.DOI.length > 0) {
      if (reference.URL === undefined || reference.URL.length === 0) {
        refHtml += '<ol class="refs">';
      }

      refHtml += '<li><a class="small" href="' + reference.DOI + '" target="_blank"> Read full article:' + reference.Title + '</a></li>';
      refHtml += '</ol>';
      refHtml += '<hr>';
    }

    refHtml += '<div class="meta-data">';
    for (const key of metaProperties) {
      refHtml += createMetaItem(key, reference);
    }

    var matchedExturlAttributes = [];
    refHtml += "<div> <hr>";
    // checking for matches with external Attribute URLs to display in reader
    for (const attribute of externalURLedAttributes) {
      matchedExturlAttributes = reference.Codes.filter(code =>
        code.AttributeId === attribute.AttributeId);
      if (matchedExturlAttributes.length > 0 && attribute.ExtURL !== "" && attribute.ExtURL !== undefined) {
        refHtml +=
        '<span>' + attribute.AttributeName + '<br>' +
          '<a href="' + attribute.ExtURL + '" target="_blank">' + attribute.ExtURL + '</a>' +
        '</span><br>';
      }
    }
    refHtml +='</div>';

    refHtml += '</div>';

    $('.read', $reader).html(refHtml);
    $('#Article').attr("aria-labeledby", "ArticleTitle" + refId);
    $announce.html(reference.Title + 'has been selected.');
  }

  /**
   * Updates the reader to show the newly filtered/changed references.
   * @param references
   */
  function updateReferenceReader(references, justOpened = false) {
    $('.refMenuItem').off();

    const readerOrder = $('#RefSortOrder').val();

    if (readerOrder === 'title') {
      references.sort(function (a, b) {
        if (a.Title > b.Title) return 1;
        else if (a.Title < b.Title) return -1;
        else return 0;
      });
    } else if (readerOrder === 'author') {
      references.sort(function (a, b) {
        if (a.Authors > b.Authors) return 1;
        else if (a.Authors < b.Authors) return -1;
        else return 0;
      });
    } else if (readerOrder === 'date') {
      references.sort(function (a, b) {

        let aDateStr = '';
        let bDateStr = '';

        if (a.Month.length !== 0) {
          aDateStr += a.Month + ' 01, ';
        }
        aDateStr += a.Year;

        if (b.Month.length !== 0) {
          bDateStr += b.Month + ' 01, ';
        }
        bDateStr += b.Year;

        const aDate = Date.parse(aDateStr);
        const bDate = Date.parse(bDateStr);

        if (aDate > bDate) return 1;
        else if (aDate < bDate) return -1;
        else return 0;
      });
    }

    let title = '';
    let textToRead = '';

    if (justOpened) {
      textToRead = 'Reader modal opened. '
    }

    if (references.length === 0) {
      textToRead += 'No search results available.'
    } else
    if (references.length === 1) {
      title = references.length + ' Record'
      textToRead += references.length + ' search result available.'
    } else {
      title = references.length + ' Records'
      textToRead += references.length + ' search results are available.'
    }

    $groupingSelect = $('.grouping-opts');

    let refsHtml = '';

    if ($groupingSelect.val() === 'none') {   // no grouping
      //#region ADDS ALL THE STUDIES INTO AN UNSEGMENTED LIST
      refsHtml = '<ul>';

      for (const ref of references) {
        let colors = [];

        for (const code of ref.Codes) {
          for (const segment of segmentAttributes) {
            if (code.AttributeId === segment.attribute.AttributeId) {
              colors.push(segment.color);
            }
          }
        }

        refsHtml += '<li class="refMenuItem" data-refid="' + ref.ItemId + '" segmented="no">' +
          '<button aria-controls="Article">' +
          '<div class="title" id="ArticleTitle' + ref.ItemId + '">' + ref.Title + '</div>' +
          '<div class="auth">' + ref.Authors + '</div>';

        refsHtml += '<div class="date">';

        if (ref.Month.length !== 0) {
          refsHtml += ref.Month + ', ';
        }

        refsHtml += ref.Year;

        for (let color of colors) {
          refsHtml += '<span class="refMenuItemLegend" style="background-color: ' + color + '" />';
        }

        refsHtml += '</div>';
        refsHtml += '</button>';
        refsHtml += '</li>';
      }

      refsHtml += '</ul>';
      // #endregion
    } else if ($groupingSelect.val() === 'segment') {  // group by segments
      //#region ADD STUDIES INTO INDIVUDUAL UNORDERED LISTS
      refsHtml = '<ul class="segmented">';

      for (const segment of segmentAttributes){
        refsHtml +=
        '<li style="border-left:2px solid ' + segment.color + ';">' +
          '<div class="segment-title" style="border-bottom: 3px solid ' + segment.color + ';border-left: 5px solid ' + segment.color + '">'
            + segment.attribute.AttributeName +
          '</div>' +
          '<ul>';
            for (const ref of references) {
              let colors = [];

              for (const code of ref.Codes) {
                for (const segment of segmentAttributes){
                  if (code.AttributeId === segment.attribute.AttributeId) {
                    colors.push(segment.color);
                  }
                }
              }
              for (const code of ref.Codes) {
                if (code.AttributeId === segment.attribute.AttributeId) {
                  refsHtml +=
                  '<li class="refMenuItem" data-refid="' + ref.ItemId + '" segmented="yes">' +
                  '<button aria-controls="Article">' +
                  '<div class="title" id="ArticleTitle' + ref.ItemId + '">' + ref.Title + '</div>' +
                  '<div class="auth">' + ref.Authors + '</div>';

                  refsHtml += '<div class="date">';

                  if (ref.Month.length !== 0) {
                    refsHtml += ref.Month + ', ';
                  }

                  refsHtml += ref.Year;

                  for (let color of colors) {
                    refsHtml +=
                    '<span class="refMenuItemLegend" style="background-color: ' + color + '" />';
                  }

                  refsHtml += '</div>';
                  refsHtml += '</button>';
                  refsHtml += '</li>';
                }
              }
            }
          refsHtml +=
          '</ul>' +
        '</li>'
      }
      refsHtml +=
      '</ul>'
      //#endregion
    }

    // alert users on search results
    $announce.html(textToRead);
    $('.nav > ul', $reader).attr('id', 'results').attr('role', 'presentation');

    $('.title > div > span', $reader).html(title);
    $('.nav', $reader).html(refsHtml);

    $('.refMenuItem').on('click', (e) => {
      $('.refMenuItem').removeClass('selected');
      $('.rerefMenuItem > .title, .auth, .date').css('pointer-events','none');

      const $target = $(e.currentTarget);
      const refId = $target.data('refid');

      $target.addClass('selected');
      selectReference(refId);
    });

    if (references.length > 0) {
      $($('.refMenuItem')[0]).trigger('click');
    } else {
      selectReference(0);
    }

    handleRisDownloadButtonClick(references);
  }

  /**
   * Gets the reference code id's from the checked items in the reader
   * filter.
   * @returns {{rows: Array, cols: Array}}
   */
  function getReaderFilterSelection() {
    const colIdList = [];
    const rowIdList = [];

    $('.reader-filter .cols li').each((index, col) => {
      const $col = $(col);
      if ($col.attr('class') === 'checked') {
        colIdList.push($col.data('id'))
      }
    });

    $('.reader-filter .rows li').each((index, row) => {
      const $row = $(row);
      if ($row.attr('class') === 'checked') {
        rowIdList.push($row.data('id'))
      }
    });

    return {
      cols: colIdList,
      rows: rowIdList
    };
  }

  /**
   * Creates the reader selector HTML
   * @returns {string}
   */
  function buildReaderFilter(rowIdList, colIdList) {
    const readerTopFilter = csvData.rows[csvData.totalColDepth - 1]
    const readerSideFilter = []

    for (let i = csvData.totalColDepth; i < csvData.rows.length; i++) {
      const row = csvData.rows[i]
      readerSideFilter.push(row[row.length - 1])
    }

    let colParent = readerTopFilter.length === colIdList.length ? 'checked' : 'indeterminate';
    if (colIdList.length === 0) colParent = 'unchecked';

    let html = '<div class="reader-filter">' +
      '<button id="codeFilterClearButton" class="btn">Clear Filters</button>' +
      '<ul>' +
      '<li class="' + colParent + '" data-parent="true" title="' + csvData.rows[0][0].title + '">' +
      checkboxCheckedSvg +
      checkboxUncheckedSvg +
      checkboxIndeterminateSvg +
      ' <span>' + csvData.rows[0][0].title + '</span>' +
      '</li>' +
      '<ul class="cols">';

    for (const item of readerTopFilter)
    {
      const state = colIdList.indexOf(item.id) >= 0 ? 'checked' : 'unchecked';
      html += '<li class="' + state + '" data-id="' + item.id + '" data-parent="false" title="' + item.title + '">' +
        checkboxCheckedSvg +
        checkboxUncheckedSvg +
        checkboxIndeterminateSvg +
        ' <span>' + item.title + '</span>' +
        '</li>';
    }

    let rowParent = readerSideFilter.length === rowIdList.length ? 'checked' : 'indeterminate';
    if (rowIdList.length === 0) rowParent = 'unchecked';

    html += '</ul>';
    html += '<li class="' + rowParent + '" data-parent="true" title="' + csvData.rows[csvData.totalColDepth][0].title + '">' +
      checkboxCheckedSvg +
      checkboxUncheckedSvg +
      checkboxIndeterminateSvg +
      ' <span>' + csvData.rows[csvData.totalColDepth][0].title + '</span>' +
      '</li>';
    html += '<ul class="rows">';

    for (const item of readerSideFilter)
    {
      const state = rowIdList.indexOf(item.id) >= 0 ? 'checked' : 'unchecked';
      html += '<li class="' + state + '" data-id="' + item.id + '" data-parent="false" title="' + item.title + '">' +
        checkboxCheckedSvg +
        checkboxUncheckedSvg +
        checkboxIndeterminateSvg +
        ' <span>' + item.title + '</span>' +
        '</li>';
    }

    html += '</ul>';
    html += '</ul>';
    html += '</div>';
    return html
  }

  /**
   * Builds the reference reader.
   * @param selectedRowIds
   * @param selectedColIds
   */
  function buildReferenceReader(selectedRowIds, selectedColIds) {
    let risDownloadButton = '';

    if (allowRISDownload) {
      risDownloadButton = '<button id="risDownload" class="btn">Download Listed References</button>';
    }

    let readerHtml =
      '<div class="title clearfix">' +
        '<div>' +
        '<button class="btn close" aria-label="Close view records" role="button">X</button>' + 
        '<span></span>' +
        '</div><div>' +
        '<select id="filter-options" class="filter-opts">' +
          '<option class="opt-all" value="1"> All </option>' +
          '<option class="opt-title" value="2"> Title </option>' +
          '<option class="opt-abstract" value="3"> Abstract </option>' +
          '<option class="opt-author" value="4"> Author </option>' +
        '</select>' +
        '<input id="searchFilter" type="text" placeholder="Filter" class="reader-filter" aria-describedby="text-desc" aria-owns="results" aria-hidden="true" aria-activedescendant="">' +
        risDownloadButton +
        '</div>' +
      '</div>' +
      '<div class="content">' +
        buildReaderFilter(selectedRowIds, selectedColIds) +
        '<div class="navTainer">' +
          '<div class="navGroupSelect">' +
            '<label for="sgroup" style="width:70px;display:block;float:left;">Group by: </label>' +
            '<select id="sgroup" class="grouping-opts">' +
            '<option value="none">None</option>' +
            '<option value="segment">Segment</option>' +
            '</select>' +
          '</div>' +
          '<div class="ref-sort-order">' +
            '<label for="RefSortOrder" style="width:70px;display:block;float:left;">Sort by: </label>' +
            '<select id="RefSortOrder">' +
              '<option value="title">Title</option>' +
              '<option value="author">Author</option>' +
              '<option value="date">Date</option>' +
            '</select>' +
          '</div>' +
          '<div class="nav">' +
          '</div>' +
        '</div>' +
        '<div class="read" id="Article" role="region" aria-labeledby="" tabindex="-1"></div>' +
      '</div>';

    $reader.html(readerHtml);

    if (segmentAttributes.length <= 0) {
      $('.navGroupSelect').hide();
    }
  }

  /**
   * Performs the search on the reader.
   * @param event
   * @param references
   * @param $readerFilter
   * @param $filterSelect
   */
  function doReaderSearch(event, references, $readerFilter, $filterSelect) {
    if (event !== null && event.which === -1) return;

    const searchTerm = $readerFilter.val().toLowerCase().trim();
    const filterOption = $filterSelect.val();
    let searchReferences = [];

    if (searchTerm.length <= 0) {
      updateReferenceReader(references);
      return;
    }
    references.forEach((ref) => {
      if (filterOption == 1){   // search across All
        if (Object.keys(ref).indexOf('Abstract') > -1){
          let titleRefs = -1;
          let abstractRefs = -1;
          let authorRefs = -1;
          titleRefs = ref.Title.toLowerCase().indexOf(searchTerm);
          abstractRefs = ref.Abstract.toLowerCase().indexOf(searchTerm);
          authorRefs = ref.Authors.toLowerCase().indexOf(searchTerm);
          if (titleRefs !== -1 || abstractRefs !== -1 || authorRefs !== -1){
            searchReferences.push(ref);
          }
        }
      } else if (filterOption == 2){   // search by Title
        if (Object.keys(ref).indexOf('Title') > -1){
          if (ref.Title.toLowerCase().indexOf(searchTerm) !== -1){
            searchReferences.push(ref);
          }
        }
      } else if (filterOption == 3){   // search by Abstract
        if (Object.keys(ref).indexOf('Abstract') > -1){
          if (ref.Abstract.toLowerCase().indexOf(searchTerm) !== -1){
            searchReferences.push(ref);
          }
        }
      } else if (filterOption == 4){   // search by Author
        if (Object.keys(ref).indexOf('Authors') > -1){
          if (ref.Authors.toLowerCase().indexOf(searchTerm) !== -1){
            searchReferences.push(ref);
          }
        }
      }
    });

    // final line: always do the update
    updateReferenceReader(searchReferences);
  }

  function closeReader() {
    $reader.removeClass('open');
    $veil.removeClass('open');
    $reader.css({display: 'none'});
    $reader.html('');
    readerFocusTrap.deactivate();
  }

  /**
   * Shows the reader for the given row and column id lists.
   * @param rowIdList
   * @param colIdList
   */
  function toggleReader(rowIdList, colIdList) {
    const references = getFilteredReferences(rowIdList, colIdList);
    buildReferenceReader(rowIdList, colIdList);
    updateReferenceReader(references, true);
    const $readerFilter = $('.reader-filter');
    const $filterSelect = $('.filter-opts');

    // autofocus on the input on opening
    $reader.slideDown(function () {
      $("#searchFilter").focus();
    });

    $readerFilter.on('keydown', (e) => {
      doReaderSearch(e, references, $readerFilter, $filterSelect);
    });

    $filterSelect.on('change', (e) => {
      doReaderSearch(null, references, $readerFilter, $filterSelect);
    });

    $('.grouping-opts').on('change', (e) => {
      updateReferenceReader(references);
    });

    $('#RefSortOrder').on('change', (e) => {
      updateReferenceReader(references);
    });

    $('.reader-filter li').on('click', (e) => {
      const $target = $(e.currentTarget);
      const klass = $target.attr('class');
      const isParent = $target.data('parent');
      const newKlass = klass === 'checked' ? 'unchecked' : 'checked';
      $('#codeFilterClearButton').attr('disabled', false);

      $target
        .removeClass(klass)
        .addClass(newKlass);

      if (isParent) {
        $target.next().children().each((index, child) => {
          $(child)
            .removeClass('checked')
            .removeClass('unchecked')
            .addClass(newKlass);
        });
      } else {
        const parent = $target.parent().prev();
        $(parent)
          .removeClass('checked')
          .removeClass('unchecked')
          .addClass('indeterminate');
      }

      const newSelection = getReaderFilterSelection();
      const references = getFilteredReferences(newSelection.rows, newSelection.cols);

      updateReferenceReader(references);
    });

    $('#codeFilterClearButton').on('click', function() {
      const $filterItems = $('.reader-filter li');
      for (const item of $filterItems){
        const $item = $(item);
        if ($item.hasClass('unchecked')){
          // do nothing; already in target state
        } else if ($item.hasClass('checked')){
          $item.removeClass('checked');
          $item.addClass('unchecked');
        } else if ($item.hasClass('indeterminate')){
          $item.removeClass('indeterminate');
          $item.addClass('unchecked');
        }
      }

      $('#codeFilterClearButton').attr('disabled', true);
      const newSelection = getReaderFilterSelection();
      const references = getFilteredReferences(newSelection.rows, newSelection.cols);
      updateReferenceReader(references);
    });

    $reader.css({display: 'block'});
    $veil.addClass('open');
    $reader.addClass('open');
    readerFocusTrap.activate();

    // Close modal on escape key
    $reader.on('keydown', function (event) {
      if (event.key === "Escape") {
        closeReader();
      }
    });

    $('.close', $reader).on('click', () => {
      closeReader();
      $announce.html('View records closed.');
    });
  }

  /**
   * Creates the external url popup.
   * @param dataAxis
   * @param headerId
   * @param pageX
   * @param pageY
   */
  function createExtUrlPopup(dataAxis, headerId, pageX, pageY) {
    const filteredExtUrlAttr = externalURLedAttributes.filter(attr =>
      attr.AttributeId === headerId &&
      attr.AttributeName !== null &&
      attr.AttributeName !== undefined &&
      attr.AttributeName !== '' &&
      ((attr.AttributeDescription !== null &&
        attr.AttributeDescription !== undefined &&
        attr.AttributeDescription !== '') ||
        (attr.ExtURL !== undefined &&
        attr.ExtURL !== null &&
        attr.ExtURL !== '' &&
        attr.ExtType !== undefined &&
        attr.ExtType !== null &&
        attr.ExtType !== '')));
    const popupHasAttributeData = filteredExtUrlAttr.length > 0;

    if (!popupHasAttributeData) return false;

    let popUpHtml = '<div class="overlay-text" data-header-id="' + headerId + '" data-axis="' + dataAxis + '">';

    for (const attribute of filteredExtUrlAttr) {
      popUpHtml += '<h4>' + attribute.AttributeName + '</h4>';

      if (attribute.AttributeDescription !== null &&
        attribute.AttributeDescription !== undefined &&
        attribute.AttributeDescription.length > 0) {
        popUpHtml += '<p>' + attribute.AttributeDescription + '</p>';
      }

      if (attribute.ExtURL !== undefined &&
        attribute.ExtURL !== null &&
        attribute.ExtURL !== '' &&
        attribute.ExtType !== undefined &&
        attribute.ExtType !== null &&
        attribute.ExtType !== '') {
        popUpHtml += '<a class="overlay-link" href="' + attribute.ExtURL + '" target="_blank">' + attribute.ExtType + '</a>';
      }
    }

    popUpHtml += '<p class="text-center text-muted">(click to view records)</p></div>'

    $attributeTooltipContent.html(popUpHtml);
    $attributeTooltip.addClass('show');

    $('.close-tooltip').on('click', (e) => {
      $attributeTooltip.removeClass('show');
    });

    $attributeTooltipContent.on('click', (e) => {
      $attributeTooltip.removeClass('show');

      const $target = $('.overlay-text');
      const headerId = parseInt($target.data('header-id'));
      const axis = $target.attr('data-axis');

      if (axis === 'col') {
        toggleReader([], [headerId]);
      } else if (axis === 'row') {
        toggleReader([headerId], []);
      }
    });

    // dynamically calculate and adjust the elements position to always draw it within the window's bounds
    const overlayHeight = $attributeTooltip.height();
    const overlayWidth = $attributeTooltip.width();
    const pageHeight = $window.height();
    const pageWidth = $window.width();

    let top = pageY;
    let left = pageX;

    if ((overlayWidth + left) > pageWidth) {
      left -= overlayWidth - 10;
    } else {
      left += 10;
    }

    if ((overlayHeight + top) > pageHeight) {
      top -= overlayHeight - 10;
    } else {
      top += 10;
    }

    $attributeTooltip.css({
      top: top,
      left: left
    });

    return true;
  }

  /**
   * Handles the table click to show the reader dialog.
   */
  function handleTableClick() {
    //#region Header Click shows popup
    // when clicking the row (i.e - side headers)
    $('.clickable-row').on('click', (e) => {
      const $target = $(e.currentTarget);
      const headerId = $target.data('id');
      const createdPopup = createExtUrlPopup('row', headerId, e.pageX, e.pageY);

      if (!createdPopup) {
        toggleReader([headerId], []);
      }
    });

    // when clicking the column (i.e - top headers)
    $('.clickable-col').on('click', (e) => {
      const $target = $(e.currentTarget);
      const headerId = $target.data('id');
      const createdPopup = createExtUrlPopup('col', headerId, e.pageX, e.pageY);

      if (!createdPopup){
        toggleReader([], [headerId]);
      }
    });
    //#endregion

    $('.cell').on('click', (e) => {
      const $target = $(e.currentTarget);
      const totalCount = $target.data('totalCount');

      if (totalCount === 0) {
        return;
      }

      let colIds = $target.data('colid');
      let rowIds = $target.data('rowid');

      if (isNaN(colIds)) {
        colIds = colIds.split(',').map(id => parseInt(id));
      } else {
        colIds = [colIds]
      }

      if (isNaN(rowIds)) {
        rowIds = rowIds.split(',').map(id => parseInt(id));
      } else {
        rowIds = [rowIds]
      }

      toggleReader(rowIds, colIds);
    });
  }

  /**
   *  handle the about button click to show the about map reader dialog
   */
  function handleAboutClick() {
    $('.menu-about').on('click', e => {
      let aboutHtml = '<div class="title clearfix">' +
        '<button class="btn close" aria-label="Close about" >X</button> <span>About This Map</span>' +
        '</div>' +
        '<div class="content">' +
        '<div class="read">' + aboutContent + '</div>' +
        '</div>';

      $reader.html(aboutHtml);

      $('.close', $reader).on('click', () => {
        closeReader();
        $announce.html('About this map closed.');
      });

      $reader.css({display: 'block'});
      $veil.addClass('open');
      $reader.addClass('open');
      readerFocusTrap.activate();

      // Close modal on escape key
      $reader.on('keydown', function (event) {
        if (event.key === "Escape") {
          closeReader();
        }
      });

      $announce.html('About this map opened.');
    });
  }

  /**
   *  handle the accessibility button click to show the accessibility dialog
   */
  function handleAccessiblityClick() {
    $('.menu-accessibility').on('click', e => {
      $('.close', $accessibility).on('click', () => {
        $accessibility.removeClass('open');
        $veil.removeClass('open');
        $accessibility.css({display: 'none'});
        accessibilityFocusTrap.deactivate();
        $announce.html('Accessibility closed.');
      });

      $accessibility.css({display: 'block'});
      $veil.addClass('open');
      $accessibility.addClass('open');
      accessibilityFocusTrap.activate();

      // Close modal on escape key
      $accessibility.on('keydown', function (event) {
        if (event.key === "Escape") {
          $accessibility.removeClass('open');
          $veil.removeClass('open');
          $accessibility.css({display: 'none'});
          accessibilityFocusTrap.deactivate();
        }
      });

      $announce.html('Accessibility opened.');
    });
  }

  /**
   * Handles the study submission click to show the information on how to
   * submit a new study to the map.
   */
  function handleStudySubmissionClick() {
    $('.menu-studysubmit').on('click', e => {
      let studySubmitHtml =
      '<div class="title clearfix">' +
        '<button class="btn close" aria-label="Close submit a study" >X</button> <span> Submit a Study </span>' +
      '</div>' +
      '<div class="content">' +
        '<div class="read">' + studySubmissionContent + '</div>' +
      '</div>';

      $reader.html(studySubmitHtml);

      $('.close', $reader).on('click',() => {
        closeReader();
        $announce.html('Submit a study closed.')
      });

      $reader.css({display: 'block'});
      $veil.addClass('open');
      $reader.addClass('open');
      readerFocusTrap.activate();

      // Close modal on escape key
      $reader.on('keydown', function (event) {
        if (event.key === "Escape") {
          closeReader();
        }
      });

      $announce.html('Submit a study opened.');
    });
  }

  /**
   * Makes the headers hide/show.
   */
  function handleExpandClick() {
    const $menuExpand = $('.menu-expand');
    const $topTable = $('table', $topHead);
    const $sideTable = $('table', $sideHead);

    $menuExpand.on('click', e => {

      if ($topTable.find('.collapsed').length > 0 || $sideTable.find('.collapsed').length > 0) {
        alert('You cannot hide the headers when they are collapsed.');
        return;
      }

      $menuExpand.toggleClass('active');
      
      if ($menuExpand.hasClass('active')) {
        $topTable.height('auto');
        $sideTable.width('auto');
        $('.inactive-text').attr('aria-hidden', 'true');
        $('.active-text').attr('aria-hidden', 'false');
      } else {
        $topTable.height(topColHeight);
        $sideTable.width(sideColWidth);
        $('.inactive-text').attr('aria-hidden', 'false');
        $('.active-text').attr('aria-hidden', 'true');
      }

      $('.header, .header-can-hide').slideToggle(200, function () {
          adjustTable();
      });
    });
  }

  /**
   * Toggles fullscreen mode.
   */
  function handleFullscreenClick() {
    const $menuFullscreen = $('.menu-fullscreen');

    $menuFullscreen.on('click', e => {
      toggleFullScreen();
      $menuFullscreen.toggleClass('active');

      if ($menuFullscreen.hasClass('active')) {
        $('.inactive-text').attr('aria-hidden', 'true');
        $('.active-text').attr('aria-hidden', 'false');
      } else {
        $('.inactive-text').attr('aria-hidden', 'false');
        $('.active-text').attr('aria-hidden', 'true');
      }
    });
  }

  /**
   * Toggles reader mode.
   */
  function handleReaderClick() {
    const $menuReader = $('.menu-reader');

    const colIdList = csvData.rows[csvData.totalColDepth - 1].map(item => item.id)
    const rowIdList = []

    for (let i = csvData.totalColDepth; i < csvData.rows.length; i++) {
      const row = csvData.rows[i]
      rowIdList.push(row[row.length - 1].id)
    }

    $menuReader.on('click', e => {
      toggleReader(rowIdList, colIdList);
      $menuReader.toggleClass('active');
    });
  }

  /**
   * Toggles the column collapse.
   * @param miss
   * @param count
   */
  function toggleTopColCollapse(miss, count) {
    const max = miss + count;

    $('.top-head tr').each((rowIndex, row) => {
      if (rowIndex <= 1) return;
      let total = 0;

      $(row).children().each((colIndex, cell) => {
        const $cell = $(cell);
        const colSpan = parseInt($cell.attr('colspan'));
        total += colSpan;

        if (total > miss && total <= max) {
          if (total - 1 === miss) {
            $cell.toggleClass('first');
          }

          if (total - 1 === max) {
            $cell.toggleClass('last');
          }

          $cell.toggleClass('collapsed');
        } else if (total > max) {
          return false;
        }
      });
    });

    buildTableRows();
    adjustTable();

    $pivotBody.trigger('scroll');

    // Update data in the table.
    updateReferenceCounts();
    updateTableDataView();
  }

  /**
   * Toggles the row collapse.
   * @param miss
   * @param count
   */
  function toggleSideColCollapse(miss, count) {
    const max = miss + count;
    let total = 0;

    $('.side-head .level-2').each((index, cell) => {
      const $cell = $(cell);
      const rowSpan = parseInt($cell.attr('rowspan'));
      total += rowSpan;

      if (total > miss && total <= max) {
        if (total - 1 === miss) {
          $cell.toggleClass('first');
        }

        if (total - 1 === max) {
          $cell.toggleClass('last');
        }

        $cell.toggleClass('collapsed')
      } else if (total > max) {
        return false;
      }
    });

    total = 0;

    $('.side-head .level-3').each((index, cell) => {
      const $cell = $(cell);
      const rowSpan = parseInt($cell.attr('rowspan'));
      total += rowSpan;

      if (total > miss && total <= max) {
        if (total - 1 === miss) {
          $cell.toggleClass('first');
        }

        if (total - 1 === max) {
          $cell.toggleClass('last');
        }

        $cell.toggleClass('collapsed')
      } else if (total > max) {
        return false;
      }
    });

    buildTableRows();
    adjustTable();

    $pivotBody.trigger('scroll');

    // Update data in the table.
    updateReferenceCounts();
    updateTableDataView();
  }

  /**
   * Collapse all the rows and columns in the map.
   */
  function collapseAll(){
    if (collapseColumnHeaders)
    {
      const $colHeaders =  $('.level-1')
        .filter(function() {
          return this.colSpan > 1;
        });

      $colHeaders.each((index, cell) => {
        const $cell = $(cell);
        
        $cell.toggleClass('collapsed');
        const count = parseInt($cell.attr('colspan'));
        let miss = 0;

        let $prev = $cell.prev();

        while ($prev.length > 0) {
          try {
            miss += parseInt($prev.attr('colspan'))
            $prev = $prev.prev();
          }
          catch (e) {
            break;
          }
        }

        if (count > 0) {
            toggleTopColCollapse(miss, count);
        }
      });
    }

    if (collapseRowHeaders)
    {
      const $rowHeaders =  $('.level-1').filter(function() {
        return this.rowSpan > 1;
      });

      $rowHeaders.each((index, cell) => {
        const $cell = $(cell);
        $cell.toggleClass('collapsed');

        const count = parseInt($cell.attr('rowspan'));
        let miss = 0;
        $('.side-head .level-1').each((index, otherCell) => {
          const $otherCell = $(otherCell);

          if ($otherCell.text() !== $cell.text()) {
            miss += parseInt($otherCell.attr('rowspan'));
          } else {
            return false;
          }
        });

        if (count > 0) {
            toggleSideColCollapse(miss, count);
        }
      });
    }
  }

  /**
   * Toggles collapsing columns and rows.
   */
  function handleTableRowColCollapse() {
    // Manage column collapse.
    $('.btnColCollapse').on('click', e => {
      const $target = $(e.currentTarget);
      const $cell = $target.parent().parent();
      $cell.toggleClass('collapsed');
      $cell.toggleClass('busy');

      const count = parseInt($cell.attr('colspan'));
      let miss = 0;

      let $prev = $cell.prev();

      while ($prev.length > 0) {
        try {
          miss += parseInt($prev.attr('colspan'))
          $prev = $prev.prev();
        }
        catch (e) {
          break;
        }
      }

      if (count > 0) {
        setTimeout(() => {
          toggleTopColCollapse(miss, count);
          $cell.toggleClass('busy');
        }, 50);
      } else {
        $cell.toggleClass('busy');
      }
    });

    // Manage row collapse.
    $('.btnRowCollapse').on('click', e => {
      const $target = $(e.currentTarget);
      const $cell = $target.parent().parent();
      $cell.toggleClass('collapsed');
      $cell.toggleClass('busy');

      const count = parseInt($cell.attr('rowspan'));
      let miss = 0;

      $('.side-head .level-1').each((index, cell) => {
        const $otherCell = $(cell);

        if ($otherCell.text() !== $cell.text()) {
          miss += parseInt($otherCell.attr('rowspan'));
        } else {
           return false;
        }
      });

      if (count > 0) {
        setTimeout(() => {
          toggleSideColCollapse(miss, count);
          $cell.toggleClass('busy');
        }, 50);
      } else {
        $cell.toggleClass('busy');
      }
    });
  }

  /**
   * Adjusts the table as the window is resized.
   */
  function adjustTable() {
    const bodyWidth = $pivotTable.width() - $sideHead.width();
    const topHeadWrapperCssHeight = $topHead.height();
    const topHeadWrapperCssPaddingLeft = $sideHead.width();
    const topHeadCssWidth = bodyWidth;
    const bodyCssWidth = bodyWidth - 1;
    let sideHeadCssHeight = $window.height() - $topHead.height() - $footer.height() - $menu.height() - 48;
    let bodyCssHeight = sideHeadCssHeight;

    $header = $('.header')

    if ($header.length > 0 && $header.css('display') !== 'none') {
      sideHeadCssHeight = sideHeadCssHeight - $header.height() - 8;
      bodyCssHeight = sideHeadCssHeight;
    }

    $topHeadWrapper.css({
      'height': topHeadWrapperCssHeight,
      'padding-left': topHeadWrapperCssPaddingLeft
    });

    $topHead.css({
      'width': topHeadCssWidth
    });

    $topHeadTable.css({
      'margin-left': '0px'
    });

    $sideHead.css({
      'height': sideHeadCssHeight
    });

    $sideHeadTable.css({
      'margin-top': '0px'
    });

    $pivotBody.css({
      overflow: 'scroll',
      width: bodyCssWidth,
      height: bodyCssHeight
    });

    $pivotBody.scroll(function (e) {
      $topHeadTable.css({
        'margin-left': e.target.scrollLeft * -1
      });

      $sideHeadTable.css({
        'margin-top': e.target.scrollTop * -1
      });
    });
  }

  function UpdateRecordCount() {
    if (!showRecordCount) return;

    const colIdList = csvData.rows[csvData.totalColDepth - 1].map(item => item.id)
    const rowIdList = []

    for (let i = csvData.totalColDepth; i < csvData.rows.length; i++) {
      const row = csvData.rows[i]
      rowIdList.push(row[row.length - 1].id)
    }

    const references = getFilteredReferences(rowIdList, colIdList);
    $recordCount.html('(' + references.length + ')');
  }

  // Call all the methods to initialize the page.
  createSettingsPanel();
  setupStyleSwitch();
  buildTable();
  adjustTable();
  buildLegend();
  handleExpandClick();
  handleFullscreenClick();
  handleReaderClick();
  handleTableRowColCollapse();
  handleAccessiblityClick();

  // Update the record count on first load.
  UpdateRecordCount();

  if(collapseColumnHeaders || collapseRowHeaders) {
    collapseAll();
  }

  if (aboutContent.trim().length === 0) {
    $('.menu-about').hide();
  }
  else {
    handleAboutClick();

    if (aboutPopup) {
      $('.menu-about').trigger('click');
    }
  }

  if (studySubmissionContent.trim().length === 0) {
    $('.menu-studysubmit').hide();
  } else {
    handleStudySubmissionClick();
  }

  // Show the loader.
  const $loader = $('.loader');
  const windowHeight = $window.height() + 200;

  $window.resize(adjustTable);

  // Slide the up after all is done.
  $loader
    .css({
      'top': -windowHeight,
      'bottom': windowHeight
    });

  // Removes the loader after the animation is complete.
  setTimeout(() => {
    $loader.remove();
  }, 2000);
});

  </script>
  <script src="https://unpkg.com/@popperjs/core@2"></script>
  <script src="https://unpkg.com/tippy.js@6"></script>
  <script>
    tippy('[data-tippy-content]');
  </script>
</body>

</html>